data_2m3c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m3c _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -141.11 144.95 35.18 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.514 -0.992 . . . . 0.0 110.543 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.9 tt -135.46 135.03 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 110.147 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.22 128.97 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.414 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.8 140.6 31.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.368 -0.833 . . . . 0.0 109.24 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -125.82 136.07 52.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.711 -1.243 . . . . 0.0 109.343 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -72.41 -38.49 68.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 110.208 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.27 157.68 22.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.068 -1.02 . . . . 0.0 110.122 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 38.1 ptt85 -71.68 -39.91 69.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.013 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.476 ' OD1' ' NH1' ' A' ' 10' ' ' ARG . 88.6 m-20 -78.26 38.13 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.619 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 10' ' ' ARG . 98.1 m-85 53.94 47.14 24.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 109.464 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.57 -158.19 8.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.72 -149.43 49.5 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -73.78 118.73 17.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -1.165 . . . . 0.0 109.221 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -100.73 155.58 17.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -146.0 124.08 12.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.08 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -97.89 121.83 40.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.14 -0.975 . . . . 0.0 109.808 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -122.33 137.79 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 81' ' ' MET . 21.3 ptt? -140.76 10.02 2.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.393 -0.817 . . . . 0.0 108.941 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -144.81 158.81 43.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.993 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 49.4 p30 -46.51 161.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.504 -0.748 . . . . 0.0 109.807 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.502 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 3.6 t -161.66 110.0 1.48 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.6 40.56 1.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 14.1 p30 -177.39 91.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.993 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -98.04 -22.45 16.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.906 . . . . 0.0 108.87 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.55 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 22.3 t-80 -57.93 -42.67 85.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 108.758 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -59.67 -16.65 28.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.741 -0.599 . . . . 0.0 109.841 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -99.98 -47.64 4.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.51 145.95 21.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.261 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 71.3 m-20 -97.34 -7.49 31.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 110.404 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -149.35 149.4 30.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.139 -0.976 . . . . 0.0 108.632 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.551 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 38.9 t -154.55 114.52 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -96.12 -16.55 21.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.716 -0.615 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 t -133.77 142.58 47.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.899 -1.126 . . . . 0.0 110.801 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.97 145.95 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -134.7 121.13 20.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.053 . . . . 0.0 111.278 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.97 117.83 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.67 -32.33 23.67 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.5 t -168.4 151.79 5.64 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.224 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 -165.19 43.06 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -123.74 153.38 40.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.397 -1.061 . . . . 0.0 109.546 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -133.64 133.39 41.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.0 tpt -103.06 122.52 44.82 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.0 m -115.05 146.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.03 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.497 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.0 m-85 -121.82 143.77 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.681 0.753 . . . . 0.0 110.481 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.76 -7.81 58.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.781 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.5 ttm180 -131.21 157.98 41.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p -69.84 155.7 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.962 0.887 . . . . 0.0 111.231 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 m120 71.93 33.5 1.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.377 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.531 ' H ' ' HG ' ' A' ' 78' ' ' SER . 3.0 m-85 61.62 55.22 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.914 -1.116 . . . . 0.0 110.049 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 50.2 mtt -143.73 174.19 11.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.302 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.65 -170.03 47.71 Favored Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.834 -1.166 . . . . 0.0 110.246 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -55.15 119.85 6.11 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -1.059 . . . . 0.0 108.418 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -101.34 132.25 46.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.331 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -124.48 136.39 53.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.995 . . . . 0.0 109.607 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -100.59 116.45 32.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 0.0 109.463 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.51 139.13 42.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 108.556 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.3 ptt180 -113.25 161.38 17.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.054 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 59' ' ' ARG . 39.9 ttp180 -35.17 115.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.509 -0.745 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.09 169.69 31.89 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.45 127.77 53.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.481 -1.011 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -107.04 100.28 31.36 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 39.6 Cg_endo -70.01 -20.11 34.1 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.38 2.053 . . . . 0.0 112.716 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 42.2 m-20 -163.65 138.66 6.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.512 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.5 p90 -148.63 26.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.548 -1.345 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.4 mtt -99.99 -43.62 6.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.933 -1.104 . . . . 0.0 109.176 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -94.61 -22.67 18.02 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.9 m -82.1 -19.41 40.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.669 -0.644 . . . . 0.0 109.835 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 mmt -105.58 -23.35 12.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.98 -1.075 . . . . 0.0 109.012 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.88 51.98 4.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.0 mtp -123.13 -171.48 2.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.044 -1.268 . . . . 0.0 109.639 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 63.4 t30 -145.79 55.99 1.2 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.168 -0.958 . . . . 0.0 109.371 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.0 m-20 150.23 -169.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.551 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -96.69 -167.11 1.5 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.341 -0.849 . . . . 0.0 109.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -88.85 148.69 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -106.74 -11.08 15.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.058 -1.027 . . . . 0.0 108.376 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.781 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.44 172.54 13.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.049 -1.032 . . . . 0.0 110.313 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.1 p -172.09 156.75 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.869 0.842 . . . . 0.0 110.84 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -134.6 139.58 45.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' A' ' 20' ' ' MET . 59.5 ttp -91.43 143.12 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.067 -1.02 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.2 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 108.943 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 63.9 m . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.445 0.641 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -110.76 116.82 31.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -169.4 125.25 0.87 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 108.775 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.406 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 42.8 ttm -107.09 121.02 43.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -95.15 115.63 27.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.0 mt -103.7 147.49 27.18 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.142 0.972 . . . . 0.0 112.55 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.559 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 30.6 m-85 -135.37 127.28 29.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.445 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 50.2 tt0 -61.52 -27.97 68.98 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 111.818 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.881 ' O ' ' OG ' ' A' ' 124' ' ' SER . 5.9 m-70 -109.72 165.67 11.51 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.671 -1.268 . . . . 0.0 111.202 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.7 m -60.52 157.06 14.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 97' ' ' SER . 8.7 t70 81.82 -96.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.8 mmt -163.29 33.09 0.09 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.71 -160.13 31.91 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.313 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 65.0 -149.33 51.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.401 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 76.5 mtm-85 -96.14 139.55 32.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.3 ptt? -96.09 119.48 34.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.195 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 104' ' ' MET . 0.3 OUTLIER -115.62 135.8 53.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.009 -1.057 . . . . 0.0 108.817 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.14 132.19 43.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.02 117.18 20.48 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 74.7 mtp -123.25 13.62 9.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.414 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 42.3 p30 -140.09 -162.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.952 . . . . 0.0 110.176 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 2.0 p30 -87.04 133.22 33.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.73 90.81 37.06 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.434 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.94 -28.09 5.3 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.206 1.938 . . . . 0.0 112.286 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -135.28 84.99 2.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.79 -27.91 66.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.552 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.5 tpt -57.01 -39.73 75.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.59 0.709 . . . . 0.0 109.205 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -84.13 -22.05 31.2 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.012 -1.055 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -79.32 -63.07 1.5 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.58 -1.325 . . . . 0.0 111.633 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -104.6 1.05 29.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.319 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 114' ' ' MET . 17.8 t30 58.87 32.5 22.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.909 -1.119 . . . . 0.0 109.425 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 4.7 ptm -150.32 133.06 15.91 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 53.7 p -116.57 5.93 13.38 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 120' ' ' SER . 53.9 m-20 -130.01 90.99 3.05 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.723 -1.236 . . . . 0.0 112.471 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.654 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -100.95 130.94 47.02 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.059 -1.026 . . . . 0.0 108.554 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -93.89 2.92 56.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 0.0 110.92 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.881 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.9 p -147.83 154.07 39.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.146 -1.596 . . . . 0.0 109.935 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 23.0 t -165.36 163.71 19.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.885 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.554 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 7.0 t60 -152.45 148.15 27.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 65.4 t -115.95 125.35 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.937 0.875 . . . . 0.0 109.252 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 10.0 tpt -72.79 -32.66 65.73 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 172.95 167.15 0.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.827 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.93 -155.19 28.68 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.541 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 89.6 m-70 -135.49 130.12 34.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.552 -0.97 . . . . 0.0 110.184 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -121.42 131.13 53.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.549 -0.719 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 mt -100.86 130.26 46.84 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 34.9 t -109.08 143.45 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.835 -1.166 . . . . 0.0 109.546 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.461 ' OH ' ' OE1' ' A' ' 144' ' ' GLN . 90.4 m-85 -121.04 125.63 47.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.729 -0.607 . . . . 0.0 110.906 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -60.26 -26.09 66.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -121.68 154.0 59.98 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 141' ' ' THR . 20.3 Cg_endo -60.64 -171.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 123.197 2.598 . . . . 0.0 113.676 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m120 46.43 30.32 1.05 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.511 0.672 . . . . 0.0 110.149 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.449 ' H ' ' CB ' ' A' ' 167' ' ' SER . 18.5 m-85 57.69 52.43 8.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.419 -0.801 . . . . 0.0 109.924 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 16.5 p -138.4 166.09 25.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.15 -179.82 33.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -55.33 113.25 1.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -1.026 . . . . 0.0 109.121 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 19.2 tt0 -87.58 141.41 28.63 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.149 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -123.85 133.91 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.541 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 81.1 t80 -95.16 102.28 14.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.517 -0.739 . . . . 0.0 109.763 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.69 120.94 38.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 149' ' ' PRO . 0.9 OUTLIER -104.96 -178.49 0.62 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 148' ' ' ARG . 51.9 Cg_exo -52.39 154.21 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.217 1.944 . . . . 0.0 111.847 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.19 -166.33 14.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.23 136.71 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -1.098 . . . . 0.0 110.44 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.54 143.45 42.38 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.627 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 59.1 mtm180 -130.09 -5.84 4.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.141 -0.974 . . . . 0.0 112.537 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 10.0 t -172.01 -178.45 2.14 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.111 -1.618 . . . . 0.0 110.726 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.5 OUTLIER -60.44 -26.88 67.07 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 156' ' ' ASN . 2.3 m120 -80.19 2.53 23.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.096 -1.002 . . . . 0.0 109.911 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.627 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -93.01 -61.13 1.64 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.167 -0.958 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -78.15 18.0 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.5 38.44 95.76 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -108.65 -160.85 20.07 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.7 t -148.75 -41.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.8 p -102.71 -158.34 0.66 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.4 p -144.36 11.68 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.842 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -63.89 74.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.096 -1.003 . . . . 0.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.47 119.88 39.45 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.248 -0.908 . . . . 0.0 109.772 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.1 -25.98 3.67 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.449 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.94 152.09 51.43 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 119.274 1.537 . . . . 0.0 111.202 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.92 142.69 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.639 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.446 ' NH2' ' OH ' ' A' ' 135' ' ' TYR . 45.3 ttp180 -123.7 136.57 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -96.05 98.08 10.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.548 -0.72 . . . . 0.0 109.4 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.005 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -149.67 147.31 27.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.166 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.405 ' CD1' ' CD2' ' A' ' 43' ' ' PHE . 13.0 tt -133.9 136.79 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 110.09 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.5 mt -122.89 130.69 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.524 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -99.21 135.09 41.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.038 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -120.17 135.2 55.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -73.8 -32.62 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.956 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -81.88 161.58 23.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.8 -44.17 33.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.981 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.68 47.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 51.25 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.539 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.53 -175.74 47.72 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.8 -146.06 23.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -75.82 116.42 16.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.972 -1.31 . . . . 0.0 108.699 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -98.19 157.96 15.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.814 . . . . 0.0 109.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -148.14 122.5 9.67 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.21 -0.931 . . . . 0.0 108.873 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -97.64 120.72 38.53 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -124.43 137.55 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -140.88 11.05 2.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -141.48 155.16 45.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 110.147 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 2.9 p30 -53.26 141.03 24.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.452 -0.78 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 t -138.93 120.45 15.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.97 -4.68 58.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.016 -1.053 . . . . 0.0 109.576 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -140.23 93.98 2.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.2 mt -91.13 -16.29 28.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.178 -0.951 . . . . 0.0 108.494 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -58.95 -39.94 83.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.806 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -59.97 -18.69 47.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.481 -0.762 . . . . 0.0 110.514 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.78 -43.26 8.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -158.86 153.87 25.14 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.325 0.583 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.631 ' H ' HD21 ' A' ' 31' ' ' ASN . 0.7 OUTLIER -100.41 -7.81 23.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -154.04 153.39 31.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.006 -1.059 . . . . 0.0 108.475 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.571 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 46.2 t -155.98 122.78 5.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.593 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 36.9 m-70 -104.63 -12.45 16.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.744 . . . . 0.0 109.94 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 t -136.06 142.27 44.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.974 . . . . 0.0 110.422 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.8 145.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -137.02 116.5 12.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.896 -1.127 . . . . 0.0 111.276 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.58 119.52 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.37 -32.72 22.26 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 108.945 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.0 t -171.24 153.46 3.66 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.244 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.57 -169.05 38.73 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 53.9 m -118.93 156.69 29.09 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.287 -1.125 . . . . 0.0 109.151 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.405 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 10.7 t80 -145.53 134.77 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 108.994 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.61 ' SD ' ' CD2' ' A' ' 146' ' ' TYR . 10.7 ttm -107.24 126.24 52.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.77 143.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.122 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 43.5 m-85 -116.8 139.94 50.02 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.63 0.728 . . . . 0.0 110.863 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 26.3 t0 -76.37 -10.0 59.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.503 -0.748 . . . . 0.0 110.013 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.681 ' O ' ' HB3' ' A' ' 78' ' ' SER . 71.5 mtt-85 -131.61 155.44 47.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 108.525 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.2 p -65.98 158.07 29.19 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.682 0.754 . . . . 0.0 110.953 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 70.73 35.47 1.8 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.094 0.473 . . . . 0.0 111.76 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.496 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.4 m-85 58.58 54.97 5.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.913 -1.117 . . . . 0.0 109.952 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.403 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 83.2 mmm -144.32 178.43 7.92 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.219 -0.925 . . . . 0.0 109.843 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.33 -173.44 53.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -54.91 124.58 17.1 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.157 -1.202 . . . . 0.0 108.427 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -102.74 133.48 47.71 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -126.47 133.58 51.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.19 -0.944 . . . . 0.0 109.36 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -96.9 120.97 38.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.179 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.32 117.33 28.26 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.147 -0.971 . . . . 0.0 111.248 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' O ' ' C ' ' A' ' 60' ' ' ARG . 62.0 ttt-85 -95.33 161.85 13.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 111.302 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 59' ' ' ARG . 47.1 ttp180 -29.33 115.14 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.433 0.635 . . . . 0.0 110.638 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.92 169.49 32.38 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.5 128.44 54.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.483 -1.01 . . . . 0.0 108.997 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -106.7 98.25 20.09 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.403 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 35.3 Cg_endo -67.5 -18.92 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.314 2.01 . . . . 0.0 112.362 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 32.5 m-20 -164.84 139.47 5.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -146.44 3.13 0.87 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.48 -1.387 . . . . 0.0 111.194 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.593 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 30.6 mtp -77.64 -39.93 43.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.13 -21.59 17.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.958 . . . . 0.0 109.42 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.2 m -83.4 -16.34 46.3 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.474 -0.767 . . . . 0.0 109.703 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mmt -109.5 -25.34 10.53 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.91 44.81 8.03 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.262 -0.97 . . . . 0.0 110.977 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.0 mtp -114.71 159.3 20.7 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.272 . . . . 0.0 109.585 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 28.8 p30 -110.4 55.8 0.64 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.101 -0.999 . . . . 0.0 109.302 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.7 p30 152.67 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.571 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.8 p -96.97 -175.09 3.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.066 0.936 . . . . 0.0 110.255 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 78' ' ' SER . 59.7 t -68.09 141.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.27 -17.91 14.16 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.707 -1.245 . . . . 0.0 107.821 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.681 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -145.49 168.85 19.59 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.9 p -161.68 146.22 13.02 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.492 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH1' ' NE ' ' A' ' 148' ' ' ARG . 63.9 ttt180 -132.43 140.3 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.5 tpp -92.36 143.1 26.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.602 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 17.2 mt . . . . . 0 C--N 1.302 -1.48 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 74.6 p . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 121.407 0.622 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -111.96 119.61 39.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.524 -0.735 . . . . 0.0 109.491 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -167.9 129.24 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.3 ttm -117.02 127.66 54.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.325 -0.859 . . . . 0.0 109.269 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -101.06 119.22 38.43 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.9 mt -101.3 149.06 24.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.119 0.961 . . . . 0.0 112.067 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 99' ' ' MET . 38.3 m-85 -132.95 122.94 25.02 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.457 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 52.6 tt0 -62.12 -26.04 68.08 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.195 -0.941 . . . . 0.0 111.828 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.516 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.93 165.4 11.6 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.839 -1.163 . . . . 0.0 110.908 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 6.1 p -63.53 158.18 21.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.8 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 97' ' ' SER . 32.2 t0 81.67 -95.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.543 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 19.9 mmt -161.64 33.56 0.13 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.18 -153.1 26.05 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.019 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.479 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 62.87 -165.57 25.11 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.454 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 79.1 mtm180 -81.01 143.74 32.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.334 . . . . 0.0 108.842 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.4 mtt -98.21 115.45 28.36 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.922 -1.111 . . . . 0.0 109.447 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.3 mpp? -114.42 135.38 54.16 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.109 -0.994 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.56 132.1 45.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.79 115.78 22.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.2 ttt -126.16 13.09 7.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.815 . . . . 0.0 109.399 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -136.71 -167.68 2.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.626 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -81.99 130.9 35.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.69 78.64 15.61 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 109.52 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -78.07 -25.8 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.087 1.858 . . . . 0.0 112.233 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 51.2 p-10 -131.27 75.61 1.66 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -18.54 61.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.93 -1.106 . . . . 0.0 110.41 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.5 tpt -60.88 -42.21 97.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -82.91 -21.51 34.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.382 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -77.21 -62.15 1.75 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.691 -1.256 . . . . 0.0 111.125 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.05 2.68 15.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.489 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 114' ' ' MET . 41.3 m-20 50.85 35.36 12.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.871 -1.143 . . . . 0.0 108.769 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.5 ptm -148.3 135.64 20.44 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 78.6 p -125.91 7.09 7.34 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.478 -0.764 . . . . 0.0 111.015 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 163' ' ' SER . 66.6 m-20 -128.42 85.68 2.37 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.552 -1.342 . . . . 0.0 112.786 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -98.74 134.69 41.29 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.95 -1.094 . . . . 0.0 108.7 177.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.405 ' CD2' ' HG ' ' A' ' 163' ' ' SER . 27.0 m170 -94.45 2.18 55.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.0 111.264 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.5 t -149.92 156.3 41.51 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.156 -1.59 . . . . 0.0 109.846 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.515 ' SG ' ' CZ3' ' A' ' 158' ' ' TRP . 0.1 OUTLIER -162.69 162.16 26.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -147.95 143.36 27.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.143 -0.973 . . . . 0.0 109.89 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.9 t -114.26 121.02 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.286 -0.884 . . . . 0.0 109.359 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 23.1 ttt -70.32 -39.44 74.78 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.565 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 0.5 OUTLIER -179.08 173.66 1.14 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.253 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 86.33 -144.13 19.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.56 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 66.3 m-70 -147.76 128.44 14.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.571 -0.958 . . . . 0.0 109.319 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -124.04 135.42 53.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.118 -0.989 . . . . 0.0 112.478 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.22 134.17 51.45 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 25.4 t -110.06 142.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.05 -1.031 . . . . 0.0 109.233 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 50.9 m-85 -119.13 124.32 46.57 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.618 -0.676 . . . . 0.0 110.762 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.516 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 78.0 tt0 -60.69 -26.62 67.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -119.34 150.98 50.55 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.484 ' O ' ' OG1' ' A' ' 141' ' ' THR . 18.1 Cg_endo -59.75 -177.84 0.15 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.921 2.414 . . . . 0.0 113.398 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.581 ' O ' ' CG ' ' A' ' 140' ' ' TYR . 26.9 m120 52.61 38.61 26.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.384 -0.822 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.581 ' CG ' ' O ' ' A' ' 139' ' ' ASN . 5.7 p90 45.75 57.09 5.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.65 -0.656 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 3.8 p -141.42 172.63 12.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.289 -0.882 . . . . 0.0 110.327 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.46 -173.76 40.85 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.645 -1.284 . . . . 0.0 110.798 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.516 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 70.3 mtm180 -58.19 106.66 0.4 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.605 -0.938 . . . . 0.0 109.432 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 11.9 mt-30 -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.62 0.724 . . . . 0.0 110.184 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -126.85 134.17 50.57 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CD2' ' SD ' ' A' ' 44' ' ' MET . 2.4 t80 -95.3 104.84 16.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.91 121.98 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 108.887 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.533 ' NE ' ' NH1' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -107.26 175.83 1.87 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.71 159.06 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.11 1.874 . . . . 0.0 111.773 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.02 -168.87 12.78 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.2 136.34 54.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -1.017 . . . . 0.0 110.487 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.531 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 17.6 m-85 -110.73 145.55 37.86 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.554 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 35.2 ptt85 -134.5 -3.86 2.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.069 -1.02 . . . . 0.0 112.168 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.579 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 53.8 p -170.17 173.23 5.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.09 -1.631 . . . . 0.0 110.661 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.638 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.77 -21.54 56.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 156' ' ' ASN . 3.1 m120 -80.99 -2.52 48.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.556 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD2' ' N ' ' A' ' 154' ' ' SER . 8.6 m-20 -88.55 -61.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.961 . . . . 0.0 109.274 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.2 p90 -76.59 16.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.19 38.26 94.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.54 -177.85 23.18 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.55 5.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 63.3 p -154.95 -157.32 0.74 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 55.7 m -141.84 12.35 2.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.437 -0.79 . . . . 0.0 110.269 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -64.02 69.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.083 -1.01 . . . . 0.0 112.826 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.2 mtt -100.36 118.83 37.42 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.054 -1.028 . . . . 0.0 110.523 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.74 -25.85 4.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.567 ' HG ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -132.47 153.55 50.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.765 -1.433 . . . . 0.0 110.596 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -150.44 141.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.561 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -122.76 133.89 54.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -98.78 102.74 14.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 171' ' ' ILE . 82.4 mt . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.811 -0.556 . . . . 0.0 111.715 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -148.43 149.24 31.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.324 -1.103 . . . . 0.0 110.892 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 tt -134.67 133.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.6 mt -118.48 130.76 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.61 157.27 16.05 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -144.69 136.35 25.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 108.454 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -80.77 -25.12 38.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.016 -1.052 . . . . 0.0 111.267 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 50.9 t0 -80.54 159.06 25.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.812 -1.18 . . . . 0.0 110.821 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' OG ' ' A' ' 35' ' ' SER . 73.7 ttt180 -61.44 -39.84 92.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.657 -0.652 . . . . 0.0 110.064 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 83.2 m-20 -87.48 -90.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.071 -1.018 . . . . 0.0 109.323 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 57.2 m-85 -158.17 63.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 108.959 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.525 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -152.42 -162.38 10.85 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.18 -149.5 39.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -74.37 117.04 15.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.868 -1.372 . . . . 0.0 108.827 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -104.74 158.81 16.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.466 -0.771 . . . . 0.0 110.101 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -149.72 124.07 9.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.069 -1.019 . . . . 0.0 109.828 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -96.45 118.12 32.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.111 -0.993 . . . . 0.0 109.2 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -114.86 139.03 50.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.3 ptp -138.44 10.78 2.74 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.5 p -143.44 161.79 37.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.666 -0.646 . . . . 0.0 109.605 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 49.8 p30 -60.02 146.02 44.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.0 110.562 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -141.15 111.93 7.09 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.93 -5.38 59.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 109.583 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 38.8 p-10 -138.23 93.94 2.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.057 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.9 mt -94.32 -20.66 19.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -58.44 -40.9 83.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.6 p -57.31 -24.24 53.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.61 -0.682 . . . . 0.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -89.46 -40.37 12.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 108.705 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -159.08 147.35 17.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.601 -0.687 . . . . 0.0 109.701 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -94.06 -9.68 35.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.113 -0.992 . . . . 0.0 110.254 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -152.5 152.23 31.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.048 -1.033 . . . . 0.0 108.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 35' ' ' SER . 7.7 t -154.45 114.6 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -95.17 -7.93 37.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.42 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.513 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 14.9 m -137.78 144.13 41.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.511 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.1 tt -156.85 154.22 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -155.54 144.82 20.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.675 -1.265 . . . . 0.0 111.815 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.55 123.61 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -84.56 -30.51 25.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 108.669 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -166.37 150.29 7.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.88 -142.16 18.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.09 163.02 39.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.63 134.47 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.871 -1.143 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.28 110.66 22.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.9 m -99.8 147.18 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.602 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 42.2 m-85 -121.73 140.6 52.12 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.684 0.754 . . . . 0.0 111.147 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.47 -8.02 55.63 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.764 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.803 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.2 ttt180 -131.38 162.58 29.82 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.0 p -74.15 163.3 28.03 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.976 0.893 . . . . 0.0 111.548 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.8 OUTLIER 64.42 31.93 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.217 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.616 ' CE2' ' NH2' ' A' ' 80' ' ' ARG . 5.0 m-85 63.08 58.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.905 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 86.2 mtp -144.29 171.62 14.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 85.42 -169.39 43.32 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -58.03 121.29 10.26 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 4.5 mp0 -104.51 136.15 44.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 109.207 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -125.77 133.34 52.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.21 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -96.97 122.37 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.388 -0.82 . . . . 0.0 109.281 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 mt -117.04 127.99 54.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.283 -0.885 . . . . 0.0 109.746 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ARG . 35.3 ptt180 -97.52 166.35 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 110.078 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 59' ' ' ARG . 44.4 ttp180 -38.52 112.17 0.21 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.576 -0.702 . . . . 0.0 109.84 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.26 171.85 40.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 47.1 mp0 -111.14 130.33 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.375 -1.074 . . . . 0.0 108.667 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.33 99.67 49.81 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ARG . 58.1 Cg_endo -75.8 -9.35 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.343 2.028 . . . . 0.0 112.725 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 44.2 m-20 -164.28 128.93 2.71 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 22.3 p90 -148.4 34.33 0.79 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.62 -1.3 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 54.5 tpp -102.83 -47.25 4.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.024 -1.047 . . . . 0.0 109.708 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -98.54 -19.52 17.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -78.9 -23.93 44.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.3 mmt -101.35 -30.99 11.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.21 49.72 3.65 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.8 mtp -123.1 143.16 50.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.986 . . . . 0.0 109.695 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.56 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.6 p30 -96.13 54.27 1.43 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.157 -0.964 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.3 m-20 150.55 -168.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.496 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.8 p -97.48 -160.49 0.81 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.489 -0.757 . . . . 0.0 109.714 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -92.13 150.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -110.78 -7.6 14.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.894 -1.129 . . . . 0.0 108.022 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.803 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -146.8 165.14 30.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.913 -1.117 . . . . 0.0 109.452 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.3 p -164.64 149.84 9.89 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.873 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.616 ' NH2' ' CE2' ' A' ' 51' ' ' PHE . 61.6 ttm-85 -138.2 142.84 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 ptm -95.53 151.38 19.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.0 p . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.383 0.611 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -111.05 119.53 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.459 -0.775 . . . . 0.0 109.527 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -171.59 125.59 0.6 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 47.2 ttm -105.38 127.72 53.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.007 -1.058 . . . . 0.0 109.298 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.496 ' HD3' ' HD1' ' A' ' 126' ' ' HIS . 29.9 mtp180 -104.7 115.56 30.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' MET . 10.1 mt -104.49 148.15 26.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.233 1.016 . . . . 0.0 113.06 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.555 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 25.3 m-85 -133.53 125.66 29.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.486 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 70.8 tt0 -62.59 -26.34 68.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 111.955 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.762 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.3 m-70 -109.63 164.18 12.78 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.658 -1.276 . . . . 0.0 110.828 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -61.89 160.63 11.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.406 -0.809 . . . . 0.0 109.219 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.518 ' O ' ' SD ' ' A' ' 99' ' ' MET . 5.7 m-20 80.05 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.6 mmt -162.78 31.72 0.1 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.34 -156.84 30.54 Favored Glycine 0 N--CA 1.491 2.357 0 CA-C-O 122.173 0.874 . . . . 0.0 111.178 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.418 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 64.38 -155.35 46.95 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.41 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 57.9 ttt85 -90.9 140.84 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.162 -1.199 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 44.0 ttp -97.36 114.89 26.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.826 -1.171 . . . . 0.0 109.834 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.7 mtm -113.81 138.79 49.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.138 -0.976 . . . . 0.0 108.656 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.72 138.31 39.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.466 -0.771 . . . . 0.0 109.169 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.49 ' CD1' ' SG ' ' A' ' 110' ' ' CYS . 1.3 tt -137.28 122.61 19.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 108.902 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.519 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 5.8 ttt -123.12 2.73 9.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 110.406 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -122.29 -162.7 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.245 -0.909 . . . . 0.0 110.078 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 42.9 p-10 -91.29 139.51 30.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.49 ' SG ' ' CD1' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -120.83 98.22 47.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -178.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.99 -23.26 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.147 1.898 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -142.25 84.81 1.89 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.946 -1.096 . . . . 0.0 108.337 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.89 -26.99 63.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.083 -1.011 . . . . 0.0 110.074 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.6 tpt -58.59 -40.48 83.32 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 108.715 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -84.1 -23.0 30.93 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 110.619 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -79.12 -62.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.538 -1.351 . . . . 0.0 110.824 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -100.3 2.01 42.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 114' ' ' MET . 28.3 t-20 59.06 30.56 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 110.014 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 9.0 ptm -153.82 138.92 17.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 62.5 m -123.75 5.82 8.8 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.754 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' SER . 37.0 m-20 -128.32 92.43 3.44 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.637 -1.225 . . . . 0.0 113.242 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -104.68 132.97 50.29 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.485 ' CD2' ' OH ' ' A' ' 155' ' ' TYR . 1.1 m-70 -92.01 2.65 56.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.061 . . . . 0.0 111.538 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.762 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.4 p -147.34 153.06 39.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 119.932 -1.73 . . . . 0.0 110.241 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 124' ' ' SER . 35.7 m -157.36 159.04 37.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.482 -0.761 . . . . 0.0 109.481 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.546 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -148.21 141.88 25.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.094 -1.004 . . . . 0.0 108.72 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.546 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 53.3 t -113.25 125.03 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.996 -1.065 . . . . 0.0 109.308 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.466 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.0 ttt -73.8 -28.58 61.72 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.671 0.748 . . . . 0.0 109.118 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m-20 166.85 166.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.828 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.61 -142.67 16.18 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -149.74 129.35 13.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.593 -0.945 . . . . 0.0 109.674 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -124.1 135.76 53.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.767 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.1 mt -105.02 133.09 50.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 43.4 t -111.1 143.0 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.084 -1.01 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.444 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 41.3 m-85 -120.42 124.19 44.86 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.522 -0.736 . . . . 0.0 111.107 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.529 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 54.0 tt0 -58.47 -27.32 64.3 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -119.97 155.2 55.54 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.69 -171.69 0.11 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.31 2.674 . . . . 0.0 113.686 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 47.52 30.5 1.68 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.507 0.67 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.452 ' H ' ' CB ' ' A' ' 167' ' ' SER . 16.3 m-85 56.86 52.62 9.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.488 -0.757 . . . . 0.0 109.54 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.6 m -136.89 164.42 28.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.414 -0.804 . . . . 0.0 109.323 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.429 ' O ' ' OE1' ' A' ' 144' ' ' GLN . . . 98.09 178.51 33.15 Favored Glycine 0 N--CA 1.504 3.177 0 O-C-N 120.886 -1.134 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 136' ' ' GLU . 69.3 mtt85 -53.98 111.42 0.75 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.942 . . . . 0.0 108.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.563 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -86.78 143.53 27.47 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.116 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.12 129.58 49.36 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.549 0.69 . . . . 0.0 109.254 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -90.75 104.0 16.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.55 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 mp -97.98 119.62 36.93 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.854 0.835 . . . . 0.0 109.331 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.458 ' H ' ' HH ' ' A' ' 152' ' ' TYR . 5.0 ptp85 -105.83 177.69 1.3 Allowed Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.01 161.67 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.86 1.707 . . . . 0.0 111.661 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.81 -179.47 18.39 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.32 136.79 49.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -1.009 . . . . 0.0 110.409 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.458 ' HH ' ' H ' ' A' ' 148' ' ' ARG . 16.8 m-85 -112.08 142.82 44.05 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.642 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 7.5 ptp180 -134.86 -4.99 2.45 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.032 -1.042 . . . . 0.0 112.476 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 57.7 m -165.57 165.66 18.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.903 -1.748 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -52.07 -21.08 2.87 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -82.5 2.5 32.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 0.0 109.652 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.642 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 2.4 m-20 -92.88 -61.68 1.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -77.04 16.09 0.6 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.87 37.69 92.42 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.19 -161.93 22.69 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.5 t -146.97 -42.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.3 p -103.82 -155.46 0.53 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.0 t -146.13 11.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -65.09 76.88 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.087 -1.008 . . . . 0.0 112.535 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -102.64 121.56 42.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.129 -0.982 . . . . 0.0 110.155 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.9 -26.88 3.41 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.452 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 1.3 t -135.4 153.49 51.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.602 -1.528 . . . . 0.0 111.249 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 19.7 mt -149.17 143.05 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -123.06 139.99 53.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.966 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 107' ' ' MET . 53.1 ttp180 -98.82 92.52 5.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.444 -0.785 . . . . 0.0 109.293 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 170' ' ' ARG . 88.8 mt . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 89.6 mttt -161.59 145.41 12.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.994 . . . . 0.0 110.604 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.0 tt -134.76 133.67 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 109.691 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.83 128.65 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.409 0.623 . . . . 0.0 109.706 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.26 165.96 14.09 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -152.92 132.61 13.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.602 -1.311 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.59 -43.13 60.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 111.313 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 88.9 m-20 -69.63 155.77 39.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.616 -1.302 . . . . 0.0 110.782 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 64' ' ' PRO . 72.0 mtp180 -62.09 -44.85 95.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.709 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 12' ' ' PHE . 7.8 p30 -74.97 -95.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 109.191 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.504 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 51.0 m-85 -156.02 56.4 0.59 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.494 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -141.81 -150.93 5.44 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 64.71 -153.37 49.76 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -74.83 120.06 19.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -1.125 . . . . 0.0 109.231 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -106.34 156.7 18.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.871 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.626 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 1.1 t60 -146.01 128.39 15.89 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.634 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.28 121.66 41.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 108.696 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.5 m -122.62 136.55 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.21 -0.932 . . . . 0.0 109.534 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -141.58 15.27 2.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.0 t -145.81 158.19 43.87 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.781 0.8 . . . . 0.0 110.503 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.07 143.66 7.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.68 114.76 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.75 8.9 41.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.07 -1.019 . . . . 0.0 108.68 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -138.85 98.17 3.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.852 -0.53 . . . . 0.0 109.779 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.2 mt -106.54 -25.31 11.88 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 31' ' ' ASN . 19.4 t-80 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.417 -0.802 . . . . 0.0 109.002 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.2 m -50.54 -58.71 5.17 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 91.4 m-85 -56.14 -49.25 74.46 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.887 -0.508 . . . . 0.0 111.209 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -155.11 149.21 25.84 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.964 -1.085 . . . . 0.0 110.19 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 27' ' ' HIS . 7.4 t-20 -95.26 -4.74 45.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.384 -0.822 . . . . 0.0 110.344 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -159.91 158.14 30.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.978 . . . . 0.0 108.485 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 14.4 t -159.11 112.89 2.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.905 -1.122 . . . . 0.0 108.419 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.571 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 60.5 m-70 -92.68 1.0 57.51 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.942 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 7.3 t -146.13 141.65 27.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.405 -1.434 . . . . 0.0 110.687 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 tt -151.11 146.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 108.921 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -143.07 133.88 25.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.93 -1.106 . . . . 0.0 111.8 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.7 t -105.04 118.89 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -79.83 -33.49 40.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.891 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -167.79 156.51 9.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.385 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.698 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 86.93 -123.19 6.43 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.698 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 99.1 m -168.64 167.75 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.52 141.05 21.64 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.846 -1.159 . . . . 0.0 109.077 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.2 tpt -99.94 115.06 28.78 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.71 142.06 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.976 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 33.2 m-85 -120.02 137.26 54.2 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.809 0.814 . . . . 0.0 111.298 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.493 ' O ' ' NE ' ' A' ' 77' ' ' ARG . 22.6 t0 -71.75 -5.86 37.11 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.056 ' O ' ' OG ' ' A' ' 78' ' ' SER . 36.2 ttm-85 -131.25 166.82 20.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.418 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 1.8 p -79.92 165.25 22.83 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.751 0.786 . . . . 0.0 110.208 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' C ' ' CG ' ' A' ' 51' ' ' PHE . 43.0 t30 63.63 33.06 13.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.713 -0.617 . . . . 0.0 110.812 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.485 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 0.6 OUTLIER 60.83 61.22 1.7 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.948 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.41 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 64.1 mtp -148.39 166.48 27.97 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.248 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.19 -166.64 30.99 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.029 -1.045 . . . . 0.0 110.582 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -57.76 112.88 1.61 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.246 -1.149 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.37 134.9 35.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.724 -0.61 . . . . 0.0 109.398 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -130.78 137.14 49.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.299 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.664 ' CE2' ' NH2' ' A' ' 169' ' ' ARG . 30.5 p90 -98.93 116.51 31.33 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.381 -0.824 . . . . 0.0 109.779 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -107.38 112.71 25.65 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.668 -1.27 . . . . 0.0 111.473 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 60' ' ' ARG . 14.2 ptm180 -85.96 160.34 19.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.437 -0.789 . . . . 0.0 110.927 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 59' ' ' ARG . 60.1 ttt-85 -35.8 114.91 0.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.646 -0.659 . . . . 0.0 110.012 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.73 166.14 31.52 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.594 -1.289 . . . . 0.0 109.947 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -103.75 128.16 51.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -1.016 . . . . 0.0 108.746 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -117.91 90.05 35.66 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.837 . . . . 0.0 109.414 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 10' ' ' ARG . 31.3 Cg_exo -55.86 -11.11 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.639 2.226 . . . . 0.0 111.973 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -170.25 146.15 2.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 108.78 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 30.9 p90 -150.41 31.61 0.66 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.672 -1.268 . . . . 0.0 109.587 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.571 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 26.1 mtp -102.04 -45.66 5.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 109.213 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -96.36 -20.8 18.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -0.953 . . . . 0.0 109.168 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 p -84.17 -12.08 55.5 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.9 mtt -110.31 -28.17 8.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 108.816 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 56.02 2.85 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -130.43 166.92 19.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.935 -1.332 . . . . 0.0 109.287 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 8.7 m120 -117.09 53.25 0.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.409 -0.807 . . . . 0.0 109.287 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.8 m-20 155.33 -168.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.4 p -98.83 -166.47 1.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.954 0.883 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.3 t -77.18 140.97 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 47' ' ' ASP . 11.8 mtm180 -102.59 -19.78 14.71 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.762 -1.211 . . . . 0.0 108.008 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 1.056 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 1.0 OUTLIER -150.11 160.19 43.84 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.629 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.05 159.15 37.65 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.351 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -146.12 142.5 28.57 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.8 160.76 19.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.155 -0.966 . . . . 0.0 108.924 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.493 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 66.2 mt . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.672 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 89.5 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.149 0.499 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -108.01 113.43 26.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.139 -0.976 . . . . 0.0 109.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -167.5 132.29 1.91 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.254 -0.904 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.492 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 1.6 ttp -116.44 132.6 56.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -106.43 119.22 38.69 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 103' ' ' MET . 18.2 mt -103.73 151.64 22.77 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.074 0.94 . . . . 0.0 112.301 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.4 129.78 31.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 25.9 tt0 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.768 . . . . 0.0 112.217 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 124' ' ' SER . 14.8 m-70 -119.86 163.3 17.72 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.032 -1.667 . . . . 0.0 111.106 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 50.1 m -55.99 157.83 4.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.5 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.577 ' N ' ' HG ' ' A' ' 124' ' ' SER . 1.0 OUTLIER 83.42 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.028 -1.045 . . . . 0.0 109.822 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 2.7 mtt -179.46 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.75 163.01 22.88 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.18 -130.5 10.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.475 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 60.5 mtt85 -104.02 119.7 39.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 108.175 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.521 ' CG ' ' O ' ' A' ' 103' ' ' MET . 12.1 ptt? -90.84 119.05 30.73 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.544 -0.722 . . . . 0.0 110.457 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.4 mpp? -114.79 135.85 53.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.82 133.72 46.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.84 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.66 117.67 25.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 9.6 ttt -125.07 15.45 8.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.496 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 107' ' ' MET . 67.4 m-20 -144.48 -165.01 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 109.895 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 20.9 p-10 -82.96 128.35 34.38 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.33 77.0 53.37 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.694 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.4 -31.96 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.54 2.16 . . . . 0.0 112.045 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -117.45 75.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.1 mt -68.48 -20.73 64.62 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.816 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.4 tpt -59.43 -40.39 86.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.4 -21.79 26.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 110.886 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -75.85 -58.81 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.617 -1.302 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -116.76 0.62 12.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 114' ' ' MET . 51.0 m-20 52.79 34.7 16.89 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 122' ' ' PHE . 2.4 ttt -147.35 134.52 20.49 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 p -134.0 11.0 3.93 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.602 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' SER . 38.5 m-20 -129.28 94.96 3.91 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.665 -1.272 . . . . 0.0 112.808 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.665 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -111.56 136.45 50.74 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -96.3 3.96 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.475 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.577 ' HG ' ' N ' ' A' ' 98' ' ' ASP . 3.6 m -146.8 152.59 39.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.341 -1.474 . . . . 0.0 110.01 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.492 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 53.3 t -161.97 159.7 26.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 110.088 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.431 ' HD1' ' HB3' ' A' ' 151' ' ' GLU . 21.6 t60 -145.91 143.48 29.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 96.5 t -113.78 123.41 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 0.0 109.344 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 23.2 ttt -76.91 -22.82 52.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.668 -0.645 . . . . 0.0 109.941 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.5 OUTLIER 170.91 -171.5 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.742 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 63.09 -135.01 43.11 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.1 m-70 -159.96 138.24 10.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.905 . . . . 0.0 109.066 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -128.51 137.77 51.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 111.635 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.7 mt -104.63 130.34 52.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 39.1 t -109.38 141.39 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.918 -1.114 . . . . 0.0 109.408 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.43 125.68 48.56 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 0.0 110.868 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -61.57 -21.45 64.32 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 141' ' ' THR . 82.0 mt-30 -130.32 138.66 33.54 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 137' ' ' GLN . 88.0 Cg_exo -43.06 -177.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.708 2.939 . . . . 0.0 114.385 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.4 t30 49.16 32.44 4.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.847 -0.533 . . . . 0.0 111.071 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.422 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 43.1 m-85 56.93 49.74 13.47 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.682 -0.637 . . . . 0.0 110.469 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 137' ' ' GLN . 87.4 m -137.05 163.29 31.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.255 -0.903 . . . . 0.0 109.454 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.6 175.02 33.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -49.96 109.78 0.32 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -1.158 . . . . 0.0 108.95 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 145' ' ' PHE . 22.8 tm0? -85.48 142.83 28.92 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.093 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.488 ' O ' ' NE2' ' A' ' 144' ' ' GLN . 54.3 m-85 -128.01 132.47 49.13 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.632 0.73 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.517 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 84.8 t80 -94.15 104.11 16.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.627 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.26 121.41 41.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.198 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -105.07 177.61 1.35 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.419 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 77.5 Cg_exo -46.64 166.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.834 1.689 . . . . 0.0 111.574 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.06 -167.64 12.47 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . 0.431 ' HB3' ' HD1' ' A' ' 126' ' ' HIS . 7.2 pt-20 -120.84 132.36 54.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.662 -0.904 . . . . 0.0 110.933 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 17.2 m-85 -110.68 144.75 39.14 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.605 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 10.6 ptm180 -135.6 0.19 2.7 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.89 -1.131 . . . . 0.0 112.132 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.565 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.3 p -169.31 167.84 9.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.904 -1.747 . . . . 0.0 109.904 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -59.6 -15.24 17.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -85.24 -1.25 56.73 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.605 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 3.7 m-20 -89.79 -62.04 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.555 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 9.9 p90 -73.32 13.28 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 67.94 35.5 84.58 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.15 -165.66 32.56 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 t -151.07 3.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.8 p -150.78 -157.33 0.8 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 25.1 p -141.41 1.21 1.56 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -64.47 77.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.965 -1.084 . . . . 0.0 111.789 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.8 mtt -107.3 115.6 30.46 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 109.125 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.96 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -125.08 144.71 50.27 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.158 1.479 . . . . 0.0 111.079 -178.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.9 mt -147.48 139.51 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.199 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.664 ' NH2' ' CE2' ' A' ' 57' ' ' PHE . 40.4 ttp180 -127.61 138.59 52.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 110.437 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 171' ' ' ILE . 8.4 ptm180 -97.11 92.5 6.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 171' ' ' ILE . 46.5 mt . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -155.74 143.47 19.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -1.055 . . . . 0.0 110.724 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.419 ' CD1' ' CD2' ' A' ' 43' ' ' PHE . 20.5 tt -135.61 135.34 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.203 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.18 122.97 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.691 -0.631 . . . . 0.0 109.338 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -88.84 151.56 22.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 108.652 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -138.07 137.85 38.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 109.387 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -73.5 -43.95 58.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -0.833 . . . . 0.0 110.647 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 60.7 m-20 -81.69 156.77 24.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.838 -1.164 . . . . 0.0 110.535 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -70.71 -37.13 73.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -80.63 35.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 54.55 55.7 7.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.614 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.09 -151.84 5.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 59.85 -147.26 43.97 Favored Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.178 -1.189 . . . . 0.0 110.155 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -77.81 129.77 35.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.396 -1.061 . . . . 0.0 109.084 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -112.47 156.22 22.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.845 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -145.21 123.26 12.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 108.821 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -97.71 118.77 35.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -112.77 136.67 52.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.4 mtp -130.1 6.56 4.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.2 p -149.74 170.98 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 110.156 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 55.8 p30 -63.77 151.12 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 t -143.47 120.64 11.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -6.82 57.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.944 -1.097 . . . . 0.0 109.879 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -140.09 94.28 2.74 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 108.817 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.3 mt -91.06 -19.59 22.99 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.109 -0.994 . . . . 0.0 108.42 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -56.27 -36.53 68.69 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.92 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.1 t -53.57 -56.4 17.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -60.53 -49.67 76.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 0.0 111.065 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -152.93 151.86 30.82 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.111 -0.993 . . . . 0.0 110.503 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -100.14 -7.26 25.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.334 -0.854 . . . . 0.0 110.102 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -152.73 151.46 30.54 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.462 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 43.3 t -157.44 120.41 3.97 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.518 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 18.0 m-70 -102.7 -4.03 25.66 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -137.84 139.33 39.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.795 -1.19 . . . . 0.0 111.063 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.7 mt -132.97 142.94 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -134.47 106.13 6.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.872 -1.143 . . . . 0.0 111.323 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.75 117.09 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -83.37 -31.97 26.45 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.364 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 t -172.23 154.8 3.42 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.168 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.92 -131.66 10.75 Favored Glycine 0 N--CA 1.486 2.007 0 CA-C-O 122.565 1.091 . . . . 0.0 111.47 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.7 m -154.1 152.66 30.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.419 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 11.1 t80 -146.77 139.2 24.92 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.556 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.9 tpt -109.99 123.53 49.81 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.19 145.82 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.916 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.8 m-85 -121.12 141.76 50.5 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.798 0.808 . . . . 0.0 111.224 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 24.5 t0 -76.77 -10.54 59.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.913 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.144 ' O ' ' OG ' ' A' ' 78' ' ' SER . 18.3 ttm180 -127.56 167.39 16.41 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 44.2 p -78.47 159.19 28.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 110.911 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.61 33.4 3.91 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.649 -0.657 . . . . 0.0 110.958 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.484 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.2 m-85 60.38 57.23 2.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.972 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.0 mmt -143.64 173.3 11.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.137 -0.977 . . . . 0.0 110.385 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.98 -162.69 39.18 Favored Glycine 0 N--CA 1.503 3.123 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 59.0 mtp180 -60.48 119.75 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 108.051 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -102.11 133.82 46.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.06 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 66.2 m-85 -123.16 133.67 54.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.059 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -98.18 117.49 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.221 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.3 mt -118.66 117.55 29.25 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.021 -1.05 . . . . 0.0 110.729 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.502 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.6 ptm180 -92.95 164.62 13.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.244 -0.91 . . . . 0.0 110.772 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.502 ' C ' ' O ' ' A' ' 59' ' ' ARG . 34.0 ttp180 -32.12 116.07 0.19 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.638 -0.664 . . . . 0.0 110.727 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.89 167.75 31.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -106.99 130.11 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -1.062 . . . . 0.0 108.925 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -114.31 91.42 23.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.573 -0.705 . . . . 0.0 109.551 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.09 -14.43 23.47 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.641 2.227 . . . . 0.0 112.429 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -169.3 146.34 3.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.897 -1.127 . . . . 0.0 108.088 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 16.6 p90 -148.94 -9.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.505 -1.372 . . . . 0.0 111.725 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.518 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 15.4 mtt -63.62 -39.93 95.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.326 -1.484 . . . . 0.0 110.099 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -92.14 -24.7 19.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.889 -1.132 . . . . 0.0 109.834 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -86.37 -8.88 57.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.527 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.585 ' SD ' ' CD1' ' A' ' 56' ' ' TYR . 19.7 mmt -111.29 -26.11 9.32 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . 80.97 49.24 5.71 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.9 mtp -127.4 154.0 45.55 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.177 -1.19 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 18.7 t-20 -107.01 60.32 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.092 -1.005 . . . . 0.0 109.014 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 7.6 p30 149.55 -169.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.457 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.2 p -98.89 -165.43 1.24 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 109.803 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.51 147.73 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -108.55 -10.9 15.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.716 -1.24 . . . . 0.0 108.154 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 1.144 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 2.5 p -148.34 164.48 33.93 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.92 -1.112 . . . . 0.0 109.696 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.85 151.23 16.11 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.88 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -136.72 140.35 42.58 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.331 0.586 . . . . 0.0 109.492 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.5 ttm -96.33 157.39 15.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.202 -0.936 . . . . 0.0 108.606 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.561 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 77.5 mt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.0 109.933 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.641 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 96.6 p . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.281 0.562 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -112.01 116.57 30.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.818 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -171.39 129.35 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 38.3 ttm -117.94 126.32 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 109.609 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -102.19 120.96 41.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' MET . 13.7 mt -104.17 152.61 21.93 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.31 1.052 . . . . 0.0 112.696 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 99' ' ' MET . 24.6 m-85 -136.88 122.58 19.83 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -59.43 -22.88 62.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.439 -0.788 . . . . 0.0 111.814 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' ' 124' ' ' SER . 4.9 m-70 -114.4 163.73 14.93 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.617 -1.302 . . . . 0.0 111.206 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.9 p -58.78 159.34 6.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 m-20 77.67 -92.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.603 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -169.48 39.05 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.66 -160.62 24.89 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.767 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 68.05 -147.88 48.34 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.87 133.79 38.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.111 -1.229 . . . . 0.0 109.369 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.2 ptt? -93.9 116.58 29.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 0.0 110.469 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 15.4 mtm -118.02 137.5 52.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.256 -0.902 . . . . 0.0 108.633 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -99.36 138.95 35.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 109.459 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.01 118.94 24.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.3 ttt -129.28 14.93 6.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.426 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -139.78 -170.35 2.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.943 . . . . 0.0 109.968 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.42 127.21 31.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.402 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -115.24 85.45 12.77 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.676 -179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.89 -23.64 6.59 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.328 2.019 . . . . 0.0 112.047 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -133.92 87.13 2.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 10.9 mt -75.07 -34.63 61.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.211 -0.931 . . . . 0.0 110.343 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.74 -40.96 76.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -80.66 -23.44 39.67 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.188 -0.945 . . . . 0.0 110.571 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -81.12 -55.23 4.89 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.515 -1.366 . . . . 0.0 111.397 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -106.32 -1.38 23.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.041 -1.037 . . . . 0.0 110.351 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.3 m120 63.29 32.89 14.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.812 -1.18 . . . . 0.0 109.12 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.5 ptm -154.91 137.66 15.29 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.9 t -121.07 9.7 10.59 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.752 -0.592 . . . . 0.0 109.616 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 163' ' ' SER . 16.3 m-20 -135.78 95.54 3.25 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.657 -1.277 . . . . 0.0 113.52 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -105.18 137.4 43.01 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.334 -0.854 . . . . 0.0 108.771 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.66 ' CD2' ' HH ' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -98.38 1.45 46.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 111.345 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 125' ' ' CYS . 5.5 t -146.3 150.12 35.13 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.079 -1.638 . . . . 0.0 109.932 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 124' ' ' SER . 11.2 m -157.0 156.7 33.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.451 ' C ' ' CD2' ' A' ' 126' ' ' HIS . 6.0 t60 -142.3 138.77 31.54 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.004 -1.06 . . . . 0.0 109.067 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.64 126.79 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.05 -1.032 . . . . 0.0 109.56 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.486 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 84.0 mmm -76.58 -26.5 55.11 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.641 ' CB ' ' H ' ' A' ' 88' ' ' SER . 1.4 m-20 165.59 -168.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.97 -173.8 37.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.561 ' NE2' ' CG2' ' A' ' 82' ' ' ILE . 29.9 m170 -116.4 122.31 44.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.997 . . . . 0.0 109.241 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.57 121.01 43.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 111.551 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.8 123.7 40.57 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.0 t -109.87 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.983 -1.073 . . . . 0.0 110.813 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -121.65 123.62 42.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.744 -0.597 . . . . 0.0 110.838 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 30.7 tt0 -58.64 -26.93 64.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 167' ' ' SER . 13.9 mt-30 -119.86 155.55 54.98 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.463 ' O ' ' OG1' ' A' ' 141' ' ' THR . 28.5 Cg_endo -63.11 -174.09 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.028 2.486 . . . . 0.0 113.356 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.0 m120 50.83 31.83 6.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.427 -0.796 . . . . 0.0 110.43 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.416 ' H ' ' CB ' ' A' ' 167' ' ' SER . 40.4 m-85 56.07 51.65 11.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.571 -0.706 . . . . 0.0 110.237 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 12.2 p -140.79 166.13 25.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 0.0 109.779 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.33 173.41 29.86 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -50.65 113.74 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -1.062 . . . . 0.0 108.655 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 13.5 mt-30 -84.0 136.13 34.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.453 -0.779 . . . . 0.0 110.062 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -119.87 125.01 47.47 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.47 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 72.9 t80 -88.07 107.41 18.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.72 124.69 49.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.206 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 149' ' ' PRO . 0.5 OUTLIER -115.32 169.64 6.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 148' ' ' ARG . 3.6 Cg_exo -35.27 160.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.59 2.194 . . . . 0.0 112.127 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.99 -168.31 12.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -118.95 129.87 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.567 -0.96 . . . . 0.0 110.842 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 125' ' ' CYS . 63.1 m-85 -109.14 140.87 42.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.682 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 57.6 mtt85 -131.36 -8.32 3.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 112.694 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.5 m -169.48 177.46 4.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.026 -1.671 . . . . 0.0 111.152 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.66 ' HH ' ' CD2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -60.02 -14.17 15.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.718 . . . . 0.0 109.428 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -91.64 0.97 57.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.12 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.682 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -90.05 -62.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 108.711 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -75.88 16.2 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.14 33.93 88.34 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.36 -161.07 31.41 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.94 -39.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.4 p -103.77 -160.96 0.8 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.1 t -145.18 7.57 1.18 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 136' ' ' GLU . 51.1 ttt-85 -64.39 79.74 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.003 -1.06 . . . . 0.0 111.926 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 60.9 mtt -103.16 116.2 32.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -110.72 -24.41 5.56 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.416 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -134.19 148.83 50.96 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.448 1.624 . . . . 0.0 111.252 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 mt -147.27 142.92 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.07 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -129.61 141.8 50.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.381 -0.825 . . . . 0.0 111.035 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -95.44 88.3 5.05 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.72 0.771 . . . . 0.0 108.992 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 171' ' ' ILE . 57.5 mt . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.434 -0.791 . . . . 0.0 111.607 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.139 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 87.1 mttt -161.16 146.77 14.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.713 -0.875 . . . . 0.0 110.533 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.63 135.87 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.808 . . . . 0.0 109.899 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.6 mt -122.19 127.18 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.699 -0.625 . . . . 0.0 109.788 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -88.95 160.05 17.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -148.2 136.05 20.92 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.82 -1.175 . . . . 0.0 108.731 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -76.69 -39.14 53.02 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 111.114 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -81.73 163.01 22.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.779 -1.201 . . . . 0.0 110.57 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -75.92 -46.65 28.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' C ' HD21 ' A' ' 11' ' ' ASN . 0.4 OUTLIER -80.61 44.13 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.056 -1.028 . . . . 0.0 109.761 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 53.44 70.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.51 -156.4 7.6 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.05 -147.43 44.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -75.01 125.82 29.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -1.191 . . . . 0.0 109.247 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -110.9 153.92 24.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -144.89 125.25 13.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.509 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -97.4 121.65 39.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.0 m -120.43 141.22 50.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 109.599 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -140.92 12.24 2.24 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.0 m -146.01 160.77 41.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.663 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -58.12 148.34 26.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 110.517 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.42 116.53 10.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.33 -4.47 58.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 108.729 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 31.4 p-10 -136.08 99.84 4.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.624 -0.673 . . . . 0.0 109.656 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.2 mt -103.78 -24.62 13.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.286 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.607 ' CE1' HD22 ' A' ' 31' ' ' ASN . 34.5 t-80 -57.74 -40.39 79.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 108.75 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -50.28 -50.33 50.69 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -65.45 -52.12 55.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -0.994 . . . . 0.0 110.916 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.2 150.29 29.68 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.003 -1.06 . . . . 0.0 110.376 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.607 HD22 ' CE1' ' A' ' 27' ' ' HIS . 3.1 m120 -95.81 -5.63 41.35 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.186 -0.946 . . . . 0.0 110.426 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -156.81 155.56 31.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.095 -1.003 . . . . 0.0 108.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.526 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 33.0 t -158.04 117.02 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -97.53 -2.87 40.91 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.724 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.501 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 9.7 t -142.71 149.27 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.759 -1.213 . . . . 0.0 111.161 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 tt -157.35 148.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.08 126.31 18.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.832 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.4 t -102.43 120.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -83.85 -29.04 27.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 109.084 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.59 ' HG ' ' N ' ' A' ' 41' ' ' GLY . 17.2 t -169.78 152.75 4.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.863 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.59 ' N ' ' HG ' ' A' ' 40' ' ' SER . . . 89.93 -122.61 6.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 43' ' ' PHE . 29.8 t -171.47 169.57 6.12 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.583 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -154.6 142.24 19.85 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 108.904 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.8 mmm -102.03 118.11 36.23 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.2 144.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.914 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.489 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 58.8 m-85 -120.43 141.8 49.81 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.754 0.787 . . . . 0.0 111.563 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 29.9 t0 -76.09 -9.76 58.87 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.157 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.752 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.6 ttt180 -127.89 159.74 33.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.463 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 12.6 p -71.81 157.83 37.18 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.729 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 71.09 33.54 2.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.637 -0.664 . . . . 0.0 111.326 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CB ' ' NH2' ' A' ' 80' ' ' ARG . 1.9 m-85 59.59 56.33 3.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 109.757 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.1 mtt -143.49 172.05 13.32 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.48 -165.27 42.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.48 123.89 17.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.114 -1.227 . . . . 0.0 108.304 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 46' ' ' TYR . 6.7 tt0 -108.33 137.51 46.18 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.31 134.84 48.12 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.014 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 20.1 p90 -96.04 120.98 37.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 10.0 mp -111.42 113.52 26.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.059 -1.026 . . . . 0.0 111.532 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.4 ptt180 -86.13 161.08 19.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 111.034 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 59' ' ' ARG . 40.5 ttp85 -37.8 118.62 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.582 0.706 . . . . 0.0 110.365 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.98 178.09 41.29 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.79 129.34 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.09 100.21 53.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.16 -6.01 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.169 1.913 . . . . 0.0 112.619 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 34.4 p-10 -168.71 136.54 2.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.328 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 36.6 p90 -148.93 24.0 0.95 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.596 -1.315 . . . . 0.0 111.298 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.1 mmt -89.13 -39.71 13.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.673 -1.267 . . . . 0.0 108.902 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -99.28 -17.09 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.0 109.458 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 -12.62 45.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.26 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.2 mtt -115.74 -27.62 7.0 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 108.895 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.92 48.37 5.81 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.328 -0.858 . . . . 0.0 111.14 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.0 ttm -120.92 138.54 54.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.932 -1.334 . . . . 0.0 109.819 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.0 t30 -90.7 56.65 3.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.048 -1.033 . . . . 0.0 109.277 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.1 p30 151.79 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.526 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.2 p -98.61 -166.96 1.43 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.927 0.87 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.4 m -81.34 147.3 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.463 ' HB3' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -105.77 -11.51 16.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.752 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -151.47 170.61 19.17 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.787 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 78' ' ' SER . 26.6 p -162.3 146.13 11.91 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.998 0.904 . . . . 0.0 110.4 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.628 ' NH1' ' NH2' ' A' ' 148' ' ' ARG . 41.2 ttm180 -132.83 139.76 47.63 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.3 ttp -94.53 152.42 18.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 24.3 mt . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 108.634 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 80.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.331 0.586 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -121.06 125.84 48.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.186 -0.947 . . . . 0.0 110.4 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.529 ' CE ' ' SD ' ' A' ' 128' ' ' MET . 33.1 ttpt -168.38 129.07 1.28 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.577 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 39.8 ttm -120.17 135.22 55.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 109.088 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -105.74 120.24 41.19 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 103' ' ' MET . 14.8 mt -103.05 149.49 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.156 0.979 . . . . 0.0 112.128 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 99' ' ' MET . 42.0 m-85 -133.8 124.71 27.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 87.7 tt0 -63.7 -26.15 68.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.535 ' O ' ' HB3' ' A' ' 124' ' ' SER . 45.6 m170 -110.38 164.39 12.73 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.602 -1.311 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.8 p -61.19 157.84 15.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 110.046 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 97' ' ' SER . 0.8 OUTLIER 81.4 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.2 mmt -162.57 35.5 0.11 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.33 -153.79 24.03 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.081 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 58.56 177.95 0.87 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.423 ' O ' ' CE ' ' A' ' 104' ' ' MET . 28.2 mmt180 -64.25 136.21 56.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.24 . . . . 0.0 109.273 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.2 ptt? -98.11 122.47 41.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.993 -1.067 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.423 ' CE ' ' O ' ' A' ' 102' ' ' ARG . 3.8 mtm -118.87 138.93 52.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.45 138.5 40.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.616 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 tp -127.84 118.61 24.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.168 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.81 -11.09 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 0.0 109.728 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.32 -159.65 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -0.934 . . . . 0.0 109.86 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.83 137.49 32.28 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -116.06 87.28 18.69 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.338 -0.851 . . . . 0.0 109.578 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.506 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.7 Cg_endo -78.09 -27.06 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.089 1.859 . . . . 0.0 112.249 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -134.16 84.1 2.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.506 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.5 mt -67.94 -26.27 65.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.004 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.4 tpt -57.67 -40.02 78.43 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.272 -0.893 . . . . 0.0 109.074 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -82.85 -23.43 33.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -77.36 -62.36 1.68 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.644 -1.285 . . . . 0.0 110.9 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.492 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.0 m-85 -105.73 4.48 30.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.7 t-20 52.57 32.72 12.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.65 -1.281 . . . . 0.0 107.612 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.453 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 5.4 ttp -147.23 132.01 17.96 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 27.8 t -115.26 4.68 14.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 110.223 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 163' ' ' SER . 14.7 m-20 -132.63 101.08 5.16 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 118.416 -1.314 . . . . 0.0 114.052 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -111.76 135.48 52.32 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -96.1 2.06 52.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 111.388 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.0 t -149.86 156.34 41.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.928 -1.733 . . . . 0.0 110.694 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.577 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 11.1 t -164.29 163.05 22.71 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.243 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.577 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 13.6 t60 -150.07 146.61 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.169 -0.957 . . . . 0.0 109.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.454 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.1 t -115.95 125.02 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 108.96 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.529 ' SD ' ' CE ' ' A' ' 90' ' ' LYS . 17.9 ttt -81.26 -32.55 33.25 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 130' ' ' GLY . 13.6 t70 -174.4 175.0 2.68 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.537 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 77.11 -140.66 25.03 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.633 ' ND1' ' HH ' ' A' ' 146' ' ' TYR . 95.4 m-70 -151.8 135.37 16.18 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.548 -0.971 . . . . 0.0 109.284 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -127.39 133.16 50.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.119 -0.988 . . . . 0.0 112.212 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 mt -106.02 134.45 49.12 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 55.0 t -111.12 144.19 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.985 -1.072 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -122.13 124.02 42.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.619 -0.675 . . . . 0.0 111.124 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.5 tt0 -57.49 -27.41 62.5 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -118.52 155.8 51.81 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.47 -179.64 0.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.271 2.647 . . . . 0.0 113.781 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.601 ' N ' ' OG ' ' A' ' 167' ' ' SER . 13.6 m120 49.82 35.14 8.66 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.696 0.76 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.646 ' H ' ' CB ' ' A' ' 167' ' ' SER . 7.7 m-85 57.33 51.42 10.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.758 -0.589 . . . . 0.0 110.378 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.9 m -136.56 164.25 28.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.57 179.42 36.46 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.03 108.73 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -1.108 . . . . 0.0 108.808 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.516 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 20.8 pt20 -87.52 143.74 27.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.783 0.802 . . . . 0.0 110.46 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -125.2 144.32 50.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.633 ' HH ' ' ND1' ' A' ' 131' ' ' HIS . 39.4 t80 -104.57 103.57 13.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.302 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.2 122.72 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.628 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 5.2 ptp180 -110.83 173.12 3.05 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 148' ' ' ARG . 68.3 Cg_exo -37.29 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.982 1.788 . . . . 0.0 112.113 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 126' ' ' HIS . . . 117.07 -166.16 12.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -123.86 136.91 54.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.335 -1.097 . . . . 0.0 110.631 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 21.2 m-85 -114.31 144.61 42.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.497 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 14.0 ptm180 -133.17 -1.66 3.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.084 . . . . 0.0 112.736 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.557 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 3.7 t -171.07 172.3 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.175 -1.578 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -62.84 -8.19 6.5 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.398 -0.814 . . . . 0.0 109.149 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -92.74 -1.14 57.07 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.172 -0.955 . . . . 0.0 108.819 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 154' ' ' SER . 10.5 m-20 -91.51 -60.08 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.511 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.7 p90 -76.45 16.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.54 40.24 96.0 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -104.56 -165.61 24.46 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.52 -39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.1 p -106.5 -161.41 0.79 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.3 p -137.56 5.62 2.69 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.474 -0.767 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 136' ' ' GLU . 70.5 ttt180 -66.79 75.8 0.11 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.889 -1.132 . . . . 0.0 112.142 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -100.5 116.93 33.6 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.095 . . . . 0.0 109.62 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.19 -25.77 4.9 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.646 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -134.2 151.51 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.361 -1.67 . . . . 0.0 111.562 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mt -146.69 140.95 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.692 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -126.9 144.17 51.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 171' ' ' ILE . 17.1 ptt180 -99.89 91.37 4.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.584 ' C ' ' O ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.994 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -148.26 136.17 20.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.56 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.3 mm -122.46 119.65 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.509 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.1 mt -113.41 117.17 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.205 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.76 132.42 36.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.559 -0.713 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.11 130.19 56.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.739 -1.226 . . . . 0.0 109.889 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.11 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.66 -0.65 . . . . 0.0 109.952 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -80.96 158.43 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 109.703 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -78.86 -37.75 39.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -84.44 43.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.986 . . . . 0.0 109.813 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 52.68 75.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.53 -171.03 34.74 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.25 -148.41 31.19 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -78.39 115.79 18.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 0.0 108.928 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -96.74 156.42 16.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.486 -0.759 . . . . 0.0 109.986 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.621 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.9 t60 -145.14 126.65 15.04 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.154 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -96.62 118.92 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -117.26 133.0 56.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.185 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -138.05 6.18 2.61 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 109.386 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -138.56 150.66 46.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.206 -0.934 . . . . 0.0 110.693 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 36.2 p-10 -47.27 144.92 2.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.46 -0.775 . . . . 0.0 110.034 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 25' ' ' ASP . 42.4 t -144.07 110.85 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.49 -17.32 49.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 108.6 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.457 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 t0 -126.73 100.72 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.5 mt -97.94 -14.48 20.61 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' SER . 18.7 t-80 -59.62 -41.32 90.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' HIS . 21.0 m -50.9 -57.28 8.91 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.621 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 52.6 m-85 -58.97 -53.52 57.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.634 -0.666 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -152.08 150.25 29.72 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.958 -1.089 . . . . 0.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -98.82 -2.18 38.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.834 . . . . 0.0 110.817 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.414 ' CD ' ' HE2' ' A' ' 34' ' ' HIS . 63.8 ttm-85 -161.72 158.36 25.74 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.053 -1.029 . . . . 0.0 108.52 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.554 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 27.9 t -161.35 128.16 3.97 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.414 ' HE2' ' CD ' ' A' ' 32' ' ' ARG . 12.9 m-70 -103.55 -20.64 13.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 109.723 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 t -134.04 146.4 50.32 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.996 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.54 143.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -129.42 113.45 14.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 111.34 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.32 114.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.53 -34.35 41.18 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.105 -0.997 . . . . 0.0 108.976 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 t -171.52 159.39 5.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.902 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.04 179.37 52.84 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.16 158.18 18.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.723 -0.869 . . . . 0.0 109.822 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -147.63 137.34 22.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.812 -1.18 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.6 tpt -107.05 127.83 53.82 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.7 m -118.53 144.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.945 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 33.5 m-85 -120.39 143.22 48.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.712 0.768 . . . . 0.0 111.334 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 28.4 t0 -77.99 -12.18 59.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.723 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.1 ttm180 -126.54 156.41 40.86 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 p -71.4 151.37 44.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.542 -0.724 . . . . 0.0 111.078 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 t30 76.1 36.23 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.814 -0.554 . . . . 0.0 111.22 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 80' ' ' ARG . 7.1 m-85 59.51 56.3 3.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.0 mtt -144.98 173.75 11.61 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.071 -1.018 . . . . 0.0 110.722 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.27 -165.88 45.43 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.32 124.52 20.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -106.85 133.82 50.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.84 137.95 54.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -101.25 116.64 33.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -0.831 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.0 mt -117.49 117.33 29.16 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.004 -1.06 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.521 ' O ' ' C ' ' A' ' 60' ' ' ARG . 37.4 ptt180 -99.67 163.98 12.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.435 -0.791 . . . . 0.0 111.332 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 59' ' ' ARG . 67.5 ttt180 -27.49 111.43 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.465 0.65 . . . . 0.0 110.741 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.69 170.5 36.51 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -107.74 124.86 50.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -105.87 100.46 27.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.12 -18.81 26.94 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.401 2.067 . . . . 0.0 113.221 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.31 140.6 3.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 108.403 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.1 p90 -148.59 29.24 0.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.746 -1.221 . . . . 0.0 110.432 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.4 mmt -98.19 -42.99 7.18 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.095 . . . . 0.0 109.092 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -100.63 -15.9 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 m -86.65 -16.53 36.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.196 -0.94 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.1 mtt -114.57 -28.23 7.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.0 108.621 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.86 52.64 4.03 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.9 mtp -120.91 140.54 51.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -1.03 . . . . 0.0 109.493 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 50.5 t30 -94.29 54.13 1.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.914 -1.116 . . . . 0.0 109.334 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.55 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.554 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.5 p -95.22 -167.25 1.59 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.033 -1.042 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 m -80.78 145.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -104.42 -14.67 15.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.723 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -139.97 165.48 27.22 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.155 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 78' ' ' SER . 12.4 m -161.0 145.9 13.98 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.623 0.725 . . . . 0.0 110.114 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.664 ' NH1' ' HE ' ' A' ' 148' ' ' ARG . 43.0 ttm180 -134.45 137.24 43.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.661 -0.65 . . . . 0.0 109.33 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 52.3 ttp -92.34 152.96 19.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.214 -0.929 . . . . 0.0 109.024 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.177 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.5 m . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.188 0.518 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.85 110.38 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -166.0 130.32 2.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 44.4 ttm -110.9 130.1 55.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 109.217 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.5 HH21 ' CD2' ' A' ' 126' ' ' HIS . 78.2 mtm180 -104.23 113.85 27.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.8 mt -99.37 146.65 26.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.036 0.922 . . . . 0.0 111.98 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 36.5 m-85 -131.52 125.8 33.31 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 62.2 tt0 -63.58 -27.09 69.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.261 -0.899 . . . . 0.0 112.198 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.832 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.7 m-70 -109.24 161.06 15.6 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.488 -1.382 . . . . 0.0 111.674 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 76.8 p -59.48 160.49 6.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.814 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 28.1 t0 81.23 -91.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.01 40.76 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.29 -152.44 11.69 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 64.04 -174.76 11.77 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -73.22 139.45 46.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 8.3 ptp -97.35 117.47 31.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.09 -1.006 . . . . 0.0 110.36 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 104' ' ' MET . 2.8 mpp? -111.81 138.63 48.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -106.57 136.9 45.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.822 . . . . 0.0 109.997 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 tp -130.37 121.91 26.85 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.424 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 11.2 ttt -121.21 6.28 10.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.368 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 107' ' ' MET . 78.4 m-20 -134.99 -163.33 1.36 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.337 -0.852 . . . . 0.0 109.832 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 168' ' ' ILE . 64.0 t0 -86.25 133.33 33.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.533 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -115.19 90.21 23.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.862 . . . . 0.0 109.797 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -78.66 -26.76 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.066 1.844 . . . . 0.0 111.733 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -135.01 86.7 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.533 ' CD2' ' HG ' ' A' ' 110' ' ' CYS . 11.8 mt -67.91 -27.55 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.2 mmt -55.48 -38.18 68.8 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.775 0.798 . . . . 0.0 109.041 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.69 -22.33 26.13 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.167 -0.958 . . . . 0.0 110.927 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.421 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 62.3 ttm-85 -80.51 -60.22 2.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.469 -1.394 . . . . 0.0 111.426 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -108.53 -0.2 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 110.085 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.1 t-20 55.83 34.39 23.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 0.0 108.384 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ptm -152.22 136.8 16.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.2 m -123.75 9.46 8.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.977 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m-20 -131.11 97.73 4.37 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 118.469 -1.292 . . . . 0.0 113.26 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -112.23 137.11 50.8 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.606 ' N ' ' HD1' ' A' ' 123' ' ' HIS . 1.3 m80 -96.17 6.69 48.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 111.147 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.832 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 3.7 p -154.55 158.59 40.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.915 -1.741 . . . . 0.0 110.348 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.1 t -168.62 168.04 11.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.27 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.564 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 17.5 t60 -152.67 148.38 27.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.323 -0.861 . . . . 0.0 109.337 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.451 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 52.9 t -114.93 124.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.73 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 77.9 mmm -74.82 -25.27 58.9 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.508 0.67 . . . . 0.0 109.394 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.8 OUTLIER 167.67 179.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.088 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 131' ' ' HIS . . . 74.94 -137.66 22.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 130' ' ' GLY . 41.2 m80 -153.98 130.51 10.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.623 -0.927 . . . . 0.0 109.185 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -119.5 130.36 55.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.233 -0.917 . . . . 0.0 111.962 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 128.21 51.36 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 48.7 t -111.01 144.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.718 -1.239 . . . . 0.0 111.224 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.74 126.12 48.17 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.833 -0.542 . . . . 0.0 111.249 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.1 -27.54 68.44 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.853 ' O ' ' OG ' ' A' ' 167' ' ' SER . 7.1 mt-30 -120.25 152.87 55.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.96 -175.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.283 2.655 . . . . 0.0 113.523 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m120 49.99 31.82 5.13 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.538 0.685 . . . . 0.0 109.93 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.436 ' OH ' ' OD2' ' A' ' 109' ' ' ASP . 13.9 m-85 56.08 52.68 10.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.103 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 86.9 m -139.57 164.59 29.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.71 177.68 32.36 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -54.08 109.56 0.49 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 108.752 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -86.99 147.02 25.91 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.049 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.81 140.46 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.456 ' HH ' ' CD2' ' A' ' 131' ' ' HIS . 78.3 t80 -101.19 104.73 15.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 109.708 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.44 ' CA ' ' HH ' ' A' ' 152' ' ' TYR . 6.8 mp -99.76 120.5 39.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 0.0 109.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.837 ' N ' ' HH ' ' A' ' 152' ' ' TYR . 4.1 ptt85 -109.48 163.6 16.68 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 148' ' ' ARG . 80.9 Cg_exo -31.78 158.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.801 2.334 . . . . 0.0 112.534 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 126' ' ' HIS . . . 114.72 -166.45 12.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.62 132.54 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.396 -1.061 . . . . 0.0 110.485 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.837 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 84.9 m-85 -105.76 143.1 34.38 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.593 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 63.2 mtm-85 -125.91 -10.86 6.61 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 112.95 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.563 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.7 t -173.65 -179.17 1.76 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.891 -1.756 . . . . 0.0 111.172 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -62.21 -15.26 45.5 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.1 0.05 56.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 108.565 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.593 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -58.53 2.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.716 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.557 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.6 p90 -77.51 13.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.723 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 69.12 39.37 83.65 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -110.09 -161.68 18.64 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.6 t -143.06 -39.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 31.3 p -109.03 -152.28 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.8 p -146.35 9.29 1.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.522 -0.736 . . . . 0.0 109.852 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -65.98 81.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.002 -1.061 . . . . 0.0 111.989 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.8 mtt -105.73 118.18 35.92 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.936 -1.102 . . . . 0.0 109.708 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.33 -24.45 6.2 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.853 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -136.7 152.01 49.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.52 -1.576 . . . . 0.0 111.276 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 16.3 mt -147.62 142.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -128.95 144.6 51.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.46 -0.775 . . . . 0.0 110.662 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 171' ' ' ILE . 19.3 ptt180 -94.6 76.16 3.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.457 -0.777 . . . . 0.0 109.751 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 170' ' ' ARG . 36.5 mt . . . . . 0 N--CA 1.508 2.461 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.487 2.088 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 15.8 ptpt 176.82 157.37 0.3 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.253 -1.145 . . . . 0.0 110.466 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 tt -136.59 135.06 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.529 0.681 . . . . 0.0 110.249 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.7 mt -117.48 124.36 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.644 -0.66 . . . . 0.0 109.412 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.23 161.27 18.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.332 -0.855 . . . . 0.0 108.721 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 29.1 m-85 -147.26 136.46 22.49 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.775 -1.203 . . . . 0.0 108.847 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -76.53 -39.66 52.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.76 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 35' ' ' SER . 49.0 t0 -81.25 138.73 35.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.874 -1.141 . . . . 0.0 110.22 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -59.66 -39.75 85.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.483 -0.76 . . . . 0.0 110.007 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -84.53 41.06 0.82 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 109.564 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 54.29 85.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.525 -0.734 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.51 -159.1 21.46 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -146.49 49.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.65 124.54 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -1.202 . . . . 0.0 109.318 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -109.38 157.08 19.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.408 -0.807 . . . . 0.0 109.804 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.622 ' CE1' ' CE1' ' A' ' 29' ' ' TYR . 5.3 t60 -147.58 125.58 12.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.0 109.777 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -95.12 119.64 33.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 17' ' ' HIS . 6.6 m -119.34 140.95 49.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 109.157 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttt -147.99 11.6 0.95 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.8 t -143.45 155.36 44.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.363 -0.835 . . . . 0.0 110.321 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -50.44 144.03 8.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.696 . . . . 0.0 110.229 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -144.55 116.87 8.48 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 4.67 51.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.009 . . . . 0.0 108.876 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 29.2 p30 -146.28 92.23 2.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.569 -0.707 . . . . 0.0 109.582 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.3 mt -91.18 -19.99 22.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.529 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 11.7 t-80 -56.95 -33.2 66.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 108.825 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.3 t -57.84 -42.93 85.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 17' ' ' HIS . 80.3 m-85 -74.96 -44.17 49.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.864 -1.147 . . . . 0.0 110.308 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.35 152.13 21.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 70.8 m-20 -98.11 -6.11 32.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.347 -0.846 . . . . 0.0 110.071 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -155.12 153.83 31.44 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 39.4 t -157.55 127.86 6.33 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -107.24 -4.48 18.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.709 -0.619 . . . . 0.0 109.627 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.0 p -138.66 139.61 38.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.899 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.75 145.67 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -138.09 114.51 10.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.798 -1.189 . . . . 0.0 111.497 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.13 119.46 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -84.72 -31.06 24.25 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.034 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -172.27 156.62 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.562 -1.255 . . . . 0.0 111.586 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.75 -159.67 46.22 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.0 m -125.3 164.03 21.25 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -1.206 . . . . 0.0 109.251 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 79' ' ' CYS . 11.4 t80 -144.59 133.33 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.998 -1.064 . . . . 0.0 108.761 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.2 tpt -103.16 118.69 37.37 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 m -109.73 142.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.971 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.492 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 35.0 m-85 -117.94 136.64 53.35 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.681 0.753 . . . . 0.0 110.753 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.25 -9.32 58.58 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.127 ' O ' ' OG ' ' A' ' 78' ' ' SER . 53.6 ttt180 -130.17 156.36 44.71 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.4 p -68.23 162.99 23.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.678 0.751 . . . . 0.0 110.964 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 t30 66.91 33.13 6.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.918 -0.488 . . . . 0.0 111.204 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.492 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.9 m-85 58.63 58.58 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.215 -0.928 . . . . 0.0 109.765 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.417 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 55.7 mtt -146.78 175.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.197 -0.94 . . . . 0.0 110.288 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 83.03 -166.33 44.43 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' NH2' ' OH ' ' A' ' 56' ' ' TYR . 77.5 mtp180 -58.26 123.63 16.71 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.221 -1.164 . . . . 0.0 108.024 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 5.8 mp0 -105.41 136.12 45.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.417 ' OH ' ' NH2' ' A' ' 54' ' ' ARG . 83.0 m-85 -128.96 129.72 45.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.534 -0.729 . . . . 0.0 109.749 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 23.1 p90 -92.77 121.73 34.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.131 -0.98 . . . . 0.0 109.039 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.3 mp -113.91 116.85 29.93 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.967 -1.083 . . . . 0.0 111.769 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.9 ttp85 -90.83 158.48 16.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.957 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 59' ' ' ARG . 37.3 ttp180 -30.58 116.09 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.31 0.576 . . . . 0.0 110.744 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.38 168.77 32.66 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -107.32 129.87 54.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -1.022 . . . . 0.0 108.786 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -110.19 100.36 43.7 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.44 -14.16 33.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -170.67 141.47 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.8 p90 -146.71 40.27 1.08 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.653 -1.279 . . . . 0.0 109.805 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.9 mmt -103.21 -48.47 4.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.222 -0.924 . . . . 0.0 109.32 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -100.69 -13.01 18.69 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 69' ' ' THR . 33.3 m -89.98 -15.8 31.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.458 -0.776 . . . . 0.0 109.763 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.4 mtt -117.22 -29.36 5.92 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.41 52.38 3.59 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.445 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.8 mtp -122.88 141.07 52.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.982 -1.305 . . . . 0.0 110.221 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.2 m120 -95.85 55.86 1.66 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 0.0 109.253 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.0 p30 150.56 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.7 p -99.44 -168.61 1.64 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.132 0.967 . . . . 0.0 109.712 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 78' ' ' SER . 27.2 t -77.0 141.46 15.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -106.28 -17.17 14.38 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 1.127 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -145.24 166.68 24.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.295 -0.878 . . . . 0.0 109.48 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 20.9 p -162.44 149.7 13.68 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.921 0.867 . . . . 0.0 110.744 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -129.73 138.9 51.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 ttp -94.6 148.96 21.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.033 -1.042 . . . . 0.0 109.086 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.42 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 71.3 mt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.447 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.2 m . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.42 0.629 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.86 119.78 37.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -170.14 128.59 0.88 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.4 ttm -113.08 126.5 55.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 109.288 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -100.73 117.74 35.43 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 103' ' ' MET . 19.7 mt -101.38 150.29 23.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.389 1.09 . . . . 0.0 112.568 -177.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -131.2 122.23 26.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 76.4 tt0 -62.49 -27.94 69.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 111.374 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.9 m-70 -109.88 164.19 12.82 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.767 -1.208 . . . . 0.0 111.542 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 44.2 m -61.77 159.5 13.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.54 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.548 ' O ' ' CG ' ' A' ' 99' ' ' MET . 5.4 m-20 80.28 -98.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' ASP . 23.2 mtt -163.82 45.49 0.11 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.04 -151.25 10.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 61.67 -171.73 8.75 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 89.0 mtt-85 -73.09 131.82 42.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.933 -1.334 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 25.1 mtm -91.62 120.92 32.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 12.1 mtm -119.41 140.06 51.02 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.145 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -105.85 136.93 44.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.38 120.86 24.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 10.0 ttt -120.69 15.67 11.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.734 . . . . 0.0 109.374 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -144.1 -163.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.875 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.418 ' CG ' ' OH ' ' A' ' 140' ' ' TYR . 47.5 t0 -85.1 133.02 34.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -119.64 84.57 30.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.401 -0.812 . . . . 0.0 109.959 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.89 -29.87 6.48 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.282 1.988 . . . . 0.0 112.131 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.516 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 35.1 p30 -127.5 81.39 2.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.427 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.8 mt -66.72 -24.06 66.19 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 2.6 ttm -60.77 -38.57 85.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.548 0.69 . . . . 0.0 109.57 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -84.13 -20.81 31.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.657 -1.277 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 63.0 ttm-85 -82.22 -58.86 2.76 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.622 -1.299 . . . . 0.0 111.212 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -107.69 0.82 22.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.979 . . . . 0.0 109.807 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 114' ' ' MET . 15.8 t30 60.12 34.17 21.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.0 109.361 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.1 ptm -152.33 137.91 17.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -118.43 8.55 12.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.869 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.46 ' C ' ' OD1' ' A' ' 121' ' ' ASP . 6.5 t0 -134.99 93.77 3.05 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.293 -1.363 . . . . 0.0 113.376 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -103.13 136.76 42.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.418 -0.801 . . . . 0.0 109.106 177.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -97.09 3.21 51.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 111.725 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.6 t -160.25 163.18 33.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.656 -1.902 . . . . 0.0 110.763 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.429 ' N ' ' HG ' ' A' ' 124' ' ' SER . 2.2 p -174.55 178.18 2.0 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 8.4 t60 -154.12 147.68 25.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.484 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 54.6 t -112.83 121.88 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.446 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 12.0 tpt -69.32 -33.98 73.97 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.1 m-20 173.32 166.38 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.433 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 131' ' ' HIS . . . 88.96 -146.32 19.09 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.532 ' CD2' ' OH ' ' A' ' 146' ' ' TYR . 26.9 m80 -141.48 129.05 21.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.906 . . . . 0.0 110.061 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -122.08 131.05 53.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.538 -0.726 . . . . 0.0 111.931 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.2 mt -101.82 130.84 48.35 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.5 t -110.47 142.38 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.913 -1.117 . . . . 0.0 109.81 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.73 125.23 49.18 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.696 -0.627 . . . . 0.0 111.312 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -24.63 63.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 167' ' ' SER . 4.3 mt-30 -126.86 154.47 76.12 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.29 -0.881 . . . . 0.0 109.001 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.14 -173.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 123.161 2.574 . . . . 0.0 113.87 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 139' ' ' ASN . 18.6 t-20 45.89 29.73 0.77 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.468 0.651 . . . . 0.0 110.702 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.418 ' OH ' ' CG ' ' A' ' 109' ' ' ASP . 34.2 m-85 59.21 48.81 9.89 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.093 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 m -131.64 162.24 30.84 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 108.917 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.61 174.52 35.35 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.558 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -54.15 110.58 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.88 -0.776 . . . . 0.0 109.387 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -86.56 145.74 26.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.582 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -127.67 132.07 49.73 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.494 0.664 . . . . 0.0 109.283 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.532 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 70.6 t80 -92.44 107.34 19.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.05 122.06 43.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.683 ' N ' ' HH ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -104.1 178.16 1.24 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -48.26 161.15 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.964 1.776 . . . . 0.0 111.672 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.16 -167.55 12.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.38 133.43 55.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.984 . . . . 0.0 110.455 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.683 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 96.4 m-85 -106.17 136.51 45.74 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.547 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 85.4 mtm-85 -123.86 -14.33 7.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.201 -0.937 . . . . 0.0 112.52 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.578 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 38.9 t -171.32 -177.98 2.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.027 -1.671 . . . . 0.0 110.99 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -63.98 -12.84 41.6 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.778 -0.576 . . . . 0.0 109.555 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -90.03 -1.2 57.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.971 -1.081 . . . . 0.0 108.55 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 154' ' ' SER . 1.1 m-20 -91.05 -60.53 1.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.509 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.2 p90 -76.51 16.84 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.03 38.71 95.75 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -103.78 -161.45 24.87 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.1 t -148.53 -40.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.3 p -103.41 -161.66 0.85 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.444 ' OG ' ' OD2' ' A' ' 121' ' ' ASP . 1.7 p -143.83 7.6 1.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.476 -0.765 . . . . 0.0 110.433 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -69.07 82.92 0.33 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.847 -1.158 . . . . 0.0 111.97 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.4 mtt -105.35 121.29 43.58 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.714 -1.241 . . . . 0.0 110.126 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.4 -25.82 3.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.04 152.03 49.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.653 -1.498 . . . . 0.0 111.388 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.5 mt -148.92 139.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 109.835 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -121.2 133.06 55.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.173 -0.954 . . . . 0.0 110.049 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 171' ' ' ILE . 43.6 ttp180 -92.59 90.69 7.23 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.327 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 170' ' ' ARG . 95.6 mt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.487 2.068 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.569 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 62.0 mttm -163.95 146.03 9.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.525 -0.985 . . . . 0.0 109.553 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mm -124.31 120.08 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.526 -0.734 . . . . 0.0 109.086 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.5 mt -116.05 122.27 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.018 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -94.68 131.84 40.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -119.37 135.17 54.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -77.07 -22.97 52.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 111.218 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.554 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.2 t70 -83.21 150.48 26.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.702 -1.249 . . . . 0.0 110.295 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 45.9 mtt-85 -60.02 -44.49 94.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 31.7 m120 -74.52 -94.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.985 . . . . 0.0 109.29 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 35.0 m-85 -157.26 58.95 0.51 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 108.882 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.554 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -151.64 -150.74 5.42 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.46 -153.78 52.72 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -70.6 119.57 14.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 109.058 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -105.34 156.64 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.0 110.311 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.537 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.0 t60 -147.87 124.94 11.38 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.724 . . . . 0.0 109.216 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -98.36 118.33 34.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.54 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 m -114.45 136.5 52.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.7 ptm -134.71 9.73 3.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 p -147.1 163.06 37.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.451 -0.781 . . . . 0.0 110.555 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 41.9 p-10 -56.89 149.18 19.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.399 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.8 t -142.58 115.24 8.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.5 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.628 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 36.3 p30 -137.84 97.1 3.35 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.58 -19.69 18.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 108.44 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.542 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 19.2 t-80 -58.5 -39.52 80.28 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.288 -0.882 . . . . 0.0 109.266 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -51.03 -57.12 9.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.537 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 89.3 m-85 -58.58 -47.71 83.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.758 -0.589 . . . . 0.0 111.257 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -156.85 150.57 24.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.886 -1.134 . . . . 0.0 110.335 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 68.8 m-20 -97.21 -5.97 35.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.958 -1.089 . . . . 0.0 110.421 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -158.89 156.24 29.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.496 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 21.2 t -158.79 126.52 5.04 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -103.28 -0.78 29.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 3.7 m -146.04 144.23 29.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.513 -1.367 . . . . 0.0 111.152 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -138.44 143.09 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.88 107.31 8.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 0.0 111.051 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.9 114.88 29.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -77.71 -32.81 53.17 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.762 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -178.5 161.04 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.633 -1.227 . . . . 0.0 111.457 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.59 -153.12 21.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.2 m -133.97 153.59 51.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -148.03 141.13 24.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.571 -1.33 . . . . 0.0 109.415 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -108.74 122.16 46.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.9 m -112.53 144.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.404 -0.81 . . . . 0.0 110.093 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.495 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 36.1 m-85 -120.52 138.44 53.84 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.016 0.912 . . . . 0.0 111.375 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.62 -8.21 55.04 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.68 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.802 ' O ' ' HB3' ' A' ' 78' ' ' SER . 38.3 ttt180 -130.9 156.5 44.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.139 -0.976 . . . . 0.0 108.847 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -66.06 156.86 32.6 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.671 0.748 . . . . 0.0 111.402 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.95 33.74 3.4 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.618 -0.676 . . . . 0.0 111.586 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.721 ' H ' ' HG ' ' A' ' 78' ' ' SER . 1.5 m-85 59.84 58.65 2.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.573 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.409 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.7 mtt -145.96 171.16 15.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.988 -1.07 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.58 -165.43 36.93 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 120.657 -1.277 . . . . 0.0 110.566 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.47 121.22 10.97 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -102.67 134.64 45.7 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -126.54 131.48 51.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.686 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -94.76 117.77 30.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.506 -0.746 . . . . 0.0 109.736 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.0 mt -120.56 122.82 41.42 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.143 -0.973 . . . . 0.0 111.112 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.494 ' O ' ' C ' ' A' ' 60' ' ' ARG . 33.4 ptt180 -103.68 168.1 9.36 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.574 0.702 . . . . 0.0 111.058 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.494 ' C ' ' O ' ' A' ' 59' ' ' ARG . 51.6 ttp180 -28.62 110.95 0.05 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.308 0.575 . . . . 0.0 110.911 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.39 31.47 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.533 -1.318 . . . . 0.0 109.957 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -104.41 126.56 51.61 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.408 -1.054 . . . . 0.0 108.422 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.36 96.98 24.18 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 10' ' ' ARG . 44.8 Cg_endo -70.05 -14.22 34.89 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.196 1.931 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -170.72 143.46 2.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 108.331 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.4 p90 -149.28 41.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.627 -1.296 . . . . 0.0 109.667 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.5 mmt -107.13 -46.43 3.9 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.335 -0.853 . . . . 0.0 109.407 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -100.23 -15.09 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -89.46 -14.46 35.3 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -115.37 -30.24 6.31 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.13 5.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.8 mtp -121.88 144.04 49.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.402 . . . . 0.0 109.401 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 81.9 m-20 -96.16 53.65 1.37 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.222 -0.923 . . . . 0.0 109.014 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.4 p30 152.86 -171.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.496 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.4 p -98.76 -168.1 1.59 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.781 0.8 . . . . 0.0 109.938 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 78' ' ' SER . 22.5 t -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 45.2 mmm-85 -106.52 -16.71 14.46 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.755 -1.215 . . . . 0.0 107.898 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.802 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.68 164.3 33.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 109.485 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 26.3 p -161.03 150.64 17.06 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.242 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.43 136.86 39.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.9 ptm -90.62 158.18 17.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.5 mt . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.615 -0.678 . . . . 0.0 110.233 -179.86 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.294 0.568 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.11 114.41 27.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -161.2 123.41 3.05 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.5 tpp -107.99 125.35 51.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.022 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -99.53 111.72 24.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 103' ' ' MET . 20.7 mt -99.79 148.91 23.9 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.881 0.848 . . . . 0.0 112.474 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 99' ' ' MET . 26.1 m-85 -136.72 127.09 26.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.06 -23.55 67.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.402 -0.811 . . . . 0.0 112.386 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.482 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.9 m-70 -113.67 162.28 16.44 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.56 -1.338 . . . . 0.0 111.178 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 77.5 p -58.13 160.3 5.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.527 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 97' ' ' SER . 4.4 m-20 79.51 -90.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.547 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 1.8 mtm -175.37 38.66 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.51 -163.11 23.47 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.416 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 72.23 -146.61 39.64 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -99.39 139.34 35.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -1.198 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 3.6 ptt? -96.96 116.81 29.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.374 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.42 ' CE ' ' SD ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -104.98 137.18 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.126 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -99.1 122.32 42.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 108.666 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.9 tt -133.8 118.83 18.47 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 19.5 ptm -129.72 21.4 5.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 109.257 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.58 ' H ' HD23 ' A' ' 106' ' ' LEU . 22.9 p-10 -133.97 -166.86 1.86 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 37.4 p-10 -86.45 132.81 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 0.0 109.256 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.488 ' SG ' ' CD2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -117.82 89.02 32.44 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.176 -0.952 . . . . 0.0 109.66 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.03 -20.95 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -139.97 85.14 2.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.4 mt -71.27 -26.78 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 110.057 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -56.16 -39.83 72.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.422 -0.799 . . . . 0.0 109.102 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.05 -21.76 29.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -80.32 -59.32 2.75 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.77 -1.207 . . . . 0.0 111.085 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -109.06 0.02 19.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.596 -0.69 . . . . 0.0 110.309 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 114' ' ' MET . 12.5 m120 56.49 32.52 20.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.476 1.131 . . . . 0.0 108.587 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.42 ' SD ' ' CE ' ' A' ' 104' ' ' MET . 9.7 ptm -153.29 137.73 16.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 47.2 m -124.86 11.25 8.36 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.466 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 120' ' ' SER . 52.2 m-20 -130.03 94.88 3.8 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.631 -1.293 . . . . 0.0 113.191 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.88 136.29 49.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -99.23 3.03 46.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 111.281 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.51 ' HG ' ' N ' ' A' ' 125' ' ' CYS . 6.9 t -148.94 154.76 39.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.063 -1.648 . . . . 0.0 110.719 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.8 t -165.31 163.14 20.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 110.312 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.514 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 5.0 t60 -147.66 145.08 28.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.416 -0.803 . . . . 0.0 108.893 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.5 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 67.8 t -113.14 123.2 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 109.808 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 21.1 ttm -77.24 -23.34 51.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.749 -0.594 . . . . 0.0 109.854 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 170.73 178.47 0.06 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.595 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 73.53 -134.22 18.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.7 m-70 -162.07 139.77 8.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.693 -0.886 . . . . 0.0 108.857 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -131.05 142.45 50.3 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.115 -0.991 . . . . 0.0 112.256 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mt -110.59 134.04 52.77 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 46.3 t -112.29 142.54 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.907 -1.12 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -120.25 125.06 47.19 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.53 -26.78 65.62 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 167' ' ' SER . 7.5 mp0 -120.51 153.86 56.53 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.372 -0.83 . . . . 0.0 108.807 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -60.92 -177.94 0.21 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.309 2.673 . . . . 0.0 113.873 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 51.05 33.3 8.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.575 ' N ' ' HG ' ' A' ' 167' ' ' SER . 23.4 m-85 56.46 51.23 11.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.649 -0.657 . . . . 0.0 110.009 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.0 m -136.69 162.7 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.768 -0.582 . . . . 0.0 109.676 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.48 174.07 32.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.8 mmm-85 -51.56 109.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.469 -1.018 . . . . 0.0 108.99 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 21.1 pt20 -87.58 147.28 25.38 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.789 0.804 . . . . 0.0 110.089 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -129.74 143.2 50.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.558 ' OH ' ' CG ' ' A' ' 131' ' ' HIS . 91.8 t80 -103.73 106.85 17.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 109.556 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 mp -100.04 121.13 40.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.383 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.564 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -107.49 168.99 7.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.4 Cg_exo -36.69 164.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.159 1.906 . . . . 0.0 112.0 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.49 -164.23 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -122.84 131.46 53.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.761 -0.847 . . . . 0.0 110.812 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.564 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 23.4 m-85 -109.24 145.83 35.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.6 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 19.0 ptt-85 -137.55 -3.62 1.88 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.789 -1.195 . . . . 0.0 112.41 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.559 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 9.2 m -169.49 167.42 9.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.025 -1.672 . . . . 0.0 109.901 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -57.34 -9.91 1.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 154' ' ' SER . 7.4 t-20 -88.62 -3.64 58.75 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.297 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 5.2 m-20 -89.64 -60.93 1.81 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 109.17 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.56 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 10.0 p90 -73.54 12.36 0.64 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 68.19 34.8 81.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.72 -160.38 30.88 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 t -149.16 -39.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.1 p -106.72 -156.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 18.7 p -139.09 3.24 2.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -63.98 77.11 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.218 -0.926 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.9 mtt -105.15 116.26 31.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.026 -1.046 . . . . 0.0 109.873 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.24 -24.59 5.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.575 ' HG ' ' N ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -130.69 149.33 52.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.59 -1.535 . . . . 0.0 111.286 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.441 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 18.8 mt -148.88 139.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.32 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.81 140.29 52.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.412 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.5 ptt85 -94.79 70.46 3.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 108.977 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.3 mm . . . . . 0 C--N 1.299 -1.593 0 C-N-CA 119.389 -0.925 . . . . 0.0 109.304 179.627 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -147.47 139.74 24.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.523 -0.986 . . . . 0.0 110.202 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 43' ' ' PHE . 7.0 tp -125.72 122.35 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.452 -0.78 . . . . 0.0 109.24 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.4 mt -121.1 126.24 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 109.272 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.94 162.14 14.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.198 -0.939 . . . . 0.0 108.917 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 18.5 m-85 -145.98 135.39 23.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.678 -1.264 . . . . 0.0 108.744 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.71 -46.21 54.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 61.1 m-20 -76.53 148.92 36.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.835 -1.166 . . . . 0.0 110.345 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -64.7 -41.26 96.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.488 -0.758 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -87.18 45.08 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 52.95 90.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.93 -171.06 42.4 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 72.15 -141.63 31.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -83.46 123.61 29.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.967 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -107.77 159.94 16.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 109.765 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -142.63 123.47 14.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 108.921 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.85 121.39 42.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.044 -1.035 . . . . 0.0 109.371 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.46 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.87 140.39 50.04 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.774 0.797 . . . . 0.0 109.379 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 48.4 mtt -131.21 6.97 4.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.1 m -149.47 168.93 22.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -53.9 151.83 6.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.336 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.66 113.18 5.32 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.85 -7.71 39.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.12 -0.988 . . . . 0.0 109.41 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.35 99.19 5.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 mt -110.0 -20.61 12.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.96 . . . . 0.0 108.905 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 33.9 t-80 -61.6 -47.15 86.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.061 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.532 ' HG ' ' N ' ' A' ' 29' ' ' TYR . 99.2 p -49.51 -55.46 13.23 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.532 ' N ' ' HG ' ' A' ' 28' ' ' SER . 84.9 m-85 -56.14 -42.57 77.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.624 -0.673 . . . . 0.0 111.056 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 30.1 p90 -159.58 153.63 23.38 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.99 -1.069 . . . . 0.0 109.901 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.605 ' H ' HD21 ' A' ' 31' ' ' ASN . 0.5 OUTLIER -104.98 -8.49 18.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.218 -0.926 . . . . 0.0 110.718 -178.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -149.37 149.01 30.18 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.992 -1.068 . . . . 0.0 108.734 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 37.0 t -155.3 125.02 6.47 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.422 ' HD1' ' HG3' ' A' ' 67' ' ' MET . 70.7 m-70 -108.51 -9.32 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.035 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.6 p -132.27 137.89 47.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 0.0 110.589 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -134.87 141.92 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.54 ' NE ' ' OE2' ' A' ' 39' ' ' GLU . 29.5 ttp180 -136.27 115.99 13.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.859 -1.151 . . . . 0.0 111.754 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.39 117.24 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 68.6 mm-40 -79.18 -35.39 41.95 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.944 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.7 t -174.31 161.94 3.53 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.903 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 177.83 51.14 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.9 m -98.47 148.79 23.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.952 . . . . 0.0 109.925 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 5.8 t80 -144.3 137.3 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.781 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 146' ' ' TYR . 50.1 mtp -113.23 128.67 56.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 m -114.22 144.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.117 -0.989 . . . . 0.0 109.896 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 31.7 m-85 -121.5 139.93 52.85 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.734 0.778 . . . . 0.0 111.694 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -75.39 -6.59 50.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.558 -0.714 . . . . 0.0 109.473 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.875 ' O ' ' HB3' ' A' ' 78' ' ' SER . 19.6 ttm180 -131.86 158.3 41.69 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.5 p -70.5 158.5 35.96 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.688 0.756 . . . . 0.0 111.131 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 68.44 33.85 3.92 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.307 0.575 . . . . 0.0 111.639 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.468 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 3.3 m-85 60.95 61.25 1.66 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.718 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 82.2 mtp -149.84 172.15 15.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.191 -0.943 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.26 -170.25 44.67 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -54.44 117.35 3.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 107.926 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -101.01 134.61 43.74 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -128.14 128.91 45.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.256 -0.903 . . . . 0.0 109.278 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.99 118.91 25.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.954 -1.091 . . . . 0.0 108.657 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' CD1' ' CZ ' ' A' ' 63' ' ' TYR . 6.3 tp -125.51 118.45 25.81 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.4 ptm180 -108.9 179.84 4.06 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 0.0 111.884 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 59' ' ' ARG . 43.5 ttp180 -31.19 108.12 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.496 0.665 . . . . 0.0 111.004 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.34 158.35 20.86 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.43 127.16 52.84 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 58' ' ' LEU . 71.0 m-85 -116.38 99.84 53.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -76.93 -6.96 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.442 2.095 . . . . 0.0 112.531 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.5 135.25 1.95 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.937 -1.102 . . . . 0.0 108.362 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 23.0 p90 -150.07 32.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.563 -1.336 . . . . 0.0 110.744 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.422 ' HG3' ' HD1' ' A' ' 34' ' ' HIS . 6.3 mmt -97.39 -46.67 5.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.827 -1.17 . . . . 0.0 109.199 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -99.34 -16.79 18.32 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 m -88.91 -20.46 24.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.521 -0.737 . . . . 0.0 109.883 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 72' ' ' MET . 42.4 ttm -107.32 -25.77 11.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.997 -1.064 . . . . 0.0 108.388 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.1 52.72 4.18 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.17 -1.014 . . . . 0.0 110.771 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 70' ' ' MET . 90.9 mtp -128.6 139.92 52.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.349 -1.089 . . . . 0.0 109.832 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 13.4 m120 -98.43 57.46 1.2 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.6 p30 150.91 -173.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 29.5 p -95.96 -174.61 3.16 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.293 1.044 . . . . 0.0 110.481 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 46' ' ' TYR . 40.6 t -78.38 143.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -108.07 -16.77 14.2 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.897 -1.127 . . . . 0.0 108.256 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.875 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.05 159.27 42.54 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.061 -1.024 . . . . 0.0 109.925 178.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.421 ' SG ' HG11 ' A' ' 76' ' ' VAL . 11.0 m -154.74 143.55 20.83 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.37 0.605 . . . . 0.0 110.231 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' CD2' ' A' ' 146' ' ' TYR . 52.7 ttp180 -134.15 138.39 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . 0.408 ' HG2' ' H ' ' A' ' 82' ' ' ILE . 4.2 ttm -99.61 159.88 14.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.076 -1.015 . . . . 0.0 109.869 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 88.0 mt . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.509 2.484 0 CA-C-O 122.074 0.94 . . . . 0.0 113.291 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -126.41 133.58 51.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.449 ' HZ3' ' HE ' ' A' ' 92' ' ' ARG . 63.9 tttm -174.17 123.21 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.1 ttm -117.68 135.62 53.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.449 ' HE ' ' HZ3' ' A' ' 90' ' ' LYS . 89.0 mtt180 -108.94 121.72 45.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 103' ' ' MET . 14.3 mt -106.02 150.48 25.69 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.948 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.406 ' CG ' ' HA ' ' A' ' 99' ' ' MET . 29.9 m-85 -134.58 121.59 21.15 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.083 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 55.5 tt0 -59.03 -26.54 64.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 111.526 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 124' ' ' SER . 39.6 m170 -110.61 162.0 15.17 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.503 -1.373 . . . . 0.0 111.12 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.2 p -59.15 154.35 16.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.754 -0.591 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 7.4 t70 84.24 -90.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -173.94 47.1 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.63 -159.44 12.61 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-O 122.242 0.912 . . . . 0.0 111.157 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.462 ' CA ' ' ND1' ' A' ' 96' ' ' HIS . . . 61.49 -159.5 30.01 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.49 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 98.1 mtt180 -79.21 127.42 32.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.99 -1.3 . . . . 0.0 110.048 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.498 ' C ' ' SD ' ' A' ' 103' ' ' MET . 10.1 tmm? -91.14 122.34 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.2 mtm -123.14 137.91 54.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 108.649 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.25 142.63 34.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.408 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.51 121.28 23.08 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.545 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 9.2 ttt -123.83 21.15 9.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 107' ' ' MET . 54.1 m-20 -145.85 -160.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.419 -0.801 . . . . 0.0 109.407 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 39.4 p-10 -90.03 133.77 34.63 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.564 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.98 80.57 14.95 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.71 -33.01 8.74 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.228 1.952 . . . . 0.0 111.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.45 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 10.6 t30 -126.38 78.97 1.82 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.564 ' CD2' ' HG ' ' A' ' 110' ' ' CYS . 8.3 mt -62.67 -15.31 51.77 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 109.178 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.6 mmt -63.3 -40.98 98.86 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.471 0.653 . . . . 0.0 109.856 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.45 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 82.0 m-20 -85.21 -23.01 28.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.921 -1.112 . . . . 0.0 110.98 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . 0.479 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 49.5 ttm-85 -79.4 -61.04 2.13 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.602 -1.311 . . . . 0.0 111.123 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 118' ' ' ASN . 8.8 m-85 -109.61 0.75 19.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.925 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' MET . 52.1 m-20 48.33 32.79 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.402 ' HG3' ' CE2' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -143.4 126.04 15.96 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -120.53 7.6 10.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.573 -0.704 . . . . 0.0 111.174 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.5 m-20 -135.34 88.96 2.46 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.634 -1.292 . . . . 0.0 112.606 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -101.42 139.45 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.185 -0.947 . . . . 0.0 108.852 177.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.484 ' N ' ' HD1' ' A' ' 123' ' ' HIS . 0.3 OUTLIER -95.11 3.82 54.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 111.244 -179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 5.3 t -152.23 157.54 41.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.148 -1.595 . . . . 0.0 110.327 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 1.5 p -169.47 167.96 9.63 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.755 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 12.7 t60 -149.09 145.91 27.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.449 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.3 t -114.36 125.3 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 108.771 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.406 ' SD ' ' CD2' ' A' ' 126' ' ' HIS . 86.2 mmm -81.66 -32.0 32.04 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.1 p30 178.29 168.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.537 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.71 -152.42 22.45 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.532 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 68.6 m-70 -137.27 123.57 20.61 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.675 -0.897 . . . . 0.0 109.347 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -112.14 122.97 49.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 0.0 112.676 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.93 123.4 43.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 42.9 t -109.15 144.82 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.816 -1.178 . . . . 0.0 110.618 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -124.12 125.8 45.11 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.039 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 68.2 tt0 -64.44 -21.41 66.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.731 -0.606 . . . . 0.0 109.678 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.663 ' O ' ' OG ' ' A' ' 167' ' ' SER . 93.7 mm-40 -127.6 134.0 25.71 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.315 -0.866 . . . . 0.0 109.646 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 137' ' ' GLN . 96.0 Cg_exo -38.86 -177.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 123.808 3.005 . . . . 0.0 114.859 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 50.21 31.04 4.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.81 -0.556 . . . . 0.0 110.899 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 57.59 54.33 6.51 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 0.0 110.435 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 142' ' ' GLY . 94.3 m -144.24 168.97 18.79 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.927 -1.108 . . . . 0.0 110.056 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.436 ' N ' ' CG2' ' A' ' 141' ' ' THR . . . 93.93 -177.01 36.66 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 63.4 mtm180 -56.35 106.74 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -1.08 . . . . 0.0 108.81 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -88.24 147.4 24.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.787 0.803 . . . . 0.0 110.184 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -128.02 141.02 51.63 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.63 0.728 . . . . 0.0 109.345 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.546 ' CD1' ' SD ' ' A' ' 44' ' ' MET . 88.1 t80 -99.02 101.66 13.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.593 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 mp -97.65 120.73 38.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.246 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.497 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -112.0 166.63 10.53 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 148' ' ' ARG . 88.1 Cg_exo -32.3 156.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.5 -169.82 14.2 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -121.23 136.2 55.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.433 -1.039 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.452 ' OH ' ' O ' ' A' ' 148' ' ' ARG . 20.6 m-85 -113.07 145.89 40.11 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.599 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 25.0 ptt180 -136.75 0.64 2.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.933 . . . . 0.0 111.975 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.553 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.0 m -174.2 171.33 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.153 -1.592 . . . . 0.0 110.121 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.8 -17.0 19.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.38 -0.825 . . . . 0.0 109.17 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.08 1.76 46.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.0 -1.063 . . . . 0.0 109.326 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.599 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 9.1 m-20 -93.29 -60.35 1.81 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.439 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.8 p90 -78.12 16.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.76 39.39 93.58 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -107.32 -161.6 21.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.37 -42.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.3 p -109.05 -150.83 0.46 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 26.2 t -147.04 17.62 1.23 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.485 -0.759 . . . . 0.0 109.561 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -67.22 74.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.289 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.8 mtt -103.88 118.02 35.69 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.035 -1.041 . . . . 0.0 108.958 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.38 -25.97 3.87 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.663 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.023 1.412 . . . . 0.0 110.71 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.3 mt -145.67 140.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.749 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -131.37 145.2 51.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.8 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 107' ' ' MET . 0.3 OUTLIER -96.4 74.7 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.9 pt . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.005 -179.447 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.663 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -146.42 161.51 40.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.265 . . . . 0.0 110.73 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 tt -136.26 136.69 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.494 -0.754 . . . . 0.0 109.974 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.2 mt -121.54 125.99 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 109.373 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -90.68 154.12 19.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 11.7 m-85 -138.85 139.42 38.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 109.515 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.82 -33.36 57.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.468 -0.77 . . . . 0.0 111.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 54.5 t0 -77.69 153.91 32.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.916 -1.115 . . . . 0.0 110.328 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 64' ' ' PRO . 96.1 mtt180 -61.84 -50.43 72.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.511 -0.743 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 88.7 m-20 -71.43 -94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.065 . . . . 0.0 109.273 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 52.0 m-85 -157.3 69.76 0.58 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 109.043 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -163.8 -174.32 33.5 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.85 -152.75 23.24 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.506 ' N ' ' CD ' ' A' ' 15' ' ' ARG . 11.2 mpt_? -75.65 125.82 29.79 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.829 -1.394 . . . . 0.0 108.833 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -109.34 157.11 19.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -145.99 123.78 11.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -95.55 117.74 30.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.293 -0.879 . . . . 0.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.8 m -122.0 140.77 52.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.17 -0.956 . . . . 0.0 109.605 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.5 ptm -147.89 14.3 1.04 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.6 p -145.25 159.8 42.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.512 -0.742 . . . . 0.0 110.093 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -51.43 145.82 8.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.51 -0.744 . . . . 0.0 110.041 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 5.1 t -148.27 115.42 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.21 12.31 22.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.118 -0.989 . . . . 0.0 108.798 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.518 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 40.3 p-10 -148.57 90.45 1.79 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.638 -0.664 . . . . 0.0 109.615 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.0 mt -107.14 -28.79 9.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 28' ' ' SER . 47.3 p-80 -63.48 -39.81 95.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 109.029 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 27' ' ' HIS . 18.5 m -55.47 -25.38 36.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.75 -0.594 . . . . 0.0 109.468 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -83.31 -37.11 23.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 17.7 p90 -152.32 151.24 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -95.15 -9.89 32.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 mtt85 -155.7 155.46 33.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.03 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 48.3 t -154.51 123.47 6.3 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -107.51 -4.26 18.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.355 -0.841 . . . . 0.0 110.437 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 t -136.43 140.66 43.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.876 -1.14 . . . . 0.0 110.983 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 91.8 mt -137.22 145.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 32.0 ttp180 -137.81 116.46 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.864 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.19 119.54 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 92.3 mt-10 -84.72 -29.19 25.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.0 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -174.93 159.41 2.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.787 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.94 -162.67 46.86 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.4 t -123.53 153.18 40.95 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.47 -1.018 . . . . 0.0 109.172 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -140.34 135.28 32.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.153 -0.967 . . . . 0.0 109.137 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 ttt -106.37 119.94 40.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.38 143.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.809 -0.757 . . . . 0.0 110.209 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 35.7 m-85 -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 41.7 t0 -74.36 -9.13 58.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.947 -0.47 . . . . 0.0 109.951 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.824 ' O ' ' HB3' ' A' ' 78' ' ' SER . 27.8 ttt85 -131.52 158.19 41.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.9 p -68.45 163.65 22.84 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.78 0.8 . . . . 0.0 111.4 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 65.71 32.13 9.22 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.106 0.479 . . . . 0.0 111.499 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.486 ' CB ' HH21 ' A' ' 80' ' ' ARG . 2.6 m-85 61.0 58.15 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.354 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.406 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.1 mtt -146.04 176.06 9.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.234 -0.917 . . . . 0.0 109.58 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 -172.68 48.36 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -55.94 124.15 16.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -102.47 134.19 46.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.055 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.0 129.27 47.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.496 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.617 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 11.1 p90 -91.19 121.38 32.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.852 . . . . 0.0 108.886 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 10.3 mp -108.77 139.74 43.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 60' ' ' ARG . 33.0 ptt180 -118.8 158.66 25.18 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 59' ' ' ARG . 50.8 ttt-85 -29.92 115.37 0.11 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.285 0.564 . . . . 0.0 110.389 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.29 164.32 26.77 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -104.62 127.43 52.37 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -110.4 97.68 32.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 108.666 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 10' ' ' ARG . 48.9 Cg_endo -71.47 -11.55 28.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.071 1.847 . . . . 0.0 112.348 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 37.5 p-10 -167.27 135.76 2.61 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 15.5 p90 -147.95 20.28 1.13 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.702 -1.249 . . . . 0.0 110.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 42.7 tpp -90.99 -44.92 9.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.683 -1.261 . . . . 0.0 109.504 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -98.45 -20.69 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -76.8 -30.56 56.48 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.046 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.9 mtt -95.08 -39.27 10.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.12 44.88 2.71 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 mmm -111.17 150.73 29.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.73 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.9 m120 -100.45 49.92 0.9 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.083 -1.011 . . . . 0.0 109.244 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.85 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 24.6 p -97.85 -170.22 1.95 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 78' ' ' SER . 46.4 t -78.7 144.38 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -111.17 -15.25 13.72 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.597 -1.314 . . . . 0.0 107.719 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.824 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -143.84 166.26 25.42 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 178.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.1 p -160.16 145.25 14.93 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.403 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.486 HH21 ' CB ' ' A' ' 51' ' ' PHE . 35.6 ttm180 -130.68 136.64 48.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.3 ttp -95.98 149.6 21.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 108.956 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 -179.736 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 54.7 m . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.312 0.577 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.62 ' CG ' ' NE ' ' A' ' 170' ' ' ARG . 10.5 m-85 -112.6 118.47 35.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -0.816 . . . . 0.0 109.496 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -171.18 126.98 0.68 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 49.2 ttm -110.43 125.2 53.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.051 -1.031 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -99.62 118.08 35.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' MET . 16.5 mt -104.52 147.31 27.74 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.191 0.996 . . . . 0.0 112.238 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 99' ' ' MET . 28.2 m-85 -133.64 125.25 28.31 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 86.8 tt0 -62.36 -27.51 69.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.942 . . . . 0.0 111.879 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.2 m-70 -108.95 164.9 12.0 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.539 -1.35 . . . . 0.0 111.145 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 58.2 m -61.55 156.19 20.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 97' ' ' SER . 2.3 m-20 81.6 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.479 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -169.91 41.55 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.68 -157.24 21.29 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.507 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.509 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 60.73 -155.64 33.31 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 79.2 mtp180 -87.49 138.6 31.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 109.836 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.6 ptt? -98.56 123.43 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 110.072 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.68 136.87 54.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.9 137.03 40.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 110.122 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.36 119.07 21.17 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.57 -15.88 12.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.544 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -111.86 -159.06 0.67 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.85 . . . . 0.0 110.352 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.4 139.36 30.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.29 88.33 27.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.459 -0.776 . . . . 0.0 109.297 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.23 -25.76 8.22 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.162 1.908 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -136.57 80.71 1.84 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 12.7 mt -64.54 -28.46 69.66 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.201 -0.937 . . . . 0.0 110.012 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.78 -39.38 73.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.35 -23.03 35.27 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 110.184 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -79.48 -69.11 0.6 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.475 -1.391 . . . . 0.0 110.515 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.8 m-85 -96.07 3.43 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.993 -1.067 . . . . 0.0 110.721 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 114' ' ' MET . 31.4 m-20 52.32 31.85 10.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.563 -1.336 . . . . 0.0 107.514 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.439 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 4.7 ttp -146.47 132.41 19.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 60.2 p -116.13 2.95 13.46 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.507 -0.746 . . . . 0.0 109.801 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 163' ' ' SER . 50.7 m-20 -131.09 113.13 13.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.564 -1.335 . . . . 0.0 111.594 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -123.33 131.77 53.77 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.479 ' N ' ' HD1' ' A' ' 123' ' ' HIS . 2.8 m80 -93.21 1.87 56.9 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.342 -0.848 . . . . 0.0 111.097 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.2 t -147.51 153.81 39.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 119.674 -1.892 . . . . 0.0 110.844 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 50.3 t -162.44 161.42 27.19 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.411 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.451 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 1.9 t-80 -147.63 141.9 26.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.173 -0.955 . . . . 0.0 109.522 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.16 122.17 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 10.4 tpt -71.87 -32.38 67.41 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 88' ' ' SER . 0.9 OUTLIER 170.95 163.2 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.062 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.92 -160.63 29.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -127.97 129.4 46.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.514 -0.992 . . . . 0.0 110.199 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -118.69 126.06 51.07 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.851 0.834 . . . . 0.0 111.91 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.24 125.68 41.95 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 50.5 t -111.23 145.12 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 141' ' ' THR . 94.8 m-85 -124.73 123.1 39.26 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.694 -0.629 . . . . 0.0 111.113 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 164' ' ' ARG . 71.8 tt0 -57.74 -29.36 64.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.838 ' O ' ' OG ' ' A' ' 167' ' ' SER . 5.8 mt-30 -117.27 153.07 49.87 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.415 ' O ' ' OG1' ' A' ' 141' ' ' THR . 19.2 Cg_endo -60.21 -170.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 123.496 2.797 . . . . 0.0 113.774 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 46.61 29.4 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.521 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 58.28 53.99 6.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 110.061 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 135' ' ' TYR . 14.2 p -140.39 168.25 20.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.95 178.21 36.28 Favored Glycine 0 N--CA 1.503 3.15 0 O-C-N 120.737 -1.227 . . . . 0.0 110.6 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -53.39 108.0 0.29 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -86.85 141.93 28.43 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.969 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -126.0 132.46 52.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -92.66 105.3 17.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.015 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.5 mp -98.35 120.17 38.31 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 109.121 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -105.02 178.73 1.07 Allowed Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -49.42 161.58 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.679 1.586 . . . . 0.0 111.64 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.51 -173.88 14.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.75 135.46 54.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.744 -0.857 . . . . 0.0 110.658 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 18.1 m-85 -112.75 143.83 43.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.575 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 41.1 ptt85 -135.12 -1.39 2.65 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.015 -1.053 . . . . 0.0 112.159 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.551 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 1.6 t -171.77 168.19 6.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 119.896 -1.752 . . . . 0.0 109.924 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -57.6 -14.6 5.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -85.82 0.01 54.13 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.231 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.4 m-20 -92.52 -59.66 2.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.529 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.7 p90 -76.78 18.14 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.23 37.82 95.06 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -102.49 -166.04 26.43 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.0 t -144.66 -40.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.6 p -107.03 -159.87 0.71 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.5 t -138.42 11.09 2.76 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 109.497 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 136' ' ' GLU . 85.6 mtt-85 -69.49 75.6 0.4 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.016 -1.053 . . . . 0.0 112.988 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 mtt -100.05 122.8 43.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.139 -0.976 . . . . 0.0 110.247 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.93 -28.5 2.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.838 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -132.85 148.5 52.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.421 -1.635 . . . . 0.0 111.2 -179.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.5 mt -144.84 140.7 23.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.328 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -125.86 143.83 50.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.304 -0.873 . . . . 0.0 110.349 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.62 ' NE ' ' CG ' ' A' ' 89' ' ' PHE . 29.5 ttt180 -97.72 85.48 3.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 171' ' ' ILE . 13.9 mt . . . . . 0 N--CA 1.503 2.197 0 O-C-N 121.747 -0.596 . . . . 0.0 112.372 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -151.9 135.61 16.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.01 117.16 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -115.0 124.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.888 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.84 159.25 15.88 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 14.3 m-85 -146.25 135.1 22.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.564 -1.335 . . . . 0.0 109.038 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.54 -42.52 58.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.123 -0.985 . . . . 0.0 111.069 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.497 ' O ' ' OG ' ' A' ' 35' ' ' SER . 12.6 t70 -81.21 151.19 28.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.889 -1.132 . . . . 0.0 110.542 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.49 -40.59 95.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 110.068 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.94 39.49 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.699 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 53.16 59.76 4.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 109.563 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.7 -154.44 6.14 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -145.63 49.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -77.7 123.41 26.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -1.085 . . . . 0.0 108.967 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -109.56 156.08 20.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.478 -0.764 . . . . 0.0 109.953 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 34.4 t60 -142.64 124.85 15.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 109.27 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -99.91 119.83 38.83 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.879 . . . . 0.0 109.575 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.37 139.72 50.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.5 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.513 ' O ' ' SD ' ' A' ' 20' ' ' MET . 0.8 OUTLIER -131.7 7.17 4.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -148.95 169.71 19.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.381 -0.824 . . . . 0.0 109.672 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 40.9 p-10 -61.4 147.32 45.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 110.285 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.1 t -140.06 115.33 9.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -8.31 56.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.0 108.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 12.2 p-10 -130.98 98.51 4.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.8 mt -104.64 -20.2 13.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 108.655 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.48 ' C ' ' HD1' ' A' ' 27' ' ' HIS . 7.9 t-80 -59.58 -44.7 93.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' HIS . 25.6 t -49.99 -46.28 52.44 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 53.6 m-85 -70.08 -51.91 28.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.11 149.24 30.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.999 -1.063 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -100.91 -5.42 26.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.359 -0.838 . . . . 0.0 110.838 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.595 ' CD ' ' HE2' ' A' ' 34' ' ' HIS . 54.9 ttm-85 -154.88 153.19 30.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.01 -1.056 . . . . 0.0 108.248 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.505 ' O ' ' OH ' ' A' ' 66' ' ' TYR . 52.7 t -158.96 113.68 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.973 -1.079 . . . . 0.0 108.791 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.6 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 35.9 m-70 -95.81 -4.84 43.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.713 -0.617 . . . . 0.0 110.994 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.7 p -139.19 145.93 39.92 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.688 -1.257 . . . . 0.0 111.236 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.0 mt -140.98 142.5 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -132.71 112.11 11.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 111.081 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.508 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 1.4 t -98.5 115.0 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -83.01 -33.75 26.46 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.685 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 8.3 t -171.74 151.34 2.84 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.138 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.729 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 103.18 -137.92 13.69 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.729 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 60.7 m -170.92 164.41 7.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -174.84 168.96 3.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.616 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.0 ttm -119.72 141.29 49.55 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 m -115.74 146.6 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.5 -0.75 . . . . 0.0 109.1 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 95.6 m-85 -120.41 142.34 49.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.39 -0.819 . . . . 0.0 111.587 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -9.33 58.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.804 ' O ' ' HB3' ' A' ' 78' ' ' SER . 89.8 mtt-85 -134.52 165.39 25.3 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.525 ' OG1' ' ND2' ' A' ' 50' ' ' ASN . 39.6 p -75.64 160.61 29.9 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.729 0.776 . . . . 0.0 111.476 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.525 ' ND2' ' OG1' ' A' ' 49' ' ' THR . 5.2 m-80 68.18 33.03 4.55 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.321 0.581 . . . . 0.0 111.168 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.416 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 4.9 m-85 61.0 60.31 1.85 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.781 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.409 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 59.1 mtt -146.34 170.95 15.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.235 -0.916 . . . . 0.0 110.033 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.15 -173.46 50.25 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -55.16 126.21 23.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.097 -1.237 . . . . 0.0 108.128 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -110.37 140.9 44.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 0.0 108.868 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -132.26 137.12 47.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.816 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 22.7 p90 -98.85 123.77 43.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.404 -0.81 . . . . 0.0 109.241 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -122.83 129.49 51.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.8 ptt180 -104.59 167.45 9.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.39 -0.819 . . . . 0.0 110.922 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 59' ' ' ARG . 72.9 ttt180 -35.6 119.53 0.54 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.701 0.763 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 168.81 164.96 25.4 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -102.84 124.42 48.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.464 -1.021 . . . . 0.0 108.48 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -108.27 97.67 23.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -16.63 41.98 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.2 1.933 . . . . 0.0 112.212 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 40.7 p-10 -169.36 145.03 3.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.871 -1.143 . . . . 0.0 107.943 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.505 ' OH ' ' O ' ' A' ' 33' ' ' CYS . 20.2 p90 -148.0 -16.21 0.35 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.0 111.407 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.6 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 43.8 mtp -57.94 -38.89 76.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.439 -1.413 . . . . 0.0 109.994 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.6 -25.66 20.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.977 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -88.53 -8.98 53.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.838 . . . . 0.0 109.838 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.3 mmt -107.98 -27.49 10.13 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 47.1 6.51 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.4 mtp -124.73 147.26 48.73 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.045 -1.268 . . . . 0.0 109.668 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 73.7 m-80 -98.06 60.18 1.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 15.4 m-20 148.9 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.504 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 30.9 p -100.45 -163.53 1.03 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 109.697 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 m -92.37 147.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -106.69 -11.14 15.9 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.168 -0.957 . . . . 0.0 108.521 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.804 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.75 164.98 28.73 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.269 179.052 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.2 p -161.09 147.51 14.75 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.734 0.778 . . . . 0.0 110.601 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.418 ' NH2' ' NH1' ' A' ' 148' ' ' ARG . 74.0 ttt-85 -140.3 141.98 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 42.1 ttm -98.35 161.52 13.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.111 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.429 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 52.5 mt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.493 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 66.5 m . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.252 0.548 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.83 111.66 23.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 109.855 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -169.51 130.77 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.403 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 43.7 ttm -114.56 133.84 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -106.18 117.6 34.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 103' ' ' MET . 23.5 mt -101.44 148.05 25.64 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.083 0.944 . . . . 0.0 112.121 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.66 127.54 29.41 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 70.3 tt0 -64.13 -23.94 67.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 112.095 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.507 ' O ' ' HB3' ' A' ' 124' ' ' SER . 6.1 m-70 -114.08 159.4 20.06 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.48 -1.387 . . . . 0.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.6 m -59.0 158.88 7.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.379 -0.825 . . . . 0.0 109.431 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 97' ' ' SER . 14.3 t0 85.49 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.832 0.825 . . . . 0.0 108.787 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -176.93 41.18 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.69 -160.32 13.0 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-O 122.281 0.934 . . . . 0.0 111.296 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 67.21 -166.71 40.89 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.41 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 17.5 mmt180 -74.47 133.85 42.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.002 -1.293 . . . . 0.0 109.648 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.7 119.14 36.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.171 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 138.39 50.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.5 126.58 45.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.025 -1.047 . . . . 0.0 109.763 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.403 HD11 ' SG ' ' A' ' 110' ' ' CYS . 1.1 tt -118.83 115.79 25.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.1 ttt -126.4 20.96 7.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.289 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 109' ' ' ASP . 12.1 t70 -144.42 -168.56 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -0.901 . . . . 0.0 110.045 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.533 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 47.8 t0 -83.82 132.18 34.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.614 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -114.89 81.5 7.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.239 -0.913 . . . . 0.0 109.978 -178.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.29 -29.06 5.19 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.178 1.918 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -134.14 79.4 1.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.614 ' CD2' ' HG ' ' A' ' 110' ' ' CYS . 9.8 mt -63.17 -18.62 63.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.942 . . . . 0.0 109.787 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 20.7 mmt -59.76 -40.72 89.12 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.705 0.764 . . . . 0.0 109.33 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -85.28 -23.38 28.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.988 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -75.58 -63.2 1.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.785 -1.197 . . . . 0.0 110.761 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 117' ' ' PHE . 1.4 m-85 -116.49 1.23 12.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.771 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 117' ' ' PHE . 14.7 t-20 49.41 35.96 8.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.9 ttt -146.5 133.28 20.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 120' ' ' SER . 1.3 t -131.56 10.53 4.78 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.3 m-20 -130.1 89.69 2.84 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 119.933 -1.729 . . . . 0.0 113.238 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -107.08 141.25 38.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.048 -1.032 . . . . 0.0 108.535 178.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.51 ' N ' ' HD1' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -96.36 3.19 53.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 111.133 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.507 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.9 t -148.98 154.3 39.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.205 -1.559 . . . . 0.0 110.177 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 38.1 t -163.89 161.98 23.29 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.971 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.495 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 0.8 OUTLIER -146.36 142.56 28.35 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.5 t -111.55 122.58 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -0.977 . . . . 0.0 109.623 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 36.1 ttm -71.94 -24.2 61.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.64 . . . . 0.0 109.638 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 163.29 171.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.859 0.838 . . . . 0.0 110.866 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 85.95 -135.71 13.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.511 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 92.5 m-70 -158.52 134.17 8.86 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.69 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -126.78 136.26 52.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 0.0 111.954 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.9 mt -103.48 132.2 49.94 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 19.2 t -110.02 143.75 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.906 -1.121 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.531 ' CZ ' ' OE1' ' A' ' 144' ' ' GLN . 36.6 m-85 -120.9 124.1 44.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.623 -0.673 . . . . 0.0 110.902 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.69 -26.93 64.36 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 167' ' ' SER . 16.8 mt-30 -122.18 154.21 61.71 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.25 -171.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.202 2.601 . . . . 0.0 113.823 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 46.66 29.32 0.93 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.387 0.613 . . . . 0.0 110.026 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.487 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 48.3 m-85 59.34 50.84 7.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.639 -0.663 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.3 p -135.89 162.77 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.63 174.76 32.39 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -54.71 111.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -1.035 . . . . 0.0 109.129 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.572 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.4 mt-30 -85.97 143.84 27.94 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -123.58 137.99 54.64 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.506 ' HH ' ' ND1' ' A' ' 131' ' ' HIS . 21.3 t80 -97.35 107.53 20.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.486 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.62 117.14 34.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 108.584 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.665 ' N ' ' HH ' ' A' ' 152' ' ' TYR . 24.7 ptt180 -103.7 178.37 1.19 Allowed Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.37 162.19 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.799 1.666 . . . . 0.0 111.805 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.34 -170.58 13.41 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.86 133.19 56.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -1.001 . . . . 0.0 110.506 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.665 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 20.9 m-85 -110.03 144.45 38.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.65 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 8.6 ptm180 -141.58 -2.42 1.22 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.877 -1.14 . . . . 0.0 112.251 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.533 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 14.2 m -165.49 166.21 18.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.039 -1.663 . . . . 0.0 110.174 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.6 OUTLIER -54.35 -20.24 6.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 108.935 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -83.15 1.44 40.47 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.879 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.65 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.9 m-20 -90.3 -62.9 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 109.138 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -75.88 13.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.54 37.95 93.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.85 -154.43 21.31 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.2 t -153.58 -41.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.4 p -103.61 -153.64 0.48 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 29.5 m -148.87 11.85 0.85 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -66.84 79.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 0.0 112.232 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.7 mtt -107.41 119.78 40.36 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.644 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.79 -26.82 4.01 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -128.92 150.29 50.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.612 -1.522 . . . . 0.0 111.135 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.16 138.96 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.945 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -122.91 136.42 54.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 171' ' ' ILE . 30.6 ptt85 -93.79 86.29 5.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.893 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 170' ' ' ARG . 97.0 mt . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.453 -0.779 . . . . 0.0 109.875 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -162.1 141.24 9.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -1.134 . . . . 0.0 109.512 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.581 ' CD1' ' CG ' ' A' ' 43' ' ' PHE . 46.7 mt -129.13 133.95 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.651 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.571 ' CD1' HH21 ' A' ' 37' ' ' ARG . 47.2 mt -119.6 117.8 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -93.59 136.65 33.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 109.463 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -122.28 131.79 54.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -70.19 -22.45 62.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.61 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 10' ' ' ARG . 53.9 t0 -80.64 160.49 25.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.876 -1.14 . . . . 0.0 110.326 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.7 mmt85 -60.6 -44.5 96.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.365 -0.835 . . . . 0.0 109.803 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -80.08 -102.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -145.35 43.06 1.29 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.159 -0.963 . . . . 0.0 109.103 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.12 -169.24 12.13 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.06 -156.11 32.24 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -65.58 114.47 4.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.376 . . . . 0.0 109.092 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -98.07 147.52 24.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.375 -0.828 . . . . 0.0 109.826 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.639 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 27.8 t60 -140.46 124.55 17.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.117 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -94.78 118.33 31.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 109.145 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.5 m -118.98 136.39 54.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.336 -0.852 . . . . 0.0 109.251 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -140.23 9.15 2.28 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.8 t -142.21 155.98 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.321 -0.862 . . . . 0.0 110.417 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 52.8 p30 -55.2 143.98 25.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 110.472 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 t -140.58 118.87 12.08 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.59 53.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.799 -1.188 . . . . 0.0 109.282 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 39.6 p-10 -134.13 94.27 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.28 -18.17 27.53 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.474 ' C ' ' ND1' ' A' ' 27' ' ' HIS . 10.5 t-80 -56.48 -35.58 68.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -54.92 -59.27 4.97 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 61.3 m-85 -59.38 -51.69 68.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 0.0 110.772 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -151.5 150.61 30.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.033 -1.042 . . . . 0.0 110.548 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' CD2' ' A' ' 27' ' ' HIS . 24.3 t30 -98.06 -5.12 34.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 110.334 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -159.04 157.32 30.94 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.548 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 45.4 t -160.28 128.6 4.73 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -107.23 -10.64 15.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.053 . . . . 0.0 109.748 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -137.01 138.17 40.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 110.794 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.3 mt -130.59 143.11 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.571 HH21 ' CD1' ' A' ' 5' ' ' ILE . 57.9 ttp85 -133.26 116.5 16.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.087 . . . . 0.0 110.719 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.8 t -104.26 119.88 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 40' ' ' SER . 83.4 tt0 -85.87 -29.17 23.9 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 108.907 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 39' ' ' GLU . 3.7 m -174.86 153.7 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.671 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.72 -144.42 15.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-O 122.445 1.025 . . . . 0.0 111.638 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.1 m -146.2 149.73 34.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.581 ' CG ' ' CD1' ' A' ' 4' ' ' ILE . 7.4 t80 -147.28 137.69 23.36 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.883 -1.136 . . . . 0.0 110.002 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.0 tpt -108.85 127.09 53.73 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -116.34 145.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 55.4 m-85 -120.82 141.48 50.51 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.69 0.757 . . . . 0.0 111.052 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -74.37 -9.88 59.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.991 -0.443 . . . . 0.0 109.997 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.844 ' O ' ' HB3' ' A' ' 78' ' ' SER . 96.1 mtt180 -131.81 160.75 34.69 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p -68.96 162.02 27.64 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.767 0.794 . . . . 0.0 111.497 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.26 33.46 7.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.793 -0.567 . . . . 0.0 111.416 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.412 ' H ' ' CB ' ' A' ' 78' ' ' SER . 1.8 m-85 59.55 58.69 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.026 -1.046 . . . . 0.0 110.199 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 55.9 mtt -146.28 174.57 11.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.843 -1.16 . . . . 0.0 110.669 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.21 -169.05 51.15 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.97 -1.081 . . . . 0.0 110.42 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -61.68 129.41 40.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -122.6 154.16 38.33 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.889 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -133.27 138.37 46.42 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.819 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -92.67 118.1 30.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 108.695 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.0 mt -116.6 115.91 26.6 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.403 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.7 ptt85 -99.39 162.28 13.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.268 -0.895 . . . . 0.0 110.839 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 59' ' ' ARG . 77.7 ttt180 -25.77 114.07 0.05 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.442 0.639 . . . . 0.0 111.099 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.84 172.94 37.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -113.17 127.36 56.16 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.944 . . . . 0.0 108.725 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -107.72 99.85 31.81 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' ARG . 56.9 Cg_endo -73.42 -14.86 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.336 2.024 . . . . 0.0 113.026 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -168.24 140.06 2.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.856 -1.152 . . . . 0.0 108.557 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 25.9 p90 -150.96 36.62 0.62 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.685 -1.26 . . . . 0.0 110.297 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.5 mmt -102.97 -46.94 4.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.069 -1.019 . . . . 0.0 109.689 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.82 -16.0 18.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -86.39 -17.14 35.18 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.8 mtt -116.85 -28.96 6.17 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.03 51.14 4.09 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.068 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 89.3 mtp -119.77 141.66 49.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.307 . . . . 0.0 109.507 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 85.5 m-20 -97.79 51.95 1.07 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.1 -171.86 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.548 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 27.5 p -97.8 -168.18 1.63 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.133 0.968 . . . . 0.0 109.925 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 78' ' ' SER . 42.4 t -75.74 141.43 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -106.36 -17.17 14.36 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.572 -1.33 . . . . 0.0 107.813 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.844 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.94 164.34 30.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.696 178.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 24.6 p -164.92 152.74 11.57 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.507 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -137.7 141.26 41.07 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.1 ttp -93.17 151.45 19.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 108.976 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.496 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 16.4 mm . . . . . 0 C--N 1.304 -1.378 0 O-C-N 121.08 -1.012 . . . . 0.0 108.891 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.8 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.249 0.547 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.88 120.12 41.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.777 . . . . 0.0 109.371 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -171.42 130.12 0.71 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.553 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 45.0 ttm -115.13 130.78 57.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.924 -1.11 . . . . 0.0 109.329 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HD2' ' HD1' ' A' ' 126' ' ' HIS . 84.2 mtt180 -101.51 117.74 35.54 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 103' ' ' MET . 12.3 mt -103.18 150.09 24.02 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.328 1.061 . . . . 0.0 112.369 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 99' ' ' MET . 37.0 m-85 -137.4 125.83 23.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -63.48 -24.22 67.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 112.07 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.846 ' O ' ' OG ' ' A' ' 124' ' ' SER . 7.5 m-70 -110.94 165.22 12.04 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.371 -1.456 . . . . 0.0 110.651 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.4 m -60.03 158.86 10.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.117 -0.989 . . . . 0.0 110.044 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.534 ' O ' ' SD ' ' A' ' 99' ' ' MET . 1.0 OUTLIER 78.42 -96.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.588 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 21.7 mmt -161.76 35.86 0.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.43 -158.31 28.9 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.293 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.73 -172.43 8.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -72.36 136.0 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.985 -1.303 . . . . 0.0 109.47 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 103' ' ' MET . 5.2 ptt? -96.79 121.31 38.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 110.307 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.634 ' SD ' ' CD2' ' A' ' 117' ' ' PHE . 13.9 mtm -118.46 139.83 50.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.948 . . . . 0.0 109.206 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 mp0 -100.37 138.19 37.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -128.31 118.01 22.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.6 ttm -123.54 -18.53 6.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.446 -0.784 . . . . 0.0 109.234 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -106.8 -170.21 1.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.831 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -76.62 130.56 38.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.819 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.3 78.86 1.95 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.092 -1.005 . . . . 0.0 109.358 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.71 -27.09 7.65 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.1 1.867 . . . . 0.0 112.407 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.464 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 7.8 t30 -136.05 83.21 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.41 -25.85 67.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.99 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 tpt -55.09 -40.38 70.36 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.858 0.837 . . . . 0.0 109.113 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.464 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 93.1 m-20 -81.01 -23.19 38.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.4 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -74.47 -61.92 1.7 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.622 -1.299 . . . . 0.0 110.629 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.634 ' CD2' ' SD ' ' A' ' 104' ' ' MET . 0.9 OUTLIER -118.92 5.39 11.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.425 -0.797 . . . . 0.0 110.547 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 55.53 41.12 31.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.574 -1.329 . . . . 0.0 107.464 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.4 tpt -143.05 122.41 13.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.2 t -111.82 6.68 19.8 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 110.191 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.8 m-20 -143.39 101.79 3.85 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.413 -1.43 . . . . 0.0 113.699 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.2 m-85 -109.49 140.57 43.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.49 -0.756 . . . . 0.0 109.152 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 8.1 m-70 -96.81 3.15 52.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 111.103 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.846 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -148.98 154.18 38.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.172 -1.58 . . . . 0.0 110.375 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.57 ' HG ' ' N ' ' A' ' 126' ' ' HIS . 15.4 t -162.19 162.11 28.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.065 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.57 ' N ' ' HG ' ' A' ' 125' ' ' CYS . 0.4 OUTLIER -149.13 143.47 26.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.139 -0.975 . . . . 0.0 109.693 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.56 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.6 t -113.59 121.7 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.932 . . . . 0.0 109.381 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.408 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 25.1 ttt -72.47 -34.97 68.1 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.0 OUTLIER 176.71 174.38 0.39 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.942 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.15 -164.87 54.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.496 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 91.8 m-70 -124.66 132.38 53.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -1.067 . . . . 0.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -122.14 129.55 52.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.682 . . . . 0.0 111.412 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -101.58 131.86 47.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 22.0 t -107.83 139.97 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.98 -1.075 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.408 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 53.9 m-85 -116.38 125.09 51.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.554 -0.716 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -60.02 -26.74 66.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.1 mp0 -122.71 154.07 63.42 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.524 ' O ' ' OG1' ' A' ' 141' ' ' THR . 24.1 Cg_endo -61.48 -176.66 0.19 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.203 2.602 . . . . 0.0 113.358 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 51.71 33.37 10.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.516 -0.74 . . . . 0.0 110.58 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.408 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 39.8 m-85 55.08 47.65 21.46 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.592 -0.693 . . . . 0.0 110.048 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 13.7 p -134.44 164.22 27.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.05 173.89 28.96 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -54.02 115.14 1.88 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.122 -1.222 . . . . 0.0 109.001 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 32.4 mt-30 -84.75 142.11 30.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.83 128.87 48.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.486 ' OH ' ' CE1' ' A' ' 131' ' ' HIS . 20.6 t80 -90.93 99.47 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.271 -0.893 . . . . 0.0 109.831 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.09 124.31 40.05 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.769 0.795 . . . . 0.0 109.078 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -112.16 178.27 1.01 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -43.42 165.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.828 1.685 . . . . 0.0 111.809 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.01 177.53 21.01 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -109.55 135.41 50.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.525 -0.985 . . . . 0.0 110.399 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 19.7 m-85 -109.93 143.44 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.566 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 42.9 ptt85 -134.9 -4.4 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.883 -1.136 . . . . 0.0 112.598 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.7 m -171.57 162.71 6.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.952 -1.718 . . . . 0.0 110.128 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -51.66 -9.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 154' ' ' SER . 0.6 OUTLIER -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.048 -1.032 . . . . 0.0 108.892 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.2 m-20 -92.46 -61.1 1.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.144 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.527 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.4 p90 -75.76 15.55 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.3 37.69 93.07 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.72 -177.06 23.93 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.03 10.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 52.1 p -158.26 -158.21 0.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.8 m -143.61 11.74 1.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -62.74 72.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.937 -1.102 . . . . 0.0 112.118 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 163' ' ' SER . 60.2 mtt -105.91 115.95 31.1 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.916 -1.115 . . . . 0.0 110.565 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.87 -22.12 6.11 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -132.92 149.83 52.21 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.368 -1.666 . . . . 0.0 111.107 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.8 mt -148.21 141.89 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.744 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -124.84 140.53 52.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 110.062 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 170' ' ' ARG . 13.4 ptt180 -100.0 102.53 13.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.761 -0.587 . . . . 0.0 111.602 -178.219 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.83 139.8 51.14 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.419 -1.047 . . . . 0.0 110.637 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.1 tt -133.48 128.99 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 110.066 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.5 mt -116.26 132.17 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.657 -0.652 . . . . 0.0 109.825 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -97.56 146.07 25.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -133.63 135.51 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -72.87 -45.03 60.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 110.45 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -78.72 151.38 32.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -67.21 -34.89 78.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 110.073 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -85.65 40.67 0.86 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.042 -1.036 . . . . 0.0 109.848 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 52.89 54.38 10.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 109.696 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.34 -153.84 6.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.88 -148.04 46.02 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -76.46 119.0 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.976 . . . . 0.0 109.476 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -100.82 157.94 16.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -149.48 123.93 9.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.187 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -97.72 124.72 42.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 m -123.7 136.76 54.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -135.46 11.78 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 p -146.21 163.12 36.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.623 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -59.52 144.36 47.54 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 110.646 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -139.03 118.35 12.77 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.42 -12.19 46.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.66 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 40.3 p-10 -132.28 98.04 4.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.4 mt -96.3 -19.29 19.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.604 ' NE2' ' ND2' ' A' ' 31' ' ' ASN . 14.4 t-80 -58.05 -40.82 81.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.309 -0.869 . . . . 0.0 108.994 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.0 m -52.03 -44.94 64.44 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -70.44 -46.07 64.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.137 -0.977 . . . . 0.0 110.756 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 27.6 p90 -154.46 151.89 29.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.976 -1.077 . . . . 0.0 109.846 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.604 ' ND2' ' NE2' ' A' ' 27' ' ' HIS . 3.1 m120 -95.97 -5.67 40.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 0.0 110.078 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -161.36 159.68 28.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 108.649 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.537 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 20.5 t -160.13 120.08 2.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.622 ' N ' ' HD1' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -95.96 -14.86 22.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.602 -0.686 . . . . 0.0 110.345 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 m -135.54 147.07 48.65 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.645 -1.284 . . . . 0.0 110.859 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.4 tt -148.09 148.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -136.22 122.87 21.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.824 -1.173 . . . . 0.0 112.076 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.05 120.8 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -91.37 -28.87 17.43 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 110.6 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -159.71 152.55 21.62 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.966 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.19 -159.48 52.65 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -132.85 178.69 6.68 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.305 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.34 140.79 19.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.68 -1.263 . . . . 0.0 109.203 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.5 tpt -101.02 117.57 35.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -110.2 143.35 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.874 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 26.4 m-85 -122.17 142.0 50.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.698 0.761 . . . . 0.0 111.011 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 29.8 t0 -75.56 -6.65 51.36 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.843 ' O ' ' HB3' ' A' ' 78' ' ' SER . 36.5 ttt180 -131.23 157.87 42.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 0.0 108.709 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 p -69.04 160.7 30.49 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.708 0.765 . . . . 0.0 111.295 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.75 32.89 6.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.7 -0.625 . . . . 0.0 111.326 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 2.5 m-85 60.63 59.99 2.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.2 -0.937 . . . . 0.0 109.371 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.423 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 58.2 mtt -147.76 171.17 16.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 -170.76 42.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -54.19 122.25 9.89 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.074 -1.25 . . . . 0.0 107.633 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -103.83 135.83 44.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 108.804 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -129.36 137.56 51.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.356 -0.84 . . . . 0.0 109.427 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -100.65 119.61 38.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.0 mt -117.15 121.99 42.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.031 -1.043 . . . . 0.0 112.164 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -84.54 166.56 17.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.388 -0.82 . . . . 0.0 109.888 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -52.4 123.16 10.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.973 . . . . 0.0 110.198 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.32 171.7 39.55 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -102.27 126.73 49.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -1.137 . . . . 0.0 108.712 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -113.02 99.65 49.23 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 51.7 Cg_endo -73.09 -11.99 25.53 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.357 2.038 . . . . 0.0 112.429 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 43.8 m-20 -165.14 136.87 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 27.7 p90 -149.64 21.66 0.91 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.669 -1.27 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 44.0 mtp -97.29 -41.33 8.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.923 -1.111 . . . . 0.0 109.752 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -93.6 -25.56 17.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -81.76 -20.62 38.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.278 -0.889 . . . . 0.0 109.549 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 mtp -101.29 -25.65 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 109.966 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.11 57.19 2.87 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.4 mtp -130.04 140.15 50.9 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -1.15 . . . . 0.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.8 p-10 -93.07 53.64 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.235 -0.915 . . . . 0.0 109.306 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.1 p30 152.98 -171.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.537 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -97.72 -167.02 1.46 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 78' ' ' SER . 59.5 t -77.73 140.96 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -105.81 -17.0 14.51 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.577 -1.327 . . . . 0.0 107.827 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.843 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.34 157.96 44.98 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.079 -1.013 . . . . 0.0 109.87 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.7 p -153.03 143.35 22.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.622 0.725 . . . . 0.0 110.432 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -137.71 140.22 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.7 ttp -90.72 151.23 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 2.1 mp . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.028 . . . . 0.0 109.197 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 17.4 m . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 121.4 0.619 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -120.38 128.66 53.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.598 0.713 . . . . 0.0 109.958 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -168.93 125.37 0.94 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.0 ttm -116.72 135.84 53.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 0.0 109.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -106.62 118.03 35.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 103' ' ' MET . 19.4 mt -101.29 148.5 25.06 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.257 1.027 . . . . 0.0 112.514 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD2' ' SD ' ' A' ' 99' ' ' MET . 38.2 m-85 -132.27 121.88 24.29 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.474 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 88.3 tt0 -61.88 -27.86 69.1 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 111.055 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.06 164.26 12.44 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.523 -1.361 . . . . 0.0 111.062 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.577 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 75.0 p -61.88 157.83 17.45 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.514 -0.741 . . . . 0.0 109.731 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 97' ' ' SER . 29.8 t0 83.47 -95.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.078 -1.014 . . . . 0.0 108.763 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' CD2' ' A' ' 94' ' ' TYR . 21.1 mmt -163.54 30.88 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -98.05 -155.56 29.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 60.29 -179.24 2.62 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -67.42 132.0 46.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.279 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 11.8 ptt? -93.67 118.24 31.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.3 mtm -119.51 140.73 50.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.053 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -100.71 137.8 38.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.177 -0.952 . . . . 0.0 109.508 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.65 117.53 27.77 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.604 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 14.9 ttt -129.96 27.45 5.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 109' ' ' ASP . 17.0 t70 -151.31 -172.26 4.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.518 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.526 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 90.1 m-20 -82.95 131.18 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -111.8 84.19 5.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.031 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.4 Cg_endo -77.37 -28.59 5.49 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.243 1.962 . . . . 0.0 111.937 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 22.3 p30 -138.17 82.82 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -63.15 -22.95 67.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.351 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 8.1 tpt -58.6 -40.67 83.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.592 0.711 . . . . 0.0 109.414 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -81.57 -22.24 37.91 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 110.335 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -77.57 -64.41 1.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.709 -1.244 . . . . 0.0 111.376 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -108.36 3.03 22.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 110.61 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 114' ' ' MET . 2.4 m-20 54.4 34.6 21.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.886 -1.134 . . . . 0.0 108.932 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 8.6 ptm -148.06 133.65 18.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 54.6 p -116.92 7.55 13.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 110.519 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 163' ' ' SER . 73.6 m-20 -131.3 93.16 3.31 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.361 -1.462 . . . . 0.0 113.379 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -105.19 133.87 49.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.04 4.07 54.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.992 -1.067 . . . . 0.0 111.688 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.2 t -156.23 161.5 40.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 119.758 -1.839 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.48 170.54 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.86 145.81 25.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.8 123.37 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.2 tpp -78.13 -34.15 50.09 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 130' ' ' GLY . 11.7 t70 -177.46 175.77 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.155 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.522 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . 78.37 -142.2 25.74 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.523 ' CD2' ' OH ' ' A' ' 146' ' ' TYR . 39.8 m80 -151.51 135.26 16.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.662 -0.905 . . . . 0.0 109.094 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -126.02 132.21 52.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 0.0 112.269 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -104.08 133.09 49.61 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 53.4 t -111.9 144.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.752 -1.218 . . . . 0.0 109.64 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.535 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 47.8 m-85 -120.73 123.37 42.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 111.128 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 164' ' ' ARG . 80.2 tt0 -57.03 -28.03 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -118.02 155.69 50.98 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.425 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 25.1 Cg_endo -62.0 -177.12 0.24 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.313 2.675 . . . . 0.0 113.661 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.589 ' N ' ' OG ' ' A' ' 167' ' ' SER . 66.6 m-20 48.67 35.49 6.33 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.622 0.725 . . . . 0.0 110.545 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.653 ' H ' ' CB ' ' A' ' 167' ' ' SER . 8.1 m-85 55.5 52.09 11.75 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.751 -0.593 . . . . 0.0 109.984 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.5 m -136.94 162.54 32.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.119 -0.988 . . . . 0.0 109.77 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.45 -179.99 32.18 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -54.2 109.89 0.54 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -1.045 . . . . 0.0 108.737 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 3.5 mt-30 -84.58 141.75 30.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.8 132.28 53.75 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.523 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 65.6 t80 -94.78 105.47 17.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.369 -0.832 . . . . 0.0 109.763 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.568 ' CA ' ' HH ' ' A' ' 152' ' ' TYR . 6.9 mp -100.47 121.5 41.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.712 ' N ' ' HH ' ' A' ' 152' ' ' TYR . 2.2 ptt180 -109.48 164.14 15.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.5 Cg_exo -32.12 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.76 2.307 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.81 -166.59 13.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.95 135.05 55.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -1.002 . . . . 0.0 110.332 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.712 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 91.6 m-85 -109.77 144.3 38.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.558 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 93.4 mtt180 -129.84 -12.09 4.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.004 . . . . 0.0 112.572 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.54 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.3 p -170.29 170.24 7.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.966 -1.709 . . . . 0.0 110.538 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.531 ' HA ' ' CE2' ' A' ' 158' ' ' TRP . 0.1 OUTLIER -53.4 -19.12 3.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.645 -0.659 . . . . 0.0 109.606 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.462 ' H ' ' HG ' ' A' ' 154' ' ' SER . 36.1 m120 -84.72 2.23 42.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.069 -1.019 . . . . 0.0 108.961 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -57.78 2.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.098 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.531 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 8.4 p90 -79.32 17.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.89 42.37 94.97 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -109.73 -169.51 20.13 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 162' ' ' THR . 4.2 m -151.66 14.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 161' ' ' VAL . 34.8 p -160.6 -163.7 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 16.8 p -137.77 5.29 2.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 109.732 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 136' ' ' GLU . 88.5 mtt180 -65.89 73.8 0.07 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 0.0 112.266 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.2 mtt -102.45 117.94 35.79 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.193 -0.942 . . . . 0.0 109.502 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.93 -26.62 4.33 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.653 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.0 151.6 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.618 -1.519 . . . . 0.0 111.601 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.07 141.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.99 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -126.72 140.95 52.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.221 -0.924 . . . . 0.0 110.632 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.604 ' NH1' ' O ' ' A' ' 107' ' ' MET . 30.3 mtp180 -94.62 102.72 14.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.284 -0.885 . . . . 0.0 108.939 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 O-C-N 121.521 -0.737 . . . . 0.0 112.136 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -151.87 145.06 24.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.468 -1.019 . . . . 0.0 110.555 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.2 tt -133.44 135.17 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.881 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.3 mt -119.36 128.73 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -93.84 154.51 17.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -141.12 133.93 28.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 108.927 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -72.2 -33.36 67.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 111.296 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -87.8 151.06 23.16 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.721 -1.237 . . . . 0.0 110.601 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.515 HH12 ' CG ' ' A' ' 65' ' ' ASP . 84.3 mtt-85 -67.34 -39.87 85.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.513 -0.742 . . . . 0.0 109.876 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -80.86 38.07 0.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 109.847 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 54.01 64.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 109.471 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.91 -157.68 8.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.16 -151.12 51.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -71.85 121.12 18.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -1.147 . . . . 0.0 108.961 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -102.83 157.86 16.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.247 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.629 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 17.3 t-80 -149.08 124.61 10.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.542 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -98.44 118.15 34.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.042 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' ND1' ' A' ' 17' ' ' HIS . 2.7 m -119.57 139.64 51.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 0.0 109.332 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -144.16 8.33 1.41 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.5 t -140.66 154.01 46.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.469 -0.769 . . . . 0.0 110.735 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 54.0 p30 -47.94 154.43 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.765 . . . . 0.0 110.295 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 15.3 t -154.99 111.79 3.28 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.97 -1.56 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 42.1 p-10 -142.96 99.42 3.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.8 -22.35 16.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.031 -1.043 . . . . 0.0 109.079 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 21.1 t-80 -55.98 -37.15 68.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -49.05 -52.88 22.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 50.8 m-85 -63.31 -45.64 90.39 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 0.0 111.319 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 20.3 p90 -155.19 151.0 27.64 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.018 -1.051 . . . . 0.0 110.091 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -92.53 -3.59 54.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.119 -0.988 . . . . 0.0 110.117 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -164.72 162.45 21.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 42.2 t -161.64 131.28 4.69 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 84.4 m-70 -110.49 -7.98 14.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.079 -1.013 . . . . 0.0 109.276 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m -135.2 142.8 46.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.931 -1.106 . . . . 0.0 110.459 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -136.28 145.82 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -135.87 116.46 13.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.889 -1.132 . . . . 0.0 111.204 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.82 118.69 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.425 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.0 t -169.89 146.33 3.13 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.493 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.615 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 96.14 -130.74 10.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.615 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 62.7 m -160.88 155.91 24.23 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -140.48 131.87 26.81 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.082 -1.011 . . . . 0.0 109.012 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -98.19 112.86 24.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.51 141.84 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.885 0.85 . . . . 0.0 110.411 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.455 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 28.0 m-85 -118.13 137.38 52.99 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.887 0.851 . . . . 0.0 111.046 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 42.7 t0 -71.43 -11.68 61.01 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.716 ' O ' ' HB2' ' A' ' 78' ' ' SER . 26.2 ttt-85 -127.88 157.66 39.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.122 -0.986 . . . . 0.0 108.436 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.662 ' HG1' ' ND2' ' A' ' 50' ' ' ASN . 18.9 p -68.79 158.08 35.11 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.632 -0.667 . . . . 0.0 111.475 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.662 ' ND2' ' HG1' ' A' ' 49' ' ' THR . 18.3 m-20 67.41 36.69 3.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 111.635 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.455 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.8 m-85 58.25 59.56 2.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.7 mtt -145.38 167.06 23.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.69 -165.63 33.69 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -60.22 124.01 18.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.09 136.71 42.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.96 138.48 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 109.85 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 38.6 p90 -101.83 122.68 44.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.304 -0.872 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.2 mt -113.06 117.5 32.18 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.933 -1.105 . . . . 0.0 111.555 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.0 ptt180 -92.71 157.03 16.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 111.209 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.482 ' C ' ' O ' ' A' ' 59' ' ' ARG . 68.9 ttt180 -31.99 109.48 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.43 0.633 . . . . 0.0 110.691 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.07 168.58 37.76 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -103.92 123.26 46.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.04 98.1 12.88 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.55 -20.06 65.45 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.254 1.969 . . . . 0.0 112.015 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.515 ' CG ' HH12 ' A' ' 10' ' ' ARG . 15.2 t0 -167.07 147.01 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 28.5 p90 -148.22 25.0 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.256 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 7.3 mmt -95.61 -42.35 8.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.373 -0.83 . . . . 0.0 109.427 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -98.09 -17.1 19.28 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.53 -10.52 45.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.715 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.8 mmt -114.32 -33.8 5.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.26 53.15 3.74 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtp -121.72 143.83 49.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -1.008 . . . . 0.0 109.35 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 29.8 t30 -94.27 57.57 2.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.962 . . . . 0.0 109.174 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.35 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.523 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.4 p -100.42 -167.59 1.46 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.935 0.874 . . . . 0.0 109.544 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 78' ' ' SER . 54.3 t -74.72 139.81 18.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -107.54 -13.84 14.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.616 -1.303 . . . . 0.0 108.335 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.716 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -149.11 165.84 30.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.963 -1.086 . . . . 0.0 109.533 177.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.2 p -163.04 154.44 17.43 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.967 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.507 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 59.0 ttt180 -136.13 141.18 44.12 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 ptm -88.33 142.35 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.078 -1.014 . . . . 0.0 109.085 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.547 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 90.4 mt . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 108.699 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.498 0.665 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -114.3 121.14 42.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.57 -0.707 . . . . 0.0 109.891 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -170.32 128.27 0.84 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.446 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 40.9 ttm -112.2 130.69 55.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.97 -1.081 . . . . 0.0 109.289 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -104.69 116.15 31.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 103' ' ' MET . 13.1 mt -100.46 149.0 24.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.112 0.958 . . . . 0.0 112.556 -177.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' O ' ' A' ' 99' ' ' MET . 31.2 m-85 -135.04 125.0 25.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.487 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 86.1 tt0 -63.28 -22.76 67.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.853 -1.154 . . . . 0.0 111.767 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.845 ' O ' ' OG ' ' A' ' 124' ' ' SER . 3.0 m-70 -113.61 162.42 16.23 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.132 -1.605 . . . . 0.0 111.504 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 25.2 p -59.19 158.54 8.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.302 -0.874 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 97' ' ' SER . 5.8 m-20 81.64 -96.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.544 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 17.1 mmt -163.68 30.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.18 -159.93 32.41 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.76 -162.89 47.69 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.445 ' O ' ' HE3' ' A' ' 104' ' ' MET . 57.7 mtp180 -85.81 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -1.172 . . . . 0.0 109.218 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.7 ptt? -95.81 113.65 25.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 110.262 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.445 ' HE3' ' O ' ' A' ' 102' ' ' ARG . 1.3 mpt? -110.66 140.46 45.0 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.59 136.6 43.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.422 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -130.8 120.76 24.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ttt -117.83 -15.84 10.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 52.6 p30 -107.63 -157.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 17.8 p-10 -93.85 138.1 32.37 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -118.99 86.3 31.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.204 -0.935 . . . . 0.0 110.354 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.81 -28.13 6.58 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.178 1.919 . . . . 0.0 112.143 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 5.9 t30 -129.74 83.9 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.34 -27.63 65.52 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.7 mtp -55.41 -39.15 69.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.203 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.487 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 94.9 m-20 -84.84 -20.94 30.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.294 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -77.32 -62.3 1.7 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.654 -1.278 . . . . 0.0 110.334 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -109.02 1.71 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 110.455 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.2 m120 57.66 36.62 26.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.068 . . . . 0.0 109.83 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . 0.453 ' CG ' ' CE2' ' A' ' 122' ' ' PHE . 8.7 ptm -152.44 136.36 16.34 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.4 p -114.41 8.0 16.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.06 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 163' ' ' SER . 46.5 p-10 -134.42 98.56 4.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.348 -1.47 . . . . 0.0 113.898 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.62 134.61 51.75 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -96.83 4.4 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.015 -1.053 . . . . 0.0 111.478 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.845 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -151.02 156.66 41.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.93 -1.731 . . . . 0.0 110.43 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' CYS . . . . . 0.446 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 16.0 t -165.42 164.66 19.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.268 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.83 144.92 26.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.021 -1.049 . . . . 0.0 109.346 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 74.5 t -115.4 126.68 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.8 ttt -76.54 -21.83 55.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.601 -0.687 . . . . 0.0 109.793 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 162.16 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.722 0.773 . . . . 0.0 110.947 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.63 -140.57 21.95 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.547 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 60.2 m-70 -148.45 130.11 15.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.948 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -123.38 132.34 53.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.392 -0.818 . . . . 0.0 111.648 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.9 mt -103.69 130.16 51.13 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 41.6 t -109.94 142.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.957 -1.089 . . . . 0.0 109.574 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 58.6 m-85 -117.84 124.36 48.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.609 -0.682 . . . . 0.0 111.936 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.4 tt0 -59.26 -27.06 65.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.0 mp0 -122.64 153.99 63.16 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.228 -0.92 . . . . 0.0 108.621 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.29 -175.23 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 123.417 2.744 . . . . 0.0 113.602 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 49.29 33.96 5.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.591 0.71 . . . . 0.0 110.055 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.435 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 31.4 m-85 54.22 52.18 13.1 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.484 0.659 . . . . 0.0 109.939 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.4 m -137.02 162.18 34.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.576 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.12 177.38 31.81 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -53.95 109.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.666 -0.903 . . . . 0.0 108.604 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.9 mt-30 -84.49 145.81 27.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 109.409 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -129.39 127.79 41.72 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.195 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.706 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 1.8 t80 -89.81 106.03 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.24 123.83 46.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.445 -0.784 . . . . 0.0 109.134 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.706 ' HE ' ' HH ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -111.48 169.13 6.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' A' ' 148' ' ' ARG . 15.0 Cg_exo -32.76 162.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.846 2.364 . . . . 0.0 112.182 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.39 -169.69 13.36 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.28 133.38 55.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.554 -0.968 . . . . 0.0 110.52 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . 0.616 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 98.3 m-85 -106.87 142.75 36.0 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 97' ' ' SER . 44.1 ptt85 -131.89 -6.61 3.55 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.848 -1.157 . . . . 0.0 113.222 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 153' ' ' ARG . 3.8 m -172.22 170.13 5.23 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.537 -1.977 . . . . 0.0 111.018 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.61 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -56.65 -24.12 46.2 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -78.99 -1.75 36.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.224 -0.922 . . . . 0.0 109.301 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 159' ' ' GLY . 3.5 t0 -89.1 -61.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.58 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 7.0 p90 -74.35 16.17 0.28 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.76 34.23 89.36 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.01 -165.95 32.81 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.9 t -146.16 -8.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.811 -0.817 . . . . 0.0 109.098 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -139.69 -156.36 0.67 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.5 p -139.79 5.32 2.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.353 -0.842 . . . . 0.0 109.797 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 136' ' ' GLU . 48.0 mtp180 -62.34 74.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.072 -1.017 . . . . 0.0 112.126 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 163' ' ' SER . 65.0 mtt -105.11 116.5 32.06 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.051 -1.031 . . . . 0.0 110.051 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.12 -22.96 4.72 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.225 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.36 150.9 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 119.572 1.686 . . . . 0.0 111.407 -178.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.81 141.36 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.265 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -128.68 144.07 51.08 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.178 -0.951 . . . . 0.0 110.368 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 171' ' ' ILE . 16.2 ptt180 -102.46 91.12 4.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.981 0 O-C-N 121.495 -0.753 . . . . 0.0 111.027 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtp . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.46 152.09 22.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -141.11 144.95 35.18 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.514 -0.992 . . . . 0.0 110.543 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.9 tt -135.46 135.03 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 110.147 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.22 128.97 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.414 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.8 140.6 31.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.368 -0.833 . . . . 0.0 109.24 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -125.82 136.07 52.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.711 -1.243 . . . . 0.0 109.343 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -72.41 -38.49 68.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 110.208 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.27 157.68 22.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.068 -1.02 . . . . 0.0 110.122 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 38.1 ptt85 -71.68 -39.91 69.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.013 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.476 ' OD1' ' NH1' ' A' ' 10' ' ' ARG . 88.6 m-20 -78.26 38.13 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.619 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.416 ' H ' ' C ' ' A' ' 10' ' ' ARG . 98.1 m-85 53.94 47.14 24.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 109.464 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.57 -158.19 8.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.72 -149.43 49.5 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -73.78 118.73 17.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -1.165 . . . . 0.0 109.221 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -100.73 155.58 17.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -146.0 124.08 12.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.08 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -97.89 121.83 40.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.14 -0.975 . . . . 0.0 109.808 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -122.33 137.79 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 81' ' ' MET . 21.3 ptt? -140.76 10.02 2.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.393 -0.817 . . . . 0.0 108.941 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -144.81 158.81 43.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.993 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 49.4 p30 -46.51 161.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.504 -0.748 . . . . 0.0 109.807 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.502 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 3.6 t -161.66 110.0 1.48 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.6 40.56 1.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 14.1 p30 -177.39 91.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.993 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -98.04 -22.45 16.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.906 . . . . 0.0 108.87 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.55 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 22.3 t-80 -57.93 -42.67 85.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 108.758 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -59.67 -16.65 28.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.741 -0.599 . . . . 0.0 109.841 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -99.98 -47.64 4.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.51 145.95 21.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.261 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 71.3 m-20 -97.34 -7.49 31.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 110.404 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -149.35 149.4 30.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.139 -0.976 . . . . 0.0 108.632 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.551 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 38.9 t -154.55 114.52 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -96.12 -16.55 21.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.716 -0.615 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 t -133.77 142.58 47.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.899 -1.126 . . . . 0.0 110.801 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.97 145.95 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -134.7 121.13 20.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.053 . . . . 0.0 111.278 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.97 117.83 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.67 -32.33 23.67 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.5 t -168.4 151.79 5.64 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.224 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 -165.19 43.06 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -123.74 153.38 40.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.397 -1.061 . . . . 0.0 109.546 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -133.64 133.39 41.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.0 tpt -103.06 122.52 44.82 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.0 m -115.05 146.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.03 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.497 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.0 m-85 -121.82 143.77 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.681 0.753 . . . . 0.0 110.481 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.76 -7.81 58.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.781 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.5 ttm180 -131.21 157.98 41.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p -69.84 155.7 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.962 0.887 . . . . 0.0 111.231 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 m120 71.93 33.5 1.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.377 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.531 ' H ' ' HG ' ' A' ' 78' ' ' SER . 3.0 m-85 61.62 55.22 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.914 -1.116 . . . . 0.0 110.049 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 50.2 mtt -143.73 174.19 11.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.302 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.65 -170.03 47.71 Favored Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.834 -1.166 . . . . 0.0 110.246 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -55.15 119.85 6.11 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -1.059 . . . . 0.0 108.418 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -101.34 132.25 46.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.331 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -124.48 136.39 53.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.995 . . . . 0.0 109.607 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -100.59 116.45 32.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 0.0 109.463 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.51 139.13 42.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 108.556 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.3 ptt180 -113.25 161.38 17.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.054 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 59' ' ' ARG . 39.9 ttp180 -35.17 115.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.509 -0.745 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.09 169.69 31.89 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.45 127.77 53.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.481 -1.011 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -107.04 100.28 31.36 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 39.6 Cg_endo -70.01 -20.11 34.1 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.38 2.053 . . . . 0.0 112.716 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 42.2 m-20 -163.65 138.66 6.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.512 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.5 p90 -148.63 26.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.548 -1.345 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.4 mtt -99.99 -43.62 6.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.933 -1.104 . . . . 0.0 109.176 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -94.61 -22.67 18.02 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.9 m -82.1 -19.41 40.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.669 -0.644 . . . . 0.0 109.835 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 mmt -105.58 -23.35 12.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.98 -1.075 . . . . 0.0 109.012 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.88 51.98 4.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.0 mtp -123.13 -171.48 2.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.044 -1.268 . . . . 0.0 109.639 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 63.4 t30 -145.79 55.99 1.2 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.168 -0.958 . . . . 0.0 109.371 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.0 m-20 150.23 -169.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.551 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -96.69 -167.11 1.5 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.341 -0.849 . . . . 0.0 109.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -88.85 148.69 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -106.74 -11.08 15.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.058 -1.027 . . . . 0.0 108.376 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.781 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.44 172.54 13.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.049 -1.032 . . . . 0.0 110.313 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.1 p -172.09 156.75 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.869 0.842 . . . . 0.0 110.84 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -134.6 139.58 45.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' A' ' 20' ' ' MET . 59.5 ttp -91.43 143.12 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.067 -1.02 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.2 mt -110.32 104.12 55.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 108.943 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.05 175.64 9.67 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.386 2.057 . . . . 0.0 112.42 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.1 mt -74.76 48.6 0.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.673 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -104.27 88.9 3.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.399 -0.813 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -134.89 93.1 2.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.765 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.64 -81.06 0.38 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 63.9 m -122.4 151.24 41.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.412 -1.052 . . . . 0.0 110.603 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -110.76 116.82 31.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -169.4 125.25 0.87 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 108.775 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.406 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 42.8 ttm -107.09 121.02 43.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -95.15 115.63 27.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.0 mt -103.7 147.49 27.18 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.142 0.972 . . . . 0.0 112.55 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.559 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 30.6 m-85 -135.37 127.28 29.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.445 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 50.2 tt0 -61.52 -27.97 68.98 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 111.818 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.881 ' O ' ' OG ' ' A' ' 124' ' ' SER . 5.9 m-70 -109.72 165.67 11.51 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.671 -1.268 . . . . 0.0 111.202 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.7 m -60.52 157.06 14.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 97' ' ' SER . 8.7 t70 81.82 -96.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.8 mmt -163.29 33.09 0.09 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.71 -160.13 31.91 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.313 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 65.0 -149.33 51.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.401 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 76.5 mtm-85 -96.14 139.55 32.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.3 ptt? -96.09 119.48 34.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.195 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 104' ' ' MET . 0.3 OUTLIER -115.62 135.8 53.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.009 -1.057 . . . . 0.0 108.817 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.14 132.19 43.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.02 117.18 20.48 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 74.7 mtp -123.25 13.62 9.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.414 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 42.3 p30 -140.09 -162.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.952 . . . . 0.0 110.176 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 2.0 p30 -87.04 133.22 33.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -117.73 90.81 37.06 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.434 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.94 -28.09 5.3 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.206 1.938 . . . . 0.0 112.286 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -135.28 84.99 2.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.79 -27.91 66.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.552 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.441 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.5 tpt -57.01 -39.73 75.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.59 0.709 . . . . 0.0 109.205 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -84.13 -22.05 31.2 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.012 -1.055 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -79.32 -63.07 1.5 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.58 -1.325 . . . . 0.0 111.633 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -104.6 1.05 29.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.319 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 114' ' ' MET . 17.8 t30 58.87 32.5 22.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.909 -1.119 . . . . 0.0 109.425 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 4.7 ptm -150.32 133.06 15.91 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 53.7 p -116.57 5.93 13.38 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 120' ' ' SER . 53.9 m-20 -130.01 90.99 3.05 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.723 -1.236 . . . . 0.0 112.471 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.654 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -100.95 130.94 47.02 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.059 -1.026 . . . . 0.0 108.554 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -93.89 2.92 56.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 0.0 110.92 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.881 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.9 p -147.83 154.07 39.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.146 -1.596 . . . . 0.0 109.935 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 23.0 t -165.36 163.71 19.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.885 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.554 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 7.0 t60 -152.45 148.15 27.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 65.4 t -115.95 125.35 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.937 0.875 . . . . 0.0 109.252 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 10.0 tpt -72.79 -32.66 65.73 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 172.95 167.15 0.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.827 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.93 -155.19 28.68 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.541 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 89.6 m-70 -135.49 130.12 34.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.552 -0.97 . . . . 0.0 110.184 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -121.42 131.13 53.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.549 -0.719 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.2 mt -100.86 130.26 46.84 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 34.9 t -109.08 143.45 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.835 -1.166 . . . . 0.0 109.546 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.461 ' OH ' ' OE1' ' A' ' 144' ' ' GLN . 90.4 m-85 -121.04 125.63 47.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.729 -0.607 . . . . 0.0 110.906 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -60.26 -26.09 66.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -121.68 154.0 59.98 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 141' ' ' THR . 20.3 Cg_endo -60.64 -171.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 123.197 2.598 . . . . 0.0 113.676 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m120 46.43 30.32 1.05 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.511 0.672 . . . . 0.0 110.149 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.449 ' H ' ' CB ' ' A' ' 167' ' ' SER . 18.5 m-85 57.69 52.43 8.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.419 -0.801 . . . . 0.0 109.924 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 16.5 p -138.4 166.09 25.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.15 -179.82 33.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -55.33 113.25 1.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -1.026 . . . . 0.0 109.121 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 19.2 tt0 -87.58 141.41 28.63 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.149 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -123.85 133.91 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.541 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 81.1 t80 -95.16 102.28 14.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.517 -0.739 . . . . 0.0 109.763 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.69 120.94 38.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 149' ' ' PRO . 0.9 OUTLIER -104.96 -178.49 0.62 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 148' ' ' ARG . 51.9 Cg_exo -52.39 154.21 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.217 1.944 . . . . 0.0 111.847 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.19 -166.33 14.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.23 136.71 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -1.098 . . . . 0.0 110.44 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.54 143.45 42.38 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.627 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 59.1 mtm180 -130.09 -5.84 4.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.141 -0.974 . . . . 0.0 112.537 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 10.0 t -172.01 -178.45 2.14 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.111 -1.618 . . . . 0.0 110.726 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.5 OUTLIER -60.44 -26.88 67.07 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 156' ' ' ASN . 2.3 m120 -80.19 2.53 23.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.096 -1.002 . . . . 0.0 109.911 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.627 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -93.01 -61.13 1.64 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.167 -0.958 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -78.15 18.0 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.5 38.44 95.76 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -108.65 -160.85 20.07 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.7 t -148.75 -41.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.8 p -102.71 -158.34 0.66 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.4 p -144.36 11.68 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.842 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -63.89 74.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.096 -1.003 . . . . 0.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.47 119.88 39.45 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.248 -0.908 . . . . 0.0 109.772 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.1 -25.98 3.67 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.449 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.94 152.09 51.43 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 119.274 1.537 . . . . 0.0 111.202 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.92 142.69 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.639 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.446 ' NH2' ' OH ' ' A' ' 135' ' ' TYR . 45.3 ttp180 -123.7 136.57 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.693 ' HE ' ' HG1' ' A' ' 172' ' ' THR . 45.4 ttp180 -96.05 98.08 10.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.548 -0.72 . . . . 0.0 109.4 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 74.5 mt -47.48 103.07 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.693 ' HG1' ' HE ' ' A' ' 170' ' ' ARG . 12.3 m -149.8 60.68 1.0 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -177.78 108.36 0.06 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.486 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.272 0.558 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -64.08 151.46 49.76 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -149.67 147.31 27.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.166 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.405 ' CD1' ' CD2' ' A' ' 43' ' ' PHE . 13.0 tt -133.9 136.79 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 110.09 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.5 mt -122.89 130.69 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.524 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -99.21 135.09 41.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.038 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -120.17 135.2 55.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -73.8 -32.62 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.956 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -81.88 161.58 23.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.8 -44.17 33.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.981 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.68 47.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 51.25 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.539 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.53 -175.74 47.72 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.8 -146.06 23.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -75.82 116.42 16.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.972 -1.31 . . . . 0.0 108.699 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -98.19 157.96 15.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.814 . . . . 0.0 109.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -148.14 122.5 9.67 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.21 -0.931 . . . . 0.0 108.873 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -97.64 120.72 38.53 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -124.43 137.55 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -140.88 11.05 2.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -141.48 155.16 45.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 110.147 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 2.9 p30 -53.26 141.03 24.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.452 -0.78 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 t -138.93 120.45 15.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.97 -4.68 58.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.016 -1.053 . . . . 0.0 109.576 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -140.23 93.98 2.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.2 mt -91.13 -16.29 28.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.178 -0.951 . . . . 0.0 108.494 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -58.95 -39.94 83.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.806 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -59.97 -18.69 47.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.481 -0.762 . . . . 0.0 110.514 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.78 -43.26 8.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -158.86 153.87 25.14 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.325 0.583 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.631 ' H ' HD21 ' A' ' 31' ' ' ASN . 0.7 OUTLIER -100.41 -7.81 23.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -154.04 153.39 31.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.006 -1.059 . . . . 0.0 108.475 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.571 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 46.2 t -155.98 122.78 5.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.593 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 36.9 m-70 -104.63 -12.45 16.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.744 . . . . 0.0 109.94 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 t -136.06 142.27 44.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.974 . . . . 0.0 110.422 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.8 145.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -137.02 116.5 12.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.896 -1.127 . . . . 0.0 111.276 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.58 119.52 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.37 -32.72 22.26 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 108.945 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.0 t -171.24 153.46 3.66 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.244 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.57 -169.05 38.73 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 53.9 m -118.93 156.69 29.09 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.287 -1.125 . . . . 0.0 109.151 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.405 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 10.7 t80 -145.53 134.77 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 108.994 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.61 ' SD ' ' CD2' ' A' ' 146' ' ' TYR . 10.7 ttm -107.24 126.24 52.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.77 143.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.122 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.496 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 43.5 m-85 -116.8 139.94 50.02 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.63 0.728 . . . . 0.0 110.863 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 26.3 t0 -76.37 -10.0 59.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.503 -0.748 . . . . 0.0 110.013 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.681 ' O ' ' HB3' ' A' ' 78' ' ' SER . 71.5 mtt-85 -131.61 155.44 47.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 108.525 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.2 p -65.98 158.07 29.19 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.682 0.754 . . . . 0.0 110.953 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 70.73 35.47 1.8 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.094 0.473 . . . . 0.0 111.76 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.496 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.4 m-85 58.58 54.97 5.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.913 -1.117 . . . . 0.0 109.952 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.403 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 83.2 mmm -144.32 178.43 7.92 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.219 -0.925 . . . . 0.0 109.843 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.33 -173.44 53.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -54.91 124.58 17.1 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.157 -1.202 . . . . 0.0 108.427 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -102.74 133.48 47.71 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -126.47 133.58 51.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.19 -0.944 . . . . 0.0 109.36 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -96.9 120.97 38.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.179 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.32 117.33 28.26 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.147 -0.971 . . . . 0.0 111.248 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.62 ' HE ' ' CD1' ' A' ' 174' ' ' LEU . 62.0 ttt-85 -95.33 161.85 13.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 111.302 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 59' ' ' ARG . 47.1 ttp180 -29.33 115.14 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.433 0.635 . . . . 0.0 110.638 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.92 169.49 32.38 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.5 128.44 54.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.483 -1.01 . . . . 0.0 108.997 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -106.7 98.25 20.09 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 35.3 Cg_endo -67.5 -18.92 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.314 2.01 . . . . 0.0 112.362 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 32.5 m-20 -164.84 139.47 5.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -146.44 3.13 0.87 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.48 -1.387 . . . . 0.0 111.194 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.593 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 30.6 mtp -77.64 -39.93 43.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.13 -21.59 17.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.958 . . . . 0.0 109.42 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.2 m -83.4 -16.34 46.3 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.474 -0.767 . . . . 0.0 109.703 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mmt -109.5 -25.34 10.53 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.91 44.81 8.03 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.262 -0.97 . . . . 0.0 110.977 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.0 mtp -114.71 159.3 20.7 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.272 . . . . 0.0 109.585 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 28.8 p30 -110.4 55.8 0.64 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.101 -0.999 . . . . 0.0 109.302 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.7 p30 152.67 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.571 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.8 p -96.97 -175.09 3.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.066 0.936 . . . . 0.0 110.255 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 78' ' ' SER . 59.7 t -68.09 141.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.27 -17.91 14.16 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.707 -1.245 . . . . 0.0 107.821 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.681 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -145.49 168.85 19.59 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 22.9 p -161.68 146.22 13.02 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.492 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH1' ' NE ' ' A' ' 148' ' ' ARG . 63.9 ttt180 -132.43 140.3 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.5 tpp -92.36 143.1 26.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.602 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 17.2 mt -85.22 130.72 50.76 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.11 -175.88 2.39 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.406 2.071 . . . . 0.0 112.323 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 85' ' ' HIS . 30.5 mt -100.68 68.88 1.35 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.451 -0.78 . . . . 0.0 109.174 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.501 ' C ' ' O ' ' A' ' 84' ' ' LEU . 25.7 p80 -33.67 147.75 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.724 -0.61 . . . . 0.0 109.736 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.445 ' N ' ' CD2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -145.77 50.21 1.2 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.801 . . . . 0.0 109.594 -178.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.03 -101.29 0.48 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 74.6 p -156.47 173.95 16.16 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.85 -0.794 . . . . 0.0 109.483 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.491 ' CE2' ' OG1' ' A' ' 172' ' ' THR . 14.0 m-85 -111.96 119.61 39.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.524 -0.735 . . . . 0.0 109.491 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -167.9 129.24 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.3 ttm -117.02 127.66 54.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.325 -0.859 . . . . 0.0 109.269 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -101.06 119.22 38.43 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.9 mt -101.3 149.06 24.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.119 0.961 . . . . 0.0 112.067 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 99' ' ' MET . 38.3 m-85 -132.95 122.94 25.02 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.457 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 52.6 tt0 -62.12 -26.04 68.08 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.195 -0.941 . . . . 0.0 111.828 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.516 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.93 165.4 11.6 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.839 -1.163 . . . . 0.0 110.908 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 6.1 p -63.53 158.18 21.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.8 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 97' ' ' SER . 32.2 t0 81.67 -95.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.543 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 19.9 mmt -161.64 33.56 0.13 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.18 -153.1 26.05 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.019 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.479 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 62.87 -165.57 25.11 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.454 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 79.1 mtm180 -81.01 143.74 32.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.334 . . . . 0.0 108.842 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.4 mtt -98.21 115.45 28.36 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.922 -1.111 . . . . 0.0 109.447 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.3 mpp? -114.42 135.38 54.16 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.109 -0.994 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.56 132.1 45.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -122.79 115.78 22.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.2 ttt -126.16 13.09 7.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.815 . . . . 0.0 109.399 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -136.71 -167.68 2.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.626 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -81.99 130.9 35.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.69 78.64 15.61 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 109.52 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -78.07 -25.8 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.087 1.858 . . . . 0.0 112.233 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 51.2 p-10 -131.27 75.61 1.66 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -18.54 61.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.93 -1.106 . . . . 0.0 110.41 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.423 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.5 tpt -60.88 -42.21 97.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -82.91 -21.51 34.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.382 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -77.21 -62.15 1.75 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.691 -1.256 . . . . 0.0 111.125 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.05 2.68 15.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.489 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 114' ' ' MET . 41.3 m-20 50.85 35.36 12.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.871 -1.143 . . . . 0.0 108.769 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.5 ptm -148.3 135.64 20.44 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 78.6 p -125.91 7.09 7.34 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.478 -0.764 . . . . 0.0 111.015 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 163' ' ' SER . 66.6 m-20 -128.42 85.68 2.37 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.552 -1.342 . . . . 0.0 112.786 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -98.74 134.69 41.29 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.95 -1.094 . . . . 0.0 108.7 177.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.405 ' CD2' ' HG ' ' A' ' 163' ' ' SER . 27.0 m170 -94.45 2.18 55.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.0 111.264 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.5 t -149.92 156.3 41.51 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.156 -1.59 . . . . 0.0 109.846 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.515 ' SG ' ' CZ3' ' A' ' 158' ' ' TRP . 0.1 OUTLIER -162.69 162.16 26.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -147.95 143.36 27.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.143 -0.973 . . . . 0.0 109.89 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.9 t -114.26 121.02 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.286 -0.884 . . . . 0.0 109.359 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 23.1 ttt -70.32 -39.44 74.78 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.565 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 0.5 OUTLIER -179.08 173.66 1.14 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.253 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 86.33 -144.13 19.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.56 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 66.3 m-70 -147.76 128.44 14.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.571 -0.958 . . . . 0.0 109.319 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -124.04 135.42 53.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.118 -0.989 . . . . 0.0 112.478 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.22 134.17 51.45 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 25.4 t -110.06 142.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.05 -1.031 . . . . 0.0 109.233 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 50.9 m-85 -119.13 124.32 46.57 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.618 -0.676 . . . . 0.0 110.762 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.516 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 78.0 tt0 -60.69 -26.62 67.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -119.34 150.98 50.55 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.484 ' O ' ' OG1' ' A' ' 141' ' ' THR . 18.1 Cg_endo -59.75 -177.84 0.15 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.921 2.414 . . . . 0.0 113.398 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.581 ' O ' ' CG ' ' A' ' 140' ' ' TYR . 26.9 m120 52.61 38.61 26.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.384 -0.822 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.581 ' CG ' ' O ' ' A' ' 139' ' ' ASN . 5.7 p90 45.75 57.09 5.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.65 -0.656 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 3.8 p -141.42 172.63 12.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.289 -0.882 . . . . 0.0 110.327 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.46 -173.76 40.85 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.645 -1.284 . . . . 0.0 110.798 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.516 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 70.3 mtm180 -58.19 106.66 0.4 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.605 -0.938 . . . . 0.0 109.432 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 11.9 mt-30 -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.62 0.724 . . . . 0.0 110.184 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -126.85 134.17 50.57 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CD2' ' SD ' ' A' ' 44' ' ' MET . 2.4 t80 -95.3 104.84 16.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.91 121.98 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 108.887 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' NE ' ' NH1' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -107.26 175.83 1.87 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.71 159.06 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.11 1.874 . . . . 0.0 111.773 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.02 -168.87 12.78 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.2 136.34 54.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -1.017 . . . . 0.0 110.487 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.531 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 17.6 m-85 -110.73 145.55 37.86 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.554 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 35.2 ptt85 -134.5 -3.86 2.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.069 -1.02 . . . . 0.0 112.168 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.579 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 53.8 p -170.17 173.23 5.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.09 -1.631 . . . . 0.0 110.661 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.638 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.77 -21.54 56.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 156' ' ' ASN . 3.1 m120 -80.99 -2.52 48.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.556 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.579 ' OD2' ' N ' ' A' ' 154' ' ' SER . 8.6 m-20 -88.55 -61.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.961 . . . . 0.0 109.274 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.2 p90 -76.59 16.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.19 38.26 94.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.54 -177.85 23.18 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.55 5.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 63.3 p -154.95 -157.32 0.74 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 55.7 m -141.84 12.35 2.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.437 -0.79 . . . . 0.0 110.269 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -64.02 69.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.083 -1.01 . . . . 0.0 112.826 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.2 mtt -100.36 118.83 37.42 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.054 -1.028 . . . . 0.0 110.523 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.74 -25.85 4.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.567 ' HG ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -132.47 153.55 50.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.765 -1.433 . . . . 0.0 110.596 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -150.44 141.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.561 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -122.76 133.89 54.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.7 ' O ' ' N ' ' A' ' 172' ' ' THR . 23.0 ptt85 -98.78 102.74 14.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.501 ' O ' HG22 ' A' ' 171' ' ' ILE . 82.4 mt -50.17 66.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.811 -0.556 . . . . 0.0 111.715 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 170' ' ' ARG . 4.5 m -139.73 50.69 1.75 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.516 -1.365 . . . . 0.0 110.538 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 172' ' ' THR . 16.1 m-20 -157.57 92.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.268 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.62 ' CD1' ' HE ' ' A' ' 59' ' ' ARG . 3.7 mm? . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 118.021 -0.99 . . . . 0.0 108.763 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' O ' ' A' ' 2' ' ' GLY . 63.0 mtt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 59.9 146.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -148.43 149.24 31.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.324 -1.103 . . . . 0.0 110.892 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.3 tt -134.67 133.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.6 mt -118.48 130.76 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.61 157.27 16.05 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -144.69 136.35 25.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 108.454 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -80.77 -25.12 38.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.016 -1.052 . . . . 0.0 111.267 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 50.9 t0 -80.54 159.06 25.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.812 -1.18 . . . . 0.0 110.821 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' OG ' ' A' ' 35' ' ' SER . 73.7 ttt180 -61.44 -39.84 92.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.657 -0.652 . . . . 0.0 110.064 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 83.2 m-20 -87.48 -90.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.071 -1.018 . . . . 0.0 109.323 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 57.2 m-85 -158.17 63.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 108.959 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -152.42 -162.38 10.85 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.18 -149.5 39.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -74.37 117.04 15.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.868 -1.372 . . . . 0.0 108.827 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -104.74 158.81 16.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.466 -0.771 . . . . 0.0 110.101 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -149.72 124.07 9.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.069 -1.019 . . . . 0.0 109.828 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -96.45 118.12 32.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.111 -0.993 . . . . 0.0 109.2 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -114.86 139.03 50.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.3 ptp -138.44 10.78 2.74 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.5 p -143.44 161.79 37.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.666 -0.646 . . . . 0.0 109.605 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 49.8 p30 -60.02 146.02 44.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.0 110.562 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -141.15 111.93 7.09 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.93 -5.38 59.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 109.583 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 38.8 p-10 -138.23 93.94 2.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.057 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 30.9 mt -94.32 -20.66 19.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -58.44 -40.9 83.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.6 p -57.31 -24.24 53.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.61 -0.682 . . . . 0.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -89.46 -40.37 12.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 108.705 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -159.08 147.35 17.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.601 -0.687 . . . . 0.0 109.701 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -94.06 -9.68 35.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.113 -0.992 . . . . 0.0 110.254 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -152.5 152.23 31.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.048 -1.033 . . . . 0.0 108.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' SG ' ' O ' ' A' ' 35' ' ' SER . 7.7 t -154.45 114.6 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -95.17 -7.93 37.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.42 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.513 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 14.9 m -137.78 144.13 41.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.511 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.1 tt -156.85 154.22 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -155.54 144.82 20.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.675 -1.265 . . . . 0.0 111.815 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.55 123.61 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -84.56 -30.51 25.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 108.669 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -166.37 150.29 7.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.88 -142.16 18.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.09 163.02 39.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.63 134.47 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.871 -1.143 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.28 110.66 22.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.9 m -99.8 147.18 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.602 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 42.2 m-85 -121.73 140.6 52.12 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.684 0.754 . . . . 0.0 111.147 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.47 -8.02 55.63 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.764 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.803 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.2 ttt180 -131.38 162.58 29.82 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.0 p -74.15 163.3 28.03 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.976 0.893 . . . . 0.0 111.548 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.8 OUTLIER 64.42 31.93 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.217 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.616 ' CE2' ' NH2' ' A' ' 80' ' ' ARG . 5.0 m-85 63.08 58.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.905 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 86.2 mtp -144.29 171.62 14.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 85.42 -169.39 43.32 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -58.03 121.29 10.26 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 4.5 mp0 -104.51 136.15 44.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 109.207 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -125.77 133.34 52.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.21 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -96.97 122.37 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.388 -0.82 . . . . 0.0 109.281 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 mt -117.04 127.99 54.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.283 -0.885 . . . . 0.0 109.746 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ARG . 35.3 ptt180 -97.52 166.35 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 110.078 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 59' ' ' ARG . 44.4 ttp180 -38.52 112.17 0.21 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.576 -0.702 . . . . 0.0 109.84 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.26 171.85 40.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 47.1 mp0 -111.14 130.33 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.375 -1.074 . . . . 0.0 108.667 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.33 99.67 49.81 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ARG . 58.1 Cg_endo -75.8 -9.35 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.343 2.028 . . . . 0.0 112.725 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 44.2 m-20 -164.28 128.93 2.71 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 22.3 p90 -148.4 34.33 0.79 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.62 -1.3 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 54.5 tpp -102.83 -47.25 4.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.024 -1.047 . . . . 0.0 109.708 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -98.54 -19.52 17.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -78.9 -23.93 44.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.3 mmt -101.35 -30.99 11.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.21 49.72 3.65 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.8 mtp -123.1 143.16 50.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.986 . . . . 0.0 109.695 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.56 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.6 p30 -96.13 54.27 1.43 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.157 -0.964 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.3 m-20 150.55 -168.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.496 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.8 p -97.48 -160.49 0.81 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.489 -0.757 . . . . 0.0 109.714 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.1 m -92.13 150.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -110.78 -7.6 14.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.894 -1.129 . . . . 0.0 108.022 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.803 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -146.8 165.14 30.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.913 -1.117 . . . . 0.0 109.452 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.3 p -164.64 149.84 9.89 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.873 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.616 ' NH2' ' CE2' ' A' ' 51' ' ' PHE . 61.6 ttm-85 -138.2 142.84 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 ptm -95.53 151.38 19.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.2 mm -105.74 101.2 31.46 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.54 152.88 8.41 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.347 2.032 . . . . 0.0 112.072 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.85 47.88 1.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -100.53 77.31 1.9 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 109.141 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.522 ' ND1' ' OXT' ' A' ' 174' ' ' LEU . 38.6 m170 -97.1 82.37 3.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.92 . . . . 0.0 109.566 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.46 -88.57 0.35 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.0 p -117.48 146.67 43.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.433 -1.04 . . . . 0.0 110.236 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -111.05 119.53 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.459 -0.775 . . . . 0.0 109.527 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -171.59 125.59 0.6 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 47.2 ttm -105.38 127.72 53.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.007 -1.058 . . . . 0.0 109.298 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.496 ' HD3' ' HD1' ' A' ' 126' ' ' HIS . 29.9 mtp180 -104.7 115.56 30.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' MET . 10.1 mt -104.49 148.15 26.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.233 1.016 . . . . 0.0 113.06 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.555 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 25.3 m-85 -133.53 125.66 29.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.486 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 70.8 tt0 -62.59 -26.34 68.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 111.955 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.762 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.3 m-70 -109.63 164.18 12.78 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.658 -1.276 . . . . 0.0 110.828 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -61.89 160.63 11.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.406 -0.809 . . . . 0.0 109.219 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.518 ' O ' ' SD ' ' A' ' 99' ' ' MET . 5.7 m-20 80.05 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.6 mmt -162.78 31.72 0.1 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.34 -156.84 30.54 Favored Glycine 0 N--CA 1.491 2.357 0 CA-C-O 122.173 0.874 . . . . 0.0 111.178 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.418 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 64.38 -155.35 46.95 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.41 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 57.9 ttt85 -90.9 140.84 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.162 -1.199 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 44.0 ttp -97.36 114.89 26.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.826 -1.171 . . . . 0.0 109.834 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.7 mtm -113.81 138.79 49.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.138 -0.976 . . . . 0.0 108.656 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.72 138.31 39.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.466 -0.771 . . . . 0.0 109.169 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.49 ' CD1' ' SG ' ' A' ' 110' ' ' CYS . 1.3 tt -137.28 122.61 19.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 108.902 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.519 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 5.8 ttt -123.12 2.73 9.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 110.406 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -122.29 -162.7 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.245 -0.909 . . . . 0.0 110.078 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 42.9 p-10 -91.29 139.51 30.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.49 ' SG ' ' CD1' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -120.83 98.22 47.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -178.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.99 -23.26 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.147 1.898 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -142.25 84.81 1.89 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.946 -1.096 . . . . 0.0 108.337 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.89 -26.99 63.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.083 -1.011 . . . . 0.0 110.074 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.6 tpt -58.59 -40.48 83.32 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 108.715 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -84.1 -23.0 30.93 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 110.619 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -79.12 -62.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.538 -1.351 . . . . 0.0 110.824 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -100.3 2.01 42.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 114' ' ' MET . 28.3 t-20 59.06 30.56 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 110.014 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 9.0 ptm -153.82 138.92 17.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 62.5 m -123.75 5.82 8.8 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.754 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' SER . 37.0 m-20 -128.32 92.43 3.44 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.637 -1.225 . . . . 0.0 113.242 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -104.68 132.97 50.29 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.485 ' CD2' ' OH ' ' A' ' 155' ' ' TYR . 1.1 m-70 -92.01 2.65 56.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.061 . . . . 0.0 111.538 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.762 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.4 p -147.34 153.06 39.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 119.932 -1.73 . . . . 0.0 110.241 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 124' ' ' SER . 35.7 m -157.36 159.04 37.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.482 -0.761 . . . . 0.0 109.481 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.546 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -148.21 141.88 25.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.094 -1.004 . . . . 0.0 108.72 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.546 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 53.3 t -113.25 125.03 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.996 -1.065 . . . . 0.0 109.308 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.466 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.0 ttt -73.8 -28.58 61.72 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.671 0.748 . . . . 0.0 109.118 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m-20 166.85 166.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.828 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.61 -142.67 16.18 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -149.74 129.35 13.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.593 -0.945 . . . . 0.0 109.674 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -124.1 135.76 53.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.767 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.1 mt -105.02 133.09 50.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 43.4 t -111.1 143.0 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.084 -1.01 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.444 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 41.3 m-85 -120.42 124.19 44.86 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.522 -0.736 . . . . 0.0 111.107 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.529 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 54.0 tt0 -58.47 -27.32 64.3 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -119.97 155.2 55.54 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.69 -171.69 0.11 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.31 2.674 . . . . 0.0 113.686 -178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 47.52 30.5 1.68 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.507 0.67 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.452 ' H ' ' CB ' ' A' ' 167' ' ' SER . 16.3 m-85 56.86 52.62 9.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.488 -0.757 . . . . 0.0 109.54 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.6 m -136.89 164.42 28.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.414 -0.804 . . . . 0.0 109.323 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.429 ' O ' ' OE1' ' A' ' 144' ' ' GLN . . . 98.09 178.51 33.15 Favored Glycine 0 N--CA 1.504 3.177 0 O-C-N 120.886 -1.134 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 136' ' ' GLU . 69.3 mtt85 -53.98 111.42 0.75 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.942 . . . . 0.0 108.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.563 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -86.78 143.53 27.47 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.116 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.12 129.58 49.36 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.549 0.69 . . . . 0.0 109.254 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -90.75 104.0 16.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.55 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 mp -97.98 119.62 36.93 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.854 0.835 . . . . 0.0 109.331 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.458 ' H ' ' HH ' ' A' ' 152' ' ' TYR . 5.0 ptp85 -105.83 177.69 1.3 Allowed Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.01 161.67 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.86 1.707 . . . . 0.0 111.661 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.81 -179.47 18.39 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.32 136.79 49.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -1.009 . . . . 0.0 110.409 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.458 ' HH ' ' H ' ' A' ' 148' ' ' ARG . 16.8 m-85 -112.08 142.82 44.05 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.642 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 7.5 ptp180 -134.86 -4.99 2.45 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.032 -1.042 . . . . 0.0 112.476 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 57.7 m -165.57 165.66 18.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.903 -1.748 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -52.07 -21.08 2.87 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -82.5 2.5 32.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 0.0 109.652 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.642 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 2.4 m-20 -92.88 -61.68 1.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 12.5 p90 -77.04 16.09 0.6 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.87 37.69 92.42 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.19 -161.93 22.69 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.5 t -146.97 -42.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.3 p -103.82 -155.46 0.53 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.0 t -146.13 11.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -65.09 76.88 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.087 -1.008 . . . . 0.0 112.535 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -102.64 121.56 42.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.129 -0.982 . . . . 0.0 110.155 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.9 -26.88 3.41 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.452 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 1.3 t -135.4 153.49 51.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.602 -1.528 . . . . 0.0 111.249 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 19.7 mt -149.17 143.05 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -123.06 139.99 53.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.966 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 107' ' ' MET . 53.1 ttp180 -98.82 92.52 5.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.444 -0.785 . . . . 0.0 109.293 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 170' ' ' ARG . 88.8 mt -39.24 100.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 170' ' ' ARG . 28.0 m -108.09 65.68 0.64 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 174' ' ' LEU . 42.9 t0 -115.7 72.86 0.82 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.468 0.651 . . . . 0.0 109.567 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.522 ' OXT' ' ND1' ' A' ' 86' ' ' HIS . 14.8 mt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.235 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . -153.7 148.61 19.49 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 89.6 mttt -161.59 145.41 12.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.994 . . . . 0.0 110.604 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.0 tt -134.76 133.67 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 109.691 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.83 128.65 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.409 0.623 . . . . 0.0 109.706 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -89.26 165.96 14.09 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -152.92 132.61 13.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.602 -1.311 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.59 -43.13 60.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 111.313 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 88.9 m-20 -69.63 155.77 39.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.616 -1.302 . . . . 0.0 110.782 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 64' ' ' PRO . 72.0 mtp180 -62.09 -44.85 95.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.709 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.504 ' CG ' ' H ' ' A' ' 12' ' ' PHE . 7.8 p30 -74.97 -95.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 109.191 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.504 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 51.0 m-85 -156.02 56.4 0.59 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.494 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -141.81 -150.93 5.44 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 64.71 -153.37 49.76 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -74.83 120.06 19.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -1.125 . . . . 0.0 109.231 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -106.34 156.7 18.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.871 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.626 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 1.1 t60 -146.01 128.39 15.89 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.634 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.28 121.66 41.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 108.696 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.5 m -122.62 136.55 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.21 -0.932 . . . . 0.0 109.534 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -141.58 15.27 2.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.0 t -145.81 158.19 43.87 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.781 0.8 . . . . 0.0 110.503 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.07 143.66 7.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.68 114.76 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.75 8.9 41.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.07 -1.019 . . . . 0.0 108.68 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -138.85 98.17 3.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.852 -0.53 . . . . 0.0 109.779 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.2 mt -106.54 -25.31 11.88 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.475 ' CD2' HD21 ' A' ' 31' ' ' ASN . 19.4 t-80 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.417 -0.802 . . . . 0.0 109.002 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.2 m -50.54 -58.71 5.17 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 91.4 m-85 -56.14 -49.25 74.46 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.887 -0.508 . . . . 0.0 111.209 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -155.11 149.21 25.84 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.964 -1.085 . . . . 0.0 110.19 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.475 HD21 ' CD2' ' A' ' 27' ' ' HIS . 7.4 t-20 -95.26 -4.74 45.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.384 -0.822 . . . . 0.0 110.344 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -159.91 158.14 30.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.978 . . . . 0.0 108.485 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 14.4 t -159.11 112.89 2.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.905 -1.122 . . . . 0.0 108.419 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.571 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 60.5 m-70 -92.68 1.0 57.51 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.942 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 7.3 t -146.13 141.65 27.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.405 -1.434 . . . . 0.0 110.687 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.0 tt -151.11 146.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 108.921 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -143.07 133.88 25.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.93 -1.106 . . . . 0.0 111.8 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.7 t -105.04 118.89 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -79.83 -33.49 40.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.891 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -167.79 156.51 9.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.385 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.698 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 86.93 -123.19 6.43 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.698 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 99.1 m -168.64 167.75 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.52 141.05 21.64 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.846 -1.159 . . . . 0.0 109.077 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.2 tpt -99.94 115.06 28.78 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.5 m -108.71 142.06 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.976 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 33.2 m-85 -120.02 137.26 54.2 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.809 0.814 . . . . 0.0 111.298 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.493 ' O ' ' NE ' ' A' ' 77' ' ' ARG . 22.6 t0 -71.75 -5.86 37.11 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.056 ' O ' ' OG ' ' A' ' 78' ' ' SER . 36.2 ttm-85 -131.25 166.82 20.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.418 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 1.8 p -79.92 165.25 22.83 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.751 0.786 . . . . 0.0 110.208 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' C ' ' CG ' ' A' ' 51' ' ' PHE . 43.0 t30 63.63 33.06 13.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.713 -0.617 . . . . 0.0 110.812 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.485 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 0.6 OUTLIER 60.83 61.22 1.7 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.948 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.41 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 64.1 mtp -148.39 166.48 27.97 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.248 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.19 -166.64 30.99 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.029 -1.045 . . . . 0.0 110.582 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -57.76 112.88 1.61 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.246 -1.149 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.37 134.9 35.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.724 -0.61 . . . . 0.0 109.398 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -130.78 137.14 49.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.299 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.664 ' CE2' ' NH2' ' A' ' 169' ' ' ARG . 30.5 p90 -98.93 116.51 31.33 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.381 -0.824 . . . . 0.0 109.779 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -107.38 112.71 25.65 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.668 -1.27 . . . . 0.0 111.473 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 60' ' ' ARG . 14.2 ptm180 -85.96 160.34 19.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.437 -0.789 . . . . 0.0 110.927 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 59' ' ' ARG . 60.1 ttt-85 -35.8 114.91 0.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.646 -0.659 . . . . 0.0 110.012 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.73 166.14 31.52 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.594 -1.289 . . . . 0.0 109.947 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -103.75 128.16 51.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -1.016 . . . . 0.0 108.746 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -117.91 90.05 35.66 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.837 . . . . 0.0 109.414 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 10' ' ' ARG . 31.3 Cg_exo -55.86 -11.11 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.639 2.226 . . . . 0.0 111.973 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -170.25 146.15 2.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 108.78 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 30.9 p90 -150.41 31.61 0.66 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.672 -1.268 . . . . 0.0 109.587 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.571 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 26.1 mtp -102.04 -45.66 5.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 109.213 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -96.36 -20.8 18.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -0.953 . . . . 0.0 109.168 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 p -84.17 -12.08 55.5 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.9 mtt -110.31 -28.17 8.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 108.816 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 56.02 2.85 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -130.43 166.92 19.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.935 -1.332 . . . . 0.0 109.287 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 8.7 m120 -117.09 53.25 0.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.409 -0.807 . . . . 0.0 109.287 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.8 m-20 155.33 -168.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.4 p -98.83 -166.47 1.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.954 0.883 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.3 t -77.18 140.97 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 47' ' ' ASP . 11.8 mtm180 -102.59 -19.78 14.71 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.762 -1.211 . . . . 0.0 108.008 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 1.056 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 1.0 OUTLIER -150.11 160.19 43.84 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.629 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.05 159.15 37.65 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.351 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -146.12 142.5 28.57 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.8 160.76 19.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.155 -0.966 . . . . 0.0 108.924 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.493 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 66.2 mt -118.22 95.92 49.07 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.672 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -47.71 148.8 5.59 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.418 2.079 . . . . 0.0 112.476 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.75 43.26 1.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -0.879 . . . . 0.0 109.558 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -110.39 105.83 14.96 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 86' ' ' HIS . 55.8 p-80 -135.94 109.5 7.97 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.62 -64.69 3.77 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 89.5 p -144.43 164.08 31.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.493 -1.004 . . . . 0.0 109.793 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -108.01 113.43 26.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.139 -0.976 . . . . 0.0 109.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -167.5 132.29 1.91 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.254 -0.904 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.492 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 1.6 ttp -116.44 132.6 56.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -106.43 119.22 38.69 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 103' ' ' MET . 18.2 mt -103.73 151.64 22.77 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.074 0.94 . . . . 0.0 112.301 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.4 129.78 31.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 25.9 tt0 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.768 . . . . 0.0 112.217 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.422 ' O ' ' HB2' ' A' ' 124' ' ' SER . 14.8 m-70 -119.86 163.3 17.72 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.032 -1.667 . . . . 0.0 111.106 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 50.1 m -55.99 157.83 4.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.5 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.577 ' N ' ' HG ' ' A' ' 124' ' ' SER . 1.0 OUTLIER 83.42 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.028 -1.045 . . . . 0.0 109.822 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.409 ' HG3' ' O ' ' A' ' 98' ' ' ASP . 2.7 mtt -179.46 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.75 163.01 22.88 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.18 -130.5 10.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.475 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 60.5 mtt85 -104.02 119.7 39.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 108.175 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.521 ' CG ' ' O ' ' A' ' 103' ' ' MET . 12.1 ptt? -90.84 119.05 30.73 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.544 -0.722 . . . . 0.0 110.457 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.4 mpp? -114.79 135.85 53.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.82 133.72 46.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.84 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.66 117.67 25.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 9.6 ttt -125.07 15.45 8.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.496 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 107' ' ' MET . 67.4 m-20 -144.48 -165.01 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 109.895 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.444 ' N ' ' OD1' ' A' ' 109' ' ' ASP . 20.9 p-10 -82.96 128.35 34.38 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.33 77.0 53.37 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.694 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.4 -31.96 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.54 2.16 . . . . 0.0 112.045 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -117.45 75.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.1 mt -68.48 -20.73 64.62 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.816 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.461 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.4 tpt -59.43 -40.39 86.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.4 -21.79 26.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 110.886 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -75.85 -58.81 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.617 -1.302 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -116.76 0.62 12.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 114' ' ' MET . 51.0 m-20 52.79 34.7 16.89 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 122' ' ' PHE . 2.4 ttt -147.35 134.52 20.49 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 p -134.0 11.0 3.93 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.602 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' SER . 38.5 m-20 -129.28 94.96 3.91 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.665 -1.272 . . . . 0.0 112.808 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.665 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -111.56 136.45 50.74 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -96.3 3.96 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.475 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.577 ' HG ' ' N ' ' A' ' 98' ' ' ASP . 3.6 m -146.8 152.59 39.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.341 -1.474 . . . . 0.0 110.01 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.492 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 53.3 t -161.97 159.7 26.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 110.088 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.431 ' HD1' ' HB3' ' A' ' 151' ' ' GLU . 21.6 t60 -145.91 143.48 29.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 96.5 t -113.78 123.41 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 0.0 109.344 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 23.2 ttt -76.91 -22.82 52.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.668 -0.645 . . . . 0.0 109.941 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.5 OUTLIER 170.91 -171.5 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.742 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 63.09 -135.01 43.11 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.1 m-70 -159.96 138.24 10.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.905 . . . . 0.0 109.066 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -128.51 137.77 51.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 111.635 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.7 mt -104.63 130.34 52.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 39.1 t -109.38 141.39 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.918 -1.114 . . . . 0.0 109.408 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.43 125.68 48.56 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 0.0 110.868 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -61.57 -21.45 64.32 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 141' ' ' THR . 82.0 mt-30 -130.32 138.66 33.54 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 137' ' ' GLN . 88.0 Cg_exo -43.06 -177.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.708 2.939 . . . . 0.0 114.385 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.4 t30 49.16 32.44 4.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.847 -0.533 . . . . 0.0 111.071 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.422 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 43.1 m-85 56.93 49.74 13.47 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.682 -0.637 . . . . 0.0 110.469 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 137' ' ' GLN . 87.4 m -137.05 163.29 31.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.255 -0.903 . . . . 0.0 109.454 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.6 175.02 33.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -49.96 109.78 0.32 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -1.158 . . . . 0.0 108.95 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 145' ' ' PHE . 22.8 tm0? -85.48 142.83 28.92 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.093 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.488 ' O ' ' NE2' ' A' ' 144' ' ' GLN . 54.3 m-85 -128.01 132.47 49.13 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.632 0.73 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.517 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 84.8 t80 -94.15 104.11 16.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.627 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -99.26 121.41 41.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.198 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -105.07 177.61 1.35 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.419 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 77.5 Cg_exo -46.64 166.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.834 1.689 . . . . 0.0 111.574 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.06 -167.64 12.47 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.431 ' HB3' ' HD1' ' A' ' 126' ' ' HIS . 7.2 pt-20 -120.84 132.36 54.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.662 -0.904 . . . . 0.0 110.933 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 17.2 m-85 -110.68 144.75 39.14 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.605 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 10.6 ptm180 -135.6 0.19 2.7 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.89 -1.131 . . . . 0.0 112.132 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.565 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.3 p -169.31 167.84 9.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.904 -1.747 . . . . 0.0 109.904 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -59.6 -15.24 17.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -85.24 -1.25 56.73 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.605 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 3.7 m-20 -89.79 -62.04 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.555 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 9.9 p90 -73.32 13.28 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 67.94 35.5 84.58 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.15 -165.66 32.56 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 t -151.07 3.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.8 p -150.78 -157.33 0.8 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 25.1 p -141.41 1.21 1.56 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -64.47 77.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.965 -1.084 . . . . 0.0 111.789 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.8 mtt -107.3 115.6 30.46 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 109.125 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.96 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -125.08 144.71 50.27 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.158 1.479 . . . . 0.0 111.079 -178.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.9 mt -147.48 139.51 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.199 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.664 ' NH2' ' CE2' ' A' ' 57' ' ' PHE . 40.4 ttp180 -127.61 138.59 52.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 110.437 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.704 ' O ' ' N ' ' A' ' 172' ' ' THR . 8.4 ptm180 -97.11 92.5 6.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 171' ' ' ILE . 46.5 mt -31.89 75.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.704 ' N ' ' O ' ' A' ' 170' ' ' ARG . 19.4 m -113.44 69.61 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.864 -1.147 . . . . 0.0 109.786 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 174.06 107.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.251 -0.905 . . . . 0.0 109.65 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.3 mt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.652 179.844 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.269 0.557 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.4 166.9 1.21 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -155.74 143.47 19.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -1.055 . . . . 0.0 110.724 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.419 ' CD1' ' CD2' ' A' ' 43' ' ' PHE . 20.5 tt -135.61 135.34 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.203 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.18 122.97 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.691 -0.631 . . . . 0.0 109.338 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -88.84 151.56 22.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 108.652 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -138.07 137.85 38.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 109.387 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -73.5 -43.95 58.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -0.833 . . . . 0.0 110.647 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 60.7 m-20 -81.69 156.77 24.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.838 -1.164 . . . . 0.0 110.535 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -70.71 -37.13 73.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -80.63 35.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 54.55 55.7 7.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.614 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.09 -151.84 5.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 59.85 -147.26 43.97 Favored Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.178 -1.189 . . . . 0.0 110.155 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -77.81 129.77 35.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.396 -1.061 . . . . 0.0 109.084 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -112.47 156.22 22.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.845 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -145.21 123.26 12.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 108.821 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -97.71 118.77 35.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -112.77 136.67 52.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.4 mtp -130.1 6.56 4.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.2 p -149.74 170.98 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 110.156 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 55.8 p30 -63.77 151.12 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 t -143.47 120.64 11.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -6.82 57.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.944 -1.097 . . . . 0.0 109.879 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -140.09 94.28 2.74 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 108.817 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.3 mt -91.06 -19.59 22.99 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.109 -0.994 . . . . 0.0 108.42 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -56.27 -36.53 68.69 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.92 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.1 t -53.57 -56.4 17.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -60.53 -49.67 76.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 0.0 111.065 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -152.93 151.86 30.82 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.111 -0.993 . . . . 0.0 110.503 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -100.14 -7.26 25.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.334 -0.854 . . . . 0.0 110.102 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -152.73 151.46 30.54 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.462 ' O ' ' CZ ' ' A' ' 66' ' ' TYR . 43.3 t -157.44 120.41 3.97 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.518 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 18.0 m-70 -102.7 -4.03 25.66 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -137.84 139.33 39.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.795 -1.19 . . . . 0.0 111.063 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.7 mt -132.97 142.94 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -134.47 106.13 6.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.872 -1.143 . . . . 0.0 111.323 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.75 117.09 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -83.37 -31.97 26.45 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.364 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 t -172.23 154.8 3.42 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.168 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.92 -131.66 10.75 Favored Glycine 0 N--CA 1.486 2.007 0 CA-C-O 122.565 1.091 . . . . 0.0 111.47 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.7 m -154.1 152.66 30.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.419 ' CD2' ' CD1' ' A' ' 4' ' ' ILE . 11.1 t80 -146.77 139.2 24.92 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.556 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.9 tpt -109.99 123.53 49.81 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -114.19 145.82 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.916 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.8 m-85 -121.12 141.76 50.5 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.798 0.808 . . . . 0.0 111.224 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 24.5 t0 -76.77 -10.54 59.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.913 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.144 ' O ' ' OG ' ' A' ' 78' ' ' SER . 18.3 ttm180 -127.56 167.39 16.41 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 44.2 p -78.47 159.19 28.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 110.911 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.61 33.4 3.91 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.649 -0.657 . . . . 0.0 110.958 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.484 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.2 m-85 60.38 57.23 2.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.972 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.0 mmt -143.64 173.3 11.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.137 -0.977 . . . . 0.0 110.385 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.98 -162.69 39.18 Favored Glycine 0 N--CA 1.503 3.123 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 59.0 mtp180 -60.48 119.75 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 108.051 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -102.11 133.82 46.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.06 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 66.2 m-85 -123.16 133.67 54.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.059 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -98.18 117.49 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.221 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.3 mt -118.66 117.55 29.25 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.021 -1.05 . . . . 0.0 110.729 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.502 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.6 ptm180 -92.95 164.62 13.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.244 -0.91 . . . . 0.0 110.772 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.502 ' C ' ' O ' ' A' ' 59' ' ' ARG . 34.0 ttp180 -32.12 116.07 0.19 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.638 -0.664 . . . . 0.0 110.727 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.89 167.75 31.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -106.99 130.11 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -1.062 . . . . 0.0 108.925 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -114.31 91.42 23.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.573 -0.705 . . . . 0.0 109.551 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.09 -14.43 23.47 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.641 2.227 . . . . 0.0 112.429 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -169.3 146.34 3.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.897 -1.127 . . . . 0.0 108.088 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 16.6 p90 -148.94 -9.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.505 -1.372 . . . . 0.0 111.725 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.518 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 15.4 mtt -63.62 -39.93 95.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.326 -1.484 . . . . 0.0 110.099 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -92.14 -24.7 19.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.889 -1.132 . . . . 0.0 109.834 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -86.37 -8.88 57.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.527 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.585 ' SD ' ' CD1' ' A' ' 56' ' ' TYR . 19.7 mmt -111.29 -26.11 9.32 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . 80.97 49.24 5.71 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.9 mtp -127.4 154.0 45.55 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.177 -1.19 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 18.7 t-20 -107.01 60.32 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.092 -1.005 . . . . 0.0 109.014 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 7.6 p30 149.55 -169.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.457 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.2 p -98.89 -165.43 1.24 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 109.803 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.5 m -85.51 147.73 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -108.55 -10.9 15.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.716 -1.24 . . . . 0.0 108.154 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 1.144 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 2.5 p -148.34 164.48 33.93 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.92 -1.112 . . . . 0.0 109.696 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.85 151.23 16.11 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.88 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -136.72 140.35 42.58 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.331 0.586 . . . . 0.0 109.492 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.5 ttm -96.33 157.39 15.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.202 -0.936 . . . . 0.0 108.606 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.561 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 77.5 mt -105.42 102.82 39.56 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.0 109.933 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.42 175.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.322 2.015 . . . . 0.0 112.075 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.2 mt -82.47 51.11 1.77 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.914 . . . . 0.0 109.727 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -101.19 87.54 3.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.232 -0.918 . . . . 0.0 109.719 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.561 ' HA ' ' H ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER -142.16 59.44 1.47 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 109.105 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.65 -62.13 6.68 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.641 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 96.6 p -138.12 162.51 34.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.534 -0.98 . . . . 0.0 110.136 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -112.01 116.57 30.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.818 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -171.39 129.35 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 38.3 ttm -117.94 126.32 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 109.609 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -102.19 120.96 41.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' MET . 13.7 mt -104.17 152.61 21.93 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.31 1.052 . . . . 0.0 112.696 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 99' ' ' MET . 24.6 m-85 -136.88 122.58 19.83 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -59.43 -22.88 62.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.439 -0.788 . . . . 0.0 111.814 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' ' 124' ' ' SER . 4.9 m-70 -114.4 163.73 14.93 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.617 -1.302 . . . . 0.0 111.206 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.9 p -58.78 159.34 6.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 m-20 77.67 -92.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.603 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -169.48 39.05 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.66 -160.62 24.89 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.767 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 68.05 -147.88 48.34 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.87 133.79 38.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.111 -1.229 . . . . 0.0 109.369 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.487 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.2 ptt? -93.9 116.58 29.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 0.0 110.469 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 15.4 mtm -118.02 137.5 52.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.256 -0.902 . . . . 0.0 108.633 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -99.36 138.95 35.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 109.459 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.01 118.94 24.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 17.3 ttt -129.28 14.93 6.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.426 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -139.78 -170.35 2.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.943 . . . . 0.0 109.968 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.42 127.21 31.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.402 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -115.24 85.45 12.77 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.676 -179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.89 -23.64 6.59 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.328 2.019 . . . . 0.0 112.047 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -133.92 87.13 2.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 10.9 mt -75.07 -34.63 61.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.211 -0.931 . . . . 0.0 110.343 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.74 -40.96 76.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -80.66 -23.44 39.67 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.188 -0.945 . . . . 0.0 110.571 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -81.12 -55.23 4.89 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.515 -1.366 . . . . 0.0 111.397 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -106.32 -1.38 23.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.041 -1.037 . . . . 0.0 110.351 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.3 m120 63.29 32.89 14.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.812 -1.18 . . . . 0.0 109.12 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.5 ptm -154.91 137.66 15.29 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.9 t -121.07 9.7 10.59 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.752 -0.592 . . . . 0.0 109.616 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 163' ' ' SER . 16.3 m-20 -135.78 95.54 3.25 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.657 -1.277 . . . . 0.0 113.52 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -105.18 137.4 43.01 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.334 -0.854 . . . . 0.0 108.771 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.66 ' CD2' ' HH ' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -98.38 1.45 46.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 111.345 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 125' ' ' CYS . 5.5 t -146.3 150.12 35.13 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.079 -1.638 . . . . 0.0 109.932 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 124' ' ' SER . 11.2 m -157.0 156.7 33.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.451 ' C ' ' CD2' ' A' ' 126' ' ' HIS . 6.0 t60 -142.3 138.77 31.54 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.004 -1.06 . . . . 0.0 109.067 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.64 126.79 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.05 -1.032 . . . . 0.0 109.56 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.486 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 84.0 mmm -76.58 -26.5 55.11 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.641 ' CB ' ' H ' ' A' ' 88' ' ' SER . 1.4 m-20 165.59 -168.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.561 ' H ' ' HA ' ' A' ' 86' ' ' HIS . . . 69.97 -173.8 37.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.561 ' NE2' ' CG2' ' A' ' 82' ' ' ILE . 29.9 m170 -116.4 122.31 44.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.997 . . . . 0.0 109.241 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.57 121.01 43.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 111.551 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.8 123.7 40.57 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.0 t -109.87 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.983 -1.073 . . . . 0.0 110.813 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -121.65 123.62 42.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.744 -0.597 . . . . 0.0 110.838 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 30.7 tt0 -58.64 -26.93 64.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.404 ' O ' ' HB3' ' A' ' 167' ' ' SER . 13.9 mt-30 -119.86 155.55 54.98 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.463 ' O ' ' OG1' ' A' ' 141' ' ' THR . 28.5 Cg_endo -63.11 -174.09 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.028 2.486 . . . . 0.0 113.356 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.0 m120 50.83 31.83 6.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.427 -0.796 . . . . 0.0 110.43 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.416 ' H ' ' CB ' ' A' ' 167' ' ' SER . 40.4 m-85 56.07 51.65 11.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.571 -0.706 . . . . 0.0 110.237 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 12.2 p -140.79 166.13 25.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 0.0 109.779 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.33 173.41 29.86 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -50.65 113.74 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -1.062 . . . . 0.0 108.655 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 13.5 mt-30 -84.0 136.13 34.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.453 -0.779 . . . . 0.0 110.062 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -119.87 125.01 47.47 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.47 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 72.9 t80 -88.07 107.41 18.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.72 124.69 49.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.206 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 149' ' ' PRO . 0.5 OUTLIER -115.32 169.64 6.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 148' ' ' ARG . 3.6 Cg_exo -35.27 160.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.59 2.194 . . . . 0.0 112.127 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.99 -168.31 12.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -118.95 129.87 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.567 -0.96 . . . . 0.0 110.842 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 125' ' ' CYS . 63.1 m-85 -109.14 140.87 42.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.682 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 57.6 mtt85 -131.36 -8.32 3.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 112.694 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.5 m -169.48 177.46 4.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.026 -1.671 . . . . 0.0 111.152 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.66 ' HH ' ' CD2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -60.02 -14.17 15.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.718 . . . . 0.0 109.428 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -91.64 0.97 57.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.12 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.682 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -90.05 -62.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 108.711 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -75.88 16.2 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.14 33.93 88.34 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.36 -161.07 31.41 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.94 -39.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.4 p -103.77 -160.96 0.8 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.1 t -145.18 7.57 1.18 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 136' ' ' GLU . 51.1 ttt-85 -64.39 79.74 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.003 -1.06 . . . . 0.0 111.926 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 60.9 mtt -103.16 116.2 32.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -110.72 -24.41 5.56 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.416 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -134.19 148.83 50.96 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.448 1.624 . . . . 0.0 111.252 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 mt -147.27 142.92 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.07 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -129.61 141.8 50.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.381 -0.825 . . . . 0.0 111.035 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 172' ' ' THR . 18.8 ptt180 -95.44 88.3 5.05 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.72 0.771 . . . . 0.0 108.992 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 171' ' ' ILE . 57.5 mt -54.72 81.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.434 -0.791 . . . . 0.0 111.607 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 170' ' ' ARG . 11.8 m -94.29 64.61 3.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.834 -1.166 . . . . 0.0 109.37 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -94.64 -120.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.307 1.051 . . . . 0.0 109.797 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.7 mt . . . . . 0 C--N 1.283 -2.326 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.794 -179.676 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.1 mmm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . -55.49 159.52 6.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 87.1 mttt -161.16 146.77 14.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.713 -0.875 . . . . 0.0 110.533 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.8 tt -134.63 135.87 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.808 . . . . 0.0 109.899 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.6 mt -122.19 127.18 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.699 -0.625 . . . . 0.0 109.788 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -88.95 160.05 17.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -148.2 136.05 20.92 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.82 -1.175 . . . . 0.0 108.731 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -76.69 -39.14 53.02 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 111.114 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -81.73 163.01 22.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.779 -1.201 . . . . 0.0 110.57 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -75.92 -46.65 28.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' C ' HD21 ' A' ' 11' ' ' ASN . 0.4 OUTLIER -80.61 44.13 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.056 -1.028 . . . . 0.0 109.761 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 53.44 70.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.51 -156.4 7.6 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.05 -147.43 44.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -75.01 125.82 29.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -1.191 . . . . 0.0 109.247 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -110.9 153.92 24.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -144.89 125.25 13.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.509 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -97.4 121.65 39.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.0 m -120.43 141.22 50.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 109.599 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -140.92 12.24 2.24 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.0 m -146.01 160.77 41.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.663 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -58.12 148.34 26.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 110.517 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.42 116.53 10.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.33 -4.47 58.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 108.729 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 31.4 p-10 -136.08 99.84 4.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.624 -0.673 . . . . 0.0 109.656 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.2 mt -103.78 -24.62 13.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.286 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.607 ' CE1' HD22 ' A' ' 31' ' ' ASN . 34.5 t-80 -57.74 -40.39 79.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 108.75 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -50.28 -50.33 50.69 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -65.45 -52.12 55.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -0.994 . . . . 0.0 110.916 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.2 150.29 29.68 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.003 -1.06 . . . . 0.0 110.376 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.607 HD22 ' CE1' ' A' ' 27' ' ' HIS . 3.1 m120 -95.81 -5.63 41.35 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.186 -0.946 . . . . 0.0 110.426 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -156.81 155.56 31.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.095 -1.003 . . . . 0.0 108.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.526 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 33.0 t -158.04 117.02 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -97.53 -2.87 40.91 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.724 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.501 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 9.7 t -142.71 149.27 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.759 -1.213 . . . . 0.0 111.161 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 tt -157.35 148.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.08 126.31 18.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.832 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.4 t -102.43 120.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -83.85 -29.04 27.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 109.084 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.59 ' HG ' ' N ' ' A' ' 41' ' ' GLY . 17.2 t -169.78 152.75 4.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.863 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.59 ' N ' ' HG ' ' A' ' 40' ' ' SER . . . 89.93 -122.61 6.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 43' ' ' PHE . 29.8 t -171.47 169.57 6.12 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.583 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -154.6 142.24 19.85 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 108.904 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.8 mmm -102.03 118.11 36.23 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.2 m -109.2 144.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.914 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.489 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 58.8 m-85 -120.43 141.8 49.81 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.754 0.787 . . . . 0.0 111.563 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 29.9 t0 -76.09 -9.76 58.87 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.157 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.752 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.6 ttt180 -127.89 159.74 33.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.463 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 12.6 p -71.81 157.83 37.18 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.729 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 71.09 33.54 2.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.637 -0.664 . . . . 0.0 111.326 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CB ' ' NH2' ' A' ' 80' ' ' ARG . 1.9 m-85 59.59 56.33 3.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 109.757 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.1 mtt -143.49 172.05 13.32 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.48 -165.27 42.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.48 123.89 17.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.114 -1.227 . . . . 0.0 108.304 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 46' ' ' TYR . 6.7 tt0 -108.33 137.51 46.18 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.31 134.84 48.12 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.014 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.569 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 20.1 p90 -96.04 120.98 37.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 10.0 mp -111.42 113.52 26.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.059 -1.026 . . . . 0.0 111.532 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.4 ptt180 -86.13 161.08 19.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 111.034 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 59' ' ' ARG . 40.5 ttp85 -37.8 118.62 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.582 0.706 . . . . 0.0 110.365 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.98 178.09 41.29 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.79 129.34 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.09 100.21 53.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.16 -6.01 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.169 1.913 . . . . 0.0 112.619 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 34.4 p-10 -168.71 136.54 2.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.328 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 36.6 p90 -148.93 24.0 0.95 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.596 -1.315 . . . . 0.0 111.298 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.1 mmt -89.13 -39.71 13.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.673 -1.267 . . . . 0.0 108.902 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -99.28 -17.09 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.0 109.458 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 -12.62 45.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.26 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.2 mtt -115.74 -27.62 7.0 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 108.895 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.92 48.37 5.81 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.328 -0.858 . . . . 0.0 111.14 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.0 ttm -120.92 138.54 54.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.932 -1.334 . . . . 0.0 109.819 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.0 t30 -90.7 56.65 3.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.048 -1.033 . . . . 0.0 109.277 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.1 p30 151.79 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.526 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.2 p -98.61 -166.96 1.43 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.927 0.87 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.4 m -81.34 147.3 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.463 ' HB3' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -105.77 -11.51 16.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.752 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -151.47 170.61 19.17 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.787 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 78' ' ' SER . 26.6 p -162.3 146.13 11.91 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.998 0.904 . . . . 0.0 110.4 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.628 ' NH1' ' NH2' ' A' ' 148' ' ' ARG . 41.2 ttm180 -132.83 139.76 47.63 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.3 ttp -94.53 152.42 18.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 24.3 mt -92.02 120.11 67.98 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 108.634 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.15 155.36 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.026 1.817 . . . . 0.0 112.116 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.7 50.17 1.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.319 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.501 ' NE2' ' OD2' ' A' ' 129' ' ' ASP . 85.9 t60 -108.12 123.71 49.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.358 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -137.81 86.05 2.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 0.0 109.999 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -101.67 -75.76 1.14 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 80.8 p -144.98 169.37 18.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -1.054 . . . . 0.0 110.391 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -121.06 125.84 48.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.186 -0.947 . . . . 0.0 110.4 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.529 ' CE ' ' SD ' ' A' ' 128' ' ' MET . 33.1 ttpt -168.38 129.07 1.28 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.577 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 39.8 ttm -120.17 135.22 55.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 109.088 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -105.74 120.24 41.19 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 103' ' ' MET . 14.8 mt -103.05 149.49 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.156 0.979 . . . . 0.0 112.128 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 99' ' ' MET . 42.0 m-85 -133.8 124.71 27.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 87.7 tt0 -63.7 -26.15 68.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.535 ' O ' ' HB3' ' A' ' 124' ' ' SER . 45.6 m170 -110.38 164.39 12.73 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.602 -1.311 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.8 p -61.19 157.84 15.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 110.046 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 97' ' ' SER . 0.8 OUTLIER 81.4 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.2 mmt -162.57 35.5 0.11 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.33 -153.79 24.03 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.081 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 58.56 177.95 0.87 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.423 ' O ' ' CE ' ' A' ' 104' ' ' MET . 28.2 mmt180 -64.25 136.21 56.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.24 . . . . 0.0 109.273 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.2 ptt? -98.11 122.47 41.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.993 -1.067 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.423 ' CE ' ' O ' ' A' ' 102' ' ' ARG . 3.8 mtm -118.87 138.93 52.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.45 138.5 40.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.616 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 tp -127.84 118.61 24.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.168 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.81 -11.09 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 0.0 109.728 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.32 -159.65 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -0.934 . . . . 0.0 109.86 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.83 137.49 32.28 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -116.06 87.28 18.69 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.338 -0.851 . . . . 0.0 109.578 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.506 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.7 Cg_endo -78.09 -27.06 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.089 1.859 . . . . 0.0 112.249 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -134.16 84.1 2.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.5 mt -67.94 -26.27 65.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.004 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.565 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.4 tpt -57.67 -40.02 78.43 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.272 -0.893 . . . . 0.0 109.074 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -82.85 -23.43 33.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -77.36 -62.36 1.68 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.644 -1.285 . . . . 0.0 110.9 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.492 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.0 m-85 -105.73 4.48 30.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.7 t-20 52.57 32.72 12.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.65 -1.281 . . . . 0.0 107.612 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.453 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 5.4 ttp -147.23 132.01 17.96 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 27.8 t -115.26 4.68 14.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 110.223 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 163' ' ' SER . 14.7 m-20 -132.63 101.08 5.16 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 118.416 -1.314 . . . . 0.0 114.052 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -111.76 135.48 52.32 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -96.1 2.06 52.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 111.388 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.535 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.0 t -149.86 156.34 41.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.928 -1.733 . . . . 0.0 110.694 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.577 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 11.1 t -164.29 163.05 22.71 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.243 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.577 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 13.6 t60 -150.07 146.61 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.169 -0.957 . . . . 0.0 109.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.454 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.1 t -115.95 125.02 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 108.96 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.529 ' SD ' ' CE ' ' A' ' 90' ' ' LYS . 17.9 ttt -81.26 -32.55 33.25 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 130' ' ' GLY . 13.6 t70 -174.4 175.0 2.68 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.537 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 77.11 -140.66 25.03 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.633 ' ND1' ' HH ' ' A' ' 146' ' ' TYR . 95.4 m-70 -151.8 135.37 16.18 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.548 -0.971 . . . . 0.0 109.284 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -127.39 133.16 50.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.119 -0.988 . . . . 0.0 112.212 -178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 mt -106.02 134.45 49.12 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 55.0 t -111.12 144.19 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.985 -1.072 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -122.13 124.02 42.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.619 -0.675 . . . . 0.0 111.124 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.5 tt0 -57.49 -27.41 62.5 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -118.52 155.8 51.81 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.47 -179.64 0.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.271 2.647 . . . . 0.0 113.781 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.601 ' N ' ' OG ' ' A' ' 167' ' ' SER . 13.6 m120 49.82 35.14 8.66 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.696 0.76 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.646 ' H ' ' CB ' ' A' ' 167' ' ' SER . 7.7 m-85 57.33 51.42 10.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.758 -0.589 . . . . 0.0 110.378 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 64.9 m -136.56 164.25 28.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.57 179.42 36.46 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.03 108.73 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -1.108 . . . . 0.0 108.808 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.516 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 20.8 pt20 -87.52 143.74 27.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.783 0.802 . . . . 0.0 110.46 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -125.2 144.32 50.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.633 ' HH ' ' ND1' ' A' ' 131' ' ' HIS . 39.4 t80 -104.57 103.57 13.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.302 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 mp -101.2 122.72 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.628 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 5.2 ptp180 -110.83 173.12 3.05 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 148' ' ' ARG . 68.3 Cg_exo -37.29 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.982 1.788 . . . . 0.0 112.113 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 126' ' ' HIS . . . 117.07 -166.16 12.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -123.86 136.91 54.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.335 -1.097 . . . . 0.0 110.631 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 21.2 m-85 -114.31 144.61 42.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.497 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 14.0 ptm180 -133.17 -1.66 3.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.084 . . . . 0.0 112.736 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.557 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 3.7 t -171.07 172.3 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.175 -1.578 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -62.84 -8.19 6.5 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.398 -0.814 . . . . 0.0 109.149 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -92.74 -1.14 57.07 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.172 -0.955 . . . . 0.0 108.819 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 154' ' ' SER . 10.5 m-20 -91.51 -60.08 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.511 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.7 p90 -76.45 16.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.54 40.24 96.0 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -104.56 -165.61 24.46 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.52 -39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.1 p -106.5 -161.41 0.79 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.3 p -137.56 5.62 2.69 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.474 -0.767 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 136' ' ' GLU . 70.5 ttt180 -66.79 75.8 0.11 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.889 -1.132 . . . . 0.0 112.142 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -100.5 116.93 33.6 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.095 . . . . 0.0 109.62 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.19 -25.77 4.9 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.646 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -134.2 151.51 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.361 -1.67 . . . . 0.0 111.562 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mt -146.69 140.95 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.692 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -126.9 144.17 51.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 171' ' ' ILE . 17.1 ptt180 -99.89 91.37 4.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.584 ' C ' ' O ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -32.78 104.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 170' ' ' ARG . 49.6 m -114.74 67.03 0.68 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -147.91 91.18 1.91 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.2 tp . . . . . 0 C--N 1.3 -1.586 0 CA-C-O 117.89 -1.053 . . . . 0.0 109.264 179.568 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.04 164.95 0.22 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -148.26 136.17 20.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.56 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.3 mm -122.46 119.65 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.509 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.1 mt -113.41 117.17 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.205 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.76 132.42 36.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.559 -0.713 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.11 130.19 56.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.739 -1.226 . . . . 0.0 109.889 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.11 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.66 -0.65 . . . . 0.0 109.952 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -80.96 158.43 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 109.703 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -78.86 -37.75 39.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -84.44 43.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.986 . . . . 0.0 109.813 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 52.68 75.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.53 -171.03 34.74 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.25 -148.41 31.19 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -78.39 115.79 18.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 0.0 108.928 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -96.74 156.42 16.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.486 -0.759 . . . . 0.0 109.986 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.621 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.9 t60 -145.14 126.65 15.04 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.154 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -96.62 118.92 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -117.26 133.0 56.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.185 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -138.05 6.18 2.61 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 109.386 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -138.56 150.66 46.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.206 -0.934 . . . . 0.0 110.693 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 36.2 p-10 -47.27 144.92 2.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.46 -0.775 . . . . 0.0 110.034 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 25' ' ' ASP . 42.4 t -144.07 110.85 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.49 -17.32 49.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 108.6 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.457 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 t0 -126.73 100.72 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.5 mt -97.94 -14.48 20.61 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' SER . 18.7 t-80 -59.62 -41.32 90.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' HIS . 21.0 m -50.9 -57.28 8.91 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.621 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 52.6 m-85 -58.97 -53.52 57.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.634 -0.666 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -152.08 150.25 29.72 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.958 -1.089 . . . . 0.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -98.82 -2.18 38.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.834 . . . . 0.0 110.817 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.414 ' CD ' ' HE2' ' A' ' 34' ' ' HIS . 63.8 ttm-85 -161.72 158.36 25.74 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.053 -1.029 . . . . 0.0 108.52 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.554 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 27.9 t -161.35 128.16 3.97 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.414 ' HE2' ' CD ' ' A' ' 32' ' ' ARG . 12.9 m-70 -103.55 -20.64 13.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 109.723 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 t -134.04 146.4 50.32 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.996 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.54 143.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -129.42 113.45 14.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 111.34 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.32 114.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.53 -34.35 41.18 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.105 -0.997 . . . . 0.0 108.976 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 t -171.52 159.39 5.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.902 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.04 179.37 52.84 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.16 158.18 18.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.723 -0.869 . . . . 0.0 109.822 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -147.63 137.34 22.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.812 -1.18 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.6 tpt -107.05 127.83 53.82 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.7 m -118.53 144.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.945 -179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 33.5 m-85 -120.39 143.22 48.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.712 0.768 . . . . 0.0 111.334 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 28.4 t0 -77.99 -12.18 59.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.723 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.1 ttm180 -126.54 156.41 40.86 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 p -71.4 151.37 44.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.542 -0.724 . . . . 0.0 111.078 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 t30 76.1 36.23 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.814 -0.554 . . . . 0.0 111.22 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 80' ' ' ARG . 7.1 m-85 59.51 56.3 3.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.0 mtt -144.98 173.75 11.61 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.071 -1.018 . . . . 0.0 110.722 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.27 -165.88 45.43 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.32 124.52 20.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -106.85 133.82 50.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.84 137.95 54.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -101.25 116.64 33.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -0.831 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.0 mt -117.49 117.33 29.16 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.004 -1.06 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.521 ' O ' ' C ' ' A' ' 60' ' ' ARG . 37.4 ptt180 -99.67 163.98 12.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.435 -0.791 . . . . 0.0 111.332 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 59' ' ' ARG . 67.5 ttt180 -27.49 111.43 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.465 0.65 . . . . 0.0 110.741 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.69 170.5 36.51 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -107.74 124.86 50.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -105.87 100.46 27.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.12 -18.81 26.94 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.401 2.067 . . . . 0.0 113.221 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.31 140.6 3.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 108.403 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.1 p90 -148.59 29.24 0.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.746 -1.221 . . . . 0.0 110.432 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.4 mmt -98.19 -42.99 7.18 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.095 . . . . 0.0 109.092 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -100.63 -15.9 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 m -86.65 -16.53 36.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.196 -0.94 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.1 mtt -114.57 -28.23 7.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.0 108.621 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.86 52.64 4.03 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.9 mtp -120.91 140.54 51.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -1.03 . . . . 0.0 109.493 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 50.5 t30 -94.29 54.13 1.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.914 -1.116 . . . . 0.0 109.334 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.55 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.554 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.5 p -95.22 -167.25 1.59 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.033 -1.042 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.4 m -80.78 145.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -104.42 -14.67 15.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.723 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -139.97 165.48 27.22 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.155 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 78' ' ' SER . 12.4 m -161.0 145.9 13.98 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.623 0.725 . . . . 0.0 110.114 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.664 ' NH1' ' HE ' ' A' ' 148' ' ' ARG . 43.0 ttm180 -134.45 137.24 43.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.661 -0.65 . . . . 0.0 109.33 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 52.3 ttp -92.34 152.96 19.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.214 -0.929 . . . . 0.0 109.024 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.1 mt -106.31 126.14 31.21 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -75.43 154.63 40.63 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.182 1.921 . . . . 0.0 112.12 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.1 mt -77.09 48.33 0.6 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.863 . . . . 0.0 109.136 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -88.1 122.82 32.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.4 -0.812 . . . . 0.0 109.446 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.426 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 16.5 t-160 -134.68 82.2 1.95 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.211 -0.931 . . . . 0.0 110.268 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.78 -94.31 1.66 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.5 m -115.8 141.59 47.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.581 -0.952 . . . . 0.0 109.829 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.85 110.38 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -166.0 130.32 2.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 44.4 ttm -110.9 130.1 55.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 109.217 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.5 HH21 ' CD2' ' A' ' 126' ' ' HIS . 78.2 mtm180 -104.23 113.85 27.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.8 mt -99.37 146.65 26.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.036 0.922 . . . . 0.0 111.98 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 36.5 m-85 -131.52 125.8 33.31 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 62.2 tt0 -63.58 -27.09 69.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.261 -0.899 . . . . 0.0 112.198 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.832 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.7 m-70 -109.24 161.06 15.6 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.488 -1.382 . . . . 0.0 111.674 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 76.8 p -59.48 160.49 6.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.814 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 28.1 t0 81.23 -91.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -171.01 40.76 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.29 -152.44 11.69 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 64.04 -174.76 11.77 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -73.22 139.45 46.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 8.3 ptp -97.35 117.47 31.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.09 -1.006 . . . . 0.0 110.36 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 104' ' ' MET . 2.8 mpp? -111.81 138.63 48.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -106.57 136.9 45.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.822 . . . . 0.0 109.997 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 tp -130.37 121.91 26.85 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.424 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 11.2 ttt -121.21 6.28 10.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.368 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 107' ' ' MET . 78.4 m-20 -134.99 -163.33 1.36 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.337 -0.852 . . . . 0.0 109.832 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 168' ' ' ILE . 64.0 t0 -86.25 133.33 33.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.533 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -115.19 90.21 23.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.862 . . . . 0.0 109.797 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -78.66 -26.76 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.066 1.844 . . . . 0.0 111.733 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -135.01 86.7 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.533 ' CD2' ' HG ' ' A' ' 110' ' ' CYS . 11.8 mt -67.91 -27.55 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.2 mmt -55.48 -38.18 68.8 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.775 0.798 . . . . 0.0 109.041 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.69 -22.33 26.13 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.167 -0.958 . . . . 0.0 110.927 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.421 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 62.3 ttm-85 -80.51 -60.22 2.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.469 -1.394 . . . . 0.0 111.426 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -108.53 -0.2 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 110.085 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.1 t-20 55.83 34.39 23.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 0.0 108.384 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ptm -152.22 136.8 16.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.2 m -123.75 9.46 8.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.977 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m-20 -131.11 97.73 4.37 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 118.469 -1.292 . . . . 0.0 113.26 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -112.23 137.11 50.8 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.606 ' N ' ' HD1' ' A' ' 123' ' ' HIS . 1.3 m80 -96.17 6.69 48.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 111.147 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.832 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 3.7 p -154.55 158.59 40.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.915 -1.741 . . . . 0.0 110.348 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.1 t -168.62 168.04 11.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.27 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.564 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 17.5 t60 -152.67 148.38 27.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.323 -0.861 . . . . 0.0 109.337 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.451 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 52.9 t -114.93 124.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.73 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 77.9 mmm -74.82 -25.27 58.9 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.508 0.67 . . . . 0.0 109.394 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.8 OUTLIER 167.67 179.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.088 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 131' ' ' HIS . . . 74.94 -137.66 22.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 130' ' ' GLY . 41.2 m80 -153.98 130.51 10.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.623 -0.927 . . . . 0.0 109.185 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -119.5 130.36 55.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.233 -0.917 . . . . 0.0 111.962 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 128.21 51.36 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 48.7 t -111.01 144.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.718 -1.239 . . . . 0.0 111.224 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.74 126.12 48.17 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.833 -0.542 . . . . 0.0 111.249 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.1 -27.54 68.44 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.853 ' O ' ' OG ' ' A' ' 167' ' ' SER . 7.1 mt-30 -120.25 152.87 55.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.96 -175.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.283 2.655 . . . . 0.0 113.523 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m120 49.99 31.82 5.13 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.538 0.685 . . . . 0.0 109.93 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.436 ' OH ' ' OD2' ' A' ' 109' ' ' ASP . 13.9 m-85 56.08 52.68 10.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.103 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 86.9 m -139.57 164.59 29.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.71 177.68 32.36 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -54.08 109.56 0.49 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 108.752 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -86.99 147.02 25.91 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.049 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.81 140.46 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.456 ' HH ' ' CD2' ' A' ' 131' ' ' HIS . 78.3 t80 -101.19 104.73 15.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 109.708 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.44 ' CA ' ' HH ' ' A' ' 152' ' ' TYR . 6.8 mp -99.76 120.5 39.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 0.0 109.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.837 ' N ' ' HH ' ' A' ' 152' ' ' TYR . 4.1 ptt85 -109.48 163.6 16.68 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 148' ' ' ARG . 80.9 Cg_exo -31.78 158.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.801 2.334 . . . . 0.0 112.534 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 126' ' ' HIS . . . 114.72 -166.45 12.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.62 132.54 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.396 -1.061 . . . . 0.0 110.485 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.837 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 84.9 m-85 -105.76 143.1 34.38 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.593 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 63.2 mtm-85 -125.91 -10.86 6.61 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 112.95 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.563 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.7 t -173.65 -179.17 1.76 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.891 -1.756 . . . . 0.0 111.172 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -62.21 -15.26 45.5 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.1 0.05 56.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 108.565 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.593 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -58.53 2.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.716 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.557 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.6 p90 -77.51 13.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.723 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 69.12 39.37 83.65 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -110.09 -161.68 18.64 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.6 t -143.06 -39.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 31.3 p -109.03 -152.28 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.8 p -146.35 9.29 1.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.522 -0.736 . . . . 0.0 109.852 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -65.98 81.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.002 -1.061 . . . . 0.0 111.989 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.8 mtt -105.73 118.18 35.92 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.936 -1.102 . . . . 0.0 109.708 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.33 -24.45 6.2 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.853 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -136.7 152.01 49.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.52 -1.576 . . . . 0.0 111.276 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 16.3 mt -147.62 142.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -128.95 144.6 51.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.46 -0.775 . . . . 0.0 110.662 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.695 ' O ' ' N ' ' A' ' 172' ' ' THR . 19.3 ptt180 -94.6 76.16 3.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.457 -0.777 . . . . 0.0 109.751 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 170' ' ' ARG . 36.5 mt -19.5 72.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 170' ' ' ARG . 3.8 t -111.56 71.59 0.75 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.963 -1.086 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 33.0 p-10 -177.19 102.35 0.05 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.179 -0.951 . . . . 0.0 110.185 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.379 179.916 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.551 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.553 0.692 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.426 ' H ' ' H3 ' ' A' ' 1' ' ' MET . . . -178.18 158.85 23.96 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 15.8 ptpt 176.82 157.37 0.3 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.253 -1.145 . . . . 0.0 110.466 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.0 tt -136.59 135.06 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.529 0.681 . . . . 0.0 110.249 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.7 mt -117.48 124.36 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.644 -0.66 . . . . 0.0 109.412 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.23 161.27 18.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.332 -0.855 . . . . 0.0 108.721 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 29.1 m-85 -147.26 136.46 22.49 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.775 -1.203 . . . . 0.0 108.847 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -76.53 -39.66 52.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.76 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 35' ' ' SER . 49.0 t0 -81.25 138.73 35.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.874 -1.141 . . . . 0.0 110.22 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -59.66 -39.75 85.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.483 -0.76 . . . . 0.0 110.007 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -84.53 41.06 0.82 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 109.564 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 54.29 85.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.525 -0.734 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.51 -159.1 21.46 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -146.49 49.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.65 124.54 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -1.202 . . . . 0.0 109.318 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -109.38 157.08 19.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.408 -0.807 . . . . 0.0 109.804 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.622 ' CE1' ' CE1' ' A' ' 29' ' ' TYR . 5.3 t60 -147.58 125.58 12.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.0 109.777 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -95.12 119.64 33.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 17' ' ' HIS . 6.6 m -119.34 140.95 49.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 109.157 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttt -147.99 11.6 0.95 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.8 t -143.45 155.36 44.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.363 -0.835 . . . . 0.0 110.321 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -50.44 144.03 8.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.696 . . . . 0.0 110.229 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -144.55 116.87 8.48 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 4.67 51.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.009 . . . . 0.0 108.876 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 29.2 p30 -146.28 92.23 2.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.569 -0.707 . . . . 0.0 109.582 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.3 mt -91.18 -19.99 22.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.529 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 11.7 t-80 -56.95 -33.2 66.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 108.825 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.3 t -57.84 -42.93 85.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 17' ' ' HIS . 80.3 m-85 -74.96 -44.17 49.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.864 -1.147 . . . . 0.0 110.308 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.35 152.13 21.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 70.8 m-20 -98.11 -6.11 32.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.347 -0.846 . . . . 0.0 110.071 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -155.12 153.83 31.44 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 39.4 t -157.55 127.86 6.33 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -107.24 -4.48 18.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.709 -0.619 . . . . 0.0 109.627 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.0 p -138.66 139.61 38.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.899 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.75 145.67 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -138.09 114.51 10.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.798 -1.189 . . . . 0.0 111.497 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.13 119.46 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -84.72 -31.06 24.25 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.034 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -172.27 156.62 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.562 -1.255 . . . . 0.0 111.586 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.75 -159.67 46.22 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.0 m -125.3 164.03 21.25 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -1.206 . . . . 0.0 109.251 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 79' ' ' CYS . 11.4 t80 -144.59 133.33 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.998 -1.064 . . . . 0.0 108.761 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.2 tpt -103.16 118.69 37.37 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 m -109.73 142.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.971 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.492 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 35.0 m-85 -117.94 136.64 53.35 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.681 0.753 . . . . 0.0 110.753 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.25 -9.32 58.58 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.127 ' O ' ' OG ' ' A' ' 78' ' ' SER . 53.6 ttt180 -130.17 156.36 44.71 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.4 p -68.23 162.99 23.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.678 0.751 . . . . 0.0 110.964 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 t30 66.91 33.13 6.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.918 -0.488 . . . . 0.0 111.204 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.492 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.9 m-85 58.63 58.58 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.215 -0.928 . . . . 0.0 109.765 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.417 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 55.7 mtt -146.78 175.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.197 -0.94 . . . . 0.0 110.288 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 83.03 -166.33 44.43 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' NH2' ' OH ' ' A' ' 56' ' ' TYR . 77.5 mtp180 -58.26 123.63 16.71 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.221 -1.164 . . . . 0.0 108.024 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 5.8 mp0 -105.41 136.12 45.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.417 ' OH ' ' NH2' ' A' ' 54' ' ' ARG . 83.0 m-85 -128.96 129.72 45.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.534 -0.729 . . . . 0.0 109.749 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.557 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 23.1 p90 -92.77 121.73 34.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.131 -0.98 . . . . 0.0 109.039 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 9.3 mp -113.91 116.85 29.93 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.967 -1.083 . . . . 0.0 111.769 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.9 ttp85 -90.83 158.48 16.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.957 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 59' ' ' ARG . 37.3 ttp180 -30.58 116.09 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.31 0.576 . . . . 0.0 110.744 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.38 168.77 32.66 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -107.32 129.87 54.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -1.022 . . . . 0.0 108.786 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -110.19 100.36 43.7 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.44 -14.16 33.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -170.67 141.47 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.8 p90 -146.71 40.27 1.08 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.653 -1.279 . . . . 0.0 109.805 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.9 mmt -103.21 -48.47 4.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.222 -0.924 . . . . 0.0 109.32 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -100.69 -13.01 18.69 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 69' ' ' THR . 33.3 m -89.98 -15.8 31.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.458 -0.776 . . . . 0.0 109.763 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.4 mtt -117.22 -29.36 5.92 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.41 52.38 3.59 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.445 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.8 mtp -122.88 141.07 52.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.982 -1.305 . . . . 0.0 110.221 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.2 m120 -95.85 55.86 1.66 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 0.0 109.253 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.0 p30 150.56 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.7 p -99.44 -168.61 1.64 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.132 0.967 . . . . 0.0 109.712 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 78' ' ' SER . 27.2 t -77.0 141.46 15.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 66.2 mtt180 -106.28 -17.17 14.38 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 1.127 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -145.24 166.68 24.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.295 -0.878 . . . . 0.0 109.48 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 20.9 p -162.44 149.7 13.68 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.921 0.867 . . . . 0.0 110.744 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -129.73 138.9 51.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 ttp -94.6 148.96 21.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.033 -1.042 . . . . 0.0 109.086 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.42 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 71.3 mt -104.38 133.78 20.03 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.09 147.53 67.39 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.892 1.728 . . . . 0.0 112.059 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.543 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.5 mm? -83.49 46.25 1.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.287 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -112.46 130.87 55.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.552 -0.717 . . . . 0.0 109.448 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -136.16 93.6 2.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.806 . . . . 0.0 109.371 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.83 -86.3 1.01 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.447 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.2 m -124.51 151.78 44.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.534 -0.98 . . . . 0.0 110.451 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.86 119.78 37.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -170.14 128.59 0.88 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.4 ttm -113.08 126.5 55.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 109.288 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -100.73 117.74 35.43 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 103' ' ' MET . 19.7 mt -101.38 150.29 23.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.389 1.09 . . . . 0.0 112.568 -177.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -131.2 122.23 26.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 76.4 tt0 -62.49 -27.94 69.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 111.374 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.9 m-70 -109.88 164.19 12.82 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.767 -1.208 . . . . 0.0 111.542 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 44.2 m -61.77 159.5 13.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.54 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.548 ' O ' ' CG ' ' A' ' 99' ' ' MET . 5.4 m-20 80.28 -98.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' ASP . 23.2 mtt -163.82 45.49 0.11 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.04 -151.25 10.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 61.67 -171.73 8.75 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 89.0 mtt-85 -73.09 131.82 42.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.933 -1.334 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.408 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 25.1 mtm -91.62 120.92 32.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 12.1 mtm -119.41 140.06 51.02 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.145 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -105.85 136.93 44.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.38 120.86 24.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 10.0 ttt -120.69 15.67 11.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.734 . . . . 0.0 109.374 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -144.1 -163.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.875 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.418 ' CG ' ' OH ' ' A' ' 140' ' ' TYR . 47.5 t0 -85.1 133.02 34.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -119.64 84.57 30.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.401 -0.812 . . . . 0.0 109.959 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.89 -29.87 6.48 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.282 1.988 . . . . 0.0 112.131 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.516 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 35.1 p30 -127.5 81.39 2.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.427 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.8 mt -66.72 -24.06 66.19 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 2.6 ttm -60.77 -38.57 85.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.548 0.69 . . . . 0.0 109.57 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -84.13 -20.81 31.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.657 -1.277 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 63.0 ttm-85 -82.22 -58.86 2.76 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.622 -1.299 . . . . 0.0 111.212 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -107.69 0.82 22.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.979 . . . . 0.0 109.807 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 114' ' ' MET . 15.8 t30 60.12 34.17 21.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.0 109.361 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.1 ptm -152.33 137.91 17.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -118.43 8.55 12.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.869 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.46 ' C ' ' OD1' ' A' ' 121' ' ' ASP . 6.5 t0 -134.99 93.77 3.05 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.293 -1.363 . . . . 0.0 113.376 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -103.13 136.76 42.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.418 -0.801 . . . . 0.0 109.106 177.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -97.09 3.21 51.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 111.725 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.6 t -160.25 163.18 33.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.656 -1.902 . . . . 0.0 110.763 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.429 ' N ' ' HG ' ' A' ' 124' ' ' SER . 2.2 p -174.55 178.18 2.0 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 8.4 t60 -154.12 147.68 25.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.484 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 54.6 t -112.83 121.88 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.446 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 12.0 tpt -69.32 -33.98 73.97 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.1 m-20 173.32 166.38 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.433 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 131' ' ' HIS . . . 88.96 -146.32 19.09 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.532 ' CD2' ' OH ' ' A' ' 146' ' ' TYR . 26.9 m80 -141.48 129.05 21.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.906 . . . . 0.0 110.061 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -122.08 131.05 53.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.538 -0.726 . . . . 0.0 111.931 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.2 mt -101.82 130.84 48.35 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.5 t -110.47 142.38 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.913 -1.117 . . . . 0.0 109.81 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.73 125.23 49.18 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.696 -0.627 . . . . 0.0 111.312 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -24.63 63.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 167' ' ' SER . 4.3 mt-30 -126.86 154.47 76.12 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.29 -0.881 . . . . 0.0 109.001 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.14 -173.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 123.161 2.574 . . . . 0.0 113.87 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 139' ' ' ASN . 18.6 t-20 45.89 29.73 0.77 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.468 0.651 . . . . 0.0 110.702 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.418 ' OH ' ' CG ' ' A' ' 109' ' ' ASP . 34.2 m-85 59.21 48.81 9.89 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.093 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.7 m -131.64 162.24 30.84 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 108.917 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.61 174.52 35.35 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.558 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -54.15 110.58 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.88 -0.776 . . . . 0.0 109.387 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -86.56 145.74 26.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.582 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -127.67 132.07 49.73 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.494 0.664 . . . . 0.0 109.283 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.532 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 70.6 t80 -92.44 107.34 19.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.0 mp -102.05 122.06 43.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.683 ' N ' ' HH ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -104.1 178.16 1.24 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -48.26 161.15 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.964 1.776 . . . . 0.0 111.672 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.16 -167.55 12.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.38 133.43 55.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.984 . . . . 0.0 110.455 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.683 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 96.4 m-85 -106.17 136.51 45.74 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.547 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 85.4 mtm-85 -123.86 -14.33 7.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.201 -0.937 . . . . 0.0 112.52 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.578 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 38.9 t -171.32 -177.98 2.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.027 -1.671 . . . . 0.0 110.99 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -63.98 -12.84 41.6 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.778 -0.576 . . . . 0.0 109.555 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -90.03 -1.2 57.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.971 -1.081 . . . . 0.0 108.55 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.578 ' OD1' ' N ' ' A' ' 154' ' ' SER . 1.1 m-20 -91.05 -60.53 1.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.509 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.2 p90 -76.51 16.84 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.03 38.71 95.75 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -103.78 -161.45 24.87 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.1 t -148.53 -40.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.3 p -103.41 -161.66 0.85 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.444 ' OG ' ' OD2' ' A' ' 121' ' ' ASP . 1.7 p -143.83 7.6 1.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.476 -0.765 . . . . 0.0 110.433 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -69.07 82.92 0.33 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.847 -1.158 . . . . 0.0 111.97 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.4 mtt -105.35 121.29 43.58 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.714 -1.241 . . . . 0.0 110.126 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.4 -25.82 3.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.04 152.03 49.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.653 -1.498 . . . . 0.0 111.388 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.5 mt -148.92 139.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 109.835 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -121.2 133.06 55.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.173 -0.954 . . . . 0.0 110.049 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 172' ' ' THR . 43.6 ttp180 -92.59 90.69 7.23 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.327 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 170' ' ' ARG . 95.6 mt -42.05 99.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 170' ' ' ARG . 12.0 m -146.69 64.81 1.18 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 172' ' ' THR . 1.5 m-20 176.13 106.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.598 0.714 . . . . 0.0 109.196 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 59.8 tp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.39 179.886 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.3 mmm . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . 73.22 155.44 3.22 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 62.0 mttm -163.95 146.03 9.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.525 -0.985 . . . . 0.0 109.553 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mm -124.31 120.08 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.526 -0.734 . . . . 0.0 109.086 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.5 mt -116.05 122.27 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.018 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -94.68 131.84 40.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -119.37 135.17 54.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -77.07 -22.97 52.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 111.218 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.554 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.2 t70 -83.21 150.48 26.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.702 -1.249 . . . . 0.0 110.295 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 45.9 mtt-85 -60.02 -44.49 94.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 31.7 m120 -74.52 -94.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.985 . . . . 0.0 109.29 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 35.0 m-85 -157.26 58.95 0.51 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 108.882 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.554 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -151.64 -150.74 5.42 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.46 -153.78 52.72 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -70.6 119.57 14.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 109.058 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -105.34 156.64 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.0 110.311 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.537 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.0 t60 -147.87 124.94 11.38 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.724 . . . . 0.0 109.216 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -98.36 118.33 34.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.54 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 m -114.45 136.5 52.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.7 ptm -134.71 9.73 3.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 p -147.1 163.06 37.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.451 -0.781 . . . . 0.0 110.555 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 41.9 p-10 -56.89 149.18 19.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.399 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.8 t -142.58 115.24 8.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.5 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.628 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 36.3 p30 -137.84 97.1 3.35 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.58 -19.69 18.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 108.44 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.542 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 19.2 t-80 -58.5 -39.52 80.28 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.288 -0.882 . . . . 0.0 109.266 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -51.03 -57.12 9.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.537 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 89.3 m-85 -58.58 -47.71 83.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.758 -0.589 . . . . 0.0 111.257 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -156.85 150.57 24.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.886 -1.134 . . . . 0.0 110.335 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 68.8 m-20 -97.21 -5.97 35.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.958 -1.089 . . . . 0.0 110.421 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -158.89 156.24 29.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.496 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 21.2 t -158.79 126.52 5.04 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -103.28 -0.78 29.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 3.7 m -146.04 144.23 29.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.513 -1.367 . . . . 0.0 111.152 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -138.44 143.09 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.88 107.31 8.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 0.0 111.051 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.9 114.88 29.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -77.71 -32.81 53.17 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.762 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -178.5 161.04 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.633 -1.227 . . . . 0.0 111.457 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.59 -153.12 21.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.2 m -133.97 153.59 51.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -148.03 141.13 24.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.571 -1.33 . . . . 0.0 109.415 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -108.74 122.16 46.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.9 m -112.53 144.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.404 -0.81 . . . . 0.0 110.093 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.495 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 36.1 m-85 -120.52 138.44 53.84 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.016 0.912 . . . . 0.0 111.375 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.62 -8.21 55.04 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.68 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.802 ' O ' ' HB3' ' A' ' 78' ' ' SER . 38.3 ttt180 -130.9 156.5 44.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.139 -0.976 . . . . 0.0 108.847 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -66.06 156.86 32.6 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.671 0.748 . . . . 0.0 111.402 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.95 33.74 3.4 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.618 -0.676 . . . . 0.0 111.586 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.721 ' H ' ' HG ' ' A' ' 78' ' ' SER . 1.5 m-85 59.84 58.65 2.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.573 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.409 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.7 mtt -145.96 171.16 15.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.988 -1.07 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.58 -165.43 36.93 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 120.657 -1.277 . . . . 0.0 110.566 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.47 121.22 10.97 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -102.67 134.64 45.7 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -126.54 131.48 51.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.686 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -94.76 117.77 30.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.506 -0.746 . . . . 0.0 109.736 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.0 mt -120.56 122.82 41.42 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.143 -0.973 . . . . 0.0 111.112 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.526 ' NH1' ' OG1' ' A' ' 172' ' ' THR . 33.4 ptt180 -103.68 168.1 9.36 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.574 0.702 . . . . 0.0 111.058 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.494 ' C ' ' O ' ' A' ' 59' ' ' ARG . 51.6 ttp180 -28.62 110.95 0.05 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.308 0.575 . . . . 0.0 110.911 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.39 31.47 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.533 -1.318 . . . . 0.0 109.957 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -104.41 126.56 51.61 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.408 -1.054 . . . . 0.0 108.422 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.36 96.98 24.18 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 10' ' ' ARG . 44.8 Cg_endo -70.05 -14.22 34.89 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.196 1.931 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -170.72 143.46 2.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 108.331 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.4 p90 -149.28 41.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.627 -1.296 . . . . 0.0 109.667 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.5 mmt -107.13 -46.43 3.9 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.335 -0.853 . . . . 0.0 109.407 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -100.23 -15.09 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -89.46 -14.46 35.3 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -115.37 -30.24 6.31 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.13 5.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.8 mtp -121.88 144.04 49.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.402 . . . . 0.0 109.401 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 81.9 m-20 -96.16 53.65 1.37 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.222 -0.923 . . . . 0.0 109.014 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.4 p30 152.86 -171.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.496 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.4 p -98.76 -168.1 1.59 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.781 0.8 . . . . 0.0 109.938 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 78' ' ' SER . 22.5 t -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 45.2 mmm-85 -106.52 -16.71 14.46 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.755 -1.215 . . . . 0.0 107.898 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.802 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.68 164.3 33.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 109.485 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 26.3 p -161.03 150.64 17.06 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.242 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.43 136.86 39.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.9 ptm -90.62 158.18 17.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.44 135.15 20.33 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.615 -0.678 . . . . 0.0 110.233 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.09 154.16 66.72 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.286 1.99 . . . . 0.0 112.286 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.3 mt -73.42 51.44 0.34 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -86.2 113.92 22.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -139.97 60.15 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 0.0 109.475 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.72 -81.01 1.01 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m -134.97 158.04 45.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.507 -0.996 . . . . 0.0 109.969 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.11 114.41 27.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -161.2 123.41 3.05 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 7.5 tpp -107.99 125.35 51.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.022 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -99.53 111.72 24.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 103' ' ' MET . 20.7 mt -99.79 148.91 23.9 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.881 0.848 . . . . 0.0 112.474 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 99' ' ' MET . 26.1 m-85 -136.72 127.09 26.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.06 -23.55 67.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.402 -0.811 . . . . 0.0 112.386 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.482 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.9 m-70 -113.67 162.28 16.44 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.56 -1.338 . . . . 0.0 111.178 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 77.5 p -58.13 160.3 5.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.527 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 97' ' ' SER . 4.4 m-20 79.51 -90.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.547 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 1.8 mtm -175.37 38.66 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.51 -163.11 23.47 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.416 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 72.23 -146.61 39.64 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -99.39 139.34 35.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -1.198 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 3.6 ptt? -96.96 116.81 29.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.374 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.42 ' CE ' ' SD ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -104.98 137.18 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.126 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -99.1 122.32 42.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 108.666 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.58 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.9 tt -133.8 118.83 18.47 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 19.5 ptm -129.72 21.4 5.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 109.257 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.58 ' H ' HD23 ' A' ' 106' ' ' LEU . 22.9 p-10 -133.97 -166.86 1.86 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 37.4 p-10 -86.45 132.81 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 0.0 109.256 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.488 ' SG ' ' CD2' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -117.82 89.02 32.44 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.176 -0.952 . . . . 0.0 109.66 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.03 -20.95 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -139.97 85.14 2.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.4 mt -71.27 -26.78 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 110.057 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.533 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -56.16 -39.83 72.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.422 -0.799 . . . . 0.0 109.102 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.05 -21.76 29.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -80.32 -59.32 2.75 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.77 -1.207 . . . . 0.0 111.085 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -109.06 0.02 19.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.596 -0.69 . . . . 0.0 110.309 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 114' ' ' MET . 12.5 m120 56.49 32.52 20.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.476 1.131 . . . . 0.0 108.587 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.42 ' SD ' ' CE ' ' A' ' 104' ' ' MET . 9.7 ptm -153.29 137.73 16.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 47.2 m -124.86 11.25 8.36 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.466 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 120' ' ' SER . 52.2 m-20 -130.03 94.88 3.8 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.631 -1.293 . . . . 0.0 113.191 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.88 136.29 49.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -99.23 3.03 46.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 111.281 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.51 ' HG ' ' N ' ' A' ' 125' ' ' CYS . 6.9 t -148.94 154.76 39.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.063 -1.648 . . . . 0.0 110.719 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.8 t -165.31 163.14 20.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 110.312 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.514 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 5.0 t60 -147.66 145.08 28.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.416 -0.803 . . . . 0.0 108.893 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.5 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 67.8 t -113.14 123.2 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 109.808 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 21.1 ttm -77.24 -23.34 51.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.749 -0.594 . . . . 0.0 109.854 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 170.73 178.47 0.06 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.595 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 73.53 -134.22 18.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.7 m-70 -162.07 139.77 8.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.693 -0.886 . . . . 0.0 108.857 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -131.05 142.45 50.3 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.115 -0.991 . . . . 0.0 112.256 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mt -110.59 134.04 52.77 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 46.3 t -112.29 142.54 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.907 -1.12 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -120.25 125.06 47.19 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.53 -26.78 65.62 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 167' ' ' SER . 7.5 mp0 -120.51 153.86 56.53 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.372 -0.83 . . . . 0.0 108.807 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -60.92 -177.94 0.21 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.309 2.673 . . . . 0.0 113.873 -178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 51.05 33.3 8.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.575 ' N ' ' HG ' ' A' ' 167' ' ' SER . 23.4 m-85 56.46 51.23 11.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.649 -0.657 . . . . 0.0 110.009 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.0 m -136.69 162.7 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.768 -0.582 . . . . 0.0 109.676 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.48 174.07 32.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.8 mmm-85 -51.56 109.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.469 -1.018 . . . . 0.0 108.99 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 21.1 pt20 -87.58 147.28 25.38 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.789 0.804 . . . . 0.0 110.089 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -129.74 143.2 50.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.558 ' OH ' ' CG ' ' A' ' 131' ' ' HIS . 91.8 t80 -103.73 106.85 17.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 109.556 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 mp -100.04 121.13 40.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.383 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.564 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -107.49 168.99 7.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.4 Cg_exo -36.69 164.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.159 1.906 . . . . 0.0 112.0 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.49 -164.23 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -122.84 131.46 53.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.761 -0.847 . . . . 0.0 110.812 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.564 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 23.4 m-85 -109.24 145.83 35.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.6 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 19.0 ptt-85 -137.55 -3.62 1.88 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.789 -1.195 . . . . 0.0 112.41 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.559 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 9.2 m -169.49 167.42 9.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.025 -1.672 . . . . 0.0 109.901 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -57.34 -9.91 1.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 154' ' ' SER . 7.4 t-20 -88.62 -3.64 58.75 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.297 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 5.2 m-20 -89.64 -60.93 1.81 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 109.17 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.56 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 10.0 p90 -73.54 12.36 0.64 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 68.19 34.8 81.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.72 -160.38 30.88 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 t -149.16 -39.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.1 p -106.72 -156.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 18.7 p -139.09 3.24 2.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -63.98 77.11 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.218 -0.926 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.9 mtt -105.15 116.26 31.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.026 -1.046 . . . . 0.0 109.873 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.24 -24.59 5.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.575 ' HG ' ' N ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -130.69 149.33 52.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.59 -1.535 . . . . 0.0 111.286 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.441 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 18.8 mt -148.88 139.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.32 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.81 140.29 52.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.412 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 27.5 ptt85 -94.79 70.46 3.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 108.977 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.521 HG22 ' H ' ' A' ' 172' ' ' THR . 5.3 mm 51.78 -141.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.389 -0.925 . . . . 0.0 109.304 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.526 ' OG1' ' NH1' ' A' ' 59' ' ' ARG . 7.5 m -138.73 42.22 2.14 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.353 0.597 . . . . 0.0 109.49 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 172' ' ' THR . 57.0 t0 36.63 41.54 0.17 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.502 0.667 . . . . 0.0 109.805 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 117.873 -1.06 . . . . 0.0 108.981 179.524 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' H3 ' ' H ' ' A' ' 2' ' ' GLY . 83.8 mtp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.341 0.591 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.421 ' H ' ' H3 ' ' A' ' 1' ' ' MET . . . 63.95 147.96 0.03 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -147.47 139.74 24.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.523 -0.986 . . . . 0.0 110.202 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 43' ' ' PHE . 7.0 tp -125.72 122.35 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.452 -0.78 . . . . 0.0 109.24 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 70.4 mt -121.1 126.24 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 109.272 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.94 162.14 14.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.198 -0.939 . . . . 0.0 108.917 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 18.5 m-85 -145.98 135.39 23.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.678 -1.264 . . . . 0.0 108.744 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.71 -46.21 54.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 61.1 m-20 -76.53 148.92 36.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.835 -1.166 . . . . 0.0 110.345 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -64.7 -41.26 96.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.488 -0.758 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -87.18 45.08 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 52.95 90.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.93 -171.06 42.4 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 72.15 -141.63 31.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -83.46 123.61 29.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.967 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -107.77 159.94 16.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 109.765 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -142.63 123.47 14.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 108.921 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.85 121.39 42.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.044 -1.035 . . . . 0.0 109.371 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' O ' HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.87 140.39 50.04 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.774 0.797 . . . . 0.0 109.379 -179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 48.4 mtt -131.21 6.97 4.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.1 m -149.47 168.93 22.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -53.9 151.83 6.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.336 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.66 113.18 5.32 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.85 -7.71 39.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.12 -0.988 . . . . 0.0 109.41 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.35 99.19 5.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.6 mt -110.0 -20.61 12.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.96 . . . . 0.0 108.905 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 33.9 t-80 -61.6 -47.15 86.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.061 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.532 ' HG ' ' N ' ' A' ' 29' ' ' TYR . 99.2 p -49.51 -55.46 13.23 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.532 ' N ' ' HG ' ' A' ' 28' ' ' SER . 84.9 m-85 -56.14 -42.57 77.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.624 -0.673 . . . . 0.0 111.056 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 30.1 p90 -159.58 153.63 23.38 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.99 -1.069 . . . . 0.0 109.901 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.605 ' H ' HD21 ' A' ' 31' ' ' ASN . 0.5 OUTLIER -104.98 -8.49 18.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.218 -0.926 . . . . 0.0 110.718 -178.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -149.37 149.01 30.18 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.992 -1.068 . . . . 0.0 108.734 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 37.0 t -155.3 125.02 6.47 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.422 ' HD1' ' HG3' ' A' ' 67' ' ' MET . 70.7 m-70 -108.51 -9.32 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.035 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.482 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.6 p -132.27 137.89 47.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 0.0 110.589 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -134.87 141.92 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.54 ' NE ' ' OE2' ' A' ' 39' ' ' GLU . 29.5 ttp180 -136.27 115.99 13.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.859 -1.151 . . . . 0.0 111.754 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.39 117.24 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 68.6 mm-40 -79.18 -35.39 41.95 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.944 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.7 t -174.31 161.94 3.53 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.903 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 177.83 51.14 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.9 m -98.47 148.79 23.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.952 . . . . 0.0 109.925 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 5.8 t80 -144.3 137.3 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.781 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 146' ' ' TYR . 50.1 mtp -113.23 128.67 56.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.6 m -114.22 144.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.117 -0.989 . . . . 0.0 109.896 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.47 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 31.7 m-85 -121.5 139.93 52.85 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.734 0.778 . . . . 0.0 111.694 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -75.39 -6.59 50.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.558 -0.714 . . . . 0.0 109.473 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.875 ' O ' ' HB3' ' A' ' 78' ' ' SER . 19.6 ttm180 -131.86 158.3 41.69 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.5 p -70.5 158.5 35.96 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.688 0.756 . . . . 0.0 111.131 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 68.44 33.85 3.92 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.307 0.575 . . . . 0.0 111.639 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.468 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 3.3 m-85 60.95 61.25 1.66 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.718 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 82.2 mtp -149.84 172.15 15.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.191 -0.943 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.26 -170.25 44.67 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -54.44 117.35 3.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 107.926 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -101.01 134.61 43.74 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -128.14 128.91 45.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.256 -0.903 . . . . 0.0 109.278 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.99 118.91 25.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.954 -1.091 . . . . 0.0 108.657 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' CD1' ' CZ ' ' A' ' 63' ' ' TYR . 6.3 tp -125.51 118.45 25.81 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.4 ptm180 -108.9 179.84 4.06 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 0.0 111.884 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 59' ' ' ARG . 43.5 ttp180 -31.19 108.12 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.496 0.665 . . . . 0.0 111.004 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.34 158.35 20.86 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.43 127.16 52.84 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CZ ' ' CD1' ' A' ' 58' ' ' LEU . 71.0 m-85 -116.38 99.84 53.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -76.93 -6.96 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.442 2.095 . . . . 0.0 112.531 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.5 135.25 1.95 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.937 -1.102 . . . . 0.0 108.362 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 23.0 p90 -150.07 32.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.563 -1.336 . . . . 0.0 110.744 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.422 ' HG3' ' HD1' ' A' ' 34' ' ' HIS . 6.3 mmt -97.39 -46.67 5.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.827 -1.17 . . . . 0.0 109.199 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -99.34 -16.79 18.32 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 m -88.91 -20.46 24.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.521 -0.737 . . . . 0.0 109.883 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 72' ' ' MET . 42.4 ttm -107.32 -25.77 11.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.997 -1.064 . . . . 0.0 108.388 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.1 52.72 4.18 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.17 -1.014 . . . . 0.0 110.771 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 70' ' ' MET . 90.9 mtp -128.6 139.92 52.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.349 -1.089 . . . . 0.0 109.832 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 13.4 m120 -98.43 57.46 1.2 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.6 p30 150.91 -173.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.517 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 29.5 p -95.96 -174.61 3.16 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.293 1.044 . . . . 0.0 110.481 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 46' ' ' TYR . 40.6 t -78.38 143.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -108.07 -16.77 14.2 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.897 -1.127 . . . . 0.0 108.256 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.875 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.05 159.27 42.54 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.061 -1.024 . . . . 0.0 109.925 178.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.421 ' SG ' HG11 ' A' ' 76' ' ' VAL . 11.0 m -154.74 143.55 20.83 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.37 0.605 . . . . 0.0 110.231 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' CD2' ' A' ' 146' ' ' TYR . 52.7 ttp180 -134.15 138.39 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.408 ' HG2' ' H ' ' A' ' 82' ' ' ILE . 4.2 ttm -99.61 159.88 14.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.076 -1.015 . . . . 0.0 109.869 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 88.0 mt -123.7 83.48 54.02 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.71 176.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.965 2.443 . . . . 0.0 112.798 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.46 57.11 4.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.341 -0.849 . . . . 0.0 109.735 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -67.04 169.43 8.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.85 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -46.0 136.25 6.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.274 -0.891 . . . . 0.0 109.955 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.595 ' O ' ' O ' ' A' ' 88' ' ' SER . . . -65.86 -66.04 2.6 Favored Glycine 0 N--CA 1.492 2.409 0 O-C-N 121.447 -0.783 . . . . 0.0 113.25 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.595 ' O ' ' O ' ' A' ' 87' ' ' GLY . 25.2 m 10.12 115.37 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.417 -1.049 . . . . 0.0 113.291 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 87' ' ' GLY . 38.7 m-85 -126.41 133.58 51.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.449 ' HZ3' ' HE ' ' A' ' 92' ' ' ARG . 63.9 tttm -174.17 123.21 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.1 ttm -117.68 135.62 53.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.449 ' HE ' ' HZ3' ' A' ' 90' ' ' LYS . 89.0 mtt180 -108.94 121.72 45.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 103' ' ' MET . 14.3 mt -106.02 150.48 25.69 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.948 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.406 ' CG ' ' HA ' ' A' ' 99' ' ' MET . 29.9 m-85 -134.58 121.59 21.15 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.083 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 55.5 tt0 -59.03 -26.54 64.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 111.526 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 124' ' ' SER . 39.6 m170 -110.61 162.0 15.17 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.503 -1.373 . . . . 0.0 111.12 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.2 p -59.15 154.35 16.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.754 -0.591 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 7.4 t70 84.24 -90.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -173.94 47.1 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.63 -159.44 12.61 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-O 122.242 0.912 . . . . 0.0 111.157 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.462 ' CA ' ' ND1' ' A' ' 96' ' ' HIS . . . 61.49 -159.5 30.01 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.49 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 98.1 mtt180 -79.21 127.42 32.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.99 -1.3 . . . . 0.0 110.048 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.498 ' C ' ' SD ' ' A' ' 103' ' ' MET . 10.1 tmm? -91.14 122.34 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.2 mtm -123.14 137.91 54.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 108.649 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.25 142.63 34.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.408 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.51 121.28 23.08 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.545 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 9.2 ttt -123.83 21.15 9.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 107' ' ' MET . 54.1 m-20 -145.85 -160.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.419 -0.801 . . . . 0.0 109.407 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 39.4 p-10 -90.03 133.77 34.63 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.564 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.98 80.57 14.95 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.71 -33.01 8.74 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.228 1.952 . . . . 0.0 111.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.45 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 10.6 t30 -126.38 78.97 1.82 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.564 ' CD2' ' HG ' ' A' ' 110' ' ' CYS . 8.3 mt -62.67 -15.31 51.77 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 109.178 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.6 mmt -63.3 -40.98 98.86 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.471 0.653 . . . . 0.0 109.856 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.45 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 82.0 m-20 -85.21 -23.01 28.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.921 -1.112 . . . . 0.0 110.98 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . 0.479 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 49.5 ttm-85 -79.4 -61.04 2.13 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.602 -1.311 . . . . 0.0 111.123 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 118' ' ' ASN . 8.8 m-85 -109.61 0.75 19.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.925 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' MET . 52.1 m-20 48.33 32.79 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.402 ' HG3' ' CE2' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -143.4 126.04 15.96 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -120.53 7.6 10.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.573 -0.704 . . . . 0.0 111.174 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.5 m-20 -135.34 88.96 2.46 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.634 -1.292 . . . . 0.0 112.606 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -101.42 139.45 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.185 -0.947 . . . . 0.0 108.852 177.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.484 ' N ' ' HD1' ' A' ' 123' ' ' HIS . 0.3 OUTLIER -95.11 3.82 54.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 111.244 -179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 5.3 t -152.23 157.54 41.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.148 -1.595 . . . . 0.0 110.327 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 1.5 p -169.47 167.96 9.63 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.755 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 12.7 t60 -149.09 145.91 27.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.449 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.3 t -114.36 125.3 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 108.771 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.406 ' SD ' ' CD2' ' A' ' 126' ' ' HIS . 86.2 mmm -81.66 -32.0 32.04 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.1 p30 178.29 168.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.537 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.71 -152.42 22.45 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.532 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 68.6 m-70 -137.27 123.57 20.61 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.675 -0.897 . . . . 0.0 109.347 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -112.14 122.97 49.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 0.0 112.676 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.93 123.4 43.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 42.9 t -109.15 144.82 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.816 -1.178 . . . . 0.0 110.618 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -124.12 125.8 45.11 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.039 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 68.2 tt0 -64.44 -21.41 66.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.731 -0.606 . . . . 0.0 109.678 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.663 ' O ' ' OG ' ' A' ' 167' ' ' SER . 93.7 mm-40 -127.6 134.0 25.71 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.315 -0.866 . . . . 0.0 109.646 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 137' ' ' GLN . 96.0 Cg_exo -38.86 -177.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 123.808 3.005 . . . . 0.0 114.859 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 50.21 31.04 4.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.81 -0.556 . . . . 0.0 110.899 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 57.59 54.33 6.51 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 0.0 110.435 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.436 ' CG2' ' N ' ' A' ' 142' ' ' GLY . 94.3 m -144.24 168.97 18.79 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.927 -1.108 . . . . 0.0 110.056 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.436 ' N ' ' CG2' ' A' ' 141' ' ' THR . . . 93.93 -177.01 36.66 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 63.4 mtm180 -56.35 106.74 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -1.08 . . . . 0.0 108.81 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.562 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -88.24 147.4 24.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.787 0.803 . . . . 0.0 110.184 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -128.02 141.02 51.63 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.63 0.728 . . . . 0.0 109.345 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.546 ' CD1' ' SD ' ' A' ' 44' ' ' MET . 88.1 t80 -99.02 101.66 13.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.593 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 mp -97.65 120.73 38.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.246 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -112.0 166.63 10.53 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 148' ' ' ARG . 88.1 Cg_exo -32.3 156.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.5 -169.82 14.2 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -121.23 136.2 55.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.433 -1.039 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.452 ' OH ' ' O ' ' A' ' 148' ' ' ARG . 20.6 m-85 -113.07 145.89 40.11 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.599 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 25.0 ptt180 -136.75 0.64 2.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.933 . . . . 0.0 111.975 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.553 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.0 m -174.2 171.33 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.153 -1.592 . . . . 0.0 110.121 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.8 -17.0 19.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.38 -0.825 . . . . 0.0 109.17 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.08 1.76 46.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.0 -1.063 . . . . 0.0 109.326 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.599 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 9.1 m-20 -93.29 -60.35 1.81 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.439 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.8 p90 -78.12 16.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.76 39.39 93.58 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -107.32 -161.6 21.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.37 -42.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.3 p -109.05 -150.83 0.46 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 26.2 t -147.04 17.62 1.23 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.485 -0.759 . . . . 0.0 109.561 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -67.22 74.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.289 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.8 mtt -103.88 118.02 35.69 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.035 -1.041 . . . . 0.0 108.958 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.38 -25.97 3.87 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.663 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.023 1.412 . . . . 0.0 110.71 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.3 mt -145.67 140.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.749 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -131.37 145.2 51.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.8 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 107' ' ' MET . 0.3 OUTLIER -96.4 74.7 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 2.9 pt -48.94 91.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.005 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 170' ' ' ARG . 1.6 t -105.95 59.2 0.66 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.068 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 172' ' ' THR . 93.3 m-20 49.88 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.025 -1.047 . . . . 0.0 109.071 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.452 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 6.5 mp . . . . . 0 C--N 1.3 -1.574 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.313 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mmt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.69 103.15 0.08 OUTLIER Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.361 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -146.42 161.51 40.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.265 . . . . 0.0 110.73 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.2 tt -136.26 136.69 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.494 -0.754 . . . . 0.0 109.974 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 72.2 mt -121.54 125.99 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 109.373 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -90.68 154.12 19.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 11.7 m-85 -138.85 139.42 38.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 109.515 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.82 -33.36 57.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.468 -0.77 . . . . 0.0 111.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.443 ' CB ' ' O ' ' A' ' 13' ' ' GLY . 54.5 t0 -77.69 153.91 32.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.916 -1.115 . . . . 0.0 110.328 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 64' ' ' PRO . 96.1 mtt180 -61.84 -50.43 72.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.511 -0.743 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 88.7 m-20 -71.43 -94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.065 . . . . 0.0 109.273 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 52.0 m-85 -157.3 69.76 0.58 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 109.043 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' ' CB ' ' A' ' 9' ' ' ASP . . . -163.8 -174.32 33.5 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.85 -152.75 23.24 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.506 ' N ' ' CD ' ' A' ' 15' ' ' ARG . 11.2 mpt_? -75.65 125.82 29.79 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.829 -1.394 . . . . 0.0 108.833 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -109.34 157.11 19.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -145.99 123.78 11.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -95.55 117.74 30.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.293 -0.879 . . . . 0.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.8 m -122.0 140.77 52.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.17 -0.956 . . . . 0.0 109.605 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.5 ptm -147.89 14.3 1.04 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.6 p -145.25 159.8 42.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.512 -0.742 . . . . 0.0 110.093 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -51.43 145.82 8.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.51 -0.744 . . . . 0.0 110.041 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 5.1 t -148.27 115.42 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.21 12.31 22.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.118 -0.989 . . . . 0.0 108.798 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.518 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 40.3 p-10 -148.57 90.45 1.79 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.638 -0.664 . . . . 0.0 109.615 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 32.0 mt -107.14 -28.79 9.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 28' ' ' SER . 47.3 p-80 -63.48 -39.81 95.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 109.029 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 27' ' ' HIS . 18.5 m -55.47 -25.38 36.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.75 -0.594 . . . . 0.0 109.468 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -83.31 -37.11 23.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 17.7 p90 -152.32 151.24 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -95.15 -9.89 32.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 mtt85 -155.7 155.46 33.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.03 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 48.3 t -154.51 123.47 6.3 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -107.51 -4.26 18.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.355 -0.841 . . . . 0.0 110.437 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 t -136.43 140.66 43.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.876 -1.14 . . . . 0.0 110.983 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 91.8 mt -137.22 145.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 32.0 ttp180 -137.81 116.46 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.864 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.19 119.54 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 92.3 mt-10 -84.72 -29.19 25.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.0 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -174.93 159.41 2.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.787 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.94 -162.67 46.86 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.4 t -123.53 153.18 40.95 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.47 -1.018 . . . . 0.0 109.172 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -140.34 135.28 32.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.153 -0.967 . . . . 0.0 109.137 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 ttt -106.37 119.94 40.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.38 143.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.809 -0.757 . . . . 0.0 110.209 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 35.7 m-85 -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 41.7 t0 -74.36 -9.13 58.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.947 -0.47 . . . . 0.0 109.951 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.824 ' O ' ' HB3' ' A' ' 78' ' ' SER . 27.8 ttt85 -131.52 158.19 41.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.9 p -68.45 163.65 22.84 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.78 0.8 . . . . 0.0 111.4 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 65.71 32.13 9.22 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.106 0.479 . . . . 0.0 111.499 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.486 ' CB ' HH21 ' A' ' 80' ' ' ARG . 2.6 m-85 61.0 58.15 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.354 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.406 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.1 mtt -146.04 176.06 9.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.234 -0.917 . . . . 0.0 109.58 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 -172.68 48.36 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -55.94 124.15 16.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -102.47 134.19 46.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.055 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.0 129.27 47.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.496 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.617 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 11.1 p90 -91.19 121.38 32.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.852 . . . . 0.0 108.886 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 10.3 mp -108.77 139.74 43.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 60' ' ' ARG . 33.0 ptt180 -118.8 158.66 25.18 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 59' ' ' ARG . 50.8 ttt-85 -29.92 115.37 0.11 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.285 0.564 . . . . 0.0 110.389 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.29 164.32 26.77 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -104.62 127.43 52.37 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -110.4 97.68 32.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 108.666 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 10' ' ' ARG . 48.9 Cg_endo -71.47 -11.55 28.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.071 1.847 . . . . 0.0 112.348 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 37.5 p-10 -167.27 135.76 2.61 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 15.5 p90 -147.95 20.28 1.13 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.702 -1.249 . . . . 0.0 110.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 42.7 tpp -90.99 -44.92 9.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.683 -1.261 . . . . 0.0 109.504 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -98.45 -20.69 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -76.8 -30.56 56.48 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.046 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.9 mtt -95.08 -39.27 10.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.12 44.88 2.71 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 mmm -111.17 150.73 29.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.73 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.9 m120 -100.45 49.92 0.9 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.083 -1.011 . . . . 0.0 109.244 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.85 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 24.6 p -97.85 -170.22 1.95 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 78' ' ' SER . 46.4 t -78.7 144.38 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -111.17 -15.25 13.72 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.597 -1.314 . . . . 0.0 107.719 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.824 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -143.84 166.26 25.42 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 178.362 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.1 p -160.16 145.25 14.93 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.403 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.486 HH21 ' CB ' ' A' ' 51' ' ' PHE . 35.6 ttm180 -130.68 136.64 48.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.3 ttp -95.98 149.6 21.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 108.956 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.3 mt -97.45 115.96 65.81 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' O ' ' CE1' ' A' ' 131' ' ' HIS . 72.9 Cg_exo -45.82 148.5 2.58 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.083 1.855 . . . . 0.0 112.0 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 9.8 mp -89.5 50.9 1.99 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -104.89 125.22 50.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.54 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -135.95 73.92 1.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.462 -0.773 . . . . 0.0 109.49 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.67 -87.37 1.13 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 54.7 m -115.68 144.4 43.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.631 -0.923 . . . . 0.0 109.77 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.62 ' CG ' ' NE ' ' A' ' 170' ' ' ARG . 10.5 m-85 -112.6 118.47 35.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -0.816 . . . . 0.0 109.496 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -171.18 126.98 0.68 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 49.2 ttm -110.43 125.2 53.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.051 -1.031 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -99.62 118.08 35.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' MET . 16.5 mt -104.52 147.31 27.74 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.191 0.996 . . . . 0.0 112.238 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 99' ' ' MET . 28.2 m-85 -133.64 125.25 28.31 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 86.8 tt0 -62.36 -27.51 69.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.942 . . . . 0.0 111.879 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.2 m-70 -108.95 164.9 12.0 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.539 -1.35 . . . . 0.0 111.145 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 58.2 m -61.55 156.19 20.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 97' ' ' SER . 2.3 m-20 81.6 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.479 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -169.91 41.55 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.68 -157.24 21.29 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.507 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.509 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 60.73 -155.64 33.31 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 79.2 mtp180 -87.49 138.6 31.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 109.836 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.6 ptt? -98.56 123.43 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 110.072 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.68 136.87 54.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.9 137.03 40.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 110.122 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.36 119.07 21.17 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.57 -15.88 12.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.544 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -111.86 -159.06 0.67 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.85 . . . . 0.0 110.352 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.4 139.36 30.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.29 88.33 27.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.459 -0.776 . . . . 0.0 109.297 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.23 -25.76 8.22 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.162 1.908 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -136.57 80.71 1.84 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 12.7 mt -64.54 -28.46 69.66 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.201 -0.937 . . . . 0.0 110.012 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.78 -39.38 73.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.35 -23.03 35.27 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 110.184 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -79.48 -69.11 0.6 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.475 -1.391 . . . . 0.0 110.515 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.8 m-85 -96.07 3.43 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.993 -1.067 . . . . 0.0 110.721 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 114' ' ' MET . 31.4 m-20 52.32 31.85 10.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.563 -1.336 . . . . 0.0 107.514 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.439 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 4.7 ttp -146.47 132.41 19.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 60.2 p -116.13 2.95 13.46 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.507 -0.746 . . . . 0.0 109.801 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 163' ' ' SER . 50.7 m-20 -131.09 113.13 13.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.564 -1.335 . . . . 0.0 111.594 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -123.33 131.77 53.77 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.479 ' N ' ' HD1' ' A' ' 123' ' ' HIS . 2.8 m80 -93.21 1.87 56.9 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.342 -0.848 . . . . 0.0 111.097 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.2 t -147.51 153.81 39.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 119.674 -1.892 . . . . 0.0 110.844 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 50.3 t -162.44 161.42 27.19 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.411 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.451 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 1.9 t-80 -147.63 141.9 26.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.173 -0.955 . . . . 0.0 109.522 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.16 122.17 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 10.4 tpt -71.87 -32.38 67.41 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 88' ' ' SER . 0.9 OUTLIER 170.95 163.2 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.062 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.92 -160.63 29.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 83' ' ' PRO . 26.0 m80 -127.97 129.4 46.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.514 -0.992 . . . . 0.0 110.199 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -118.69 126.06 51.07 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.851 0.834 . . . . 0.0 111.91 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.24 125.68 41.95 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 50.5 t -111.23 145.12 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 141' ' ' THR . 94.8 m-85 -124.73 123.1 39.26 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.694 -0.629 . . . . 0.0 111.113 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 164' ' ' ARG . 71.8 tt0 -57.74 -29.36 64.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.838 ' O ' ' OG ' ' A' ' 167' ' ' SER . 5.8 mt-30 -117.27 153.07 49.87 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.415 ' O ' ' OG1' ' A' ' 141' ' ' THR . 19.2 Cg_endo -60.21 -170.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 123.496 2.797 . . . . 0.0 113.774 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 46.61 29.4 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.521 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 58.28 53.99 6.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 110.061 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.433 ' O ' ' HB3' ' A' ' 135' ' ' TYR . 14.2 p -140.39 168.25 20.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.95 178.21 36.28 Favored Glycine 0 N--CA 1.503 3.15 0 O-C-N 120.737 -1.227 . . . . 0.0 110.6 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -53.39 108.0 0.29 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -86.85 141.93 28.43 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.969 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -126.0 132.46 52.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -92.66 105.3 17.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.015 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.5 mp -98.35 120.17 38.31 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 109.121 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -105.02 178.73 1.07 Allowed Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -49.42 161.58 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.679 1.586 . . . . 0.0 111.64 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.51 -173.88 14.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.75 135.46 54.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.744 -0.857 . . . . 0.0 110.658 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 18.1 m-85 -112.75 143.83 43.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.575 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 41.1 ptt85 -135.12 -1.39 2.65 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.015 -1.053 . . . . 0.0 112.159 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.551 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 1.6 t -171.77 168.19 6.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 119.896 -1.752 . . . . 0.0 109.924 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -57.6 -14.6 5.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -85.82 0.01 54.13 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.231 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.575 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.4 m-20 -92.52 -59.66 2.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.529 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.7 p90 -76.78 18.14 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.554 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.23 37.82 95.06 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -102.49 -166.04 26.43 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.0 t -144.66 -40.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.6 p -107.03 -159.87 0.71 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.5 t -138.42 11.09 2.76 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 109.497 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 136' ' ' GLU . 85.6 mtt-85 -69.49 75.6 0.4 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.016 -1.053 . . . . 0.0 112.988 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 mtt -100.05 122.8 43.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.139 -0.976 . . . . 0.0 110.247 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.93 -28.5 2.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.838 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -132.85 148.5 52.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.421 -1.635 . . . . 0.0 111.2 -179.109 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.5 mt -144.84 140.7 23.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.328 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -125.86 143.83 50.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.304 -0.873 . . . . 0.0 110.349 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.764 ' O ' ' N ' ' A' ' 172' ' ' THR . 29.5 ttt180 -97.72 85.48 3.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 171' ' ' ILE . 13.9 mt -38.04 71.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.747 -0.596 . . . . 0.0 112.372 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 170' ' ' ARG . 64.1 m -159.55 75.85 0.65 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.861 -1.149 . . . . 0.0 110.07 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 172' ' ' THR . 14.4 m-20 -157.23 73.03 0.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.113 -0.992 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.18 -0.914 . . . . 0.0 108.868 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . 85.17 162.68 36.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -151.9 135.61 16.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.01 117.16 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -115.0 124.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.888 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.84 159.25 15.88 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 14.3 m-85 -146.25 135.1 22.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.564 -1.335 . . . . 0.0 109.038 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.54 -42.52 58.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.123 -0.985 . . . . 0.0 111.069 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.497 ' O ' ' OG ' ' A' ' 35' ' ' SER . 12.6 t70 -81.21 151.19 28.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.889 -1.132 . . . . 0.0 110.542 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.49 -40.59 95.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 110.068 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.94 39.49 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.699 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 53.16 59.76 4.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 109.563 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.7 -154.44 6.14 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -145.63 49.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -77.7 123.41 26.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -1.085 . . . . 0.0 108.967 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -109.56 156.08 20.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.478 -0.764 . . . . 0.0 109.953 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 34.4 t60 -142.64 124.85 15.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 109.27 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -99.91 119.83 38.83 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.879 . . . . 0.0 109.575 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.37 139.72 50.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.5 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.513 ' O ' ' SD ' ' A' ' 20' ' ' MET . 0.8 OUTLIER -131.7 7.17 4.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -148.95 169.71 19.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.381 -0.824 . . . . 0.0 109.672 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 40.9 p-10 -61.4 147.32 45.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 110.285 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.1 t -140.06 115.33 9.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -8.31 56.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.0 108.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 12.2 p-10 -130.98 98.51 4.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.8 mt -104.64 -20.2 13.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 108.655 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.48 ' C ' ' HD1' ' A' ' 27' ' ' HIS . 7.9 t-80 -59.58 -44.7 93.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' HIS . 25.6 t -49.99 -46.28 52.44 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 53.6 m-85 -70.08 -51.91 28.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.11 149.24 30.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.999 -1.063 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -100.91 -5.42 26.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.359 -0.838 . . . . 0.0 110.838 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.595 ' CD ' ' HE2' ' A' ' 34' ' ' HIS . 54.9 ttm-85 -154.88 153.19 30.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.01 -1.056 . . . . 0.0 108.248 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.505 ' O ' ' OH ' ' A' ' 66' ' ' TYR . 52.7 t -158.96 113.68 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.973 -1.079 . . . . 0.0 108.791 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.6 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 35.9 m-70 -95.81 -4.84 43.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.713 -0.617 . . . . 0.0 110.994 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.7 p -139.19 145.93 39.92 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.688 -1.257 . . . . 0.0 111.236 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.0 mt -140.98 142.5 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -132.71 112.11 11.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 111.081 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.508 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 1.4 t -98.5 115.0 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -83.01 -33.75 26.46 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.685 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 8.3 t -171.74 151.34 2.84 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.138 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.729 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 103.18 -137.92 13.69 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.729 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 60.7 m -170.92 164.41 7.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -174.84 168.96 3.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.616 179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.0 ttm -119.72 141.29 49.55 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 m -115.74 146.6 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.5 -0.75 . . . . 0.0 109.1 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 95.6 m-85 -120.41 142.34 49.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.39 -0.819 . . . . 0.0 111.587 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -9.33 58.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.804 ' O ' ' HB3' ' A' ' 78' ' ' SER . 89.8 mtt-85 -134.52 165.39 25.3 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.525 ' OG1' ' ND2' ' A' ' 50' ' ' ASN . 39.6 p -75.64 160.61 29.9 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.729 0.776 . . . . 0.0 111.476 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.525 ' ND2' ' OG1' ' A' ' 49' ' ' THR . 5.2 m-80 68.18 33.03 4.55 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.321 0.581 . . . . 0.0 111.168 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.416 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 4.9 m-85 61.0 60.31 1.85 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.781 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.409 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 59.1 mtt -146.34 170.95 15.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.235 -0.916 . . . . 0.0 110.033 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.15 -173.46 50.25 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -55.16 126.21 23.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.097 -1.237 . . . . 0.0 108.128 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -110.37 140.9 44.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 0.0 108.868 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -132.26 137.12 47.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.816 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 22.7 p90 -98.85 123.77 43.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.404 -0.81 . . . . 0.0 109.241 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -122.83 129.49 51.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.8 ptt180 -104.59 167.45 9.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.39 -0.819 . . . . 0.0 110.922 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 59' ' ' ARG . 72.9 ttt180 -35.6 119.53 0.54 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.701 0.763 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 168.81 164.96 25.4 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -102.84 124.42 48.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.464 -1.021 . . . . 0.0 108.48 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -108.27 97.67 23.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -16.63 41.98 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.2 1.933 . . . . 0.0 112.212 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 40.7 p-10 -169.36 145.03 3.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.871 -1.143 . . . . 0.0 107.943 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.505 ' OH ' ' O ' ' A' ' 33' ' ' CYS . 20.2 p90 -148.0 -16.21 0.35 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.0 111.407 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.6 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 43.8 mtp -57.94 -38.89 76.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.439 -1.413 . . . . 0.0 109.994 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.6 -25.66 20.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.977 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -88.53 -8.98 53.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.838 . . . . 0.0 109.838 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.3 mmt -107.98 -27.49 10.13 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 47.1 6.51 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.4 mtp -124.73 147.26 48.73 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.045 -1.268 . . . . 0.0 109.668 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 73.7 m-80 -98.06 60.18 1.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 15.4 m-20 148.9 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.504 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 30.9 p -100.45 -163.53 1.03 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 109.697 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 m -92.37 147.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 65.6 mtp180 -106.69 -11.14 15.9 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.168 -0.957 . . . . 0.0 108.521 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.804 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.75 164.98 28.73 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.269 179.052 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.2 p -161.09 147.51 14.75 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.734 0.778 . . . . 0.0 110.601 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.418 ' NH2' ' NH1' ' A' ' 148' ' ' ARG . 74.0 ttt-85 -140.3 141.98 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 42.1 ttm -98.35 161.52 13.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.111 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.429 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 52.5 mt -99.87 135.19 20.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.6 150.72 75.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.21 1.94 . . . . 0.0 111.974 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.8 mt -82.0 51.91 1.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.641 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -105.45 117.5 34.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.302 -0.874 . . . . 0.0 109.535 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -133.48 78.23 1.76 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.0 109.48 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.75 -78.19 1.1 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.493 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 66.5 m -135.45 156.43 48.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.684 -0.892 . . . . 0.0 110.054 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.83 111.66 23.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 109.855 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -169.51 130.77 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.403 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 43.7 ttm -114.56 133.84 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -106.18 117.6 34.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 103' ' ' MET . 23.5 mt -101.44 148.05 25.64 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.083 0.944 . . . . 0.0 112.121 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.66 127.54 29.41 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 70.3 tt0 -64.13 -23.94 67.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 112.095 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.507 ' O ' ' HB3' ' A' ' 124' ' ' SER . 6.1 m-70 -114.08 159.4 20.06 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.48 -1.387 . . . . 0.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.6 m -59.0 158.88 7.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.379 -0.825 . . . . 0.0 109.431 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 97' ' ' SER . 14.3 t0 85.49 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.832 0.825 . . . . 0.0 108.787 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -176.93 41.18 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.69 -160.32 13.0 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-O 122.281 0.934 . . . . 0.0 111.296 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 67.21 -166.71 40.89 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.41 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 17.5 mmt180 -74.47 133.85 42.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.002 -1.293 . . . . 0.0 109.648 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.7 119.14 36.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.171 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 138.39 50.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.5 126.58 45.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.025 -1.047 . . . . 0.0 109.763 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.403 HD11 ' SG ' ' A' ' 110' ' ' CYS . 1.1 tt -118.83 115.79 25.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.1 ttt -126.4 20.96 7.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.289 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.533 ' CG ' ' H ' ' A' ' 109' ' ' ASP . 12.1 t70 -144.42 -168.56 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -0.901 . . . . 0.0 110.045 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.533 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 47.8 t0 -83.82 132.18 34.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.614 ' HG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -114.89 81.5 7.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.239 -0.913 . . . . 0.0 109.978 -178.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.29 -29.06 5.19 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.178 1.918 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -134.14 79.4 1.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.614 ' CD2' ' HG ' ' A' ' 110' ' ' CYS . 9.8 mt -63.17 -18.62 63.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.942 . . . . 0.0 109.787 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 20.7 mmt -59.76 -40.72 89.12 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.705 0.764 . . . . 0.0 109.33 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -85.28 -23.38 28.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.988 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -75.58 -63.2 1.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.785 -1.197 . . . . 0.0 110.761 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 117' ' ' PHE . 1.4 m-85 -116.49 1.23 12.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.771 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 117' ' ' PHE . 14.7 t-20 49.41 35.96 8.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.9 ttt -146.5 133.28 20.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 120' ' ' SER . 1.3 t -131.56 10.53 4.78 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.3 m-20 -130.1 89.69 2.84 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 119.933 -1.729 . . . . 0.0 113.238 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -107.08 141.25 38.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.048 -1.032 . . . . 0.0 108.535 178.082 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.51 ' N ' ' HD1' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -96.36 3.19 53.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 111.133 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.507 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.9 t -148.98 154.3 39.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.205 -1.559 . . . . 0.0 110.177 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 38.1 t -163.89 161.98 23.29 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.971 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.495 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 0.8 OUTLIER -146.36 142.56 28.35 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.5 t -111.55 122.58 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -0.977 . . . . 0.0 109.623 -179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 36.1 ttm -71.94 -24.2 61.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.64 . . . . 0.0 109.638 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 163.29 171.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.859 0.838 . . . . 0.0 110.866 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 85.95 -135.71 13.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.511 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 92.5 m-70 -158.52 134.17 8.86 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.69 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -126.78 136.26 52.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 0.0 111.954 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.9 mt -103.48 132.2 49.94 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 19.2 t -110.02 143.75 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.906 -1.121 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.531 ' CZ ' ' OE1' ' A' ' 144' ' ' GLN . 36.6 m-85 -120.9 124.1 44.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.623 -0.673 . . . . 0.0 110.902 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.69 -26.93 64.36 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 167' ' ' SER . 16.8 mt-30 -122.18 154.21 61.71 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.25 -171.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.202 2.601 . . . . 0.0 113.823 -178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 46.66 29.32 0.93 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.387 0.613 . . . . 0.0 110.026 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.487 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 48.3 m-85 59.34 50.84 7.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.639 -0.663 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.3 p -135.89 162.77 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.63 174.76 32.39 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -54.71 111.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -1.035 . . . . 0.0 109.129 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.572 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.4 mt-30 -85.97 143.84 27.94 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -123.58 137.99 54.64 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.506 ' HH ' ' ND1' ' A' ' 131' ' ' HIS . 21.3 t80 -97.35 107.53 20.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.486 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.62 117.14 34.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 108.584 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.665 ' N ' ' HH ' ' A' ' 152' ' ' TYR . 24.7 ptt180 -103.7 178.37 1.19 Allowed Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.37 162.19 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.799 1.666 . . . . 0.0 111.805 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.34 -170.58 13.41 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.86 133.19 56.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -1.001 . . . . 0.0 110.506 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.665 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 20.9 m-85 -110.03 144.45 38.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.65 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 8.6 ptm180 -141.58 -2.42 1.22 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.877 -1.14 . . . . 0.0 112.251 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.533 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 14.2 m -165.49 166.21 18.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.039 -1.663 . . . . 0.0 110.174 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.6 OUTLIER -54.35 -20.24 6.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 108.935 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -83.15 1.44 40.47 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.879 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.65 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.9 m-20 -90.3 -62.9 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 109.138 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -75.88 13.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.54 37.95 93.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.85 -154.43 21.31 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.2 t -153.58 -41.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.4 p -103.61 -153.64 0.48 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 29.5 m -148.87 11.85 0.85 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -66.84 79.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 0.0 112.232 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.7 mtt -107.41 119.78 40.36 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.644 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.79 -26.82 4.01 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -128.92 150.29 50.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.612 -1.522 . . . . 0.0 111.135 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.16 138.96 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.945 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -122.91 136.42 54.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 172' ' ' THR . 30.6 ptt85 -93.79 86.29 5.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.893 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 170' ' ' ARG . 97.0 mt -34.76 92.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.453 -0.779 . . . . 0.0 109.875 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 170' ' ' ARG . 25.6 m -136.22 76.92 1.63 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 172' ' ' THR . 0.2 OUTLIER 169.5 109.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -0.791 . . . . 0.0 109.43 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.482 179.742 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.359 0.6 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.17 162.08 32.03 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -162.1 141.24 9.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -1.134 . . . . 0.0 109.512 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.581 ' CD1' ' CG ' ' A' ' 43' ' ' PHE . 46.7 mt -129.13 133.95 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.651 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.571 ' CD1' HH21 ' A' ' 37' ' ' ARG . 47.2 mt -119.6 117.8 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -93.59 136.65 33.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 109.463 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -122.28 131.79 54.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -70.19 -22.45 62.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.61 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 10' ' ' ARG . 53.9 t0 -80.64 160.49 25.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.876 -1.14 . . . . 0.0 110.326 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.7 mmt85 -60.6 -44.5 96.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.365 -0.835 . . . . 0.0 109.803 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -80.08 -102.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -145.35 43.06 1.29 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.159 -0.963 . . . . 0.0 109.103 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.12 -169.24 12.13 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.06 -156.11 32.24 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -65.58 114.47 4.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.376 . . . . 0.0 109.092 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -98.07 147.52 24.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.375 -0.828 . . . . 0.0 109.826 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.639 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 27.8 t60 -140.46 124.55 17.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.117 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -94.78 118.33 31.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 109.145 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.5 m -118.98 136.39 54.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.336 -0.852 . . . . 0.0 109.251 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -140.23 9.15 2.28 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.8 t -142.21 155.98 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.321 -0.862 . . . . 0.0 110.417 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 52.8 p30 -55.2 143.98 25.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 110.472 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 t -140.58 118.87 12.08 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.59 53.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.799 -1.188 . . . . 0.0 109.282 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 39.6 p-10 -134.13 94.27 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.28 -18.17 27.53 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.474 ' C ' ' ND1' ' A' ' 27' ' ' HIS . 10.5 t-80 -56.48 -35.58 68.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -54.92 -59.27 4.97 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 61.3 m-85 -59.38 -51.69 68.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 0.0 110.772 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -151.5 150.61 30.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.033 -1.042 . . . . 0.0 110.548 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' CD2' ' A' ' 27' ' ' HIS . 24.3 t30 -98.06 -5.12 34.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 110.334 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -159.04 157.32 30.94 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.548 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 45.4 t -160.28 128.6 4.73 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -107.23 -10.64 15.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.053 . . . . 0.0 109.748 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -137.01 138.17 40.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 110.794 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.3 mt -130.59 143.11 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.571 HH21 ' CD1' ' A' ' 5' ' ' ILE . 57.9 ttp85 -133.26 116.5 16.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.087 . . . . 0.0 110.719 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.8 t -104.26 119.88 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' O ' ' OG ' ' A' ' 40' ' ' SER . 83.4 tt0 -85.87 -29.17 23.9 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 108.907 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 39' ' ' GLU . 3.7 m -174.86 153.7 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.671 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.72 -144.42 15.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-O 122.445 1.025 . . . . 0.0 111.638 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.1 m -146.2 149.73 34.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.581 ' CG ' ' CD1' ' A' ' 4' ' ' ILE . 7.4 t80 -147.28 137.69 23.36 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.883 -1.136 . . . . 0.0 110.002 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.0 tpt -108.85 127.09 53.73 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.6 m -116.34 145.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.469 ' O ' ' CG1' ' A' ' 76' ' ' VAL . 55.4 m-85 -120.82 141.48 50.51 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.69 0.757 . . . . 0.0 111.052 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -74.37 -9.88 59.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.991 -0.443 . . . . 0.0 109.997 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.844 ' O ' ' HB3' ' A' ' 78' ' ' SER . 96.1 mtt180 -131.81 160.75 34.69 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p -68.96 162.02 27.64 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.767 0.794 . . . . 0.0 111.497 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.26 33.46 7.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.793 -0.567 . . . . 0.0 111.416 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.412 ' H ' ' CB ' ' A' ' 78' ' ' SER . 1.8 m-85 59.55 58.69 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.026 -1.046 . . . . 0.0 110.199 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 55.9 mtt -146.28 174.57 11.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.843 -1.16 . . . . 0.0 110.669 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.21 -169.05 51.15 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.97 -1.081 . . . . 0.0 110.42 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -61.68 129.41 40.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -122.6 154.16 38.33 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.889 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -133.27 138.37 46.42 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.819 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -92.67 118.1 30.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 108.695 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.0 mt -116.6 115.91 26.6 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.403 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.7 ptt85 -99.39 162.28 13.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.268 -0.895 . . . . 0.0 110.839 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 59' ' ' ARG . 77.7 ttt180 -25.77 114.07 0.05 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.442 0.639 . . . . 0.0 111.099 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.84 172.94 37.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -113.17 127.36 56.16 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.944 . . . . 0.0 108.725 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -107.72 99.85 31.81 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' ARG . 56.9 Cg_endo -73.42 -14.86 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.336 2.024 . . . . 0.0 113.026 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -168.24 140.06 2.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.856 -1.152 . . . . 0.0 108.557 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 25.9 p90 -150.96 36.62 0.62 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.685 -1.26 . . . . 0.0 110.297 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.5 mmt -102.97 -46.94 4.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.069 -1.019 . . . . 0.0 109.689 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.82 -16.0 18.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -86.39 -17.14 35.18 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.8 mtt -116.85 -28.96 6.17 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.03 51.14 4.09 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.068 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 89.3 mtp -119.77 141.66 49.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.307 . . . . 0.0 109.507 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 85.5 m-20 -97.79 51.95 1.07 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.1 -171.86 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.548 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 27.5 p -97.8 -168.18 1.63 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.133 0.968 . . . . 0.0 109.925 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 78' ' ' SER . 42.4 t -75.74 141.43 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -106.36 -17.17 14.36 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.572 -1.33 . . . . 0.0 107.813 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.844 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.94 164.34 30.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.696 178.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 24.6 p -164.92 152.74 11.57 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.507 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -137.7 141.26 41.07 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.1 ttp -93.17 151.45 19.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 108.976 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.496 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 16.4 mm -88.88 129.23 49.23 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.08 -1.012 . . . . 0.0 108.891 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.71 148.13 41.12 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.189 1.926 . . . . 0.0 111.976 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.0 mt -80.19 47.37 0.9 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -110.99 73.42 0.82 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -91.5 89.95 7.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.585 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.43 -90.86 1.29 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.8 m -121.02 148.06 44.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -1.02 . . . . 0.0 109.81 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.88 120.12 41.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.777 . . . . 0.0 109.371 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -171.42 130.12 0.71 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.553 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 45.0 ttm -115.13 130.78 57.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.924 -1.11 . . . . 0.0 109.329 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.414 ' HD2' ' HD1' ' A' ' 126' ' ' HIS . 84.2 mtt180 -101.51 117.74 35.54 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 103' ' ' MET . 12.3 mt -103.18 150.09 24.02 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.328 1.061 . . . . 0.0 112.369 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 99' ' ' MET . 37.0 m-85 -137.4 125.83 23.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -63.48 -24.22 67.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 112.07 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.846 ' O ' ' OG ' ' A' ' 124' ' ' SER . 7.5 m-70 -110.94 165.22 12.04 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.371 -1.456 . . . . 0.0 110.651 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.4 m -60.03 158.86 10.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.117 -0.989 . . . . 0.0 110.044 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.534 ' O ' ' SD ' ' A' ' 99' ' ' MET . 1.0 OUTLIER 78.42 -96.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.407 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.588 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 21.7 mmt -161.76 35.86 0.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.43 -158.31 28.9 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.293 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.73 -172.43 8.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -72.36 136.0 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.985 -1.303 . . . . 0.0 109.47 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 103' ' ' MET . 5.2 ptt? -96.79 121.31 38.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 110.307 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.634 ' SD ' ' CD2' ' A' ' 117' ' ' PHE . 13.9 mtm -118.46 139.83 50.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.948 . . . . 0.0 109.206 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 mp0 -100.37 138.19 37.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.8 tp -128.31 118.01 22.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.6 ttm -123.54 -18.53 6.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.446 -0.784 . . . . 0.0 109.234 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.4 p30 -106.8 -170.21 1.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.831 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -76.62 130.56 38.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.819 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.3 78.86 1.95 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.092 -1.005 . . . . 0.0 109.358 -179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.71 -27.09 7.65 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.1 1.867 . . . . 0.0 112.407 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.464 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 7.8 t30 -136.05 83.21 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.41 -25.85 67.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.99 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 tpt -55.09 -40.38 70.36 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.858 0.837 . . . . 0.0 109.113 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.464 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 93.1 m-20 -81.01 -23.19 38.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.4 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -74.47 -61.92 1.7 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.622 -1.299 . . . . 0.0 110.629 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.634 ' CD2' ' SD ' ' A' ' 104' ' ' MET . 0.9 OUTLIER -118.92 5.39 11.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.425 -0.797 . . . . 0.0 110.547 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 55.53 41.12 31.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.574 -1.329 . . . . 0.0 107.464 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.4 tpt -143.05 122.41 13.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.2 t -111.82 6.68 19.8 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 110.191 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.8 m-20 -143.39 101.79 3.85 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.413 -1.43 . . . . 0.0 113.699 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.2 m-85 -109.49 140.57 43.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.49 -0.756 . . . . 0.0 109.152 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 8.1 m-70 -96.81 3.15 52.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 111.103 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.846 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -148.98 154.18 38.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.172 -1.58 . . . . 0.0 110.375 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.57 ' HG ' ' N ' ' A' ' 126' ' ' HIS . 15.4 t -162.19 162.11 28.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.065 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.57 ' N ' ' HG ' ' A' ' 125' ' ' CYS . 0.4 OUTLIER -149.13 143.47 26.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.139 -0.975 . . . . 0.0 109.693 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.56 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.6 t -113.59 121.7 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.932 . . . . 0.0 109.381 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.408 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 25.1 ttt -72.47 -34.97 68.1 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.0 OUTLIER 176.71 174.38 0.39 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.942 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.15 -164.87 54.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.496 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 91.8 m-70 -124.66 132.38 53.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -1.067 . . . . 0.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -122.14 129.55 52.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.682 . . . . 0.0 111.412 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -101.58 131.86 47.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 22.0 t -107.83 139.97 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.98 -1.075 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.408 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 53.9 m-85 -116.38 125.09 51.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.554 -0.716 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -60.02 -26.74 66.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.485 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.1 mp0 -122.71 154.07 63.42 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.524 ' O ' ' OG1' ' A' ' 141' ' ' THR . 24.1 Cg_endo -61.48 -176.66 0.19 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.203 2.602 . . . . 0.0 113.358 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 51.71 33.37 10.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.516 -0.74 . . . . 0.0 110.58 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.408 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 39.8 m-85 55.08 47.65 21.46 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.592 -0.693 . . . . 0.0 110.048 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 13.7 p -134.44 164.22 27.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.05 173.89 28.96 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -54.02 115.14 1.88 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.122 -1.222 . . . . 0.0 109.001 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 32.4 mt-30 -84.75 142.11 30.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.83 128.87 48.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.486 ' OH ' ' CE1' ' A' ' 131' ' ' HIS . 20.6 t80 -90.93 99.47 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.271 -0.893 . . . . 0.0 109.831 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.0 mp -96.09 124.31 40.05 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.769 0.795 . . . . 0.0 109.078 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -112.16 178.27 1.01 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -43.42 165.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.828 1.685 . . . . 0.0 111.809 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.01 177.53 21.01 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -109.55 135.41 50.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.525 -0.985 . . . . 0.0 110.399 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 19.7 m-85 -109.93 143.44 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.566 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 42.9 ptt85 -134.9 -4.4 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.883 -1.136 . . . . 0.0 112.598 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.7 m -171.57 162.71 6.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.952 -1.718 . . . . 0.0 110.128 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -51.66 -9.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 154' ' ' SER . 0.6 OUTLIER -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.048 -1.032 . . . . 0.0 108.892 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.2 m-20 -92.46 -61.1 1.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.144 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.527 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.4 p90 -75.76 15.55 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.3 37.69 93.07 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.72 -177.06 23.93 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.03 10.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 52.1 p -158.26 -158.21 0.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.8 m -143.61 11.74 1.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -62.74 72.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.937 -1.102 . . . . 0.0 112.118 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 163' ' ' SER . 60.2 mtt -105.91 115.95 31.1 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.916 -1.115 . . . . 0.0 110.565 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.87 -22.12 6.11 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -132.92 149.83 52.21 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.368 -1.666 . . . . 0.0 111.107 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.8 mt -148.21 141.89 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.744 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -124.84 140.53 52.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 110.062 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 172' ' ' THR . 13.4 ptt180 -100.0 102.53 13.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 3.5 mt -51.26 68.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.761 -0.587 . . . . 0.0 111.602 -178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.671 ' N ' ' O ' ' A' ' 170' ' ' ARG . 14.4 m -131.13 78.74 1.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 0.0 110.466 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 0.9 OUTLIER 168.75 111.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 108.806 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.271 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.72 154.66 5.75 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.83 139.8 51.14 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.419 -1.047 . . . . 0.0 110.637 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.1 tt -133.48 128.99 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 110.066 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.5 mt -116.26 132.17 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.657 -0.652 . . . . 0.0 109.825 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -97.56 146.07 25.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -133.63 135.51 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -72.87 -45.03 60.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 110.45 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -78.72 151.38 32.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -67.21 -34.89 78.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 110.073 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -85.65 40.67 0.86 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.042 -1.036 . . . . 0.0 109.848 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 52.89 54.38 10.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 109.696 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -139.34 -153.84 6.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.88 -148.04 46.02 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -76.46 119.0 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.976 . . . . 0.0 109.476 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -100.82 157.94 16.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -149.48 123.93 9.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.187 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -97.72 124.72 42.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 m -123.7 136.76 54.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -135.46 11.78 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 p -146.21 163.12 36.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.623 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -59.52 144.36 47.54 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 110.646 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -139.03 118.35 12.77 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.42 -12.19 46.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.66 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 40.3 p-10 -132.28 98.04 4.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.4 mt -96.3 -19.29 19.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.604 ' NE2' ' ND2' ' A' ' 31' ' ' ASN . 14.4 t-80 -58.05 -40.82 81.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.309 -0.869 . . . . 0.0 108.994 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.0 m -52.03 -44.94 64.44 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -70.44 -46.07 64.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.137 -0.977 . . . . 0.0 110.756 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 27.6 p90 -154.46 151.89 29.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.976 -1.077 . . . . 0.0 109.846 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.604 ' ND2' ' NE2' ' A' ' 27' ' ' HIS . 3.1 m120 -95.97 -5.67 40.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 0.0 110.078 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -161.36 159.68 28.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 108.649 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.537 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 20.5 t -160.13 120.08 2.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.622 ' N ' ' HD1' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -95.96 -14.86 22.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.602 -0.686 . . . . 0.0 110.345 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 m -135.54 147.07 48.65 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.645 -1.284 . . . . 0.0 110.859 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.4 tt -148.09 148.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -136.22 122.87 21.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.824 -1.173 . . . . 0.0 112.076 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.05 120.8 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -91.37 -28.87 17.43 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 110.6 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -159.71 152.55 21.62 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.966 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.19 -159.48 52.65 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -132.85 178.69 6.68 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.305 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.34 140.79 19.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.68 -1.263 . . . . 0.0 109.203 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.5 tpt -101.02 117.57 35.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -110.2 143.35 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.874 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.462 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 26.4 m-85 -122.17 142.0 50.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.698 0.761 . . . . 0.0 111.011 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 29.8 t0 -75.56 -6.65 51.36 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.843 ' O ' ' HB3' ' A' ' 78' ' ' SER . 36.5 ttt180 -131.23 157.87 42.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 0.0 108.709 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 p -69.04 160.7 30.49 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.708 0.765 . . . . 0.0 111.295 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.75 32.89 6.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.7 -0.625 . . . . 0.0 111.326 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.462 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 2.5 m-85 60.63 59.99 2.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.2 -0.937 . . . . 0.0 109.371 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.423 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 58.2 mtt -147.76 171.17 16.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 -170.76 42.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -54.19 122.25 9.89 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.074 -1.25 . . . . 0.0 107.633 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -103.83 135.83 44.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 108.804 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -129.36 137.56 51.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.356 -0.84 . . . . 0.0 109.427 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -100.65 119.61 38.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.0 mt -117.15 121.99 42.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.031 -1.043 . . . . 0.0 112.164 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -84.54 166.56 17.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.388 -0.82 . . . . 0.0 109.888 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' CZ ' ' OXT' ' A' ' 174' ' ' LEU . 31.7 ptt180 -52.4 123.16 10.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.973 . . . . 0.0 110.198 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.32 171.7 39.55 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -102.27 126.73 49.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -1.137 . . . . 0.0 108.712 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -113.02 99.65 49.23 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 51.7 Cg_endo -73.09 -11.99 25.53 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.357 2.038 . . . . 0.0 112.429 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 43.8 m-20 -165.14 136.87 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 27.7 p90 -149.64 21.66 0.91 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.669 -1.27 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 44.0 mtp -97.29 -41.33 8.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.923 -1.111 . . . . 0.0 109.752 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -93.6 -25.56 17.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -81.76 -20.62 38.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.278 -0.889 . . . . 0.0 109.549 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 mtp -101.29 -25.65 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 109.966 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.11 57.19 2.87 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.4 mtp -130.04 140.15 50.9 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -1.15 . . . . 0.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.8 p-10 -93.07 53.64 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.235 -0.915 . . . . 0.0 109.306 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.1 p30 152.98 -171.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.537 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -97.72 -167.02 1.46 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 78' ' ' SER . 59.5 t -77.73 140.96 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -105.81 -17.0 14.51 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.577 -1.327 . . . . 0.0 107.827 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.843 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.34 157.96 44.98 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.079 -1.013 . . . . 0.0 109.87 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.7 p -153.03 143.35 22.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.622 0.725 . . . . 0.0 110.432 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.404 HH22 ' CG ' ' A' ' 83' ' ' PRO . 78.0 ttt-85 -137.71 140.22 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.7 ttp -90.72 151.23 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.512 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 2.1 mp -74.02 123.22 89.08 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.028 . . . . 0.0 109.197 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' O ' ' O ' ' A' ' 82' ' ' ILE . 73.2 Cg_exo -45.71 177.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.337 2.025 . . . . 0.0 112.549 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.3 mt -102.65 64.8 0.89 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.409 -0.807 . . . . 0.0 109.617 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -46.25 147.73 1.04 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.168 -0.958 . . . . 0.0 109.739 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.414 ' N ' ' CD2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -151.27 33.13 0.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.024 -1.047 . . . . 0.0 109.591 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.06 -90.61 0.62 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 17.4 m -164.93 -171.32 2.21 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.61 -0.935 . . . . 0.0 110.148 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -120.38 128.66 53.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.598 0.713 . . . . 0.0 109.958 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -168.93 125.37 0.94 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.0 ttm -116.72 135.84 53.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 0.0 109.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -106.62 118.03 35.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 103' ' ' MET . 19.4 mt -101.29 148.5 25.06 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.257 1.027 . . . . 0.0 112.514 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD2' ' SD ' ' A' ' 99' ' ' MET . 38.2 m-85 -132.27 121.88 24.29 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.474 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 88.3 tt0 -61.88 -27.86 69.1 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 111.055 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.06 164.26 12.44 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.523 -1.361 . . . . 0.0 111.062 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.577 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 75.0 p -61.88 157.83 17.45 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.514 -0.741 . . . . 0.0 109.731 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 97' ' ' SER . 29.8 t0 83.47 -95.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.078 -1.014 . . . . 0.0 108.763 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' CD2' ' A' ' 94' ' ' TYR . 21.1 mmt -163.54 30.88 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -98.05 -155.56 29.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 60.29 -179.24 2.62 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -67.42 132.0 46.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.279 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.454 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 11.8 ptt? -93.67 118.24 31.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.3 mtm -119.51 140.73 50.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.053 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -100.71 137.8 38.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.177 -0.952 . . . . 0.0 109.508 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.65 117.53 27.77 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.604 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 14.9 ttt -129.96 27.45 5.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 109' ' ' ASP . 17.0 t70 -151.31 -172.26 4.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.518 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.526 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 90.1 m-20 -82.95 131.18 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -111.8 84.19 5.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.031 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.4 Cg_endo -77.37 -28.59 5.49 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.243 1.962 . . . . 0.0 111.937 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 22.3 p30 -138.17 82.82 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -63.15 -22.95 67.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.351 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 8.1 tpt -58.6 -40.67 83.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.592 0.711 . . . . 0.0 109.414 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -81.57 -22.24 37.91 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 110.335 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -77.57 -64.41 1.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.709 -1.244 . . . . 0.0 111.376 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -108.36 3.03 22.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 110.61 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 114' ' ' MET . 2.4 m-20 54.4 34.6 21.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.886 -1.134 . . . . 0.0 108.932 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 8.6 ptm -148.06 133.65 18.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 54.6 p -116.92 7.55 13.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 110.519 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.482 ' HA ' ' O ' ' A' ' 163' ' ' SER . 73.6 m-20 -131.3 93.16 3.31 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.361 -1.462 . . . . 0.0 113.379 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -105.19 133.87 49.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.04 4.07 54.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.992 -1.067 . . . . 0.0 111.688 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.2 t -156.23 161.5 40.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 119.758 -1.839 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.48 170.54 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.86 145.81 25.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 76.2 t -113.8 123.37 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.2 tpp -78.13 -34.15 50.09 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 130' ' ' GLY . 11.7 t70 -177.46 175.77 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.155 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.522 ' H ' ' CG ' ' A' ' 129' ' ' ASP . . . 78.37 -142.2 25.74 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.523 ' CD2' ' OH ' ' A' ' 146' ' ' TYR . 39.8 m80 -151.51 135.26 16.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.662 -0.905 . . . . 0.0 109.094 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -126.02 132.21 52.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 0.0 112.269 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -104.08 133.09 49.61 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 53.4 t -111.9 144.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.752 -1.218 . . . . 0.0 109.64 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.535 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 47.8 m-85 -120.73 123.37 42.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 111.128 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 164' ' ' ARG . 80.2 tt0 -57.03 -28.03 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -118.02 155.69 50.98 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.425 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 25.1 Cg_endo -62.0 -177.12 0.24 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.313 2.675 . . . . 0.0 113.661 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.589 ' N ' ' OG ' ' A' ' 167' ' ' SER . 66.6 m-20 48.67 35.49 6.33 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.622 0.725 . . . . 0.0 110.545 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.653 ' H ' ' CB ' ' A' ' 167' ' ' SER . 8.1 m-85 55.5 52.09 11.75 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.751 -0.593 . . . . 0.0 109.984 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.5 m -136.94 162.54 32.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.119 -0.988 . . . . 0.0 109.77 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.45 -179.99 32.18 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -54.2 109.89 0.54 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -1.045 . . . . 0.0 108.737 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 3.5 mt-30 -84.58 141.75 30.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.8 132.28 53.75 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.523 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 65.6 t80 -94.78 105.47 17.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.369 -0.832 . . . . 0.0 109.763 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.568 ' CA ' ' HH ' ' A' ' 152' ' ' TYR . 6.9 mp -100.47 121.5 41.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.712 ' N ' ' HH ' ' A' ' 152' ' ' TYR . 2.2 ptt180 -109.48 164.14 15.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.5 Cg_exo -32.12 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.76 2.307 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.81 -166.59 13.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.95 135.05 55.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -1.002 . . . . 0.0 110.332 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.712 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 91.6 m-85 -109.77 144.3 38.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.558 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 93.4 mtt180 -129.84 -12.09 4.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.004 . . . . 0.0 112.572 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.54 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.3 p -170.29 170.24 7.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.966 -1.709 . . . . 0.0 110.538 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.531 ' HA ' ' CE2' ' A' ' 158' ' ' TRP . 0.1 OUTLIER -53.4 -19.12 3.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.645 -0.659 . . . . 0.0 109.606 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.462 ' H ' ' HG ' ' A' ' 154' ' ' SER . 36.1 m120 -84.72 2.23 42.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.069 -1.019 . . . . 0.0 108.961 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -57.78 2.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.098 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.531 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 8.4 p90 -79.32 17.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.89 42.37 94.97 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -109.73 -169.51 20.13 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.428 ' O ' ' CG2' ' A' ' 162' ' ' THR . 4.2 m -151.66 14.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 161' ' ' VAL . 34.8 p -160.6 -163.7 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 16.8 p -137.77 5.29 2.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 109.732 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 136' ' ' GLU . 88.5 mtt180 -65.89 73.8 0.07 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 0.0 112.266 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.2 mtt -102.45 117.94 35.79 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.193 -0.942 . . . . 0.0 109.502 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.93 -26.62 4.33 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.653 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.0 151.6 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.618 -1.519 . . . . 0.0 111.601 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.07 141.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.99 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -126.72 140.95 52.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.221 -0.924 . . . . 0.0 110.632 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.755 ' O ' ' N ' ' A' ' 172' ' ' THR . 30.3 mtp180 -94.62 102.72 14.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.284 -0.885 . . . . 0.0 108.939 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -45.57 69.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.521 -0.737 . . . . 0.0 112.136 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 170' ' ' ARG . 20.6 p -116.78 64.64 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.161 -0.962 . . . . 0.0 110.357 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -175.5 104.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.224 -0.923 . . . . 0.0 109.304 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.482 ' OXT' ' CZ ' ' A' ' 60' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.902 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 mtm . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.289 0.566 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -63.04 162.31 31.86 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -151.87 145.06 24.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.468 -1.019 . . . . 0.0 110.555 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.2 tt -133.44 135.17 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.881 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.3 mt -119.36 128.73 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -93.84 154.51 17.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -141.12 133.93 28.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 108.927 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -72.2 -33.36 67.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 111.296 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -87.8 151.06 23.16 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.721 -1.237 . . . . 0.0 110.601 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.515 HH12 ' CG ' ' A' ' 65' ' ' ASP . 84.3 mtt-85 -67.34 -39.87 85.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.513 -0.742 . . . . 0.0 109.876 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -80.86 38.07 0.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 109.847 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 54.01 64.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 109.471 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.91 -157.68 8.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.16 -151.12 51.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -71.85 121.12 18.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -1.147 . . . . 0.0 108.961 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -102.83 157.86 16.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.247 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.629 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 17.3 t-80 -149.08 124.61 10.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.542 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -98.44 118.15 34.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.042 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' ND1' ' A' ' 17' ' ' HIS . 2.7 m -119.57 139.64 51.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 0.0 109.332 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -144.16 8.33 1.41 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.5 t -140.66 154.01 46.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.469 -0.769 . . . . 0.0 110.735 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 54.0 p30 -47.94 154.43 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.765 . . . . 0.0 110.295 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 15.3 t -154.99 111.79 3.28 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.97 -1.56 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 42.1 p-10 -142.96 99.42 3.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.8 -22.35 16.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.031 -1.043 . . . . 0.0 109.079 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 21.1 t-80 -55.98 -37.15 68.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -49.05 -52.88 22.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 50.8 m-85 -63.31 -45.64 90.39 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 0.0 111.319 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.433 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 20.3 p90 -155.19 151.0 27.64 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.018 -1.051 . . . . 0.0 110.091 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -92.53 -3.59 54.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.119 -0.988 . . . . 0.0 110.117 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -164.72 162.45 21.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 42.2 t -161.64 131.28 4.69 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 84.4 m-70 -110.49 -7.98 14.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.079 -1.013 . . . . 0.0 109.276 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m -135.2 142.8 46.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.931 -1.106 . . . . 0.0 110.459 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -136.28 145.82 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -135.87 116.46 13.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.889 -1.132 . . . . 0.0 111.204 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.82 118.69 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.425 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.0 t -169.89 146.33 3.13 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.493 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.615 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 96.14 -130.74 10.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.615 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 62.7 m -160.88 155.91 24.23 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -140.48 131.87 26.81 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.082 -1.011 . . . . 0.0 109.012 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -98.19 112.86 24.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.51 141.84 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.885 0.85 . . . . 0.0 110.411 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.455 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 28.0 m-85 -118.13 137.38 52.99 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.887 0.851 . . . . 0.0 111.046 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 42.7 t0 -71.43 -11.68 61.01 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.716 ' O ' ' HB2' ' A' ' 78' ' ' SER . 26.2 ttt-85 -127.88 157.66 39.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.122 -0.986 . . . . 0.0 108.436 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.662 ' HG1' ' ND2' ' A' ' 50' ' ' ASN . 18.9 p -68.79 158.08 35.11 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.632 -0.667 . . . . 0.0 111.475 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.662 ' ND2' ' HG1' ' A' ' 49' ' ' THR . 18.3 m-20 67.41 36.69 3.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 111.635 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.455 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.8 m-85 58.25 59.56 2.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.7 mtt -145.38 167.06 23.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.69 -165.63 33.69 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -60.22 124.01 18.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.09 136.71 42.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.96 138.48 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 109.85 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 38.6 p90 -101.83 122.68 44.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.304 -0.872 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.2 mt -113.06 117.5 32.18 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.933 -1.105 . . . . 0.0 111.555 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.0 ptt180 -92.71 157.03 16.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 111.209 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' C ' ' O ' ' A' ' 59' ' ' ARG . 68.9 ttt180 -31.99 109.48 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.43 0.633 . . . . 0.0 110.691 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.07 168.58 37.76 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -103.92 123.26 46.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.04 98.1 12.88 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.55 -20.06 65.45 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.254 1.969 . . . . 0.0 112.015 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.515 ' CG ' HH12 ' A' ' 10' ' ' ARG . 15.2 t0 -167.07 147.01 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 28.5 p90 -148.22 25.0 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.256 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 7.3 mmt -95.61 -42.35 8.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.373 -0.83 . . . . 0.0 109.427 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -98.09 -17.1 19.28 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.53 -10.52 45.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.715 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.8 mmt -114.32 -33.8 5.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.26 53.15 3.74 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtp -121.72 143.83 49.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -1.008 . . . . 0.0 109.35 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 29.8 t30 -94.27 57.57 2.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.962 . . . . 0.0 109.174 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.35 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.523 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.4 p -100.42 -167.59 1.46 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.935 0.874 . . . . 0.0 109.544 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 78' ' ' SER . 54.3 t -74.72 139.81 18.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -107.54 -13.84 14.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.616 -1.303 . . . . 0.0 108.335 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.716 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -149.11 165.84 30.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.963 -1.086 . . . . 0.0 109.533 177.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.2 p -163.04 154.44 17.43 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.967 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.507 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 59.0 ttt180 -136.13 141.18 44.12 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 ptm -88.33 142.35 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.078 -1.014 . . . . 0.0 109.085 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.547 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 90.4 mt -93.92 113.73 61.29 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 108.699 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.77 150.56 2.49 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.121 1.88 . . . . 0.0 112.383 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.4 mt -92.49 47.35 1.3 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 109.523 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -112.64 132.25 55.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.482 -0.761 . . . . 0.0 109.104 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -135.83 73.34 1.46 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.317 -0.864 . . . . 0.0 109.711 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.18 -85.96 0.37 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.3 m -125.49 149.83 47.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.347 -1.09 . . . . 0.0 110.708 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -114.3 121.14 42.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.57 -0.707 . . . . 0.0 109.891 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -170.32 128.27 0.84 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.446 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 40.9 ttm -112.2 130.69 55.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.97 -1.081 . . . . 0.0 109.289 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -104.69 116.15 31.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 103' ' ' MET . 13.1 mt -100.46 149.0 24.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.112 0.958 . . . . 0.0 112.556 -177.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' O ' ' A' ' 99' ' ' MET . 31.2 m-85 -135.04 125.0 25.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.487 ' C ' ' HD1' ' A' ' 96' ' ' HIS . 86.1 tt0 -63.28 -22.76 67.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.853 -1.154 . . . . 0.0 111.767 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.845 ' O ' ' OG ' ' A' ' 124' ' ' SER . 3.0 m-70 -113.61 162.42 16.23 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.132 -1.605 . . . . 0.0 111.504 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 25.2 p -59.19 158.54 8.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.302 -0.874 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 97' ' ' SER . 5.8 m-20 81.64 -96.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.544 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 17.1 mmt -163.68 30.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.18 -159.93 32.41 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.76 -162.89 47.69 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.445 ' O ' ' HE3' ' A' ' 104' ' ' MET . 57.7 mtp180 -85.81 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -1.172 . . . . 0.0 109.218 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.7 ptt? -95.81 113.65 25.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 110.262 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.445 ' HE3' ' O ' ' A' ' 102' ' ' ARG . 1.3 mpt? -110.66 140.46 45.0 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.59 136.6 43.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.422 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -130.8 120.76 24.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ttt -117.83 -15.84 10.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 52.6 p30 -107.63 -157.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 17.8 p-10 -93.85 138.1 32.37 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -118.99 86.3 31.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.204 -0.935 . . . . 0.0 110.354 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.81 -28.13 6.58 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.178 1.919 . . . . 0.0 112.143 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 5.9 t30 -129.74 83.9 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.34 -27.63 65.52 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.618 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.7 mtp -55.41 -39.15 69.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.203 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.487 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 94.9 m-20 -84.84 -20.94 30.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.294 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -77.32 -62.3 1.7 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.654 -1.278 . . . . 0.0 110.334 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -109.02 1.71 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 110.455 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.2 m120 57.66 36.62 26.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.068 . . . . 0.0 109.83 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . 0.453 ' CG ' ' CE2' ' A' ' 122' ' ' PHE . 8.7 ptm -152.44 136.36 16.34 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.4 p -114.41 8.0 16.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.06 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 163' ' ' SER . 46.5 p-10 -134.42 98.56 4.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.348 -1.47 . . . . 0.0 113.898 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.62 134.61 51.75 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -96.83 4.4 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.015 -1.053 . . . . 0.0 111.478 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.845 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -151.02 156.66 41.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.93 -1.731 . . . . 0.0 110.43 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' CYS . . . . . 0.446 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 16.0 t -165.42 164.66 19.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.268 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.83 144.92 26.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.021 -1.049 . . . . 0.0 109.346 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 74.5 t -115.4 126.68 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.8 ttt -76.54 -21.83 55.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.601 -0.687 . . . . 0.0 109.793 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 162.16 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.722 0.773 . . . . 0.0 110.947 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.63 -140.57 21.95 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.547 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 60.2 m-70 -148.45 130.11 15.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.948 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -123.38 132.34 53.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.392 -0.818 . . . . 0.0 111.648 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.9 mt -103.69 130.16 51.13 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 41.6 t -109.94 142.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.957 -1.089 . . . . 0.0 109.574 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 58.6 m-85 -117.84 124.36 48.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.609 -0.682 . . . . 0.0 111.936 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.4 tt0 -59.26 -27.06 65.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.0 mp0 -122.64 153.99 63.16 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.228 -0.92 . . . . 0.0 108.621 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.29 -175.23 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 123.417 2.744 . . . . 0.0 113.602 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 49.29 33.96 5.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.591 0.71 . . . . 0.0 110.055 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.435 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 31.4 m-85 54.22 52.18 13.1 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.484 0.659 . . . . 0.0 109.939 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 85.4 m -137.02 162.18 34.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.576 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.12 177.38 31.81 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -53.95 109.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.666 -0.903 . . . . 0.0 108.604 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.9 mt-30 -84.49 145.81 27.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 109.409 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -129.39 127.79 41.72 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.195 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.706 ' HH ' ' HE ' ' A' ' 148' ' ' ARG . 1.8 t80 -89.81 106.03 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.24 123.83 46.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.445 -0.784 . . . . 0.0 109.134 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.706 ' HE ' ' HH ' ' A' ' 146' ' ' TYR . 0.1 OUTLIER -111.48 169.13 6.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' A' ' 148' ' ' ARG . 15.0 Cg_exo -32.76 162.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.846 2.364 . . . . 0.0 112.182 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.39 -169.69 13.36 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.28 133.38 55.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.554 -0.968 . . . . 0.0 110.52 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . 0.616 ' HH ' ' N ' ' A' ' 148' ' ' ARG . 98.3 m-85 -106.87 142.75 36.0 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 97' ' ' SER . 44.1 ptt85 -131.89 -6.61 3.55 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.848 -1.157 . . . . 0.0 113.222 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 153' ' ' ARG . 3.8 m -172.22 170.13 5.23 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.537 -1.977 . . . . 0.0 111.018 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.61 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -56.65 -24.12 46.2 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -78.99 -1.75 36.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.224 -0.922 . . . . 0.0 109.301 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 159' ' ' GLY . 3.5 t0 -89.1 -61.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.58 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 7.0 p90 -74.35 16.17 0.28 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.76 34.23 89.36 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.01 -165.95 32.81 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 47.9 t -146.16 -8.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.811 -0.817 . . . . 0.0 109.098 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -139.69 -156.36 0.67 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.5 p -139.79 5.32 2.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.353 -0.842 . . . . 0.0 109.797 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 136' ' ' GLU . 48.0 mtp180 -62.34 74.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.072 -1.017 . . . . 0.0 112.126 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 163' ' ' SER . 65.0 mtt -105.11 116.5 32.06 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.051 -1.031 . . . . 0.0 110.051 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.12 -22.96 4.72 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.225 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.426 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.36 150.9 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 119.572 1.686 . . . . 0.0 111.407 -178.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.81 141.36 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.265 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -128.68 144.07 51.08 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.178 -0.951 . . . . 0.0 110.368 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 172' ' ' THR . 16.2 ptt180 -102.46 91.12 4.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -40.39 86.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.495 -0.753 . . . . 0.0 111.027 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 170' ' ' ARG . 3.6 t -127.06 76.68 1.67 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.977 -1.077 . . . . 0.0 108.895 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 0.8 OUTLIER 169.46 111.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.34 -0.85 . . . . 0.0 109.09 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.2 tp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.401 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -141.11 144.95 35.18 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.514 -0.992 . . . . 0.0 110.543 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.605 HD13 ' CD2' ' A' ' 43' ' ' PHE . 15.9 tt -135.46 135.03 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.22 128.97 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.414 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.8 140.6 31.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.368 -0.833 . . . . 0.0 109.24 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -125.82 136.07 52.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.711 -1.243 . . . . 0.0 109.343 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -72.41 -38.49 68.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 110.208 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.3 t70 -83.27 157.68 22.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.068 -1.02 . . . . 0.0 110.122 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 38.1 ptt85 -71.68 -39.91 69.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.013 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.476 ' OD1' ' NH1' ' A' ' 10' ' ' ARG . 88.6 m-20 -78.26 38.13 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.619 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 53.94 47.14 24.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 109.464 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.57 -158.19 8.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.72 -149.43 49.5 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -73.78 118.73 17.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -1.165 . . . . 0.0 109.221 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -100.73 155.58 17.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -146.0 124.08 12.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.08 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -97.89 121.83 40.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.14 -0.975 . . . . 0.0 109.808 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -122.33 137.79 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 81' ' ' MET . 21.3 ptt? -140.76 10.02 2.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.393 -0.817 . . . . 0.0 108.941 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -144.81 158.81 43.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.993 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 49.4 p30 -46.51 161.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.504 -0.748 . . . . 0.0 109.807 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 3.6 t -161.66 110.0 1.48 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.6 40.56 1.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 14.1 p30 -177.39 91.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.993 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD21 ' SG ' ' A' ' 79' ' ' CYS . 96.4 mt -98.04 -22.45 16.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.906 . . . . 0.0 108.87 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.55 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 22.3 t-80 -57.93 -42.67 85.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 108.758 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -59.67 -16.65 28.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.741 -0.599 . . . . 0.0 109.841 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -99.98 -47.64 4.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.51 145.95 21.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.261 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 71.3 m-20 -97.34 -7.49 31.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 110.404 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -149.35 149.4 30.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.139 -0.976 . . . . 0.0 108.632 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 38.9 t -154.55 114.52 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -96.12 -16.55 21.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.716 -0.615 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 t -133.77 142.58 47.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.899 -1.126 . . . . 0.0 110.801 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.97 145.95 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -134.7 121.13 20.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.053 . . . . 0.0 111.278 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.97 117.83 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.67 -32.33 23.67 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.5 t -168.4 151.79 5.64 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.224 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 -165.19 43.06 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -123.74 153.38 40.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.397 -1.061 . . . . 0.0 109.546 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.605 ' CD2' HD13 ' A' ' 4' ' ' ILE . 4.2 t80 -133.64 133.39 41.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.0 tpt -103.06 122.52 44.82 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.686 ' HB ' HG11 ' A' ' 76' ' ' VAL . 21.0 m -115.05 146.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.03 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.497 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.0 m-85 -121.82 143.77 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.681 0.753 . . . . 0.0 110.481 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.76 -7.81 58.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.799 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.5 ttm180 -131.21 157.98 41.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p -69.84 155.7 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.962 0.887 . . . . 0.0 111.231 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 71.93 33.5 1.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.377 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.0 m-85 61.62 55.22 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.914 -1.116 . . . . 0.0 110.049 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 50.2 mtt -143.73 174.19 11.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.302 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.65 -170.03 47.71 Favored Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.834 -1.166 . . . . 0.0 110.246 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -55.15 119.85 6.11 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -1.059 . . . . 0.0 108.418 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -101.34 132.25 46.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.331 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -124.48 136.39 53.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.995 . . . . 0.0 109.607 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -100.59 116.45 32.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 0.0 109.463 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.51 139.13 42.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 108.556 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.3 ptt180 -113.25 161.38 17.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.054 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 59' ' ' ARG . 39.9 ttp180 -35.17 115.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.509 -0.745 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.09 169.69 31.89 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.45 127.77 53.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.481 -1.011 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -107.04 100.28 31.36 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 39.6 Cg_endo -70.01 -20.11 34.1 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.38 2.053 . . . . 0.0 112.716 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 42.2 m-20 -163.65 138.66 6.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.512 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.5 p90 -148.63 26.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.548 -1.345 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.4 mtt -99.99 -43.62 6.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.933 -1.104 . . . . 0.0 109.176 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -94.61 -22.67 18.02 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.9 m -82.1 -19.41 40.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.669 -0.644 . . . . 0.0 109.835 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 mmt -105.58 -23.35 12.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.98 -1.075 . . . . 0.0 109.012 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.88 51.98 4.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.0 mtp -123.13 -171.48 2.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.044 -1.268 . . . . 0.0 109.639 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 63.4 t30 -145.79 55.99 1.2 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.168 -0.958 . . . . 0.0 109.371 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.0 m-20 150.23 -169.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -96.69 -167.11 1.5 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.341 -0.849 . . . . 0.0 109.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.686 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.5 m -88.85 148.69 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -106.74 -11.08 15.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.058 -1.027 . . . . 0.0 108.376 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.799 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.44 172.54 13.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.049 -1.032 . . . . 0.0 110.313 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' SG ' HD21 ' A' ' 26' ' ' LEU . 22.1 p -172.09 156.75 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.869 0.842 . . . . 0.0 110.84 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -134.6 139.58 45.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' A' ' 20' ' ' MET . 59.5 ttp -91.43 143.12 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.067 -1.02 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.2 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 108.943 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 63.9 m . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.445 0.641 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -110.76 116.82 31.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -169.4 125.25 0.87 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 108.775 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.406 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 42.8 ttm -107.09 121.02 43.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -95.15 115.63 27.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.0 mt -103.7 147.49 27.18 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.142 0.972 . . . . 0.0 112.55 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.559 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 30.6 m-85 -135.37 127.28 29.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.491 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 50.2 tt0 -61.52 -27.97 68.98 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 111.818 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.881 ' O ' ' OG ' ' A' ' 124' ' ' SER . 5.9 m-70 -109.72 165.67 11.51 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.671 -1.268 . . . . 0.0 111.202 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.7 m -60.52 157.06 14.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 97' ' ' SER . 8.7 t70 81.82 -96.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.8 mmt -163.29 33.09 0.09 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.71 -160.13 31.91 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.313 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 65.0 -149.33 51.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.423 ' H ' ' HB2' ' A' ' 95' ' ' GLU . 76.5 mtm-85 -96.14 139.55 32.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.3 ptt? -96.09 119.48 34.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.195 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 104' ' ' MET . 0.3 OUTLIER -115.62 135.8 53.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.009 -1.057 . . . . 0.0 108.817 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.14 132.19 43.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.9 OUTLIER -129.02 117.18 20.48 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 74.7 mtp -123.25 13.62 9.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.548 ' H ' HD23 ' A' ' 106' ' ' LEU . 42.3 p30 -140.09 -162.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.952 . . . . 0.0 110.176 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 2.0 p30 -87.04 133.22 33.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.57 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -117.73 90.81 37.06 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.434 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.94 -28.09 5.3 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.206 1.938 . . . . 0.0 112.286 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -135.28 84.99 2.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.79 -27.91 66.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.552 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.5 tpt -57.01 -39.73 75.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.59 0.709 . . . . 0.0 109.205 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -84.13 -22.05 31.2 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.012 -1.055 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -79.32 -63.07 1.5 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.58 -1.325 . . . . 0.0 111.633 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -104.6 1.05 29.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.319 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 114' ' ' MET . 17.8 t30 58.87 32.5 22.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.909 -1.119 . . . . 0.0 109.425 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 4.7 ptm -150.32 133.06 15.91 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 53.7 p -116.57 5.93 13.38 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 120' ' ' SER . 53.9 m-20 -130.01 90.99 3.05 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.723 -1.236 . . . . 0.0 112.471 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.654 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -100.95 130.94 47.02 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.059 -1.026 . . . . 0.0 108.554 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -93.89 2.92 56.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 0.0 110.92 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.881 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.9 p -147.83 154.07 39.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.146 -1.596 . . . . 0.0 109.935 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 23.0 t -165.36 163.71 19.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.885 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.554 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 7.0 t60 -152.45 148.15 27.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 65.4 t -115.95 125.35 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.937 0.875 . . . . 0.0 109.252 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 10.0 tpt -72.79 -32.66 65.73 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 172.95 167.15 0.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.827 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.93 -155.19 28.68 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.541 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 89.6 m-70 -135.49 130.12 34.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.552 -0.97 . . . . 0.0 110.184 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -121.42 131.13 53.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.549 -0.719 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.484 HD22 ' NE2' ' A' ' 144' ' ' GLN . 5.2 mt -100.86 130.26 46.84 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 34.9 t -109.08 143.45 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.835 -1.166 . . . . 0.0 109.546 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.446 ' OH ' ' NH2' ' A' ' 169' ' ' ARG . 90.4 m-85 -121.04 125.63 47.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.729 -0.607 . . . . 0.0 110.906 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -60.26 -26.09 66.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 167' ' ' SER . 26.0 mt-30 -121.68 154.0 59.98 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 20.3 Cg_endo -60.64 -171.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 123.197 2.598 . . . . 0.0 113.676 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m120 46.43 30.32 1.05 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.511 0.672 . . . . 0.0 110.149 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.532 ' H ' ' CB ' ' A' ' 167' ' ' SER . 18.5 m-85 57.69 52.43 8.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.419 -0.801 . . . . 0.0 109.924 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -138.4 166.09 25.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.15 -179.82 33.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -55.33 113.25 1.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -1.026 . . . . 0.0 109.121 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.484 ' NE2' HD22 ' A' ' 133' ' ' LEU . 19.2 tt0 -87.58 141.41 28.63 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.149 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -123.85 133.91 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.541 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 81.1 t80 -95.16 102.28 14.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.517 -0.739 . . . . 0.0 109.763 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.1 mp -97.69 120.94 38.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 149' ' ' PRO . 0.9 OUTLIER -104.96 -178.49 0.62 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 148' ' ' ARG . 51.9 Cg_exo -52.39 154.21 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.217 1.944 . . . . 0.0 111.847 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.19 -166.33 14.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.23 136.71 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -1.098 . . . . 0.0 110.44 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.54 143.45 42.38 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.679 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 59.1 mtm180 -130.09 -5.84 4.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.141 -0.974 . . . . 0.0 112.537 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 10.0 t -172.01 -178.45 2.14 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.111 -1.618 . . . . 0.0 110.726 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.5 OUTLIER -60.44 -26.88 67.07 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -80.19 2.53 23.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.096 -1.002 . . . . 0.0 109.911 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.679 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -93.01 -61.13 1.64 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.167 -0.958 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -78.15 18.0 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.5 38.44 95.76 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -108.65 -160.85 20.07 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.7 t -148.75 -41.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.8 p -102.71 -158.34 0.66 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.4 p -144.36 11.68 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.842 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -63.89 74.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.096 -1.003 . . . . 0.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.47 119.88 39.45 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.248 -0.908 . . . . 0.0 109.772 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.1 -25.98 3.67 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.532 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.94 152.09 51.43 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 119.274 1.537 . . . . 0.0 111.202 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.92 142.69 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.639 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.446 ' NH2' ' OH ' ' A' ' 135' ' ' TYR . 45.3 ttp180 -123.7 136.57 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -96.05 98.08 10.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.548 -0.72 . . . . 0.0 109.4 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.005 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -149.67 147.31 27.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.166 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.669 HD13 ' CD2' ' A' ' 43' ' ' PHE . 13.0 tt -133.9 136.79 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 110.09 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.5 mt -122.89 130.69 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.524 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -99.21 135.09 41.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.038 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -120.17 135.2 55.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -73.8 -32.62 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.956 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -81.88 161.58 23.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.8 -44.17 33.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.981 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.68 47.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 51.25 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.539 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.53 -175.74 47.72 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.8 -146.06 23.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -75.82 116.42 16.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.972 -1.31 . . . . 0.0 108.699 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -98.19 157.96 15.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.814 . . . . 0.0 109.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -148.14 122.5 9.67 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.21 -0.931 . . . . 0.0 108.873 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -97.64 120.72 38.53 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -124.43 137.55 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -140.88 11.05 2.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -141.48 155.16 45.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 110.147 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 2.9 p30 -53.26 141.03 24.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.452 -0.78 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 t -138.93 120.45 15.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.97 -4.68 58.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.016 -1.053 . . . . 0.0 109.576 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -140.23 93.98 2.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 26' ' ' LEU . 34.2 mt -91.13 -16.29 28.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.178 -0.951 . . . . 0.0 108.494 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -58.95 -39.94 83.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.806 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -59.97 -18.69 47.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.481 -0.762 . . . . 0.0 110.514 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.78 -43.26 8.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -158.86 153.87 25.14 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.325 0.583 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -100.41 -7.81 23.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -154.04 153.39 31.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.006 -1.059 . . . . 0.0 108.475 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.589 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 46.2 t -155.98 122.78 5.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.593 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 36.9 m-70 -104.63 -12.45 16.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.744 . . . . 0.0 109.94 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 t -136.06 142.27 44.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.974 . . . . 0.0 110.422 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.8 145.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -137.02 116.5 12.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.896 -1.127 . . . . 0.0 111.276 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.58 119.52 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.37 -32.72 22.26 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 108.945 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.0 t -171.24 153.46 3.66 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.244 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.57 -169.05 38.73 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 53.9 m -118.93 156.69 29.09 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.287 -1.125 . . . . 0.0 109.151 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CD2' HD13 ' A' ' 4' ' ' ILE . 10.7 t80 -145.53 134.77 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 108.994 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.61 ' SD ' ' CD2' ' A' ' 146' ' ' TYR . 10.7 ttm -107.24 126.24 52.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.77 143.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.122 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.7 ' O ' HG13 ' A' ' 76' ' ' VAL . 43.5 m-85 -116.8 139.94 50.02 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.63 0.728 . . . . 0.0 110.863 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 26.3 t0 -76.37 -10.0 59.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.503 -0.748 . . . . 0.0 110.013 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.697 ' O ' ' HB3' ' A' ' 78' ' ' SER . 71.5 mtt-85 -131.61 155.44 47.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 108.525 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.2 p -65.98 158.07 29.19 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.682 0.754 . . . . 0.0 110.953 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 70.73 35.47 1.8 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.094 0.473 . . . . 0.0 111.76 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.496 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.4 m-85 58.58 54.97 5.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.913 -1.117 . . . . 0.0 109.952 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.403 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 83.2 mmm -144.32 178.43 7.92 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.219 -0.925 . . . . 0.0 109.843 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.33 -173.44 53.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -54.91 124.58 17.1 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.157 -1.202 . . . . 0.0 108.427 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -102.74 133.48 47.71 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -126.47 133.58 51.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.19 -0.944 . . . . 0.0 109.36 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -96.9 120.97 38.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.179 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.32 117.33 28.26 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.147 -0.971 . . . . 0.0 111.248 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' O ' ' C ' ' A' ' 60' ' ' ARG . 62.0 ttt-85 -95.33 161.85 13.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 111.302 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 59' ' ' ARG . 47.1 ttp180 -29.33 115.14 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.433 0.635 . . . . 0.0 110.638 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.92 169.49 32.38 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 9.3 pt-20 -108.5 128.44 54.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.483 -1.01 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -106.7 98.25 20.09 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.403 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 35.3 Cg_endo -67.5 -18.92 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.314 2.01 . . . . 0.0 112.362 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 32.5 m-20 -164.84 139.47 5.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -146.44 3.13 0.87 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.48 -1.387 . . . . 0.0 111.194 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.593 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 30.6 mtp -77.64 -39.93 43.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.13 -21.59 17.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.958 . . . . 0.0 109.42 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.2 m -83.4 -16.34 46.3 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.474 -0.767 . . . . 0.0 109.703 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mmt -109.5 -25.34 10.53 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.91 44.81 8.03 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.262 -0.97 . . . . 0.0 110.977 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.0 mtp -114.71 159.3 20.7 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.272 . . . . 0.0 109.585 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 28.8 p30 -110.4 55.8 0.64 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.101 -0.999 . . . . 0.0 109.302 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.7 p30 152.67 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.589 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.8 p -96.97 -175.09 3.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.066 0.936 . . . . 0.0 110.255 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 46' ' ' TYR . 59.7 t -68.09 141.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.27 -17.91 14.16 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.707 -1.245 . . . . 0.0 107.821 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.697 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -145.49 168.85 19.59 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.422 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 22.9 p -161.68 146.22 13.02 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.492 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH1' ' NE ' ' A' ' 148' ' ' ARG . 63.9 ttt180 -132.43 140.3 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.5 tpp -92.36 143.1 26.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.602 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 17.2 mt . . . . . 0 C--N 1.302 -1.48 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 74.6 p . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 121.407 0.622 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -111.96 119.61 39.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.524 -0.735 . . . . 0.0 109.491 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -167.9 129.24 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.3 ttm -117.02 127.66 54.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.325 -0.859 . . . . 0.0 109.269 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -101.06 119.22 38.43 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 125' ' ' CYS . 15.9 mt -101.3 149.06 24.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.119 0.961 . . . . 0.0 112.067 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 99' ' ' MET . 38.3 m-85 -132.95 122.94 25.02 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 52.6 tt0 -62.12 -26.04 68.08 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.195 -0.941 . . . . 0.0 111.828 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.93 165.4 11.6 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.839 -1.163 . . . . 0.0 110.908 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 6.1 p -63.53 158.18 21.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.8 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 97' ' ' SER . 32.2 t0 81.67 -95.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.543 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 19.9 mmt -161.64 33.56 0.13 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.18 -153.1 26.05 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.019 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 62.87 -165.57 25.11 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.455 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 79.1 mtm180 -81.01 143.74 32.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.334 . . . . 0.0 108.842 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.4 mtt -98.21 115.45 28.36 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.922 -1.111 . . . . 0.0 109.447 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.3 mpp? -114.42 135.38 54.16 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.109 -0.994 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.56 132.1 45.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.708 HD11 ' HB2' ' A' ' 110' ' ' CYS . 1.0 OUTLIER -122.79 115.78 22.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.2 ttt -126.16 13.09 7.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.815 . . . . 0.0 109.399 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.542 ' H ' HD23 ' A' ' 106' ' ' LEU . 77.3 m-20 -136.71 -167.68 2.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.626 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -81.99 130.9 35.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.708 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -118.69 78.64 15.61 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 109.52 -179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -78.07 -25.8 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.087 1.858 . . . . 0.0 112.233 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 51.2 p-10 -131.27 75.61 1.66 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -18.54 61.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.93 -1.106 . . . . 0.0 110.41 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.5 tpt -60.88 -42.21 97.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -82.91 -21.51 34.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.382 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -77.21 -62.15 1.75 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.691 -1.256 . . . . 0.0 111.125 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.05 2.68 15.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.489 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' MET . 8.7 m120 50.85 35.36 12.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.871 -1.143 . . . . 0.0 108.769 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.5 ptm -148.3 135.64 20.44 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 78.6 p -125.91 7.09 7.34 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.478 -0.764 . . . . 0.0 111.015 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 163' ' ' SER . 66.6 m-20 -128.42 85.68 2.37 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.552 -1.342 . . . . 0.0 112.786 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -98.74 134.69 41.29 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.95 -1.094 . . . . 0.0 108.7 177.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.45 2.18 55.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.0 111.264 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.5 t -149.92 156.3 41.51 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.156 -1.59 . . . . 0.0 109.846 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.539 ' HB3' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -162.69 162.16 26.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -147.95 143.36 27.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.143 -0.973 . . . . 0.0 109.89 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.9 t -114.26 121.02 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.286 -0.884 . . . . 0.0 109.359 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 23.1 ttt -70.32 -39.44 74.78 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.565 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 0.5 OUTLIER -179.08 173.66 1.14 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.253 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 86.33 -144.13 19.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.56 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 66.3 m-70 -147.76 128.44 14.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.571 -0.958 . . . . 0.0 109.319 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -124.04 135.42 53.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.118 -0.989 . . . . 0.0 112.478 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.22 134.17 51.45 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 25.4 t -110.06 142.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.05 -1.031 . . . . 0.0 109.233 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 50.9 m-85 -119.13 124.32 46.57 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.618 -0.676 . . . . 0.0 110.762 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.516 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 78.0 tt0 -60.69 -26.62 67.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' A' ' 167' ' ' SER . 12.2 mm100 -119.34 150.98 50.55 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.483 ' O ' ' OG1' ' A' ' 141' ' ' THR . 18.1 Cg_endo -59.75 -177.84 0.15 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.921 2.414 . . . . 0.0 113.398 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.581 ' O ' ' CG ' ' A' ' 140' ' ' TYR . 26.9 m120 52.61 38.61 26.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.384 -0.822 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.581 ' CG ' ' O ' ' A' ' 139' ' ' ASN . 5.7 p90 45.75 57.09 5.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.65 -0.656 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 3.8 p -141.42 172.63 12.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.289 -0.882 . . . . 0.0 110.327 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.46 -173.76 40.85 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.645 -1.284 . . . . 0.0 110.798 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.516 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 70.3 mtm180 -58.19 106.66 0.4 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.605 -0.938 . . . . 0.0 109.432 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 11.9 mt-30 -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.62 0.724 . . . . 0.0 110.184 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -126.85 134.17 50.57 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CD2' ' SD ' ' A' ' 44' ' ' MET . 2.4 t80 -95.3 104.84 16.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.0 mp -96.91 121.98 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 108.887 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.533 ' NE ' ' NH1' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -107.26 175.83 1.87 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.71 159.06 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.11 1.874 . . . . 0.0 111.773 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.02 -168.87 12.78 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.2 136.34 54.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -1.017 . . . . 0.0 110.487 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.524 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 17.6 m-85 -110.73 145.55 37.86 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.601 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 35.2 ptt85 -134.5 -3.86 2.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.069 -1.02 . . . . 0.0 112.168 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.579 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 53.8 p -170.17 173.23 5.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.09 -1.631 . . . . 0.0 110.661 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.638 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.77 -21.54 56.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -80.99 -2.52 48.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.556 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.6 m-20 -88.55 -61.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.961 . . . . 0.0 109.274 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.535 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.2 p90 -76.59 16.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.19 38.26 94.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.54 -177.85 23.18 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.55 5.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 63.3 p -154.95 -157.32 0.74 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 55.7 m -141.84 12.35 2.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.437 -0.79 . . . . 0.0 110.269 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -64.02 69.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.083 -1.01 . . . . 0.0 112.826 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.2 mtt -100.36 118.83 37.42 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.054 -1.028 . . . . 0.0 110.523 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.74 -25.85 4.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.442 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -132.47 153.55 50.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.765 -1.433 . . . . 0.0 110.596 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -150.44 141.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.561 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -122.76 133.89 54.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -98.78 102.74 14.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 171' ' ' ILE . 82.4 mt . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.811 -0.556 . . . . 0.0 111.715 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -148.43 149.24 31.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.324 -1.103 . . . . 0.0 110.892 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 36' ' ' ILE . 17.3 tt -134.67 133.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.6 mt -118.48 130.76 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.61 157.27 16.05 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -144.69 136.35 25.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 108.454 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -80.77 -25.12 38.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.016 -1.052 . . . . 0.0 111.267 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 50.9 t0 -80.54 159.06 25.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.812 -1.18 . . . . 0.0 110.821 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' OG ' ' A' ' 35' ' ' SER . 73.7 ttt180 -61.44 -39.84 92.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.657 -0.652 . . . . 0.0 110.064 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 83.2 m-20 -87.48 -90.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.071 -1.018 . . . . 0.0 109.323 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 57.2 m-85 -158.17 63.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 108.959 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.617 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -152.42 -162.38 10.85 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.18 -149.5 39.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -74.37 117.04 15.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.868 -1.372 . . . . 0.0 108.827 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -104.74 158.81 16.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.466 -0.771 . . . . 0.0 110.101 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -149.72 124.07 9.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.069 -1.019 . . . . 0.0 109.828 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -96.45 118.12 32.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.111 -0.993 . . . . 0.0 109.2 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -114.86 139.03 50.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.3 ptp -138.44 10.78 2.74 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.5 p -143.44 161.79 37.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.666 -0.646 . . . . 0.0 109.605 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 49.8 p30 -60.02 146.02 44.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.0 110.562 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -141.15 111.93 7.09 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 50' ' ' ASN . . . -83.93 -5.38 59.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 109.583 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 38.8 p-10 -138.23 93.94 2.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.057 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 79' ' ' CYS . 30.9 mt -94.32 -20.66 19.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -58.44 -40.9 83.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.6 p -57.31 -24.24 53.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.61 -0.682 . . . . 0.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -89.46 -40.37 12.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 108.705 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -159.08 147.35 17.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.601 -0.687 . . . . 0.0 109.701 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -94.06 -9.68 35.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.113 -0.992 . . . . 0.0 110.254 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -152.5 152.23 31.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.048 -1.033 . . . . 0.0 108.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 7.7 t -154.45 114.6 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -95.17 -7.93 37.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.42 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.513 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 14.9 m -137.78 144.13 41.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.511 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 4' ' ' ILE . 9.1 tt -156.85 154.22 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -155.54 144.82 20.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.675 -1.265 . . . . 0.0 111.815 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.55 123.61 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -84.56 -30.51 25.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 108.669 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -166.37 150.29 7.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.88 -142.16 18.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.09 163.02 39.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.63 134.47 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.871 -1.143 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.28 110.66 22.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.658 ' HB ' HG11 ' A' ' 76' ' ' VAL . 18.9 m -99.8 147.18 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.602 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 42.2 m-85 -121.73 140.6 52.12 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.684 0.754 . . . . 0.0 111.147 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.47 -8.02 55.63 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.764 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.823 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.2 ttt180 -131.38 162.58 29.82 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.0 p -74.15 163.3 28.03 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.976 0.893 . . . . 0.0 111.548 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.8 OUTLIER 64.42 31.93 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.217 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.616 ' CE2' ' NH2' ' A' ' 80' ' ' ARG . 5.0 m-85 63.08 58.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.905 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 86.2 mtp -144.29 171.62 14.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 85.42 -169.39 43.32 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -58.03 121.29 10.26 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 4.5 mp0 -104.51 136.15 44.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 109.207 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -125.77 133.34 52.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.21 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -96.97 122.37 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.388 -0.82 . . . . 0.0 109.281 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 mt -117.04 127.99 54.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.283 -0.885 . . . . 0.0 109.746 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ARG . 35.3 ptt180 -97.52 166.35 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 110.078 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 59' ' ' ARG . 44.4 ttp180 -38.52 112.17 0.21 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.576 -0.702 . . . . 0.0 109.84 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.26 171.85 40.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 47.1 mp0 -111.14 130.33 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.375 -1.074 . . . . 0.0 108.667 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.33 99.67 49.81 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ARG . 58.1 Cg_endo -75.8 -9.35 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.343 2.028 . . . . 0.0 112.725 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 44.2 m-20 -164.28 128.93 2.71 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 22.3 p90 -148.4 34.33 0.79 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.62 -1.3 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 54.5 tpp -102.83 -47.25 4.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.024 -1.047 . . . . 0.0 109.708 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -98.54 -19.52 17.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -78.9 -23.93 44.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.3 mmt -101.35 -30.99 11.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.21 49.72 3.65 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.8 mtp -123.1 143.16 50.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.986 . . . . 0.0 109.695 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.56 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 9.7 p-10 -96.13 54.27 1.43 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.157 -0.964 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.3 m-20 150.55 -168.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.514 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.8 p -97.48 -160.49 0.81 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.489 -0.757 . . . . 0.0 109.714 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.658 HG11 ' HB ' ' A' ' 45' ' ' VAL . 6.1 m -92.13 150.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -110.78 -7.6 14.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.894 -1.129 . . . . 0.0 108.022 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.823 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -146.8 165.14 30.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.913 -1.117 . . . . 0.0 109.452 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 26' ' ' LEU . 23.3 p -164.64 149.84 9.89 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.873 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.616 ' NH2' ' CE2' ' A' ' 51' ' ' PHE . 61.6 ttm-85 -138.2 142.84 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 ptm -95.53 151.38 19.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 28.2 mm . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.0 p . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.383 0.611 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -111.05 119.53 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.459 -0.775 . . . . 0.0 109.527 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -171.59 125.59 0.6 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 47.2 ttm -105.38 127.72 53.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.007 -1.058 . . . . 0.0 109.298 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -104.7 115.56 30.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.534 HD23 ' SG ' ' A' ' 125' ' ' CYS . 10.1 mt -104.49 148.15 26.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.233 1.016 . . . . 0.0 113.06 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.555 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 25.3 m-85 -133.53 125.66 29.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' CB ' ' H ' ' A' ' 102' ' ' ARG . 70.8 tt0 -62.59 -26.34 68.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 111.955 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.762 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.3 m-70 -109.63 164.18 12.78 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.658 -1.276 . . . . 0.0 110.828 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -61.89 160.63 11.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.406 -0.809 . . . . 0.0 109.219 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.518 ' O ' ' SD ' ' A' ' 99' ' ' MET . 5.7 m-20 80.05 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.6 mmt -162.78 31.72 0.1 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.34 -156.84 30.54 Favored Glycine 0 N--CA 1.491 2.357 0 CA-C-O 122.173 0.874 . . . . 0.0 111.178 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.418 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 64.38 -155.35 46.95 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 57.9 ttt85 -90.9 140.84 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.162 -1.199 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 44.0 ttp -97.36 114.89 26.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.826 -1.171 . . . . 0.0 109.834 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.7 mtm -113.81 138.79 49.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.138 -0.976 . . . . 0.0 108.656 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.72 138.31 39.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.466 -0.771 . . . . 0.0 109.169 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.3 tt -137.28 122.61 19.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 108.902 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.519 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 5.8 ttt -123.12 2.73 9.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 110.406 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.495 ' H ' HD23 ' A' ' 106' ' ' LEU . 81.1 m-20 -122.29 -162.7 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.245 -0.909 . . . . 0.0 110.078 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 42.9 p-10 -91.29 139.51 30.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.509 ' CB ' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -120.83 98.22 47.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -178.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.99 -23.26 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.147 1.898 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -142.25 84.81 1.89 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.946 -1.096 . . . . 0.0 108.337 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 110' ' ' CYS . 96.0 mt -70.89 -26.99 63.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.083 -1.011 . . . . 0.0 110.074 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.6 tpt -58.59 -40.48 83.32 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 108.715 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -84.1 -23.0 30.93 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 110.619 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -79.12 -62.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.538 -1.351 . . . . 0.0 110.824 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -100.3 2.01 42.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 114' ' ' MET . 28.3 t-20 59.06 30.56 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 110.014 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 9.0 ptm -153.82 138.92 17.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 62.5 m -123.75 5.82 8.8 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.754 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 163' ' ' SER . 37.0 m-20 -128.32 92.43 3.44 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.637 -1.225 . . . . 0.0 113.242 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -104.68 132.97 50.29 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 27.0 m170 -92.01 2.65 56.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.061 . . . . 0.0 111.538 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.762 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.4 p -147.34 153.06 39.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 119.932 -1.73 . . . . 0.0 110.241 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 124' ' ' SER . 35.7 m -157.36 159.04 37.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.482 -0.761 . . . . 0.0 109.481 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.546 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -148.21 141.88 25.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.094 -1.004 . . . . 0.0 108.72 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.546 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 53.3 t -113.25 125.03 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.996 -1.065 . . . . 0.0 109.308 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.466 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.0 ttt -73.8 -28.58 61.72 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.671 0.748 . . . . 0.0 109.118 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m-20 166.85 166.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.828 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.61 -142.67 16.18 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.444 ' CE1' ' CG2' ' A' ' 82' ' ' ILE . 94.0 m-70 -149.74 129.35 13.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.593 -0.945 . . . . 0.0 109.674 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -124.1 135.76 53.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.767 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 168' ' ' ILE . 6.1 mt -105.02 133.09 50.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 43.4 t -111.1 143.0 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.084 -1.01 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.444 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 41.3 m-85 -120.42 124.19 44.86 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.522 -0.736 . . . . 0.0 111.107 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.529 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 54.0 tt0 -58.47 -27.32 64.3 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -119.97 155.2 55.54 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 26.0 Cg_endo -62.69 -171.69 0.11 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.31 2.674 . . . . 0.0 113.686 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 47.52 30.5 1.68 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.507 0.67 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.536 ' H ' ' CB ' ' A' ' 167' ' ' SER . 16.3 m-85 56.86 52.62 9.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.488 -0.757 . . . . 0.0 109.54 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 142' ' ' GLY . 85.6 m -136.89 164.42 28.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.414 -0.804 . . . . 0.0 109.323 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.09 178.51 33.15 Favored Glycine 0 N--CA 1.504 3.177 0 O-C-N 120.886 -1.134 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 136' ' ' GLU . 69.3 mtt85 -53.98 111.42 0.75 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.942 . . . . 0.0 108.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.626 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -86.78 143.53 27.47 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.116 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.12 129.58 49.36 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.549 0.69 . . . . 0.0 109.254 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -90.75 104.0 16.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.55 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.3 mp -97.98 119.62 36.93 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.854 0.835 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -105.83 177.69 1.3 Allowed Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.2 Cg_exo -47.01 161.67 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.86 1.707 . . . . 0.0 111.661 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.81 -179.47 18.39 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.32 136.79 49.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -1.009 . . . . 0.0 110.409 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 16.8 m-85 -112.08 142.82 44.05 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.683 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 7.5 ptp180 -134.86 -4.99 2.45 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.032 -1.042 . . . . 0.0 112.476 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 57.7 m -165.57 165.66 18.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.903 -1.748 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -52.07 -21.08 2.87 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -82.5 2.5 32.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 0.0 109.652 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.683 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 2.4 m-20 -92.88 -61.68 1.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.403 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.5 p90 -77.04 16.09 0.6 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.87 37.69 92.42 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.19 -161.93 22.69 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.5 t -146.97 -42.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.3 p -103.82 -155.46 0.53 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.0 t -146.13 11.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -65.09 76.88 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.087 -1.008 . . . . 0.0 112.535 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -102.64 121.56 42.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.129 -0.982 . . . . 0.0 110.155 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.9 -26.88 3.41 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.536 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 1.3 t -135.4 153.49 51.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.602 -1.528 . . . . 0.0 111.249 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 19.7 mt -149.17 143.05 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -123.06 139.99 53.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.966 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 107' ' ' MET . 53.1 ttp180 -98.82 92.52 5.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.444 -0.785 . . . . 0.0 109.293 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 170' ' ' ARG . 88.8 mt . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 89.6 mttt -161.59 145.41 12.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.994 . . . . 0.0 110.604 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 36' ' ' ILE . 21.0 tt -134.76 133.67 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 109.691 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.83 128.65 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.409 0.623 . . . . 0.0 109.706 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 36' ' ' ILE . 90.1 m-85 -89.26 165.96 14.09 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -152.92 132.61 13.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.602 -1.311 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.59 -43.13 60.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 111.313 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.601 ' HB2' ' H ' ' A' ' 13' ' ' GLY . 88.9 m-20 -69.63 155.77 39.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.616 -1.302 . . . . 0.0 110.782 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 64' ' ' PRO . 72.0 mtp180 -62.09 -44.85 95.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.709 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 12' ' ' PHE . 7.8 p30 -74.97 -95.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 109.191 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 51.0 m-85 -156.02 56.4 0.59 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -141.81 -150.93 5.44 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 64.71 -153.37 49.76 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -74.83 120.06 19.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -1.125 . . . . 0.0 109.231 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -106.34 156.7 18.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.871 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.626 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 1.1 t60 -146.01 128.39 15.89 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.634 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.28 121.66 41.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 108.696 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.5 m -122.62 136.55 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.21 -0.932 . . . . 0.0 109.534 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -141.58 15.27 2.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.0 t -145.81 158.19 43.87 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.781 0.8 . . . . 0.0 110.503 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.07 143.66 7.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.68 114.76 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.75 8.9 41.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.07 -1.019 . . . . 0.0 108.68 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -138.85 98.17 3.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.852 -0.53 . . . . 0.0 109.779 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 78' ' ' SER . 89.2 mt -106.54 -25.31 11.88 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.417 -0.802 . . . . 0.0 109.002 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.2 m -50.54 -58.71 5.17 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 91.4 m-85 -56.14 -49.25 74.46 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.887 -0.508 . . . . 0.0 111.209 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -155.11 149.21 25.84 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.964 -1.085 . . . . 0.0 110.19 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -95.26 -4.74 45.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.384 -0.822 . . . . 0.0 110.344 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -159.91 158.14 30.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.978 . . . . 0.0 108.485 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.542 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 14.4 t -159.11 112.89 2.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.905 -1.122 . . . . 0.0 108.419 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.571 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 60.5 m-70 -92.68 1.0 57.51 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.942 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 7.3 t -146.13 141.65 27.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.405 -1.434 . . . . 0.0 110.687 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 4' ' ' ILE . 19.0 tt -151.11 146.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 108.921 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -143.07 133.88 25.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.93 -1.106 . . . . 0.0 111.8 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 22.7 t -105.04 118.89 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -79.83 -33.49 40.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.891 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -167.79 156.51 9.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.385 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.688 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 86.93 -123.19 6.43 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 99.1 m -168.64 167.75 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.52 141.05 21.64 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.846 -1.159 . . . . 0.0 109.077 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.2 tpt -99.94 115.06 28.78 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 56' ' ' TYR . 4.5 m -108.71 142.06 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.976 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 33.2 m-85 -120.02 137.26 54.2 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.809 0.814 . . . . 0.0 111.298 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.493 ' O ' ' NE ' ' A' ' 77' ' ' ARG . 22.6 t0 -71.75 -5.86 37.11 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.056 ' O ' ' OG ' ' A' ' 78' ' ' SER . 36.2 ttm-85 -131.25 166.82 20.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.443 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 1.8 p -79.92 165.25 22.83 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.751 0.786 . . . . 0.0 110.208 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' C ' ' CG ' ' A' ' 51' ' ' PHE . 43.0 t30 63.63 33.06 13.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.713 -0.617 . . . . 0.0 110.812 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.536 ' H ' ' CB ' ' A' ' 78' ' ' SER . 0.6 OUTLIER 60.83 61.22 1.7 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.948 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.41 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 64.1 mtp -148.39 166.48 27.97 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.248 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.19 -166.64 30.99 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.029 -1.045 . . . . 0.0 110.582 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -57.76 112.88 1.61 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.246 -1.149 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -93.37 134.9 35.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.724 -0.61 . . . . 0.0 109.398 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB2' HG23 ' A' ' 45' ' ' VAL . 55.1 m-85 -130.78 137.14 49.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.664 ' CE2' ' NH2' ' A' ' 169' ' ' ARG . 30.5 p90 -98.93 116.51 31.33 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.381 -0.824 . . . . 0.0 109.779 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -107.38 112.71 25.65 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.668 -1.27 . . . . 0.0 111.473 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 60' ' ' ARG . 14.2 ptm180 -85.96 160.34 19.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.437 -0.789 . . . . 0.0 110.927 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 59' ' ' ARG . 60.1 ttt-85 -35.8 114.91 0.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.646 -0.659 . . . . 0.0 110.012 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 173.73 166.14 31.52 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.594 -1.289 . . . . 0.0 109.947 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -103.75 128.16 51.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -1.016 . . . . 0.0 108.746 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -117.91 90.05 35.66 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.837 . . . . 0.0 109.414 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 10' ' ' ARG . 31.3 Cg_exo -55.86 -11.11 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.639 2.226 . . . . 0.0 111.973 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -170.25 146.15 2.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 108.78 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 30.9 p90 -150.41 31.61 0.66 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.672 -1.268 . . . . 0.0 109.587 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.571 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 26.1 mtp -102.04 -45.66 5.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 109.213 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -96.36 -20.8 18.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -0.953 . . . . 0.0 109.168 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 p -84.17 -12.08 55.5 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.9 mtt -110.31 -28.17 8.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 108.816 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 56.02 2.85 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -130.43 166.92 19.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.935 -1.332 . . . . 0.0 109.287 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 8.7 m120 -117.09 53.25 0.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.409 -0.807 . . . . 0.0 109.287 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.8 m-20 155.33 -168.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.542 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.4 p -98.83 -166.47 1.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.954 0.883 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 46' ' ' TYR . 19.3 t -77.18 140.97 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 47' ' ' ASP . 11.8 mtm180 -102.59 -19.78 14.71 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.762 -1.211 . . . . 0.0 108.008 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 1.056 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 1.0 OUTLIER -150.11 160.19 43.84 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.629 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.05 159.15 37.65 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.351 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -146.12 142.5 28.57 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.8 160.76 19.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.155 -0.966 . . . . 0.0 108.924 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.493 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 66.2 mt . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.672 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 89.5 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.149 0.499 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -108.01 113.43 26.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.139 -0.976 . . . . 0.0 109.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -167.5 132.29 1.91 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.254 -0.904 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.492 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 1.6 ttp -116.44 132.6 56.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -106.43 119.22 38.69 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 103' ' ' MET . 18.2 mt -103.73 151.64 22.77 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.074 0.94 . . . . 0.0 112.301 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.4 129.78 31.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 25.9 tt0 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.768 . . . . 0.0 112.217 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 124' ' ' SER . 14.8 m-70 -119.86 163.3 17.72 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.032 -1.667 . . . . 0.0 111.106 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 50.1 m -55.99 157.83 4.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.5 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 97' ' ' SER . 1.0 OUTLIER 83.42 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.028 -1.045 . . . . 0.0 109.822 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.7 mtt -179.46 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.75 163.01 22.88 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.18 -130.5 10.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.525 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 60.5 mtt85 -104.02 119.7 39.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 108.175 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.521 ' CG ' ' O ' ' A' ' 103' ' ' MET . 12.1 ptt? -90.84 119.05 30.73 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.544 -0.722 . . . . 0.0 110.457 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.4 mpp? -114.79 135.85 53.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.82 133.72 46.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.84 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.8 OUTLIER -123.66 117.67 25.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 9.6 ttt -125.07 15.45 8.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.496 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.467 ' H ' HD23 ' A' ' 106' ' ' LEU . 67.4 m-20 -144.48 -165.01 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 109.895 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 20.9 p-10 -82.96 128.35 34.38 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.689 ' HB2' HD11 ' A' ' 106' ' ' LEU . 1.2 m -123.33 77.0 53.37 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.694 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.4 -31.96 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.54 2.16 . . . . 0.0 112.045 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -117.45 75.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 113' ' ' LEU . 41.1 mt -68.48 -20.73 64.62 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.816 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.475 ' O ' ' ND2' ' A' ' 118' ' ' ASN . 5.4 tpt -59.43 -40.39 86.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.4 -21.79 26.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 110.886 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -75.85 -58.81 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.617 -1.302 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -116.76 0.62 12.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 114' ' ' MET . 11.7 m120 52.79 34.7 16.89 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' A' ' 122' ' ' PHE . 2.4 ttt -147.35 134.52 20.49 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 p -134.0 11.0 3.93 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.602 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 163' ' ' SER . 38.5 m-20 -129.28 94.96 3.91 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.665 -1.272 . . . . 0.0 112.808 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.665 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -111.56 136.45 50.74 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.215 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -96.3 3.96 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.475 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 98' ' ' ASP . 3.6 m -146.8 152.59 39.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.341 -1.474 . . . . 0.0 110.01 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.492 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 53.3 t -161.97 159.7 26.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 110.088 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.401 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 21.6 t60 -145.91 143.48 29.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 96.5 t -113.78 123.41 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 0.0 109.344 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 23.2 ttt -76.91 -22.82 52.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.668 -0.645 . . . . 0.0 109.941 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.5 OUTLIER 170.91 -171.5 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.742 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 63.09 -135.01 43.11 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.1 m-70 -159.96 138.24 10.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.905 . . . . 0.0 109.066 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -128.51 137.77 51.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 111.635 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.7 mt -104.63 130.34 52.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 39.1 t -109.38 141.39 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.918 -1.114 . . . . 0.0 109.408 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.43 125.68 48.56 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 0.0 110.868 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -61.57 -21.45 64.32 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 141' ' ' THR . 82.0 mt-30 -130.32 138.66 33.54 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 88.0 Cg_exo -43.06 -177.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.708 2.939 . . . . 0.0 114.385 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.4 t30 49.16 32.44 4.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.847 -0.533 . . . . 0.0 111.071 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.482 ' H ' ' CB ' ' A' ' 167' ' ' SER . 43.1 m-85 56.93 49.74 13.47 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.682 -0.637 . . . . 0.0 110.469 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 142' ' ' GLY . 87.4 m -137.05 163.29 31.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.255 -0.903 . . . . 0.0 109.454 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 141' ' ' THR . . . 97.6 175.02 33.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -49.96 109.78 0.32 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -1.158 . . . . 0.0 108.95 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.9 OUTLIER -85.48 142.83 28.92 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.093 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -128.01 132.47 49.13 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.632 0.73 . . . . 0.0 109.384 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.443 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 84.8 t80 -94.15 104.11 16.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.627 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.9 mp -99.26 121.41 41.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.198 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -105.07 177.61 1.35 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.482 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 77.5 Cg_exo -46.64 166.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.834 1.689 . . . . 0.0 111.574 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.06 -167.64 12.47 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -120.84 132.36 54.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.662 -0.904 . . . . 0.0 110.933 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 17.2 m-85 -110.68 144.75 39.14 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.642 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 10.6 ptm180 -135.6 0.19 2.7 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.89 -1.131 . . . . 0.0 112.132 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.565 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.3 p -169.31 167.84 9.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.904 -1.747 . . . . 0.0 109.904 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -59.6 -15.24 17.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -85.24 -1.25 56.73 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.642 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 3.7 m-20 -89.79 -62.04 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.566 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 9.9 p90 -73.32 13.28 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 67.94 35.5 84.58 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.15 -165.66 32.56 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 t -151.07 3.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.8 p -150.78 -157.33 0.8 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 25.1 p -141.41 1.21 1.56 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -64.47 77.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.965 -1.084 . . . . 0.0 111.789 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.8 mtt -107.3 115.6 30.46 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 109.125 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.96 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.482 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -125.08 144.71 50.27 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.158 1.479 . . . . 0.0 111.079 -178.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.9 mt -147.48 139.51 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.199 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.664 ' NH2' ' CE2' ' A' ' 57' ' ' PHE . 40.4 ttp180 -127.61 138.59 52.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 110.437 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 171' ' ' ILE . 8.4 ptm180 -97.11 92.5 6.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.787 ' O ' HG22 ' A' ' 171' ' ' ILE . 46.5 mt . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -155.74 143.47 19.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -1.055 . . . . 0.0 110.724 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.557 HD13 ' CD2' ' A' ' 43' ' ' PHE . 20.5 tt -135.61 135.34 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.203 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.18 122.97 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.691 -0.631 . . . . 0.0 109.338 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -88.84 151.56 22.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 108.652 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -138.07 137.85 38.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 109.387 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -73.5 -43.95 58.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -0.833 . . . . 0.0 110.647 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 60.7 m-20 -81.69 156.77 24.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.838 -1.164 . . . . 0.0 110.535 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -70.71 -37.13 73.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -80.63 35.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 54.55 55.7 7.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.614 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -139.09 -151.84 5.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 59.85 -147.26 43.97 Favored Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.178 -1.189 . . . . 0.0 110.155 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -77.81 129.77 35.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.396 -1.061 . . . . 0.0 109.084 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -112.47 156.22 22.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.845 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -145.21 123.26 12.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 108.821 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -97.71 118.77 35.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -112.77 136.67 52.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.4 mtp -130.1 6.56 4.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.2 p -149.74 170.98 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 110.156 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 55.8 p30 -63.77 151.12 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 t -143.47 120.64 11.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -6.82 57.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.944 -1.097 . . . . 0.0 109.879 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -140.09 94.28 2.74 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 108.817 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.3 mt -91.06 -19.59 22.99 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.109 -0.994 . . . . 0.0 108.42 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 42.5 t-80 -56.27 -36.53 68.69 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.92 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.1 t -53.57 -56.4 17.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -60.53 -49.67 76.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 0.0 111.065 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 32.4 p90 -152.93 151.86 30.82 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.111 -0.993 . . . . 0.0 110.503 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -100.14 -7.26 25.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.334 -0.854 . . . . 0.0 110.102 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -152.73 151.46 30.54 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.478 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 43.3 t -157.44 120.41 3.97 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.518 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 18.0 m-70 -102.7 -4.03 25.66 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -137.84 139.33 39.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.795 -1.19 . . . . 0.0 111.063 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.7 mt -132.97 142.94 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -134.47 106.13 6.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.872 -1.143 . . . . 0.0 111.323 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.75 117.09 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -83.37 -31.97 26.45 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.364 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 t -172.23 154.8 3.42 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.168 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.92 -131.66 10.75 Favored Glycine 0 N--CA 1.486 2.007 0 CA-C-O 122.565 1.091 . . . . 0.0 111.47 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.7 m -154.1 152.66 30.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.557 ' CD2' HD13 ' A' ' 4' ' ' ILE . 11.1 t80 -146.77 139.2 24.92 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.556 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.9 tpt -109.99 123.53 49.81 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.663 ' HB ' HG11 ' A' ' 76' ' ' VAL . 16.6 m -114.19 145.82 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.916 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.8 m-85 -121.12 141.76 50.5 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.798 0.808 . . . . 0.0 111.224 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 24.5 t0 -76.77 -10.54 59.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.913 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.144 ' O ' ' OG ' ' A' ' 78' ' ' SER . 18.3 ttm180 -127.56 167.39 16.41 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 44.2 p -78.47 159.19 28.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 110.911 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.61 33.4 3.91 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.649 -0.657 . . . . 0.0 110.958 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.484 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.2 m-85 60.38 57.23 2.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.972 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.0 mmt -143.64 173.3 11.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.137 -0.977 . . . . 0.0 110.385 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.98 -162.69 39.18 Favored Glycine 0 N--CA 1.503 3.123 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 59.0 mtp180 -60.48 119.75 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 108.051 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -102.11 133.82 46.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.06 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 66.2 m-85 -123.16 133.67 54.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.059 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -98.18 117.49 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.221 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.3 mt -118.66 117.55 29.25 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.021 -1.05 . . . . 0.0 110.729 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.502 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.6 ptm180 -92.95 164.62 13.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.244 -0.91 . . . . 0.0 110.772 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.502 ' C ' ' O ' ' A' ' 59' ' ' ARG . 34.0 ttp180 -32.12 116.07 0.19 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.638 -0.664 . . . . 0.0 110.727 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.89 167.75 31.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 79.0 mt-10 -106.99 130.11 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -1.062 . . . . 0.0 108.925 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -114.31 91.42 23.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.573 -0.705 . . . . 0.0 109.551 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 25.7 Cg_exo -59.09 -14.43 23.47 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.641 2.227 . . . . 0.0 112.429 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -169.3 146.34 3.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.897 -1.127 . . . . 0.0 108.088 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 16.6 p90 -148.94 -9.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.505 -1.372 . . . . 0.0 111.725 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.518 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 15.4 mtt -63.62 -39.93 95.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.326 -1.484 . . . . 0.0 110.099 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -92.14 -24.7 19.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.889 -1.132 . . . . 0.0 109.834 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -86.37 -8.88 57.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.527 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.585 ' SD ' ' CD1' ' A' ' 56' ' ' TYR . 19.7 mmt -111.29 -26.11 9.32 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . 80.97 49.24 5.71 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.9 mtp -127.4 154.0 45.55 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.177 -1.19 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 18.7 t-20 -107.01 60.32 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.092 -1.005 . . . . 0.0 109.014 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 7.6 p30 149.55 -169.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.478 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.2 p -98.89 -165.43 1.24 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 109.803 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.663 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.5 m -85.51 147.73 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -108.55 -10.9 15.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.716 -1.24 . . . . 0.0 108.154 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 1.144 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 2.5 p -148.34 164.48 33.93 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.92 -1.112 . . . . 0.0 109.696 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.85 151.23 16.11 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.88 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -136.72 140.35 42.58 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.331 0.586 . . . . 0.0 109.492 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 82' ' ' ILE . 51.5 ttm -96.33 157.39 15.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.202 -0.936 . . . . 0.0 108.606 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.76 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 77.5 mt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.0 109.933 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.281 0.562 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -112.01 116.57 30.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.818 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -171.39 129.35 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 38.3 ttm -117.94 126.32 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 109.609 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -102.19 120.96 41.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.527 HD23 ' SG ' ' A' ' 125' ' ' CYS . 13.7 mt -104.17 152.61 21.93 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.31 1.052 . . . . 0.0 112.696 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 99' ' ' MET . 24.6 m-85 -136.88 122.58 19.83 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -59.43 -22.88 62.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.439 -0.788 . . . . 0.0 111.814 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 124' ' ' SER . 4.9 m-70 -114.4 163.73 14.93 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.617 -1.302 . . . . 0.0 111.206 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.9 p -58.78 159.34 6.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 m-20 77.67 -92.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.603 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -169.48 39.05 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.66 -160.62 24.89 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.767 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 68.05 -147.88 48.34 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.87 133.79 38.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.111 -1.229 . . . . 0.0 109.369 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.2 ptt? -93.9 116.58 29.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 0.0 110.469 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 15.4 mtm -118.02 137.5 52.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.256 -0.902 . . . . 0.0 108.633 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -99.36 138.95 35.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 109.459 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 110' ' ' CYS . 1.0 OUTLIER -128.01 118.94 24.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.406 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 ttt -129.28 14.93 6.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.426 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.534 ' H ' HD23 ' A' ' 106' ' ' LEU . 5.2 p-10 -139.78 -170.35 2.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.943 . . . . 0.0 109.968 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.42 127.21 31.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.656 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -115.24 85.45 12.77 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.676 -179.362 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.89 -23.64 6.59 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.328 2.019 . . . . 0.0 112.047 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -133.92 87.13 2.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 10.9 mt -75.07 -34.63 61.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.211 -0.931 . . . . 0.0 110.343 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.74 -40.96 76.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -80.66 -23.44 39.67 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.188 -0.945 . . . . 0.0 110.571 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -81.12 -55.23 4.89 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.515 -1.366 . . . . 0.0 111.397 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -106.32 -1.38 23.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.041 -1.037 . . . . 0.0 110.351 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.3 m120 63.29 32.89 14.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.812 -1.18 . . . . 0.0 109.12 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.5 ptm -154.91 137.66 15.29 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.9 t -121.07 9.7 10.59 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.752 -0.592 . . . . 0.0 109.616 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 163' ' ' SER . 16.3 m-20 -135.78 95.54 3.25 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.657 -1.277 . . . . 0.0 113.52 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -105.18 137.4 43.01 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.334 -0.854 . . . . 0.0 108.771 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.62 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 22.0 m170 -98.38 1.45 46.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 111.345 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 125' ' ' CYS . 5.5 t -146.3 150.12 35.13 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.079 -1.638 . . . . 0.0 109.932 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 124' ' ' SER . 11.2 m -157.0 156.7 33.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.451 ' C ' ' CD2' ' A' ' 126' ' ' HIS . 6.0 t60 -142.3 138.77 31.54 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.004 -1.06 . . . . 0.0 109.067 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.64 126.79 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.05 -1.032 . . . . 0.0 109.56 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.486 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 84.0 mmm -76.58 -26.5 55.11 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.4 m-20 165.59 -168.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.97 -173.8 37.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.76 ' CE1' ' CG2' ' A' ' 82' ' ' ILE . 38.4 m-70 -116.4 122.31 44.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.997 . . . . 0.0 109.241 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.57 121.01 43.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 111.551 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.639 HD23 HD11 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -96.8 123.7 40.57 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.0 t -109.87 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.983 -1.073 . . . . 0.0 110.813 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.567 ' CE1' HD12 ' A' ' 133' ' ' LEU . 85.1 m-85 -121.65 123.62 42.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.744 -0.597 . . . . 0.0 110.838 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 30.7 tt0 -58.64 -26.93 64.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' SER . 13.9 mt-30 -119.86 155.55 54.98 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.463 ' O ' ' OG1' ' A' ' 141' ' ' THR . 28.5 Cg_endo -63.11 -174.09 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.028 2.486 . . . . 0.0 113.356 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.0 m120 50.83 31.83 6.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.427 -0.796 . . . . 0.0 110.43 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.506 ' H ' ' CB ' ' A' ' 167' ' ' SER . 40.4 m-85 56.07 51.65 11.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.571 -0.706 . . . . 0.0 110.237 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 12.2 p -140.79 166.13 25.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 0.0 109.779 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.33 173.41 29.86 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -50.65 113.74 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -1.062 . . . . 0.0 108.655 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 50.4 mt-30 -84.0 136.13 34.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.453 -0.779 . . . . 0.0 110.062 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -119.87 125.01 47.47 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -88.07 107.41 18.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.1 mp -105.72 124.69 49.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.206 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 149' ' ' PRO . 0.5 OUTLIER -115.32 169.64 6.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 148' ' ' ARG . 3.6 Cg_exo -35.27 160.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.59 2.194 . . . . 0.0 112.127 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.99 -168.31 12.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -118.95 129.87 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.567 -0.96 . . . . 0.0 110.842 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 125' ' ' CYS . 63.1 m-85 -109.14 140.87 42.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.748 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 57.6 mtt85 -131.36 -8.32 3.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 112.694 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.5 m -169.48 177.46 4.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.026 -1.671 . . . . 0.0 111.152 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.609 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -60.02 -14.17 15.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.718 . . . . 0.0 109.428 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -91.64 0.97 57.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.12 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.748 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -90.05 -62.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 108.711 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -75.88 16.2 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.14 33.93 88.34 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.36 -161.07 31.41 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.94 -39.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.4 p -103.77 -160.96 0.8 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.1 t -145.18 7.57 1.18 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 136' ' ' GLU . 51.1 ttt-85 -64.39 79.74 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.003 -1.06 . . . . 0.0 111.926 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 60.9 mtt -103.16 116.2 32.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -110.72 -24.41 5.56 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.506 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -134.19 148.83 50.96 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.448 1.624 . . . . 0.0 111.252 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 mt -147.27 142.92 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.07 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -129.61 141.8 50.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.381 -0.825 . . . . 0.0 111.035 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -95.44 88.3 5.05 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.72 0.771 . . . . 0.0 108.992 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 171' ' ' ILE . 57.5 mt . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.434 -0.791 . . . . 0.0 111.607 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.139 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 87.1 mttt -161.16 146.77 14.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.713 -0.875 . . . . 0.0 110.533 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 36' ' ' ILE . 20.8 tt -134.63 135.87 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.808 . . . . 0.0 109.899 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.6 mt -122.19 127.18 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.699 -0.625 . . . . 0.0 109.788 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.617 ' CE2' HD12 ' A' ' 36' ' ' ILE . 84.4 m-85 -88.95 160.05 17.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -148.2 136.05 20.92 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.82 -1.175 . . . . 0.0 108.731 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -76.69 -39.14 53.02 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 111.114 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -81.73 163.01 22.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.779 -1.201 . . . . 0.0 110.57 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -75.92 -46.65 28.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -80.61 44.13 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.056 -1.028 . . . . 0.0 109.761 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 53.44 70.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.51 -156.4 7.6 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.05 -147.43 44.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -75.01 125.82 29.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -1.191 . . . . 0.0 109.247 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -110.9 153.92 24.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -144.89 125.25 13.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.509 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -97.4 121.65 39.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.0 m -120.43 141.22 50.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 109.599 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -140.92 12.24 2.24 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.0 m -146.01 160.77 41.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.663 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -58.12 148.34 26.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 110.517 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.42 116.53 10.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.33 -4.47 58.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 108.729 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 31.4 p-10 -136.08 99.84 4.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.624 -0.673 . . . . 0.0 109.656 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.2 mt -103.78 -24.62 13.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.286 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.406 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 34.5 t-80 -57.74 -40.39 79.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 108.75 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -50.28 -50.33 50.69 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -65.45 -52.12 55.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -0.994 . . . . 0.0 110.916 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.2 150.29 29.68 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.003 -1.06 . . . . 0.0 110.376 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.406 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 43.6 m-20 -95.81 -5.63 41.35 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.186 -0.946 . . . . 0.0 110.426 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -156.81 155.56 31.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.095 -1.003 . . . . 0.0 108.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.547 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 33.0 t -158.04 117.02 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -97.53 -2.87 40.91 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.724 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.501 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 9.7 t -142.71 149.27 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.759 -1.213 . . . . 0.0 111.161 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 4' ' ' ILE . 18.5 tt -157.35 148.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.08 126.31 18.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.832 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.4 t -102.43 120.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -83.85 -29.04 27.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 109.084 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.2 t -169.78 152.75 4.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.863 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.93 -122.61 6.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 43' ' ' PHE . 29.8 t -171.47 169.57 6.12 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.583 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -154.6 142.24 19.85 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 108.904 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.8 mmm -102.03 118.11 36.23 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.7 ' HB ' HG11 ' A' ' 76' ' ' VAL . 18.2 m -109.2 144.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.914 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.489 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 58.8 m-85 -120.43 141.8 49.81 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.754 0.787 . . . . 0.0 111.563 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 29.9 t0 -76.09 -9.76 58.87 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.157 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.767 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.6 ttt180 -127.89 159.74 33.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.484 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 12.6 p -71.81 157.83 37.18 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.729 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 71.09 33.54 2.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.637 -0.664 . . . . 0.0 111.326 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CB ' ' NH2' ' A' ' 80' ' ' ARG . 1.9 m-85 59.59 56.33 3.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 109.757 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.1 mtt -143.49 172.05 13.32 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.48 -165.27 42.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.48 123.89 17.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.114 -1.227 . . . . 0.0 108.304 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 46' ' ' TYR . 6.7 tt0 -108.33 137.51 46.18 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.31 134.84 48.12 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.014 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.609 ' C ' HD12 ' A' ' 58' ' ' LEU . 20.1 p90 -96.04 120.98 37.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 57' ' ' PHE . 10.0 mp -111.42 113.52 26.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.059 -1.026 . . . . 0.0 111.532 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.4 ptt180 -86.13 161.08 19.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 111.034 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 59' ' ' ARG . 40.5 ttp85 -37.8 118.62 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.582 0.706 . . . . 0.0 110.365 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.98 178.09 41.29 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.79 129.34 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.09 100.21 53.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.16 -6.01 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.169 1.913 . . . . 0.0 112.619 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 34.4 p-10 -168.71 136.54 2.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.328 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 36.6 p90 -148.93 24.0 0.95 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.596 -1.315 . . . . 0.0 111.298 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.1 mmt -89.13 -39.71 13.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.673 -1.267 . . . . 0.0 108.902 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -99.28 -17.09 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.0 109.458 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 -12.62 45.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.26 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.2 mtt -115.74 -27.62 7.0 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 108.895 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.92 48.37 5.81 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.328 -0.858 . . . . 0.0 111.14 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.0 ttm -120.92 138.54 54.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.932 -1.334 . . . . 0.0 109.819 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.0 t30 -90.7 56.65 3.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.048 -1.033 . . . . 0.0 109.277 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.1 p30 151.79 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.547 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.2 p -98.61 -166.96 1.43 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.927 0.87 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.7 HG11 ' HB ' ' A' ' 45' ' ' VAL . 6.4 m -81.34 147.3 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.484 ' HB3' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -105.77 -11.51 16.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.767 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -151.47 170.61 19.17 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.787 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 78' ' ' SER . 26.6 p -162.3 146.13 11.91 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.998 0.904 . . . . 0.0 110.4 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.628 ' NH1' ' NH2' ' A' ' 148' ' ' ARG . 41.2 ttm180 -132.83 139.76 47.63 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.3 ttp -94.53 152.42 18.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 24.3 mt . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 108.634 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 80.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.331 0.586 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -121.06 125.84 48.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.186 -0.947 . . . . 0.0 110.4 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.529 ' CE ' ' SD ' ' A' ' 128' ' ' MET . 33.1 ttpt -168.38 129.07 1.28 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.577 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 39.8 ttm -120.17 135.22 55.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 109.088 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -105.74 120.24 41.19 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 125' ' ' CYS . 14.8 mt -103.05 149.49 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.156 0.979 . . . . 0.0 112.128 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 99' ' ' MET . 42.0 m-85 -133.8 124.71 27.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 87.7 tt0 -63.7 -26.15 68.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.553 ' O ' ' HB3' ' A' ' 124' ' ' SER . 45.6 m170 -110.38 164.39 12.73 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.602 -1.311 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.8 p -61.19 157.84 15.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 110.046 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 97' ' ' SER . 0.8 OUTLIER 81.4 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.2 mmt -162.57 35.5 0.11 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.33 -153.79 24.03 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.081 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 58.56 177.95 0.87 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.423 ' O ' ' CE ' ' A' ' 104' ' ' MET . 28.2 mmt180 -64.25 136.21 56.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.24 . . . . 0.0 109.273 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.2 ptt? -98.11 122.47 41.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.993 -1.067 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.423 ' CE ' ' O ' ' A' ' 102' ' ' ARG . 3.8 mtm -118.87 138.93 52.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.45 138.5 40.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.616 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 ' CZ3' ' A' ' 132' ' ' TRP . 5.6 tp -127.84 118.61 24.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.168 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.81 -11.09 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 0.0 109.728 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.32 -159.65 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -0.934 . . . . 0.0 109.86 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.83 137.49 32.28 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -116.06 87.28 18.69 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.338 -0.851 . . . . 0.0 109.578 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.5 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.7 Cg_endo -78.09 -27.06 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.089 1.859 . . . . 0.0 112.249 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -134.16 84.1 2.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.506 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.5 mt -67.94 -26.27 65.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.004 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.4 tpt -57.67 -40.02 78.43 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.272 -0.893 . . . . 0.0 109.074 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -82.85 -23.43 33.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -77.36 -62.36 1.68 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.644 -1.285 . . . . 0.0 110.9 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.492 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.0 m-85 -105.73 4.48 30.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.7 t-20 52.57 32.72 12.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.65 -1.281 . . . . 0.0 107.612 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.453 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 5.4 ttp -147.23 132.01 17.96 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 27.8 t -115.26 4.68 14.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 110.223 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 120' ' ' SER . 14.7 m-20 -132.63 101.08 5.16 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 118.416 -1.314 . . . . 0.0 114.052 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -111.76 135.48 52.32 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -96.1 2.06 52.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 111.388 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.0 t -149.86 156.34 41.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.928 -1.733 . . . . 0.0 110.694 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.577 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 11.1 t -164.29 163.05 22.71 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.243 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.577 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 13.6 t60 -150.07 146.61 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.169 -0.957 . . . . 0.0 109.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.454 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.1 t -115.95 125.02 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 108.96 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.529 ' SD ' ' CE ' ' A' ' 90' ' ' LYS . 17.9 ttt -81.26 -32.55 33.25 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 130' ' ' GLY . 13.6 t70 -174.4 175.0 2.68 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.537 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 77.11 -140.66 25.03 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.469 ' CE1' ' CG2' ' A' ' 82' ' ' ILE . 95.4 m-70 -151.8 135.37 16.18 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.548 -0.971 . . . . 0.0 109.284 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TRP . . . . . 0.485 ' CZ3' HD23 ' A' ' 106' ' ' LEU . 87.0 m95 -127.39 133.16 50.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.119 -0.988 . . . . 0.0 112.212 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 mt -106.02 134.45 49.12 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 55.0 t -111.12 144.19 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.985 -1.072 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -122.13 124.02 42.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.619 -0.675 . . . . 0.0 111.124 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.5 tt0 -57.49 -27.41 62.5 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -118.52 155.8 51.81 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.45 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 23.4 Cg_endo -61.47 -179.64 0.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.271 2.647 . . . . 0.0 113.781 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.601 ' N ' ' OG ' ' A' ' 167' ' ' SER . 13.6 m120 49.82 35.14 8.66 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.696 0.76 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.714 ' H ' ' CB ' ' A' ' 167' ' ' SER . 7.7 m-85 57.33 51.42 10.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.758 -0.589 . . . . 0.0 110.378 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 142' ' ' GLY . 64.9 m -136.56 164.25 28.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 141' ' ' THR . . . 95.57 179.42 36.46 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.03 108.73 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -1.108 . . . . 0.0 108.808 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 6.2 pt20 -87.52 143.74 27.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.783 0.802 . . . . 0.0 110.46 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -125.2 144.32 50.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -104.57 103.57 13.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.302 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.7 mp -101.2 122.72 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.628 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 5.2 ptp180 -110.83 173.12 3.05 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 148' ' ' ARG . 68.3 Cg_exo -37.29 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.982 1.788 . . . . 0.0 112.113 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 126' ' ' HIS . . . 117.07 -166.16 12.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -123.86 136.91 54.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.335 -1.097 . . . . 0.0 110.631 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 21.2 m-85 -114.31 144.61 42.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.55 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 14.0 ptm180 -133.17 -1.66 3.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.084 . . . . 0.0 112.736 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.557 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 3.7 t -171.07 172.3 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.175 -1.578 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -62.84 -8.19 6.5 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.398 -0.814 . . . . 0.0 109.149 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -92.74 -1.14 57.07 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.172 -0.955 . . . . 0.0 108.819 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 154' ' ' SER . 10.5 m-20 -91.51 -60.08 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.7 p90 -76.45 16.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.54 40.24 96.0 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -104.56 -165.61 24.46 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.52 -39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.1 p -106.5 -161.41 0.79 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.3 p -137.56 5.62 2.69 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.474 -0.767 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 136' ' ' GLU . 70.5 ttt180 -66.79 75.8 0.11 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.889 -1.132 . . . . 0.0 112.142 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -100.5 116.93 33.6 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.095 . . . . 0.0 109.62 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.19 -25.77 4.9 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.714 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -134.2 151.51 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.361 -1.67 . . . . 0.0 111.562 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mt -146.69 140.95 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.692 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -126.9 144.17 51.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 171' ' ' ILE . 17.1 ptt180 -99.89 91.37 4.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.584 ' C ' ' O ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.994 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -148.26 136.17 20.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.56 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.3 mm -122.46 119.65 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.509 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.1 mt -113.41 117.17 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.205 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.76 132.42 36.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.559 -0.713 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.11 130.19 56.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.739 -1.226 . . . . 0.0 109.889 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.11 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.66 -0.65 . . . . 0.0 109.952 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -80.96 158.43 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 109.703 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -78.86 -37.75 39.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -84.44 43.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.986 . . . . 0.0 109.813 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 52.68 75.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.53 -171.03 34.74 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.25 -148.41 31.19 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -78.39 115.79 18.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 0.0 108.928 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -96.74 156.42 16.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.486 -0.759 . . . . 0.0 109.986 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.621 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.9 t60 -145.14 126.65 15.04 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.154 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -96.62 118.92 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -117.26 133.0 56.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.185 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -138.05 6.18 2.61 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 109.386 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -138.56 150.66 46.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.206 -0.934 . . . . 0.0 110.693 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 36.2 p-10 -47.27 144.92 2.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.46 -0.775 . . . . 0.0 110.034 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 25' ' ' ASP . 42.4 t -144.07 110.85 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.49 -17.32 49.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 108.6 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.457 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 t0 -126.73 100.72 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.488 HD11 ' SG ' ' A' ' 79' ' ' CYS . 14.5 mt -97.94 -14.48 20.61 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' SER . 18.7 t-80 -59.62 -41.32 90.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' HIS . 21.0 m -50.9 -57.28 8.91 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.621 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 52.6 m-85 -58.97 -53.52 57.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.634 -0.666 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -152.08 150.25 29.72 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.958 -1.089 . . . . 0.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -98.82 -2.18 38.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.834 . . . . 0.0 110.817 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -161.72 158.36 25.74 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.053 -1.029 . . . . 0.0 108.52 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 27.9 t -161.35 128.16 3.97 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -103.55 -20.64 13.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 109.723 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 t -134.04 146.4 50.32 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.996 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.54 143.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -129.42 113.45 14.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 111.34 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.32 114.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.53 -34.35 41.18 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.105 -0.997 . . . . 0.0 108.976 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 t -171.52 159.39 5.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.902 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.04 179.37 52.84 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.16 158.18 18.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.723 -0.869 . . . . 0.0 109.822 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -147.63 137.34 22.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.812 -1.18 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.6 tpt -107.05 127.83 53.82 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.645 ' HB ' HG11 ' A' ' 76' ' ' VAL . 16.7 m -118.53 144.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.945 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 33.5 m-85 -120.39 143.22 48.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.712 0.768 . . . . 0.0 111.334 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 28.4 t0 -77.99 -12.18 59.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.741 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.1 ttm180 -126.54 156.41 40.86 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 p -71.4 151.37 44.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.542 -0.724 . . . . 0.0 111.078 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 t30 76.1 36.23 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.814 -0.554 . . . . 0.0 111.22 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 80' ' ' ARG . 7.1 m-85 59.51 56.3 3.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.0 mtt -144.98 173.75 11.61 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.071 -1.018 . . . . 0.0 110.722 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.27 -165.88 45.43 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.32 124.52 20.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -106.85 133.82 50.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.84 137.95 54.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -101.25 116.64 33.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -0.831 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.0 mt -117.49 117.33 29.16 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.004 -1.06 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.521 ' O ' ' C ' ' A' ' 60' ' ' ARG . 37.4 ptt180 -99.67 163.98 12.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.435 -0.791 . . . . 0.0 111.332 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 59' ' ' ARG . 67.5 ttt180 -27.49 111.43 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.465 0.65 . . . . 0.0 110.741 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.69 170.5 36.51 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -107.74 124.86 50.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -105.87 100.46 27.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.12 -18.81 26.94 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.401 2.067 . . . . 0.0 113.221 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.31 140.6 3.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 108.403 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.1 p90 -148.59 29.24 0.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.746 -1.221 . . . . 0.0 110.432 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.4 mmt -98.19 -42.99 7.18 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.095 . . . . 0.0 109.092 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -100.63 -15.9 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 m -86.65 -16.53 36.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.196 -0.94 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.1 mtt -114.57 -28.23 7.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.0 108.621 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.86 52.64 4.03 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.9 mtp -120.91 140.54 51.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -1.03 . . . . 0.0 109.493 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 50.5 t30 -94.29 54.13 1.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.914 -1.116 . . . . 0.0 109.334 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.55 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.5 p -95.22 -167.25 1.59 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.033 -1.042 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.4 m -80.78 145.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -104.42 -14.67 15.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.741 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -139.97 165.48 27.22 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.155 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 78' ' ' SER . 12.4 m -161.0 145.9 13.98 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.623 0.725 . . . . 0.0 110.114 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.689 ' NH1' ' HE ' ' A' ' 148' ' ' ARG . 43.0 ttm180 -134.45 137.24 43.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.661 -0.65 . . . . 0.0 109.33 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 52.3 ttp -92.34 152.96 19.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.214 -0.929 . . . . 0.0 109.024 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.177 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.5 m . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.188 0.518 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.85 110.38 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -166.0 130.32 2.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 44.4 ttm -110.9 130.1 55.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 109.217 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.519 HH21 ' CD2' ' A' ' 126' ' ' HIS . 78.2 mtm180 -104.23 113.85 27.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.8 mt -99.37 146.65 26.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.036 0.922 . . . . 0.0 111.98 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 36.5 m-85 -131.52 125.8 33.31 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.466 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 62.2 tt0 -63.58 -27.09 69.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.261 -0.899 . . . . 0.0 112.198 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.826 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.7 m-70 -109.24 161.06 15.6 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.488 -1.382 . . . . 0.0 111.674 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 76.8 p -59.48 160.49 6.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.814 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 28.1 t0 81.23 -91.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.442 ' H ' ' HB3' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -171.01 40.76 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.29 -152.44 11.69 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 64.04 -174.76 11.77 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -73.22 139.45 46.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 8.3 ptp -97.35 117.47 31.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.09 -1.006 . . . . 0.0 110.36 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 104' ' ' MET . 2.8 mpp? -111.81 138.63 48.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -106.57 136.9 45.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.822 . . . . 0.0 109.997 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 tp -130.37 121.91 26.85 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.424 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 11.2 ttt -121.21 6.28 10.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.368 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 107' ' ' MET . 78.4 m-20 -134.99 -163.33 1.36 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.337 -0.852 . . . . 0.0 109.832 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 168' ' ' ILE . 64.0 t0 -86.25 133.33 33.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -115.19 90.21 23.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.862 . . . . 0.0 109.797 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -78.66 -26.76 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.066 1.844 . . . . 0.0 111.733 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -135.01 86.7 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.425 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.8 mt -67.91 -27.55 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.2 mmt -55.48 -38.18 68.8 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.775 0.798 . . . . 0.0 109.041 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.69 -22.33 26.13 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.167 -0.958 . . . . 0.0 110.927 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.421 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 62.3 ttm-85 -80.51 -60.22 2.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.469 -1.394 . . . . 0.0 111.426 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -108.53 -0.2 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 110.085 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.1 t-20 55.83 34.39 23.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 0.0 108.384 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ptm -152.22 136.8 16.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.2 m -123.75 9.46 8.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.977 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m-20 -131.11 97.73 4.37 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 118.469 -1.292 . . . . 0.0 113.26 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -112.23 137.11 50.8 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.002 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.543 ' N ' ' ND1' ' A' ' 123' ' ' HIS . 1.3 m80 -96.17 6.69 48.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 111.147 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.826 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 3.7 p -154.55 158.59 40.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.915 -1.741 . . . . 0.0 110.348 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.1 t -168.62 168.04 11.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.27 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.564 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 17.5 t60 -152.67 148.38 27.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.323 -0.861 . . . . 0.0 109.337 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.451 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 52.9 t -114.93 124.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.73 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 77.9 mmm -74.82 -25.27 58.9 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.508 0.67 . . . . 0.0 109.394 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.8 OUTLIER 167.67 179.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.088 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.94 -137.66 22.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.437 ' HB3' HD12 ' A' ' 171' ' ' ILE . 93.2 m-70 -153.98 130.51 10.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.623 -0.927 . . . . 0.0 109.185 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -119.5 130.36 55.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.233 -0.917 . . . . 0.0 111.962 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.468 HD23 HD11 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -103.87 128.21 51.36 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.685 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 48.7 t -111.01 144.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.718 -1.239 . . . . 0.0 111.224 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.74 126.12 48.17 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.833 -0.542 . . . . 0.0 111.249 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.1 -27.54 68.44 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.853 ' O ' ' OG ' ' A' ' 167' ' ' SER . 27.9 mt-30 -120.25 152.87 55.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 19.0 Cg_endo -59.96 -175.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.283 2.655 . . . . 0.0 113.523 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m120 49.99 31.82 5.13 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.538 0.685 . . . . 0.0 109.93 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.469 ' H ' ' CB ' ' A' ' 167' ' ' SER . 13.9 m-85 56.08 52.68 10.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.103 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 142' ' ' GLY . 86.9 m -139.57 164.59 29.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.71 177.68 32.36 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -54.08 109.56 0.49 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 108.752 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -86.99 147.02 25.91 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.049 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.81 140.46 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -101.19 104.73 15.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 109.708 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.8 mp -99.76 120.5 39.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 0.0 109.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.689 ' HE ' ' NH1' ' A' ' 80' ' ' ARG . 4.1 ptt85 -109.48 163.6 16.68 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 148' ' ' ARG . 80.9 Cg_exo -31.78 158.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.801 2.334 . . . . 0.0 112.534 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 126' ' ' HIS . . . 114.72 -166.45 12.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.62 132.54 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.396 -1.061 . . . . 0.0 110.485 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.504 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 84.9 m-85 -105.76 143.1 34.38 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.661 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 63.2 mtm-85 -125.91 -10.86 6.61 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 112.95 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.563 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.7 t -173.65 -179.17 1.76 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.891 -1.756 . . . . 0.0 111.172 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -62.21 -15.26 45.5 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -88.1 0.05 56.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 108.565 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -58.53 2.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.716 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.571 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.6 p90 -77.51 13.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.723 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 69.12 39.37 83.65 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -110.09 -161.68 18.64 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.6 t -143.06 -39.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 31.3 p -109.03 -152.28 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.8 p -146.35 9.29 1.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.522 -0.736 . . . . 0.0 109.852 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -65.98 81.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.002 -1.061 . . . . 0.0 111.989 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.8 mtt -105.73 118.18 35.92 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.936 -1.102 . . . . 0.0 109.708 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.33 -24.45 6.2 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.853 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -136.7 152.01 49.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.52 -1.576 . . . . 0.0 111.276 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 16.3 mt -147.62 142.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -128.95 144.6 51.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.46 -0.775 . . . . 0.0 110.662 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 171' ' ' ILE . 19.3 ptt180 -94.6 76.16 3.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.457 -0.777 . . . . 0.0 109.751 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 170' ' ' ARG . 36.5 mt . . . . . 0 N--CA 1.508 2.461 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.487 2.088 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 15.8 ptpt 176.82 157.37 0.3 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.253 -1.145 . . . . 0.0 110.466 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 43' ' ' PHE . 18.0 tt -136.59 135.06 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.529 0.681 . . . . 0.0 110.249 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.7 mt -117.48 124.36 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.644 -0.66 . . . . 0.0 109.412 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.23 161.27 18.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.332 -0.855 . . . . 0.0 108.721 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 29.1 m-85 -147.26 136.46 22.49 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.775 -1.203 . . . . 0.0 108.847 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -76.53 -39.66 52.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.76 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -81.25 138.73 35.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.874 -1.141 . . . . 0.0 110.22 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -59.66 -39.75 85.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.483 -0.76 . . . . 0.0 110.007 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -84.53 41.06 0.82 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 109.564 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 54.29 85.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.525 -0.734 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.51 -159.1 21.46 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -146.49 49.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.65 124.54 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -1.202 . . . . 0.0 109.318 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -109.38 157.08 19.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.408 -0.807 . . . . 0.0 109.804 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.739 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 16.1 t-160 -147.58 125.58 12.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.0 109.777 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -95.12 119.64 33.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.6 m -119.34 140.95 49.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 109.157 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttt -147.99 11.6 0.95 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.8 t -143.45 155.36 44.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.363 -0.835 . . . . 0.0 110.321 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -50.44 144.03 8.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.696 . . . . 0.0 110.229 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -144.55 116.87 8.48 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 4.67 51.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.009 . . . . 0.0 108.876 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 29.2 p30 -146.28 92.23 2.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.569 -0.707 . . . . 0.0 109.582 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 26' ' ' LEU . 74.3 mt -91.18 -19.99 22.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.529 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 11.7 t-80 -56.95 -33.2 66.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 108.825 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.3 t -57.84 -42.93 85.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.739 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 80.3 m-85 -74.96 -44.17 49.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.864 -1.147 . . . . 0.0 110.308 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.35 152.13 21.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 70.8 m-20 -98.11 -6.11 32.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.347 -0.846 . . . . 0.0 110.071 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -155.12 153.83 31.44 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.55 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 39.4 t -157.55 127.86 6.33 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -107.24 -4.48 18.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.709 -0.619 . . . . 0.0 109.627 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.42 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 2.0 p -138.66 139.61 38.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.899 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.75 145.67 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -138.09 114.51 10.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.798 -1.189 . . . . 0.0 111.497 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.13 119.46 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -84.72 -31.06 24.25 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.034 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -172.27 156.62 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.562 -1.255 . . . . 0.0 111.586 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.75 -159.67 46.22 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.0 m -125.3 164.03 21.25 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -1.206 . . . . 0.0 109.251 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD2' HD13 ' A' ' 4' ' ' ILE . 11.4 t80 -144.59 133.33 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.998 -1.064 . . . . 0.0 108.761 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.2 tpt -103.16 118.69 37.37 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 m -109.73 142.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.971 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.615 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.0 m-85 -117.94 136.64 53.35 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.681 0.753 . . . . 0.0 110.753 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.25 -9.32 58.58 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.127 ' O ' ' OG ' ' A' ' 78' ' ' SER . 53.6 ttt180 -130.17 156.36 44.71 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 77' ' ' ARG . 25.4 p -68.23 162.99 23.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.678 0.751 . . . . 0.0 110.964 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 t30 66.91 33.13 6.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.918 -0.488 . . . . 0.0 111.204 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.492 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.9 m-85 58.63 58.58 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.215 -0.928 . . . . 0.0 109.765 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.417 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 55.7 mtt -146.78 175.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.197 -0.94 . . . . 0.0 110.288 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 83.03 -166.33 44.43 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' NH2' ' OH ' ' A' ' 56' ' ' TYR . 77.5 mtp180 -58.26 123.63 16.71 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.221 -1.164 . . . . 0.0 108.024 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 5.8 mp0 -105.41 136.12 45.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.417 ' OH ' ' NH2' ' A' ' 54' ' ' ARG . 83.0 m-85 -128.96 129.72 45.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.534 -0.729 . . . . 0.0 109.749 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.644 ' C ' HD12 ' A' ' 58' ' ' LEU . 23.1 p90 -92.77 121.73 34.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.131 -0.98 . . . . 0.0 109.039 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 57' ' ' PHE . 9.3 mp -113.91 116.85 29.93 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.967 -1.083 . . . . 0.0 111.769 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.9 ttp85 -90.83 158.48 16.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.957 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 59' ' ' ARG . 37.3 ttp180 -30.58 116.09 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.31 0.576 . . . . 0.0 110.744 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.38 168.77 32.66 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -107.32 129.87 54.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -1.022 . . . . 0.0 108.786 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -110.19 100.36 43.7 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.44 -14.16 33.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -170.67 141.47 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.8 p90 -146.71 40.27 1.08 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.653 -1.279 . . . . 0.0 109.805 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.9 mmt -103.21 -48.47 4.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.222 -0.924 . . . . 0.0 109.32 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -100.69 -13.01 18.69 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.3 m -89.98 -15.8 31.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.458 -0.776 . . . . 0.0 109.763 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.4 mtt -117.22 -29.36 5.92 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.41 52.38 3.59 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.445 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.8 mtp -122.88 141.07 52.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.982 -1.305 . . . . 0.0 110.221 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.2 m120 -95.85 55.86 1.66 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 0.0 109.253 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.0 p30 150.56 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.55 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.7 p -99.44 -168.61 1.64 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.132 0.967 . . . . 0.0 109.712 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 46' ' ' TYR . 27.2 t -77.0 141.46 15.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 49' ' ' THR . 66.2 mtt180 -106.28 -17.17 14.38 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 1.127 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -145.24 166.68 24.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.295 -0.878 . . . . 0.0 109.48 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 20.9 p -162.44 149.7 13.68 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.921 0.867 . . . . 0.0 110.744 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -129.73 138.9 51.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 ttp -94.6 148.96 21.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.033 -1.042 . . . . 0.0 109.086 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.3 mt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.627 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.447 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.2 m . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.42 0.629 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.86 119.78 37.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -170.14 128.59 0.88 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.4 ttm -113.08 126.5 55.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 109.288 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -100.73 117.74 35.43 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.482 HD23 ' CB ' ' A' ' 125' ' ' CYS . 19.7 mt -101.38 150.29 23.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.389 1.09 . . . . 0.0 112.568 -177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -131.2 122.23 26.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 76.4 tt0 -62.49 -27.94 69.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 111.374 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.9 m-70 -109.88 164.19 12.82 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.767 -1.208 . . . . 0.0 111.542 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 44.2 m -61.77 159.5 13.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.54 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.548 ' O ' ' CG ' ' A' ' 99' ' ' MET . 5.4 m-20 80.28 -98.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' ASP . 23.2 mtt -163.82 45.49 0.11 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.04 -151.25 10.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 61.67 -171.73 8.75 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 89.0 mtt-85 -73.09 131.82 42.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.933 -1.334 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 25.1 mtm -91.62 120.92 32.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 12.1 mtm -119.41 140.06 51.02 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.145 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -105.85 136.93 44.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.38 120.86 24.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 10.0 ttt -120.69 15.67 11.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.734 . . . . 0.0 109.374 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -144.1 -163.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.875 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.418 ' CG ' ' OH ' ' A' ' 140' ' ' TYR . 47.5 t0 -85.1 133.02 34.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -119.64 84.57 30.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.401 -0.812 . . . . 0.0 109.959 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.89 -29.87 6.48 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.282 1.988 . . . . 0.0 112.131 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.516 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 35.1 p30 -127.5 81.39 2.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.427 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.8 mt -66.72 -24.06 66.19 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 2.6 ttm -60.77 -38.57 85.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.548 0.69 . . . . 0.0 109.57 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -84.13 -20.81 31.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.657 -1.277 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 63.0 ttm-85 -82.22 -58.86 2.76 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.622 -1.299 . . . . 0.0 111.212 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -107.69 0.82 22.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.979 . . . . 0.0 109.807 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 114' ' ' MET . 15.8 t30 60.12 34.17 21.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.0 109.361 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.1 ptm -152.33 137.91 17.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -118.43 8.55 12.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.869 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.46 ' C ' ' OD1' ' A' ' 121' ' ' ASP . 6.5 t0 -134.99 93.77 3.05 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.293 -1.363 . . . . 0.0 113.376 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -103.13 136.76 42.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.418 -0.801 . . . . 0.0 109.106 177.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -97.09 3.21 51.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 111.725 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.6 t -160.25 163.18 33.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.656 -1.902 . . . . 0.0 110.763 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.482 ' CB ' HD23 ' A' ' 93' ' ' LEU . 2.2 p -174.55 178.18 2.0 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 8.4 t60 -154.12 147.68 25.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.484 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 54.6 t -112.83 121.88 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.446 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 12.0 tpt -69.32 -33.98 73.97 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.1 m-20 173.32 166.38 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.433 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.96 -146.32 19.09 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.461 ' CG ' ' OH ' ' A' ' 146' ' ' TYR . 54.4 m-70 -141.48 129.05 21.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.906 . . . . 0.0 110.061 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -122.08 131.05 53.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.538 -0.726 . . . . 0.0 111.931 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.2 mt -101.82 130.84 48.35 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.5 t -110.47 142.38 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.913 -1.117 . . . . 0.0 109.81 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.73 125.23 49.18 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.696 -0.627 . . . . 0.0 111.312 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -24.63 63.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 167' ' ' SER . 4.3 mt-30 -126.86 154.47 76.12 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.29 -0.881 . . . . 0.0 109.001 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.14 -173.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 123.161 2.574 . . . . 0.0 113.87 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 139' ' ' ASN . 18.6 t-20 45.89 29.73 0.77 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.468 0.651 . . . . 0.0 110.702 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.467 ' H ' ' CB ' ' A' ' 167' ' ' SER . 34.2 m-85 59.21 48.81 9.89 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.093 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 142' ' ' GLY . 61.7 m -131.64 162.24 30.84 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 108.917 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 141' ' ' THR . . . 96.61 174.52 35.35 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.558 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -54.15 110.58 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.88 -0.776 . . . . 0.0 109.387 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.3 OUTLIER -86.56 145.74 26.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.582 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -127.67 132.07 49.73 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.494 0.664 . . . . 0.0 109.283 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.461 ' OH ' ' CG ' ' A' ' 131' ' ' HIS . 70.6 t80 -92.44 107.34 19.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.0 mp -102.05 122.06 43.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.646 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -104.1 178.16 1.24 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -48.26 161.15 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.964 1.776 . . . . 0.0 111.672 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.16 -167.55 12.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.38 133.43 55.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.984 . . . . 0.0 110.455 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 96.4 m-85 -106.17 136.51 45.74 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.612 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 85.4 mtm-85 -123.86 -14.33 7.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.201 -0.937 . . . . 0.0 112.52 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.578 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 38.9 t -171.32 -177.98 2.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.027 -1.671 . . . . 0.0 110.99 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -63.98 -12.84 41.6 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.778 -0.576 . . . . 0.0 109.555 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -90.03 -1.2 57.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.971 -1.081 . . . . 0.0 108.55 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.612 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.1 m-20 -91.05 -60.53 1.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.526 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.2 p90 -76.51 16.84 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.03 38.71 95.75 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -103.78 -161.45 24.87 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.1 t -148.53 -40.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.3 p -103.41 -161.66 0.85 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 p -143.83 7.6 1.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.476 -0.765 . . . . 0.0 110.433 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -69.07 82.92 0.33 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.847 -1.158 . . . . 0.0 111.97 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.4 mtt -105.35 121.29 43.58 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.714 -1.241 . . . . 0.0 110.126 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.4 -25.82 3.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.467 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -130.04 152.03 49.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.653 -1.498 . . . . 0.0 111.388 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.5 mt -148.92 139.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 109.835 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -121.2 133.06 55.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.173 -0.954 . . . . 0.0 110.049 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 171' ' ' ILE . 43.6 ttp180 -92.59 90.69 7.23 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.327 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 170' ' ' ARG . 95.6 mt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.487 2.068 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.569 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 62.0 mttm -163.95 146.03 9.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.525 -0.985 . . . . 0.0 109.553 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' A' ' 43' ' ' PHE . 9.5 mm -124.31 120.08 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.526 -0.734 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.5 mt -116.05 122.27 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.018 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -94.68 131.84 40.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -119.37 135.17 54.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -77.07 -22.97 52.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 111.218 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.649 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.2 t70 -83.21 150.48 26.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.702 -1.249 . . . . 0.0 110.295 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 45.9 mtt-85 -60.02 -44.49 94.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 31.7 m120 -74.52 -94.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.985 . . . . 0.0 109.29 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 35.0 m-85 -157.26 58.95 0.51 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 108.882 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.649 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -151.64 -150.74 5.42 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.46 -153.78 52.72 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -70.6 119.57 14.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 109.058 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -105.34 156.64 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.0 110.311 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.537 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.0 t60 -147.87 124.94 11.38 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.724 . . . . 0.0 109.216 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -98.36 118.33 34.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.54 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 m -114.45 136.5 52.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.7 ptm -134.71 9.73 3.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 p -147.1 163.06 37.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.451 -0.781 . . . . 0.0 110.555 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 41.9 p-10 -56.89 149.18 19.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.399 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.8 t -142.58 115.24 8.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.5 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.628 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 36.3 p30 -137.84 97.1 3.35 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.58 -19.69 18.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 108.44 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.542 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 19.2 t-80 -58.5 -39.52 80.28 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.288 -0.882 . . . . 0.0 109.266 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -51.03 -57.12 9.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.537 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 89.3 m-85 -58.58 -47.71 83.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.758 -0.589 . . . . 0.0 111.257 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -156.85 150.57 24.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.886 -1.134 . . . . 0.0 110.335 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 68.8 m-20 -97.21 -5.97 35.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.958 -1.089 . . . . 0.0 110.421 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -158.89 156.24 29.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 21.2 t -158.79 126.52 5.04 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -103.28 -0.78 29.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 3.7 m -146.04 144.23 29.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.513 -1.367 . . . . 0.0 111.152 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -138.44 143.09 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.88 107.31 8.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 0.0 111.051 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.9 114.88 29.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -77.71 -32.81 53.17 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.762 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -178.5 161.04 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.633 -1.227 . . . . 0.0 111.457 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.59 -153.12 21.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.2 m -133.97 153.59 51.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.479 ' HB2' HD11 ' A' ' 4' ' ' ILE . 12.5 t80 -148.03 141.13 24.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.571 -1.33 . . . . 0.0 109.415 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -108.74 122.16 46.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' TYR . 17.9 m -112.53 144.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.404 -0.81 . . . . 0.0 110.093 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.565 ' O ' HG13 ' A' ' 76' ' ' VAL . 36.1 m-85 -120.52 138.44 53.84 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.016 0.912 . . . . 0.0 111.375 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.62 -8.21 55.04 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.68 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.818 ' O ' ' HB3' ' A' ' 78' ' ' SER . 38.3 ttt180 -130.9 156.5 44.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.139 -0.976 . . . . 0.0 108.847 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -66.06 156.86 32.6 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.671 0.748 . . . . 0.0 111.402 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.95 33.74 3.4 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.618 -0.676 . . . . 0.0 111.586 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.495 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.5 m-85 59.84 58.65 2.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.573 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.409 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.7 mtt -145.96 171.16 15.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.988 -1.07 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.58 -165.43 36.93 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 120.657 -1.277 . . . . 0.0 110.566 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.47 121.22 10.97 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -102.67 134.64 45.7 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.443 ' O ' HG22 ' A' ' 45' ' ' VAL . 80.9 m-85 -126.54 131.48 51.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.686 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -94.76 117.77 30.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.506 -0.746 . . . . 0.0 109.736 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.0 mt -120.56 122.82 41.42 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.143 -0.973 . . . . 0.0 111.112 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.494 ' O ' ' C ' ' A' ' 60' ' ' ARG . 33.4 ptt180 -103.68 168.1 9.36 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.574 0.702 . . . . 0.0 111.058 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.494 ' C ' ' O ' ' A' ' 59' ' ' ARG . 51.6 ttp180 -28.62 110.95 0.05 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.308 0.575 . . . . 0.0 110.911 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.39 31.47 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.533 -1.318 . . . . 0.0 109.957 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -104.41 126.56 51.61 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.408 -1.054 . . . . 0.0 108.422 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.36 96.98 24.18 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 10' ' ' ARG . 44.8 Cg_endo -70.05 -14.22 34.89 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.196 1.931 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -170.72 143.46 2.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 108.331 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.4 p90 -149.28 41.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.627 -1.296 . . . . 0.0 109.667 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.5 mmt -107.13 -46.43 3.9 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.335 -0.853 . . . . 0.0 109.407 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -100.23 -15.09 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -89.46 -14.46 35.3 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -115.37 -30.24 6.31 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.13 5.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.8 mtp -121.88 144.04 49.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.402 . . . . 0.0 109.401 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 81.9 m-20 -96.16 53.65 1.37 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.222 -0.923 . . . . 0.0 109.014 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.4 p30 152.86 -171.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.513 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.4 p -98.76 -168.1 1.59 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.781 0.8 . . . . 0.0 109.938 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 46' ' ' TYR . 22.5 t -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 45.2 mmm-85 -106.52 -16.71 14.46 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.755 -1.215 . . . . 0.0 107.898 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.818 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.68 164.3 33.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 109.485 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.416 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 26.3 p -161.03 150.64 17.06 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.242 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.43 136.86 39.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.9 ptm -90.62 158.18 17.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.5 mt . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.615 -0.678 . . . . 0.0 110.233 -179.86 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.294 0.568 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.11 114.41 27.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -161.2 123.41 3.05 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.635 ' SD ' HG22 ' A' ' 127' ' ' VAL . 7.5 tpp -107.99 125.35 51.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.022 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -99.53 111.72 24.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 103' ' ' MET . 20.7 mt -99.79 148.91 23.9 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.881 0.848 . . . . 0.0 112.474 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 99' ' ' MET . 26.1 m-85 -136.72 127.09 26.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.06 -23.55 67.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.402 -0.811 . . . . 0.0 112.386 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.5 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.9 m-70 -113.67 162.28 16.44 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.56 -1.338 . . . . 0.0 111.178 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 77.5 p -58.13 160.3 5.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.527 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 97' ' ' SER . 4.4 m-20 79.51 -90.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.547 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 1.8 mtm -175.37 38.66 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.51 -163.11 23.47 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.416 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 72.23 -146.61 39.64 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -99.39 139.34 35.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -1.198 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 3.6 ptt? -96.96 116.81 29.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.374 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.42 ' CE ' ' SD ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -104.98 137.18 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.126 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -99.1 122.32 42.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 108.666 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.9 tt -133.8 118.83 18.47 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 19.5 ptm -129.72 21.4 5.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 109.257 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.661 ' H ' HD23 ' A' ' 106' ' ' LEU . 22.9 p-10 -133.97 -166.86 1.86 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 37.4 p-10 -86.45 132.81 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 0.0 109.256 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -117.82 89.02 32.44 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.176 -0.952 . . . . 0.0 109.66 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.03 -20.95 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -139.97 85.14 2.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.4 mt -71.27 -26.78 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 110.057 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -56.16 -39.83 72.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.422 -0.799 . . . . 0.0 109.102 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.05 -21.76 29.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -80.32 -59.32 2.75 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.77 -1.207 . . . . 0.0 111.085 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -109.06 0.02 19.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.596 -0.69 . . . . 0.0 110.309 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 114' ' ' MET . 12.5 m120 56.49 32.52 20.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.476 1.131 . . . . 0.0 108.587 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.42 ' SD ' ' CE ' ' A' ' 104' ' ' MET . 9.7 ptm -153.29 137.73 16.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 47.2 m -124.86 11.25 8.36 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.466 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 120' ' ' SER . 52.2 m-20 -130.03 94.88 3.8 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.631 -1.293 . . . . 0.0 113.191 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.88 136.29 49.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -99.23 3.03 46.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 111.281 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.9 t -148.94 154.76 39.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.063 -1.648 . . . . 0.0 110.719 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.8 t -165.31 163.14 20.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 110.312 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.537 ' CD2' ' HG2' ' A' ' 151' ' ' GLU . 4.6 t-80 -147.66 145.08 28.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.416 -0.803 . . . . 0.0 108.893 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.635 HG22 ' SD ' ' A' ' 91' ' ' MET . 67.8 t -113.14 123.2 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 109.808 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 21.1 ttm -77.24 -23.34 51.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.749 -0.594 . . . . 0.0 109.854 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 170.73 178.47 0.06 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.595 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 73.53 -134.22 18.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.7 m-70 -162.07 139.77 8.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.693 -0.886 . . . . 0.0 108.857 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -131.05 142.45 50.3 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.115 -0.991 . . . . 0.0 112.256 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mt -110.59 134.04 52.77 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 46.3 t -112.29 142.54 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.907 -1.12 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -120.25 125.06 47.19 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.53 -26.78 65.62 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 167' ' ' SER . 7.5 mp0 -120.51 153.86 56.53 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.372 -0.83 . . . . 0.0 108.807 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 24.8 Cg_endo -60.92 -177.94 0.21 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.309 2.673 . . . . 0.0 113.873 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 51.05 33.3 8.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.442 ' H ' ' CB ' ' A' ' 167' ' ' SER . 23.4 m-85 56.46 51.23 11.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.649 -0.657 . . . . 0.0 110.009 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 142' ' ' GLY . 50.0 m -136.69 162.7 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.768 -0.582 . . . . 0.0 109.676 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.48 174.07 32.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.8 mmm-85 -51.56 109.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.469 -1.018 . . . . 0.0 108.99 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 6.9 pt20 -87.58 147.28 25.38 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.789 0.804 . . . . 0.0 110.089 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -129.74 143.2 50.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.558 ' OH ' ' CG ' ' A' ' 131' ' ' HIS . 91.8 t80 -103.73 106.85 17.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 109.556 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.7 mp -100.04 121.13 40.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.383 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.564 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -107.49 168.99 7.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.4 Cg_exo -36.69 164.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.159 1.906 . . . . 0.0 112.0 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.49 -164.23 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.537 ' HG2' ' CD2' ' A' ' 126' ' ' HIS . 17.6 mt-10 -122.84 131.46 53.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.761 -0.847 . . . . 0.0 110.812 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.564 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 23.4 m-85 -109.24 145.83 35.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.635 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 19.0 ptt-85 -137.55 -3.62 1.88 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.789 -1.195 . . . . 0.0 112.41 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.559 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 9.2 m -169.49 167.42 9.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.025 -1.672 . . . . 0.0 109.901 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -57.34 -9.91 1.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -88.62 -3.64 58.75 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.297 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.635 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 5.2 m-20 -89.64 -60.93 1.81 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 109.17 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.568 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 10.0 p90 -73.54 12.36 0.64 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 68.19 34.8 81.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.72 -160.38 30.88 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 t -149.16 -39.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.1 p -106.72 -156.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 18.7 p -139.09 3.24 2.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -63.98 77.11 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.218 -0.926 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.9 mtt -105.15 116.26 31.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.026 -1.046 . . . . 0.0 109.873 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.24 -24.59 5.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.69 149.33 52.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.59 -1.535 . . . . 0.0 111.286 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.456 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 18.8 mt -148.88 139.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.32 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.81 140.29 52.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.412 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 170' ' ' ARG . 27.5 ptt85 -94.79 70.46 3.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 108.977 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.3 mm . . . . . 0 C--N 1.299 -1.593 0 C-N-CA 119.389 -0.925 . . . . 0.0 109.304 179.627 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -147.47 139.74 24.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.523 -0.986 . . . . 0.0 110.202 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 4' ' ' ILE . 7.0 tp -125.72 122.35 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.452 -0.78 . . . . 0.0 109.24 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 HH21 ' A' ' 37' ' ' ARG . 70.4 mt -121.1 126.24 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.94 162.14 14.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.198 -0.939 . . . . 0.0 108.917 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 18.5 m-85 -145.98 135.39 23.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.678 -1.264 . . . . 0.0 108.744 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.71 -46.21 54.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 61.1 m-20 -76.53 148.92 36.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.835 -1.166 . . . . 0.0 110.345 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -64.7 -41.26 96.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.488 -0.758 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -87.18 45.08 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 52.95 90.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.93 -171.06 42.4 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 72.15 -141.63 31.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -83.46 123.61 29.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.967 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -107.77 159.94 16.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 109.765 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -142.63 123.47 14.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 108.921 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.85 121.39 42.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.044 -1.035 . . . . 0.0 109.371 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 140.39 50.04 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.774 0.797 . . . . 0.0 109.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 48.4 mtt -131.21 6.97 4.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.1 m -149.47 168.93 22.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -53.9 151.83 6.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.336 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.66 113.18 5.32 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.85 -7.71 39.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.12 -0.988 . . . . 0.0 109.41 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.35 99.19 5.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 26' ' ' LEU . 34.6 mt -110.0 -20.61 12.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.96 . . . . 0.0 108.905 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 28' ' ' SER . 33.9 t-80 -61.6 -47.15 86.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.061 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' HIS . 99.2 p -49.51 -55.46 13.23 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -56.14 -42.57 77.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.624 -0.673 . . . . 0.0 111.056 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 30.1 p90 -159.58 153.63 23.38 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.99 -1.069 . . . . 0.0 109.901 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -104.98 -8.49 18.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.218 -0.926 . . . . 0.0 110.718 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -149.37 149.01 30.18 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.992 -1.068 . . . . 0.0 108.734 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.541 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 37.0 t -155.3 125.02 6.47 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -108.51 -9.32 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.035 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.448 ' OG ' ' CB ' ' A' ' 7' ' ' TYR . 2.6 p -132.27 137.89 47.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 0.0 110.589 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -134.87 141.92 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.54 ' NE ' ' OE2' ' A' ' 39' ' ' GLU . 29.5 ttp180 -136.27 115.99 13.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.859 -1.151 . . . . 0.0 111.754 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.39 117.24 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 68.6 mm-40 -79.18 -35.39 41.95 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.944 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.7 t -174.31 161.94 3.53 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.903 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 177.83 51.14 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.9 m -98.47 148.79 23.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.952 . . . . 0.0 109.925 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.531 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 5.8 t80 -144.3 137.3 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.781 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 146' ' ' TYR . 50.1 mtp -113.23 128.67 56.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.418 ' HB ' HG11 ' A' ' 76' ' ' VAL . 21.6 m -114.22 144.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.117 -0.989 . . . . 0.0 109.896 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 76' ' ' VAL . 31.7 m-85 -121.5 139.93 52.85 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.734 0.778 . . . . 0.0 111.694 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -75.39 -6.59 50.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.558 -0.714 . . . . 0.0 109.473 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.893 ' O ' ' HB3' ' A' ' 78' ' ' SER . 19.6 ttm180 -131.86 158.3 41.69 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.5 p -70.5 158.5 35.96 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.688 0.756 . . . . 0.0 111.131 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 68.44 33.85 3.92 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.307 0.575 . . . . 0.0 111.639 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.485 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 3.3 m-85 60.95 61.25 1.66 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.718 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 82.2 mtp -149.84 172.15 15.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.191 -0.943 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.26 -170.25 44.67 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -54.44 117.35 3.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 107.926 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -101.01 134.61 43.74 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -128.14 128.91 45.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.256 -0.903 . . . . 0.0 109.278 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.99 118.91 25.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.954 -1.091 . . . . 0.0 108.657 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.702 HD11 ' CZ ' ' A' ' 63' ' ' TYR . 6.3 tp -125.51 118.45 25.81 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.4 ptm180 -108.9 179.84 4.06 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 0.0 111.884 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 59' ' ' ARG . 43.5 ttp180 -31.19 108.12 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.496 0.665 . . . . 0.0 111.004 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.34 158.35 20.86 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.43 127.16 52.84 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.702 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 71.0 m-85 -116.38 99.84 53.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -76.93 -6.96 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.442 2.095 . . . . 0.0 112.531 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.5 135.25 1.95 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.937 -1.102 . . . . 0.0 108.362 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 23.0 p90 -150.07 32.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.563 -1.336 . . . . 0.0 110.744 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 6.3 mmt -97.39 -46.67 5.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.827 -1.17 . . . . 0.0 109.199 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -99.34 -16.79 18.32 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 m -88.91 -20.46 24.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.521 -0.737 . . . . 0.0 109.883 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 72' ' ' MET . 42.4 ttm -107.32 -25.77 11.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.997 -1.064 . . . . 0.0 108.388 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.1 52.72 4.18 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.17 -1.014 . . . . 0.0 110.771 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 70' ' ' MET . 90.9 mtp -128.6 139.92 52.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.349 -1.089 . . . . 0.0 109.832 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 13.4 m120 -98.43 57.46 1.2 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.6 p30 150.91 -173.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 29.5 p -95.96 -174.61 3.16 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.293 1.044 . . . . 0.0 110.481 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 46' ' ' TYR . 40.6 t -78.38 143.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -108.07 -16.77 14.2 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.897 -1.127 . . . . 0.0 108.256 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.893 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.05 159.27 42.54 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.061 -1.024 . . . . 0.0 109.925 178.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 26' ' ' LEU . 11.0 m -154.74 143.55 20.83 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.37 0.605 . . . . 0.0 110.231 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' CD2' ' A' ' 146' ' ' TYR . 52.7 ttp180 -134.15 138.39 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.2 ttm -99.61 159.88 14.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.076 -1.015 . . . . 0.0 109.869 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 88.0 mt . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.509 2.484 0 CA-C-O 122.074 0.94 . . . . 0.0 113.291 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -126.41 133.58 51.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -174.17 123.21 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.1 ttm -117.68 135.62 53.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -108.94 121.72 45.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' MET . 14.3 mt -106.02 150.48 25.69 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.948 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CG ' ' HA ' ' A' ' 99' ' ' MET . 29.9 m-85 -134.58 121.59 21.15 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.083 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 55.5 tt0 -59.03 -26.54 64.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 111.526 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 124' ' ' SER . 39.6 m170 -110.61 162.0 15.17 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.503 -1.373 . . . . 0.0 111.12 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.2 p -59.15 154.35 16.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.754 -0.591 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 7.4 t70 84.24 -90.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -173.94 47.1 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.63 -159.44 12.61 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-O 122.242 0.912 . . . . 0.0 111.157 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.462 ' CA ' ' ND1' ' A' ' 96' ' ' HIS . . . 61.49 -159.5 30.01 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 98.1 mtt180 -79.21 127.42 32.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.99 -1.3 . . . . 0.0 110.048 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.498 ' C ' ' SD ' ' A' ' 103' ' ' MET . 10.1 tmm? -91.14 122.34 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.2 mtm -123.14 137.91 54.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 108.649 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.25 142.63 34.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.408 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.51 121.28 23.08 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.545 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 9.2 ttt -123.83 21.15 9.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 107' ' ' MET . 54.1 m-20 -145.85 -160.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.419 -0.801 . . . . 0.0 109.407 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 39.4 p-10 -90.03 133.77 34.63 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.98 80.57 14.95 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.71 -33.01 8.74 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.228 1.952 . . . . 0.0 111.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -126.38 78.97 1.82 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.514 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -62.67 -15.31 51.77 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 109.178 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.544 ' O ' ' ND2' ' A' ' 118' ' ' ASN . 5.6 mmt -63.3 -40.98 98.86 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.471 0.653 . . . . 0.0 109.856 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -85.21 -23.01 28.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.921 -1.112 . . . . 0.0 110.98 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . 0.479 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 49.5 ttm-85 -79.4 -61.04 2.13 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.602 -1.311 . . . . 0.0 111.123 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 118' ' ' ASN . 8.8 m-85 -109.61 0.75 19.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.925 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 114' ' ' MET . 11.5 m120 48.33 32.79 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.424 ' HG3' ' CE2' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -143.4 126.04 15.96 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -120.53 7.6 10.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.573 -0.704 . . . . 0.0 111.174 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.5 m-20 -135.34 88.96 2.46 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.634 -1.292 . . . . 0.0 112.606 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -101.42 139.45 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.185 -0.947 . . . . 0.0 108.852 177.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.11 3.82 54.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 111.244 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 5.3 t -152.23 157.54 41.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.148 -1.595 . . . . 0.0 110.327 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 1.5 p -169.47 167.96 9.63 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.755 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 12.7 t60 -149.09 145.91 27.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.449 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.3 t -114.36 125.3 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 108.771 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.406 ' SD ' ' CD2' ' A' ' 126' ' ' HIS . 86.2 mmm -81.66 -32.0 32.04 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.1 p30 178.29 168.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.537 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.71 -152.42 22.45 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.532 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 68.6 m-70 -137.27 123.57 20.61 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.675 -0.897 . . . . 0.0 109.347 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -112.14 122.97 49.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 0.0 112.676 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.657 HD12 ' CE2' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -98.93 123.4 43.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 42.9 t -109.15 144.82 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.816 -1.178 . . . . 0.0 110.618 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.657 ' CE2' HD12 ' A' ' 133' ' ' LEU . 62.6 m-85 -124.12 125.8 45.11 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.039 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 68.2 tt0 -64.44 -21.41 66.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.731 -0.606 . . . . 0.0 109.678 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.663 ' O ' ' OG ' ' A' ' 167' ' ' SER . 28.7 mm100 -127.6 134.0 25.71 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.315 -0.866 . . . . 0.0 109.646 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 137' ' ' GLN . 96.0 Cg_exo -38.86 -177.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 123.808 3.005 . . . . 0.0 114.859 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 50.21 31.04 4.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.81 -0.556 . . . . 0.0 110.899 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.469 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 57.59 54.33 6.51 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 0.0 110.435 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 142' ' ' GLY . 94.3 m -144.24 168.97 18.79 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.927 -1.108 . . . . 0.0 110.056 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 141' ' ' THR . . . 93.93 -177.01 36.66 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 63.4 mtm180 -56.35 106.74 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -1.08 . . . . 0.0 108.81 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -88.24 147.4 24.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.787 0.803 . . . . 0.0 110.184 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -128.02 141.02 51.63 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.63 0.728 . . . . 0.0 109.345 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.546 ' CD1' ' SD ' ' A' ' 44' ' ' MET . 88.1 t80 -99.02 101.66 13.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.593 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.3 mp -97.65 120.73 38.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.246 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.497 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -112.0 166.63 10.53 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 148' ' ' ARG . 88.1 Cg_exo -32.3 156.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.5 -169.82 14.2 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -121.23 136.2 55.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.433 -1.039 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.437 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 20.6 m-85 -113.07 145.89 40.11 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.639 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 25.0 ptt180 -136.75 0.64 2.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.933 . . . . 0.0 111.975 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.553 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.0 m -174.2 171.33 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.153 -1.592 . . . . 0.0 110.121 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.8 -17.0 19.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.38 -0.825 . . . . 0.0 109.17 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.08 1.76 46.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.0 -1.063 . . . . 0.0 109.326 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.639 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 9.1 m-20 -93.29 -60.35 1.81 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.451 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.8 p90 -78.12 16.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.76 39.39 93.58 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -107.32 -161.6 21.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.37 -42.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.3 p -109.05 -150.83 0.46 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 26.2 t -147.04 17.62 1.23 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.485 -0.759 . . . . 0.0 109.561 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -67.22 74.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.289 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.8 mtt -103.88 118.02 35.69 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.035 -1.041 . . . . 0.0 108.958 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.38 -25.97 3.87 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.663 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.023 1.412 . . . . 0.0 110.71 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.3 mt -145.67 140.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.749 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -131.37 145.2 51.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.8 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 107' ' ' MET . 0.3 OUTLIER -96.4 74.7 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 171' ' ' ILE . 2.9 pt . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.005 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.663 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -146.42 161.51 40.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.265 . . . . 0.0 110.73 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.624 HD13 ' CD2' ' A' ' 43' ' ' PHE . 12.2 tt -136.26 136.69 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.494 -0.754 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.456 HD12 HH21 ' A' ' 37' ' ' ARG . 72.2 mt -121.54 125.99 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 109.373 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -90.68 154.12 19.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -138.85 139.42 38.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 109.515 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.82 -33.36 57.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.468 -0.77 . . . . 0.0 111.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 54.5 t0 -77.69 153.91 32.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.916 -1.115 . . . . 0.0 110.328 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 64' ' ' PRO . 96.1 mtt180 -61.84 -50.43 72.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.511 -0.743 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 88.7 m-20 -71.43 -94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.065 . . . . 0.0 109.273 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 52.0 m-85 -157.3 69.76 0.58 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 109.043 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -163.8 -174.32 33.5 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.85 -152.75 23.24 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.506 ' N ' ' CD ' ' A' ' 15' ' ' ARG . 11.2 mpt_? -75.65 125.82 29.79 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.829 -1.394 . . . . 0.0 108.833 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -109.34 157.11 19.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -145.99 123.78 11.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -95.55 117.74 30.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.293 -0.879 . . . . 0.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.8 m -122.0 140.77 52.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.17 -0.956 . . . . 0.0 109.605 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.5 ptm -147.89 14.3 1.04 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.6 p -145.25 159.8 42.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.512 -0.742 . . . . 0.0 110.093 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -51.43 145.82 8.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.51 -0.744 . . . . 0.0 110.041 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.512 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 5.1 t -148.27 115.42 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.21 12.31 22.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.118 -0.989 . . . . 0.0 108.798 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.512 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 40.3 p-10 -148.57 90.45 1.79 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.638 -0.664 . . . . 0.0 109.615 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.525 HD11 ' SG ' ' A' ' 79' ' ' CYS . 32.0 mt -107.14 -28.79 9.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 28' ' ' SER . 47.3 p-80 -63.48 -39.81 95.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 109.029 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 27' ' ' HIS . 18.5 m -55.47 -25.38 36.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.75 -0.594 . . . . 0.0 109.468 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -83.31 -37.11 23.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 17.7 p90 -152.32 151.24 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -95.15 -9.89 32.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 mtt85 -155.7 155.46 33.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.03 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.595 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 48.3 t -154.51 123.47 6.3 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -107.51 -4.26 18.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.355 -0.841 . . . . 0.0 110.437 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 t -136.43 140.66 43.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.876 -1.14 . . . . 0.0 110.983 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 91.8 mt -137.22 145.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 32.0 ttp180 -137.81 116.46 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.864 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.19 119.54 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 92.3 mt-10 -84.72 -29.19 25.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.0 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -174.93 159.41 2.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.787 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.94 -162.67 46.86 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.4 t -123.53 153.18 40.95 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.47 -1.018 . . . . 0.0 109.172 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.624 ' CD2' HD13 ' A' ' 4' ' ' ILE . 10.1 t80 -140.34 135.28 32.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.153 -0.967 . . . . 0.0 109.137 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 ttt -106.37 119.94 40.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.38 143.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.809 -0.757 . . . . 0.0 110.209 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.7 m-85 -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 41.7 t0 -74.36 -9.13 58.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.947 -0.47 . . . . 0.0 109.951 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.843 ' O ' ' HB3' ' A' ' 78' ' ' SER . 27.8 ttt85 -131.52 158.19 41.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.9 p -68.45 163.65 22.84 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.78 0.8 . . . . 0.0 111.4 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 65.71 32.13 9.22 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.106 0.479 . . . . 0.0 111.499 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CB ' HH21 ' A' ' 80' ' ' ARG . 2.6 m-85 61.0 58.15 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.354 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.406 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.1 mtt -146.04 176.06 9.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.234 -0.917 . . . . 0.0 109.58 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 -172.68 48.36 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -55.94 124.15 16.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -102.47 134.19 46.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.055 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.0 129.27 47.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.496 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.642 ' C ' HD12 ' A' ' 58' ' ' LEU . 11.1 p90 -91.19 121.38 32.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.852 . . . . 0.0 108.886 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 57' ' ' PHE . 10.3 mp -108.77 139.74 43.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 60' ' ' ARG . 33.0 ptt180 -118.8 158.66 25.18 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 59' ' ' ARG . 50.8 ttt-85 -29.92 115.37 0.11 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.285 0.564 . . . . 0.0 110.389 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.29 164.32 26.77 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -104.62 127.43 52.37 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -110.4 97.68 32.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 108.666 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 10' ' ' ARG . 48.9 Cg_endo -71.47 -11.55 28.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.071 1.847 . . . . 0.0 112.348 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 37.5 p-10 -167.27 135.76 2.61 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 15.5 p90 -147.95 20.28 1.13 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.702 -1.249 . . . . 0.0 110.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 42.7 tpp -90.99 -44.92 9.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.683 -1.261 . . . . 0.0 109.504 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 68' ' ' ARG . 12.5 ptp180 -98.45 -20.69 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -76.8 -30.56 56.48 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.046 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.9 mtt -95.08 -39.27 10.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.12 44.88 2.71 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 mmm -111.17 150.73 29.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.73 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.9 m120 -100.45 49.92 0.9 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.083 -1.011 . . . . 0.0 109.244 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.85 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.595 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 24.6 p -97.85 -170.22 1.95 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 46' ' ' TYR . 46.4 t -78.7 144.38 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -111.17 -15.25 13.72 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.597 -1.314 . . . . 0.0 107.719 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.843 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -143.84 166.26 25.42 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 178.362 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.525 ' SG ' HD11 ' A' ' 26' ' ' LEU . 30.1 p -160.16 145.25 14.93 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.504 HH21 ' CB ' ' A' ' 51' ' ' PHE . 35.6 ttm180 -130.68 136.64 48.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.3 ttp -95.98 149.6 21.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 108.956 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 -179.736 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 54.7 m . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.312 0.577 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.62 ' CG ' ' NE ' ' A' ' 170' ' ' ARG . 10.5 m-85 -112.6 118.47 35.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -0.816 . . . . 0.0 109.496 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -171.18 126.98 0.68 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 49.2 ttm -110.43 125.2 53.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.051 -1.031 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -99.62 118.08 35.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' MET . 16.5 mt -104.52 147.31 27.74 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.191 0.996 . . . . 0.0 112.238 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 99' ' ' MET . 28.2 m-85 -133.64 125.25 28.31 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 86.8 tt0 -62.36 -27.51 69.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.942 . . . . 0.0 111.879 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.2 m-70 -108.95 164.9 12.0 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.539 -1.35 . . . . 0.0 111.145 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 58.2 m -61.55 156.19 20.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 97' ' ' SER . 2.3 m-20 81.6 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.484 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -169.91 41.55 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.68 -157.24 21.29 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.507 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.509 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 60.73 -155.64 33.31 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 79.2 mtp180 -87.49 138.6 31.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 109.836 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.6 ptt? -98.56 123.43 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 110.072 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.68 136.87 54.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.9 137.03 40.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 110.122 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.36 119.07 21.17 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.57 -15.88 12.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.544 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -111.86 -159.06 0.67 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.85 . . . . 0.0 110.352 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.4 139.36 30.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.29 88.33 27.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.459 -0.776 . . . . 0.0 109.297 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.23 -25.76 8.22 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.162 1.908 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -136.57 80.71 1.84 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 12.7 mt -64.54 -28.46 69.66 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.201 -0.937 . . . . 0.0 110.012 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.78 -39.38 73.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.35 -23.03 35.27 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 110.184 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -79.48 -69.11 0.6 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.475 -1.391 . . . . 0.0 110.515 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.8 m-85 -96.07 3.43 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.993 -1.067 . . . . 0.0 110.721 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 114' ' ' MET . 31.4 m-20 52.32 31.85 10.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.563 -1.336 . . . . 0.0 107.514 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.439 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 4.7 ttp -146.47 132.41 19.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 60.2 p -116.13 2.95 13.46 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.507 -0.746 . . . . 0.0 109.801 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 163' ' ' SER . 50.7 m-20 -131.09 113.13 13.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.564 -1.335 . . . . 0.0 111.594 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -123.33 131.77 53.77 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.478 ' N ' ' ND1' ' A' ' 123' ' ' HIS . 2.8 m80 -93.21 1.87 56.9 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.342 -0.848 . . . . 0.0 111.097 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.2 t -147.51 153.81 39.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 119.674 -1.892 . . . . 0.0 110.844 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 50.3 t -162.44 161.42 27.19 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.411 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.451 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 1.9 t-80 -147.63 141.9 26.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.173 -0.955 . . . . 0.0 109.522 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 60.2 t -112.16 122.17 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 10.4 tpt -71.87 -32.38 67.41 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 88' ' ' SER . 0.9 OUTLIER 170.95 163.2 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.062 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.92 -160.63 29.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -127.97 129.4 46.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.514 -0.992 . . . . 0.0 110.199 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -118.69 126.06 51.07 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.851 0.834 . . . . 0.0 111.91 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.24 125.68 41.95 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 50.5 t -111.23 145.12 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 141' ' ' THR . 94.8 m-85 -124.73 123.1 39.26 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.694 -0.629 . . . . 0.0 111.113 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 164' ' ' ARG . 71.8 tt0 -57.74 -29.36 64.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.838 ' O ' ' OG ' ' A' ' 167' ' ' SER . 5.8 mt-30 -117.27 153.07 49.87 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 19.2 Cg_endo -60.21 -170.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 123.496 2.797 . . . . 0.0 113.774 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 46.61 29.4 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.603 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 58.28 53.99 6.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 110.061 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 135' ' ' TYR . 14.2 p -140.39 168.25 20.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.95 178.21 36.28 Favored Glycine 0 N--CA 1.503 3.15 0 O-C-N 120.737 -1.227 . . . . 0.0 110.6 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -53.39 108.0 0.29 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -86.85 141.93 28.43 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.969 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -126.0 132.46 52.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -92.66 105.3 17.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.015 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.5 mp -98.35 120.17 38.31 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 109.121 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -105.02 178.73 1.07 Allowed Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 66.3 Cg_exo -49.42 161.58 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.679 1.586 . . . . 0.0 111.64 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.51 -173.88 14.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.75 135.46 54.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.744 -0.857 . . . . 0.0 110.658 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 18.1 m-85 -112.75 143.83 43.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.614 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 41.1 ptt85 -135.12 -1.39 2.65 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.015 -1.053 . . . . 0.0 112.159 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.551 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 1.6 t -171.77 168.19 6.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 119.896 -1.752 . . . . 0.0 109.924 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -57.6 -14.6 5.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -85.82 0.01 54.13 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.231 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.614 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.4 m-20 -92.52 -59.66 2.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.542 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.7 p90 -76.78 18.14 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.23 37.82 95.06 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -102.49 -166.04 26.43 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.0 t -144.66 -40.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.6 p -107.03 -159.87 0.71 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.5 t -138.42 11.09 2.76 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 109.497 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 136' ' ' GLU . 85.6 mtt-85 -69.49 75.6 0.4 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.016 -1.053 . . . . 0.0 112.988 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 mtt -100.05 122.8 43.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.139 -0.976 . . . . 0.0 110.247 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.93 -28.5 2.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.838 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -132.85 148.5 52.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.421 -1.635 . . . . 0.0 111.2 -179.109 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.5 mt -144.84 140.7 23.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.328 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -125.86 143.83 50.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.304 -0.873 . . . . 0.0 110.349 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.62 ' NE ' ' CG ' ' A' ' 89' ' ' PHE . 29.5 ttt180 -97.72 85.48 3.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 171' ' ' ILE . 13.9 mt . . . . . 0 N--CA 1.503 2.197 0 O-C-N 121.747 -0.596 . . . . 0.0 112.372 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -151.9 135.61 16.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.433 HD11 ' CG2' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -122.01 117.16 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -115.0 124.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.888 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.84 159.25 15.88 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 14.3 m-85 -146.25 135.1 22.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.564 -1.335 . . . . 0.0 109.038 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.54 -42.52 58.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.123 -0.985 . . . . 0.0 111.069 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 35' ' ' SER . 12.6 t70 -81.21 151.19 28.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.889 -1.132 . . . . 0.0 110.542 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.49 -40.59 95.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 110.068 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.94 39.49 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.699 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 53.16 59.76 4.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 109.563 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.7 -154.44 6.14 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -145.63 49.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -77.7 123.41 26.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -1.085 . . . . 0.0 108.967 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -109.56 156.08 20.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.478 -0.764 . . . . 0.0 109.953 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.411 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 7.9 t-80 -142.64 124.85 15.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 109.27 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -99.91 119.83 38.83 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.879 . . . . 0.0 109.575 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.37 139.72 50.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.5 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.513 ' O ' ' SD ' ' A' ' 20' ' ' MET . 0.8 OUTLIER -131.7 7.17 4.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -148.95 169.71 19.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.381 -0.824 . . . . 0.0 109.672 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 40.9 p-10 -61.4 147.32 45.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 110.285 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.1 t -140.06 115.33 9.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -8.31 56.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.0 108.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 12.2 p-10 -130.98 98.51 4.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 26' ' ' LEU . 57.8 mt -104.64 -20.2 13.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 108.655 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.468 ' C ' ' ND1' ' A' ' 27' ' ' HIS . 7.9 t-80 -59.58 -44.7 93.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' HIS . 25.6 t -49.99 -46.28 52.44 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.411 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 53.6 m-85 -70.08 -51.91 28.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.11 149.24 30.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.999 -1.063 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -100.91 -5.42 26.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.359 -0.838 . . . . 0.0 110.838 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -154.88 153.19 30.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.01 -1.056 . . . . 0.0 108.248 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 52.7 t -158.96 113.68 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.973 -1.079 . . . . 0.0 108.791 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.6 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 35.9 m-70 -95.81 -4.84 43.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.713 -0.617 . . . . 0.0 110.994 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.7 p -139.19 145.93 39.92 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.688 -1.257 . . . . 0.0 111.236 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.433 ' CG2' HD11 ' A' ' 4' ' ' ILE . 26.0 mt -140.98 142.5 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -132.71 112.11 11.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 111.081 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.522 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 1.4 t -98.5 115.0 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -83.01 -33.75 26.46 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.685 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 8.3 t -171.74 151.34 2.84 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.138 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.727 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 103.18 -137.92 13.69 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.727 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 60.7 m -170.92 164.41 7.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 2.8 p90 -174.84 168.96 3.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.616 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.0 ttm -119.72 141.29 49.55 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.706 ' HB ' HG11 ' A' ' 76' ' ' VAL . 34.8 m -115.74 146.6 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.5 -0.75 . . . . 0.0 109.1 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 95.6 m-85 -120.41 142.34 49.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.39 -0.819 . . . . 0.0 111.587 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -9.33 58.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.82 ' O ' ' HB3' ' A' ' 78' ' ' SER . 89.8 mtt-85 -134.52 165.39 25.3 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 p -75.64 160.61 29.9 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.729 0.776 . . . . 0.0 111.476 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m120 68.18 33.03 4.55 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.321 0.581 . . . . 0.0 111.168 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 4.9 m-85 61.0 60.31 1.85 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.781 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.423 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 59.1 mtt -146.34 170.95 15.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.235 -0.916 . . . . 0.0 110.033 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.15 -173.46 50.25 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -55.16 126.21 23.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.097 -1.237 . . . . 0.0 108.128 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -110.37 140.9 44.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 0.0 108.868 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -132.26 137.12 47.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.816 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 22.7 p90 -98.85 123.77 43.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.404 -0.81 . . . . 0.0 109.241 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -122.83 129.49 51.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.8 ptt180 -104.59 167.45 9.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.39 -0.819 . . . . 0.0 110.922 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 59' ' ' ARG . 72.9 ttt180 -35.6 119.53 0.54 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.701 0.763 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 168.81 164.96 25.4 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -102.84 124.42 48.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.464 -1.021 . . . . 0.0 108.48 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -108.27 97.67 23.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -16.63 41.98 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.2 1.933 . . . . 0.0 112.212 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 40.7 p-10 -169.36 145.03 3.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.871 -1.143 . . . . 0.0 107.943 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 20.2 p90 -148.0 -16.21 0.35 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.0 111.407 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.6 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 43.8 mtp -57.94 -38.89 76.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.439 -1.413 . . . . 0.0 109.994 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.6 -25.66 20.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.977 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -88.53 -8.98 53.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.838 . . . . 0.0 109.838 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.3 mmt -107.98 -27.49 10.13 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 47.1 6.51 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.4 mtp -124.73 147.26 48.73 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.045 -1.268 . . . . 0.0 109.668 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 73.7 m-80 -98.06 60.18 1.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 15.4 m-20 148.9 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 30.9 p -100.45 -163.53 1.03 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 109.697 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.706 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.9 m -92.37 147.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.441 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 65.6 mtp180 -106.69 -11.14 15.9 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.168 -0.957 . . . . 0.0 108.521 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.82 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.75 164.98 28.73 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.269 179.052 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.443 ' SG ' HD11 ' A' ' 26' ' ' LEU . 30.2 p -161.09 147.51 14.75 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.734 0.778 . . . . 0.0 110.601 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.418 ' NH2' ' NH1' ' A' ' 148' ' ' ARG . 74.0 ttt-85 -140.3 141.98 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 42.1 ttm -98.35 161.52 13.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.111 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.429 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 52.5 mt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.252 0.548 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.83 111.66 23.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 109.855 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -169.51 130.77 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.403 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 43.7 ttm -114.56 133.84 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -106.18 117.6 34.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 103' ' ' MET . 23.5 mt -101.44 148.05 25.64 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.083 0.944 . . . . 0.0 112.121 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.66 127.54 29.41 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 70.3 tt0 -64.13 -23.94 67.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 112.095 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.527 ' O ' ' HB3' ' A' ' 124' ' ' SER . 6.1 m-70 -114.08 159.4 20.06 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.48 -1.387 . . . . 0.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.6 m -59.0 158.88 7.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.379 -0.825 . . . . 0.0 109.431 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 97' ' ' SER . 14.3 t0 85.49 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.832 0.825 . . . . 0.0 108.787 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.443 ' H ' ' HB3' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -176.93 41.18 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.69 -160.32 13.0 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-O 122.281 0.934 . . . . 0.0 111.296 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 67.21 -166.71 40.89 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 17.5 mmt180 -74.47 133.85 42.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.002 -1.293 . . . . 0.0 109.648 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.7 119.14 36.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.171 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 138.39 50.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.5 126.58 45.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.025 -1.047 . . . . 0.0 109.763 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.1 tt -118.83 115.79 25.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.1 ttt -126.4 20.96 7.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.289 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.544 ' H ' HD23 ' A' ' 106' ' ' LEU . 12.1 t70 -144.42 -168.56 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -0.901 . . . . 0.0 110.045 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 47.8 t0 -83.82 132.18 34.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -114.89 81.5 7.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.239 -0.913 . . . . 0.0 109.978 -178.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.29 -29.06 5.19 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.178 1.918 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -134.14 79.4 1.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.517 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 9.8 mt -63.17 -18.62 63.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.942 . . . . 0.0 109.787 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 20.7 mmt -59.76 -40.72 89.12 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.705 0.764 . . . . 0.0 109.33 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -85.28 -23.38 28.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.988 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -75.58 -63.2 1.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.785 -1.197 . . . . 0.0 110.761 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 117' ' ' PHE . 1.4 m-85 -116.49 1.23 12.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.771 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 117' ' ' PHE . 14.7 t-20 49.41 35.96 8.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.9 ttt -146.5 133.28 20.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 120' ' ' SER . 1.3 t -131.56 10.53 4.78 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.3 m-20 -130.1 89.69 2.84 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 119.933 -1.729 . . . . 0.0 113.238 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -107.08 141.25 38.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.048 -1.032 . . . . 0.0 108.535 178.082 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.62 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 19.8 m170 -96.36 3.19 53.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 111.133 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.9 t -148.98 154.3 39.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.205 -1.559 . . . . 0.0 110.177 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 38.1 t -163.89 161.98 23.29 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.971 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.495 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 0.8 OUTLIER -146.36 142.56 28.35 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 53.5 t -111.55 122.58 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -0.977 . . . . 0.0 109.623 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 36.1 ttm -71.94 -24.2 61.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.64 . . . . 0.0 109.638 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 163.29 171.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.859 0.838 . . . . 0.0 110.866 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 85.95 -135.71 13.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.553 ' CG ' ' HH ' ' A' ' 146' ' ' TYR . 92.5 m-70 -158.52 134.17 8.86 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.69 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -126.78 136.26 52.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 0.0 111.954 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.9 mt -103.48 132.2 49.94 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 19.2 t -110.02 143.75 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.906 -1.121 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.531 ' CZ ' ' OE1' ' A' ' 144' ' ' GLN . 36.6 m-85 -120.9 124.1 44.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.623 -0.673 . . . . 0.0 110.902 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.69 -26.93 64.36 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 167' ' ' SER . 16.8 mt-30 -122.18 154.21 61.71 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 26.7 Cg_endo -62.25 -171.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.202 2.601 . . . . 0.0 113.823 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 46.66 29.32 0.93 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.387 0.613 . . . . 0.0 110.026 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.487 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 48.3 m-85 59.34 50.84 7.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.639 -0.663 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.3 p -135.89 162.77 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.63 174.76 32.39 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -54.71 111.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -1.035 . . . . 0.0 109.129 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.4 mt-30 -85.97 143.84 27.94 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -123.58 137.99 54.64 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.553 ' HH ' ' CG ' ' A' ' 131' ' ' HIS . 21.3 t80 -97.35 107.53 20.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.486 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.8 mp -102.62 117.14 34.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 108.584 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.511 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 24.7 ptt180 -103.7 178.37 1.19 Allowed Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 Cg_exo -49.37 162.19 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.799 1.666 . . . . 0.0 111.805 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.34 -170.58 13.41 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.86 133.19 56.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -1.001 . . . . 0.0 110.506 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.511 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 20.9 m-85 -110.03 144.45 38.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.704 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 8.6 ptm180 -141.58 -2.42 1.22 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.877 -1.14 . . . . 0.0 112.251 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.533 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 14.2 m -165.49 166.21 18.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.039 -1.663 . . . . 0.0 110.174 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.6 OUTLIER -54.35 -20.24 6.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 108.935 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -83.15 1.44 40.47 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.879 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.704 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.9 m-20 -90.3 -62.9 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 109.138 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -75.88 13.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.54 37.95 93.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.85 -154.43 21.31 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.2 t -153.58 -41.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.4 p -103.61 -153.64 0.48 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 29.5 m -148.87 11.85 0.85 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -66.84 79.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 0.0 112.232 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.7 mtt -107.41 119.78 40.36 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.644 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.79 -26.82 4.01 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.481 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -128.92 150.29 50.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.612 -1.522 . . . . 0.0 111.135 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.16 138.96 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.945 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -122.91 136.42 54.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 171' ' ' ILE . 30.6 ptt85 -93.79 86.29 5.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.893 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 170' ' ' ARG . 97.0 mt . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.453 -0.779 . . . . 0.0 109.875 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -162.1 141.24 9.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -1.134 . . . . 0.0 109.512 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.581 ' CD1' ' CG ' ' A' ' 43' ' ' PHE . 46.7 mt -129.13 133.95 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.651 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.594 HD12 HH21 ' A' ' 37' ' ' ARG . 47.2 mt -119.6 117.8 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -93.59 136.65 33.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 109.463 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE2' HG22 ' A' ' 5' ' ' ILE . 52.5 m-85 -122.28 131.79 54.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -70.19 -22.45 62.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.61 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.532 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 53.9 t0 -80.64 160.49 25.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.876 -1.14 . . . . 0.0 110.326 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.7 mmt85 -60.6 -44.5 96.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.365 -0.835 . . . . 0.0 109.803 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -80.08 -102.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -145.35 43.06 1.29 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.159 -0.963 . . . . 0.0 109.103 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.532 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.12 -169.24 12.13 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.06 -156.11 32.24 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -65.58 114.47 4.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.376 . . . . 0.0 109.092 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -98.07 147.52 24.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.375 -0.828 . . . . 0.0 109.826 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.639 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 27.8 t60 -140.46 124.55 17.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.117 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -94.78 118.33 31.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 109.145 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.5 m -118.98 136.39 54.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.336 -0.852 . . . . 0.0 109.251 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -140.23 9.15 2.28 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.8 t -142.21 155.98 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.321 -0.862 . . . . 0.0 110.417 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 52.8 p30 -55.2 143.98 25.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 110.472 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 t -140.58 118.87 12.08 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.59 53.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.799 -1.188 . . . . 0.0 109.282 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 39.6 p-10 -134.13 94.27 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.28 -18.17 27.53 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.474 ' C ' ' ND1' ' A' ' 27' ' ' HIS . 10.5 t-80 -56.48 -35.58 68.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -54.92 -59.27 4.97 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 61.3 m-85 -59.38 -51.69 68.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 0.0 110.772 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -151.5 150.61 30.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.033 -1.042 . . . . 0.0 110.548 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' CD2' ' A' ' 27' ' ' HIS . 24.3 t30 -98.06 -5.12 34.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 110.334 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -159.04 157.32 30.94 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.563 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 45.4 t -160.28 128.6 4.73 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -107.23 -10.64 15.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.053 . . . . 0.0 109.748 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -137.01 138.17 40.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 110.794 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.3 mt -130.59 143.11 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.594 HH21 HD12 ' A' ' 5' ' ' ILE . 57.9 ttp85 -133.26 116.5 16.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.087 . . . . 0.0 110.719 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.8 t -104.26 119.88 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -85.87 -29.17 23.9 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 108.907 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -174.86 153.7 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.671 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.72 -144.42 15.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-O 122.445 1.025 . . . . 0.0 111.638 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.1 m -146.2 149.73 34.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.581 ' CG ' ' CD1' ' A' ' 4' ' ' ILE . 7.4 t80 -147.28 137.69 23.36 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.883 -1.136 . . . . 0.0 110.002 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.0 tpt -108.85 127.09 53.73 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 56' ' ' TYR . 16.6 m -116.34 145.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 76' ' ' VAL . 55.4 m-85 -120.82 141.48 50.51 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.69 0.757 . . . . 0.0 111.052 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -74.37 -9.88 59.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.991 -0.443 . . . . 0.0 109.997 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.863 ' O ' ' HB3' ' A' ' 78' ' ' SER . 96.1 mtt180 -131.81 160.75 34.69 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p -68.96 162.02 27.64 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.767 0.794 . . . . 0.0 111.497 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.26 33.46 7.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.793 -0.567 . . . . 0.0 111.416 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.48 ' H ' ' CB ' ' A' ' 78' ' ' SER . 1.8 m-85 59.55 58.69 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.026 -1.046 . . . . 0.0 110.199 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 55.9 mtt -146.28 174.57 11.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.843 -1.16 . . . . 0.0 110.669 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.21 -169.05 51.15 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.97 -1.081 . . . . 0.0 110.42 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -61.68 129.41 40.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -122.6 154.16 38.33 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.889 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' O ' HG22 ' A' ' 45' ' ' VAL . 94.6 m-85 -133.27 138.37 46.42 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.819 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -92.67 118.1 30.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 108.695 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.0 mt -116.6 115.91 26.6 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.403 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.7 ptt85 -99.39 162.28 13.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.268 -0.895 . . . . 0.0 110.839 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 59' ' ' ARG . 77.7 ttt180 -25.77 114.07 0.05 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.442 0.639 . . . . 0.0 111.099 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.84 172.94 37.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -113.17 127.36 56.16 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.944 . . . . 0.0 108.725 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -107.72 99.85 31.81 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' ARG . 56.9 Cg_endo -73.42 -14.86 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.336 2.024 . . . . 0.0 113.026 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -168.24 140.06 2.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.856 -1.152 . . . . 0.0 108.557 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 25.9 p90 -150.96 36.62 0.62 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.685 -1.26 . . . . 0.0 110.297 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.5 mmt -102.97 -46.94 4.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.069 -1.019 . . . . 0.0 109.689 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.82 -16.0 18.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -86.39 -17.14 35.18 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.8 mtt -116.85 -28.96 6.17 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.03 51.14 4.09 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.068 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 89.3 mtp -119.77 141.66 49.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.307 . . . . 0.0 109.507 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 85.5 m-20 -97.79 51.95 1.07 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.1 -171.86 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.563 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 27.5 p -97.8 -168.18 1.63 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.133 0.968 . . . . 0.0 109.925 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 46' ' ' TYR . 42.4 t -75.74 141.43 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -106.36 -17.17 14.36 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.572 -1.33 . . . . 0.0 107.813 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.863 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.94 164.34 30.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.696 178.557 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 24.6 p -164.92 152.74 11.57 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.507 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -137.7 141.26 41.07 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.1 ttp -93.17 151.45 19.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 108.976 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.496 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 16.4 mm . . . . . 0 C--N 1.304 -1.378 0 O-C-N 121.08 -1.012 . . . . 0.0 108.891 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.8 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.249 0.547 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.88 120.12 41.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.777 . . . . 0.0 109.371 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -171.42 130.12 0.71 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.553 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 45.0 ttm -115.13 130.78 57.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.924 -1.11 . . . . 0.0 109.329 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -101.51 117.74 35.54 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' MET . 12.3 mt -103.18 150.09 24.02 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.328 1.061 . . . . 0.0 112.369 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 99' ' ' MET . 37.0 m-85 -137.4 125.83 23.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -63.48 -24.22 67.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 112.07 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.84 ' O ' ' OG ' ' A' ' 124' ' ' SER . 7.5 m-70 -110.94 165.22 12.04 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.371 -1.456 . . . . 0.0 110.651 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.4 m -60.03 158.86 10.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.117 -0.989 . . . . 0.0 110.044 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.534 ' O ' ' SD ' ' A' ' 99' ' ' MET . 1.0 OUTLIER 78.42 -96.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.407 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.588 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 21.7 mmt -161.76 35.86 0.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.43 -158.31 28.9 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.293 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.73 -172.43 8.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -72.36 136.0 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.985 -1.303 . . . . 0.0 109.47 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 103' ' ' MET . 5.2 ptt? -96.79 121.31 38.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 110.307 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.634 ' SD ' ' CD2' ' A' ' 117' ' ' PHE . 13.9 mtm -118.46 139.83 50.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.948 . . . . 0.0 109.206 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 mp0 -100.37 138.19 37.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.612 HD13 ' SG ' ' A' ' 110' ' ' CYS . 16.8 tp -128.31 118.01 22.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.6 ttm -123.54 -18.53 6.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.446 -0.784 . . . . 0.0 109.234 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.49 ' O ' HD11 ' A' ' 106' ' ' LEU . 52.4 p30 -106.8 -170.21 1.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.831 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -76.62 130.56 38.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.819 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.612 ' SG ' HD13 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -111.3 78.86 1.95 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.092 -1.005 . . . . 0.0 109.358 -179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.71 -27.09 7.65 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.1 1.867 . . . . 0.0 112.407 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -136.05 83.21 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.41 -25.85 67.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.99 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 tpt -55.09 -40.38 70.36 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.858 0.837 . . . . 0.0 109.113 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -81.01 -23.19 38.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.4 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -74.47 -61.92 1.7 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.622 -1.299 . . . . 0.0 110.629 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.634 ' CD2' ' SD ' ' A' ' 104' ' ' MET . 0.9 OUTLIER -118.92 5.39 11.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.425 -0.797 . . . . 0.0 110.547 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.7 m120 55.53 41.12 31.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.574 -1.329 . . . . 0.0 107.464 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.4 tpt -143.05 122.41 13.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.2 t -111.82 6.68 19.8 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 110.191 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.8 m-20 -143.39 101.79 3.85 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.413 -1.43 . . . . 0.0 113.699 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.2 m-85 -109.49 140.57 43.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.49 -0.756 . . . . 0.0 109.152 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 8.1 m-70 -96.81 3.15 52.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 111.103 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.84 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -148.98 154.18 38.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.172 -1.58 . . . . 0.0 110.375 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.553 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 15.4 t -162.19 162.11 28.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.065 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.56 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -149.13 143.47 26.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.139 -0.975 . . . . 0.0 109.693 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.56 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.6 t -113.59 121.7 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.932 . . . . 0.0 109.381 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.408 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 25.1 ttt -72.47 -34.97 68.1 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.0 OUTLIER 176.71 174.38 0.39 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.942 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.15 -164.87 54.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.646 ' CE1' ' HH ' ' A' ' 146' ' ' TYR . 91.8 m-70 -124.66 132.38 53.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -1.067 . . . . 0.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -122.14 129.55 52.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.682 . . . . 0.0 111.412 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -101.58 131.86 47.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 22.0 t -107.83 139.97 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.98 -1.075 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.408 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 53.9 m-85 -116.38 125.09 51.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.554 -0.716 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -60.02 -26.74 66.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.1 mp0 -122.71 154.07 63.42 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.523 ' O ' ' OG1' ' A' ' 141' ' ' THR . 24.1 Cg_endo -61.48 -176.66 0.19 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.203 2.602 . . . . 0.0 113.358 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 51.71 33.37 10.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.516 -0.74 . . . . 0.0 110.58 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.408 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 39.8 m-85 55.08 47.65 21.46 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.592 -0.693 . . . . 0.0 110.048 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 13.7 p -134.44 164.22 27.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.05 173.89 28.96 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -54.02 115.14 1.88 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.122 -1.222 . . . . 0.0 109.001 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 32.4 mt-30 -84.75 142.11 30.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.83 128.87 48.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.646 ' HH ' ' CE1' ' A' ' 131' ' ' HIS . 20.6 t80 -90.93 99.47 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.271 -0.893 . . . . 0.0 109.831 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.0 mp -96.09 124.31 40.05 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.769 0.795 . . . . 0.0 109.078 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.437 ' HB2' ' HD2' ' A' ' 149' ' ' PRO . 20.0 ptt-85 -112.16 178.27 1.01 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 148' ' ' ARG . 85.2 Cg_exo -43.42 165.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.828 1.685 . . . . 0.0 111.809 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.01 177.53 21.01 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -109.55 135.41 50.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.525 -0.985 . . . . 0.0 110.399 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 19.7 m-85 -109.93 143.44 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.59 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 42.9 ptt85 -134.9 -4.4 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.883 -1.136 . . . . 0.0 112.598 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.7 m -171.57 162.71 6.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.952 -1.718 . . . . 0.0 110.128 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -51.66 -9.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 154' ' ' SER . 0.6 OUTLIER -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.048 -1.032 . . . . 0.0 108.892 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.2 m-20 -92.46 -61.1 1.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.144 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.546 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.4 p90 -75.76 15.55 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.3 37.69 93.07 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.72 -177.06 23.93 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 162' ' ' THR . 2.8 m -139.03 10.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 161' ' ' VAL . 52.1 p -158.26 -158.21 0.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.8 m -143.61 11.74 1.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -62.74 72.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.937 -1.102 . . . . 0.0 112.118 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 163' ' ' SER . 60.2 mtt -105.91 115.95 31.1 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.916 -1.115 . . . . 0.0 110.565 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.87 -22.12 6.11 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -132.92 149.83 52.21 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.368 -1.666 . . . . 0.0 111.107 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.8 mt -148.21 141.89 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.744 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -124.84 140.53 52.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 110.062 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 170' ' ' ARG . 13.4 ptt180 -100.0 102.53 13.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 131' ' ' HIS . 3.5 mt . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.761 -0.587 . . . . 0.0 111.602 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.83 139.8 51.14 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.419 -1.047 . . . . 0.0 110.637 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.678 HD11 HD11 ' A' ' 36' ' ' ILE . 19.1 tt -133.48 128.99 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 110.066 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.5 mt -116.26 132.17 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.657 -0.652 . . . . 0.0 109.825 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.592 ' CE2' HD12 ' A' ' 36' ' ' ILE . 86.6 m-85 -97.56 146.07 25.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -133.63 135.51 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -72.87 -45.03 60.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 110.45 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 12.8 t70 -78.72 151.38 32.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -67.21 -34.89 78.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 110.073 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -85.65 40.67 0.86 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.042 -1.036 . . . . 0.0 109.848 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 52.89 54.38 10.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 109.696 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -139.34 -153.84 6.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.88 -148.04 46.02 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -76.46 119.0 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.976 . . . . 0.0 109.476 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -100.82 157.94 16.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -149.48 123.93 9.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.187 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -97.72 124.72 42.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 m -123.7 136.76 54.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -135.46 11.78 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 p -146.21 163.12 36.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.623 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -59.52 144.36 47.54 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 110.646 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -139.03 118.35 12.77 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.42 -12.19 46.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.66 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 40.3 p-10 -132.28 98.04 4.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 79' ' ' CYS . 21.4 mt -96.3 -19.29 19.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.441 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 14.4 t-80 -58.05 -40.82 81.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.309 -0.869 . . . . 0.0 108.994 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.0 m -52.03 -44.94 64.44 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -70.44 -46.07 64.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.137 -0.977 . . . . 0.0 110.756 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 27.6 p90 -154.46 151.89 29.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.976 -1.077 . . . . 0.0 109.846 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.612 HD21 ' N ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER -95.97 -5.67 40.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 0.0 110.078 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -161.36 159.68 28.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 108.649 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 20.5 t -160.13 120.08 2.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.502 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -95.96 -14.86 22.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.602 -0.686 . . . . 0.0 110.345 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 m -135.54 147.07 48.65 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.645 -1.284 . . . . 0.0 110.859 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.678 HD11 HD11 ' A' ' 4' ' ' ILE . 20.4 tt -148.09 148.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -136.22 122.87 21.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.824 -1.173 . . . . 0.0 112.076 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.05 120.8 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -91.37 -28.87 17.43 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 110.6 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -159.71 152.55 21.62 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.966 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.19 -159.48 52.65 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -132.85 178.69 6.68 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.305 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.34 140.79 19.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.68 -1.263 . . . . 0.0 109.203 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.5 tpt -101.02 117.57 35.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -110.2 143.35 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.874 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.675 ' O ' HG13 ' A' ' 76' ' ' VAL . 26.4 m-85 -122.17 142.0 50.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.698 0.761 . . . . 0.0 111.011 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 29.8 t0 -75.56 -6.65 51.36 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.865 ' O ' ' HB3' ' A' ' 78' ' ' SER . 36.5 ttt180 -131.23 157.87 42.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 0.0 108.709 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 p -69.04 160.7 30.49 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.708 0.765 . . . . 0.0 111.295 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.75 32.89 6.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.7 -0.625 . . . . 0.0 111.326 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.477 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 2.5 m-85 60.63 59.99 2.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.2 -0.937 . . . . 0.0 109.371 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 58.2 mtt -147.76 171.17 16.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 -170.76 42.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -54.19 122.25 9.89 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.074 -1.25 . . . . 0.0 107.633 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -103.83 135.83 44.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 108.804 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -129.36 137.56 51.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.356 -0.84 . . . . 0.0 109.427 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -100.65 119.61 38.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.0 mt -117.15 121.99 42.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.031 -1.043 . . . . 0.0 112.164 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -84.54 166.56 17.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.388 -0.82 . . . . 0.0 109.888 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -52.4 123.16 10.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.973 . . . . 0.0 110.198 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.32 171.7 39.55 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 9.9 pt-20 -102.27 126.73 49.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -1.137 . . . . 0.0 108.712 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -113.02 99.65 49.23 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 51.7 Cg_endo -73.09 -11.99 25.53 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.357 2.038 . . . . 0.0 112.429 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 43.8 m-20 -165.14 136.87 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 27.7 p90 -149.64 21.66 0.91 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.669 -1.27 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 44.0 mtp -97.29 -41.33 8.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.923 -1.111 . . . . 0.0 109.752 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -93.6 -25.56 17.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -81.76 -20.62 38.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.278 -0.889 . . . . 0.0 109.549 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 mtp -101.29 -25.65 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 109.966 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.11 57.19 2.87 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.4 mtp -130.04 140.15 50.9 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -1.15 . . . . 0.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.8 p-10 -93.07 53.64 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.235 -0.915 . . . . 0.0 109.306 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.1 p30 152.98 -171.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.557 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -97.72 -167.02 1.46 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 46' ' ' TYR . 59.5 t -77.73 140.96 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -105.81 -17.0 14.51 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.577 -1.327 . . . . 0.0 107.827 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.865 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.34 157.96 44.98 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.079 -1.013 . . . . 0.0 109.87 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 26' ' ' LEU . 15.7 p -153.03 143.35 22.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.622 0.725 . . . . 0.0 110.432 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -137.71 140.22 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.7 ttp -90.72 151.23 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.727 ' N ' HD12 ' A' ' 82' ' ' ILE . 2.1 mp . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.028 . . . . 0.0 109.197 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 17.4 m . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 121.4 0.619 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -120.38 128.66 53.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.598 0.713 . . . . 0.0 109.958 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -168.93 125.37 0.94 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.0 ttm -116.72 135.84 53.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 0.0 109.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -106.62 118.03 35.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 103' ' ' MET . 19.4 mt -101.29 148.5 25.06 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.257 1.027 . . . . 0.0 112.514 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD2' ' SD ' ' A' ' 99' ' ' MET . 38.2 m-85 -132.27 121.88 24.29 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 88.3 tt0 -61.88 -27.86 69.1 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 111.055 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.557 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.06 164.26 12.44 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.523 -1.361 . . . . 0.0 111.062 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.577 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 75.0 p -61.88 157.83 17.45 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.514 -0.741 . . . . 0.0 109.731 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 97' ' ' SER . 29.8 t0 83.47 -95.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.078 -1.014 . . . . 0.0 108.763 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' CD2' ' A' ' 94' ' ' TYR . 21.1 mmt -163.54 30.88 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -98.05 -155.56 29.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 60.29 -179.24 2.62 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -67.42 132.0 46.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.279 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 11.8 ptt? -93.67 118.24 31.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.3 mtm -119.51 140.73 50.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.053 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -100.71 137.8 38.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.177 -0.952 . . . . 0.0 109.508 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.8 OUTLIER -120.65 117.53 27.77 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.604 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 14.9 ttt -129.96 27.45 5.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 109' ' ' ASP . 17.0 t70 -151.31 -172.26 4.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.518 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 90.1 m-20 -82.95 131.18 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -111.8 84.19 5.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.031 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.4 Cg_endo -77.37 -28.59 5.49 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.243 1.962 . . . . 0.0 111.937 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 22.3 p30 -138.17 82.82 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -63.15 -22.95 67.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.351 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 8.1 tpt -58.6 -40.67 83.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.592 0.711 . . . . 0.0 109.414 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -81.57 -22.24 37.91 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 110.335 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -77.57 -64.41 1.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.709 -1.244 . . . . 0.0 111.376 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -108.36 3.03 22.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 110.61 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 114' ' ' MET . 2.4 m-20 54.4 34.6 21.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.886 -1.134 . . . . 0.0 108.932 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 8.6 ptm -148.06 133.65 18.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 54.6 p -116.92 7.55 13.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 110.519 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 163' ' ' SER . 73.6 m-20 -131.3 93.16 3.31 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.361 -1.462 . . . . 0.0 113.379 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -105.19 133.87 49.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.213 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.04 4.07 54.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.992 -1.067 . . . . 0.0 111.688 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.2 t -156.23 161.5 40.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 119.758 -1.839 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.48 170.54 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.86 145.81 25.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 76.2 t -113.8 123.37 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.2 tpp -78.13 -34.15 50.09 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 11.7 t70 -177.46 175.77 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.155 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 78.37 -142.2 25.74 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.467 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 90.4 m-70 -151.51 135.26 16.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.662 -0.905 . . . . 0.0 109.094 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -126.02 132.21 52.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 0.0 112.269 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -104.08 133.09 49.61 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 53.4 t -111.9 144.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.752 -1.218 . . . . 0.0 109.64 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.535 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 47.8 m-85 -120.73 123.37 42.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 111.128 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 164' ' ' ARG . 80.2 tt0 -57.03 -28.03 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -118.02 155.69 50.98 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.501 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 25.1 Cg_endo -62.0 -177.12 0.24 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.313 2.675 . . . . 0.0 113.661 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.589 ' N ' ' OG ' ' A' ' 167' ' ' SER . 66.6 m-20 48.67 35.49 6.33 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.622 0.725 . . . . 0.0 110.545 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.726 ' H ' ' CB ' ' A' ' 167' ' ' SER . 8.1 m-85 55.5 52.09 11.75 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.751 -0.593 . . . . 0.0 109.984 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 142' ' ' GLY . 90.5 m -136.94 162.54 32.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.119 -0.988 . . . . 0.0 109.77 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.45 -179.99 32.18 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -54.2 109.89 0.54 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -1.045 . . . . 0.0 108.737 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 13.0 mt-30 -84.58 141.75 30.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.8 132.28 53.75 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -94.78 105.47 17.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.369 -0.832 . . . . 0.0 109.763 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.9 mp -100.47 121.5 41.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.567 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 2.2 ptt180 -109.48 164.14 15.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.5 Cg_exo -32.12 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.76 2.307 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.81 -166.59 13.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.95 135.05 55.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -1.002 . . . . 0.0 110.332 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.567 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 91.6 m-85 -109.77 144.3 38.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.62 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 93.4 mtt180 -129.84 -12.09 4.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.004 . . . . 0.0 112.572 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.54 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.3 p -170.29 170.24 7.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.966 -1.709 . . . . 0.0 110.538 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.547 ' HA ' ' CE2' ' A' ' 158' ' ' TRP . 0.1 OUTLIER -53.4 -19.12 3.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.645 -0.659 . . . . 0.0 109.606 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -84.72 2.23 42.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.069 -1.019 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -57.78 2.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.098 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.547 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 8.4 p90 -79.32 17.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.89 42.37 94.97 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -109.73 -169.51 20.13 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 162' ' ' THR . 4.2 m -151.66 14.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 161' ' ' VAL . 34.8 p -160.6 -163.7 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 16.8 p -137.77 5.29 2.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 109.732 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 136' ' ' GLU . 88.5 mtt180 -65.89 73.8 0.07 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 0.0 112.266 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.2 mtt -102.45 117.94 35.79 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.193 -0.942 . . . . 0.0 109.502 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.93 -26.62 4.33 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.726 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.0 151.6 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.618 -1.519 . . . . 0.0 111.601 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.07 141.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.99 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -126.72 140.95 52.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.221 -0.924 . . . . 0.0 110.632 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.604 ' NH1' ' O ' ' A' ' 107' ' ' MET . 30.3 mtp180 -94.62 102.72 14.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.284 -0.885 . . . . 0.0 108.939 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 O-C-N 121.521 -0.737 . . . . 0.0 112.136 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -151.87 145.06 24.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.468 -1.019 . . . . 0.0 110.555 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' CD2' ' A' ' 43' ' ' PHE . 15.2 tt -133.44 135.17 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.881 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.3 mt -119.36 128.73 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -93.84 154.51 17.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -141.12 133.93 28.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 108.927 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -72.2 -33.36 67.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 111.296 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -87.8 151.06 23.16 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.721 -1.237 . . . . 0.0 110.601 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 65' ' ' ASP . 84.3 mtt-85 -67.34 -39.87 85.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.513 -0.742 . . . . 0.0 109.876 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -80.86 38.07 0.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 109.847 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 54.01 64.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 109.471 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.91 -157.68 8.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.16 -151.12 51.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -71.85 121.12 18.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -1.147 . . . . 0.0 108.961 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -102.83 157.86 16.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.247 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.629 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 17.3 t-80 -149.08 124.61 10.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.542 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -98.44 118.15 34.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.042 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' ND1' ' A' ' 17' ' ' HIS . 2.7 m -119.57 139.64 51.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 0.0 109.332 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -144.16 8.33 1.41 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.5 t -140.66 154.01 46.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.469 -0.769 . . . . 0.0 110.735 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 54.0 p30 -47.94 154.43 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.765 . . . . 0.0 110.295 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 15.3 t -154.99 111.79 3.28 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.97 -1.56 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 42.1 p-10 -142.96 99.42 3.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 76' ' ' VAL . 27.7 mt -97.8 -22.35 16.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.031 -1.043 . . . . 0.0 109.079 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 21.1 t-80 -55.98 -37.15 68.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -49.05 -52.88 22.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 50.8 m-85 -63.31 -45.64 90.39 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 0.0 111.319 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 20.3 p90 -155.19 151.0 27.64 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.018 -1.051 . . . . 0.0 110.091 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -92.53 -3.59 54.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.119 -0.988 . . . . 0.0 110.117 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -164.72 162.45 21.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.542 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 42.2 t -161.64 131.28 4.69 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 84.4 m-70 -110.49 -7.98 14.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.079 -1.013 . . . . 0.0 109.276 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m -135.2 142.8 46.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.931 -1.106 . . . . 0.0 110.459 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -136.28 145.82 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -135.87 116.46 13.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.889 -1.132 . . . . 0.0 111.204 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 21.7 t -103.82 118.69 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.425 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.0 t -169.89 146.33 3.13 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.493 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.581 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 96.14 -130.74 10.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 62.7 m -160.88 155.91 24.23 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.509 ' CD2' HD13 ' A' ' 4' ' ' ILE . 5.3 t80 -140.48 131.87 26.81 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.082 -1.011 . . . . 0.0 109.012 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -98.19 112.86 24.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.51 141.84 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.885 0.85 . . . . 0.0 110.411 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.612 ' O ' HG13 ' A' ' 76' ' ' VAL . 28.0 m-85 -118.13 137.38 52.99 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.887 0.851 . . . . 0.0 111.046 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 42.7 t0 -71.43 -11.68 61.01 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.734 ' O ' ' HB2' ' A' ' 78' ' ' SER . 26.2 ttt-85 -127.88 157.66 39.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.122 -0.986 . . . . 0.0 108.436 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.501 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 18.9 p -68.79 158.08 35.11 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.632 -0.667 . . . . 0.0 111.475 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.584 ' N ' ' OG ' ' A' ' 78' ' ' SER . 18.3 m-20 67.41 36.69 3.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 111.635 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.455 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.8 m-85 58.25 59.56 2.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.7 mtt -145.38 167.06 23.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.69 -165.63 33.69 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -60.22 124.01 18.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.09 136.71 42.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.96 138.48 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 109.85 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 38.6 p90 -101.83 122.68 44.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.304 -0.872 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.2 mt -113.06 117.5 32.18 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.933 -1.105 . . . . 0.0 111.555 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.0 ptt180 -92.71 157.03 16.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 111.209 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.482 ' C ' ' O ' ' A' ' 59' ' ' ARG . 68.9 ttt180 -31.99 109.48 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.43 0.633 . . . . 0.0 110.691 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 178.07 168.58 37.76 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -103.92 123.26 46.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.04 98.1 12.88 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.55 -20.06 65.45 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.254 1.969 . . . . 0.0 112.015 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 10' ' ' ARG . 15.2 t0 -167.07 147.01 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 28.5 p90 -148.22 25.0 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.256 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 7.3 mmt -95.61 -42.35 8.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.373 -0.83 . . . . 0.0 109.427 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -98.09 -17.1 19.28 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.53 -10.52 45.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.715 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.8 mmt -114.32 -33.8 5.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.26 53.15 3.74 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtp -121.72 143.83 49.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -1.008 . . . . 0.0 109.35 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 29.8 t30 -94.27 57.57 2.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.962 . . . . 0.0 109.174 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.35 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.542 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.4 p -100.42 -167.59 1.46 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.935 0.874 . . . . 0.0 109.544 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 46' ' ' TYR . 54.3 t -74.72 139.81 18.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.442 ' HB3' HG22 ' A' ' 49' ' ' THR . 93.4 mtt180 -107.54 -13.84 14.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.616 -1.303 . . . . 0.0 108.335 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.734 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -149.11 165.84 30.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.963 -1.086 . . . . 0.0 109.533 177.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.2 p -163.04 154.44 17.43 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.967 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.507 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 59.0 ttt180 -136.13 141.18 44.12 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 ptm -88.33 142.35 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.078 -1.014 . . . . 0.0 109.085 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.547 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 90.4 mt . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 108.699 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.498 0.665 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -114.3 121.14 42.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.57 -0.707 . . . . 0.0 109.891 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -170.32 128.27 0.84 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.446 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 40.9 ttm -112.2 130.69 55.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.97 -1.081 . . . . 0.0 109.289 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -104.69 116.15 31.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 103' ' ' MET . 13.1 mt -100.46 149.0 24.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.112 0.958 . . . . 0.0 112.556 -177.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' O ' ' A' ' 99' ' ' MET . 31.2 m-85 -135.04 125.0 25.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 86.1 tt0 -63.28 -22.76 67.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.853 -1.154 . . . . 0.0 111.767 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.844 ' O ' ' OG ' ' A' ' 124' ' ' SER . 3.0 m-70 -113.61 162.42 16.23 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.132 -1.605 . . . . 0.0 111.504 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 25.2 p -59.19 158.54 8.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.302 -0.874 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 97' ' ' SER . 5.8 m-20 81.64 -96.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.544 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 17.1 mmt -163.68 30.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.18 -159.93 32.41 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.76 -162.89 47.69 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.451 ' O ' ' HE3' ' A' ' 104' ' ' MET . 57.7 mtp180 -85.81 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -1.172 . . . . 0.0 109.218 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.7 ptt? -95.81 113.65 25.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 110.262 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.451 ' HE3' ' O ' ' A' ' 102' ' ' ARG . 1.3 mpt? -110.66 140.46 45.0 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.59 136.6 43.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.422 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -130.8 120.76 24.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ttt -117.83 -15.84 10.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 52.6 p30 -107.63 -157.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 17.8 p-10 -93.85 138.1 32.37 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -118.99 86.3 31.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.204 -0.935 . . . . 0.0 110.354 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.81 -28.13 6.58 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.178 1.919 . . . . 0.0 112.143 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -129.74 83.9 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.34 -27.63 65.52 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.7 mtp -55.41 -39.15 69.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.203 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -84.84 -20.94 30.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.294 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -77.32 -62.3 1.7 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.654 -1.278 . . . . 0.0 110.334 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -109.02 1.71 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 110.455 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.2 m120 57.66 36.62 26.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.068 . . . . 0.0 109.83 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.453 ' CG ' ' CE2' ' A' ' 122' ' ' PHE . 8.7 ptm -152.44 136.36 16.34 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.4 p -114.41 8.0 16.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.06 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 163' ' ' SER . 46.5 p-10 -134.42 98.56 4.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.348 -1.47 . . . . 0.0 113.898 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.62 134.61 51.75 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -96.83 4.4 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.015 -1.053 . . . . 0.0 111.478 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.844 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -151.02 156.66 41.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.93 -1.731 . . . . 0.0 110.43 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' CYS . . . . . 0.446 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 16.0 t -165.42 164.66 19.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.268 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.83 144.92 26.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.021 -1.049 . . . . 0.0 109.346 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 74.5 t -115.4 126.68 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.8 ttt -76.54 -21.83 55.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.601 -0.687 . . . . 0.0 109.793 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 162.16 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.722 0.773 . . . . 0.0 110.947 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.63 -140.57 21.95 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.591 ' CE1' ' HH ' ' A' ' 146' ' ' TYR . 60.2 m-70 -148.45 130.11 15.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.948 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -123.38 132.34 53.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.392 -0.818 . . . . 0.0 111.648 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.9 mt -103.69 130.16 51.13 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 41.6 t -109.94 142.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.957 -1.089 . . . . 0.0 109.574 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 58.6 m-85 -117.84 124.36 48.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.609 -0.682 . . . . 0.0 111.936 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.4 tt0 -59.26 -27.06 65.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.0 mp0 -122.64 153.99 63.16 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.228 -0.92 . . . . 0.0 108.621 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.417 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 22.6 Cg_endo -61.29 -175.23 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 123.417 2.744 . . . . 0.0 113.602 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 49.29 33.96 5.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.591 0.71 . . . . 0.0 110.055 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.435 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 31.4 m-85 54.22 52.18 13.1 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.484 0.659 . . . . 0.0 109.939 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 142' ' ' GLY . 85.4 m -137.02 162.18 34.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.576 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 141' ' ' THR . . . 99.12 177.38 31.81 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -53.95 109.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.666 -0.903 . . . . 0.0 108.604 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.9 mt-30 -84.49 145.81 27.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 109.409 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -129.39 127.79 41.72 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.195 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.591 ' HH ' ' CE1' ' A' ' 131' ' ' HIS . 1.8 t80 -89.81 106.03 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.8 mp -102.24 123.83 46.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.445 -0.784 . . . . 0.0 109.134 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.569 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -111.48 169.13 6.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' A' ' 148' ' ' ARG . 15.0 Cg_exo -32.76 162.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.846 2.364 . . . . 0.0 112.182 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.39 -169.69 13.36 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.28 133.38 55.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.554 -0.968 . . . . 0.0 110.52 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.569 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 98.3 m-85 -106.87 142.75 36.0 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' SER . 44.1 ptt85 -131.89 -6.61 3.55 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.848 -1.157 . . . . 0.0 113.222 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 153' ' ' ARG . 3.8 m -172.22 170.13 5.23 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.537 -1.977 . . . . 0.0 111.018 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.61 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -56.65 -24.12 46.2 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -78.99 -1.75 36.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.224 -0.922 . . . . 0.0 109.301 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 159' ' ' GLY . 3.5 t0 -89.1 -61.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.593 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 7.0 p90 -74.35 16.17 0.28 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.76 34.23 89.36 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.01 -165.95 32.81 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 161' ' ' VAL . 47.9 t -146.16 -8.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.811 -0.817 . . . . 0.0 109.098 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -139.69 -156.36 0.67 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.5 p -139.79 5.32 2.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.353 -0.842 . . . . 0.0 109.797 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 136' ' ' GLU . 48.0 mtp180 -62.34 74.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.072 -1.017 . . . . 0.0 112.126 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 163' ' ' SER . 65.0 mtt -105.11 116.5 32.06 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.051 -1.031 . . . . 0.0 110.051 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.12 -22.96 4.72 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.225 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.36 150.9 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 119.572 1.686 . . . . 0.0 111.407 -178.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.81 141.36 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.265 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -128.68 144.07 51.08 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.178 -0.951 . . . . 0.0 110.368 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 171' ' ' ILE . 16.2 ptt180 -102.46 91.12 4.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 131' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.981 0 O-C-N 121.495 -0.753 . . . . 0.0 111.027 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtp . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.46 152.09 22.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -141.11 144.95 35.18 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.514 -0.992 . . . . 0.0 110.543 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.605 HD13 ' CD2' ' A' ' 43' ' ' PHE . 15.9 tt -135.46 135.03 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.22 128.97 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.414 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.8 140.6 31.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.368 -0.833 . . . . 0.0 109.24 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -125.82 136.07 52.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.711 -1.243 . . . . 0.0 109.343 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -72.41 -38.49 68.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 110.208 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.3 t70 -83.27 157.68 22.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.068 -1.02 . . . . 0.0 110.122 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 38.1 ptt85 -71.68 -39.91 69.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.013 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.476 ' OD1' ' NH1' ' A' ' 10' ' ' ARG . 88.6 m-20 -78.26 38.13 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.619 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 53.94 47.14 24.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 109.464 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.57 -158.19 8.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.72 -149.43 49.5 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -73.78 118.73 17.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -1.165 . . . . 0.0 109.221 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -100.73 155.58 17.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -146.0 124.08 12.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.08 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -97.89 121.83 40.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.14 -0.975 . . . . 0.0 109.808 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -122.33 137.79 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 81' ' ' MET . 21.3 ptt? -140.76 10.02 2.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.393 -0.817 . . . . 0.0 108.941 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -144.81 158.81 43.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.993 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 49.4 p30 -46.51 161.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.504 -0.748 . . . . 0.0 109.807 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 3.6 t -161.66 110.0 1.48 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.6 40.56 1.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 14.1 p30 -177.39 91.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.993 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD21 ' SG ' ' A' ' 79' ' ' CYS . 96.4 mt -98.04 -22.45 16.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.906 . . . . 0.0 108.87 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.55 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 22.3 t-80 -57.93 -42.67 85.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 108.758 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -59.67 -16.65 28.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.741 -0.599 . . . . 0.0 109.841 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -99.98 -47.64 4.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.51 145.95 21.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.261 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 71.3 m-20 -97.34 -7.49 31.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 110.404 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -149.35 149.4 30.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.139 -0.976 . . . . 0.0 108.632 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 38.9 t -154.55 114.52 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -96.12 -16.55 21.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.716 -0.615 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 t -133.77 142.58 47.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.899 -1.126 . . . . 0.0 110.801 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.97 145.95 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -134.7 121.13 20.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.053 . . . . 0.0 111.278 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.97 117.83 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.67 -32.33 23.67 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.5 t -168.4 151.79 5.64 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.224 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 -165.19 43.06 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -123.74 153.38 40.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.397 -1.061 . . . . 0.0 109.546 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.605 ' CD2' HD13 ' A' ' 4' ' ' ILE . 4.2 t80 -133.64 133.39 41.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.0 tpt -103.06 122.52 44.82 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.686 ' HB ' HG11 ' A' ' 76' ' ' VAL . 21.0 m -115.05 146.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.03 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.497 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.0 m-85 -121.82 143.77 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.681 0.753 . . . . 0.0 110.481 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.76 -7.81 58.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.799 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.5 ttm180 -131.21 157.98 41.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p -69.84 155.7 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.962 0.887 . . . . 0.0 111.231 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 71.93 33.5 1.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.377 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.0 m-85 61.62 55.22 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.914 -1.116 . . . . 0.0 110.049 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 50.2 mtt -143.73 174.19 11.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.302 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.65 -170.03 47.71 Favored Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.834 -1.166 . . . . 0.0 110.246 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -55.15 119.85 6.11 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -1.059 . . . . 0.0 108.418 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -101.34 132.25 46.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.331 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -124.48 136.39 53.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.995 . . . . 0.0 109.607 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -100.59 116.45 32.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 0.0 109.463 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.51 139.13 42.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 108.556 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.3 ptt180 -113.25 161.38 17.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.054 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 59' ' ' ARG . 39.9 ttp180 -35.17 115.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.509 -0.745 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.09 169.69 31.89 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.45 127.77 53.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.481 -1.011 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -107.04 100.28 31.36 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 39.6 Cg_endo -70.01 -20.11 34.1 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.38 2.053 . . . . 0.0 112.716 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 42.2 m-20 -163.65 138.66 6.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.512 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.5 p90 -148.63 26.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.548 -1.345 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.4 mtt -99.99 -43.62 6.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.933 -1.104 . . . . 0.0 109.176 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -94.61 -22.67 18.02 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.9 m -82.1 -19.41 40.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.669 -0.644 . . . . 0.0 109.835 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 mmt -105.58 -23.35 12.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.98 -1.075 . . . . 0.0 109.012 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.88 51.98 4.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.0 mtp -123.13 -171.48 2.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.044 -1.268 . . . . 0.0 109.639 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 63.4 t30 -145.79 55.99 1.2 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.168 -0.958 . . . . 0.0 109.371 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.0 m-20 150.23 -169.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -96.69 -167.11 1.5 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.341 -0.849 . . . . 0.0 109.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.686 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.5 m -88.85 148.69 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -106.74 -11.08 15.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.058 -1.027 . . . . 0.0 108.376 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.799 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.44 172.54 13.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.049 -1.032 . . . . 0.0 110.313 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' SG ' HD21 ' A' ' 26' ' ' LEU . 22.1 p -172.09 156.75 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.869 0.842 . . . . 0.0 110.84 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -134.6 139.58 45.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' A' ' 20' ' ' MET . 59.5 ttp -91.43 143.12 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.067 -1.02 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.2 mt -110.32 104.12 55.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 108.943 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.05 175.64 9.67 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.386 2.057 . . . . 0.0 112.42 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.1 mt -74.76 48.6 0.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.673 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -104.27 88.9 3.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.399 -0.813 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -134.89 93.1 2.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.765 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.64 -81.06 0.38 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 63.9 m -122.4 151.24 41.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.412 -1.052 . . . . 0.0 110.603 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -110.76 116.82 31.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -169.4 125.25 0.87 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 108.775 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.406 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 42.8 ttm -107.09 121.02 43.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -95.15 115.63 27.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.0 mt -103.7 147.49 27.18 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.142 0.972 . . . . 0.0 112.55 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.559 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 30.6 m-85 -135.37 127.28 29.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.491 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 50.2 tt0 -61.52 -27.97 68.98 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 111.818 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.881 ' O ' ' OG ' ' A' ' 124' ' ' SER . 5.9 m-70 -109.72 165.67 11.51 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.671 -1.268 . . . . 0.0 111.202 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.7 m -60.52 157.06 14.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 97' ' ' SER . 8.7 t70 81.82 -96.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.8 mmt -163.29 33.09 0.09 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.71 -160.13 31.91 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.313 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 65.0 -149.33 51.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.423 ' H ' ' HB2' ' A' ' 95' ' ' GLU . 76.5 mtm-85 -96.14 139.55 32.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.3 ptt? -96.09 119.48 34.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.195 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 104' ' ' MET . 0.3 OUTLIER -115.62 135.8 53.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.009 -1.057 . . . . 0.0 108.817 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.14 132.19 43.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.9 OUTLIER -129.02 117.18 20.48 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 74.7 mtp -123.25 13.62 9.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.548 ' H ' HD23 ' A' ' 106' ' ' LEU . 42.3 p30 -140.09 -162.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.952 . . . . 0.0 110.176 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 2.0 p30 -87.04 133.22 33.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.57 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -117.73 90.81 37.06 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.434 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.94 -28.09 5.3 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.206 1.938 . . . . 0.0 112.286 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -135.28 84.99 2.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.79 -27.91 66.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.552 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.5 tpt -57.01 -39.73 75.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.59 0.709 . . . . 0.0 109.205 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -84.13 -22.05 31.2 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.012 -1.055 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -79.32 -63.07 1.5 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.58 -1.325 . . . . 0.0 111.633 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -104.6 1.05 29.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.319 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 114' ' ' MET . 17.8 t30 58.87 32.5 22.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.909 -1.119 . . . . 0.0 109.425 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 4.7 ptm -150.32 133.06 15.91 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 53.7 p -116.57 5.93 13.38 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 120' ' ' SER . 53.9 m-20 -130.01 90.99 3.05 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.723 -1.236 . . . . 0.0 112.471 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.654 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -100.95 130.94 47.02 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.059 -1.026 . . . . 0.0 108.554 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -93.89 2.92 56.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 0.0 110.92 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.881 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.9 p -147.83 154.07 39.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.146 -1.596 . . . . 0.0 109.935 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 23.0 t -165.36 163.71 19.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.885 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.554 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 7.0 t60 -152.45 148.15 27.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 65.4 t -115.95 125.35 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.937 0.875 . . . . 0.0 109.252 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 10.0 tpt -72.79 -32.66 65.73 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 172.95 167.15 0.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.827 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.93 -155.19 28.68 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.541 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 89.6 m-70 -135.49 130.12 34.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.552 -0.97 . . . . 0.0 110.184 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -121.42 131.13 53.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.549 -0.719 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.484 HD22 ' NE2' ' A' ' 144' ' ' GLN . 5.2 mt -100.86 130.26 46.84 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 34.9 t -109.08 143.45 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.835 -1.166 . . . . 0.0 109.546 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.446 ' OH ' ' NH2' ' A' ' 169' ' ' ARG . 90.4 m-85 -121.04 125.63 47.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.729 -0.607 . . . . 0.0 110.906 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -60.26 -26.09 66.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 167' ' ' SER . 26.0 mt-30 -121.68 154.0 59.98 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 20.3 Cg_endo -60.64 -171.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 123.197 2.598 . . . . 0.0 113.676 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m120 46.43 30.32 1.05 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.511 0.672 . . . . 0.0 110.149 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.532 ' H ' ' CB ' ' A' ' 167' ' ' SER . 18.5 m-85 57.69 52.43 8.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.419 -0.801 . . . . 0.0 109.924 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -138.4 166.09 25.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.15 -179.82 33.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -55.33 113.25 1.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -1.026 . . . . 0.0 109.121 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.484 ' NE2' HD22 ' A' ' 133' ' ' LEU . 19.2 tt0 -87.58 141.41 28.63 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.149 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -123.85 133.91 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.541 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 81.1 t80 -95.16 102.28 14.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.517 -0.739 . . . . 0.0 109.763 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.1 mp -97.69 120.94 38.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 149' ' ' PRO . 0.9 OUTLIER -104.96 -178.49 0.62 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 148' ' ' ARG . 51.9 Cg_exo -52.39 154.21 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.217 1.944 . . . . 0.0 111.847 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.19 -166.33 14.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.23 136.71 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -1.098 . . . . 0.0 110.44 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.54 143.45 42.38 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.679 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 59.1 mtm180 -130.09 -5.84 4.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.141 -0.974 . . . . 0.0 112.537 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 10.0 t -172.01 -178.45 2.14 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.111 -1.618 . . . . 0.0 110.726 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.5 OUTLIER -60.44 -26.88 67.07 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -80.19 2.53 23.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.096 -1.002 . . . . 0.0 109.911 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.679 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -93.01 -61.13 1.64 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.167 -0.958 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -78.15 18.0 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.5 38.44 95.76 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -108.65 -160.85 20.07 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.7 t -148.75 -41.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.8 p -102.71 -158.34 0.66 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.4 p -144.36 11.68 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.842 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -63.89 74.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.096 -1.003 . . . . 0.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.47 119.88 39.45 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.248 -0.908 . . . . 0.0 109.772 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.1 -25.98 3.67 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.532 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.94 152.09 51.43 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 119.274 1.537 . . . . 0.0 111.202 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.92 142.69 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.639 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.446 ' NH2' ' OH ' ' A' ' 135' ' ' TYR . 45.3 ttp180 -123.7 136.57 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.53 ' NE ' ' OG1' ' A' ' 172' ' ' THR . 45.4 ttp180 -96.05 98.08 10.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.548 -0.72 . . . . 0.0 109.4 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 74.5 mt -47.48 103.07 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.53 ' OG1' ' NE ' ' A' ' 170' ' ' ARG . 12.3 m -149.8 60.68 1.0 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -177.78 108.36 0.06 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.486 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.272 0.558 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -64.08 151.46 49.76 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -149.67 147.31 27.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.166 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.669 HD13 ' CD2' ' A' ' 43' ' ' PHE . 13.0 tt -133.9 136.79 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 110.09 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.5 mt -122.89 130.69 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.524 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -99.21 135.09 41.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.038 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -120.17 135.2 55.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -73.8 -32.62 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.956 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -81.88 161.58 23.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.8 -44.17 33.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.981 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.68 47.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 51.25 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.539 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.53 -175.74 47.72 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.8 -146.06 23.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -75.82 116.42 16.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.972 -1.31 . . . . 0.0 108.699 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -98.19 157.96 15.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.814 . . . . 0.0 109.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -148.14 122.5 9.67 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.21 -0.931 . . . . 0.0 108.873 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -97.64 120.72 38.53 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -124.43 137.55 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -140.88 11.05 2.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -141.48 155.16 45.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 110.147 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 2.9 p30 -53.26 141.03 24.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.452 -0.78 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 t -138.93 120.45 15.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.97 -4.68 58.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.016 -1.053 . . . . 0.0 109.576 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -140.23 93.98 2.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 26' ' ' LEU . 34.2 mt -91.13 -16.29 28.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.178 -0.951 . . . . 0.0 108.494 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -58.95 -39.94 83.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.806 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -59.97 -18.69 47.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.481 -0.762 . . . . 0.0 110.514 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.78 -43.26 8.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -158.86 153.87 25.14 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.325 0.583 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -100.41 -7.81 23.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -154.04 153.39 31.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.006 -1.059 . . . . 0.0 108.475 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.589 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 46.2 t -155.98 122.78 5.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.593 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 36.9 m-70 -104.63 -12.45 16.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.744 . . . . 0.0 109.94 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 t -136.06 142.27 44.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.974 . . . . 0.0 110.422 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.8 145.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -137.02 116.5 12.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.896 -1.127 . . . . 0.0 111.276 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.58 119.52 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.37 -32.72 22.26 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 108.945 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.0 t -171.24 153.46 3.66 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.244 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.57 -169.05 38.73 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 53.9 m -118.93 156.69 29.09 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.287 -1.125 . . . . 0.0 109.151 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CD2' HD13 ' A' ' 4' ' ' ILE . 10.7 t80 -145.53 134.77 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 108.994 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.61 ' SD ' ' CD2' ' A' ' 146' ' ' TYR . 10.7 ttm -107.24 126.24 52.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.77 143.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.122 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.7 ' O ' HG13 ' A' ' 76' ' ' VAL . 43.5 m-85 -116.8 139.94 50.02 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.63 0.728 . . . . 0.0 110.863 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 26.3 t0 -76.37 -10.0 59.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.503 -0.748 . . . . 0.0 110.013 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.697 ' O ' ' HB3' ' A' ' 78' ' ' SER . 71.5 mtt-85 -131.61 155.44 47.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 108.525 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.2 p -65.98 158.07 29.19 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.682 0.754 . . . . 0.0 110.953 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 70.73 35.47 1.8 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.094 0.473 . . . . 0.0 111.76 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.496 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.4 m-85 58.58 54.97 5.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.913 -1.117 . . . . 0.0 109.952 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.403 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 83.2 mmm -144.32 178.43 7.92 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.219 -0.925 . . . . 0.0 109.843 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.33 -173.44 53.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -54.91 124.58 17.1 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.157 -1.202 . . . . 0.0 108.427 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -102.74 133.48 47.71 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -126.47 133.58 51.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.19 -0.944 . . . . 0.0 109.36 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -96.9 120.97 38.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.179 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.32 117.33 28.26 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.147 -0.971 . . . . 0.0 111.248 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HE ' ' CD1' ' A' ' 174' ' ' LEU . 62.0 ttt-85 -95.33 161.85 13.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 111.302 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 59' ' ' ARG . 47.1 ttp180 -29.33 115.14 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.433 0.635 . . . . 0.0 110.638 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.92 169.49 32.38 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 9.3 pt-20 -108.5 128.44 54.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.483 -1.01 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -106.7 98.25 20.09 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 35.3 Cg_endo -67.5 -18.92 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.314 2.01 . . . . 0.0 112.362 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 32.5 m-20 -164.84 139.47 5.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -146.44 3.13 0.87 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.48 -1.387 . . . . 0.0 111.194 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.593 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 30.6 mtp -77.64 -39.93 43.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.13 -21.59 17.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.958 . . . . 0.0 109.42 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.2 m -83.4 -16.34 46.3 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.474 -0.767 . . . . 0.0 109.703 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mmt -109.5 -25.34 10.53 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.91 44.81 8.03 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.262 -0.97 . . . . 0.0 110.977 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.0 mtp -114.71 159.3 20.7 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.272 . . . . 0.0 109.585 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 28.8 p30 -110.4 55.8 0.64 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.101 -0.999 . . . . 0.0 109.302 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.7 p30 152.67 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.589 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.8 p -96.97 -175.09 3.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.066 0.936 . . . . 0.0 110.255 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 46' ' ' TYR . 59.7 t -68.09 141.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.27 -17.91 14.16 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.707 -1.245 . . . . 0.0 107.821 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.697 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -145.49 168.85 19.59 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.422 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 22.9 p -161.68 146.22 13.02 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.492 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH1' ' NE ' ' A' ' 148' ' ' ARG . 63.9 ttt180 -132.43 140.3 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.5 tpp -92.36 143.1 26.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.602 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 17.2 mt -85.22 130.72 50.76 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.11 -175.88 2.39 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.406 2.071 . . . . 0.0 112.323 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 85' ' ' HIS . 30.5 mt -100.68 68.88 1.35 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.451 -0.78 . . . . 0.0 109.174 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.501 ' C ' ' O ' ' A' ' 84' ' ' LEU . 25.7 p80 -33.67 147.75 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.724 -0.61 . . . . 0.0 109.736 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 50.21 1.2 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.801 . . . . 0.0 109.594 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.03 -101.29 0.48 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 74.6 p -156.47 173.95 16.16 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.85 -0.794 . . . . 0.0 109.483 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.491 ' CE2' ' OG1' ' A' ' 172' ' ' THR . 14.0 m-85 -111.96 119.61 39.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.524 -0.735 . . . . 0.0 109.491 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -167.9 129.24 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.3 ttm -117.02 127.66 54.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.325 -0.859 . . . . 0.0 109.269 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -101.06 119.22 38.43 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 125' ' ' CYS . 15.9 mt -101.3 149.06 24.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.119 0.961 . . . . 0.0 112.067 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 99' ' ' MET . 38.3 m-85 -132.95 122.94 25.02 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 52.6 tt0 -62.12 -26.04 68.08 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.195 -0.941 . . . . 0.0 111.828 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.93 165.4 11.6 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.839 -1.163 . . . . 0.0 110.908 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 6.1 p -63.53 158.18 21.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.8 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 97' ' ' SER . 32.2 t0 81.67 -95.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.543 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 19.9 mmt -161.64 33.56 0.13 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.18 -153.1 26.05 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.019 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 62.87 -165.57 25.11 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.455 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 79.1 mtm180 -81.01 143.74 32.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.334 . . . . 0.0 108.842 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.4 mtt -98.21 115.45 28.36 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.922 -1.111 . . . . 0.0 109.447 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.3 mpp? -114.42 135.38 54.16 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.109 -0.994 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.56 132.1 45.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.708 HD11 ' HB2' ' A' ' 110' ' ' CYS . 1.0 OUTLIER -122.79 115.78 22.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.2 ttt -126.16 13.09 7.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.815 . . . . 0.0 109.399 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.542 ' H ' HD23 ' A' ' 106' ' ' LEU . 77.3 m-20 -136.71 -167.68 2.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.626 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -81.99 130.9 35.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.708 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -118.69 78.64 15.61 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 109.52 -179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -78.07 -25.8 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.087 1.858 . . . . 0.0 112.233 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 51.2 p-10 -131.27 75.61 1.66 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -18.54 61.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.93 -1.106 . . . . 0.0 110.41 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.5 tpt -60.88 -42.21 97.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -82.91 -21.51 34.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.382 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -77.21 -62.15 1.75 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.691 -1.256 . . . . 0.0 111.125 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.05 2.68 15.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.489 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' MET . 8.7 m120 50.85 35.36 12.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.871 -1.143 . . . . 0.0 108.769 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.5 ptm -148.3 135.64 20.44 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 78.6 p -125.91 7.09 7.34 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.478 -0.764 . . . . 0.0 111.015 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 163' ' ' SER . 66.6 m-20 -128.42 85.68 2.37 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.552 -1.342 . . . . 0.0 112.786 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -98.74 134.69 41.29 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.95 -1.094 . . . . 0.0 108.7 177.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -94.45 2.18 55.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.0 111.264 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.5 t -149.92 156.3 41.51 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.156 -1.59 . . . . 0.0 109.846 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.539 ' HB3' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -162.69 162.16 26.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -147.95 143.36 27.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.143 -0.973 . . . . 0.0 109.89 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.9 t -114.26 121.02 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.286 -0.884 . . . . 0.0 109.359 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 23.1 ttt -70.32 -39.44 74.78 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.565 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 0.5 OUTLIER -179.08 173.66 1.14 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.253 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 86.33 -144.13 19.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.56 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 66.3 m-70 -147.76 128.44 14.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.571 -0.958 . . . . 0.0 109.319 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -124.04 135.42 53.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.118 -0.989 . . . . 0.0 112.478 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.22 134.17 51.45 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 25.4 t -110.06 142.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.05 -1.031 . . . . 0.0 109.233 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 50.9 m-85 -119.13 124.32 46.57 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.618 -0.676 . . . . 0.0 110.762 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.516 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 78.0 tt0 -60.69 -26.62 67.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' A' ' 167' ' ' SER . 12.2 mm100 -119.34 150.98 50.55 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.483 ' O ' ' OG1' ' A' ' 141' ' ' THR . 18.1 Cg_endo -59.75 -177.84 0.15 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.921 2.414 . . . . 0.0 113.398 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.581 ' O ' ' CG ' ' A' ' 140' ' ' TYR . 26.9 m120 52.61 38.61 26.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.384 -0.822 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.581 ' CG ' ' O ' ' A' ' 139' ' ' ASN . 5.7 p90 45.75 57.09 5.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.65 -0.656 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 3.8 p -141.42 172.63 12.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.289 -0.882 . . . . 0.0 110.327 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.46 -173.76 40.85 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.645 -1.284 . . . . 0.0 110.798 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.516 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 70.3 mtm180 -58.19 106.66 0.4 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.605 -0.938 . . . . 0.0 109.432 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 11.9 mt-30 -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.62 0.724 . . . . 0.0 110.184 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -126.85 134.17 50.57 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CD2' ' SD ' ' A' ' 44' ' ' MET . 2.4 t80 -95.3 104.84 16.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.0 mp -96.91 121.98 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 108.887 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' NE ' ' NH1' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -107.26 175.83 1.87 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.71 159.06 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.11 1.874 . . . . 0.0 111.773 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.02 -168.87 12.78 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.2 136.34 54.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -1.017 . . . . 0.0 110.487 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.524 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 17.6 m-85 -110.73 145.55 37.86 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.601 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 35.2 ptt85 -134.5 -3.86 2.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.069 -1.02 . . . . 0.0 112.168 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.579 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 53.8 p -170.17 173.23 5.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.09 -1.631 . . . . 0.0 110.661 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.638 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.77 -21.54 56.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -80.99 -2.52 48.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.556 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.6 m-20 -88.55 -61.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.961 . . . . 0.0 109.274 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.535 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.2 p90 -76.59 16.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.19 38.26 94.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.54 -177.85 23.18 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.55 5.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 63.3 p -154.95 -157.32 0.74 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 55.7 m -141.84 12.35 2.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.437 -0.79 . . . . 0.0 110.269 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -64.02 69.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.083 -1.01 . . . . 0.0 112.826 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.2 mtt -100.36 118.83 37.42 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.054 -1.028 . . . . 0.0 110.523 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.74 -25.85 4.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.442 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -132.47 153.55 50.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.765 -1.433 . . . . 0.0 110.596 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -150.44 141.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.561 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -122.76 133.89 54.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.7 ' O ' ' N ' ' A' ' 172' ' ' THR . 23.0 ptt85 -98.78 102.74 14.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.748 ' O ' HG22 ' A' ' 171' ' ' ILE . 82.4 mt -50.17 66.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.811 -0.556 . . . . 0.0 111.715 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 170' ' ' ARG . 4.5 m -139.73 50.69 1.75 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.516 -1.365 . . . . 0.0 110.538 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 172' ' ' THR . 16.1 m-20 -157.57 92.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.268 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.653 ' CD1' ' HE ' ' A' ' 59' ' ' ARG . 3.7 mm? . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 118.021 -0.99 . . . . 0.0 108.763 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' O ' ' A' ' 2' ' ' GLY . 63.0 mtt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 59.9 146.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -148.43 149.24 31.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.324 -1.103 . . . . 0.0 110.892 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 36' ' ' ILE . 17.3 tt -134.67 133.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.6 mt -118.48 130.76 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.61 157.27 16.05 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -144.69 136.35 25.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 108.454 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -80.77 -25.12 38.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.016 -1.052 . . . . 0.0 111.267 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 50.9 t0 -80.54 159.06 25.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.812 -1.18 . . . . 0.0 110.821 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' OG ' ' A' ' 35' ' ' SER . 73.7 ttt180 -61.44 -39.84 92.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.657 -0.652 . . . . 0.0 110.064 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 83.2 m-20 -87.48 -90.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.071 -1.018 . . . . 0.0 109.323 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 57.2 m-85 -158.17 63.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 108.959 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.617 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -152.42 -162.38 10.85 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.18 -149.5 39.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -74.37 117.04 15.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.868 -1.372 . . . . 0.0 108.827 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -104.74 158.81 16.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.466 -0.771 . . . . 0.0 110.101 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -149.72 124.07 9.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.069 -1.019 . . . . 0.0 109.828 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -96.45 118.12 32.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.111 -0.993 . . . . 0.0 109.2 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -114.86 139.03 50.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.3 ptp -138.44 10.78 2.74 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.5 p -143.44 161.79 37.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.666 -0.646 . . . . 0.0 109.605 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 49.8 p30 -60.02 146.02 44.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.0 110.562 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -141.15 111.93 7.09 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 50' ' ' ASN . . . -83.93 -5.38 59.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 109.583 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 38.8 p-10 -138.23 93.94 2.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.057 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 79' ' ' CYS . 30.9 mt -94.32 -20.66 19.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -58.44 -40.9 83.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.6 p -57.31 -24.24 53.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.61 -0.682 . . . . 0.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -89.46 -40.37 12.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 108.705 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -159.08 147.35 17.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.601 -0.687 . . . . 0.0 109.701 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -94.06 -9.68 35.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.113 -0.992 . . . . 0.0 110.254 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -152.5 152.23 31.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.048 -1.033 . . . . 0.0 108.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 7.7 t -154.45 114.6 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -95.17 -7.93 37.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.42 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.513 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 14.9 m -137.78 144.13 41.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.511 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 4' ' ' ILE . 9.1 tt -156.85 154.22 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -155.54 144.82 20.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.675 -1.265 . . . . 0.0 111.815 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.55 123.61 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -84.56 -30.51 25.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 108.669 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -166.37 150.29 7.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.88 -142.16 18.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.09 163.02 39.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.63 134.47 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.871 -1.143 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.28 110.66 22.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.658 ' HB ' HG11 ' A' ' 76' ' ' VAL . 18.9 m -99.8 147.18 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.602 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 42.2 m-85 -121.73 140.6 52.12 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.684 0.754 . . . . 0.0 111.147 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.47 -8.02 55.63 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.764 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.823 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.2 ttt180 -131.38 162.58 29.82 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.0 p -74.15 163.3 28.03 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.976 0.893 . . . . 0.0 111.548 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.8 OUTLIER 64.42 31.93 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.217 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.616 ' CE2' ' NH2' ' A' ' 80' ' ' ARG . 5.0 m-85 63.08 58.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.905 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 86.2 mtp -144.29 171.62 14.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 85.42 -169.39 43.32 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -58.03 121.29 10.26 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 4.5 mp0 -104.51 136.15 44.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 109.207 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -125.77 133.34 52.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.21 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -96.97 122.37 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.388 -0.82 . . . . 0.0 109.281 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 mt -117.04 127.99 54.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.283 -0.885 . . . . 0.0 109.746 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ARG . 35.3 ptt180 -97.52 166.35 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 110.078 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 59' ' ' ARG . 44.4 ttp180 -38.52 112.17 0.21 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.576 -0.702 . . . . 0.0 109.84 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.26 171.85 40.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 47.1 mp0 -111.14 130.33 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.375 -1.074 . . . . 0.0 108.667 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.33 99.67 49.81 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ARG . 58.1 Cg_endo -75.8 -9.35 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.343 2.028 . . . . 0.0 112.725 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 44.2 m-20 -164.28 128.93 2.71 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 22.3 p90 -148.4 34.33 0.79 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.62 -1.3 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 54.5 tpp -102.83 -47.25 4.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.024 -1.047 . . . . 0.0 109.708 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -98.54 -19.52 17.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -78.9 -23.93 44.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.3 mmt -101.35 -30.99 11.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.21 49.72 3.65 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.8 mtp -123.1 143.16 50.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.986 . . . . 0.0 109.695 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.56 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 9.7 p-10 -96.13 54.27 1.43 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.157 -0.964 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.3 m-20 150.55 -168.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.514 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.8 p -97.48 -160.49 0.81 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.489 -0.757 . . . . 0.0 109.714 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.658 HG11 ' HB ' ' A' ' 45' ' ' VAL . 6.1 m -92.13 150.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -110.78 -7.6 14.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.894 -1.129 . . . . 0.0 108.022 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.823 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -146.8 165.14 30.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.913 -1.117 . . . . 0.0 109.452 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 26' ' ' LEU . 23.3 p -164.64 149.84 9.89 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.873 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.616 ' NH2' ' CE2' ' A' ' 51' ' ' PHE . 61.6 ttm-85 -138.2 142.84 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 ptm -95.53 151.38 19.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.444 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 28.2 mm -105.74 101.2 31.46 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.54 152.88 8.41 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.347 2.032 . . . . 0.0 112.072 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.85 47.88 1.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -100.53 77.31 1.9 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 109.141 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.538 ' ND1' ' OXT' ' A' ' 174' ' ' LEU . 38.6 m170 -97.1 82.37 3.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.92 . . . . 0.0 109.566 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.46 -88.57 0.35 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.0 p -117.48 146.67 43.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.433 -1.04 . . . . 0.0 110.236 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -111.05 119.53 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.459 -0.775 . . . . 0.0 109.527 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -171.59 125.59 0.6 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 47.2 ttm -105.38 127.72 53.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.007 -1.058 . . . . 0.0 109.298 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -104.7 115.56 30.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.534 HD23 ' SG ' ' A' ' 125' ' ' CYS . 10.1 mt -104.49 148.15 26.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.233 1.016 . . . . 0.0 113.06 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.555 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 25.3 m-85 -133.53 125.66 29.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' CB ' ' H ' ' A' ' 102' ' ' ARG . 70.8 tt0 -62.59 -26.34 68.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 111.955 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.762 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.3 m-70 -109.63 164.18 12.78 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.658 -1.276 . . . . 0.0 110.828 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -61.89 160.63 11.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.406 -0.809 . . . . 0.0 109.219 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.518 ' O ' ' SD ' ' A' ' 99' ' ' MET . 5.7 m-20 80.05 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.6 mmt -162.78 31.72 0.1 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.34 -156.84 30.54 Favored Glycine 0 N--CA 1.491 2.357 0 CA-C-O 122.173 0.874 . . . . 0.0 111.178 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.418 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 64.38 -155.35 46.95 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 57.9 ttt85 -90.9 140.84 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.162 -1.199 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 44.0 ttp -97.36 114.89 26.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.826 -1.171 . . . . 0.0 109.834 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.7 mtm -113.81 138.79 49.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.138 -0.976 . . . . 0.0 108.656 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.72 138.31 39.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.466 -0.771 . . . . 0.0 109.169 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.3 tt -137.28 122.61 19.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 108.902 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.519 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 5.8 ttt -123.12 2.73 9.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 110.406 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.495 ' H ' HD23 ' A' ' 106' ' ' LEU . 81.1 m-20 -122.29 -162.7 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.245 -0.909 . . . . 0.0 110.078 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 42.9 p-10 -91.29 139.51 30.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.509 ' CB ' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -120.83 98.22 47.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -178.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.99 -23.26 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.147 1.898 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -142.25 84.81 1.89 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.946 -1.096 . . . . 0.0 108.337 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 110' ' ' CYS . 96.0 mt -70.89 -26.99 63.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.083 -1.011 . . . . 0.0 110.074 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.6 tpt -58.59 -40.48 83.32 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 108.715 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -84.1 -23.0 30.93 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 110.619 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -79.12 -62.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.538 -1.351 . . . . 0.0 110.824 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -100.3 2.01 42.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 114' ' ' MET . 28.3 t-20 59.06 30.56 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 110.014 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 9.0 ptm -153.82 138.92 17.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 62.5 m -123.75 5.82 8.8 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.754 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 163' ' ' SER . 37.0 m-20 -128.32 92.43 3.44 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.637 -1.225 . . . . 0.0 113.242 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -104.68 132.97 50.29 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 27.0 m170 -92.01 2.65 56.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.061 . . . . 0.0 111.538 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.762 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.4 p -147.34 153.06 39.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 119.932 -1.73 . . . . 0.0 110.241 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 124' ' ' SER . 35.7 m -157.36 159.04 37.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.482 -0.761 . . . . 0.0 109.481 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.546 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -148.21 141.88 25.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.094 -1.004 . . . . 0.0 108.72 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.546 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 53.3 t -113.25 125.03 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.996 -1.065 . . . . 0.0 109.308 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.466 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.0 ttt -73.8 -28.58 61.72 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.671 0.748 . . . . 0.0 109.118 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m-20 166.85 166.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.828 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.61 -142.67 16.18 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.444 ' CE1' ' CG2' ' A' ' 82' ' ' ILE . 94.0 m-70 -149.74 129.35 13.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.593 -0.945 . . . . 0.0 109.674 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -124.1 135.76 53.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.767 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 168' ' ' ILE . 6.1 mt -105.02 133.09 50.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 43.4 t -111.1 143.0 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.084 -1.01 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.444 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 41.3 m-85 -120.42 124.19 44.86 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.522 -0.736 . . . . 0.0 111.107 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.529 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 54.0 tt0 -58.47 -27.32 64.3 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -119.97 155.2 55.54 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 26.0 Cg_endo -62.69 -171.69 0.11 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.31 2.674 . . . . 0.0 113.686 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 47.52 30.5 1.68 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.507 0.67 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.536 ' H ' ' CB ' ' A' ' 167' ' ' SER . 16.3 m-85 56.86 52.62 9.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.488 -0.757 . . . . 0.0 109.54 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 142' ' ' GLY . 85.6 m -136.89 164.42 28.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.414 -0.804 . . . . 0.0 109.323 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.09 178.51 33.15 Favored Glycine 0 N--CA 1.504 3.177 0 O-C-N 120.886 -1.134 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 136' ' ' GLU . 69.3 mtt85 -53.98 111.42 0.75 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.942 . . . . 0.0 108.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.626 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -86.78 143.53 27.47 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.116 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.12 129.58 49.36 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.549 0.69 . . . . 0.0 109.254 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -90.75 104.0 16.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.55 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.3 mp -97.98 119.62 36.93 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.854 0.835 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -105.83 177.69 1.3 Allowed Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.2 Cg_exo -47.01 161.67 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.86 1.707 . . . . 0.0 111.661 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.81 -179.47 18.39 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.32 136.79 49.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -1.009 . . . . 0.0 110.409 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 16.8 m-85 -112.08 142.82 44.05 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.683 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 7.5 ptp180 -134.86 -4.99 2.45 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.032 -1.042 . . . . 0.0 112.476 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 57.7 m -165.57 165.66 18.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.903 -1.748 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -52.07 -21.08 2.87 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -82.5 2.5 32.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 0.0 109.652 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.683 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 2.4 m-20 -92.88 -61.68 1.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.403 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.5 p90 -77.04 16.09 0.6 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.87 37.69 92.42 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.19 -161.93 22.69 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.5 t -146.97 -42.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.3 p -103.82 -155.46 0.53 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.0 t -146.13 11.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -65.09 76.88 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.087 -1.008 . . . . 0.0 112.535 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -102.64 121.56 42.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.129 -0.982 . . . . 0.0 110.155 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.9 -26.88 3.41 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.536 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 1.3 t -135.4 153.49 51.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.602 -1.528 . . . . 0.0 111.249 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 19.7 mt -149.17 143.05 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -123.06 139.99 53.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.966 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 107' ' ' MET . 53.1 ttp180 -98.82 92.52 5.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.444 -0.785 . . . . 0.0 109.293 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 170' ' ' ARG . 88.8 mt -39.24 100.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 170' ' ' ARG . 28.0 m -108.09 65.68 0.64 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 174' ' ' LEU . 42.9 t0 -115.7 72.86 0.82 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.468 0.651 . . . . 0.0 109.567 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.538 ' OXT' ' ND1' ' A' ' 86' ' ' HIS . 14.8 mt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.235 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . -153.7 148.61 19.49 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 89.6 mttt -161.59 145.41 12.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.994 . . . . 0.0 110.604 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 36' ' ' ILE . 21.0 tt -134.76 133.67 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 109.691 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.83 128.65 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.409 0.623 . . . . 0.0 109.706 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 36' ' ' ILE . 90.1 m-85 -89.26 165.96 14.09 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -152.92 132.61 13.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.602 -1.311 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.59 -43.13 60.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 111.313 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.601 ' HB2' ' H ' ' A' ' 13' ' ' GLY . 88.9 m-20 -69.63 155.77 39.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.616 -1.302 . . . . 0.0 110.782 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 64' ' ' PRO . 72.0 mtp180 -62.09 -44.85 95.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.709 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 12' ' ' PHE . 7.8 p30 -74.97 -95.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 109.191 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 51.0 m-85 -156.02 56.4 0.59 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -141.81 -150.93 5.44 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 64.71 -153.37 49.76 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -74.83 120.06 19.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -1.125 . . . . 0.0 109.231 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -106.34 156.7 18.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.871 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.626 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 1.1 t60 -146.01 128.39 15.89 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.634 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.28 121.66 41.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 108.696 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.5 m -122.62 136.55 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.21 -0.932 . . . . 0.0 109.534 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -141.58 15.27 2.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.0 t -145.81 158.19 43.87 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.781 0.8 . . . . 0.0 110.503 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.07 143.66 7.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.68 114.76 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.75 8.9 41.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.07 -1.019 . . . . 0.0 108.68 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -138.85 98.17 3.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.852 -0.53 . . . . 0.0 109.779 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 78' ' ' SER . 89.2 mt -106.54 -25.31 11.88 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.417 -0.802 . . . . 0.0 109.002 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.2 m -50.54 -58.71 5.17 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 91.4 m-85 -56.14 -49.25 74.46 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.887 -0.508 . . . . 0.0 111.209 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -155.11 149.21 25.84 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.964 -1.085 . . . . 0.0 110.19 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -95.26 -4.74 45.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.384 -0.822 . . . . 0.0 110.344 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -159.91 158.14 30.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.978 . . . . 0.0 108.485 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.542 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 14.4 t -159.11 112.89 2.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.905 -1.122 . . . . 0.0 108.419 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.571 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 60.5 m-70 -92.68 1.0 57.51 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.942 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 7.3 t -146.13 141.65 27.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.405 -1.434 . . . . 0.0 110.687 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 4' ' ' ILE . 19.0 tt -151.11 146.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 108.921 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -143.07 133.88 25.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.93 -1.106 . . . . 0.0 111.8 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 22.7 t -105.04 118.89 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -79.83 -33.49 40.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.891 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -167.79 156.51 9.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.385 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.688 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 86.93 -123.19 6.43 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 99.1 m -168.64 167.75 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.52 141.05 21.64 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.846 -1.159 . . . . 0.0 109.077 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.2 tpt -99.94 115.06 28.78 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 56' ' ' TYR . 4.5 m -108.71 142.06 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.976 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 33.2 m-85 -120.02 137.26 54.2 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.809 0.814 . . . . 0.0 111.298 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.493 ' O ' ' NE ' ' A' ' 77' ' ' ARG . 22.6 t0 -71.75 -5.86 37.11 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.056 ' O ' ' OG ' ' A' ' 78' ' ' SER . 36.2 ttm-85 -131.25 166.82 20.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.443 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 1.8 p -79.92 165.25 22.83 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.751 0.786 . . . . 0.0 110.208 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' C ' ' CG ' ' A' ' 51' ' ' PHE . 43.0 t30 63.63 33.06 13.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.713 -0.617 . . . . 0.0 110.812 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.536 ' H ' ' CB ' ' A' ' 78' ' ' SER . 0.6 OUTLIER 60.83 61.22 1.7 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.948 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.41 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 64.1 mtp -148.39 166.48 27.97 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.248 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.19 -166.64 30.99 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.029 -1.045 . . . . 0.0 110.582 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -57.76 112.88 1.61 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.246 -1.149 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -93.37 134.9 35.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.724 -0.61 . . . . 0.0 109.398 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB2' HG23 ' A' ' 45' ' ' VAL . 55.1 m-85 -130.78 137.14 49.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.664 ' CE2' ' NH2' ' A' ' 169' ' ' ARG . 30.5 p90 -98.93 116.51 31.33 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.381 -0.824 . . . . 0.0 109.779 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -107.38 112.71 25.65 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.668 -1.27 . . . . 0.0 111.473 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 60' ' ' ARG . 14.2 ptm180 -85.96 160.34 19.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.437 -0.789 . . . . 0.0 110.927 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 59' ' ' ARG . 60.1 ttt-85 -35.8 114.91 0.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.646 -0.659 . . . . 0.0 110.012 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 173.73 166.14 31.52 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.594 -1.289 . . . . 0.0 109.947 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -103.75 128.16 51.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -1.016 . . . . 0.0 108.746 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -117.91 90.05 35.66 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.837 . . . . 0.0 109.414 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 10' ' ' ARG . 31.3 Cg_exo -55.86 -11.11 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.639 2.226 . . . . 0.0 111.973 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -170.25 146.15 2.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 108.78 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 30.9 p90 -150.41 31.61 0.66 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.672 -1.268 . . . . 0.0 109.587 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.571 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 26.1 mtp -102.04 -45.66 5.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 109.213 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -96.36 -20.8 18.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -0.953 . . . . 0.0 109.168 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 p -84.17 -12.08 55.5 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.9 mtt -110.31 -28.17 8.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 108.816 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 56.02 2.85 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -130.43 166.92 19.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.935 -1.332 . . . . 0.0 109.287 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 8.7 m120 -117.09 53.25 0.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.409 -0.807 . . . . 0.0 109.287 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.8 m-20 155.33 -168.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.542 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.4 p -98.83 -166.47 1.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.954 0.883 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 46' ' ' TYR . 19.3 t -77.18 140.97 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 47' ' ' ASP . 11.8 mtm180 -102.59 -19.78 14.71 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.762 -1.211 . . . . 0.0 108.008 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 1.056 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 1.0 OUTLIER -150.11 160.19 43.84 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.629 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.05 159.15 37.65 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.351 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -146.12 142.5 28.57 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.8 160.76 19.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.155 -0.966 . . . . 0.0 108.924 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.493 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 66.2 mt -118.22 95.92 49.07 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.672 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -47.71 148.8 5.59 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.418 2.079 . . . . 0.0 112.476 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -89.75 43.26 1.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -0.879 . . . . 0.0 109.558 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -110.39 105.83 14.96 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 86' ' ' HIS . 55.8 p-80 -135.94 109.5 7.97 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.62 -64.69 3.77 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.468 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 89.5 p -144.43 164.08 31.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.493 -1.004 . . . . 0.0 109.793 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -108.01 113.43 26.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.139 -0.976 . . . . 0.0 109.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -167.5 132.29 1.91 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.254 -0.904 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.492 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 1.6 ttp -116.44 132.6 56.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -106.43 119.22 38.69 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 103' ' ' MET . 18.2 mt -103.73 151.64 22.77 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.074 0.94 . . . . 0.0 112.301 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.4 129.78 31.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 25.9 tt0 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.768 . . . . 0.0 112.217 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 124' ' ' SER . 14.8 m-70 -119.86 163.3 17.72 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.032 -1.667 . . . . 0.0 111.106 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 50.1 m -55.99 157.83 4.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.5 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 97' ' ' SER . 1.0 OUTLIER 83.42 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.028 -1.045 . . . . 0.0 109.822 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.7 mtt -179.46 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.75 163.01 22.88 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.18 -130.5 10.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.525 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 60.5 mtt85 -104.02 119.7 39.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 108.175 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.521 ' CG ' ' O ' ' A' ' 103' ' ' MET . 12.1 ptt? -90.84 119.05 30.73 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.544 -0.722 . . . . 0.0 110.457 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.4 mpp? -114.79 135.85 53.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.82 133.72 46.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.84 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.8 OUTLIER -123.66 117.67 25.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 9.6 ttt -125.07 15.45 8.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.496 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.467 ' H ' HD23 ' A' ' 106' ' ' LEU . 67.4 m-20 -144.48 -165.01 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 109.895 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 20.9 p-10 -82.96 128.35 34.38 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.689 ' HB2' HD11 ' A' ' 106' ' ' LEU . 1.2 m -123.33 77.0 53.37 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.694 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.4 -31.96 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.54 2.16 . . . . 0.0 112.045 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -117.45 75.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 113' ' ' LEU . 41.1 mt -68.48 -20.73 64.62 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.816 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.475 ' O ' ' ND2' ' A' ' 118' ' ' ASN . 5.4 tpt -59.43 -40.39 86.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.4 -21.79 26.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 110.886 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -75.85 -58.81 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.617 -1.302 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -116.76 0.62 12.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 114' ' ' MET . 11.7 m120 52.79 34.7 16.89 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' A' ' 122' ' ' PHE . 2.4 ttt -147.35 134.52 20.49 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 p -134.0 11.0 3.93 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.602 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 163' ' ' SER . 38.5 m-20 -129.28 94.96 3.91 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.665 -1.272 . . . . 0.0 112.808 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.665 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -111.56 136.45 50.74 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.215 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -96.3 3.96 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.475 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 98' ' ' ASP . 3.6 m -146.8 152.59 39.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.341 -1.474 . . . . 0.0 110.01 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.492 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 53.3 t -161.97 159.7 26.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 110.088 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.401 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 21.6 t60 -145.91 143.48 29.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 96.5 t -113.78 123.41 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 0.0 109.344 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 23.2 ttt -76.91 -22.82 52.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.668 -0.645 . . . . 0.0 109.941 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' CB ' ' H ' ' A' ' 88' ' ' SER . 0.5 OUTLIER 170.91 -171.5 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.742 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 63.09 -135.01 43.11 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.1 m-70 -159.96 138.24 10.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.905 . . . . 0.0 109.066 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -128.51 137.77 51.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 111.635 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.7 mt -104.63 130.34 52.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 39.1 t -109.38 141.39 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.918 -1.114 . . . . 0.0 109.408 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.43 125.68 48.56 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 0.0 110.868 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -61.57 -21.45 64.32 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 141' ' ' THR . 82.0 mt-30 -130.32 138.66 33.54 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 88.0 Cg_exo -43.06 -177.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.708 2.939 . . . . 0.0 114.385 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.4 t30 49.16 32.44 4.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.847 -0.533 . . . . 0.0 111.071 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.482 ' H ' ' CB ' ' A' ' 167' ' ' SER . 43.1 m-85 56.93 49.74 13.47 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.682 -0.637 . . . . 0.0 110.469 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 142' ' ' GLY . 87.4 m -137.05 163.29 31.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.255 -0.903 . . . . 0.0 109.454 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 141' ' ' THR . . . 97.6 175.02 33.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -49.96 109.78 0.32 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -1.158 . . . . 0.0 108.95 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.9 OUTLIER -85.48 142.83 28.92 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.093 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -128.01 132.47 49.13 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.632 0.73 . . . . 0.0 109.384 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.443 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 84.8 t80 -94.15 104.11 16.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.627 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.9 mp -99.26 121.41 41.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.198 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -105.07 177.61 1.35 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.482 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 77.5 Cg_exo -46.64 166.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.834 1.689 . . . . 0.0 111.574 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.06 -167.64 12.47 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -120.84 132.36 54.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.662 -0.904 . . . . 0.0 110.933 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 17.2 m-85 -110.68 144.75 39.14 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.642 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 10.6 ptm180 -135.6 0.19 2.7 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.89 -1.131 . . . . 0.0 112.132 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.565 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.3 p -169.31 167.84 9.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.904 -1.747 . . . . 0.0 109.904 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -59.6 -15.24 17.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -85.24 -1.25 56.73 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.642 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 3.7 m-20 -89.79 -62.04 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.566 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 9.9 p90 -73.32 13.28 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 67.94 35.5 84.58 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.15 -165.66 32.56 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 t -151.07 3.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.8 p -150.78 -157.33 0.8 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 25.1 p -141.41 1.21 1.56 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -64.47 77.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.965 -1.084 . . . . 0.0 111.789 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.8 mtt -107.3 115.6 30.46 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 109.125 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.96 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.482 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -125.08 144.71 50.27 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.158 1.479 . . . . 0.0 111.079 -178.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.9 mt -147.48 139.51 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.199 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.664 ' NH2' ' CE2' ' A' ' 57' ' ' PHE . 40.4 ttp180 -127.61 138.59 52.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 110.437 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.704 ' O ' ' N ' ' A' ' 172' ' ' THR . 8.4 ptm180 -97.11 92.5 6.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.787 ' O ' HG22 ' A' ' 171' ' ' ILE . 46.5 mt -31.89 75.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.704 ' N ' ' O ' ' A' ' 170' ' ' ARG . 19.4 m -113.44 69.61 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.864 -1.147 . . . . 0.0 109.786 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 174.06 107.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.251 -0.905 . . . . 0.0 109.65 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.3 mt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.652 179.844 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.269 0.557 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.4 166.9 1.21 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -155.74 143.47 19.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -1.055 . . . . 0.0 110.724 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.557 HD13 ' CD2' ' A' ' 43' ' ' PHE . 20.5 tt -135.61 135.34 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.203 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.18 122.97 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.691 -0.631 . . . . 0.0 109.338 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -88.84 151.56 22.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 108.652 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -138.07 137.85 38.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 109.387 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -73.5 -43.95 58.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -0.833 . . . . 0.0 110.647 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 60.7 m-20 -81.69 156.77 24.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.838 -1.164 . . . . 0.0 110.535 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -70.71 -37.13 73.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -80.63 35.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 54.55 55.7 7.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.614 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -139.09 -151.84 5.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 59.85 -147.26 43.97 Favored Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.178 -1.189 . . . . 0.0 110.155 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -77.81 129.77 35.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.396 -1.061 . . . . 0.0 109.084 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -112.47 156.22 22.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.845 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -145.21 123.26 12.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 108.821 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -97.71 118.77 35.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -112.77 136.67 52.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.4 mtp -130.1 6.56 4.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.2 p -149.74 170.98 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 110.156 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.511 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 55.8 p30 -63.77 151.12 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 t -143.47 120.64 11.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -6.82 57.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.944 -1.097 . . . . 0.0 109.879 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -140.09 94.28 2.74 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 108.817 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.3 mt -91.06 -19.59 22.99 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.109 -0.994 . . . . 0.0 108.42 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 42.5 t-80 -56.27 -36.53 68.69 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.92 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.1 t -53.57 -56.4 17.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -60.53 -49.67 76.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 0.0 111.065 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 32.4 p90 -152.93 151.86 30.82 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.111 -0.993 . . . . 0.0 110.503 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -100.14 -7.26 25.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.334 -0.854 . . . . 0.0 110.102 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -152.73 151.46 30.54 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.478 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 43.3 t -157.44 120.41 3.97 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.518 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 18.0 m-70 -102.7 -4.03 25.66 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -137.84 139.33 39.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.795 -1.19 . . . . 0.0 111.063 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.7 mt -132.97 142.94 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -134.47 106.13 6.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.872 -1.143 . . . . 0.0 111.323 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.75 117.09 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -83.37 -31.97 26.45 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.364 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 t -172.23 154.8 3.42 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.168 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.92 -131.66 10.75 Favored Glycine 0 N--CA 1.486 2.007 0 CA-C-O 122.565 1.091 . . . . 0.0 111.47 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.7 m -154.1 152.66 30.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.557 ' CD2' HD13 ' A' ' 4' ' ' ILE . 11.1 t80 -146.77 139.2 24.92 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.556 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.9 tpt -109.99 123.53 49.81 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.663 ' HB ' HG11 ' A' ' 76' ' ' VAL . 16.6 m -114.19 145.82 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.916 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.8 m-85 -121.12 141.76 50.5 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.798 0.808 . . . . 0.0 111.224 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 24.5 t0 -76.77 -10.54 59.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.913 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.144 ' O ' ' OG ' ' A' ' 78' ' ' SER . 18.3 ttm180 -127.56 167.39 16.41 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 44.2 p -78.47 159.19 28.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 110.911 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.61 33.4 3.91 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.649 -0.657 . . . . 0.0 110.958 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.484 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.2 m-85 60.38 57.23 2.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.972 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.0 mmt -143.64 173.3 11.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.137 -0.977 . . . . 0.0 110.385 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.98 -162.69 39.18 Favored Glycine 0 N--CA 1.503 3.123 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 59.0 mtp180 -60.48 119.75 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 108.051 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -102.11 133.82 46.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.06 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 66.2 m-85 -123.16 133.67 54.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.059 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -98.18 117.49 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.221 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.3 mt -118.66 117.55 29.25 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.021 -1.05 . . . . 0.0 110.729 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.502 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.6 ptm180 -92.95 164.62 13.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.244 -0.91 . . . . 0.0 110.772 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.502 ' C ' ' O ' ' A' ' 59' ' ' ARG . 34.0 ttp180 -32.12 116.07 0.19 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.638 -0.664 . . . . 0.0 110.727 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.89 167.75 31.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 79.0 mt-10 -106.99 130.11 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -1.062 . . . . 0.0 108.925 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -114.31 91.42 23.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.573 -0.705 . . . . 0.0 109.551 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 25.7 Cg_exo -59.09 -14.43 23.47 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.641 2.227 . . . . 0.0 112.429 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -169.3 146.34 3.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.897 -1.127 . . . . 0.0 108.088 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 16.6 p90 -148.94 -9.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.505 -1.372 . . . . 0.0 111.725 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.518 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 15.4 mtt -63.62 -39.93 95.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.326 -1.484 . . . . 0.0 110.099 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -92.14 -24.7 19.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.889 -1.132 . . . . 0.0 109.834 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -86.37 -8.88 57.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.527 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.585 ' SD ' ' CD1' ' A' ' 56' ' ' TYR . 19.7 mmt -111.29 -26.11 9.32 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . 80.97 49.24 5.71 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.9 mtp -127.4 154.0 45.55 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.177 -1.19 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 18.7 t-20 -107.01 60.32 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.092 -1.005 . . . . 0.0 109.014 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 7.6 p30 149.55 -169.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.478 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.2 p -98.89 -165.43 1.24 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 109.803 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.663 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.5 m -85.51 147.73 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -108.55 -10.9 15.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.716 -1.24 . . . . 0.0 108.154 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 1.144 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 2.5 p -148.34 164.48 33.93 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.92 -1.112 . . . . 0.0 109.696 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.85 151.23 16.11 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.88 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -136.72 140.35 42.58 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.331 0.586 . . . . 0.0 109.492 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 82' ' ' ILE . 51.5 ttm -96.33 157.39 15.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.202 -0.936 . . . . 0.0 108.606 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.76 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 77.5 mt -105.42 102.82 39.56 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.0 109.933 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.42 175.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.322 2.015 . . . . 0.0 112.075 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.2 mt -82.47 51.11 1.77 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.914 . . . . 0.0 109.727 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -101.19 87.54 3.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.232 -0.918 . . . . 0.0 109.719 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.655 ' HA ' ' H ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER -142.16 59.44 1.47 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 109.105 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.65 -62.13 6.68 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.68 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 96.6 p -138.12 162.51 34.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.534 -0.98 . . . . 0.0 110.136 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -112.01 116.57 30.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.818 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -171.39 129.35 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 38.3 ttm -117.94 126.32 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 109.609 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -102.19 120.96 41.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.527 HD23 ' SG ' ' A' ' 125' ' ' CYS . 13.7 mt -104.17 152.61 21.93 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.31 1.052 . . . . 0.0 112.696 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 99' ' ' MET . 24.6 m-85 -136.88 122.58 19.83 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -59.43 -22.88 62.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.439 -0.788 . . . . 0.0 111.814 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 124' ' ' SER . 4.9 m-70 -114.4 163.73 14.93 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.617 -1.302 . . . . 0.0 111.206 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.9 p -58.78 159.34 6.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 m-20 77.67 -92.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.603 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -169.48 39.05 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.66 -160.62 24.89 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.767 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 68.05 -147.88 48.34 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.87 133.79 38.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.111 -1.229 . . . . 0.0 109.369 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.2 ptt? -93.9 116.58 29.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 0.0 110.469 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 15.4 mtm -118.02 137.5 52.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.256 -0.902 . . . . 0.0 108.633 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -99.36 138.95 35.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 109.459 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 110' ' ' CYS . 1.0 OUTLIER -128.01 118.94 24.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.406 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 ttt -129.28 14.93 6.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.426 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.534 ' H ' HD23 ' A' ' 106' ' ' LEU . 5.2 p-10 -139.78 -170.35 2.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.943 . . . . 0.0 109.968 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.42 127.21 31.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.656 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -115.24 85.45 12.77 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.676 -179.362 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.89 -23.64 6.59 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.328 2.019 . . . . 0.0 112.047 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -133.92 87.13 2.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 10.9 mt -75.07 -34.63 61.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.211 -0.931 . . . . 0.0 110.343 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.74 -40.96 76.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -80.66 -23.44 39.67 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.188 -0.945 . . . . 0.0 110.571 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -81.12 -55.23 4.89 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.515 -1.366 . . . . 0.0 111.397 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -106.32 -1.38 23.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.041 -1.037 . . . . 0.0 110.351 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.3 m120 63.29 32.89 14.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.812 -1.18 . . . . 0.0 109.12 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.5 ptm -154.91 137.66 15.29 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.9 t -121.07 9.7 10.59 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.752 -0.592 . . . . 0.0 109.616 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 163' ' ' SER . 16.3 m-20 -135.78 95.54 3.25 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.657 -1.277 . . . . 0.0 113.52 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -105.18 137.4 43.01 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.334 -0.854 . . . . 0.0 108.771 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.62 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 22.0 m170 -98.38 1.45 46.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 111.345 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 125' ' ' CYS . 5.5 t -146.3 150.12 35.13 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.079 -1.638 . . . . 0.0 109.932 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 124' ' ' SER . 11.2 m -157.0 156.7 33.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.451 ' C ' ' CD2' ' A' ' 126' ' ' HIS . 6.0 t60 -142.3 138.77 31.54 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.004 -1.06 . . . . 0.0 109.067 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.64 126.79 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.05 -1.032 . . . . 0.0 109.56 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.486 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 84.0 mmm -76.58 -26.5 55.11 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.68 ' CB ' ' H ' ' A' ' 88' ' ' SER . 1.4 m-20 165.59 -168.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.655 ' H ' ' HA ' ' A' ' 86' ' ' HIS . . . 69.97 -173.8 37.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.76 ' CE1' ' CG2' ' A' ' 82' ' ' ILE . 38.4 m-70 -116.4 122.31 44.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.997 . . . . 0.0 109.241 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.57 121.01 43.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 111.551 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.639 HD23 HD11 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -96.8 123.7 40.57 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.0 t -109.87 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.983 -1.073 . . . . 0.0 110.813 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.567 ' CE1' HD12 ' A' ' 133' ' ' LEU . 85.1 m-85 -121.65 123.62 42.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.744 -0.597 . . . . 0.0 110.838 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 30.7 tt0 -58.64 -26.93 64.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' SER . 13.9 mt-30 -119.86 155.55 54.98 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.463 ' O ' ' OG1' ' A' ' 141' ' ' THR . 28.5 Cg_endo -63.11 -174.09 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.028 2.486 . . . . 0.0 113.356 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.0 m120 50.83 31.83 6.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.427 -0.796 . . . . 0.0 110.43 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.506 ' H ' ' CB ' ' A' ' 167' ' ' SER . 40.4 m-85 56.07 51.65 11.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.571 -0.706 . . . . 0.0 110.237 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 12.2 p -140.79 166.13 25.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 0.0 109.779 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.33 173.41 29.86 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -50.65 113.74 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -1.062 . . . . 0.0 108.655 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 50.4 mt-30 -84.0 136.13 34.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.453 -0.779 . . . . 0.0 110.062 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -119.87 125.01 47.47 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -88.07 107.41 18.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.1 mp -105.72 124.69 49.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.206 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 149' ' ' PRO . 0.5 OUTLIER -115.32 169.64 6.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 148' ' ' ARG . 3.6 Cg_exo -35.27 160.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.59 2.194 . . . . 0.0 112.127 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.99 -168.31 12.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -118.95 129.87 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.567 -0.96 . . . . 0.0 110.842 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 125' ' ' CYS . 63.1 m-85 -109.14 140.87 42.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.748 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 57.6 mtt85 -131.36 -8.32 3.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 112.694 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.5 m -169.48 177.46 4.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.026 -1.671 . . . . 0.0 111.152 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.609 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -60.02 -14.17 15.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.718 . . . . 0.0 109.428 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -91.64 0.97 57.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.12 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.748 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -90.05 -62.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 108.711 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -75.88 16.2 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.14 33.93 88.34 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.36 -161.07 31.41 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.94 -39.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.4 p -103.77 -160.96 0.8 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.1 t -145.18 7.57 1.18 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 136' ' ' GLU . 51.1 ttt-85 -64.39 79.74 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.003 -1.06 . . . . 0.0 111.926 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 60.9 mtt -103.16 116.2 32.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -110.72 -24.41 5.56 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.506 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -134.19 148.83 50.96 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.448 1.624 . . . . 0.0 111.252 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 mt -147.27 142.92 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.07 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -129.61 141.8 50.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.381 -0.825 . . . . 0.0 111.035 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 172' ' ' THR . 18.8 ptt180 -95.44 88.3 5.05 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.72 0.771 . . . . 0.0 108.992 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.643 ' O ' HG22 ' A' ' 171' ' ' ILE . 57.5 mt -54.72 81.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.434 -0.791 . . . . 0.0 111.607 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 170' ' ' ARG . 11.8 m -94.29 64.61 3.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.834 -1.166 . . . . 0.0 109.37 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -94.64 -120.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.307 1.051 . . . . 0.0 109.797 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.7 mt . . . . . 0 C--N 1.283 -2.326 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.794 -179.676 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.1 mmm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . -55.49 159.52 6.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 87.1 mttt -161.16 146.77 14.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.713 -0.875 . . . . 0.0 110.533 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 36' ' ' ILE . 20.8 tt -134.63 135.87 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.808 . . . . 0.0 109.899 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.6 mt -122.19 127.18 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.699 -0.625 . . . . 0.0 109.788 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.617 ' CE2' HD12 ' A' ' 36' ' ' ILE . 84.4 m-85 -88.95 160.05 17.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -148.2 136.05 20.92 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.82 -1.175 . . . . 0.0 108.731 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -76.69 -39.14 53.02 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 111.114 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -81.73 163.01 22.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.779 -1.201 . . . . 0.0 110.57 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -75.92 -46.65 28.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -80.61 44.13 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.056 -1.028 . . . . 0.0 109.761 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 53.44 70.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.51 -156.4 7.6 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.05 -147.43 44.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -75.01 125.82 29.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -1.191 . . . . 0.0 109.247 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -110.9 153.92 24.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -144.89 125.25 13.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.509 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -97.4 121.65 39.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.0 m -120.43 141.22 50.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 109.599 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -140.92 12.24 2.24 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.0 m -146.01 160.77 41.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.663 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -58.12 148.34 26.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 110.517 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.42 116.53 10.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.33 -4.47 58.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 108.729 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 31.4 p-10 -136.08 99.84 4.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.624 -0.673 . . . . 0.0 109.656 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.2 mt -103.78 -24.62 13.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.286 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.406 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 34.5 t-80 -57.74 -40.39 79.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 108.75 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -50.28 -50.33 50.69 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -65.45 -52.12 55.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -0.994 . . . . 0.0 110.916 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.2 150.29 29.68 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.003 -1.06 . . . . 0.0 110.376 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.406 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 43.6 m-20 -95.81 -5.63 41.35 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.186 -0.946 . . . . 0.0 110.426 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -156.81 155.56 31.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.095 -1.003 . . . . 0.0 108.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.547 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 33.0 t -158.04 117.02 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -97.53 -2.87 40.91 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.724 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.501 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 9.7 t -142.71 149.27 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.759 -1.213 . . . . 0.0 111.161 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 4' ' ' ILE . 18.5 tt -157.35 148.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.08 126.31 18.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.832 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.4 t -102.43 120.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -83.85 -29.04 27.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 109.084 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.2 t -169.78 152.75 4.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.863 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.93 -122.61 6.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 43' ' ' PHE . 29.8 t -171.47 169.57 6.12 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.583 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -154.6 142.24 19.85 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 108.904 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.8 mmm -102.03 118.11 36.23 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.7 ' HB ' HG11 ' A' ' 76' ' ' VAL . 18.2 m -109.2 144.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.914 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.489 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 58.8 m-85 -120.43 141.8 49.81 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.754 0.787 . . . . 0.0 111.563 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 29.9 t0 -76.09 -9.76 58.87 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.157 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.767 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.6 ttt180 -127.89 159.74 33.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.484 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 12.6 p -71.81 157.83 37.18 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.729 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 71.09 33.54 2.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.637 -0.664 . . . . 0.0 111.326 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CB ' ' NH2' ' A' ' 80' ' ' ARG . 1.9 m-85 59.59 56.33 3.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 109.757 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.1 mtt -143.49 172.05 13.32 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.48 -165.27 42.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.48 123.89 17.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.114 -1.227 . . . . 0.0 108.304 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 46' ' ' TYR . 6.7 tt0 -108.33 137.51 46.18 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.31 134.84 48.12 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.014 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.609 ' C ' HD12 ' A' ' 58' ' ' LEU . 20.1 p90 -96.04 120.98 37.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 57' ' ' PHE . 10.0 mp -111.42 113.52 26.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.059 -1.026 . . . . 0.0 111.532 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.4 ptt180 -86.13 161.08 19.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 111.034 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 59' ' ' ARG . 40.5 ttp85 -37.8 118.62 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.582 0.706 . . . . 0.0 110.365 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.98 178.09 41.29 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.79 129.34 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.09 100.21 53.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.16 -6.01 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.169 1.913 . . . . 0.0 112.619 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 34.4 p-10 -168.71 136.54 2.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.328 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 36.6 p90 -148.93 24.0 0.95 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.596 -1.315 . . . . 0.0 111.298 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.1 mmt -89.13 -39.71 13.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.673 -1.267 . . . . 0.0 108.902 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -99.28 -17.09 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.0 109.458 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 -12.62 45.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.26 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.2 mtt -115.74 -27.62 7.0 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 108.895 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.92 48.37 5.81 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.328 -0.858 . . . . 0.0 111.14 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.0 ttm -120.92 138.54 54.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.932 -1.334 . . . . 0.0 109.819 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.0 t30 -90.7 56.65 3.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.048 -1.033 . . . . 0.0 109.277 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.1 p30 151.79 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.547 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.2 p -98.61 -166.96 1.43 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.927 0.87 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.7 HG11 ' HB ' ' A' ' 45' ' ' VAL . 6.4 m -81.34 147.3 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.484 ' HB3' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -105.77 -11.51 16.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.767 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -151.47 170.61 19.17 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.787 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 78' ' ' SER . 26.6 p -162.3 146.13 11.91 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.998 0.904 . . . . 0.0 110.4 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.628 ' NH1' ' NH2' ' A' ' 148' ' ' ARG . 41.2 ttm180 -132.83 139.76 47.63 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.3 ttp -94.53 152.42 18.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 24.3 mt -92.02 120.11 67.98 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 108.634 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.15 155.36 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.026 1.817 . . . . 0.0 112.116 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.7 50.17 1.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.319 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.501 ' NE2' ' OD2' ' A' ' 129' ' ' ASP . 85.9 t60 -108.12 123.71 49.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.358 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -137.81 86.05 2.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 0.0 109.999 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -101.67 -75.76 1.14 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 80.8 p -144.98 169.37 18.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -1.054 . . . . 0.0 110.391 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -121.06 125.84 48.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.186 -0.947 . . . . 0.0 110.4 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.529 ' CE ' ' SD ' ' A' ' 128' ' ' MET . 33.1 ttpt -168.38 129.07 1.28 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.577 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 39.8 ttm -120.17 135.22 55.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 109.088 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -105.74 120.24 41.19 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 125' ' ' CYS . 14.8 mt -103.05 149.49 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.156 0.979 . . . . 0.0 112.128 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 99' ' ' MET . 42.0 m-85 -133.8 124.71 27.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 87.7 tt0 -63.7 -26.15 68.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.553 ' O ' ' HB3' ' A' ' 124' ' ' SER . 45.6 m170 -110.38 164.39 12.73 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.602 -1.311 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.8 p -61.19 157.84 15.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 110.046 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 97' ' ' SER . 0.8 OUTLIER 81.4 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.2 mmt -162.57 35.5 0.11 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.33 -153.79 24.03 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.081 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 58.56 177.95 0.87 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.423 ' O ' ' CE ' ' A' ' 104' ' ' MET . 28.2 mmt180 -64.25 136.21 56.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.24 . . . . 0.0 109.273 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.2 ptt? -98.11 122.47 41.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.993 -1.067 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.423 ' CE ' ' O ' ' A' ' 102' ' ' ARG . 3.8 mtm -118.87 138.93 52.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.45 138.5 40.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.616 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 ' CZ3' ' A' ' 132' ' ' TRP . 5.6 tp -127.84 118.61 24.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.168 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.81 -11.09 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 0.0 109.728 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.32 -159.65 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -0.934 . . . . 0.0 109.86 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.83 137.49 32.28 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -116.06 87.28 18.69 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.338 -0.851 . . . . 0.0 109.578 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.5 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.7 Cg_endo -78.09 -27.06 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.089 1.859 . . . . 0.0 112.249 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -134.16 84.1 2.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.5 mt -67.94 -26.27 65.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.004 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.4 tpt -57.67 -40.02 78.43 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.272 -0.893 . . . . 0.0 109.074 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -82.85 -23.43 33.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -77.36 -62.36 1.68 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.644 -1.285 . . . . 0.0 110.9 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.492 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.0 m-85 -105.73 4.48 30.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.7 t-20 52.57 32.72 12.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.65 -1.281 . . . . 0.0 107.612 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.453 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 5.4 ttp -147.23 132.01 17.96 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 27.8 t -115.26 4.68 14.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 110.223 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 120' ' ' SER . 14.7 m-20 -132.63 101.08 5.16 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 118.416 -1.314 . . . . 0.0 114.052 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -111.76 135.48 52.32 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -96.1 2.06 52.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 111.388 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.0 t -149.86 156.34 41.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.928 -1.733 . . . . 0.0 110.694 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.577 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 11.1 t -164.29 163.05 22.71 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.243 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.577 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 13.6 t60 -150.07 146.61 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.169 -0.957 . . . . 0.0 109.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.454 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.1 t -115.95 125.02 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 108.96 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.529 ' SD ' ' CE ' ' A' ' 90' ' ' LYS . 17.9 ttt -81.26 -32.55 33.25 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 130' ' ' GLY . 13.6 t70 -174.4 175.0 2.68 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.537 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 77.11 -140.66 25.03 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.469 ' CE1' ' CG2' ' A' ' 82' ' ' ILE . 95.4 m-70 -151.8 135.37 16.18 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.548 -0.971 . . . . 0.0 109.284 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TRP . . . . . 0.485 ' CZ3' HD23 ' A' ' 106' ' ' LEU . 87.0 m95 -127.39 133.16 50.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.119 -0.988 . . . . 0.0 112.212 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 mt -106.02 134.45 49.12 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 55.0 t -111.12 144.19 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.985 -1.072 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -122.13 124.02 42.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.619 -0.675 . . . . 0.0 111.124 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.5 tt0 -57.49 -27.41 62.5 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -118.52 155.8 51.81 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.45 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 23.4 Cg_endo -61.47 -179.64 0.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.271 2.647 . . . . 0.0 113.781 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.601 ' N ' ' OG ' ' A' ' 167' ' ' SER . 13.6 m120 49.82 35.14 8.66 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.696 0.76 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.714 ' H ' ' CB ' ' A' ' 167' ' ' SER . 7.7 m-85 57.33 51.42 10.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.758 -0.589 . . . . 0.0 110.378 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 142' ' ' GLY . 64.9 m -136.56 164.25 28.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 141' ' ' THR . . . 95.57 179.42 36.46 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.03 108.73 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -1.108 . . . . 0.0 108.808 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 6.2 pt20 -87.52 143.74 27.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.783 0.802 . . . . 0.0 110.46 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -125.2 144.32 50.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -104.57 103.57 13.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.302 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.7 mp -101.2 122.72 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.628 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 5.2 ptp180 -110.83 173.12 3.05 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 148' ' ' ARG . 68.3 Cg_exo -37.29 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.982 1.788 . . . . 0.0 112.113 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 126' ' ' HIS . . . 117.07 -166.16 12.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -123.86 136.91 54.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.335 -1.097 . . . . 0.0 110.631 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 21.2 m-85 -114.31 144.61 42.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.55 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 14.0 ptm180 -133.17 -1.66 3.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.084 . . . . 0.0 112.736 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.557 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 3.7 t -171.07 172.3 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.175 -1.578 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -62.84 -8.19 6.5 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.398 -0.814 . . . . 0.0 109.149 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -92.74 -1.14 57.07 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.172 -0.955 . . . . 0.0 108.819 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 154' ' ' SER . 10.5 m-20 -91.51 -60.08 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.7 p90 -76.45 16.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.54 40.24 96.0 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -104.56 -165.61 24.46 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.52 -39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.1 p -106.5 -161.41 0.79 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.3 p -137.56 5.62 2.69 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.474 -0.767 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 136' ' ' GLU . 70.5 ttt180 -66.79 75.8 0.11 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.889 -1.132 . . . . 0.0 112.142 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -100.5 116.93 33.6 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.095 . . . . 0.0 109.62 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.19 -25.77 4.9 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.714 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -134.2 151.51 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.361 -1.67 . . . . 0.0 111.562 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mt -146.69 140.95 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.692 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -126.9 144.17 51.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 171' ' ' ILE . 17.1 ptt180 -99.89 91.37 4.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.584 ' C ' ' O ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -32.78 104.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.329 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 170' ' ' ARG . 49.6 m -114.74 67.03 0.68 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -147.91 91.18 1.91 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.2 tp . . . . . 0 C--N 1.3 -1.586 0 CA-C-O 117.89 -1.053 . . . . 0.0 109.264 179.568 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.04 164.95 0.22 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -148.26 136.17 20.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.56 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.3 mm -122.46 119.65 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.509 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.1 mt -113.41 117.17 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.205 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.76 132.42 36.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.559 -0.713 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.11 130.19 56.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.739 -1.226 . . . . 0.0 109.889 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.11 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.66 -0.65 . . . . 0.0 109.952 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -80.96 158.43 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 109.703 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -78.86 -37.75 39.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -84.44 43.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.986 . . . . 0.0 109.813 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 52.68 75.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.53 -171.03 34.74 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.25 -148.41 31.19 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -78.39 115.79 18.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 0.0 108.928 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -96.74 156.42 16.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.486 -0.759 . . . . 0.0 109.986 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.621 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.9 t60 -145.14 126.65 15.04 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.154 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -96.62 118.92 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -117.26 133.0 56.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.185 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -138.05 6.18 2.61 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 109.386 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -138.56 150.66 46.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.206 -0.934 . . . . 0.0 110.693 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 36.2 p-10 -47.27 144.92 2.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.46 -0.775 . . . . 0.0 110.034 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 25' ' ' ASP . 42.4 t -144.07 110.85 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.49 -17.32 49.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 108.6 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.457 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 t0 -126.73 100.72 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.488 HD11 ' SG ' ' A' ' 79' ' ' CYS . 14.5 mt -97.94 -14.48 20.61 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' SER . 18.7 t-80 -59.62 -41.32 90.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' HIS . 21.0 m -50.9 -57.28 8.91 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.621 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 52.6 m-85 -58.97 -53.52 57.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.634 -0.666 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -152.08 150.25 29.72 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.958 -1.089 . . . . 0.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -98.82 -2.18 38.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.834 . . . . 0.0 110.817 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -161.72 158.36 25.74 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.053 -1.029 . . . . 0.0 108.52 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 27.9 t -161.35 128.16 3.97 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -103.55 -20.64 13.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 109.723 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 t -134.04 146.4 50.32 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.996 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.54 143.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -129.42 113.45 14.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 111.34 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.32 114.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.53 -34.35 41.18 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.105 -0.997 . . . . 0.0 108.976 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 t -171.52 159.39 5.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.902 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.04 179.37 52.84 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.16 158.18 18.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.723 -0.869 . . . . 0.0 109.822 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -147.63 137.34 22.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.812 -1.18 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.6 tpt -107.05 127.83 53.82 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.645 ' HB ' HG11 ' A' ' 76' ' ' VAL . 16.7 m -118.53 144.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.945 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 33.5 m-85 -120.39 143.22 48.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.712 0.768 . . . . 0.0 111.334 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 28.4 t0 -77.99 -12.18 59.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.741 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.1 ttm180 -126.54 156.41 40.86 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 p -71.4 151.37 44.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.542 -0.724 . . . . 0.0 111.078 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 t30 76.1 36.23 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.814 -0.554 . . . . 0.0 111.22 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 80' ' ' ARG . 7.1 m-85 59.51 56.3 3.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.0 mtt -144.98 173.75 11.61 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.071 -1.018 . . . . 0.0 110.722 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.27 -165.88 45.43 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.32 124.52 20.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -106.85 133.82 50.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.84 137.95 54.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -101.25 116.64 33.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -0.831 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.0 mt -117.49 117.33 29.16 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.004 -1.06 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.521 ' O ' ' C ' ' A' ' 60' ' ' ARG . 37.4 ptt180 -99.67 163.98 12.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.435 -0.791 . . . . 0.0 111.332 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 59' ' ' ARG . 67.5 ttt180 -27.49 111.43 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.465 0.65 . . . . 0.0 110.741 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.69 170.5 36.51 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -107.74 124.86 50.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -105.87 100.46 27.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.12 -18.81 26.94 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.401 2.067 . . . . 0.0 113.221 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.31 140.6 3.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 108.403 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.1 p90 -148.59 29.24 0.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.746 -1.221 . . . . 0.0 110.432 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.4 mmt -98.19 -42.99 7.18 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.095 . . . . 0.0 109.092 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -100.63 -15.9 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 m -86.65 -16.53 36.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.196 -0.94 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.1 mtt -114.57 -28.23 7.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.0 108.621 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.86 52.64 4.03 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.9 mtp -120.91 140.54 51.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -1.03 . . . . 0.0 109.493 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 50.5 t30 -94.29 54.13 1.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.914 -1.116 . . . . 0.0 109.334 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.55 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.5 p -95.22 -167.25 1.59 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.033 -1.042 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.4 m -80.78 145.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -104.42 -14.67 15.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.741 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -139.97 165.48 27.22 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.155 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 78' ' ' SER . 12.4 m -161.0 145.9 13.98 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.623 0.725 . . . . 0.0 110.114 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.689 ' NH1' ' HE ' ' A' ' 148' ' ' ARG . 43.0 ttm180 -134.45 137.24 43.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.661 -0.65 . . . . 0.0 109.33 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 52.3 ttp -92.34 152.96 19.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.214 -0.929 . . . . 0.0 109.024 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.1 mt -106.31 126.14 31.21 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -75.43 154.63 40.63 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.182 1.921 . . . . 0.0 112.12 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.1 mt -77.09 48.33 0.6 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.863 . . . . 0.0 109.136 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -88.1 122.82 32.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.4 -0.812 . . . . 0.0 109.446 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -134.68 82.2 1.95 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.211 -0.931 . . . . 0.0 110.268 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.78 -94.31 1.66 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.5 m -115.8 141.59 47.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.581 -0.952 . . . . 0.0 109.829 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.85 110.38 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -166.0 130.32 2.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 44.4 ttm -110.9 130.1 55.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 109.217 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.519 HH21 ' CD2' ' A' ' 126' ' ' HIS . 78.2 mtm180 -104.23 113.85 27.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.8 mt -99.37 146.65 26.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.036 0.922 . . . . 0.0 111.98 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 36.5 m-85 -131.52 125.8 33.31 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.466 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 62.2 tt0 -63.58 -27.09 69.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.261 -0.899 . . . . 0.0 112.198 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.826 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.7 m-70 -109.24 161.06 15.6 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.488 -1.382 . . . . 0.0 111.674 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 76.8 p -59.48 160.49 6.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.814 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 28.1 t0 81.23 -91.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.442 ' H ' ' HB3' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -171.01 40.76 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.29 -152.44 11.69 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 64.04 -174.76 11.77 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -73.22 139.45 46.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 8.3 ptp -97.35 117.47 31.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.09 -1.006 . . . . 0.0 110.36 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 104' ' ' MET . 2.8 mpp? -111.81 138.63 48.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -106.57 136.9 45.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.822 . . . . 0.0 109.997 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 tp -130.37 121.91 26.85 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.424 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 11.2 ttt -121.21 6.28 10.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.368 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 107' ' ' MET . 78.4 m-20 -134.99 -163.33 1.36 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.337 -0.852 . . . . 0.0 109.832 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 168' ' ' ILE . 64.0 t0 -86.25 133.33 33.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -115.19 90.21 23.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.862 . . . . 0.0 109.797 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -78.66 -26.76 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.066 1.844 . . . . 0.0 111.733 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -135.01 86.7 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.425 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.8 mt -67.91 -27.55 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.2 mmt -55.48 -38.18 68.8 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.775 0.798 . . . . 0.0 109.041 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.69 -22.33 26.13 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.167 -0.958 . . . . 0.0 110.927 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.421 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 62.3 ttm-85 -80.51 -60.22 2.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.469 -1.394 . . . . 0.0 111.426 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -108.53 -0.2 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 110.085 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.1 t-20 55.83 34.39 23.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 0.0 108.384 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ptm -152.22 136.8 16.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.2 m -123.75 9.46 8.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.977 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m-20 -131.11 97.73 4.37 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 118.469 -1.292 . . . . 0.0 113.26 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -112.23 137.11 50.8 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.002 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.543 ' N ' ' ND1' ' A' ' 123' ' ' HIS . 1.3 m80 -96.17 6.69 48.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 111.147 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.826 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 3.7 p -154.55 158.59 40.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.915 -1.741 . . . . 0.0 110.348 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.1 t -168.62 168.04 11.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.27 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.564 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 17.5 t60 -152.67 148.38 27.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.323 -0.861 . . . . 0.0 109.337 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.451 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 52.9 t -114.93 124.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.73 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 77.9 mmm -74.82 -25.27 58.9 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.508 0.67 . . . . 0.0 109.394 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.8 OUTLIER 167.67 179.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.088 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.94 -137.66 22.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.437 ' HB3' HD12 ' A' ' 171' ' ' ILE . 93.2 m-70 -153.98 130.51 10.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.623 -0.927 . . . . 0.0 109.185 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -119.5 130.36 55.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.233 -0.917 . . . . 0.0 111.962 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.468 HD23 HD11 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -103.87 128.21 51.36 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 48.7 t -111.01 144.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.718 -1.239 . . . . 0.0 111.224 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.74 126.12 48.17 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.833 -0.542 . . . . 0.0 111.249 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.1 -27.54 68.44 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.853 ' O ' ' OG ' ' A' ' 167' ' ' SER . 27.9 mt-30 -120.25 152.87 55.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 19.0 Cg_endo -59.96 -175.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.283 2.655 . . . . 0.0 113.523 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m120 49.99 31.82 5.13 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.538 0.685 . . . . 0.0 109.93 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.469 ' H ' ' CB ' ' A' ' 167' ' ' SER . 13.9 m-85 56.08 52.68 10.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.103 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 142' ' ' GLY . 86.9 m -139.57 164.59 29.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.71 177.68 32.36 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -54.08 109.56 0.49 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 108.752 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -86.99 147.02 25.91 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.049 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.81 140.46 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -101.19 104.73 15.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 109.708 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.8 mp -99.76 120.5 39.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 0.0 109.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.689 ' HE ' ' NH1' ' A' ' 80' ' ' ARG . 4.1 ptt85 -109.48 163.6 16.68 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 148' ' ' ARG . 80.9 Cg_exo -31.78 158.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.801 2.334 . . . . 0.0 112.534 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 126' ' ' HIS . . . 114.72 -166.45 12.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.62 132.54 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.396 -1.061 . . . . 0.0 110.485 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.504 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 84.9 m-85 -105.76 143.1 34.38 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.661 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 63.2 mtm-85 -125.91 -10.86 6.61 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 112.95 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.563 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.7 t -173.65 -179.17 1.76 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.891 -1.756 . . . . 0.0 111.172 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -62.21 -15.26 45.5 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -88.1 0.05 56.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 108.565 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -58.53 2.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.716 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.571 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.6 p90 -77.51 13.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.723 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 69.12 39.37 83.65 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -110.09 -161.68 18.64 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.6 t -143.06 -39.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 31.3 p -109.03 -152.28 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.8 p -146.35 9.29 1.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.522 -0.736 . . . . 0.0 109.852 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -65.98 81.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.002 -1.061 . . . . 0.0 111.989 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.8 mtt -105.73 118.18 35.92 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.936 -1.102 . . . . 0.0 109.708 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.33 -24.45 6.2 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.853 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -136.7 152.01 49.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.52 -1.576 . . . . 0.0 111.276 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 16.3 mt -147.62 142.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -128.95 144.6 51.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.46 -0.775 . . . . 0.0 110.662 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.695 ' O ' ' N ' ' A' ' 172' ' ' THR . 19.3 ptt180 -94.6 76.16 3.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.457 -0.777 . . . . 0.0 109.751 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 170' ' ' ARG . 36.5 mt -19.5 72.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 170' ' ' ARG . 3.8 t -111.56 71.59 0.75 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.963 -1.086 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 33.0 p-10 -177.19 102.35 0.05 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.179 -0.951 . . . . 0.0 110.185 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.379 179.916 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.553 0.692 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 3' ' ' LYS . . . -178.18 158.85 23.96 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 15.8 ptpt 176.82 157.37 0.3 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.253 -1.145 . . . . 0.0 110.466 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 43' ' ' PHE . 18.0 tt -136.59 135.06 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.529 0.681 . . . . 0.0 110.249 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.7 mt -117.48 124.36 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.644 -0.66 . . . . 0.0 109.412 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.23 161.27 18.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.332 -0.855 . . . . 0.0 108.721 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 29.1 m-85 -147.26 136.46 22.49 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.775 -1.203 . . . . 0.0 108.847 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -76.53 -39.66 52.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.76 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -81.25 138.73 35.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.874 -1.141 . . . . 0.0 110.22 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -59.66 -39.75 85.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.483 -0.76 . . . . 0.0 110.007 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -84.53 41.06 0.82 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 109.564 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 54.29 85.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.525 -0.734 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.51 -159.1 21.46 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -146.49 49.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.65 124.54 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -1.202 . . . . 0.0 109.318 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -109.38 157.08 19.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.408 -0.807 . . . . 0.0 109.804 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.739 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 16.1 t-160 -147.58 125.58 12.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.0 109.777 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -95.12 119.64 33.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.6 m -119.34 140.95 49.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 109.157 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttt -147.99 11.6 0.95 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.8 t -143.45 155.36 44.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.363 -0.835 . . . . 0.0 110.321 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -50.44 144.03 8.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.696 . . . . 0.0 110.229 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -144.55 116.87 8.48 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 4.67 51.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.009 . . . . 0.0 108.876 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 29.2 p30 -146.28 92.23 2.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.569 -0.707 . . . . 0.0 109.582 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 26' ' ' LEU . 74.3 mt -91.18 -19.99 22.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.529 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 11.7 t-80 -56.95 -33.2 66.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 108.825 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.3 t -57.84 -42.93 85.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.739 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 80.3 m-85 -74.96 -44.17 49.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.864 -1.147 . . . . 0.0 110.308 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.35 152.13 21.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 70.8 m-20 -98.11 -6.11 32.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.347 -0.846 . . . . 0.0 110.071 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -155.12 153.83 31.44 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.55 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 39.4 t -157.55 127.86 6.33 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -107.24 -4.48 18.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.709 -0.619 . . . . 0.0 109.627 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.42 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 2.0 p -138.66 139.61 38.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.899 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.75 145.67 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -138.09 114.51 10.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.798 -1.189 . . . . 0.0 111.497 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.13 119.46 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -84.72 -31.06 24.25 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.034 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -172.27 156.62 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.562 -1.255 . . . . 0.0 111.586 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.75 -159.67 46.22 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.0 m -125.3 164.03 21.25 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -1.206 . . . . 0.0 109.251 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD2' HD13 ' A' ' 4' ' ' ILE . 11.4 t80 -144.59 133.33 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.998 -1.064 . . . . 0.0 108.761 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.2 tpt -103.16 118.69 37.37 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 m -109.73 142.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.971 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.615 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.0 m-85 -117.94 136.64 53.35 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.681 0.753 . . . . 0.0 110.753 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.25 -9.32 58.58 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.127 ' O ' ' OG ' ' A' ' 78' ' ' SER . 53.6 ttt180 -130.17 156.36 44.71 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 77' ' ' ARG . 25.4 p -68.23 162.99 23.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.678 0.751 . . . . 0.0 110.964 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 t30 66.91 33.13 6.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.918 -0.488 . . . . 0.0 111.204 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.492 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.9 m-85 58.63 58.58 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.215 -0.928 . . . . 0.0 109.765 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.417 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 55.7 mtt -146.78 175.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.197 -0.94 . . . . 0.0 110.288 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 83.03 -166.33 44.43 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' NH2' ' OH ' ' A' ' 56' ' ' TYR . 77.5 mtp180 -58.26 123.63 16.71 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.221 -1.164 . . . . 0.0 108.024 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 5.8 mp0 -105.41 136.12 45.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.417 ' OH ' ' NH2' ' A' ' 54' ' ' ARG . 83.0 m-85 -128.96 129.72 45.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.534 -0.729 . . . . 0.0 109.749 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.644 ' C ' HD12 ' A' ' 58' ' ' LEU . 23.1 p90 -92.77 121.73 34.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.131 -0.98 . . . . 0.0 109.039 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 57' ' ' PHE . 9.3 mp -113.91 116.85 29.93 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.967 -1.083 . . . . 0.0 111.769 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.9 ttp85 -90.83 158.48 16.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.957 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 59' ' ' ARG . 37.3 ttp180 -30.58 116.09 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.31 0.576 . . . . 0.0 110.744 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.38 168.77 32.66 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -107.32 129.87 54.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -1.022 . . . . 0.0 108.786 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -110.19 100.36 43.7 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.44 -14.16 33.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -170.67 141.47 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.8 p90 -146.71 40.27 1.08 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.653 -1.279 . . . . 0.0 109.805 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.9 mmt -103.21 -48.47 4.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.222 -0.924 . . . . 0.0 109.32 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -100.69 -13.01 18.69 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.3 m -89.98 -15.8 31.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.458 -0.776 . . . . 0.0 109.763 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.4 mtt -117.22 -29.36 5.92 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.41 52.38 3.59 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.445 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.8 mtp -122.88 141.07 52.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.982 -1.305 . . . . 0.0 110.221 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.2 m120 -95.85 55.86 1.66 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 0.0 109.253 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.0 p30 150.56 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.55 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.7 p -99.44 -168.61 1.64 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.132 0.967 . . . . 0.0 109.712 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 46' ' ' TYR . 27.2 t -77.0 141.46 15.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 49' ' ' THR . 66.2 mtt180 -106.28 -17.17 14.38 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 1.127 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -145.24 166.68 24.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.295 -0.878 . . . . 0.0 109.48 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 20.9 p -162.44 149.7 13.68 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.921 0.867 . . . . 0.0 110.744 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -129.73 138.9 51.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 ttp -94.6 148.96 21.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.033 -1.042 . . . . 0.0 109.086 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.3 mt -104.38 133.78 20.03 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.09 147.53 67.39 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.892 1.728 . . . . 0.0 112.059 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.626 ' N ' HD22 ' A' ' 84' ' ' LEU . 3.5 mm? -83.49 46.25 1.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.287 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -112.46 130.87 55.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.552 -0.717 . . . . 0.0 109.448 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -136.16 93.6 2.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.806 . . . . 0.0 109.371 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.83 -86.3 1.01 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.447 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.2 m -124.51 151.78 44.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.534 -0.98 . . . . 0.0 110.451 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.86 119.78 37.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -170.14 128.59 0.88 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.4 ttm -113.08 126.5 55.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 109.288 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -100.73 117.74 35.43 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.482 HD23 ' CB ' ' A' ' 125' ' ' CYS . 19.7 mt -101.38 150.29 23.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.389 1.09 . . . . 0.0 112.568 -177.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -131.2 122.23 26.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 76.4 tt0 -62.49 -27.94 69.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 111.374 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.9 m-70 -109.88 164.19 12.82 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.767 -1.208 . . . . 0.0 111.542 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 44.2 m -61.77 159.5 13.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.54 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.548 ' O ' ' CG ' ' A' ' 99' ' ' MET . 5.4 m-20 80.28 -98.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' ASP . 23.2 mtt -163.82 45.49 0.11 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.04 -151.25 10.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 61.67 -171.73 8.75 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 89.0 mtt-85 -73.09 131.82 42.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.933 -1.334 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 25.1 mtm -91.62 120.92 32.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 12.1 mtm -119.41 140.06 51.02 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.145 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -105.85 136.93 44.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.38 120.86 24.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 10.0 ttt -120.69 15.67 11.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.734 . . . . 0.0 109.374 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -144.1 -163.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.875 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.418 ' CG ' ' OH ' ' A' ' 140' ' ' TYR . 47.5 t0 -85.1 133.02 34.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -119.64 84.57 30.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.401 -0.812 . . . . 0.0 109.959 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.89 -29.87 6.48 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.282 1.988 . . . . 0.0 112.131 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.516 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 35.1 p30 -127.5 81.39 2.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.427 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.8 mt -66.72 -24.06 66.19 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 2.6 ttm -60.77 -38.57 85.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.548 0.69 . . . . 0.0 109.57 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -84.13 -20.81 31.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.657 -1.277 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 63.0 ttm-85 -82.22 -58.86 2.76 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.622 -1.299 . . . . 0.0 111.212 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -107.69 0.82 22.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.979 . . . . 0.0 109.807 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 114' ' ' MET . 15.8 t30 60.12 34.17 21.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.0 109.361 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.1 ptm -152.33 137.91 17.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -118.43 8.55 12.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.869 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.46 ' C ' ' OD1' ' A' ' 121' ' ' ASP . 6.5 t0 -134.99 93.77 3.05 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.293 -1.363 . . . . 0.0 113.376 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -103.13 136.76 42.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.418 -0.801 . . . . 0.0 109.106 177.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -97.09 3.21 51.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 111.725 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.6 t -160.25 163.18 33.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.656 -1.902 . . . . 0.0 110.763 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.482 ' CB ' HD23 ' A' ' 93' ' ' LEU . 2.2 p -174.55 178.18 2.0 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 8.4 t60 -154.12 147.68 25.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.484 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 54.6 t -112.83 121.88 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.446 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 12.0 tpt -69.32 -33.98 73.97 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.1 m-20 173.32 166.38 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.433 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.96 -146.32 19.09 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.461 ' CG ' ' OH ' ' A' ' 146' ' ' TYR . 54.4 m-70 -141.48 129.05 21.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.906 . . . . 0.0 110.061 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -122.08 131.05 53.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.538 -0.726 . . . . 0.0 111.931 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.2 mt -101.82 130.84 48.35 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.5 t -110.47 142.38 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.913 -1.117 . . . . 0.0 109.81 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.73 125.23 49.18 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.696 -0.627 . . . . 0.0 111.312 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -24.63 63.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 167' ' ' SER . 4.3 mt-30 -126.86 154.47 76.12 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.29 -0.881 . . . . 0.0 109.001 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.14 -173.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 123.161 2.574 . . . . 0.0 113.87 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.428 ' O ' ' OD1' ' A' ' 139' ' ' ASN . 18.6 t-20 45.89 29.73 0.77 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.468 0.651 . . . . 0.0 110.702 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.467 ' H ' ' CB ' ' A' ' 167' ' ' SER . 34.2 m-85 59.21 48.81 9.89 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.093 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 142' ' ' GLY . 61.7 m -131.64 162.24 30.84 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 108.917 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 141' ' ' THR . . . 96.61 174.52 35.35 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.558 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -54.15 110.58 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.88 -0.776 . . . . 0.0 109.387 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.3 OUTLIER -86.56 145.74 26.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.582 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -127.67 132.07 49.73 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.494 0.664 . . . . 0.0 109.283 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.461 ' OH ' ' CG ' ' A' ' 131' ' ' HIS . 70.6 t80 -92.44 107.34 19.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.462 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.0 mp -102.05 122.06 43.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.646 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -104.1 178.16 1.24 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -48.26 161.15 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.964 1.776 . . . . 0.0 111.672 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.16 -167.55 12.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.38 133.43 55.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.984 . . . . 0.0 110.455 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 96.4 m-85 -106.17 136.51 45.74 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.612 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 85.4 mtm-85 -123.86 -14.33 7.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.201 -0.937 . . . . 0.0 112.52 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.578 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 38.9 t -171.32 -177.98 2.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.027 -1.671 . . . . 0.0 110.99 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -63.98 -12.84 41.6 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.778 -0.576 . . . . 0.0 109.555 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -90.03 -1.2 57.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.971 -1.081 . . . . 0.0 108.55 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.612 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.1 m-20 -91.05 -60.53 1.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.526 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.2 p90 -76.51 16.84 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.03 38.71 95.75 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -103.78 -161.45 24.87 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.1 t -148.53 -40.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.3 p -103.41 -161.66 0.85 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 p -143.83 7.6 1.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.476 -0.765 . . . . 0.0 110.433 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -69.07 82.92 0.33 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.847 -1.158 . . . . 0.0 111.97 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.4 mtt -105.35 121.29 43.58 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.714 -1.241 . . . . 0.0 110.126 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.4 -25.82 3.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.467 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -130.04 152.03 49.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.653 -1.498 . . . . 0.0 111.388 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.5 mt -148.92 139.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 109.835 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -121.2 133.06 55.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.173 -0.954 . . . . 0.0 110.049 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 172' ' ' THR . 43.6 ttp180 -92.59 90.69 7.23 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.327 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 170' ' ' ARG . 95.6 mt -42.05 99.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 170' ' ' ARG . 12.0 m -146.69 64.81 1.18 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 172' ' ' THR . 1.5 m-20 176.13 106.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.598 0.714 . . . . 0.0 109.196 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 59.8 tp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.39 179.886 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.3 mmm . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . 73.22 155.44 3.22 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 62.0 mttm -163.95 146.03 9.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.525 -0.985 . . . . 0.0 109.553 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' A' ' 43' ' ' PHE . 9.5 mm -124.31 120.08 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.526 -0.734 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.5 mt -116.05 122.27 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.018 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -94.68 131.84 40.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -119.37 135.17 54.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -77.07 -22.97 52.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 111.218 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.649 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.2 t70 -83.21 150.48 26.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.702 -1.249 . . . . 0.0 110.295 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 45.9 mtt-85 -60.02 -44.49 94.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 31.7 m120 -74.52 -94.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.985 . . . . 0.0 109.29 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 35.0 m-85 -157.26 58.95 0.51 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 108.882 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.649 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -151.64 -150.74 5.42 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.46 -153.78 52.72 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -70.6 119.57 14.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 109.058 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -105.34 156.64 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.0 110.311 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.537 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.0 t60 -147.87 124.94 11.38 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.724 . . . . 0.0 109.216 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -98.36 118.33 34.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.54 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 m -114.45 136.5 52.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.7 ptm -134.71 9.73 3.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 p -147.1 163.06 37.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.451 -0.781 . . . . 0.0 110.555 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 41.9 p-10 -56.89 149.18 19.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.399 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.8 t -142.58 115.24 8.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.5 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.628 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 36.3 p30 -137.84 97.1 3.35 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.58 -19.69 18.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 108.44 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.542 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 19.2 t-80 -58.5 -39.52 80.28 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.288 -0.882 . . . . 0.0 109.266 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -51.03 -57.12 9.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.537 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 89.3 m-85 -58.58 -47.71 83.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.758 -0.589 . . . . 0.0 111.257 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -156.85 150.57 24.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.886 -1.134 . . . . 0.0 110.335 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 68.8 m-20 -97.21 -5.97 35.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.958 -1.089 . . . . 0.0 110.421 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -158.89 156.24 29.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 21.2 t -158.79 126.52 5.04 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -103.28 -0.78 29.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 3.7 m -146.04 144.23 29.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.513 -1.367 . . . . 0.0 111.152 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -138.44 143.09 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.88 107.31 8.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 0.0 111.051 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.9 114.88 29.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -77.71 -32.81 53.17 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.762 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -178.5 161.04 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.633 -1.227 . . . . 0.0 111.457 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.59 -153.12 21.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.2 m -133.97 153.59 51.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.479 ' HB2' HD11 ' A' ' 4' ' ' ILE . 12.5 t80 -148.03 141.13 24.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.571 -1.33 . . . . 0.0 109.415 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -108.74 122.16 46.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' TYR . 17.9 m -112.53 144.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.404 -0.81 . . . . 0.0 110.093 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.565 ' O ' HG13 ' A' ' 76' ' ' VAL . 36.1 m-85 -120.52 138.44 53.84 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.016 0.912 . . . . 0.0 111.375 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.62 -8.21 55.04 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.68 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.818 ' O ' ' HB3' ' A' ' 78' ' ' SER . 38.3 ttt180 -130.9 156.5 44.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.139 -0.976 . . . . 0.0 108.847 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -66.06 156.86 32.6 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.671 0.748 . . . . 0.0 111.402 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.95 33.74 3.4 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.618 -0.676 . . . . 0.0 111.586 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.495 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.5 m-85 59.84 58.65 2.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.573 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.409 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.7 mtt -145.96 171.16 15.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.988 -1.07 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.58 -165.43 36.93 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 120.657 -1.277 . . . . 0.0 110.566 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.47 121.22 10.97 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -102.67 134.64 45.7 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.443 ' O ' HG22 ' A' ' 45' ' ' VAL . 80.9 m-85 -126.54 131.48 51.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.686 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -94.76 117.77 30.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.506 -0.746 . . . . 0.0 109.736 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.0 mt -120.56 122.82 41.42 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.143 -0.973 . . . . 0.0 111.112 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.526 ' NH1' ' OG1' ' A' ' 172' ' ' THR . 33.4 ptt180 -103.68 168.1 9.36 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.574 0.702 . . . . 0.0 111.058 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.494 ' C ' ' O ' ' A' ' 59' ' ' ARG . 51.6 ttp180 -28.62 110.95 0.05 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.308 0.575 . . . . 0.0 110.911 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.39 31.47 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.533 -1.318 . . . . 0.0 109.957 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -104.41 126.56 51.61 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.408 -1.054 . . . . 0.0 108.422 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.36 96.98 24.18 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 10' ' ' ARG . 44.8 Cg_endo -70.05 -14.22 34.89 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.196 1.931 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -170.72 143.46 2.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 108.331 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.4 p90 -149.28 41.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.627 -1.296 . . . . 0.0 109.667 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.5 mmt -107.13 -46.43 3.9 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.335 -0.853 . . . . 0.0 109.407 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -100.23 -15.09 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -89.46 -14.46 35.3 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -115.37 -30.24 6.31 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.13 5.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.8 mtp -121.88 144.04 49.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.402 . . . . 0.0 109.401 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 81.9 m-20 -96.16 53.65 1.37 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.222 -0.923 . . . . 0.0 109.014 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.4 p30 152.86 -171.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.513 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.4 p -98.76 -168.1 1.59 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.781 0.8 . . . . 0.0 109.938 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 46' ' ' TYR . 22.5 t -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 45.2 mmm-85 -106.52 -16.71 14.46 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.755 -1.215 . . . . 0.0 107.898 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.818 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.68 164.3 33.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 109.485 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.416 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 26.3 p -161.03 150.64 17.06 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.242 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.43 136.86 39.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.9 ptm -90.62 158.18 17.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.44 135.15 20.33 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.615 -0.678 . . . . 0.0 110.233 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.09 154.16 66.72 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.286 1.99 . . . . 0.0 112.286 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.3 mt -73.42 51.44 0.34 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -86.2 113.92 22.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -139.97 60.15 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 0.0 109.475 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.72 -81.01 1.01 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m -134.97 158.04 45.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.507 -0.996 . . . . 0.0 109.969 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.11 114.41 27.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -161.2 123.41 3.05 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.635 ' SD ' HG22 ' A' ' 127' ' ' VAL . 7.5 tpp -107.99 125.35 51.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.022 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -99.53 111.72 24.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 103' ' ' MET . 20.7 mt -99.79 148.91 23.9 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.881 0.848 . . . . 0.0 112.474 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 99' ' ' MET . 26.1 m-85 -136.72 127.09 26.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.06 -23.55 67.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.402 -0.811 . . . . 0.0 112.386 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.5 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.9 m-70 -113.67 162.28 16.44 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.56 -1.338 . . . . 0.0 111.178 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 77.5 p -58.13 160.3 5.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.527 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 97' ' ' SER . 4.4 m-20 79.51 -90.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.547 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 1.8 mtm -175.37 38.66 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.51 -163.11 23.47 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.416 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 72.23 -146.61 39.64 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -99.39 139.34 35.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -1.198 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 3.6 ptt? -96.96 116.81 29.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.374 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.42 ' CE ' ' SD ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -104.98 137.18 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.126 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -99.1 122.32 42.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 108.666 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.9 tt -133.8 118.83 18.47 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 19.5 ptm -129.72 21.4 5.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 109.257 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.661 ' H ' HD23 ' A' ' 106' ' ' LEU . 22.9 p-10 -133.97 -166.86 1.86 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 37.4 p-10 -86.45 132.81 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 0.0 109.256 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -117.82 89.02 32.44 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.176 -0.952 . . . . 0.0 109.66 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.03 -20.95 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -139.97 85.14 2.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.4 mt -71.27 -26.78 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 110.057 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -56.16 -39.83 72.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.422 -0.799 . . . . 0.0 109.102 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.05 -21.76 29.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -80.32 -59.32 2.75 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.77 -1.207 . . . . 0.0 111.085 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -109.06 0.02 19.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.596 -0.69 . . . . 0.0 110.309 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 114' ' ' MET . 12.5 m120 56.49 32.52 20.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.476 1.131 . . . . 0.0 108.587 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.42 ' SD ' ' CE ' ' A' ' 104' ' ' MET . 9.7 ptm -153.29 137.73 16.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 47.2 m -124.86 11.25 8.36 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.466 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 120' ' ' SER . 52.2 m-20 -130.03 94.88 3.8 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.631 -1.293 . . . . 0.0 113.191 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.88 136.29 49.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -99.23 3.03 46.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 111.281 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.9 t -148.94 154.76 39.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.063 -1.648 . . . . 0.0 110.719 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.8 t -165.31 163.14 20.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 110.312 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.537 ' CD2' ' HG2' ' A' ' 151' ' ' GLU . 4.6 t-80 -147.66 145.08 28.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.416 -0.803 . . . . 0.0 108.893 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.635 HG22 ' SD ' ' A' ' 91' ' ' MET . 67.8 t -113.14 123.2 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 109.808 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 21.1 ttm -77.24 -23.34 51.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.749 -0.594 . . . . 0.0 109.854 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 170.73 178.47 0.06 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.595 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 73.53 -134.22 18.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.7 m-70 -162.07 139.77 8.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.693 -0.886 . . . . 0.0 108.857 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -131.05 142.45 50.3 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.115 -0.991 . . . . 0.0 112.256 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mt -110.59 134.04 52.77 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 46.3 t -112.29 142.54 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.907 -1.12 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -120.25 125.06 47.19 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.53 -26.78 65.62 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 167' ' ' SER . 7.5 mp0 -120.51 153.86 56.53 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.372 -0.83 . . . . 0.0 108.807 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 24.8 Cg_endo -60.92 -177.94 0.21 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.309 2.673 . . . . 0.0 113.873 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 51.05 33.3 8.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.442 ' H ' ' CB ' ' A' ' 167' ' ' SER . 23.4 m-85 56.46 51.23 11.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.649 -0.657 . . . . 0.0 110.009 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 142' ' ' GLY . 50.0 m -136.69 162.7 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.768 -0.582 . . . . 0.0 109.676 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.48 174.07 32.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.8 mmm-85 -51.56 109.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.469 -1.018 . . . . 0.0 108.99 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 6.9 pt20 -87.58 147.28 25.38 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.789 0.804 . . . . 0.0 110.089 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -129.74 143.2 50.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.558 ' OH ' ' CG ' ' A' ' 131' ' ' HIS . 91.8 t80 -103.73 106.85 17.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 109.556 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.7 mp -100.04 121.13 40.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.383 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.564 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -107.49 168.99 7.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.4 Cg_exo -36.69 164.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.159 1.906 . . . . 0.0 112.0 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.49 -164.23 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.537 ' HG2' ' CD2' ' A' ' 126' ' ' HIS . 17.6 mt-10 -122.84 131.46 53.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.761 -0.847 . . . . 0.0 110.812 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.564 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 23.4 m-85 -109.24 145.83 35.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.635 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 19.0 ptt-85 -137.55 -3.62 1.88 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.789 -1.195 . . . . 0.0 112.41 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.559 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 9.2 m -169.49 167.42 9.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.025 -1.672 . . . . 0.0 109.901 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -57.34 -9.91 1.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -88.62 -3.64 58.75 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.297 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.635 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 5.2 m-20 -89.64 -60.93 1.81 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 109.17 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.568 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 10.0 p90 -73.54 12.36 0.64 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 68.19 34.8 81.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.72 -160.38 30.88 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 t -149.16 -39.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.1 p -106.72 -156.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 18.7 p -139.09 3.24 2.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -63.98 77.11 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.218 -0.926 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.9 mtt -105.15 116.26 31.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.026 -1.046 . . . . 0.0 109.873 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.24 -24.59 5.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.69 149.33 52.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.59 -1.535 . . . . 0.0 111.286 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.456 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 18.8 mt -148.88 139.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.32 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.81 140.29 52.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.412 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 170' ' ' ARG . 27.5 ptt85 -94.79 70.46 3.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 108.977 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 172' ' ' THR . 5.3 mm 51.78 -141.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.389 -0.925 . . . . 0.0 109.304 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.631 ' H ' HG22 ' A' ' 171' ' ' ILE . 7.5 m -138.73 42.22 2.14 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.353 0.597 . . . . 0.0 109.49 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 172' ' ' THR . 57.0 t0 36.63 41.54 0.17 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.502 0.667 . . . . 0.0 109.805 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 117.873 -1.06 . . . . 0.0 108.981 179.524 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.341 0.591 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.95 147.96 0.03 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -147.47 139.74 24.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.523 -0.986 . . . . 0.0 110.202 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 4' ' ' ILE . 7.0 tp -125.72 122.35 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.452 -0.78 . . . . 0.0 109.24 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 HH21 ' A' ' 37' ' ' ARG . 70.4 mt -121.1 126.24 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.94 162.14 14.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.198 -0.939 . . . . 0.0 108.917 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 18.5 m-85 -145.98 135.39 23.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.678 -1.264 . . . . 0.0 108.744 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.71 -46.21 54.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 61.1 m-20 -76.53 148.92 36.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.835 -1.166 . . . . 0.0 110.345 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -64.7 -41.26 96.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.488 -0.758 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -87.18 45.08 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 52.95 90.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.93 -171.06 42.4 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 72.15 -141.63 31.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -83.46 123.61 29.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.967 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -107.77 159.94 16.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 109.765 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -142.63 123.47 14.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 108.921 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.85 121.39 42.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.044 -1.035 . . . . 0.0 109.371 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 140.39 50.04 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.774 0.797 . . . . 0.0 109.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 48.4 mtt -131.21 6.97 4.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.1 m -149.47 168.93 22.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -53.9 151.83 6.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.336 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.66 113.18 5.32 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.85 -7.71 39.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.12 -0.988 . . . . 0.0 109.41 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.35 99.19 5.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 26' ' ' LEU . 34.6 mt -110.0 -20.61 12.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.96 . . . . 0.0 108.905 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 28' ' ' SER . 33.9 t-80 -61.6 -47.15 86.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.061 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' HIS . 99.2 p -49.51 -55.46 13.23 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -56.14 -42.57 77.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.624 -0.673 . . . . 0.0 111.056 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 30.1 p90 -159.58 153.63 23.38 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.99 -1.069 . . . . 0.0 109.901 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -104.98 -8.49 18.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.218 -0.926 . . . . 0.0 110.718 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -149.37 149.01 30.18 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.992 -1.068 . . . . 0.0 108.734 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.541 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 37.0 t -155.3 125.02 6.47 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -108.51 -9.32 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.035 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.448 ' OG ' ' CB ' ' A' ' 7' ' ' TYR . 2.6 p -132.27 137.89 47.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 0.0 110.589 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -134.87 141.92 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.54 ' NE ' ' OE2' ' A' ' 39' ' ' GLU . 29.5 ttp180 -136.27 115.99 13.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.859 -1.151 . . . . 0.0 111.754 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.39 117.24 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 68.6 mm-40 -79.18 -35.39 41.95 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.944 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.7 t -174.31 161.94 3.53 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.903 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 177.83 51.14 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.9 m -98.47 148.79 23.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.952 . . . . 0.0 109.925 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.531 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 5.8 t80 -144.3 137.3 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.781 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 146' ' ' TYR . 50.1 mtp -113.23 128.67 56.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' HB ' HG11 ' A' ' 76' ' ' VAL . 21.6 m -114.22 144.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.117 -0.989 . . . . 0.0 109.896 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 76' ' ' VAL . 31.7 m-85 -121.5 139.93 52.85 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.734 0.778 . . . . 0.0 111.694 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -75.39 -6.59 50.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.558 -0.714 . . . . 0.0 109.473 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.893 ' O ' ' HB3' ' A' ' 78' ' ' SER . 19.6 ttm180 -131.86 158.3 41.69 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.5 p -70.5 158.5 35.96 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.688 0.756 . . . . 0.0 111.131 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.478 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 68.44 33.85 3.92 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.307 0.575 . . . . 0.0 111.639 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.485 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 3.3 m-85 60.95 61.25 1.66 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.718 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 82.2 mtp -149.84 172.15 15.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.191 -0.943 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.26 -170.25 44.67 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -54.44 117.35 3.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 107.926 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -101.01 134.61 43.74 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -128.14 128.91 45.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.256 -0.903 . . . . 0.0 109.278 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.99 118.91 25.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.954 -1.091 . . . . 0.0 108.657 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.702 HD11 ' CZ ' ' A' ' 63' ' ' TYR . 6.3 tp -125.51 118.45 25.81 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.4 ptm180 -108.9 179.84 4.06 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 0.0 111.884 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 59' ' ' ARG . 43.5 ttp180 -31.19 108.12 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.496 0.665 . . . . 0.0 111.004 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.34 158.35 20.86 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.43 127.16 52.84 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.702 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 71.0 m-85 -116.38 99.84 53.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -76.93 -6.96 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.442 2.095 . . . . 0.0 112.531 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.5 135.25 1.95 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.937 -1.102 . . . . 0.0 108.362 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 23.0 p90 -150.07 32.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.563 -1.336 . . . . 0.0 110.744 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 6.3 mmt -97.39 -46.67 5.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.827 -1.17 . . . . 0.0 109.199 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -99.34 -16.79 18.32 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 m -88.91 -20.46 24.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.521 -0.737 . . . . 0.0 109.883 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 72' ' ' MET . 42.4 ttm -107.32 -25.77 11.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.997 -1.064 . . . . 0.0 108.388 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.1 52.72 4.18 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.17 -1.014 . . . . 0.0 110.771 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 70' ' ' MET . 90.9 mtp -128.6 139.92 52.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.349 -1.089 . . . . 0.0 109.832 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 13.4 m120 -98.43 57.46 1.2 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.6 p30 150.91 -173.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 29.5 p -95.96 -174.61 3.16 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.293 1.044 . . . . 0.0 110.481 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 46' ' ' TYR . 40.6 t -78.38 143.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -108.07 -16.77 14.2 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.897 -1.127 . . . . 0.0 108.256 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.893 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.05 159.27 42.54 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.061 -1.024 . . . . 0.0 109.925 178.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 26' ' ' LEU . 11.0 m -154.74 143.55 20.83 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.37 0.605 . . . . 0.0 110.231 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' CD2' ' A' ' 146' ' ' TYR . 52.7 ttp180 -134.15 138.39 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.2 ttm -99.61 159.88 14.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.076 -1.015 . . . . 0.0 109.869 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 88.0 mt -123.7 83.48 54.02 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.71 176.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.965 2.443 . . . . 0.0 112.798 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.46 57.11 4.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.341 -0.849 . . . . 0.0 109.735 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -67.04 169.43 8.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.85 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -46.0 136.25 6.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.274 -0.891 . . . . 0.0 109.955 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.595 ' O ' ' O ' ' A' ' 88' ' ' SER . . . -65.86 -66.04 2.6 Favored Glycine 0 N--CA 1.492 2.409 0 O-C-N 121.447 -0.783 . . . . 0.0 113.25 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.595 ' O ' ' O ' ' A' ' 87' ' ' GLY . 25.2 m 10.12 115.37 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.417 -1.049 . . . . 0.0 113.291 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 87' ' ' GLY . 38.7 m-85 -126.41 133.58 51.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -174.17 123.21 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.1 ttm -117.68 135.62 53.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -108.94 121.72 45.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' MET . 14.3 mt -106.02 150.48 25.69 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.948 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CG ' ' HA ' ' A' ' 99' ' ' MET . 29.9 m-85 -134.58 121.59 21.15 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.083 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 55.5 tt0 -59.03 -26.54 64.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 111.526 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 124' ' ' SER . 39.6 m170 -110.61 162.0 15.17 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.503 -1.373 . . . . 0.0 111.12 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.2 p -59.15 154.35 16.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.754 -0.591 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 7.4 t70 84.24 -90.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -173.94 47.1 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.63 -159.44 12.61 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-O 122.242 0.912 . . . . 0.0 111.157 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.462 ' CA ' ' ND1' ' A' ' 96' ' ' HIS . . . 61.49 -159.5 30.01 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 98.1 mtt180 -79.21 127.42 32.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.99 -1.3 . . . . 0.0 110.048 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.498 ' C ' ' SD ' ' A' ' 103' ' ' MET . 10.1 tmm? -91.14 122.34 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.2 mtm -123.14 137.91 54.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 108.649 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.25 142.63 34.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.408 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.51 121.28 23.08 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.545 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 9.2 ttt -123.83 21.15 9.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 107' ' ' MET . 54.1 m-20 -145.85 -160.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.419 -0.801 . . . . 0.0 109.407 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 39.4 p-10 -90.03 133.77 34.63 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.98 80.57 14.95 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.71 -33.01 8.74 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.228 1.952 . . . . 0.0 111.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -126.38 78.97 1.82 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.514 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -62.67 -15.31 51.77 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 109.178 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.544 ' O ' ' ND2' ' A' ' 118' ' ' ASN . 5.6 mmt -63.3 -40.98 98.86 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.471 0.653 . . . . 0.0 109.856 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -85.21 -23.01 28.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.921 -1.112 . . . . 0.0 110.98 -178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . 0.479 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 49.5 ttm-85 -79.4 -61.04 2.13 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.602 -1.311 . . . . 0.0 111.123 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 118' ' ' ASN . 8.8 m-85 -109.61 0.75 19.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.925 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 114' ' ' MET . 11.5 m120 48.33 32.79 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.424 ' HG3' ' CE2' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -143.4 126.04 15.96 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -120.53 7.6 10.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.573 -0.704 . . . . 0.0 111.174 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.5 m-20 -135.34 88.96 2.46 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.634 -1.292 . . . . 0.0 112.606 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -101.42 139.45 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.185 -0.947 . . . . 0.0 108.852 177.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.11 3.82 54.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 111.244 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 5.3 t -152.23 157.54 41.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.148 -1.595 . . . . 0.0 110.327 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 1.5 p -169.47 167.96 9.63 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.755 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 12.7 t60 -149.09 145.91 27.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.449 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.3 t -114.36 125.3 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 108.771 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.406 ' SD ' ' CD2' ' A' ' 126' ' ' HIS . 86.2 mmm -81.66 -32.0 32.04 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.1 p30 178.29 168.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.537 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.71 -152.42 22.45 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.532 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 68.6 m-70 -137.27 123.57 20.61 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.675 -0.897 . . . . 0.0 109.347 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -112.14 122.97 49.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 0.0 112.676 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.657 HD12 ' CE2' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -98.93 123.4 43.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 42.9 t -109.15 144.82 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.816 -1.178 . . . . 0.0 110.618 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.657 ' CE2' HD12 ' A' ' 133' ' ' LEU . 62.6 m-85 -124.12 125.8 45.11 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.039 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 68.2 tt0 -64.44 -21.41 66.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.731 -0.606 . . . . 0.0 109.678 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.663 ' O ' ' OG ' ' A' ' 167' ' ' SER . 28.7 mm100 -127.6 134.0 25.71 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.315 -0.866 . . . . 0.0 109.646 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 137' ' ' GLN . 96.0 Cg_exo -38.86 -177.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 123.808 3.005 . . . . 0.0 114.859 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 50.21 31.04 4.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.81 -0.556 . . . . 0.0 110.899 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.469 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 57.59 54.33 6.51 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 0.0 110.435 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 142' ' ' GLY . 94.3 m -144.24 168.97 18.79 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.927 -1.108 . . . . 0.0 110.056 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 141' ' ' THR . . . 93.93 -177.01 36.66 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 63.4 mtm180 -56.35 106.74 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -1.08 . . . . 0.0 108.81 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -88.24 147.4 24.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.787 0.803 . . . . 0.0 110.184 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -128.02 141.02 51.63 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.63 0.728 . . . . 0.0 109.345 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.546 ' CD1' ' SD ' ' A' ' 44' ' ' MET . 88.1 t80 -99.02 101.66 13.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.593 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.601 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.3 mp -97.65 120.73 38.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.246 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -112.0 166.63 10.53 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 148' ' ' ARG . 88.1 Cg_exo -32.3 156.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.5 -169.82 14.2 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -121.23 136.2 55.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.433 -1.039 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.437 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 20.6 m-85 -113.07 145.89 40.11 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.639 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 25.0 ptt180 -136.75 0.64 2.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.933 . . . . 0.0 111.975 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.553 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.0 m -174.2 171.33 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.153 -1.592 . . . . 0.0 110.121 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.8 -17.0 19.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.38 -0.825 . . . . 0.0 109.17 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.08 1.76 46.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.0 -1.063 . . . . 0.0 109.326 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.639 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 9.1 m-20 -93.29 -60.35 1.81 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.451 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.8 p90 -78.12 16.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.76 39.39 93.58 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -107.32 -161.6 21.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.37 -42.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.3 p -109.05 -150.83 0.46 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 26.2 t -147.04 17.62 1.23 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.485 -0.759 . . . . 0.0 109.561 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -67.22 74.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.289 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.8 mtt -103.88 118.02 35.69 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.035 -1.041 . . . . 0.0 108.958 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.38 -25.97 3.87 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.663 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.023 1.412 . . . . 0.0 110.71 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.3 mt -145.67 140.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.749 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -131.37 145.2 51.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.8 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 107' ' ' MET . 0.3 OUTLIER -96.4 74.7 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 171' ' ' ILE . 2.9 pt -48.94 91.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.005 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 170' ' ' ARG . 1.6 t -105.95 59.2 0.66 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.068 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 172' ' ' THR . 93.3 m-20 49.88 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.025 -1.047 . . . . 0.0 109.071 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 174' ' ' LEU . 6.5 mp . . . . . 0 C--N 1.3 -1.574 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.313 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mmt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.69 103.15 0.08 OUTLIER Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.361 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -146.42 161.51 40.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.265 . . . . 0.0 110.73 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.624 HD13 ' CD2' ' A' ' 43' ' ' PHE . 12.2 tt -136.26 136.69 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.494 -0.754 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.456 HD12 HH21 ' A' ' 37' ' ' ARG . 72.2 mt -121.54 125.99 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 109.373 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -90.68 154.12 19.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -138.85 139.42 38.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 109.515 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.82 -33.36 57.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.468 -0.77 . . . . 0.0 111.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 54.5 t0 -77.69 153.91 32.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.916 -1.115 . . . . 0.0 110.328 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 64' ' ' PRO . 96.1 mtt180 -61.84 -50.43 72.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.511 -0.743 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 88.7 m-20 -71.43 -94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.065 . . . . 0.0 109.273 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 52.0 m-85 -157.3 69.76 0.58 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 109.043 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -163.8 -174.32 33.5 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.85 -152.75 23.24 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.506 ' N ' ' CD ' ' A' ' 15' ' ' ARG . 11.2 mpt_? -75.65 125.82 29.79 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.829 -1.394 . . . . 0.0 108.833 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -109.34 157.11 19.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -145.99 123.78 11.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -95.55 117.74 30.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.293 -0.879 . . . . 0.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.8 m -122.0 140.77 52.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.17 -0.956 . . . . 0.0 109.605 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.5 ptm -147.89 14.3 1.04 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.6 p -145.25 159.8 42.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.512 -0.742 . . . . 0.0 110.093 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -51.43 145.82 8.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.51 -0.744 . . . . 0.0 110.041 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.512 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 5.1 t -148.27 115.42 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.21 12.31 22.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.118 -0.989 . . . . 0.0 108.798 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.512 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 40.3 p-10 -148.57 90.45 1.79 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.638 -0.664 . . . . 0.0 109.615 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.525 HD11 ' SG ' ' A' ' 79' ' ' CYS . 32.0 mt -107.14 -28.79 9.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 28' ' ' SER . 47.3 p-80 -63.48 -39.81 95.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 109.029 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 27' ' ' HIS . 18.5 m -55.47 -25.38 36.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.75 -0.594 . . . . 0.0 109.468 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -83.31 -37.11 23.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 17.7 p90 -152.32 151.24 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -95.15 -9.89 32.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 mtt85 -155.7 155.46 33.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.03 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.595 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 48.3 t -154.51 123.47 6.3 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -107.51 -4.26 18.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.355 -0.841 . . . . 0.0 110.437 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 t -136.43 140.66 43.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.876 -1.14 . . . . 0.0 110.983 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 91.8 mt -137.22 145.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 32.0 ttp180 -137.81 116.46 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.864 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.19 119.54 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 92.3 mt-10 -84.72 -29.19 25.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.0 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -174.93 159.41 2.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.787 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.94 -162.67 46.86 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.4 t -123.53 153.18 40.95 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.47 -1.018 . . . . 0.0 109.172 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.624 ' CD2' HD13 ' A' ' 4' ' ' ILE . 10.1 t80 -140.34 135.28 32.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.153 -0.967 . . . . 0.0 109.137 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 ttt -106.37 119.94 40.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.38 143.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.809 -0.757 . . . . 0.0 110.209 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.7 m-85 -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 41.7 t0 -74.36 -9.13 58.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.947 -0.47 . . . . 0.0 109.951 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.843 ' O ' ' HB3' ' A' ' 78' ' ' SER . 27.8 ttt85 -131.52 158.19 41.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.9 p -68.45 163.65 22.84 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.78 0.8 . . . . 0.0 111.4 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 65.71 32.13 9.22 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.106 0.479 . . . . 0.0 111.499 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CB ' HH21 ' A' ' 80' ' ' ARG . 2.6 m-85 61.0 58.15 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.354 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.406 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.1 mtt -146.04 176.06 9.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.234 -0.917 . . . . 0.0 109.58 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 -172.68 48.36 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -55.94 124.15 16.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -102.47 134.19 46.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.055 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.0 129.27 47.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.496 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.642 ' C ' HD12 ' A' ' 58' ' ' LEU . 11.1 p90 -91.19 121.38 32.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.852 . . . . 0.0 108.886 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 57' ' ' PHE . 10.3 mp -108.77 139.74 43.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 60' ' ' ARG . 33.0 ptt180 -118.8 158.66 25.18 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 59' ' ' ARG . 50.8 ttt-85 -29.92 115.37 0.11 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.285 0.564 . . . . 0.0 110.389 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.29 164.32 26.77 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -104.62 127.43 52.37 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -110.4 97.68 32.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 108.666 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 10' ' ' ARG . 48.9 Cg_endo -71.47 -11.55 28.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.071 1.847 . . . . 0.0 112.348 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 65' ' ' ASP . 37.5 p-10 -167.27 135.76 2.61 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 15.5 p90 -147.95 20.28 1.13 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.702 -1.249 . . . . 0.0 110.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 42.7 tpp -90.99 -44.92 9.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.683 -1.261 . . . . 0.0 109.504 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 68' ' ' ARG . 12.5 ptp180 -98.45 -20.69 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -76.8 -30.56 56.48 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.046 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.9 mtt -95.08 -39.27 10.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.12 44.88 2.71 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 mmm -111.17 150.73 29.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.73 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.9 m120 -100.45 49.92 0.9 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.083 -1.011 . . . . 0.0 109.244 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.85 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.595 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 24.6 p -97.85 -170.22 1.95 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 46' ' ' TYR . 46.4 t -78.7 144.38 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -111.17 -15.25 13.72 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.597 -1.314 . . . . 0.0 107.719 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.843 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -143.84 166.26 25.42 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 178.362 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' SG ' HD11 ' A' ' 26' ' ' LEU . 30.1 p -160.16 145.25 14.93 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.504 HH21 ' CB ' ' A' ' 51' ' ' PHE . 35.6 ttm180 -130.68 136.64 48.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.3 ttp -95.98 149.6 21.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 108.956 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.3 mt -97.45 115.96 65.81 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.509 ' O ' ' CE1' ' A' ' 131' ' ' HIS . 72.9 Cg_exo -45.82 148.5 2.58 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.083 1.855 . . . . 0.0 112.0 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 84' ' ' LEU . 9.8 mp -89.5 50.9 1.99 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -104.89 125.22 50.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.54 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -135.95 73.92 1.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.462 -0.773 . . . . 0.0 109.49 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.67 -87.37 1.13 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 54.7 m -115.68 144.4 43.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.631 -0.923 . . . . 0.0 109.77 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.62 ' CG ' ' NE ' ' A' ' 170' ' ' ARG . 10.5 m-85 -112.6 118.47 35.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -0.816 . . . . 0.0 109.496 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -171.18 126.98 0.68 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 49.2 ttm -110.43 125.2 53.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.051 -1.031 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -99.62 118.08 35.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' MET . 16.5 mt -104.52 147.31 27.74 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.191 0.996 . . . . 0.0 112.238 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 99' ' ' MET . 28.2 m-85 -133.64 125.25 28.31 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 86.8 tt0 -62.36 -27.51 69.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.942 . . . . 0.0 111.879 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.2 m-70 -108.95 164.9 12.0 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.539 -1.35 . . . . 0.0 111.145 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 58.2 m -61.55 156.19 20.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 97' ' ' SER . 2.3 m-20 81.6 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.484 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -169.91 41.55 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.68 -157.24 21.29 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.507 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.509 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 60.73 -155.64 33.31 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 79.2 mtp180 -87.49 138.6 31.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 109.836 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.6 ptt? -98.56 123.43 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 110.072 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.68 136.87 54.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.9 137.03 40.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 110.122 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.36 119.07 21.17 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.57 -15.88 12.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.544 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -111.86 -159.06 0.67 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.85 . . . . 0.0 110.352 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.4 139.36 30.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.29 88.33 27.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.459 -0.776 . . . . 0.0 109.297 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.23 -25.76 8.22 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.162 1.908 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -136.57 80.71 1.84 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 12.7 mt -64.54 -28.46 69.66 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.201 -0.937 . . . . 0.0 110.012 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.78 -39.38 73.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.35 -23.03 35.27 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 110.184 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -79.48 -69.11 0.6 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.475 -1.391 . . . . 0.0 110.515 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.8 m-85 -96.07 3.43 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.993 -1.067 . . . . 0.0 110.721 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 114' ' ' MET . 31.4 m-20 52.32 31.85 10.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.563 -1.336 . . . . 0.0 107.514 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.439 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 4.7 ttp -146.47 132.41 19.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 60.2 p -116.13 2.95 13.46 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.507 -0.746 . . . . 0.0 109.801 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 163' ' ' SER . 50.7 m-20 -131.09 113.13 13.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.564 -1.335 . . . . 0.0 111.594 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -123.33 131.77 53.77 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.478 ' N ' ' ND1' ' A' ' 123' ' ' HIS . 2.8 m80 -93.21 1.87 56.9 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.342 -0.848 . . . . 0.0 111.097 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.2 t -147.51 153.81 39.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 119.674 -1.892 . . . . 0.0 110.844 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 50.3 t -162.44 161.42 27.19 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.411 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.451 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 1.9 t-80 -147.63 141.9 26.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.173 -0.955 . . . . 0.0 109.522 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 60.2 t -112.16 122.17 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 10.4 tpt -71.87 -32.38 67.41 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 88' ' ' SER . 0.9 OUTLIER 170.95 163.2 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.062 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.92 -160.63 29.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.509 ' CE1' ' O ' ' A' ' 83' ' ' PRO . 71.9 m-70 -127.97 129.4 46.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.514 -0.992 . . . . 0.0 110.199 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -118.69 126.06 51.07 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.851 0.834 . . . . 0.0 111.91 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.24 125.68 41.95 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 50.5 t -111.23 145.12 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 141' ' ' THR . 94.8 m-85 -124.73 123.1 39.26 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.694 -0.629 . . . . 0.0 111.113 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 164' ' ' ARG . 71.8 tt0 -57.74 -29.36 64.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.838 ' O ' ' OG ' ' A' ' 167' ' ' SER . 5.8 mt-30 -117.27 153.07 49.87 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 19.2 Cg_endo -60.21 -170.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 123.496 2.797 . . . . 0.0 113.774 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 46.61 29.4 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.603 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 58.28 53.99 6.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 110.061 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 135' ' ' TYR . 14.2 p -140.39 168.25 20.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.95 178.21 36.28 Favored Glycine 0 N--CA 1.503 3.15 0 O-C-N 120.737 -1.227 . . . . 0.0 110.6 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -53.39 108.0 0.29 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -86.85 141.93 28.43 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.969 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -126.0 132.46 52.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -92.66 105.3 17.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.015 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.5 mp -98.35 120.17 38.31 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 109.121 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -105.02 178.73 1.07 Allowed Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 66.3 Cg_exo -49.42 161.58 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.679 1.586 . . . . 0.0 111.64 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.51 -173.88 14.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.75 135.46 54.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.744 -0.857 . . . . 0.0 110.658 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 18.1 m-85 -112.75 143.83 43.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.614 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 41.1 ptt85 -135.12 -1.39 2.65 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.015 -1.053 . . . . 0.0 112.159 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.551 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 1.6 t -171.77 168.19 6.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 119.896 -1.752 . . . . 0.0 109.924 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -57.6 -14.6 5.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -85.82 0.01 54.13 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.231 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.614 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.4 m-20 -92.52 -59.66 2.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.542 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.7 p90 -76.78 18.14 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.23 37.82 95.06 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -102.49 -166.04 26.43 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.0 t -144.66 -40.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.6 p -107.03 -159.87 0.71 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.5 t -138.42 11.09 2.76 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 109.497 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 136' ' ' GLU . 85.6 mtt-85 -69.49 75.6 0.4 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.016 -1.053 . . . . 0.0 112.988 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 mtt -100.05 122.8 43.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.139 -0.976 . . . . 0.0 110.247 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.93 -28.5 2.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.838 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -132.85 148.5 52.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.421 -1.635 . . . . 0.0 111.2 -179.109 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.5 mt -144.84 140.7 23.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.328 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -125.86 143.83 50.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.304 -0.873 . . . . 0.0 110.349 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.764 ' O ' ' N ' ' A' ' 172' ' ' THR . 29.5 ttt180 -97.72 85.48 3.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 171' ' ' ILE . 13.9 mt -38.04 71.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.747 -0.596 . . . . 0.0 112.372 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 170' ' ' ARG . 64.1 m -159.55 75.85 0.65 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.861 -1.149 . . . . 0.0 110.07 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 172' ' ' THR . 14.4 m-20 -157.23 73.03 0.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.113 -0.992 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 174' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.18 -0.914 . . . . 0.0 108.868 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . 85.17 162.68 36.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -151.9 135.61 16.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.433 HD11 ' CG2' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -122.01 117.16 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -115.0 124.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.888 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.84 159.25 15.88 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 14.3 m-85 -146.25 135.1 22.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.564 -1.335 . . . . 0.0 109.038 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.54 -42.52 58.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.123 -0.985 . . . . 0.0 111.069 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 35' ' ' SER . 12.6 t70 -81.21 151.19 28.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.889 -1.132 . . . . 0.0 110.542 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.49 -40.59 95.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 110.068 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.94 39.49 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.699 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 53.16 59.76 4.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 109.563 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.7 -154.44 6.14 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -145.63 49.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -77.7 123.41 26.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -1.085 . . . . 0.0 108.967 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -109.56 156.08 20.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.478 -0.764 . . . . 0.0 109.953 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.411 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 7.9 t-80 -142.64 124.85 15.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 109.27 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -99.91 119.83 38.83 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.879 . . . . 0.0 109.575 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.37 139.72 50.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.5 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.513 ' O ' ' SD ' ' A' ' 20' ' ' MET . 0.8 OUTLIER -131.7 7.17 4.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -148.95 169.71 19.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.381 -0.824 . . . . 0.0 109.672 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 40.9 p-10 -61.4 147.32 45.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 110.285 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.1 t -140.06 115.33 9.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -8.31 56.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.0 108.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 12.2 p-10 -130.98 98.51 4.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 26' ' ' LEU . 57.8 mt -104.64 -20.2 13.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 108.655 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.468 ' C ' ' ND1' ' A' ' 27' ' ' HIS . 7.9 t-80 -59.58 -44.7 93.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' HIS . 25.6 t -49.99 -46.28 52.44 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.411 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 53.6 m-85 -70.08 -51.91 28.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.11 149.24 30.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.999 -1.063 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -100.91 -5.42 26.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.359 -0.838 . . . . 0.0 110.838 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -154.88 153.19 30.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.01 -1.056 . . . . 0.0 108.248 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 52.7 t -158.96 113.68 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.973 -1.079 . . . . 0.0 108.791 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.6 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 35.9 m-70 -95.81 -4.84 43.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.713 -0.617 . . . . 0.0 110.994 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.7 p -139.19 145.93 39.92 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.688 -1.257 . . . . 0.0 111.236 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.433 ' CG2' HD11 ' A' ' 4' ' ' ILE . 26.0 mt -140.98 142.5 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -132.71 112.11 11.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 111.081 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.522 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 1.4 t -98.5 115.0 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -83.01 -33.75 26.46 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.685 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 8.3 t -171.74 151.34 2.84 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.138 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.727 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 103.18 -137.92 13.69 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.727 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 60.7 m -170.92 164.41 7.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 2.8 p90 -174.84 168.96 3.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.616 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.0 ttm -119.72 141.29 49.55 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.706 ' HB ' HG11 ' A' ' 76' ' ' VAL . 34.8 m -115.74 146.6 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.5 -0.75 . . . . 0.0 109.1 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 95.6 m-85 -120.41 142.34 49.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.39 -0.819 . . . . 0.0 111.587 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -9.33 58.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.82 ' O ' ' HB3' ' A' ' 78' ' ' SER . 89.8 mtt-85 -134.52 165.39 25.3 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 p -75.64 160.61 29.9 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.729 0.776 . . . . 0.0 111.476 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.8 m120 68.18 33.03 4.55 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.321 0.581 . . . . 0.0 111.168 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 4.9 m-85 61.0 60.31 1.85 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.781 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.423 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 59.1 mtt -146.34 170.95 15.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.235 -0.916 . . . . 0.0 110.033 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.15 -173.46 50.25 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -55.16 126.21 23.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.097 -1.237 . . . . 0.0 108.128 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -110.37 140.9 44.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 0.0 108.868 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -132.26 137.12 47.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.816 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 22.7 p90 -98.85 123.77 43.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.404 -0.81 . . . . 0.0 109.241 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -122.83 129.49 51.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.8 ptt180 -104.59 167.45 9.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.39 -0.819 . . . . 0.0 110.922 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 59' ' ' ARG . 72.9 ttt180 -35.6 119.53 0.54 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.701 0.763 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 168.81 164.96 25.4 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -102.84 124.42 48.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.464 -1.021 . . . . 0.0 108.48 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -108.27 97.67 23.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -16.63 41.98 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.2 1.933 . . . . 0.0 112.212 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 40.7 p-10 -169.36 145.03 3.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.871 -1.143 . . . . 0.0 107.943 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 20.2 p90 -148.0 -16.21 0.35 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.0 111.407 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.6 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 43.8 mtp -57.94 -38.89 76.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.439 -1.413 . . . . 0.0 109.994 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.6 -25.66 20.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.977 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -88.53 -8.98 53.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.838 . . . . 0.0 109.838 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.3 mmt -107.98 -27.49 10.13 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 47.1 6.51 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.4 mtp -124.73 147.26 48.73 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.045 -1.268 . . . . 0.0 109.668 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 73.7 m-80 -98.06 60.18 1.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 15.4 m-20 148.9 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 30.9 p -100.45 -163.53 1.03 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 109.697 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.706 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.9 m -92.37 147.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 65.6 mtp180 -106.69 -11.14 15.9 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.168 -0.957 . . . . 0.0 108.521 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.82 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.75 164.98 28.73 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.269 179.052 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.443 ' SG ' HD11 ' A' ' 26' ' ' LEU . 30.2 p -161.09 147.51 14.75 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.734 0.778 . . . . 0.0 110.601 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.418 ' NH2' ' NH1' ' A' ' 148' ' ' ARG . 74.0 ttt-85 -140.3 141.98 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 42.1 ttm -98.35 161.52 13.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.111 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.429 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 52.5 mt -99.87 135.19 20.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.6 150.72 75.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.21 1.94 . . . . 0.0 111.974 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.8 mt -82.0 51.91 1.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.641 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -105.45 117.5 34.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.302 -0.874 . . . . 0.0 109.535 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -133.48 78.23 1.76 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.0 109.48 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.75 -78.19 1.1 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.545 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 66.5 m -135.45 156.43 48.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.684 -0.892 . . . . 0.0 110.054 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.83 111.66 23.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 109.855 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -169.51 130.77 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.403 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 43.7 ttm -114.56 133.84 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -106.18 117.6 34.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 103' ' ' MET . 23.5 mt -101.44 148.05 25.64 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.083 0.944 . . . . 0.0 112.121 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.66 127.54 29.41 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 70.3 tt0 -64.13 -23.94 67.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 112.095 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.527 ' O ' ' HB3' ' A' ' 124' ' ' SER . 6.1 m-70 -114.08 159.4 20.06 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.48 -1.387 . . . . 0.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.6 m -59.0 158.88 7.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.379 -0.825 . . . . 0.0 109.431 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 97' ' ' SER . 14.3 t0 85.49 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.832 0.825 . . . . 0.0 108.787 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.443 ' H ' ' HB3' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -176.93 41.18 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.69 -160.32 13.0 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-O 122.281 0.934 . . . . 0.0 111.296 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 67.21 -166.71 40.89 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 17.5 mmt180 -74.47 133.85 42.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.002 -1.293 . . . . 0.0 109.648 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.7 119.14 36.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.171 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 138.39 50.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.5 126.58 45.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.025 -1.047 . . . . 0.0 109.763 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.1 tt -118.83 115.79 25.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.1 ttt -126.4 20.96 7.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.289 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.544 ' H ' HD23 ' A' ' 106' ' ' LEU . 12.1 t70 -144.42 -168.56 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -0.901 . . . . 0.0 110.045 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 47.8 t0 -83.82 132.18 34.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -114.89 81.5 7.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.239 -0.913 . . . . 0.0 109.978 -178.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.29 -29.06 5.19 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.178 1.918 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -134.14 79.4 1.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.517 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 9.8 mt -63.17 -18.62 63.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.942 . . . . 0.0 109.787 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 20.7 mmt -59.76 -40.72 89.12 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.705 0.764 . . . . 0.0 109.33 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -85.28 -23.38 28.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.988 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -75.58 -63.2 1.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.785 -1.197 . . . . 0.0 110.761 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 117' ' ' PHE . 1.4 m-85 -116.49 1.23 12.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.771 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 117' ' ' PHE . 14.7 t-20 49.41 35.96 8.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.9 ttt -146.5 133.28 20.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 120' ' ' SER . 1.3 t -131.56 10.53 4.78 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.3 m-20 -130.1 89.69 2.84 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 119.933 -1.729 . . . . 0.0 113.238 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -107.08 141.25 38.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.048 -1.032 . . . . 0.0 108.535 178.082 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.62 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 19.8 m170 -96.36 3.19 53.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 111.133 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.9 t -148.98 154.3 39.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.205 -1.559 . . . . 0.0 110.177 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 38.1 t -163.89 161.98 23.29 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.971 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.495 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 0.8 OUTLIER -146.36 142.56 28.35 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 53.5 t -111.55 122.58 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -0.977 . . . . 0.0 109.623 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 36.1 ttm -71.94 -24.2 61.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.64 . . . . 0.0 109.638 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.545 ' CB ' ' H ' ' A' ' 88' ' ' SER . 1.3 m-20 163.29 171.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.859 0.838 . . . . 0.0 110.866 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 85.95 -135.71 13.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.553 ' CG ' ' HH ' ' A' ' 146' ' ' TYR . 92.5 m-70 -158.52 134.17 8.86 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.69 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -126.78 136.26 52.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 0.0 111.954 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.9 mt -103.48 132.2 49.94 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 19.2 t -110.02 143.75 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.906 -1.121 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.531 ' CZ ' ' OE1' ' A' ' 144' ' ' GLN . 36.6 m-85 -120.9 124.1 44.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.623 -0.673 . . . . 0.0 110.902 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.69 -26.93 64.36 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 167' ' ' SER . 16.8 mt-30 -122.18 154.21 61.71 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 26.7 Cg_endo -62.25 -171.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.202 2.601 . . . . 0.0 113.823 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 46.66 29.32 0.93 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.387 0.613 . . . . 0.0 110.026 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.487 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 48.3 m-85 59.34 50.84 7.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.639 -0.663 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.3 p -135.89 162.77 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.63 174.76 32.39 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -54.71 111.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -1.035 . . . . 0.0 109.129 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.4 mt-30 -85.97 143.84 27.94 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -123.58 137.99 54.64 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.553 ' HH ' ' CG ' ' A' ' 131' ' ' HIS . 21.3 t80 -97.35 107.53 20.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.486 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.8 mp -102.62 117.14 34.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 108.584 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.511 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 24.7 ptt180 -103.7 178.37 1.19 Allowed Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 Cg_exo -49.37 162.19 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.799 1.666 . . . . 0.0 111.805 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.34 -170.58 13.41 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.86 133.19 56.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -1.001 . . . . 0.0 110.506 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.511 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 20.9 m-85 -110.03 144.45 38.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.704 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 8.6 ptm180 -141.58 -2.42 1.22 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.877 -1.14 . . . . 0.0 112.251 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.533 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 14.2 m -165.49 166.21 18.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.039 -1.663 . . . . 0.0 110.174 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.6 OUTLIER -54.35 -20.24 6.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 108.935 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -83.15 1.44 40.47 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.879 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.704 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.9 m-20 -90.3 -62.9 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 109.138 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -75.88 13.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.54 37.95 93.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.85 -154.43 21.31 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.2 t -153.58 -41.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.4 p -103.61 -153.64 0.48 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 29.5 m -148.87 11.85 0.85 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -66.84 79.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 0.0 112.232 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.7 mtt -107.41 119.78 40.36 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.644 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.79 -26.82 4.01 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.481 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -128.92 150.29 50.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.612 -1.522 . . . . 0.0 111.135 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.16 138.96 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.945 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -122.91 136.42 54.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 172' ' ' THR . 30.6 ptt85 -93.79 86.29 5.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.893 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 170' ' ' ARG . 97.0 mt -34.76 92.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.453 -0.779 . . . . 0.0 109.875 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 170' ' ' ARG . 25.6 m -136.22 76.92 1.63 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 172' ' ' THR . 0.2 OUTLIER 169.5 109.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -0.791 . . . . 0.0 109.43 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.482 179.742 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.359 0.6 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.17 162.08 32.03 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -162.1 141.24 9.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -1.134 . . . . 0.0 109.512 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.581 ' CD1' ' CG ' ' A' ' 43' ' ' PHE . 46.7 mt -129.13 133.95 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.651 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.594 HD12 HH21 ' A' ' 37' ' ' ARG . 47.2 mt -119.6 117.8 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -93.59 136.65 33.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 109.463 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE2' HG22 ' A' ' 5' ' ' ILE . 52.5 m-85 -122.28 131.79 54.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -70.19 -22.45 62.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.61 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.532 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 53.9 t0 -80.64 160.49 25.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.876 -1.14 . . . . 0.0 110.326 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.7 mmt85 -60.6 -44.5 96.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.365 -0.835 . . . . 0.0 109.803 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -80.08 -102.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -145.35 43.06 1.29 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.159 -0.963 . . . . 0.0 109.103 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.532 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.12 -169.24 12.13 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.06 -156.11 32.24 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -65.58 114.47 4.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.376 . . . . 0.0 109.092 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -98.07 147.52 24.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.375 -0.828 . . . . 0.0 109.826 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.639 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 27.8 t60 -140.46 124.55 17.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.117 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -94.78 118.33 31.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 109.145 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.5 m -118.98 136.39 54.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.336 -0.852 . . . . 0.0 109.251 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -140.23 9.15 2.28 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.8 t -142.21 155.98 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.321 -0.862 . . . . 0.0 110.417 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 52.8 p30 -55.2 143.98 25.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 110.472 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 t -140.58 118.87 12.08 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.59 53.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.799 -1.188 . . . . 0.0 109.282 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 39.6 p-10 -134.13 94.27 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.28 -18.17 27.53 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.474 ' C ' ' ND1' ' A' ' 27' ' ' HIS . 10.5 t-80 -56.48 -35.58 68.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -54.92 -59.27 4.97 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 61.3 m-85 -59.38 -51.69 68.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 0.0 110.772 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -151.5 150.61 30.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.033 -1.042 . . . . 0.0 110.548 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' CD2' ' A' ' 27' ' ' HIS . 24.3 t30 -98.06 -5.12 34.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 110.334 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -159.04 157.32 30.94 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.563 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 45.4 t -160.28 128.6 4.73 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -107.23 -10.64 15.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.053 . . . . 0.0 109.748 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -137.01 138.17 40.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 110.794 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.3 mt -130.59 143.11 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.594 HH21 HD12 ' A' ' 5' ' ' ILE . 57.9 ttp85 -133.26 116.5 16.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.087 . . . . 0.0 110.719 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.8 t -104.26 119.88 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -85.87 -29.17 23.9 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 108.907 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -174.86 153.7 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.671 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.72 -144.42 15.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-O 122.445 1.025 . . . . 0.0 111.638 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.1 m -146.2 149.73 34.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.581 ' CG ' ' CD1' ' A' ' 4' ' ' ILE . 7.4 t80 -147.28 137.69 23.36 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.883 -1.136 . . . . 0.0 110.002 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.0 tpt -108.85 127.09 53.73 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 56' ' ' TYR . 16.6 m -116.34 145.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 76' ' ' VAL . 55.4 m-85 -120.82 141.48 50.51 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.69 0.757 . . . . 0.0 111.052 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -74.37 -9.88 59.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.991 -0.443 . . . . 0.0 109.997 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.863 ' O ' ' HB3' ' A' ' 78' ' ' SER . 96.1 mtt180 -131.81 160.75 34.69 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p -68.96 162.02 27.64 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.767 0.794 . . . . 0.0 111.497 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 66.26 33.46 7.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.793 -0.567 . . . . 0.0 111.416 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.48 ' H ' ' CB ' ' A' ' 78' ' ' SER . 1.8 m-85 59.55 58.69 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.026 -1.046 . . . . 0.0 110.199 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 55.9 mtt -146.28 174.57 11.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.843 -1.16 . . . . 0.0 110.669 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.21 -169.05 51.15 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.97 -1.081 . . . . 0.0 110.42 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -61.68 129.41 40.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.443 ' CD ' ' N ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -122.6 154.16 38.33 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.889 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' O ' HG22 ' A' ' 45' ' ' VAL . 94.6 m-85 -133.27 138.37 46.42 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.819 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -92.67 118.1 30.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 108.695 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.0 mt -116.6 115.91 26.6 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.403 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.7 ptt85 -99.39 162.28 13.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.268 -0.895 . . . . 0.0 110.839 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 59' ' ' ARG . 77.7 ttt180 -25.77 114.07 0.05 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.442 0.639 . . . . 0.0 111.099 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.84 172.94 37.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -113.17 127.36 56.16 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.944 . . . . 0.0 108.725 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -107.72 99.85 31.81 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' ARG . 56.9 Cg_endo -73.42 -14.86 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.336 2.024 . . . . 0.0 113.026 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -168.24 140.06 2.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.856 -1.152 . . . . 0.0 108.557 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 25.9 p90 -150.96 36.62 0.62 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.685 -1.26 . . . . 0.0 110.297 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.5 mmt -102.97 -46.94 4.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.069 -1.019 . . . . 0.0 109.689 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.82 -16.0 18.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -86.39 -17.14 35.18 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.8 mtt -116.85 -28.96 6.17 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.03 51.14 4.09 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.068 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 89.3 mtp -119.77 141.66 49.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.307 . . . . 0.0 109.507 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 85.5 m-20 -97.79 51.95 1.07 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.1 -171.86 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.563 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 27.5 p -97.8 -168.18 1.63 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.133 0.968 . . . . 0.0 109.925 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 46' ' ' TYR . 42.4 t -75.74 141.43 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -106.36 -17.17 14.36 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.572 -1.33 . . . . 0.0 107.813 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.863 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.94 164.34 30.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.696 178.557 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 24.6 p -164.92 152.74 11.57 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.507 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -137.7 141.26 41.07 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.1 ttp -93.17 151.45 19.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 108.976 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.496 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 16.4 mm -88.88 129.23 49.23 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.08 -1.012 . . . . 0.0 108.891 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.71 148.13 41.12 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.189 1.926 . . . . 0.0 111.976 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.0 mt -80.19 47.37 0.9 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -110.99 73.42 0.82 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -91.5 89.95 7.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.585 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.43 -90.86 1.29 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.8 m -121.02 148.06 44.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -1.02 . . . . 0.0 109.81 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.88 120.12 41.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.777 . . . . 0.0 109.371 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -171.42 130.12 0.71 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.553 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 45.0 ttm -115.13 130.78 57.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.924 -1.11 . . . . 0.0 109.329 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -101.51 117.74 35.54 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' MET . 12.3 mt -103.18 150.09 24.02 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.328 1.061 . . . . 0.0 112.369 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 99' ' ' MET . 37.0 m-85 -137.4 125.83 23.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -63.48 -24.22 67.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 112.07 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.84 ' O ' ' OG ' ' A' ' 124' ' ' SER . 7.5 m-70 -110.94 165.22 12.04 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.371 -1.456 . . . . 0.0 110.651 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.4 m -60.03 158.86 10.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.117 -0.989 . . . . 0.0 110.044 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.534 ' O ' ' SD ' ' A' ' 99' ' ' MET . 1.0 OUTLIER 78.42 -96.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.407 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.588 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 21.7 mmt -161.76 35.86 0.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.43 -158.31 28.9 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.293 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.73 -172.43 8.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -72.36 136.0 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.985 -1.303 . . . . 0.0 109.47 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 103' ' ' MET . 5.2 ptt? -96.79 121.31 38.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 110.307 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.634 ' SD ' ' CD2' ' A' ' 117' ' ' PHE . 13.9 mtm -118.46 139.83 50.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.948 . . . . 0.0 109.206 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 mp0 -100.37 138.19 37.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.612 HD13 ' SG ' ' A' ' 110' ' ' CYS . 16.8 tp -128.31 118.01 22.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.6 ttm -123.54 -18.53 6.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.446 -0.784 . . . . 0.0 109.234 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.49 ' O ' HD11 ' A' ' 106' ' ' LEU . 52.4 p30 -106.8 -170.21 1.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.831 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -76.62 130.56 38.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.819 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.612 ' SG ' HD13 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -111.3 78.86 1.95 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.092 -1.005 . . . . 0.0 109.358 -179.351 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.71 -27.09 7.65 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.1 1.867 . . . . 0.0 112.407 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -136.05 83.21 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.41 -25.85 67.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.99 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 tpt -55.09 -40.38 70.36 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.858 0.837 . . . . 0.0 109.113 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -81.01 -23.19 38.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.4 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -74.47 -61.92 1.7 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.622 -1.299 . . . . 0.0 110.629 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.634 ' CD2' ' SD ' ' A' ' 104' ' ' MET . 0.9 OUTLIER -118.92 5.39 11.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.425 -0.797 . . . . 0.0 110.547 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.7 m120 55.53 41.12 31.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.574 -1.329 . . . . 0.0 107.464 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.4 tpt -143.05 122.41 13.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.2 t -111.82 6.68 19.8 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 110.191 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.8 m-20 -143.39 101.79 3.85 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.413 -1.43 . . . . 0.0 113.699 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.2 m-85 -109.49 140.57 43.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.49 -0.756 . . . . 0.0 109.152 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.442 ' CD2' ' N ' ' A' ' 123' ' ' HIS . 8.1 m-70 -96.81 3.15 52.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 111.103 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.84 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -148.98 154.18 38.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.172 -1.58 . . . . 0.0 110.375 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.553 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 15.4 t -162.19 162.11 28.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.065 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.56 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -149.13 143.47 26.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.139 -0.975 . . . . 0.0 109.693 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.56 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.6 t -113.59 121.7 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.932 . . . . 0.0 109.381 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.408 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 25.1 ttt -72.47 -34.97 68.1 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.0 OUTLIER 176.71 174.38 0.39 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.942 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.15 -164.87 54.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.646 ' CE1' ' HH ' ' A' ' 146' ' ' TYR . 91.8 m-70 -124.66 132.38 53.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -1.067 . . . . 0.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -122.14 129.55 52.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.682 . . . . 0.0 111.412 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -101.58 131.86 47.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 22.0 t -107.83 139.97 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.98 -1.075 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.408 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 53.9 m-85 -116.38 125.09 51.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.554 -0.716 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -60.02 -26.74 66.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.1 mp0 -122.71 154.07 63.42 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.523 ' O ' ' OG1' ' A' ' 141' ' ' THR . 24.1 Cg_endo -61.48 -176.66 0.19 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.203 2.602 . . . . 0.0 113.358 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 51.71 33.37 10.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.516 -0.74 . . . . 0.0 110.58 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.408 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 39.8 m-85 55.08 47.65 21.46 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.592 -0.693 . . . . 0.0 110.048 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 13.7 p -134.44 164.22 27.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.05 173.89 28.96 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -54.02 115.14 1.88 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.122 -1.222 . . . . 0.0 109.001 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 32.4 mt-30 -84.75 142.11 30.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.83 128.87 48.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.646 ' HH ' ' CE1' ' A' ' 131' ' ' HIS . 20.6 t80 -90.93 99.47 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.271 -0.893 . . . . 0.0 109.831 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.447 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.0 mp -96.09 124.31 40.05 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.769 0.795 . . . . 0.0 109.078 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.437 ' HB2' ' HD2' ' A' ' 149' ' ' PRO . 20.0 ptt-85 -112.16 178.27 1.01 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 148' ' ' ARG . 85.2 Cg_exo -43.42 165.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.828 1.685 . . . . 0.0 111.809 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.01 177.53 21.01 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -109.55 135.41 50.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.525 -0.985 . . . . 0.0 110.399 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 19.7 m-85 -109.93 143.44 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.59 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 42.9 ptt85 -134.9 -4.4 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.883 -1.136 . . . . 0.0 112.598 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.7 m -171.57 162.71 6.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.952 -1.718 . . . . 0.0 110.128 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -51.66 -9.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 154' ' ' SER . 0.6 OUTLIER -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.048 -1.032 . . . . 0.0 108.892 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.2 m-20 -92.46 -61.1 1.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.144 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.546 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.4 p90 -75.76 15.55 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.3 37.69 93.07 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.72 -177.06 23.93 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 162' ' ' THR . 2.8 m -139.03 10.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 161' ' ' VAL . 52.1 p -158.26 -158.21 0.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.8 m -143.61 11.74 1.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -62.74 72.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.937 -1.102 . . . . 0.0 112.118 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 163' ' ' SER . 60.2 mtt -105.91 115.95 31.1 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.916 -1.115 . . . . 0.0 110.565 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.87 -22.12 6.11 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -132.92 149.83 52.21 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.368 -1.666 . . . . 0.0 111.107 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.8 mt -148.21 141.89 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.744 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -124.84 140.53 52.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 110.062 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 172' ' ' THR . 13.4 ptt180 -100.0 102.53 13.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 131' ' ' HIS . 3.5 mt -51.26 68.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.761 -0.587 . . . . 0.0 111.602 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.671 ' N ' ' O ' ' A' ' 170' ' ' ARG . 14.4 m -131.13 78.74 1.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 0.0 110.466 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 0.9 OUTLIER 168.75 111.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 108.806 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.271 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.72 154.66 5.75 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.83 139.8 51.14 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.419 -1.047 . . . . 0.0 110.637 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.678 HD11 HD11 ' A' ' 36' ' ' ILE . 19.1 tt -133.48 128.99 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 110.066 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.5 mt -116.26 132.17 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.657 -0.652 . . . . 0.0 109.825 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.592 ' CE2' HD12 ' A' ' 36' ' ' ILE . 86.6 m-85 -97.56 146.07 25.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -133.63 135.51 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -72.87 -45.03 60.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 110.45 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 12.8 t70 -78.72 151.38 32.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -67.21 -34.89 78.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 110.073 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -85.65 40.67 0.86 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.042 -1.036 . . . . 0.0 109.848 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 52.89 54.38 10.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 109.696 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -139.34 -153.84 6.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.88 -148.04 46.02 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -76.46 119.0 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.976 . . . . 0.0 109.476 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -100.82 157.94 16.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -149.48 123.93 9.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.187 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -97.72 124.72 42.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 m -123.7 136.76 54.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -135.46 11.78 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 p -146.21 163.12 36.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.623 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -59.52 144.36 47.54 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 110.646 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -139.03 118.35 12.77 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.42 -12.19 46.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.66 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 40.3 p-10 -132.28 98.04 4.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 79' ' ' CYS . 21.4 mt -96.3 -19.29 19.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.441 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 14.4 t-80 -58.05 -40.82 81.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.309 -0.869 . . . . 0.0 108.994 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.0 m -52.03 -44.94 64.44 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -70.44 -46.07 64.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.137 -0.977 . . . . 0.0 110.756 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 27.6 p90 -154.46 151.89 29.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.976 -1.077 . . . . 0.0 109.846 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.612 HD21 ' N ' ' A' ' 31' ' ' ASN . 1.0 OUTLIER -95.97 -5.67 40.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 0.0 110.078 -179.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -161.36 159.68 28.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 108.649 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 20.5 t -160.13 120.08 2.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.502 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -95.96 -14.86 22.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.602 -0.686 . . . . 0.0 110.345 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 m -135.54 147.07 48.65 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.645 -1.284 . . . . 0.0 110.859 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.678 HD11 HD11 ' A' ' 4' ' ' ILE . 20.4 tt -148.09 148.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -136.22 122.87 21.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.824 -1.173 . . . . 0.0 112.076 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.05 120.8 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -91.37 -28.87 17.43 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 110.6 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -159.71 152.55 21.62 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.966 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.19 -159.48 52.65 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -132.85 178.69 6.68 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.305 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.34 140.79 19.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.68 -1.263 . . . . 0.0 109.203 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.5 tpt -101.02 117.57 35.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -110.2 143.35 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.874 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.675 ' O ' HG13 ' A' ' 76' ' ' VAL . 26.4 m-85 -122.17 142.0 50.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.698 0.761 . . . . 0.0 111.011 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 29.8 t0 -75.56 -6.65 51.36 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.865 ' O ' ' HB3' ' A' ' 78' ' ' SER . 36.5 ttt180 -131.23 157.87 42.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 0.0 108.709 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 p -69.04 160.7 30.49 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.708 0.765 . . . . 0.0 111.295 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.75 32.89 6.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.7 -0.625 . . . . 0.0 111.326 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.477 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 2.5 m-85 60.63 59.99 2.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.2 -0.937 . . . . 0.0 109.371 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 58.2 mtt -147.76 171.17 16.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 -170.76 42.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -54.19 122.25 9.89 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.074 -1.25 . . . . 0.0 107.633 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -103.83 135.83 44.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 108.804 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -129.36 137.56 51.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.356 -0.84 . . . . 0.0 109.427 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -100.65 119.61 38.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.0 mt -117.15 121.99 42.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.031 -1.043 . . . . 0.0 112.164 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -84.54 166.56 17.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.388 -0.82 . . . . 0.0 109.888 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' CZ ' ' OXT' ' A' ' 174' ' ' LEU . 31.7 ptt180 -52.4 123.16 10.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.973 . . . . 0.0 110.198 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.32 171.7 39.55 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 9.9 pt-20 -102.27 126.73 49.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -1.137 . . . . 0.0 108.712 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -113.02 99.65 49.23 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 51.7 Cg_endo -73.09 -11.99 25.53 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.357 2.038 . . . . 0.0 112.429 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 43.8 m-20 -165.14 136.87 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 27.7 p90 -149.64 21.66 0.91 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.669 -1.27 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 44.0 mtp -97.29 -41.33 8.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.923 -1.111 . . . . 0.0 109.752 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -93.6 -25.56 17.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -81.76 -20.62 38.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.278 -0.889 . . . . 0.0 109.549 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 mtp -101.29 -25.65 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 109.966 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.11 57.19 2.87 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.4 mtp -130.04 140.15 50.9 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -1.15 . . . . 0.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.8 p-10 -93.07 53.64 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.235 -0.915 . . . . 0.0 109.306 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.1 p30 152.98 -171.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.557 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -97.72 -167.02 1.46 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 46' ' ' TYR . 59.5 t -77.73 140.96 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -105.81 -17.0 14.51 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.577 -1.327 . . . . 0.0 107.827 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.865 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.34 157.96 44.98 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.079 -1.013 . . . . 0.0 109.87 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 26' ' ' LEU . 15.7 p -153.03 143.35 22.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.622 0.725 . . . . 0.0 110.432 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.418 HH22 ' CG ' ' A' ' 83' ' ' PRO . 78.0 ttt-85 -137.71 140.22 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.7 ttp -90.72 151.23 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.727 ' N ' HD12 ' A' ' 82' ' ' ILE . 2.1 mp -74.02 123.22 89.08 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.028 . . . . 0.0 109.197 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD2' ' CE1' ' A' ' 131' ' ' HIS . 73.2 Cg_exo -45.71 177.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.337 2.025 . . . . 0.0 112.549 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.3 mt -102.65 64.8 0.89 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.409 -0.807 . . . . 0.0 109.617 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -46.25 147.73 1.04 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.168 -0.958 . . . . 0.0 109.739 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.27 33.13 0.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.024 -1.047 . . . . 0.0 109.591 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.06 -90.61 0.62 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 17.4 m -164.93 -171.32 2.21 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.61 -0.935 . . . . 0.0 110.148 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -120.38 128.66 53.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.598 0.713 . . . . 0.0 109.958 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -168.93 125.37 0.94 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.0 ttm -116.72 135.84 53.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 0.0 109.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -106.62 118.03 35.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 103' ' ' MET . 19.4 mt -101.29 148.5 25.06 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.257 1.027 . . . . 0.0 112.514 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD2' ' SD ' ' A' ' 99' ' ' MET . 38.2 m-85 -132.27 121.88 24.29 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 88.3 tt0 -61.88 -27.86 69.1 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 111.055 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.557 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.06 164.26 12.44 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.523 -1.361 . . . . 0.0 111.062 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.577 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 75.0 p -61.88 157.83 17.45 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.514 -0.741 . . . . 0.0 109.731 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 97' ' ' SER . 29.8 t0 83.47 -95.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.078 -1.014 . . . . 0.0 108.763 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' CD2' ' A' ' 94' ' ' TYR . 21.1 mmt -163.54 30.88 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -98.05 -155.56 29.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 60.29 -179.24 2.62 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -67.42 132.0 46.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.279 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 11.8 ptt? -93.67 118.24 31.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.3 mtm -119.51 140.73 50.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.053 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -100.71 137.8 38.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.177 -0.952 . . . . 0.0 109.508 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.8 OUTLIER -120.65 117.53 27.77 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.604 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 14.9 ttt -129.96 27.45 5.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 109' ' ' ASP . 17.0 t70 -151.31 -172.26 4.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.518 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 90.1 m-20 -82.95 131.18 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -111.8 84.19 5.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.031 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.4 Cg_endo -77.37 -28.59 5.49 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.243 1.962 . . . . 0.0 111.937 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' O ' ' OD1' ' A' ' 112' ' ' ASN . 22.3 p30 -138.17 82.82 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -63.15 -22.95 67.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.351 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 8.1 tpt -58.6 -40.67 83.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.592 0.711 . . . . 0.0 109.414 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -81.57 -22.24 37.91 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 110.335 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -77.57 -64.41 1.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.709 -1.244 . . . . 0.0 111.376 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -108.36 3.03 22.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 110.61 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 114' ' ' MET . 2.4 m-20 54.4 34.6 21.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.886 -1.134 . . . . 0.0 108.932 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 8.6 ptm -148.06 133.65 18.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 54.6 p -116.92 7.55 13.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 110.519 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 163' ' ' SER . 73.6 m-20 -131.3 93.16 3.31 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.361 -1.462 . . . . 0.0 113.379 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -105.19 133.87 49.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.04 4.07 54.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.992 -1.067 . . . . 0.0 111.688 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.2 t -156.23 161.5 40.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 119.758 -1.839 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.48 170.54 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.86 145.81 25.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 76.2 t -113.8 123.37 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.2 tpp -78.13 -34.15 50.09 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 11.7 t70 -177.46 175.77 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.155 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 78.37 -142.2 25.74 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.467 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 90.4 m-70 -151.51 135.26 16.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.662 -0.905 . . . . 0.0 109.094 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -126.02 132.21 52.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 0.0 112.269 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -104.08 133.09 49.61 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 53.4 t -111.9 144.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.752 -1.218 . . . . 0.0 109.64 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.535 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 47.8 m-85 -120.73 123.37 42.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 111.128 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 164' ' ' ARG . 80.2 tt0 -57.03 -28.03 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -118.02 155.69 50.98 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.501 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 25.1 Cg_endo -62.0 -177.12 0.24 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.313 2.675 . . . . 0.0 113.661 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.589 ' N ' ' OG ' ' A' ' 167' ' ' SER . 66.6 m-20 48.67 35.49 6.33 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.622 0.725 . . . . 0.0 110.545 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.726 ' H ' ' CB ' ' A' ' 167' ' ' SER . 8.1 m-85 55.5 52.09 11.75 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.751 -0.593 . . . . 0.0 109.984 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 142' ' ' GLY . 90.5 m -136.94 162.54 32.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.119 -0.988 . . . . 0.0 109.77 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.45 -179.99 32.18 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -54.2 109.89 0.54 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -1.045 . . . . 0.0 108.737 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 13.0 mt-30 -84.58 141.75 30.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.8 132.28 53.75 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -94.78 105.47 17.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.369 -0.832 . . . . 0.0 109.763 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.512 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.9 mp -100.47 121.5 41.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.567 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 2.2 ptt180 -109.48 164.14 15.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.5 Cg_exo -32.12 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.76 2.307 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.81 -166.59 13.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.95 135.05 55.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -1.002 . . . . 0.0 110.332 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.567 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 91.6 m-85 -109.77 144.3 38.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.62 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 93.4 mtt180 -129.84 -12.09 4.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.004 . . . . 0.0 112.572 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.54 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.3 p -170.29 170.24 7.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.966 -1.709 . . . . 0.0 110.538 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.547 ' HA ' ' CE2' ' A' ' 158' ' ' TRP . 0.1 OUTLIER -53.4 -19.12 3.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.645 -0.659 . . . . 0.0 109.606 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -84.72 2.23 42.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.069 -1.019 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -57.78 2.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.098 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.547 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 8.4 p90 -79.32 17.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.89 42.37 94.97 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -109.73 -169.51 20.13 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 162' ' ' THR . 4.2 m -151.66 14.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 161' ' ' VAL . 34.8 p -160.6 -163.7 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 16.8 p -137.77 5.29 2.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 109.732 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 136' ' ' GLU . 88.5 mtt180 -65.89 73.8 0.07 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 0.0 112.266 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.2 mtt -102.45 117.94 35.79 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.193 -0.942 . . . . 0.0 109.502 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.93 -26.62 4.33 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.726 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.0 151.6 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.618 -1.519 . . . . 0.0 111.601 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.07 141.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.99 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -126.72 140.95 52.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.221 -0.924 . . . . 0.0 110.632 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.755 ' O ' ' N ' ' A' ' 172' ' ' THR . 30.3 mtp180 -94.62 102.72 14.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.284 -0.885 . . . . 0.0 108.939 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -45.57 69.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.521 -0.737 . . . . 0.0 112.136 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 170' ' ' ARG . 20.6 p -116.78 64.64 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.161 -0.962 . . . . 0.0 110.357 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -175.5 104.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.224 -0.923 . . . . 0.0 109.304 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.482 ' OXT' ' CZ ' ' A' ' 60' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.902 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 mtm . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.289 0.566 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -63.04 162.31 31.86 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -151.87 145.06 24.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.468 -1.019 . . . . 0.0 110.555 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' CD2' ' A' ' 43' ' ' PHE . 15.2 tt -133.44 135.17 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.881 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.3 mt -119.36 128.73 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -93.84 154.51 17.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -141.12 133.93 28.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 108.927 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -72.2 -33.36 67.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 111.296 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -87.8 151.06 23.16 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.721 -1.237 . . . . 0.0 110.601 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 65' ' ' ASP . 84.3 mtt-85 -67.34 -39.87 85.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.513 -0.742 . . . . 0.0 109.876 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -80.86 38.07 0.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 109.847 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 54.01 64.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 109.471 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.91 -157.68 8.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.16 -151.12 51.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -71.85 121.12 18.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -1.147 . . . . 0.0 108.961 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -102.83 157.86 16.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.247 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.629 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 17.3 t-80 -149.08 124.61 10.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.542 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -98.44 118.15 34.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.042 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' ND1' ' A' ' 17' ' ' HIS . 2.7 m -119.57 139.64 51.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 0.0 109.332 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -144.16 8.33 1.41 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.5 t -140.66 154.01 46.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.469 -0.769 . . . . 0.0 110.735 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 54.0 p30 -47.94 154.43 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.765 . . . . 0.0 110.295 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 15.3 t -154.99 111.79 3.28 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.97 -1.56 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 42.1 p-10 -142.96 99.42 3.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 76' ' ' VAL . 27.7 mt -97.8 -22.35 16.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.031 -1.043 . . . . 0.0 109.079 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 21.1 t-80 -55.98 -37.15 68.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -49.05 -52.88 22.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 50.8 m-85 -63.31 -45.64 90.39 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 0.0 111.319 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 20.3 p90 -155.19 151.0 27.64 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.018 -1.051 . . . . 0.0 110.091 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -92.53 -3.59 54.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.119 -0.988 . . . . 0.0 110.117 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -164.72 162.45 21.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.542 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 42.2 t -161.64 131.28 4.69 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 84.4 m-70 -110.49 -7.98 14.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.079 -1.013 . . . . 0.0 109.276 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m -135.2 142.8 46.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.931 -1.106 . . . . 0.0 110.459 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -136.28 145.82 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -135.87 116.46 13.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.889 -1.132 . . . . 0.0 111.204 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 21.7 t -103.82 118.69 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.425 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.0 t -169.89 146.33 3.13 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.493 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.581 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 96.14 -130.74 10.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 62.7 m -160.88 155.91 24.23 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.509 ' CD2' HD13 ' A' ' 4' ' ' ILE . 5.3 t80 -140.48 131.87 26.81 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.082 -1.011 . . . . 0.0 109.012 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -98.19 112.86 24.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.51 141.84 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.885 0.85 . . . . 0.0 110.411 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.612 ' O ' HG13 ' A' ' 76' ' ' VAL . 28.0 m-85 -118.13 137.38 52.99 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.887 0.851 . . . . 0.0 111.046 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 47' ' ' ASP . 42.7 t0 -71.43 -11.68 61.01 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.734 ' O ' ' HB2' ' A' ' 78' ' ' SER . 26.2 ttt-85 -127.88 157.66 39.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.122 -0.986 . . . . 0.0 108.436 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.501 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 18.9 p -68.79 158.08 35.11 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.632 -0.667 . . . . 0.0 111.475 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.584 ' N ' ' OG ' ' A' ' 78' ' ' SER . 18.3 m-20 67.41 36.69 3.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 111.635 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.455 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.8 m-85 58.25 59.56 2.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.7 mtt -145.38 167.06 23.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.69 -165.63 33.69 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -60.22 124.01 18.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.09 136.71 42.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.96 138.48 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 109.85 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 38.6 p90 -101.83 122.68 44.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.304 -0.872 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.2 mt -113.06 117.5 32.18 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.933 -1.105 . . . . 0.0 111.555 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.0 ptt180 -92.71 157.03 16.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 111.209 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' C ' ' O ' ' A' ' 59' ' ' ARG . 68.9 ttt180 -31.99 109.48 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.43 0.633 . . . . 0.0 110.691 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 178.07 168.58 37.76 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -103.92 123.26 46.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.04 98.1 12.88 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.55 -20.06 65.45 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.254 1.969 . . . . 0.0 112.015 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 10' ' ' ARG . 15.2 t0 -167.07 147.01 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 28.5 p90 -148.22 25.0 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.256 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 7.3 mmt -95.61 -42.35 8.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.373 -0.83 . . . . 0.0 109.427 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -98.09 -17.1 19.28 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.53 -10.52 45.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.715 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.8 mmt -114.32 -33.8 5.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.26 53.15 3.74 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtp -121.72 143.83 49.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -1.008 . . . . 0.0 109.35 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 29.8 t30 -94.27 57.57 2.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.962 . . . . 0.0 109.174 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.35 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.542 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.4 p -100.42 -167.59 1.46 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.935 0.874 . . . . 0.0 109.544 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 46' ' ' TYR . 54.3 t -74.72 139.81 18.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.442 ' HB3' HG22 ' A' ' 49' ' ' THR . 93.4 mtt180 -107.54 -13.84 14.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.616 -1.303 . . . . 0.0 108.335 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.734 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -149.11 165.84 30.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.963 -1.086 . . . . 0.0 109.533 177.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.2 p -163.04 154.44 17.43 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.967 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.507 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 59.0 ttt180 -136.13 141.18 44.12 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 ptm -88.33 142.35 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.078 -1.014 . . . . 0.0 109.085 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.547 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 90.4 mt -93.92 113.73 61.29 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 108.699 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.77 150.56 2.49 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.121 1.88 . . . . 0.0 112.383 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.4 mt -92.49 47.35 1.3 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 109.523 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -112.64 132.25 55.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.482 -0.761 . . . . 0.0 109.104 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -135.83 73.34 1.46 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.317 -0.864 . . . . 0.0 109.711 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.18 -85.96 0.37 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.3 m -125.49 149.83 47.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.347 -1.09 . . . . 0.0 110.708 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -114.3 121.14 42.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.57 -0.707 . . . . 0.0 109.891 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -170.32 128.27 0.84 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.446 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 40.9 ttm -112.2 130.69 55.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.97 -1.081 . . . . 0.0 109.289 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -104.69 116.15 31.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 103' ' ' MET . 13.1 mt -100.46 149.0 24.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.112 0.958 . . . . 0.0 112.556 -177.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' O ' ' A' ' 99' ' ' MET . 31.2 m-85 -135.04 125.0 25.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 86.1 tt0 -63.28 -22.76 67.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.853 -1.154 . . . . 0.0 111.767 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.844 ' O ' ' OG ' ' A' ' 124' ' ' SER . 3.0 m-70 -113.61 162.42 16.23 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.132 -1.605 . . . . 0.0 111.504 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 25.2 p -59.19 158.54 8.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.302 -0.874 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 97' ' ' SER . 5.8 m-20 81.64 -96.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.544 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 17.1 mmt -163.68 30.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.18 -159.93 32.41 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.76 -162.89 47.69 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.451 ' O ' ' HE3' ' A' ' 104' ' ' MET . 57.7 mtp180 -85.81 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -1.172 . . . . 0.0 109.218 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.7 ptt? -95.81 113.65 25.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 110.262 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.451 ' HE3' ' O ' ' A' ' 102' ' ' ARG . 1.3 mpt? -110.66 140.46 45.0 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.59 136.6 43.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.422 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -130.8 120.76 24.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ttt -117.83 -15.84 10.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 52.6 p30 -107.63 -157.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 17.8 p-10 -93.85 138.1 32.37 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -118.99 86.3 31.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.204 -0.935 . . . . 0.0 110.354 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.81 -28.13 6.58 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.178 1.919 . . . . 0.0 112.143 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -129.74 83.9 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.34 -27.63 65.52 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.7 mtp -55.41 -39.15 69.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.203 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -84.84 -20.94 30.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.294 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -77.32 -62.3 1.7 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.654 -1.278 . . . . 0.0 110.334 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -109.02 1.71 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 110.455 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.2 m120 57.66 36.62 26.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.068 . . . . 0.0 109.83 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.453 ' CG ' ' CE2' ' A' ' 122' ' ' PHE . 8.7 ptm -152.44 136.36 16.34 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.4 p -114.41 8.0 16.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.06 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 163' ' ' SER . 46.5 p-10 -134.42 98.56 4.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.348 -1.47 . . . . 0.0 113.898 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.62 134.61 51.75 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -96.83 4.4 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.015 -1.053 . . . . 0.0 111.478 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.844 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -151.02 156.66 41.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.93 -1.731 . . . . 0.0 110.43 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' CYS . . . . . 0.446 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 16.0 t -165.42 164.66 19.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.268 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.83 144.92 26.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.021 -1.049 . . . . 0.0 109.346 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 74.5 t -115.4 126.68 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.8 ttt -76.54 -21.83 55.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.601 -0.687 . . . . 0.0 109.793 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 162.16 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.722 0.773 . . . . 0.0 110.947 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.63 -140.57 21.95 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.591 ' CE1' ' HH ' ' A' ' 146' ' ' TYR . 60.2 m-70 -148.45 130.11 15.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.948 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -123.38 132.34 53.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.392 -0.818 . . . . 0.0 111.648 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.9 mt -103.69 130.16 51.13 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 41.6 t -109.94 142.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.957 -1.089 . . . . 0.0 109.574 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 58.6 m-85 -117.84 124.36 48.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.609 -0.682 . . . . 0.0 111.936 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.4 tt0 -59.26 -27.06 65.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.0 mp0 -122.64 153.99 63.16 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.228 -0.92 . . . . 0.0 108.621 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.417 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 22.6 Cg_endo -61.29 -175.23 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 123.417 2.744 . . . . 0.0 113.602 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 49.29 33.96 5.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.591 0.71 . . . . 0.0 110.055 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.435 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 31.4 m-85 54.22 52.18 13.1 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.484 0.659 . . . . 0.0 109.939 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 142' ' ' GLY . 85.4 m -137.02 162.18 34.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.576 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 141' ' ' THR . . . 99.12 177.38 31.81 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -53.95 109.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.666 -0.903 . . . . 0.0 108.604 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.9 mt-30 -84.49 145.81 27.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 109.409 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -129.39 127.79 41.72 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.195 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.591 ' HH ' ' CE1' ' A' ' 131' ' ' HIS . 1.8 t80 -89.81 106.03 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 147' ' ' LEU . 6.8 mp -102.24 123.83 46.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.445 -0.784 . . . . 0.0 109.134 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.569 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -111.48 169.13 6.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' A' ' 148' ' ' ARG . 15.0 Cg_exo -32.76 162.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.846 2.364 . . . . 0.0 112.182 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.39 -169.69 13.36 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.28 133.38 55.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.554 -0.968 . . . . 0.0 110.52 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.569 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 98.3 m-85 -106.87 142.75 36.0 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' SER . 44.1 ptt85 -131.89 -6.61 3.55 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.848 -1.157 . . . . 0.0 113.222 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 153' ' ' ARG . 3.8 m -172.22 170.13 5.23 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.537 -1.977 . . . . 0.0 111.018 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.61 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -56.65 -24.12 46.2 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -78.99 -1.75 36.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.224 -0.922 . . . . 0.0 109.301 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 159' ' ' GLY . 3.5 t0 -89.1 -61.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.593 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 7.0 p90 -74.35 16.17 0.28 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.76 34.23 89.36 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.01 -165.95 32.81 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 161' ' ' VAL . 47.9 t -146.16 -8.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.811 -0.817 . . . . 0.0 109.098 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -139.69 -156.36 0.67 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.5 p -139.79 5.32 2.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.353 -0.842 . . . . 0.0 109.797 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 136' ' ' GLU . 48.0 mtp180 -62.34 74.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.072 -1.017 . . . . 0.0 112.126 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 163' ' ' SER . 65.0 mtt -105.11 116.5 32.06 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.051 -1.031 . . . . 0.0 110.051 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.12 -22.96 4.72 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.225 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.36 150.9 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 119.572 1.686 . . . . 0.0 111.407 -178.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.81 141.36 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.265 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -128.68 144.07 51.08 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.178 -0.951 . . . . 0.0 110.368 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 172' ' ' THR . 16.2 ptt180 -102.46 91.12 4.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 131' ' ' HIS . 0.8 OUTLIER -40.39 86.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.495 -0.753 . . . . 0.0 111.027 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 170' ' ' ARG . 3.6 t -127.06 76.68 1.67 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.977 -1.077 . . . . 0.0 108.895 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 0.8 OUTLIER 169.46 111.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.34 -0.85 . . . . 0.0 109.09 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.2 tp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.401 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -141.11 144.95 35.18 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.514 -0.992 . . . . 0.0 110.543 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.605 HD13 ' CD2' ' A' ' 43' ' ' PHE . 15.9 tt -135.46 135.03 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.22 128.97 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.414 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.8 140.6 31.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.368 -0.833 . . . . 0.0 109.24 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -125.82 136.07 52.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.711 -1.243 . . . . 0.0 109.343 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -72.41 -38.49 68.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 110.208 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.3 t70 -83.27 157.68 22.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.068 -1.02 . . . . 0.0 110.122 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 38.1 ptt85 -71.68 -39.91 69.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.013 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.476 ' OD1' ' NH1' ' A' ' 10' ' ' ARG . 88.6 m-20 -78.26 38.13 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.619 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 53.94 47.14 24.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 109.464 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.57 -158.19 8.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.72 -149.43 49.5 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -73.78 118.73 17.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -1.165 . . . . 0.0 109.221 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -100.73 155.58 17.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -146.0 124.08 12.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.08 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -97.89 121.83 40.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.14 -0.975 . . . . 0.0 109.808 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -122.33 137.79 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 81' ' ' MET . 21.3 ptt? -140.76 10.02 2.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.393 -0.817 . . . . 0.0 108.941 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -144.81 158.81 43.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.993 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 49.4 p30 -46.51 161.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.504 -0.748 . . . . 0.0 109.807 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.4 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 3.6 t -161.66 110.0 1.48 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' A' ' 50' ' ' ASN . . . -94.6 40.56 1.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 14.1 p30 -177.39 91.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.993 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD21 ' SG ' ' A' ' 79' ' ' CYS . 96.4 mt -98.04 -22.45 16.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.906 . . . . 0.0 108.87 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.55 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 22.3 t-80 -57.93 -42.67 85.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 108.758 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -59.67 -16.65 28.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.741 -0.599 . . . . 0.0 109.841 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -99.98 -47.64 4.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.51 145.95 21.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.261 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 71.3 m-20 -97.34 -7.49 31.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 110.404 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -149.35 149.4 30.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.139 -0.976 . . . . 0.0 108.632 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 38.9 t -154.55 114.52 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -96.12 -16.55 21.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.716 -0.615 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 t -133.77 142.58 47.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.899 -1.126 . . . . 0.0 110.801 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.97 145.95 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -134.7 121.13 20.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.053 . . . . 0.0 111.278 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.97 117.83 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.67 -32.33 23.67 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.5 t -168.4 151.79 5.64 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.224 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 -165.19 43.06 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -123.74 153.38 40.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.397 -1.061 . . . . 0.0 109.546 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.605 ' CD2' HD13 ' A' ' 4' ' ' ILE . 4.2 t80 -133.64 133.39 41.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.0 tpt -103.06 122.52 44.82 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.686 ' HB ' HG11 ' A' ' 76' ' ' VAL . 21.0 m -115.05 146.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.03 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.497 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.0 m-85 -121.82 143.77 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.681 0.753 . . . . 0.0 110.481 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.76 -7.81 58.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.799 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.5 ttm180 -131.21 157.98 41.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p -69.84 155.7 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.962 0.887 . . . . 0.0 111.231 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.419 HD22 ' HB1' ' A' ' 24' ' ' ALA . 1.1 m120 71.93 33.5 1.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.377 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.0 m-85 61.62 55.22 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.914 -1.116 . . . . 0.0 110.049 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 50.2 mtt -143.73 174.19 11.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.302 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.65 -170.03 47.71 Favored Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.834 -1.166 . . . . 0.0 110.246 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -55.15 119.85 6.11 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -1.059 . . . . 0.0 108.418 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -101.34 132.25 46.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.331 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -124.48 136.39 53.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.995 . . . . 0.0 109.607 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -100.59 116.45 32.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 0.0 109.463 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.51 139.13 42.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 108.556 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.3 ptt180 -113.25 161.38 17.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.054 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 59' ' ' ARG . 39.9 ttp180 -35.17 115.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.509 -0.745 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.09 169.69 31.89 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.45 127.77 53.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.481 -1.011 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -107.04 100.28 31.36 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 39.6 Cg_endo -70.01 -20.11 34.1 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.38 2.053 . . . . 0.0 112.716 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 42.2 m-20 -163.65 138.66 6.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.512 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.5 p90 -148.63 26.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.548 -1.345 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.4 mtt -99.99 -43.62 6.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.933 -1.104 . . . . 0.0 109.176 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -94.61 -22.67 18.02 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.9 m -82.1 -19.41 40.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.669 -0.644 . . . . 0.0 109.835 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 mmt -105.58 -23.35 12.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.98 -1.075 . . . . 0.0 109.012 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.88 51.98 4.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.0 mtp -123.13 -171.48 2.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.044 -1.268 . . . . 0.0 109.639 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 63.4 t30 -145.79 55.99 1.2 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.168 -0.958 . . . . 0.0 109.371 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.0 m-20 150.23 -169.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -96.69 -167.11 1.5 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.341 -0.849 . . . . 0.0 109.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.686 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.5 m -88.85 148.69 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -106.74 -11.08 15.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.058 -1.027 . . . . 0.0 108.376 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.799 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.44 172.54 13.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.049 -1.032 . . . . 0.0 110.313 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' SG ' HD21 ' A' ' 26' ' ' LEU . 22.1 p -172.09 156.75 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.869 0.842 . . . . 0.0 110.84 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -134.6 139.58 45.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' A' ' 20' ' ' MET . 59.5 ttp -91.43 143.12 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.067 -1.02 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.2 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 108.943 179.403 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 63.9 m . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.445 0.641 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -110.76 116.82 31.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -169.4 125.25 0.87 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 108.775 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.406 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 42.8 ttm -107.09 121.02 43.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -95.15 115.63 27.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.0 mt -103.7 147.49 27.18 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.142 0.972 . . . . 0.0 112.55 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.559 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 30.6 m-85 -135.37 127.28 29.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.491 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 50.2 tt0 -61.52 -27.97 68.98 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 111.818 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.881 ' O ' ' OG ' ' A' ' 124' ' ' SER . 5.9 m-70 -109.72 165.67 11.51 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.671 -1.268 . . . . 0.0 111.202 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.7 m -60.52 157.06 14.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 97' ' ' SER . 8.7 t70 81.82 -96.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.8 mmt -163.29 33.09 0.09 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.71 -160.13 31.91 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.313 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 65.0 -149.33 51.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.423 ' H ' ' HB2' ' A' ' 95' ' ' GLU . 76.5 mtm-85 -96.14 139.55 32.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.3 ptt? -96.09 119.48 34.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.195 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 104' ' ' MET . 0.3 OUTLIER -115.62 135.8 53.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.009 -1.057 . . . . 0.0 108.817 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.14 132.19 43.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.9 OUTLIER -129.02 117.18 20.48 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 74.7 mtp -123.25 13.62 9.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.548 ' H ' HD23 ' A' ' 106' ' ' LEU . 42.3 p30 -140.09 -162.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.952 . . . . 0.0 110.176 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 2.0 p30 -87.04 133.22 33.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.57 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -117.73 90.81 37.06 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.434 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.94 -28.09 5.3 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.206 1.938 . . . . 0.0 112.286 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -135.28 84.99 2.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.79 -27.91 66.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.552 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.5 tpt -57.01 -39.73 75.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.59 0.709 . . . . 0.0 109.205 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -84.13 -22.05 31.2 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.012 -1.055 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -79.32 -63.07 1.5 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.58 -1.325 . . . . 0.0 111.633 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -104.6 1.05 29.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.319 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 114' ' ' MET . 17.8 t30 58.87 32.5 22.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.909 -1.119 . . . . 0.0 109.425 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 4.7 ptm -150.32 133.06 15.91 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 53.7 p -116.57 5.93 13.38 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 120' ' ' SER . 53.9 m-20 -130.01 90.99 3.05 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.723 -1.236 . . . . 0.0 112.471 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.654 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -100.95 130.94 47.02 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.059 -1.026 . . . . 0.0 108.554 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -93.89 2.92 56.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 0.0 110.92 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.881 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.9 p -147.83 154.07 39.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.146 -1.596 . . . . 0.0 109.935 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 23.0 t -165.36 163.71 19.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.885 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.554 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 7.0 t60 -152.45 148.15 27.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 65.4 t -115.95 125.35 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.937 0.875 . . . . 0.0 109.252 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 10.0 tpt -72.79 -32.66 65.73 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 172.95 167.15 0.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.827 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.93 -155.19 28.68 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.541 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 89.6 m-70 -135.49 130.12 34.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.552 -0.97 . . . . 0.0 110.184 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -121.42 131.13 53.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.549 -0.719 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.484 HD22 ' NE2' ' A' ' 144' ' ' GLN . 5.2 mt -100.86 130.26 46.84 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 34.9 t -109.08 143.45 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.835 -1.166 . . . . 0.0 109.546 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.446 ' OH ' ' NH2' ' A' ' 169' ' ' ARG . 90.4 m-85 -121.04 125.63 47.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.729 -0.607 . . . . 0.0 110.906 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -60.26 -26.09 66.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 167' ' ' SER . 26.0 mt-30 -121.68 154.0 59.98 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 20.3 Cg_endo -60.64 -171.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 123.197 2.598 . . . . 0.0 113.676 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m120 46.43 30.32 1.05 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.511 0.672 . . . . 0.0 110.149 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.532 ' H ' ' CB ' ' A' ' 167' ' ' SER . 18.5 m-85 57.69 52.43 8.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.419 -0.801 . . . . 0.0 109.924 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -138.4 166.09 25.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.15 -179.82 33.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -55.33 113.25 1.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -1.026 . . . . 0.0 109.121 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.484 ' NE2' HD22 ' A' ' 133' ' ' LEU . 19.2 tt0 -87.58 141.41 28.63 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.149 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -123.85 133.91 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.541 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 81.1 t80 -95.16 102.28 14.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.517 -0.739 . . . . 0.0 109.763 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.1 mp -97.69 120.94 38.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 149' ' ' PRO . 0.9 OUTLIER -104.96 -178.49 0.62 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 148' ' ' ARG . 51.9 Cg_exo -52.39 154.21 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.217 1.944 . . . . 0.0 111.847 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.19 -166.33 14.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.23 136.71 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -1.098 . . . . 0.0 110.44 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.54 143.45 42.38 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.679 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 59.1 mtm180 -130.09 -5.84 4.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.141 -0.974 . . . . 0.0 112.537 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 10.0 t -172.01 -178.45 2.14 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.111 -1.618 . . . . 0.0 110.726 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.5 OUTLIER -60.44 -26.88 67.07 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.508 HD22 ' N ' ' A' ' 156' ' ' ASN . 2.3 m120 -80.19 2.53 23.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.096 -1.002 . . . . 0.0 109.911 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.679 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -93.01 -61.13 1.64 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.167 -0.958 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -78.15 18.0 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.5 38.44 95.76 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -108.65 -160.85 20.07 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.7 t -148.75 -41.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.8 p -102.71 -158.34 0.66 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.4 p -144.36 11.68 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.842 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -63.89 74.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.096 -1.003 . . . . 0.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.47 119.88 39.45 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.248 -0.908 . . . . 0.0 109.772 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.1 -25.98 3.67 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.532 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.94 152.09 51.43 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 119.274 1.537 . . . . 0.0 111.202 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.92 142.69 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.639 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.446 ' NH2' ' OH ' ' A' ' 135' ' ' TYR . 45.3 ttp180 -123.7 136.57 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -96.05 98.08 10.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.548 -0.72 . . . . 0.0 109.4 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.005 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -149.67 147.31 27.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.166 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.669 HD13 ' CD2' ' A' ' 43' ' ' PHE . 13.0 tt -133.9 136.79 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 110.09 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.5 mt -122.89 130.69 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.524 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -99.21 135.09 41.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.038 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -120.17 135.2 55.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -73.8 -32.62 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.956 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -81.88 161.58 23.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.8 -44.17 33.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.981 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.68 47.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 51.25 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.539 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.53 -175.74 47.72 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.8 -146.06 23.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -75.82 116.42 16.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.972 -1.31 . . . . 0.0 108.699 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -98.19 157.96 15.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.814 . . . . 0.0 109.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -148.14 122.5 9.67 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.21 -0.931 . . . . 0.0 108.873 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -97.64 120.72 38.53 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -124.43 137.55 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -140.88 11.05 2.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -141.48 155.16 45.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 110.147 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 2.9 p30 -53.26 141.03 24.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.452 -0.78 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 t -138.93 120.45 15.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.97 -4.68 58.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.016 -1.053 . . . . 0.0 109.576 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -140.23 93.98 2.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 26' ' ' LEU . 34.2 mt -91.13 -16.29 28.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.178 -0.951 . . . . 0.0 108.494 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -58.95 -39.94 83.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.806 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -59.97 -18.69 47.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.481 -0.762 . . . . 0.0 110.514 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.78 -43.26 8.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -158.86 153.87 25.14 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.325 0.583 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.698 HD22 ' H ' ' A' ' 31' ' ' ASN . 0.7 OUTLIER -100.41 -7.81 23.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -154.04 153.39 31.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.006 -1.059 . . . . 0.0 108.475 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.589 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 46.2 t -155.98 122.78 5.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.593 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 36.9 m-70 -104.63 -12.45 16.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.744 . . . . 0.0 109.94 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 t -136.06 142.27 44.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.974 . . . . 0.0 110.422 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.8 145.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -137.02 116.5 12.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.896 -1.127 . . . . 0.0 111.276 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.58 119.52 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.37 -32.72 22.26 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 108.945 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.0 t -171.24 153.46 3.66 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.244 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.57 -169.05 38.73 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 53.9 m -118.93 156.69 29.09 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.287 -1.125 . . . . 0.0 109.151 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CD2' HD13 ' A' ' 4' ' ' ILE . 10.7 t80 -145.53 134.77 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 108.994 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.61 ' SD ' ' CD2' ' A' ' 146' ' ' TYR . 10.7 ttm -107.24 126.24 52.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.77 143.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.122 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.7 ' O ' HG13 ' A' ' 76' ' ' VAL . 43.5 m-85 -116.8 139.94 50.02 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.63 0.728 . . . . 0.0 110.863 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 26.3 t0 -76.37 -10.0 59.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.503 -0.748 . . . . 0.0 110.013 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.697 ' O ' ' HB3' ' A' ' 78' ' ' SER . 71.5 mtt-85 -131.61 155.44 47.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 108.525 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.2 p -65.98 158.07 29.19 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.682 0.754 . . . . 0.0 110.953 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 70.73 35.47 1.8 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.094 0.473 . . . . 0.0 111.76 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.496 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.4 m-85 58.58 54.97 5.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.913 -1.117 . . . . 0.0 109.952 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.403 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 83.2 mmm -144.32 178.43 7.92 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.219 -0.925 . . . . 0.0 109.843 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.33 -173.44 53.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -54.91 124.58 17.1 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.157 -1.202 . . . . 0.0 108.427 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -102.74 133.48 47.71 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -126.47 133.58 51.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.19 -0.944 . . . . 0.0 109.36 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -96.9 120.97 38.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.179 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.32 117.33 28.26 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.147 -0.971 . . . . 0.0 111.248 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.496 ' O ' ' C ' ' A' ' 60' ' ' ARG . 62.0 ttt-85 -95.33 161.85 13.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 111.302 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 59' ' ' ARG . 47.1 ttp180 -29.33 115.14 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.433 0.635 . . . . 0.0 110.638 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.92 169.49 32.38 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 9.3 pt-20 -108.5 128.44 54.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.483 -1.01 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -106.7 98.25 20.09 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.403 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 35.3 Cg_endo -67.5 -18.92 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.314 2.01 . . . . 0.0 112.362 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 32.5 m-20 -164.84 139.47 5.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -146.44 3.13 0.87 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.48 -1.387 . . . . 0.0 111.194 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.593 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 30.6 mtp -77.64 -39.93 43.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.13 -21.59 17.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.958 . . . . 0.0 109.42 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.2 m -83.4 -16.34 46.3 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.474 -0.767 . . . . 0.0 109.703 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mmt -109.5 -25.34 10.53 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.91 44.81 8.03 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.262 -0.97 . . . . 0.0 110.977 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.0 mtp -114.71 159.3 20.7 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.272 . . . . 0.0 109.585 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 28.8 p30 -110.4 55.8 0.64 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.101 -0.999 . . . . 0.0 109.302 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.7 p30 152.67 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.589 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.8 p -96.97 -175.09 3.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.066 0.936 . . . . 0.0 110.255 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 46' ' ' TYR . 59.7 t -68.09 141.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.27 -17.91 14.16 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.707 -1.245 . . . . 0.0 107.821 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.697 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -145.49 168.85 19.59 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.422 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 22.9 p -161.68 146.22 13.02 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.492 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH1' ' NE ' ' A' ' 148' ' ' ARG . 63.9 ttt180 -132.43 140.3 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.5 tpp -92.36 143.1 26.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.602 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 17.2 mt . . . . . 0 C--N 1.302 -1.48 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 74.6 p . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 121.407 0.622 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -111.96 119.61 39.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.524 -0.735 . . . . 0.0 109.491 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -167.9 129.24 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.3 ttm -117.02 127.66 54.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.325 -0.859 . . . . 0.0 109.269 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -101.06 119.22 38.43 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 125' ' ' CYS . 15.9 mt -101.3 149.06 24.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.119 0.961 . . . . 0.0 112.067 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 99' ' ' MET . 38.3 m-85 -132.95 122.94 25.02 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 52.6 tt0 -62.12 -26.04 68.08 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.195 -0.941 . . . . 0.0 111.828 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.93 165.4 11.6 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.839 -1.163 . . . . 0.0 110.908 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 6.1 p -63.53 158.18 21.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.8 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 97' ' ' SER . 32.2 t0 81.67 -95.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.543 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 19.9 mmt -161.64 33.56 0.13 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.18 -153.1 26.05 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.019 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 62.87 -165.57 25.11 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.455 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 79.1 mtm180 -81.01 143.74 32.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.334 . . . . 0.0 108.842 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.4 mtt -98.21 115.45 28.36 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.922 -1.111 . . . . 0.0 109.447 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.3 mpp? -114.42 135.38 54.16 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.109 -0.994 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.56 132.1 45.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.708 HD11 ' HB2' ' A' ' 110' ' ' CYS . 1.0 OUTLIER -122.79 115.78 22.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.2 ttt -126.16 13.09 7.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.815 . . . . 0.0 109.399 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.542 ' H ' HD23 ' A' ' 106' ' ' LEU . 77.3 m-20 -136.71 -167.68 2.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.626 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -81.99 130.9 35.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.708 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -118.69 78.64 15.61 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 109.52 -179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -78.07 -25.8 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.087 1.858 . . . . 0.0 112.233 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 51.2 p-10 -131.27 75.61 1.66 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -18.54 61.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.93 -1.106 . . . . 0.0 110.41 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.5 tpt -60.88 -42.21 97.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -82.91 -21.51 34.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.382 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -77.21 -62.15 1.75 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.691 -1.256 . . . . 0.0 111.125 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.05 2.68 15.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.489 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' MET . 41.3 m-20 50.85 35.36 12.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.871 -1.143 . . . . 0.0 108.769 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.5 ptm -148.3 135.64 20.44 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 78.6 p -125.91 7.09 7.34 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.478 -0.764 . . . . 0.0 111.015 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 163' ' ' SER . 66.6 m-20 -128.42 85.68 2.37 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.552 -1.342 . . . . 0.0 112.786 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -98.74 134.69 41.29 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.95 -1.094 . . . . 0.0 108.7 177.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -94.45 2.18 55.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.0 111.264 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.5 t -149.92 156.3 41.51 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.156 -1.59 . . . . 0.0 109.846 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.539 ' HB3' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -162.69 162.16 26.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -147.95 143.36 27.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.143 -0.973 . . . . 0.0 109.89 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.9 t -114.26 121.02 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.286 -0.884 . . . . 0.0 109.359 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 23.1 ttt -70.32 -39.44 74.78 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.565 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 0.5 OUTLIER -179.08 173.66 1.14 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.253 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 86.33 -144.13 19.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.56 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 66.3 m-70 -147.76 128.44 14.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.571 -0.958 . . . . 0.0 109.319 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -124.04 135.42 53.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.118 -0.989 . . . . 0.0 112.478 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.22 134.17 51.45 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 25.4 t -110.06 142.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.05 -1.031 . . . . 0.0 109.233 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 50.9 m-85 -119.13 124.32 46.57 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.618 -0.676 . . . . 0.0 110.762 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.516 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 78.0 tt0 -60.69 -26.62 67.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' A' ' 167' ' ' SER . 12.2 mm100 -119.34 150.98 50.55 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.483 ' O ' ' OG1' ' A' ' 141' ' ' THR . 18.1 Cg_endo -59.75 -177.84 0.15 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.921 2.414 . . . . 0.0 113.398 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.581 ' O ' ' CG ' ' A' ' 140' ' ' TYR . 26.9 m120 52.61 38.61 26.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.384 -0.822 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.581 ' CG ' ' O ' ' A' ' 139' ' ' ASN . 5.7 p90 45.75 57.09 5.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.65 -0.656 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 3.8 p -141.42 172.63 12.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.289 -0.882 . . . . 0.0 110.327 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.46 -173.76 40.85 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.645 -1.284 . . . . 0.0 110.798 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.516 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 70.3 mtm180 -58.19 106.66 0.4 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.605 -0.938 . . . . 0.0 109.432 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 11.9 mt-30 -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.62 0.724 . . . . 0.0 110.184 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -126.85 134.17 50.57 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CD2' ' SD ' ' A' ' 44' ' ' MET . 2.4 t80 -95.3 104.84 16.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.0 mp -96.91 121.98 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 108.887 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.533 ' NE ' ' NH1' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -107.26 175.83 1.87 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.71 159.06 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.11 1.874 . . . . 0.0 111.773 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.02 -168.87 12.78 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.2 136.34 54.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -1.017 . . . . 0.0 110.487 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.524 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 17.6 m-85 -110.73 145.55 37.86 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.601 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 35.2 ptt85 -134.5 -3.86 2.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.069 -1.02 . . . . 0.0 112.168 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.579 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 53.8 p -170.17 173.23 5.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.09 -1.631 . . . . 0.0 110.661 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.638 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.77 -21.54 56.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 156' ' ' ASN . 3.1 m120 -80.99 -2.52 48.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.556 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.6 m-20 -88.55 -61.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.961 . . . . 0.0 109.274 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.535 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.2 p90 -76.59 16.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.19 38.26 94.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.54 -177.85 23.18 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.55 5.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 63.3 p -154.95 -157.32 0.74 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 55.7 m -141.84 12.35 2.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.437 -0.79 . . . . 0.0 110.269 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -64.02 69.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.083 -1.01 . . . . 0.0 112.826 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.2 mtt -100.36 118.83 37.42 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.054 -1.028 . . . . 0.0 110.523 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.74 -25.85 4.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.442 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -132.47 153.55 50.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.765 -1.433 . . . . 0.0 110.596 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -150.44 141.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.561 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -122.76 133.89 54.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 23.0 ptt85 -98.78 102.74 14.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 171' ' ' ILE . 82.4 mt . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.811 -0.556 . . . . 0.0 111.715 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -148.43 149.24 31.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.324 -1.103 . . . . 0.0 110.892 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 36' ' ' ILE . 17.3 tt -134.67 133.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.6 mt -118.48 130.76 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.61 157.27 16.05 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -144.69 136.35 25.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 108.454 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -80.77 -25.12 38.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.016 -1.052 . . . . 0.0 111.267 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 50.9 t0 -80.54 159.06 25.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.812 -1.18 . . . . 0.0 110.821 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' OG ' ' A' ' 35' ' ' SER . 73.7 ttt180 -61.44 -39.84 92.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.657 -0.652 . . . . 0.0 110.064 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 83.2 m-20 -87.48 -90.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.071 -1.018 . . . . 0.0 109.323 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 57.2 m-85 -158.17 63.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 108.959 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.617 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -152.42 -162.38 10.85 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.18 -149.5 39.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -74.37 117.04 15.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.868 -1.372 . . . . 0.0 108.827 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -104.74 158.81 16.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.466 -0.771 . . . . 0.0 110.101 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -149.72 124.07 9.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.069 -1.019 . . . . 0.0 109.828 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -96.45 118.12 32.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.111 -0.993 . . . . 0.0 109.2 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -114.86 139.03 50.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.3 ptp -138.44 10.78 2.74 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.5 p -143.44 161.79 37.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.666 -0.646 . . . . 0.0 109.605 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 49.8 p30 -60.02 146.02 44.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.0 110.562 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -141.15 111.93 7.09 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 50' ' ' ASN . . . -83.93 -5.38 59.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 109.583 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 38.8 p-10 -138.23 93.94 2.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.057 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 79' ' ' CYS . 30.9 mt -94.32 -20.66 19.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -58.44 -40.9 83.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.6 p -57.31 -24.24 53.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.61 -0.682 . . . . 0.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -89.46 -40.37 12.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 108.705 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -159.08 147.35 17.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.601 -0.687 . . . . 0.0 109.701 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -94.06 -9.68 35.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.113 -0.992 . . . . 0.0 110.254 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -152.5 152.23 31.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.048 -1.033 . . . . 0.0 108.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.514 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 7.7 t -154.45 114.6 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -95.17 -7.93 37.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.42 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.513 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 14.9 m -137.78 144.13 41.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.511 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 4' ' ' ILE . 9.1 tt -156.85 154.22 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -155.54 144.82 20.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.675 -1.265 . . . . 0.0 111.815 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.55 123.61 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -84.56 -30.51 25.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 108.669 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -166.37 150.29 7.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.88 -142.16 18.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.09 163.02 39.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.63 134.47 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.871 -1.143 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.28 110.66 22.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.658 ' HB ' HG11 ' A' ' 76' ' ' VAL . 18.9 m -99.8 147.18 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.602 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 42.2 m-85 -121.73 140.6 52.12 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.684 0.754 . . . . 0.0 111.147 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.47 -8.02 55.63 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.764 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.823 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.2 ttt180 -131.38 162.58 29.82 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.0 p -74.15 163.3 28.03 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.976 0.893 . . . . 0.0 111.548 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.8 OUTLIER 64.42 31.93 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.217 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.616 ' CE2' ' NH2' ' A' ' 80' ' ' ARG . 5.0 m-85 63.08 58.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.905 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 86.2 mtp -144.29 171.62 14.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 85.42 -169.39 43.32 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -58.03 121.29 10.26 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 4.5 mp0 -104.51 136.15 44.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 109.207 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -125.77 133.34 52.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.21 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -96.97 122.37 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.388 -0.82 . . . . 0.0 109.281 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 mt -117.04 127.99 54.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.283 -0.885 . . . . 0.0 109.746 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ARG . 35.3 ptt180 -97.52 166.35 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 110.078 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 59' ' ' ARG . 44.4 ttp180 -38.52 112.17 0.21 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.576 -0.702 . . . . 0.0 109.84 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.26 171.85 40.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 47.1 mp0 -111.14 130.33 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.375 -1.074 . . . . 0.0 108.667 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.33 99.67 49.81 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ARG . 58.1 Cg_endo -75.8 -9.35 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.343 2.028 . . . . 0.0 112.725 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 44.2 m-20 -164.28 128.93 2.71 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 22.3 p90 -148.4 34.33 0.79 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.62 -1.3 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 54.5 tpp -102.83 -47.25 4.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.024 -1.047 . . . . 0.0 109.708 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -98.54 -19.52 17.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -78.9 -23.93 44.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.3 mmt -101.35 -30.99 11.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.21 49.72 3.65 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.8 mtp -123.1 143.16 50.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.986 . . . . 0.0 109.695 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.56 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.6 p30 -96.13 54.27 1.43 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.157 -0.964 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.3 m-20 150.55 -168.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.514 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.8 p -97.48 -160.49 0.81 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.489 -0.757 . . . . 0.0 109.714 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.658 HG11 ' HB ' ' A' ' 45' ' ' VAL . 6.1 m -92.13 150.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -110.78 -7.6 14.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.894 -1.129 . . . . 0.0 108.022 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.823 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -146.8 165.14 30.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.913 -1.117 . . . . 0.0 109.452 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 26' ' ' LEU . 23.3 p -164.64 149.84 9.89 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.873 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.616 ' NH2' ' CE2' ' A' ' 51' ' ' PHE . 61.6 ttm-85 -138.2 142.84 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 ptm -95.53 151.38 19.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.901 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.0 p . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.383 0.611 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -111.05 119.53 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.459 -0.775 . . . . 0.0 109.527 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -171.59 125.59 0.6 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 47.2 ttm -105.38 127.72 53.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.007 -1.058 . . . . 0.0 109.298 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -104.7 115.56 30.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.534 HD23 ' SG ' ' A' ' 125' ' ' CYS . 10.1 mt -104.49 148.15 26.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.233 1.016 . . . . 0.0 113.06 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.555 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 25.3 m-85 -133.53 125.66 29.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.432 ' CB ' ' H ' ' A' ' 102' ' ' ARG . 70.8 tt0 -62.59 -26.34 68.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 111.955 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.762 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.3 m-70 -109.63 164.18 12.78 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.658 -1.276 . . . . 0.0 110.828 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -61.89 160.63 11.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.406 -0.809 . . . . 0.0 109.219 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.518 ' O ' ' SD ' ' A' ' 99' ' ' MET . 5.7 m-20 80.05 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.6 mmt -162.78 31.72 0.1 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.34 -156.84 30.54 Favored Glycine 0 N--CA 1.491 2.357 0 CA-C-O 122.173 0.874 . . . . 0.0 111.178 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.418 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 64.38 -155.35 46.95 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 57.9 ttt85 -90.9 140.84 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.162 -1.199 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 44.0 ttp -97.36 114.89 26.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.826 -1.171 . . . . 0.0 109.834 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.7 mtm -113.81 138.79 49.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.138 -0.976 . . . . 0.0 108.656 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.72 138.31 39.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.466 -0.771 . . . . 0.0 109.169 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.3 tt -137.28 122.61 19.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 108.902 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.519 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 5.8 ttt -123.12 2.73 9.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 110.406 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.495 ' H ' HD23 ' A' ' 106' ' ' LEU . 81.1 m-20 -122.29 -162.7 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.245 -0.909 . . . . 0.0 110.078 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 42.9 p-10 -91.29 139.51 30.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.509 ' CB ' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -120.83 98.22 47.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -178.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.99 -23.26 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.147 1.898 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -142.25 84.81 1.89 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.946 -1.096 . . . . 0.0 108.337 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 110' ' ' CYS . 96.0 mt -70.89 -26.99 63.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.083 -1.011 . . . . 0.0 110.074 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.6 tpt -58.59 -40.48 83.32 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 108.715 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -84.1 -23.0 30.93 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 110.619 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -79.12 -62.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.538 -1.351 . . . . 0.0 110.824 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -100.3 2.01 42.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 114' ' ' MET . 28.3 t-20 59.06 30.56 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 110.014 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 9.0 ptm -153.82 138.92 17.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 62.5 m -123.75 5.82 8.8 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.754 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 163' ' ' SER . 37.0 m-20 -128.32 92.43 3.44 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.637 -1.225 . . . . 0.0 113.242 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -104.68 132.97 50.29 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.485 ' CD2' ' OH ' ' A' ' 155' ' ' TYR . 1.1 m-70 -92.01 2.65 56.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.061 . . . . 0.0 111.538 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.762 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.4 p -147.34 153.06 39.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 119.932 -1.73 . . . . 0.0 110.241 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 124' ' ' SER . 35.7 m -157.36 159.04 37.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.482 -0.761 . . . . 0.0 109.481 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.546 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -148.21 141.88 25.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.094 -1.004 . . . . 0.0 108.72 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.546 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 53.3 t -113.25 125.03 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.996 -1.065 . . . . 0.0 109.308 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.466 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.0 ttt -73.8 -28.58 61.72 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.671 0.748 . . . . 0.0 109.118 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m-20 166.85 166.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.828 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.61 -142.67 16.18 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -149.74 129.35 13.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.593 -0.945 . . . . 0.0 109.674 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -124.1 135.76 53.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.767 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 168' ' ' ILE . 6.1 mt -105.02 133.09 50.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 43.4 t -111.1 143.0 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.084 -1.01 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.444 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 41.3 m-85 -120.42 124.19 44.86 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.522 -0.736 . . . . 0.0 111.107 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.529 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 54.0 tt0 -58.47 -27.32 64.3 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -119.97 155.2 55.54 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 26.0 Cg_endo -62.69 -171.69 0.11 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.31 2.674 . . . . 0.0 113.686 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 47.52 30.5 1.68 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.507 0.67 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.536 ' H ' ' CB ' ' A' ' 167' ' ' SER . 16.3 m-85 56.86 52.62 9.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.488 -0.757 . . . . 0.0 109.54 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 142' ' ' GLY . 85.6 m -136.89 164.42 28.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.414 -0.804 . . . . 0.0 109.323 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.09 178.51 33.15 Favored Glycine 0 N--CA 1.504 3.177 0 O-C-N 120.886 -1.134 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 136' ' ' GLU . 69.3 mtt85 -53.98 111.42 0.75 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.942 . . . . 0.0 108.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.626 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -86.78 143.53 27.47 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.116 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.12 129.58 49.36 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.549 0.69 . . . . 0.0 109.254 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -90.75 104.0 16.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.55 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.3 mp -97.98 119.62 36.93 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.854 0.835 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -105.83 177.69 1.3 Allowed Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.2 Cg_exo -47.01 161.67 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.86 1.707 . . . . 0.0 111.661 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.81 -179.47 18.39 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.32 136.79 49.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -1.009 . . . . 0.0 110.409 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 16.8 m-85 -112.08 142.82 44.05 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.683 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 7.5 ptp180 -134.86 -4.99 2.45 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.032 -1.042 . . . . 0.0 112.476 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 57.7 m -165.57 165.66 18.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.903 -1.748 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -52.07 -21.08 2.87 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -82.5 2.5 32.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 0.0 109.652 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.683 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 2.4 m-20 -92.88 -61.68 1.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.403 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.5 p90 -77.04 16.09 0.6 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.87 37.69 92.42 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.19 -161.93 22.69 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.5 t -146.97 -42.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.3 p -103.82 -155.46 0.53 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.0 t -146.13 11.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -65.09 76.88 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.087 -1.008 . . . . 0.0 112.535 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -102.64 121.56 42.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.129 -0.982 . . . . 0.0 110.155 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.9 -26.88 3.41 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.536 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 1.3 t -135.4 153.49 51.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.602 -1.528 . . . . 0.0 111.249 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 19.7 mt -149.17 143.05 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -123.06 139.99 53.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.966 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 107' ' ' MET . 53.1 ttp180 -98.82 92.52 5.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.444 -0.785 . . . . 0.0 109.293 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 170' ' ' ARG . 88.8 mt . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 89.6 mttt -161.59 145.41 12.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.994 . . . . 0.0 110.604 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 36' ' ' ILE . 21.0 tt -134.76 133.67 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 109.691 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.83 128.65 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.409 0.623 . . . . 0.0 109.706 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 36' ' ' ILE . 90.1 m-85 -89.26 165.96 14.09 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -152.92 132.61 13.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.602 -1.311 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.59 -43.13 60.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 111.313 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.601 ' HB2' ' H ' ' A' ' 13' ' ' GLY . 88.9 m-20 -69.63 155.77 39.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.616 -1.302 . . . . 0.0 110.782 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 64' ' ' PRO . 72.0 mtp180 -62.09 -44.85 95.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.709 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 12' ' ' PHE . 7.8 p30 -74.97 -95.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 109.191 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 51.0 m-85 -156.02 56.4 0.59 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -141.81 -150.93 5.44 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 64.71 -153.37 49.76 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -74.83 120.06 19.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -1.125 . . . . 0.0 109.231 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -106.34 156.7 18.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.871 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.626 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 1.1 t60 -146.01 128.39 15.89 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.634 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.28 121.66 41.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 108.696 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.5 m -122.62 136.55 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.21 -0.932 . . . . 0.0 109.534 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -141.58 15.27 2.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.0 t -145.81 158.19 43.87 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.781 0.8 . . . . 0.0 110.503 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.07 143.66 7.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.68 114.76 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.75 8.9 41.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.07 -1.019 . . . . 0.0 108.68 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -138.85 98.17 3.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.852 -0.53 . . . . 0.0 109.779 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 78' ' ' SER . 89.2 mt -106.54 -25.31 11.88 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.498 ' CD2' HD22 ' A' ' 31' ' ' ASN . 19.4 t-80 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.417 -0.802 . . . . 0.0 109.002 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.2 m -50.54 -58.71 5.17 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 91.4 m-85 -56.14 -49.25 74.46 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.887 -0.508 . . . . 0.0 111.209 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -155.11 149.21 25.84 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.964 -1.085 . . . . 0.0 110.19 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.498 HD22 ' CD2' ' A' ' 27' ' ' HIS . 7.4 t-20 -95.26 -4.74 45.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.384 -0.822 . . . . 0.0 110.344 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -159.91 158.14 30.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.978 . . . . 0.0 108.485 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.542 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 14.4 t -159.11 112.89 2.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.905 -1.122 . . . . 0.0 108.419 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.571 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 60.5 m-70 -92.68 1.0 57.51 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.942 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 7.3 t -146.13 141.65 27.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.405 -1.434 . . . . 0.0 110.687 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 4' ' ' ILE . 19.0 tt -151.11 146.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 108.921 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -143.07 133.88 25.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.93 -1.106 . . . . 0.0 111.8 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 22.7 t -105.04 118.89 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -79.83 -33.49 40.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.891 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -167.79 156.51 9.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.385 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.688 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 86.93 -123.19 6.43 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 99.1 m -168.64 167.75 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.52 141.05 21.64 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.846 -1.159 . . . . 0.0 109.077 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.2 tpt -99.94 115.06 28.78 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 56' ' ' TYR . 4.5 m -108.71 142.06 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.976 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 33.2 m-85 -120.02 137.26 54.2 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.809 0.814 . . . . 0.0 111.298 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.493 ' O ' ' NE ' ' A' ' 77' ' ' ARG . 22.6 t0 -71.75 -5.86 37.11 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.056 ' O ' ' OG ' ' A' ' 78' ' ' SER . 36.2 ttm-85 -131.25 166.82 20.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.443 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 1.8 p -79.92 165.25 22.83 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.751 0.786 . . . . 0.0 110.208 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' C ' ' CG ' ' A' ' 51' ' ' PHE . 43.0 t30 63.63 33.06 13.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.713 -0.617 . . . . 0.0 110.812 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.536 ' H ' ' CB ' ' A' ' 78' ' ' SER . 0.6 OUTLIER 60.83 61.22 1.7 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.948 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.41 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 64.1 mtp -148.39 166.48 27.97 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.248 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.19 -166.64 30.99 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.029 -1.045 . . . . 0.0 110.582 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -57.76 112.88 1.61 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.246 -1.149 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.37 134.9 35.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.724 -0.61 . . . . 0.0 109.398 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB2' HG23 ' A' ' 45' ' ' VAL . 55.1 m-85 -130.78 137.14 49.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.664 ' CE2' ' NH2' ' A' ' 169' ' ' ARG . 30.5 p90 -98.93 116.51 31.33 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.381 -0.824 . . . . 0.0 109.779 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -107.38 112.71 25.65 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.668 -1.27 . . . . 0.0 111.473 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 60' ' ' ARG . 14.2 ptm180 -85.96 160.34 19.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.437 -0.789 . . . . 0.0 110.927 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 59' ' ' ARG . 60.1 ttt-85 -35.8 114.91 0.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.646 -0.659 . . . . 0.0 110.012 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 173.73 166.14 31.52 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.594 -1.289 . . . . 0.0 109.947 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -103.75 128.16 51.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -1.016 . . . . 0.0 108.746 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -117.91 90.05 35.66 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.837 . . . . 0.0 109.414 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 10' ' ' ARG . 31.3 Cg_exo -55.86 -11.11 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.639 2.226 . . . . 0.0 111.973 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -170.25 146.15 2.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 108.78 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 30.9 p90 -150.41 31.61 0.66 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.672 -1.268 . . . . 0.0 109.587 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.571 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 26.1 mtp -102.04 -45.66 5.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 109.213 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -96.36 -20.8 18.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -0.953 . . . . 0.0 109.168 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 p -84.17 -12.08 55.5 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.9 mtt -110.31 -28.17 8.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 108.816 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 56.02 2.85 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -130.43 166.92 19.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.935 -1.332 . . . . 0.0 109.287 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 8.7 m120 -117.09 53.25 0.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.409 -0.807 . . . . 0.0 109.287 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.8 m-20 155.33 -168.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.542 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.4 p -98.83 -166.47 1.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.954 0.883 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 46' ' ' TYR . 19.3 t -77.18 140.97 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 47' ' ' ASP . 11.8 mtm180 -102.59 -19.78 14.71 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.762 -1.211 . . . . 0.0 108.008 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 1.056 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 1.0 OUTLIER -150.11 160.19 43.84 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.629 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.05 159.15 37.65 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.351 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -146.12 142.5 28.57 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.8 160.76 19.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.155 -0.966 . . . . 0.0 108.924 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.493 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 66.2 mt . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.672 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 89.5 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.149 0.499 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -108.01 113.43 26.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.139 -0.976 . . . . 0.0 109.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -167.5 132.29 1.91 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.254 -0.904 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.492 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 1.6 ttp -116.44 132.6 56.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -106.43 119.22 38.69 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 103' ' ' MET . 18.2 mt -103.73 151.64 22.77 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.074 0.94 . . . . 0.0 112.301 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.4 129.78 31.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 25.9 tt0 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.768 . . . . 0.0 112.217 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 124' ' ' SER . 14.8 m-70 -119.86 163.3 17.72 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.032 -1.667 . . . . 0.0 111.106 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 50.1 m -55.99 157.83 4.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.5 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 97' ' ' SER . 1.0 OUTLIER 83.42 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.028 -1.045 . . . . 0.0 109.822 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.7 mtt -179.46 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.75 163.01 22.88 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.18 -130.5 10.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.525 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 60.5 mtt85 -104.02 119.7 39.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 108.175 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.521 ' O ' ' CG ' ' A' ' 103' ' ' MET . 12.1 ptt? -90.84 119.05 30.73 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.544 -0.722 . . . . 0.0 110.457 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.4 mpp? -114.79 135.85 53.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.82 133.72 46.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.84 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.8 OUTLIER -123.66 117.67 25.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 9.6 ttt -125.07 15.45 8.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.496 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.467 ' H ' HD23 ' A' ' 106' ' ' LEU . 67.4 m-20 -144.48 -165.01 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 109.895 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 20.9 p-10 -82.96 128.35 34.38 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.689 ' HB2' HD11 ' A' ' 106' ' ' LEU . 1.2 m -123.33 77.0 53.37 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.694 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.4 -31.96 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.54 2.16 . . . . 0.0 112.045 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -117.45 75.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 113' ' ' LEU . 41.1 mt -68.48 -20.73 64.62 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.816 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.4 tpt -59.43 -40.39 86.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.4 -21.79 26.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 110.886 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -75.85 -58.81 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.617 -1.302 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -116.76 0.62 12.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 114' ' ' MET . 51.0 m-20 52.79 34.7 16.89 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' A' ' 122' ' ' PHE . 2.4 ttt -147.35 134.52 20.49 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 p -134.0 11.0 3.93 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.602 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 163' ' ' SER . 38.5 m-20 -129.28 94.96 3.91 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.665 -1.272 . . . . 0.0 112.808 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.665 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -111.56 136.45 50.74 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -96.3 3.96 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.475 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 98' ' ' ASP . 3.6 m -146.8 152.59 39.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.341 -1.474 . . . . 0.0 110.01 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.492 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 53.3 t -161.97 159.7 26.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 110.088 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.401 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 21.6 t60 -145.91 143.48 29.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 96.5 t -113.78 123.41 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 0.0 109.344 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 23.2 ttt -76.91 -22.82 52.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.668 -0.645 . . . . 0.0 109.941 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.43 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.5 OUTLIER 170.91 -171.5 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.742 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 63.09 -135.01 43.11 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.1 m-70 -159.96 138.24 10.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.905 . . . . 0.0 109.066 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -128.51 137.77 51.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 111.635 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.7 mt -104.63 130.34 52.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 39.1 t -109.38 141.39 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.918 -1.114 . . . . 0.0 109.408 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.43 125.68 48.56 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 0.0 110.868 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -61.57 -21.45 64.32 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 141' ' ' THR . 82.0 mt-30 -130.32 138.66 33.54 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 88.0 Cg_exo -43.06 -177.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.708 2.939 . . . . 0.0 114.385 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.4 t30 49.16 32.44 4.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.847 -0.533 . . . . 0.0 111.071 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.482 ' H ' ' CB ' ' A' ' 167' ' ' SER . 43.1 m-85 56.93 49.74 13.47 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.682 -0.637 . . . . 0.0 110.469 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 142' ' ' GLY . 87.4 m -137.05 163.29 31.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.255 -0.903 . . . . 0.0 109.454 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 141' ' ' THR . . . 97.6 175.02 33.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -49.96 109.78 0.32 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -1.158 . . . . 0.0 108.95 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 145' ' ' PHE . 22.8 tm0? -85.48 142.83 28.92 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.093 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.488 ' O ' ' NE2' ' A' ' 144' ' ' GLN . 54.3 m-85 -128.01 132.47 49.13 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.632 0.73 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.443 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 84.8 t80 -94.15 104.11 16.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.627 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.9 mp -99.26 121.41 41.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.198 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -105.07 177.61 1.35 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.482 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 77.5 Cg_exo -46.64 166.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.834 1.689 . . . . 0.0 111.574 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.06 -167.64 12.47 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -120.84 132.36 54.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.662 -0.904 . . . . 0.0 110.933 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 17.2 m-85 -110.68 144.75 39.14 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.642 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 10.6 ptm180 -135.6 0.19 2.7 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.89 -1.131 . . . . 0.0 112.132 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.565 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.3 p -169.31 167.84 9.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.904 -1.747 . . . . 0.0 109.904 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -59.6 -15.24 17.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -85.24 -1.25 56.73 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.642 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 3.7 m-20 -89.79 -62.04 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.566 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 9.9 p90 -73.32 13.28 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 67.94 35.5 84.58 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.15 -165.66 32.56 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 t -151.07 3.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.8 p -150.78 -157.33 0.8 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 25.1 p -141.41 1.21 1.56 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -64.47 77.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.965 -1.084 . . . . 0.0 111.789 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.8 mtt -107.3 115.6 30.46 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 109.125 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.96 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.482 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -125.08 144.71 50.27 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.158 1.479 . . . . 0.0 111.079 -178.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.9 mt -147.48 139.51 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.199 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.664 ' NH2' ' CE2' ' A' ' 57' ' ' PHE . 40.4 ttp180 -127.61 138.59 52.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 110.437 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 171' ' ' ILE . 8.4 ptm180 -97.11 92.5 6.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 171' ' ' ILE . 46.5 mt . . . . . 0 N--CA 1.504 2.234 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -155.74 143.47 19.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -1.055 . . . . 0.0 110.724 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.557 HD13 ' CD2' ' A' ' 43' ' ' PHE . 20.5 tt -135.61 135.34 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.203 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.18 122.97 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.691 -0.631 . . . . 0.0 109.338 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -88.84 151.56 22.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 108.652 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -138.07 137.85 38.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 109.387 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -73.5 -43.95 58.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -0.833 . . . . 0.0 110.647 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 60.7 m-20 -81.69 156.77 24.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.838 -1.164 . . . . 0.0 110.535 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -70.71 -37.13 73.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -80.63 35.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 54.55 55.7 7.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.614 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -139.09 -151.84 5.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 59.85 -147.26 43.97 Favored Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.178 -1.189 . . . . 0.0 110.155 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -77.81 129.77 35.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.396 -1.061 . . . . 0.0 109.084 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -112.47 156.22 22.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.845 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -145.21 123.26 12.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 108.821 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -97.71 118.77 35.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -112.77 136.67 52.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.4 mtp -130.1 6.56 4.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.2 p -149.74 170.98 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 110.156 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.511 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 55.8 p30 -63.77 151.12 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 t -143.47 120.64 11.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -6.82 57.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.944 -1.097 . . . . 0.0 109.879 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -140.09 94.28 2.74 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 108.817 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.3 mt -91.06 -19.59 22.99 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.109 -0.994 . . . . 0.0 108.42 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 42.5 t-80 -56.27 -36.53 68.69 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.92 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.1 t -53.57 -56.4 17.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -60.53 -49.67 76.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 0.0 111.065 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 32.4 p90 -152.93 151.86 30.82 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.111 -0.993 . . . . 0.0 110.503 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -100.14 -7.26 25.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.334 -0.854 . . . . 0.0 110.102 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -152.73 151.46 30.54 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.478 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 43.3 t -157.44 120.41 3.97 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.518 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 18.0 m-70 -102.7 -4.03 25.66 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -137.84 139.33 39.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.795 -1.19 . . . . 0.0 111.063 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.7 mt -132.97 142.94 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -134.47 106.13 6.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.872 -1.143 . . . . 0.0 111.323 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.75 117.09 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -83.37 -31.97 26.45 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.364 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 t -172.23 154.8 3.42 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.168 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.92 -131.66 10.75 Favored Glycine 0 N--CA 1.486 2.007 0 CA-C-O 122.565 1.091 . . . . 0.0 111.47 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.7 m -154.1 152.66 30.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.557 ' CD2' HD13 ' A' ' 4' ' ' ILE . 11.1 t80 -146.77 139.2 24.92 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.556 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.9 tpt -109.99 123.53 49.81 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.663 ' HB ' HG11 ' A' ' 76' ' ' VAL . 16.6 m -114.19 145.82 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.916 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.8 m-85 -121.12 141.76 50.5 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.798 0.808 . . . . 0.0 111.224 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 24.5 t0 -76.77 -10.54 59.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.913 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.144 ' O ' ' OG ' ' A' ' 78' ' ' SER . 18.3 ttm180 -127.56 167.39 16.41 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 44.2 p -78.47 159.19 28.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 110.911 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.61 33.4 3.91 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.649 -0.657 . . . . 0.0 110.958 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.484 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.2 m-85 60.38 57.23 2.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.972 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.0 mmt -143.64 173.3 11.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.137 -0.977 . . . . 0.0 110.385 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.98 -162.69 39.18 Favored Glycine 0 N--CA 1.503 3.123 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 59.0 mtp180 -60.48 119.75 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 108.051 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -102.11 133.82 46.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.06 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 66.2 m-85 -123.16 133.67 54.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.059 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -98.18 117.49 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.221 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.3 mt -118.66 117.55 29.25 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.021 -1.05 . . . . 0.0 110.729 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.502 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.6 ptm180 -92.95 164.62 13.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.244 -0.91 . . . . 0.0 110.772 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.502 ' C ' ' O ' ' A' ' 59' ' ' ARG . 34.0 ttp180 -32.12 116.07 0.19 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.638 -0.664 . . . . 0.0 110.727 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.89 167.75 31.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 79.0 mt-10 -106.99 130.11 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -1.062 . . . . 0.0 108.925 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -114.31 91.42 23.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.573 -0.705 . . . . 0.0 109.551 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 25.7 Cg_exo -59.09 -14.43 23.47 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.641 2.227 . . . . 0.0 112.429 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -169.3 146.34 3.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.897 -1.127 . . . . 0.0 108.088 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 16.6 p90 -148.94 -9.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.505 -1.372 . . . . 0.0 111.725 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.518 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 15.4 mtt -63.62 -39.93 95.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.326 -1.484 . . . . 0.0 110.099 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -92.14 -24.7 19.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.889 -1.132 . . . . 0.0 109.834 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -86.37 -8.88 57.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.527 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.585 ' SD ' ' CD1' ' A' ' 56' ' ' TYR . 19.7 mmt -111.29 -26.11 9.32 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . 80.97 49.24 5.71 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.9 mtp -127.4 154.0 45.55 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.177 -1.19 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 18.7 t-20 -107.01 60.32 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.092 -1.005 . . . . 0.0 109.014 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 7.6 p30 149.55 -169.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.478 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.2 p -98.89 -165.43 1.24 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 109.803 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.663 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.5 m -85.51 147.73 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -108.55 -10.9 15.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.716 -1.24 . . . . 0.0 108.154 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 1.144 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 2.5 p -148.34 164.48 33.93 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.92 -1.112 . . . . 0.0 109.696 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.85 151.23 16.11 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.88 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -136.72 140.35 42.58 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.331 0.586 . . . . 0.0 109.492 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 82' ' ' ILE . 51.5 ttm -96.33 157.39 15.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.202 -0.936 . . . . 0.0 108.606 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.561 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 77.5 mt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.0 109.933 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 96.6 p . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.281 0.562 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -112.01 116.57 30.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.818 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -171.39 129.35 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 38.3 ttm -117.94 126.32 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 109.609 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -102.19 120.96 41.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.527 HD23 ' SG ' ' A' ' 125' ' ' CYS . 13.7 mt -104.17 152.61 21.93 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.31 1.052 . . . . 0.0 112.696 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 99' ' ' MET . 24.6 m-85 -136.88 122.58 19.83 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -59.43 -22.88 62.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.439 -0.788 . . . . 0.0 111.814 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 124' ' ' SER . 4.9 m-70 -114.4 163.73 14.93 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.617 -1.302 . . . . 0.0 111.206 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.9 p -58.78 159.34 6.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 m-20 77.67 -92.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.603 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -169.48 39.05 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.66 -160.62 24.89 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.767 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 68.05 -147.88 48.34 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.87 133.79 38.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.111 -1.229 . . . . 0.0 109.369 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.2 ptt? -93.9 116.58 29.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 0.0 110.469 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 15.4 mtm -118.02 137.5 52.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.256 -0.902 . . . . 0.0 108.633 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -99.36 138.95 35.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 109.459 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 110' ' ' CYS . 1.0 OUTLIER -128.01 118.94 24.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.406 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 ttt -129.28 14.93 6.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.426 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.534 ' H ' HD23 ' A' ' 106' ' ' LEU . 5.2 p-10 -139.78 -170.35 2.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.943 . . . . 0.0 109.968 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.42 127.21 31.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.656 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -115.24 85.45 12.77 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.676 -179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.89 -23.64 6.59 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.328 2.019 . . . . 0.0 112.047 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -133.92 87.13 2.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 10.9 mt -75.07 -34.63 61.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.211 -0.931 . . . . 0.0 110.343 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.74 -40.96 76.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -80.66 -23.44 39.67 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.188 -0.945 . . . . 0.0 110.571 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -81.12 -55.23 4.89 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.515 -1.366 . . . . 0.0 111.397 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -106.32 -1.38 23.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.041 -1.037 . . . . 0.0 110.351 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.3 m120 63.29 32.89 14.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.812 -1.18 . . . . 0.0 109.12 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.5 ptm -154.91 137.66 15.29 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.9 t -121.07 9.7 10.59 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.752 -0.592 . . . . 0.0 109.616 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 163' ' ' SER . 16.3 m-20 -135.78 95.54 3.25 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.657 -1.277 . . . . 0.0 113.52 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -105.18 137.4 43.01 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.334 -0.854 . . . . 0.0 108.771 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.523 ' CD2' ' OH ' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -98.38 1.45 46.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 111.345 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 125' ' ' CYS . 5.5 t -146.3 150.12 35.13 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.079 -1.638 . . . . 0.0 109.932 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 124' ' ' SER . 11.2 m -157.0 156.7 33.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.451 ' C ' ' CD2' ' A' ' 126' ' ' HIS . 6.0 t60 -142.3 138.77 31.54 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.004 -1.06 . . . . 0.0 109.067 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.64 126.79 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.05 -1.032 . . . . 0.0 109.56 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.486 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 84.0 mmm -76.58 -26.5 55.11 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.4 m-20 165.59 -168.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.97 -173.8 37.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.561 ' NE2' ' CG2' ' A' ' 82' ' ' ILE . 29.9 m170 -116.4 122.31 44.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.997 . . . . 0.0 109.241 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.57 121.01 43.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 111.551 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.639 HD23 HD11 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -96.8 123.7 40.57 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.0 t -109.87 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.983 -1.073 . . . . 0.0 110.813 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.567 ' CE1' HD12 ' A' ' 133' ' ' LEU . 85.1 m-85 -121.65 123.62 42.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.744 -0.597 . . . . 0.0 110.838 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 30.7 tt0 -58.64 -26.93 64.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' SER . 13.9 mt-30 -119.86 155.55 54.98 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.463 ' O ' ' OG1' ' A' ' 141' ' ' THR . 28.5 Cg_endo -63.11 -174.09 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.028 2.486 . . . . 0.0 113.356 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.0 m120 50.83 31.83 6.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.427 -0.796 . . . . 0.0 110.43 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.506 ' H ' ' CB ' ' A' ' 167' ' ' SER . 40.4 m-85 56.07 51.65 11.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.571 -0.706 . . . . 0.0 110.237 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 12.2 p -140.79 166.13 25.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 0.0 109.779 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.33 173.41 29.86 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -50.65 113.74 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -1.062 . . . . 0.0 108.655 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 13.5 mt-30 -84.0 136.13 34.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.453 -0.779 . . . . 0.0 110.062 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -119.87 125.01 47.47 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.47 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 72.9 t80 -88.07 107.41 18.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.1 mp -105.72 124.69 49.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.206 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 149' ' ' PRO . 0.5 OUTLIER -115.32 169.64 6.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 148' ' ' ARG . 3.6 Cg_exo -35.27 160.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.59 2.194 . . . . 0.0 112.127 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.99 -168.31 12.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -118.95 129.87 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.567 -0.96 . . . . 0.0 110.842 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 125' ' ' CYS . 63.1 m-85 -109.14 140.87 42.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.748 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 57.6 mtt85 -131.36 -8.32 3.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 112.694 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.5 m -169.48 177.46 4.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.026 -1.671 . . . . 0.0 111.152 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.609 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -60.02 -14.17 15.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.718 . . . . 0.0 109.428 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -91.64 0.97 57.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.12 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.748 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -90.05 -62.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 108.711 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -75.88 16.2 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.14 33.93 88.34 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.36 -161.07 31.41 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.94 -39.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.4 p -103.77 -160.96 0.8 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.1 t -145.18 7.57 1.18 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 136' ' ' GLU . 51.1 ttt-85 -64.39 79.74 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.003 -1.06 . . . . 0.0 111.926 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 60.9 mtt -103.16 116.2 32.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -110.72 -24.41 5.56 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.506 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -134.19 148.83 50.96 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.448 1.624 . . . . 0.0 111.252 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 mt -147.27 142.92 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.07 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -129.61 141.8 50.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.381 -0.825 . . . . 0.0 111.035 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -95.44 88.3 5.05 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.72 0.771 . . . . 0.0 108.992 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 171' ' ' ILE . 57.5 mt . . . . . 0 N--CA 1.496 1.844 0 O-C-N 121.434 -0.791 . . . . 0.0 111.607 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.488 2.139 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 87.1 mttt -161.16 146.77 14.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.713 -0.875 . . . . 0.0 110.533 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 36' ' ' ILE . 20.8 tt -134.63 135.87 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.808 . . . . 0.0 109.899 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.6 mt -122.19 127.18 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.699 -0.625 . . . . 0.0 109.788 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.617 ' CE2' HD12 ' A' ' 36' ' ' ILE . 84.4 m-85 -88.95 160.05 17.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -148.2 136.05 20.92 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.82 -1.175 . . . . 0.0 108.731 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -76.69 -39.14 53.02 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 111.114 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -81.73 163.01 22.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.779 -1.201 . . . . 0.0 110.57 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -75.92 -46.65 28.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.541 ' C ' HD22 ' A' ' 11' ' ' ASN . 0.4 OUTLIER -80.61 44.13 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.056 -1.028 . . . . 0.0 109.761 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 53.44 70.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.51 -156.4 7.6 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.05 -147.43 44.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -75.01 125.82 29.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -1.191 . . . . 0.0 109.247 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -110.9 153.92 24.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -144.89 125.25 13.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.509 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -97.4 121.65 39.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.0 m -120.43 141.22 50.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 109.599 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -140.92 12.24 2.24 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.0 m -146.01 160.77 41.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.663 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -58.12 148.34 26.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 110.517 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.42 116.53 10.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.33 -4.47 58.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 108.729 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 31.4 p-10 -136.08 99.84 4.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.624 -0.673 . . . . 0.0 109.656 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.2 mt -103.78 -24.62 13.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.286 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.624 ' CE1' HD21 ' A' ' 31' ' ' ASN . 34.5 t-80 -57.74 -40.39 79.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 108.75 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -50.28 -50.33 50.69 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -65.45 -52.12 55.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -0.994 . . . . 0.0 110.916 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.2 150.29 29.68 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.003 -1.06 . . . . 0.0 110.376 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.624 HD21 ' CE1' ' A' ' 27' ' ' HIS . 3.1 m120 -95.81 -5.63 41.35 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.186 -0.946 . . . . 0.0 110.426 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -156.81 155.56 31.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.095 -1.003 . . . . 0.0 108.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.547 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 33.0 t -158.04 117.02 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -97.53 -2.87 40.91 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.724 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.501 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 9.7 t -142.71 149.27 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.759 -1.213 . . . . 0.0 111.161 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 4' ' ' ILE . 18.5 tt -157.35 148.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.08 126.31 18.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.832 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.4 t -102.43 120.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -83.85 -29.04 27.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 109.084 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.2 t -169.78 152.75 4.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.863 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.93 -122.61 6.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 43' ' ' PHE . 29.8 t -171.47 169.57 6.12 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.583 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -154.6 142.24 19.85 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 108.904 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.8 mmm -102.03 118.11 36.23 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.7 ' HB ' HG11 ' A' ' 76' ' ' VAL . 18.2 m -109.2 144.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.914 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.489 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 58.8 m-85 -120.43 141.8 49.81 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.754 0.787 . . . . 0.0 111.563 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 29.9 t0 -76.09 -9.76 58.87 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.157 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.767 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.6 ttt180 -127.89 159.74 33.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.484 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 12.6 p -71.81 157.83 37.18 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.729 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 71.09 33.54 2.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.637 -0.664 . . . . 0.0 111.326 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CB ' ' NH2' ' A' ' 80' ' ' ARG . 1.9 m-85 59.59 56.33 3.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 109.757 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.1 mtt -143.49 172.05 13.32 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.48 -165.27 42.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.48 123.89 17.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.114 -1.227 . . . . 0.0 108.304 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 46' ' ' TYR . 6.7 tt0 -108.33 137.51 46.18 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.31 134.84 48.12 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.014 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.609 ' C ' HD12 ' A' ' 58' ' ' LEU . 20.1 p90 -96.04 120.98 37.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 57' ' ' PHE . 10.0 mp -111.42 113.52 26.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.059 -1.026 . . . . 0.0 111.532 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.4 ptt180 -86.13 161.08 19.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 111.034 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 59' ' ' ARG . 40.5 ttp85 -37.8 118.62 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.582 0.706 . . . . 0.0 110.365 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.98 178.09 41.29 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.79 129.34 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.09 100.21 53.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.16 -6.01 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.169 1.913 . . . . 0.0 112.619 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 34.4 p-10 -168.71 136.54 2.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.328 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 36.6 p90 -148.93 24.0 0.95 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.596 -1.315 . . . . 0.0 111.298 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.1 mmt -89.13 -39.71 13.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.673 -1.267 . . . . 0.0 108.902 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -99.28 -17.09 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.0 109.458 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 -12.62 45.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.26 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.2 mtt -115.74 -27.62 7.0 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 108.895 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.92 48.37 5.81 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.328 -0.858 . . . . 0.0 111.14 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.0 ttm -120.92 138.54 54.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.932 -1.334 . . . . 0.0 109.819 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.0 t30 -90.7 56.65 3.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.048 -1.033 . . . . 0.0 109.277 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.1 p30 151.79 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.547 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.2 p -98.61 -166.96 1.43 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.927 0.87 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.7 HG11 ' HB ' ' A' ' 45' ' ' VAL . 6.4 m -81.34 147.3 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.484 ' HB3' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -105.77 -11.51 16.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.767 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -151.47 170.61 19.17 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.787 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 78' ' ' SER . 26.6 p -162.3 146.13 11.91 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.998 0.904 . . . . 0.0 110.4 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.628 ' NH1' ' NH2' ' A' ' 148' ' ' ARG . 41.2 ttm180 -132.83 139.76 47.63 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.3 ttp -94.53 152.42 18.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 24.3 mt . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 108.634 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 80.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.331 0.586 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -121.06 125.84 48.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.186 -0.947 . . . . 0.0 110.4 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.529 ' CE ' ' SD ' ' A' ' 128' ' ' MET . 33.1 ttpt -168.38 129.07 1.28 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.577 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 39.8 ttm -120.17 135.22 55.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 109.088 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -105.74 120.24 41.19 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 125' ' ' CYS . 14.8 mt -103.05 149.49 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.156 0.979 . . . . 0.0 112.128 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 99' ' ' MET . 42.0 m-85 -133.8 124.71 27.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 87.7 tt0 -63.7 -26.15 68.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.553 ' O ' ' HB3' ' A' ' 124' ' ' SER . 45.6 m170 -110.38 164.39 12.73 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.602 -1.311 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.8 p -61.19 157.84 15.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 110.046 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 97' ' ' SER . 0.8 OUTLIER 81.4 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.2 mmt -162.57 35.5 0.11 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.33 -153.79 24.03 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.081 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 58.56 177.95 0.87 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.423 ' O ' ' CE ' ' A' ' 104' ' ' MET . 28.2 mmt180 -64.25 136.21 56.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.24 . . . . 0.0 109.273 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.2 ptt? -98.11 122.47 41.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.993 -1.067 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.423 ' CE ' ' O ' ' A' ' 102' ' ' ARG . 3.8 mtm -118.87 138.93 52.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.45 138.5 40.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.616 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 ' CZ3' ' A' ' 132' ' ' TRP . 5.6 tp -127.84 118.61 24.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.168 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.81 -11.09 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 0.0 109.728 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.32 -159.65 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -0.934 . . . . 0.0 109.86 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.83 137.49 32.28 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -116.06 87.28 18.69 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.338 -0.851 . . . . 0.0 109.578 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.5 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.7 Cg_endo -78.09 -27.06 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.089 1.859 . . . . 0.0 112.249 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -134.16 84.1 2.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.506 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.5 mt -67.94 -26.27 65.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.004 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.4 tpt -57.67 -40.02 78.43 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.272 -0.893 . . . . 0.0 109.074 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -82.85 -23.43 33.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -77.36 -62.36 1.68 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.644 -1.285 . . . . 0.0 110.9 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.492 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.0 m-85 -105.73 4.48 30.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.7 t-20 52.57 32.72 12.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.65 -1.281 . . . . 0.0 107.612 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.453 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 5.4 ttp -147.23 132.01 17.96 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 27.8 t -115.26 4.68 14.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 110.223 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 120' ' ' SER . 14.7 m-20 -132.63 101.08 5.16 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 118.416 -1.314 . . . . 0.0 114.052 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -111.76 135.48 52.32 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -96.1 2.06 52.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 111.388 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.0 t -149.86 156.34 41.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.928 -1.733 . . . . 0.0 110.694 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.577 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 11.1 t -164.29 163.05 22.71 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.243 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.577 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 13.6 t60 -150.07 146.61 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.169 -0.957 . . . . 0.0 109.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.454 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.1 t -115.95 125.02 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 108.96 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.529 ' SD ' ' CE ' ' A' ' 90' ' ' LYS . 17.9 ttt -81.26 -32.55 33.25 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 130' ' ' GLY . 13.6 t70 -174.4 175.0 2.68 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.537 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 77.11 -140.66 25.03 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.469 ' CE1' ' CG2' ' A' ' 82' ' ' ILE . 95.4 m-70 -151.8 135.37 16.18 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.548 -0.971 . . . . 0.0 109.284 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . 0.485 ' CZ3' HD23 ' A' ' 106' ' ' LEU . 87.0 m95 -127.39 133.16 50.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.119 -0.988 . . . . 0.0 112.212 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 mt -106.02 134.45 49.12 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 55.0 t -111.12 144.19 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.985 -1.072 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -122.13 124.02 42.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.619 -0.675 . . . . 0.0 111.124 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.5 tt0 -57.49 -27.41 62.5 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -118.52 155.8 51.81 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.45 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 23.4 Cg_endo -61.47 -179.64 0.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.271 2.647 . . . . 0.0 113.781 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.601 ' N ' ' OG ' ' A' ' 167' ' ' SER . 13.6 m120 49.82 35.14 8.66 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.696 0.76 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.714 ' H ' ' CB ' ' A' ' 167' ' ' SER . 7.7 m-85 57.33 51.42 10.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.758 -0.589 . . . . 0.0 110.378 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 142' ' ' GLY . 64.9 m -136.56 164.25 28.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 141' ' ' THR . . . 95.57 179.42 36.46 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.03 108.73 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -1.108 . . . . 0.0 108.808 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 20.8 pt20 -87.52 143.74 27.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.783 0.802 . . . . 0.0 110.46 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -125.2 144.32 50.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -104.57 103.57 13.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.302 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.7 mp -101.2 122.72 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.628 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 5.2 ptp180 -110.83 173.12 3.05 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 148' ' ' ARG . 68.3 Cg_exo -37.29 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.982 1.788 . . . . 0.0 112.113 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 126' ' ' HIS . . . 117.07 -166.16 12.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -123.86 136.91 54.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.335 -1.097 . . . . 0.0 110.631 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 21.2 m-85 -114.31 144.61 42.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.55 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 14.0 ptm180 -133.17 -1.66 3.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.084 . . . . 0.0 112.736 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.557 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 3.7 t -171.07 172.3 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.175 -1.578 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -62.84 -8.19 6.5 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.398 -0.814 . . . . 0.0 109.149 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -92.74 -1.14 57.07 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.172 -0.955 . . . . 0.0 108.819 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 154' ' ' SER . 10.5 m-20 -91.51 -60.08 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.7 p90 -76.45 16.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.54 40.24 96.0 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -104.56 -165.61 24.46 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.52 -39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.1 p -106.5 -161.41 0.79 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.3 p -137.56 5.62 2.69 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.474 -0.767 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 136' ' ' GLU . 70.5 ttt180 -66.79 75.8 0.11 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.889 -1.132 . . . . 0.0 112.142 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -100.5 116.93 33.6 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.095 . . . . 0.0 109.62 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.19 -25.77 4.9 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.714 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -134.2 151.51 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.361 -1.67 . . . . 0.0 111.562 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mt -146.69 140.95 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.692 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -126.9 144.17 51.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 171' ' ' ILE . 17.1 ptt180 -99.89 91.37 4.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.584 ' C ' ' O ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.994 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -148.26 136.17 20.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.56 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.3 mm -122.46 119.65 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.509 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.1 mt -113.41 117.17 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.205 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.76 132.42 36.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.559 -0.713 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.11 130.19 56.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.739 -1.226 . . . . 0.0 109.889 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.11 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.66 -0.65 . . . . 0.0 109.952 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -80.96 158.43 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 109.703 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -78.86 -37.75 39.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -84.44 43.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.986 . . . . 0.0 109.813 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 52.68 75.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.53 -171.03 34.74 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.25 -148.41 31.19 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -78.39 115.79 18.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 0.0 108.928 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -96.74 156.42 16.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.486 -0.759 . . . . 0.0 109.986 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.621 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.9 t60 -145.14 126.65 15.04 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.154 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -96.62 118.92 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -117.26 133.0 56.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.185 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -138.05 6.18 2.61 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 109.386 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -138.56 150.66 46.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.206 -0.934 . . . . 0.0 110.693 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 36.2 p-10 -47.27 144.92 2.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.46 -0.775 . . . . 0.0 110.034 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 25' ' ' ASP . 42.4 t -144.07 110.85 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.49 -17.32 49.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 108.6 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.457 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 t0 -126.73 100.72 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.488 HD11 ' SG ' ' A' ' 79' ' ' CYS . 14.5 mt -97.94 -14.48 20.61 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' SER . 18.7 t-80 -59.62 -41.32 90.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' HIS . 21.0 m -50.9 -57.28 8.91 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.621 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 52.6 m-85 -58.97 -53.52 57.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.634 -0.666 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -152.08 150.25 29.72 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.958 -1.089 . . . . 0.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -98.82 -2.18 38.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.834 . . . . 0.0 110.817 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -161.72 158.36 25.74 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.053 -1.029 . . . . 0.0 108.52 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 27.9 t -161.35 128.16 3.97 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -103.55 -20.64 13.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 109.723 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 t -134.04 146.4 50.32 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.996 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.54 143.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -129.42 113.45 14.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 111.34 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.32 114.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.53 -34.35 41.18 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.105 -0.997 . . . . 0.0 108.976 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 t -171.52 159.39 5.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.902 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.04 179.37 52.84 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.16 158.18 18.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.723 -0.869 . . . . 0.0 109.822 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -147.63 137.34 22.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.812 -1.18 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.6 tpt -107.05 127.83 53.82 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.645 ' HB ' HG11 ' A' ' 76' ' ' VAL . 16.7 m -118.53 144.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.945 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 33.5 m-85 -120.39 143.22 48.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.712 0.768 . . . . 0.0 111.334 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 28.4 t0 -77.99 -12.18 59.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.741 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.1 ttm180 -126.54 156.41 40.86 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 p -71.4 151.37 44.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.542 -0.724 . . . . 0.0 111.078 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 t30 76.1 36.23 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.814 -0.554 . . . . 0.0 111.22 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 80' ' ' ARG . 7.1 m-85 59.51 56.3 3.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.0 mtt -144.98 173.75 11.61 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.071 -1.018 . . . . 0.0 110.722 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.27 -165.88 45.43 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.32 124.52 20.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -106.85 133.82 50.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.84 137.95 54.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -101.25 116.64 33.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -0.831 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.0 mt -117.49 117.33 29.16 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.004 -1.06 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.521 ' O ' ' C ' ' A' ' 60' ' ' ARG . 37.4 ptt180 -99.67 163.98 12.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.435 -0.791 . . . . 0.0 111.332 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 59' ' ' ARG . 67.5 ttt180 -27.49 111.43 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.465 0.65 . . . . 0.0 110.741 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.69 170.5 36.51 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -107.74 124.86 50.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -105.87 100.46 27.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.12 -18.81 26.94 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.401 2.067 . . . . 0.0 113.221 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.31 140.6 3.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 108.403 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.1 p90 -148.59 29.24 0.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.746 -1.221 . . . . 0.0 110.432 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.4 mmt -98.19 -42.99 7.18 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.095 . . . . 0.0 109.092 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -100.63 -15.9 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 m -86.65 -16.53 36.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.196 -0.94 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.1 mtt -114.57 -28.23 7.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.0 108.621 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.86 52.64 4.03 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.9 mtp -120.91 140.54 51.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -1.03 . . . . 0.0 109.493 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 50.5 t30 -94.29 54.13 1.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.914 -1.116 . . . . 0.0 109.334 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.55 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.5 p -95.22 -167.25 1.59 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.033 -1.042 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.4 m -80.78 145.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -104.42 -14.67 15.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.741 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -139.97 165.48 27.22 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.155 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 78' ' ' SER . 12.4 m -161.0 145.9 13.98 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.623 0.725 . . . . 0.0 110.114 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.689 ' NH1' ' HE ' ' A' ' 148' ' ' ARG . 43.0 ttm180 -134.45 137.24 43.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.661 -0.65 . . . . 0.0 109.33 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 52.3 ttp -92.34 152.96 19.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.214 -0.929 . . . . 0.0 109.024 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.177 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.5 m . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.188 0.518 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.85 110.38 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -166.0 130.32 2.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 44.4 ttm -110.9 130.1 55.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 109.217 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.519 HH21 ' CD2' ' A' ' 126' ' ' HIS . 78.2 mtm180 -104.23 113.85 27.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.8 mt -99.37 146.65 26.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.036 0.922 . . . . 0.0 111.98 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 36.5 m-85 -131.52 125.8 33.31 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.466 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 62.2 tt0 -63.58 -27.09 69.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.261 -0.899 . . . . 0.0 112.198 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.826 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.7 m-70 -109.24 161.06 15.6 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.488 -1.382 . . . . 0.0 111.674 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 76.8 p -59.48 160.49 6.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.814 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 28.1 t0 81.23 -91.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.442 ' H ' ' HB3' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -171.01 40.76 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.29 -152.44 11.69 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 64.04 -174.76 11.77 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -73.22 139.45 46.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 8.3 ptp -97.35 117.47 31.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.09 -1.006 . . . . 0.0 110.36 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 104' ' ' MET . 2.8 mpp? -111.81 138.63 48.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -106.57 136.9 45.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.822 . . . . 0.0 109.997 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 tp -130.37 121.91 26.85 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.424 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 11.2 ttt -121.21 6.28 10.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.368 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 107' ' ' MET . 78.4 m-20 -134.99 -163.33 1.36 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.337 -0.852 . . . . 0.0 109.832 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 168' ' ' ILE . 64.0 t0 -86.25 133.33 33.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -115.19 90.21 23.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.862 . . . . 0.0 109.797 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -78.66 -26.76 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.066 1.844 . . . . 0.0 111.733 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -135.01 86.7 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.425 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.8 mt -67.91 -27.55 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.2 mmt -55.48 -38.18 68.8 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.775 0.798 . . . . 0.0 109.041 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.69 -22.33 26.13 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.167 -0.958 . . . . 0.0 110.927 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.421 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 62.3 ttm-85 -80.51 -60.22 2.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.469 -1.394 . . . . 0.0 111.426 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -108.53 -0.2 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 110.085 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.1 t-20 55.83 34.39 23.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 0.0 108.384 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ptm -152.22 136.8 16.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.2 m -123.75 9.46 8.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.977 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m-20 -131.11 97.73 4.37 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 118.469 -1.292 . . . . 0.0 113.26 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -112.23 137.11 50.8 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.543 ' ND1' ' N ' ' A' ' 123' ' ' HIS . 1.3 m80 -96.17 6.69 48.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 111.147 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.826 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 3.7 p -154.55 158.59 40.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.915 -1.741 . . . . 0.0 110.348 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.1 t -168.62 168.04 11.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.27 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.564 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 17.5 t60 -152.67 148.38 27.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.323 -0.861 . . . . 0.0 109.337 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.451 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 52.9 t -114.93 124.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.73 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 77.9 mmm -74.82 -25.27 58.9 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.508 0.67 . . . . 0.0 109.394 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.8 OUTLIER 167.67 179.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.088 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 131' ' ' HIS . . . 74.94 -137.66 22.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 130' ' ' GLY . 41.2 m80 -153.98 130.51 10.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.623 -0.927 . . . . 0.0 109.185 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -119.5 130.36 55.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.233 -0.917 . . . . 0.0 111.962 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.468 HD23 HD11 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -103.87 128.21 51.36 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 48.7 t -111.01 144.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.718 -1.239 . . . . 0.0 111.224 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.74 126.12 48.17 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.833 -0.542 . . . . 0.0 111.249 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.1 -27.54 68.44 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.853 ' O ' ' OG ' ' A' ' 167' ' ' SER . 7.1 mt-30 -120.25 152.87 55.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 19.0 Cg_endo -59.96 -175.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.283 2.655 . . . . 0.0 113.523 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m120 49.99 31.82 5.13 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.538 0.685 . . . . 0.0 109.93 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.469 ' H ' ' CB ' ' A' ' 167' ' ' SER . 13.9 m-85 56.08 52.68 10.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.103 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 142' ' ' GLY . 86.9 m -139.57 164.59 29.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.71 177.68 32.36 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -54.08 109.56 0.49 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 108.752 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -86.99 147.02 25.91 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.049 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.81 140.46 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.421 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 78.3 t80 -101.19 104.73 15.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 109.708 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.8 mp -99.76 120.5 39.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 0.0 109.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.689 ' HE ' ' NH1' ' A' ' 80' ' ' ARG . 4.1 ptt85 -109.48 163.6 16.68 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 148' ' ' ARG . 80.9 Cg_exo -31.78 158.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.801 2.334 . . . . 0.0 112.534 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 126' ' ' HIS . . . 114.72 -166.45 12.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.62 132.54 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.396 -1.061 . . . . 0.0 110.485 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.504 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 84.9 m-85 -105.76 143.1 34.38 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.661 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 63.2 mtm-85 -125.91 -10.86 6.61 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 112.95 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.563 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.7 t -173.65 -179.17 1.76 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.891 -1.756 . . . . 0.0 111.172 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -62.21 -15.26 45.5 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.1 0.05 56.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 108.565 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -58.53 2.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.716 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.571 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.6 p90 -77.51 13.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.723 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 69.12 39.37 83.65 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -110.09 -161.68 18.64 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.6 t -143.06 -39.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 31.3 p -109.03 -152.28 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.8 p -146.35 9.29 1.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.522 -0.736 . . . . 0.0 109.852 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -65.98 81.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.002 -1.061 . . . . 0.0 111.989 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.8 mtt -105.73 118.18 35.92 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.936 -1.102 . . . . 0.0 109.708 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.33 -24.45 6.2 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.853 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -136.7 152.01 49.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.52 -1.576 . . . . 0.0 111.276 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 16.3 mt -147.62 142.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -128.95 144.6 51.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.46 -0.775 . . . . 0.0 110.662 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 171' ' ' ILE . 19.3 ptt180 -94.6 76.16 3.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.457 -0.777 . . . . 0.0 109.751 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 170' ' ' ARG . 36.5 mt . . . . . 0 N--CA 1.508 2.461 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.487 2.088 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 15.8 ptpt 176.82 157.37 0.3 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.253 -1.145 . . . . 0.0 110.466 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 43' ' ' PHE . 18.0 tt -136.59 135.06 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.529 0.681 . . . . 0.0 110.249 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.7 mt -117.48 124.36 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.644 -0.66 . . . . 0.0 109.412 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.23 161.27 18.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.332 -0.855 . . . . 0.0 108.721 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 29.1 m-85 -147.26 136.46 22.49 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.775 -1.203 . . . . 0.0 108.847 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -76.53 -39.66 52.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.76 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -81.25 138.73 35.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.874 -1.141 . . . . 0.0 110.22 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -59.66 -39.75 85.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.483 -0.76 . . . . 0.0 110.007 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -84.53 41.06 0.82 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 109.564 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 54.29 85.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.525 -0.734 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.51 -159.1 21.46 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -146.49 49.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.65 124.54 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -1.202 . . . . 0.0 109.318 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -109.38 157.08 19.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.408 -0.807 . . . . 0.0 109.804 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.622 ' CE1' ' CE1' ' A' ' 29' ' ' TYR . 5.3 t60 -147.58 125.58 12.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.0 109.777 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -95.12 119.64 33.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 17' ' ' HIS . 6.6 m -119.34 140.95 49.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 109.157 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttt -147.99 11.6 0.95 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.8 t -143.45 155.36 44.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.363 -0.835 . . . . 0.0 110.321 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -50.44 144.03 8.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.696 . . . . 0.0 110.229 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -144.55 116.87 8.48 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 4.67 51.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.009 . . . . 0.0 108.876 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 29.2 p30 -146.28 92.23 2.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.569 -0.707 . . . . 0.0 109.582 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 26' ' ' LEU . 74.3 mt -91.18 -19.99 22.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.529 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 11.7 t-80 -56.95 -33.2 66.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 108.825 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.3 t -57.84 -42.93 85.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 17' ' ' HIS . 80.3 m-85 -74.96 -44.17 49.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.864 -1.147 . . . . 0.0 110.308 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.35 152.13 21.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 70.8 m-20 -98.11 -6.11 32.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.347 -0.846 . . . . 0.0 110.071 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -155.12 153.83 31.44 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.55 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 39.4 t -157.55 127.86 6.33 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -107.24 -4.48 18.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.709 -0.619 . . . . 0.0 109.627 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.42 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 2.0 p -138.66 139.61 38.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.899 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.75 145.67 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -138.09 114.51 10.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.798 -1.189 . . . . 0.0 111.497 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.13 119.46 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -84.72 -31.06 24.25 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.034 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -172.27 156.62 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.562 -1.255 . . . . 0.0 111.586 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.75 -159.67 46.22 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.0 m -125.3 164.03 21.25 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -1.206 . . . . 0.0 109.251 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD2' HD13 ' A' ' 4' ' ' ILE . 11.4 t80 -144.59 133.33 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.998 -1.064 . . . . 0.0 108.761 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.2 tpt -103.16 118.69 37.37 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 m -109.73 142.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.971 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.615 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.0 m-85 -117.94 136.64 53.35 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.681 0.753 . . . . 0.0 110.753 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.25 -9.32 58.58 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.127 ' O ' ' OG ' ' A' ' 78' ' ' SER . 53.6 ttt180 -130.17 156.36 44.71 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 77' ' ' ARG . 25.4 p -68.23 162.99 23.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.678 0.751 . . . . 0.0 110.964 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 t30 66.91 33.13 6.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.918 -0.488 . . . . 0.0 111.204 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.492 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.9 m-85 58.63 58.58 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.215 -0.928 . . . . 0.0 109.765 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.417 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 55.7 mtt -146.78 175.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.197 -0.94 . . . . 0.0 110.288 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 83.03 -166.33 44.43 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' NH2' ' OH ' ' A' ' 56' ' ' TYR . 77.5 mtp180 -58.26 123.63 16.71 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.221 -1.164 . . . . 0.0 108.024 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 5.8 mp0 -105.41 136.12 45.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.417 ' OH ' ' NH2' ' A' ' 54' ' ' ARG . 83.0 m-85 -128.96 129.72 45.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.534 -0.729 . . . . 0.0 109.749 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.644 ' C ' HD12 ' A' ' 58' ' ' LEU . 23.1 p90 -92.77 121.73 34.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.131 -0.98 . . . . 0.0 109.039 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 57' ' ' PHE . 9.3 mp -113.91 116.85 29.93 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.967 -1.083 . . . . 0.0 111.769 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.9 ttp85 -90.83 158.48 16.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.957 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 59' ' ' ARG . 37.3 ttp180 -30.58 116.09 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.31 0.576 . . . . 0.0 110.744 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.38 168.77 32.66 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -107.32 129.87 54.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -1.022 . . . . 0.0 108.786 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -110.19 100.36 43.7 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.44 -14.16 33.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -170.67 141.47 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.8 p90 -146.71 40.27 1.08 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.653 -1.279 . . . . 0.0 109.805 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.9 mmt -103.21 -48.47 4.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.222 -0.924 . . . . 0.0 109.32 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -100.69 -13.01 18.69 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.3 m -89.98 -15.8 31.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.458 -0.776 . . . . 0.0 109.763 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.4 mtt -117.22 -29.36 5.92 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.41 52.38 3.59 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.445 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.8 mtp -122.88 141.07 52.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.982 -1.305 . . . . 0.0 110.221 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.2 m120 -95.85 55.86 1.66 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 0.0 109.253 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.0 p30 150.56 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.55 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.7 p -99.44 -168.61 1.64 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.132 0.967 . . . . 0.0 109.712 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 46' ' ' TYR . 27.2 t -77.0 141.46 15.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 49' ' ' THR . 66.2 mtt180 -106.28 -17.17 14.38 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 1.127 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -145.24 166.68 24.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.295 -0.878 . . . . 0.0 109.48 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 20.9 p -162.44 149.7 13.68 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.921 0.867 . . . . 0.0 110.744 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -129.73 138.9 51.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 ttp -94.6 148.96 21.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.033 -1.042 . . . . 0.0 109.086 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.42 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 71.3 mt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.447 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.2 m . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.42 0.629 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.86 119.78 37.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -170.14 128.59 0.88 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.4 ttm -113.08 126.5 55.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 109.288 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -100.73 117.74 35.43 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.482 HD23 ' CB ' ' A' ' 125' ' ' CYS . 19.7 mt -101.38 150.29 23.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.389 1.09 . . . . 0.0 112.568 -177.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -131.2 122.23 26.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 76.4 tt0 -62.49 -27.94 69.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 111.374 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.9 m-70 -109.88 164.19 12.82 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.767 -1.208 . . . . 0.0 111.542 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 44.2 m -61.77 159.5 13.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.54 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.548 ' O ' ' CG ' ' A' ' 99' ' ' MET . 5.4 m-20 80.28 -98.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' ASP . 23.2 mtt -163.82 45.49 0.11 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.04 -151.25 10.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 61.67 -171.73 8.75 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 89.0 mtt-85 -73.09 131.82 42.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.933 -1.334 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 25.1 mtm -91.62 120.92 32.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 12.1 mtm -119.41 140.06 51.02 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.145 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -105.85 136.93 44.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.38 120.86 24.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 10.0 ttt -120.69 15.67 11.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.734 . . . . 0.0 109.374 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -144.1 -163.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.875 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.418 ' CG ' ' OH ' ' A' ' 140' ' ' TYR . 47.5 t0 -85.1 133.02 34.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -119.64 84.57 30.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.401 -0.812 . . . . 0.0 109.959 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.89 -29.87 6.48 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.282 1.988 . . . . 0.0 112.131 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.516 ' OD1' ' O ' ' A' ' 112' ' ' ASN . 35.1 p30 -127.5 81.39 2.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.427 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.8 mt -66.72 -24.06 66.19 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 2.6 ttm -60.77 -38.57 85.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.548 0.69 . . . . 0.0 109.57 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -84.13 -20.81 31.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.657 -1.277 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 63.0 ttm-85 -82.22 -58.86 2.76 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.622 -1.299 . . . . 0.0 111.212 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -107.69 0.82 22.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.979 . . . . 0.0 109.807 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 114' ' ' MET . 15.8 t30 60.12 34.17 21.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.0 109.361 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.1 ptm -152.33 137.91 17.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -118.43 8.55 12.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.869 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.46 ' OD1' ' C ' ' A' ' 121' ' ' ASP . 6.5 t0 -134.99 93.77 3.05 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.293 -1.363 . . . . 0.0 113.376 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -103.13 136.76 42.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.418 -0.801 . . . . 0.0 109.106 177.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -97.09 3.21 51.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 111.725 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.6 t -160.25 163.18 33.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.656 -1.902 . . . . 0.0 110.763 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.482 ' CB ' HD23 ' A' ' 93' ' ' LEU . 2.2 p -174.55 178.18 2.0 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 8.4 t60 -154.12 147.68 25.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.484 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 54.6 t -112.83 121.88 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.446 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 12.0 tpt -69.32 -33.98 73.97 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.1 m-20 173.32 166.38 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.433 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 131' ' ' HIS . . . 88.96 -146.32 19.09 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.532 ' CD2' ' OH ' ' A' ' 146' ' ' TYR . 26.9 m80 -141.48 129.05 21.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.906 . . . . 0.0 110.061 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -122.08 131.05 53.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.538 -0.726 . . . . 0.0 111.931 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.2 mt -101.82 130.84 48.35 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.5 t -110.47 142.38 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.913 -1.117 . . . . 0.0 109.81 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.73 125.23 49.18 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.696 -0.627 . . . . 0.0 111.312 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -24.63 63.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 167' ' ' SER . 4.3 mt-30 -126.86 154.47 76.12 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.29 -0.881 . . . . 0.0 109.001 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.14 -173.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 123.161 2.574 . . . . 0.0 113.87 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 139' ' ' ASN . 18.6 t-20 45.89 29.73 0.77 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.468 0.651 . . . . 0.0 110.702 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.467 ' H ' ' CB ' ' A' ' 167' ' ' SER . 34.2 m-85 59.21 48.81 9.89 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.093 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 142' ' ' GLY . 61.7 m -131.64 162.24 30.84 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 108.917 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 141' ' ' THR . . . 96.61 174.52 35.35 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.558 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -54.15 110.58 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.88 -0.776 . . . . 0.0 109.387 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.3 OUTLIER -86.56 145.74 26.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.582 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -127.67 132.07 49.73 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.494 0.664 . . . . 0.0 109.283 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.532 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 70.6 t80 -92.44 107.34 19.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.0 mp -102.05 122.06 43.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.646 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -104.1 178.16 1.24 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -48.26 161.15 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.964 1.776 . . . . 0.0 111.672 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.16 -167.55 12.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.38 133.43 55.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.984 . . . . 0.0 110.455 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 96.4 m-85 -106.17 136.51 45.74 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.612 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 85.4 mtm-85 -123.86 -14.33 7.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.201 -0.937 . . . . 0.0 112.52 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.578 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 38.9 t -171.32 -177.98 2.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.027 -1.671 . . . . 0.0 110.99 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -63.98 -12.84 41.6 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.778 -0.576 . . . . 0.0 109.555 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -90.03 -1.2 57.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.971 -1.081 . . . . 0.0 108.55 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.612 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.1 m-20 -91.05 -60.53 1.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.526 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.2 p90 -76.51 16.84 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.03 38.71 95.75 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -103.78 -161.45 24.87 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.1 t -148.53 -40.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.3 p -103.41 -161.66 0.85 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 p -143.83 7.6 1.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.476 -0.765 . . . . 0.0 110.433 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -69.07 82.92 0.33 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.847 -1.158 . . . . 0.0 111.97 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.4 mtt -105.35 121.29 43.58 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.714 -1.241 . . . . 0.0 110.126 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.4 -25.82 3.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.467 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -130.04 152.03 49.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.653 -1.498 . . . . 0.0 111.388 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.5 mt -148.92 139.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 109.835 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -121.2 133.06 55.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.173 -0.954 . . . . 0.0 110.049 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.488 ' O ' ' C ' ' A' ' 171' ' ' ILE . 43.6 ttp180 -92.59 90.69 7.23 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.327 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 170' ' ' ARG . 95.6 mt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.487 2.068 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.569 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 62.0 mttm -163.95 146.03 9.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.525 -0.985 . . . . 0.0 109.553 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' A' ' 43' ' ' PHE . 9.5 mm -124.31 120.08 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.526 -0.734 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.5 mt -116.05 122.27 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.018 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -94.68 131.84 40.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -119.37 135.17 54.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -77.07 -22.97 52.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 111.218 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.649 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.2 t70 -83.21 150.48 26.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.702 -1.249 . . . . 0.0 110.295 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 45.9 mtt-85 -60.02 -44.49 94.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 31.7 m120 -74.52 -94.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.985 . . . . 0.0 109.29 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 35.0 m-85 -157.26 58.95 0.51 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 108.882 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.649 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -151.64 -150.74 5.42 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.46 -153.78 52.72 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -70.6 119.57 14.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 109.058 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -105.34 156.64 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.0 110.311 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.537 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.0 t60 -147.87 124.94 11.38 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.724 . . . . 0.0 109.216 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -98.36 118.33 34.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.54 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 m -114.45 136.5 52.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.7 ptm -134.71 9.73 3.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 p -147.1 163.06 37.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.451 -0.781 . . . . 0.0 110.555 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 41.9 p-10 -56.89 149.18 19.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.399 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.8 t -142.58 115.24 8.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.5 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.628 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 36.3 p30 -137.84 97.1 3.35 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.58 -19.69 18.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 108.44 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.542 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 19.2 t-80 -58.5 -39.52 80.28 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.288 -0.882 . . . . 0.0 109.266 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -51.03 -57.12 9.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.537 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 89.3 m-85 -58.58 -47.71 83.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.758 -0.589 . . . . 0.0 111.257 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -156.85 150.57 24.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.886 -1.134 . . . . 0.0 110.335 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 68.8 m-20 -97.21 -5.97 35.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.958 -1.089 . . . . 0.0 110.421 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -158.89 156.24 29.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 21.2 t -158.79 126.52 5.04 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -103.28 -0.78 29.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 3.7 m -146.04 144.23 29.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.513 -1.367 . . . . 0.0 111.152 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -138.44 143.09 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.88 107.31 8.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 0.0 111.051 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.9 114.88 29.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -77.71 -32.81 53.17 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.762 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -178.5 161.04 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.633 -1.227 . . . . 0.0 111.457 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.59 -153.12 21.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.2 m -133.97 153.59 51.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.479 ' HB2' HD11 ' A' ' 4' ' ' ILE . 12.5 t80 -148.03 141.13 24.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.571 -1.33 . . . . 0.0 109.415 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -108.74 122.16 46.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' TYR . 17.9 m -112.53 144.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.404 -0.81 . . . . 0.0 110.093 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.565 ' O ' HG13 ' A' ' 76' ' ' VAL . 36.1 m-85 -120.52 138.44 53.84 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.016 0.912 . . . . 0.0 111.375 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.62 -8.21 55.04 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.68 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.818 ' O ' ' HB3' ' A' ' 78' ' ' SER . 38.3 ttt180 -130.9 156.5 44.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.139 -0.976 . . . . 0.0 108.847 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -66.06 156.86 32.6 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.671 0.748 . . . . 0.0 111.402 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.95 33.74 3.4 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.618 -0.676 . . . . 0.0 111.586 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.495 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.5 m-85 59.84 58.65 2.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.573 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.409 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.7 mtt -145.96 171.16 15.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.988 -1.07 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.58 -165.43 36.93 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 120.657 -1.277 . . . . 0.0 110.566 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.47 121.22 10.97 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -102.67 134.64 45.7 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.443 ' O ' HG22 ' A' ' 45' ' ' VAL . 80.9 m-85 -126.54 131.48 51.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.686 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -94.76 117.77 30.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.506 -0.746 . . . . 0.0 109.736 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.0 mt -120.56 122.82 41.42 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.143 -0.973 . . . . 0.0 111.112 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.494 ' O ' ' C ' ' A' ' 60' ' ' ARG . 33.4 ptt180 -103.68 168.1 9.36 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.574 0.702 . . . . 0.0 111.058 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.494 ' C ' ' O ' ' A' ' 59' ' ' ARG . 51.6 ttp180 -28.62 110.95 0.05 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.308 0.575 . . . . 0.0 110.911 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.39 31.47 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.533 -1.318 . . . . 0.0 109.957 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -104.41 126.56 51.61 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.408 -1.054 . . . . 0.0 108.422 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.36 96.98 24.18 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 10' ' ' ARG . 44.8 Cg_endo -70.05 -14.22 34.89 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.196 1.931 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -170.72 143.46 2.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 108.331 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.4 p90 -149.28 41.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.627 -1.296 . . . . 0.0 109.667 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.5 mmt -107.13 -46.43 3.9 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.335 -0.853 . . . . 0.0 109.407 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -100.23 -15.09 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -89.46 -14.46 35.3 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -115.37 -30.24 6.31 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.13 5.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.8 mtp -121.88 144.04 49.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.402 . . . . 0.0 109.401 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 81.9 m-20 -96.16 53.65 1.37 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.222 -0.923 . . . . 0.0 109.014 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.4 p30 152.86 -171.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.513 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.4 p -98.76 -168.1 1.59 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.781 0.8 . . . . 0.0 109.938 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 46' ' ' TYR . 22.5 t -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 45.2 mmm-85 -106.52 -16.71 14.46 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.755 -1.215 . . . . 0.0 107.898 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.818 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.68 164.3 33.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 109.485 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.416 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 26.3 p -161.03 150.64 17.06 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.242 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.43 136.86 39.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.9 ptm -90.62 158.18 17.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.5 mt . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.615 -0.678 . . . . 0.0 110.233 -179.86 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.294 0.568 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.11 114.41 27.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -161.2 123.41 3.05 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.635 ' SD ' HG22 ' A' ' 127' ' ' VAL . 7.5 tpp -107.99 125.35 51.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.022 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -99.53 111.72 24.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 103' ' ' MET . 20.7 mt -99.79 148.91 23.9 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.881 0.848 . . . . 0.0 112.474 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 99' ' ' MET . 26.1 m-85 -136.72 127.09 26.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.06 -23.55 67.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.402 -0.811 . . . . 0.0 112.386 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.5 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.9 m-70 -113.67 162.28 16.44 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.56 -1.338 . . . . 0.0 111.178 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 77.5 p -58.13 160.3 5.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.527 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 97' ' ' SER . 4.4 m-20 79.51 -90.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.547 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 1.8 mtm -175.37 38.66 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.51 -163.11 23.47 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.416 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 72.23 -146.61 39.64 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -99.39 139.34 35.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -1.198 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 3.6 ptt? -96.96 116.81 29.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.374 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.42 ' CE ' ' SD ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -104.98 137.18 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.126 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -99.1 122.32 42.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 108.666 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.9 tt -133.8 118.83 18.47 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 19.5 ptm -129.72 21.4 5.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 109.257 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.661 ' H ' HD23 ' A' ' 106' ' ' LEU . 22.9 p-10 -133.97 -166.86 1.86 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 37.4 p-10 -86.45 132.81 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 0.0 109.256 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -117.82 89.02 32.44 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.176 -0.952 . . . . 0.0 109.66 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.03 -20.95 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -139.97 85.14 2.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.4 mt -71.27 -26.78 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 110.057 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -56.16 -39.83 72.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.422 -0.799 . . . . 0.0 109.102 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.05 -21.76 29.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -80.32 -59.32 2.75 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.77 -1.207 . . . . 0.0 111.085 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -109.06 0.02 19.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.596 -0.69 . . . . 0.0 110.309 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 114' ' ' MET . 12.5 m120 56.49 32.52 20.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.476 1.131 . . . . 0.0 108.587 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.42 ' SD ' ' CE ' ' A' ' 104' ' ' MET . 9.7 ptm -153.29 137.73 16.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 47.2 m -124.86 11.25 8.36 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.466 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 120' ' ' SER . 52.2 m-20 -130.03 94.88 3.8 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.631 -1.293 . . . . 0.0 113.191 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.88 136.29 49.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -99.23 3.03 46.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 111.281 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.9 t -148.94 154.76 39.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.063 -1.648 . . . . 0.0 110.719 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.8 t -165.31 163.14 20.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 110.312 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.514 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 5.0 t60 -147.66 145.08 28.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.416 -0.803 . . . . 0.0 108.893 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.635 HG22 ' SD ' ' A' ' 91' ' ' MET . 67.8 t -113.14 123.2 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 109.808 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 21.1 ttm -77.24 -23.34 51.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.749 -0.594 . . . . 0.0 109.854 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 170.73 178.47 0.06 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.595 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 73.53 -134.22 18.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.7 m-70 -162.07 139.77 8.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.693 -0.886 . . . . 0.0 108.857 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -131.05 142.45 50.3 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.115 -0.991 . . . . 0.0 112.256 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mt -110.59 134.04 52.77 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 46.3 t -112.29 142.54 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.907 -1.12 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -120.25 125.06 47.19 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.53 -26.78 65.62 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 167' ' ' SER . 7.5 mp0 -120.51 153.86 56.53 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.372 -0.83 . . . . 0.0 108.807 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 24.8 Cg_endo -60.92 -177.94 0.21 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.309 2.673 . . . . 0.0 113.873 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 51.05 33.3 8.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.442 ' H ' ' CB ' ' A' ' 167' ' ' SER . 23.4 m-85 56.46 51.23 11.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.649 -0.657 . . . . 0.0 110.009 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 142' ' ' GLY . 50.0 m -136.69 162.7 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.768 -0.582 . . . . 0.0 109.676 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.48 174.07 32.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.8 mmm-85 -51.56 109.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.469 -1.018 . . . . 0.0 108.99 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 21.1 pt20 -87.58 147.28 25.38 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.789 0.804 . . . . 0.0 110.089 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -129.74 143.2 50.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.558 ' OH ' ' CG ' ' A' ' 131' ' ' HIS . 91.8 t80 -103.73 106.85 17.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 109.556 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.7 mp -100.04 121.13 40.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.383 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.564 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -107.49 168.99 7.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.4 Cg_exo -36.69 164.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.159 1.906 . . . . 0.0 112.0 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.49 -164.23 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -122.84 131.46 53.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.761 -0.847 . . . . 0.0 110.812 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.564 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 23.4 m-85 -109.24 145.83 35.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.635 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 19.0 ptt-85 -137.55 -3.62 1.88 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.789 -1.195 . . . . 0.0 112.41 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.559 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 9.2 m -169.49 167.42 9.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.025 -1.672 . . . . 0.0 109.901 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -57.34 -9.91 1.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -88.62 -3.64 58.75 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.297 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.635 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 5.2 m-20 -89.64 -60.93 1.81 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 109.17 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.568 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 10.0 p90 -73.54 12.36 0.64 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 68.19 34.8 81.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.72 -160.38 30.88 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 t -149.16 -39.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.1 p -106.72 -156.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 18.7 p -139.09 3.24 2.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -63.98 77.11 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.218 -0.926 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.9 mtt -105.15 116.26 31.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.026 -1.046 . . . . 0.0 109.873 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.24 -24.59 5.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.69 149.33 52.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.59 -1.535 . . . . 0.0 111.286 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.456 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 18.8 mt -148.88 139.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.32 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.81 140.29 52.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.412 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 170' ' ' ARG . 27.5 ptt85 -94.79 70.46 3.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 108.977 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 5.3 mm . . . . . 0 C--N 1.299 -1.593 0 C-N-CA 119.389 -0.925 . . . . 0.0 109.304 179.627 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.094 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -147.47 139.74 24.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.523 -0.986 . . . . 0.0 110.202 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 4' ' ' ILE . 7.0 tp -125.72 122.35 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.452 -0.78 . . . . 0.0 109.24 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 HH21 ' A' ' 37' ' ' ARG . 70.4 mt -121.1 126.24 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.94 162.14 14.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.198 -0.939 . . . . 0.0 108.917 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 18.5 m-85 -145.98 135.39 23.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.678 -1.264 . . . . 0.0 108.744 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.71 -46.21 54.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 61.1 m-20 -76.53 148.92 36.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.835 -1.166 . . . . 0.0 110.345 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -64.7 -41.26 96.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.488 -0.758 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -87.18 45.08 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 52.95 90.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.93 -171.06 42.4 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 72.15 -141.63 31.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -83.46 123.61 29.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.967 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -107.77 159.94 16.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 109.765 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -142.63 123.47 14.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 108.921 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.85 121.39 42.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.044 -1.035 . . . . 0.0 109.371 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 140.39 50.04 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.774 0.797 . . . . 0.0 109.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 48.4 mtt -131.21 6.97 4.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.1 m -149.47 168.93 22.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -53.9 151.83 6.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.336 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.66 113.18 5.32 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.85 -7.71 39.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.12 -0.988 . . . . 0.0 109.41 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.35 99.19 5.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 26' ' ' LEU . 34.6 mt -110.0 -20.61 12.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.96 . . . . 0.0 108.905 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 28' ' ' SER . 33.9 t-80 -61.6 -47.15 86.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.061 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' HIS . 99.2 p -49.51 -55.46 13.23 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -56.14 -42.57 77.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.624 -0.673 . . . . 0.0 111.056 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 30.1 p90 -159.58 153.63 23.38 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.99 -1.069 . . . . 0.0 109.901 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.658 ' ND2' ' H ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -104.98 -8.49 18.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.218 -0.926 . . . . 0.0 110.718 -178.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -149.37 149.01 30.18 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.992 -1.068 . . . . 0.0 108.734 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.541 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 37.0 t -155.3 125.02 6.47 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -108.51 -9.32 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.035 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.448 ' OG ' ' CB ' ' A' ' 7' ' ' TYR . 2.6 p -132.27 137.89 47.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 0.0 110.589 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -134.87 141.92 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.54 ' NE ' ' OE2' ' A' ' 39' ' ' GLU . 29.5 ttp180 -136.27 115.99 13.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.859 -1.151 . . . . 0.0 111.754 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.39 117.24 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 68.6 mm-40 -79.18 -35.39 41.95 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.944 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.7 t -174.31 161.94 3.53 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.903 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 177.83 51.14 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.9 m -98.47 148.79 23.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.952 . . . . 0.0 109.925 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.531 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 5.8 t80 -144.3 137.3 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.781 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 146' ' ' TYR . 50.1 mtp -113.23 128.67 56.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.418 ' HB ' HG11 ' A' ' 76' ' ' VAL . 21.6 m -114.22 144.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.117 -0.989 . . . . 0.0 109.896 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 76' ' ' VAL . 31.7 m-85 -121.5 139.93 52.85 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.734 0.778 . . . . 0.0 111.694 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -75.39 -6.59 50.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.558 -0.714 . . . . 0.0 109.473 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.893 ' O ' ' HB3' ' A' ' 78' ' ' SER . 19.6 ttm180 -131.86 158.3 41.69 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.5 p -70.5 158.5 35.96 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.688 0.756 . . . . 0.0 111.131 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 68.44 33.85 3.92 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.307 0.575 . . . . 0.0 111.639 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.485 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 3.3 m-85 60.95 61.25 1.66 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.718 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 82.2 mtp -149.84 172.15 15.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.191 -0.943 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.26 -170.25 44.67 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -54.44 117.35 3.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 107.926 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -101.01 134.61 43.74 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -128.14 128.91 45.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.256 -0.903 . . . . 0.0 109.278 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.99 118.91 25.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.954 -1.091 . . . . 0.0 108.657 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.702 HD11 ' CZ ' ' A' ' 63' ' ' TYR . 6.3 tp -125.51 118.45 25.81 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.4 ptm180 -108.9 179.84 4.06 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 0.0 111.884 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 59' ' ' ARG . 43.5 ttp180 -31.19 108.12 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.496 0.665 . . . . 0.0 111.004 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.34 158.35 20.86 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.43 127.16 52.84 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.702 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 71.0 m-85 -116.38 99.84 53.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -76.93 -6.96 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.442 2.095 . . . . 0.0 112.531 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.5 135.25 1.95 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.937 -1.102 . . . . 0.0 108.362 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 23.0 p90 -150.07 32.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.563 -1.336 . . . . 0.0 110.744 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 6.3 mmt -97.39 -46.67 5.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.827 -1.17 . . . . 0.0 109.199 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -99.34 -16.79 18.32 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 m -88.91 -20.46 24.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.521 -0.737 . . . . 0.0 109.883 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 72' ' ' MET . 42.4 ttm -107.32 -25.77 11.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.997 -1.064 . . . . 0.0 108.388 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.1 52.72 4.18 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.17 -1.014 . . . . 0.0 110.771 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 70' ' ' MET . 90.9 mtp -128.6 139.92 52.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.349 -1.089 . . . . 0.0 109.832 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 13.4 m120 -98.43 57.46 1.2 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.6 p30 150.91 -173.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 29.5 p -95.96 -174.61 3.16 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.293 1.044 . . . . 0.0 110.481 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 46' ' ' TYR . 40.6 t -78.38 143.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -108.07 -16.77 14.2 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.897 -1.127 . . . . 0.0 108.256 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.893 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.05 159.27 42.54 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.061 -1.024 . . . . 0.0 109.925 178.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 26' ' ' LEU . 11.0 m -154.74 143.55 20.83 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.37 0.605 . . . . 0.0 110.231 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' CD2' ' A' ' 146' ' ' TYR . 52.7 ttp180 -134.15 138.39 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.2 ttm -99.61 159.88 14.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.076 -1.015 . . . . 0.0 109.869 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 88.0 mt . . . . . 0 N--CA 1.496 1.829 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.509 2.484 0 CA-C-O 122.074 0.94 . . . . 0.0 113.291 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -126.41 133.58 51.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -174.17 123.21 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.1 ttm -117.68 135.62 53.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -108.94 121.72 45.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' MET . 14.3 mt -106.02 150.48 25.69 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.948 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CG ' ' HA ' ' A' ' 99' ' ' MET . 29.9 m-85 -134.58 121.59 21.15 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.083 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 55.5 tt0 -59.03 -26.54 64.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 111.526 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 124' ' ' SER . 39.6 m170 -110.61 162.0 15.17 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.503 -1.373 . . . . 0.0 111.12 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.2 p -59.15 154.35 16.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.754 -0.591 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 7.4 t70 84.24 -90.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -173.94 47.1 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.63 -159.44 12.61 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-O 122.242 0.912 . . . . 0.0 111.157 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.462 ' CA ' ' ND1' ' A' ' 96' ' ' HIS . . . 61.49 -159.5 30.01 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 98.1 mtt180 -79.21 127.42 32.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.99 -1.3 . . . . 0.0 110.048 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.498 ' C ' ' SD ' ' A' ' 103' ' ' MET . 10.1 tmm? -91.14 122.34 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.2 mtm -123.14 137.91 54.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 108.649 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.25 142.63 34.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.408 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.51 121.28 23.08 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.545 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 9.2 ttt -123.83 21.15 9.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 107' ' ' MET . 54.1 m-20 -145.85 -160.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.419 -0.801 . . . . 0.0 109.407 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 39.4 p-10 -90.03 133.77 34.63 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.98 80.57 14.95 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.71 -33.01 8.74 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.228 1.952 . . . . 0.0 111.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.461 HD22 ' H ' ' A' ' 115' ' ' ASP . 10.6 t30 -126.38 78.97 1.82 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.514 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -62.67 -15.31 51.77 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 109.178 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.6 mmt -63.3 -40.98 98.86 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.471 0.653 . . . . 0.0 109.856 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.461 ' H ' HD22 ' A' ' 112' ' ' ASN . 82.0 m-20 -85.21 -23.01 28.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.921 -1.112 . . . . 0.0 110.98 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . 0.479 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 49.5 ttm-85 -79.4 -61.04 2.13 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.602 -1.311 . . . . 0.0 111.123 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 118' ' ' ASN . 8.8 m-85 -109.61 0.75 19.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.925 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 117' ' ' PHE . 52.1 m-20 48.33 32.79 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.424 ' HG3' ' CE2' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -143.4 126.04 15.96 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -120.53 7.6 10.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.573 -0.704 . . . . 0.0 111.174 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.5 m-20 -135.34 88.96 2.46 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.634 -1.292 . . . . 0.0 112.606 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -101.42 139.45 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.185 -0.947 . . . . 0.0 108.852 177.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.11 3.82 54.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 111.244 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 5.3 t -152.23 157.54 41.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.148 -1.595 . . . . 0.0 110.327 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 1.5 p -169.47 167.96 9.63 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.755 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 12.7 t60 -149.09 145.91 27.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.449 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.3 t -114.36 125.3 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 108.771 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.406 ' SD ' ' CD2' ' A' ' 126' ' ' HIS . 86.2 mmm -81.66 -32.0 32.04 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.1 p30 178.29 168.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.537 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.71 -152.42 22.45 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.532 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 68.6 m-70 -137.27 123.57 20.61 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.675 -0.897 . . . . 0.0 109.347 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -112.14 122.97 49.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 0.0 112.676 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.657 HD12 ' CE2' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -98.93 123.4 43.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 42.9 t -109.15 144.82 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.816 -1.178 . . . . 0.0 110.618 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.657 ' CE2' HD12 ' A' ' 133' ' ' LEU . 62.6 m-85 -124.12 125.8 45.11 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.039 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 68.2 tt0 -64.44 -21.41 66.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.731 -0.606 . . . . 0.0 109.678 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.663 ' O ' ' OG ' ' A' ' 167' ' ' SER . 93.7 mm-40 -127.6 134.0 25.71 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.315 -0.866 . . . . 0.0 109.646 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 137' ' ' GLN . 96.0 Cg_exo -38.86 -177.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 123.808 3.005 . . . . 0.0 114.859 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 50.21 31.04 4.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.81 -0.556 . . . . 0.0 110.899 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.469 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 57.59 54.33 6.51 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 0.0 110.435 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 142' ' ' GLY . 94.3 m -144.24 168.97 18.79 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.927 -1.108 . . . . 0.0 110.056 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 141' ' ' THR . . . 93.93 -177.01 36.66 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 63.4 mtm180 -56.35 106.74 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -1.08 . . . . 0.0 108.81 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -88.24 147.4 24.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.787 0.803 . . . . 0.0 110.184 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -128.02 141.02 51.63 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.63 0.728 . . . . 0.0 109.345 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.546 ' CD1' ' SD ' ' A' ' 44' ' ' MET . 88.1 t80 -99.02 101.66 13.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.593 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.3 mp -97.65 120.73 38.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.246 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.497 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -112.0 166.63 10.53 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 148' ' ' ARG . 88.1 Cg_exo -32.3 156.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.5 -169.82 14.2 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -121.23 136.2 55.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.433 -1.039 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.437 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 20.6 m-85 -113.07 145.89 40.11 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.639 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 25.0 ptt180 -136.75 0.64 2.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.933 . . . . 0.0 111.975 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.553 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.0 m -174.2 171.33 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.153 -1.592 . . . . 0.0 110.121 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.8 -17.0 19.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.38 -0.825 . . . . 0.0 109.17 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.08 1.76 46.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.0 -1.063 . . . . 0.0 109.326 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.639 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 9.1 m-20 -93.29 -60.35 1.81 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.451 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.8 p90 -78.12 16.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.76 39.39 93.58 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -107.32 -161.6 21.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.37 -42.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.3 p -109.05 -150.83 0.46 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 26.2 t -147.04 17.62 1.23 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.485 -0.759 . . . . 0.0 109.561 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -67.22 74.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.289 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.8 mtt -103.88 118.02 35.69 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.035 -1.041 . . . . 0.0 108.958 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.38 -25.97 3.87 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.663 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.023 1.412 . . . . 0.0 110.71 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.3 mt -145.67 140.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.749 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -131.37 145.2 51.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.8 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 107' ' ' MET . 0.3 OUTLIER -96.4 74.7 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 171' ' ' ILE . 2.9 pt . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.005 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.663 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -146.42 161.51 40.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.265 . . . . 0.0 110.73 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.624 HD13 ' CD2' ' A' ' 43' ' ' PHE . 12.2 tt -136.26 136.69 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.494 -0.754 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.456 HD12 HH21 ' A' ' 37' ' ' ARG . 72.2 mt -121.54 125.99 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 109.373 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -90.68 154.12 19.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -138.85 139.42 38.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 109.515 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.82 -33.36 57.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.468 -0.77 . . . . 0.0 111.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 54.5 t0 -77.69 153.91 32.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.916 -1.115 . . . . 0.0 110.328 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 64' ' ' PRO . 96.1 mtt180 -61.84 -50.43 72.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.511 -0.743 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 88.7 m-20 -71.43 -94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.065 . . . . 0.0 109.273 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 52.0 m-85 -157.3 69.76 0.58 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 109.043 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -163.8 -174.32 33.5 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.85 -152.75 23.24 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.506 ' N ' ' CD ' ' A' ' 15' ' ' ARG . 11.2 mpt_? -75.65 125.82 29.79 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.829 -1.394 . . . . 0.0 108.833 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -109.34 157.11 19.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -145.99 123.78 11.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -95.55 117.74 30.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.293 -0.879 . . . . 0.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.8 m -122.0 140.77 52.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.17 -0.956 . . . . 0.0 109.605 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.5 ptm -147.89 14.3 1.04 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.6 p -145.25 159.8 42.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.512 -0.742 . . . . 0.0 110.093 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -51.43 145.82 8.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.51 -0.744 . . . . 0.0 110.041 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.512 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 5.1 t -148.27 115.42 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.21 12.31 22.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.118 -0.989 . . . . 0.0 108.798 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.512 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 40.3 p-10 -148.57 90.45 1.79 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.638 -0.664 . . . . 0.0 109.615 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.525 HD11 ' SG ' ' A' ' 79' ' ' CYS . 32.0 mt -107.14 -28.79 9.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 28' ' ' SER . 47.3 p-80 -63.48 -39.81 95.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 109.029 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 27' ' ' HIS . 18.5 m -55.47 -25.38 36.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.75 -0.594 . . . . 0.0 109.468 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -83.31 -37.11 23.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 17.7 p90 -152.32 151.24 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -95.15 -9.89 32.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 mtt85 -155.7 155.46 33.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.03 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.595 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 48.3 t -154.51 123.47 6.3 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -107.51 -4.26 18.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.355 -0.841 . . . . 0.0 110.437 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 t -136.43 140.66 43.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.876 -1.14 . . . . 0.0 110.983 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 91.8 mt -137.22 145.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 32.0 ttp180 -137.81 116.46 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.864 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.19 119.54 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 92.3 mt-10 -84.72 -29.19 25.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.0 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -174.93 159.41 2.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.787 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.94 -162.67 46.86 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.4 t -123.53 153.18 40.95 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.47 -1.018 . . . . 0.0 109.172 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.624 ' CD2' HD13 ' A' ' 4' ' ' ILE . 10.1 t80 -140.34 135.28 32.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.153 -0.967 . . . . 0.0 109.137 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 ttt -106.37 119.94 40.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.38 143.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.809 -0.757 . . . . 0.0 110.209 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.7 m-85 -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 41.7 t0 -74.36 -9.13 58.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.947 -0.47 . . . . 0.0 109.951 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.843 ' O ' ' HB3' ' A' ' 78' ' ' SER . 27.8 ttt85 -131.52 158.19 41.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.9 p -68.45 163.65 22.84 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.78 0.8 . . . . 0.0 111.4 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 65.71 32.13 9.22 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.106 0.479 . . . . 0.0 111.499 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CB ' HH21 ' A' ' 80' ' ' ARG . 2.6 m-85 61.0 58.15 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.354 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.406 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.1 mtt -146.04 176.06 9.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.234 -0.917 . . . . 0.0 109.58 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 -172.68 48.36 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -55.94 124.15 16.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -102.47 134.19 46.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.055 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.0 129.27 47.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.496 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.642 ' C ' HD12 ' A' ' 58' ' ' LEU . 11.1 p90 -91.19 121.38 32.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.852 . . . . 0.0 108.886 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 57' ' ' PHE . 10.3 mp -108.77 139.74 43.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 60' ' ' ARG . 33.0 ptt180 -118.8 158.66 25.18 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 59' ' ' ARG . 50.8 ttt-85 -29.92 115.37 0.11 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.285 0.564 . . . . 0.0 110.389 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.29 164.32 26.77 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -104.62 127.43 52.37 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -110.4 97.68 32.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 108.666 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 10' ' ' ARG . 48.9 Cg_endo -71.47 -11.55 28.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.071 1.847 . . . . 0.0 112.348 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 37.5 p-10 -167.27 135.76 2.61 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 15.5 p90 -147.95 20.28 1.13 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.702 -1.249 . . . . 0.0 110.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 42.7 tpp -90.99 -44.92 9.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.683 -1.261 . . . . 0.0 109.504 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 68' ' ' ARG . 12.5 ptp180 -98.45 -20.69 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -76.8 -30.56 56.48 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.046 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.9 mtt -95.08 -39.27 10.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.12 44.88 2.71 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 mmm -111.17 150.73 29.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.73 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.9 m120 -100.45 49.92 0.9 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.083 -1.011 . . . . 0.0 109.244 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.85 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.595 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 24.6 p -97.85 -170.22 1.95 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 46' ' ' TYR . 46.4 t -78.7 144.38 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -111.17 -15.25 13.72 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.597 -1.314 . . . . 0.0 107.719 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.843 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -143.84 166.26 25.42 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 178.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.525 ' SG ' HD11 ' A' ' 26' ' ' LEU . 30.1 p -160.16 145.25 14.93 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.504 HH21 ' CB ' ' A' ' 51' ' ' PHE . 35.6 ttm180 -130.68 136.64 48.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.3 ttp -95.98 149.6 21.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 108.956 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.3 mt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 -179.736 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 54.7 m . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.312 0.577 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.62 ' CG ' ' NE ' ' A' ' 170' ' ' ARG . 10.5 m-85 -112.6 118.47 35.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -0.816 . . . . 0.0 109.496 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -171.18 126.98 0.68 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 49.2 ttm -110.43 125.2 53.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.051 -1.031 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -99.62 118.08 35.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' MET . 16.5 mt -104.52 147.31 27.74 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.191 0.996 . . . . 0.0 112.238 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 99' ' ' MET . 28.2 m-85 -133.64 125.25 28.31 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 86.8 tt0 -62.36 -27.51 69.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.942 . . . . 0.0 111.879 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.2 m-70 -108.95 164.9 12.0 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.539 -1.35 . . . . 0.0 111.145 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 58.2 m -61.55 156.19 20.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 97' ' ' SER . 2.3 m-20 81.6 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.484 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -169.91 41.55 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.68 -157.24 21.29 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.507 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.509 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 60.73 -155.64 33.31 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 79.2 mtp180 -87.49 138.6 31.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 109.836 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.6 ptt? -98.56 123.43 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 110.072 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.68 136.87 54.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.9 137.03 40.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 110.122 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.36 119.07 21.17 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.57 -15.88 12.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.544 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -111.86 -159.06 0.67 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.85 . . . . 0.0 110.352 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.4 139.36 30.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.29 88.33 27.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.459 -0.776 . . . . 0.0 109.297 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.23 -25.76 8.22 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.162 1.908 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -136.57 80.71 1.84 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.532 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 12.7 mt -64.54 -28.46 69.66 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.201 -0.937 . . . . 0.0 110.012 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.78 -39.38 73.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.35 -23.03 35.27 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 110.184 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -79.48 -69.11 0.6 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.475 -1.391 . . . . 0.0 110.515 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.8 m-85 -96.07 3.43 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.993 -1.067 . . . . 0.0 110.721 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 114' ' ' MET . 31.4 m-20 52.32 31.85 10.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.563 -1.336 . . . . 0.0 107.514 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.439 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 4.7 ttp -146.47 132.41 19.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 60.2 p -116.13 2.95 13.46 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.507 -0.746 . . . . 0.0 109.801 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 163' ' ' SER . 50.7 m-20 -131.09 113.13 13.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.564 -1.335 . . . . 0.0 111.594 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -123.33 131.77 53.77 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.478 ' ND1' ' N ' ' A' ' 123' ' ' HIS . 2.8 m80 -93.21 1.87 56.9 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.342 -0.848 . . . . 0.0 111.097 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.2 t -147.51 153.81 39.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 119.674 -1.892 . . . . 0.0 110.844 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 50.3 t -162.44 161.42 27.19 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.411 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.451 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 1.9 t-80 -147.63 141.9 26.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.173 -0.955 . . . . 0.0 109.522 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 60.2 t -112.16 122.17 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 10.4 tpt -71.87 -32.38 67.41 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 88' ' ' SER . 0.9 OUTLIER 170.95 163.2 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.062 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.92 -160.63 29.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -127.97 129.4 46.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.514 -0.992 . . . . 0.0 110.199 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -118.69 126.06 51.07 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.851 0.834 . . . . 0.0 111.91 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.24 125.68 41.95 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 50.5 t -111.23 145.12 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 141' ' ' THR . 94.8 m-85 -124.73 123.1 39.26 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.694 -0.629 . . . . 0.0 111.113 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 164' ' ' ARG . 71.8 tt0 -57.74 -29.36 64.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.838 ' O ' ' OG ' ' A' ' 167' ' ' SER . 5.8 mt-30 -117.27 153.07 49.87 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 19.2 Cg_endo -60.21 -170.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 123.496 2.797 . . . . 0.0 113.774 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 46.61 29.4 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.603 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 58.28 53.99 6.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 110.061 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 135' ' ' TYR . 14.2 p -140.39 168.25 20.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.95 178.21 36.28 Favored Glycine 0 N--CA 1.503 3.15 0 O-C-N 120.737 -1.227 . . . . 0.0 110.6 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -53.39 108.0 0.29 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -86.85 141.93 28.43 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.969 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -126.0 132.46 52.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -92.66 105.3 17.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.015 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.5 mp -98.35 120.17 38.31 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 109.121 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -105.02 178.73 1.07 Allowed Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 66.3 Cg_exo -49.42 161.58 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.679 1.586 . . . . 0.0 111.64 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.51 -173.88 14.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.75 135.46 54.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.744 -0.857 . . . . 0.0 110.658 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 18.1 m-85 -112.75 143.83 43.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.614 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 41.1 ptt85 -135.12 -1.39 2.65 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.015 -1.053 . . . . 0.0 112.159 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.551 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 1.6 t -171.77 168.19 6.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 119.896 -1.752 . . . . 0.0 109.924 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -57.6 -14.6 5.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -85.82 0.01 54.13 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.231 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.614 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.4 m-20 -92.52 -59.66 2.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.542 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.7 p90 -76.78 18.14 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.23 37.82 95.06 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -102.49 -166.04 26.43 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.0 t -144.66 -40.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.6 p -107.03 -159.87 0.71 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.5 t -138.42 11.09 2.76 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 109.497 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 136' ' ' GLU . 85.6 mtt-85 -69.49 75.6 0.4 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.016 -1.053 . . . . 0.0 112.988 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 mtt -100.05 122.8 43.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.139 -0.976 . . . . 0.0 110.247 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.93 -28.5 2.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.838 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -132.85 148.5 52.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.421 -1.635 . . . . 0.0 111.2 -179.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.5 mt -144.84 140.7 23.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.328 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -125.86 143.83 50.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.304 -0.873 . . . . 0.0 110.349 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.62 ' NE ' ' CG ' ' A' ' 89' ' ' PHE . 29.5 ttt180 -97.72 85.48 3.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 171' ' ' ILE . 13.9 mt . . . . . 0 N--CA 1.503 2.197 0 O-C-N 121.747 -0.596 . . . . 0.0 112.372 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -151.9 135.61 16.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.433 HD11 ' CG2' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -122.01 117.16 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -115.0 124.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.888 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.84 159.25 15.88 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 14.3 m-85 -146.25 135.1 22.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.564 -1.335 . . . . 0.0 109.038 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.54 -42.52 58.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.123 -0.985 . . . . 0.0 111.069 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 35' ' ' SER . 12.6 t70 -81.21 151.19 28.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.889 -1.132 . . . . 0.0 110.542 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.49 -40.59 95.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 110.068 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.94 39.49 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.699 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 53.16 59.76 4.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 109.563 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.7 -154.44 6.14 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -145.63 49.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -77.7 123.41 26.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -1.085 . . . . 0.0 108.967 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -109.56 156.08 20.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.478 -0.764 . . . . 0.0 109.953 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 34.4 t60 -142.64 124.85 15.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 109.27 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -99.91 119.83 38.83 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.879 . . . . 0.0 109.575 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.37 139.72 50.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.5 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' A' ' 20' ' ' MET . 0.8 OUTLIER -131.7 7.17 4.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -148.95 169.71 19.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.381 -0.824 . . . . 0.0 109.672 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 40.9 p-10 -61.4 147.32 45.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 110.285 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.1 t -140.06 115.33 9.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -8.31 56.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.0 108.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 12.2 p-10 -130.98 98.51 4.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 26' ' ' LEU . 57.8 mt -104.64 -20.2 13.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 108.655 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 27' ' ' HIS . 7.9 t-80 -59.58 -44.7 93.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' HIS . 25.6 t -49.99 -46.28 52.44 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 53.6 m-85 -70.08 -51.91 28.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.11 149.24 30.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.999 -1.063 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -100.91 -5.42 26.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.359 -0.838 . . . . 0.0 110.838 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -154.88 153.19 30.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.01 -1.056 . . . . 0.0 108.248 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 52.7 t -158.96 113.68 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.973 -1.079 . . . . 0.0 108.791 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.6 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 35.9 m-70 -95.81 -4.84 43.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.713 -0.617 . . . . 0.0 110.994 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.7 p -139.19 145.93 39.92 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.688 -1.257 . . . . 0.0 111.236 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.433 ' CG2' HD11 ' A' ' 4' ' ' ILE . 26.0 mt -140.98 142.5 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -132.71 112.11 11.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 111.081 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.522 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 1.4 t -98.5 115.0 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -83.01 -33.75 26.46 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.685 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 8.3 t -171.74 151.34 2.84 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.138 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.727 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 103.18 -137.92 13.69 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.727 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 60.7 m -170.92 164.41 7.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 2.8 p90 -174.84 168.96 3.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.616 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.0 ttm -119.72 141.29 49.55 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.706 ' HB ' HG11 ' A' ' 76' ' ' VAL . 34.8 m -115.74 146.6 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.5 -0.75 . . . . 0.0 109.1 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 95.6 m-85 -120.41 142.34 49.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.39 -0.819 . . . . 0.0 111.587 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -9.33 58.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.82 ' O ' ' HB3' ' A' ' 78' ' ' SER . 89.8 mtt-85 -134.52 165.39 25.3 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.525 ' OG1' ' ND2' ' A' ' 50' ' ' ASN . 39.6 p -75.64 160.61 29.9 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.729 0.776 . . . . 0.0 111.476 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.525 ' ND2' ' OG1' ' A' ' 49' ' ' THR . 5.2 m-80 68.18 33.03 4.55 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.321 0.581 . . . . 0.0 111.168 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 4.9 m-85 61.0 60.31 1.85 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.781 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.423 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 59.1 mtt -146.34 170.95 15.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.235 -0.916 . . . . 0.0 110.033 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.15 -173.46 50.25 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -55.16 126.21 23.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.097 -1.237 . . . . 0.0 108.128 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -110.37 140.9 44.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 0.0 108.868 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -132.26 137.12 47.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.816 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 22.7 p90 -98.85 123.77 43.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.404 -0.81 . . . . 0.0 109.241 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -122.83 129.49 51.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.8 ptt180 -104.59 167.45 9.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.39 -0.819 . . . . 0.0 110.922 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 59' ' ' ARG . 72.9 ttt180 -35.6 119.53 0.54 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.701 0.763 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 168.81 164.96 25.4 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -102.84 124.42 48.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.464 -1.021 . . . . 0.0 108.48 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -108.27 97.67 23.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -16.63 41.98 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.2 1.933 . . . . 0.0 112.212 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 40.7 p-10 -169.36 145.03 3.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.871 -1.143 . . . . 0.0 107.943 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 20.2 p90 -148.0 -16.21 0.35 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.0 111.407 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.6 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 43.8 mtp -57.94 -38.89 76.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.439 -1.413 . . . . 0.0 109.994 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.6 -25.66 20.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.977 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -88.53 -8.98 53.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.838 . . . . 0.0 109.838 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.3 mmt -107.98 -27.49 10.13 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 47.1 6.51 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.4 mtp -124.73 147.26 48.73 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.045 -1.268 . . . . 0.0 109.668 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 73.7 m-80 -98.06 60.18 1.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 15.4 m-20 148.9 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 30.9 p -100.45 -163.53 1.03 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 109.697 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.706 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.9 m -92.37 147.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.441 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 65.6 mtp180 -106.69 -11.14 15.9 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.168 -0.957 . . . . 0.0 108.521 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.82 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.75 164.98 28.73 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.269 179.052 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.443 ' SG ' HD11 ' A' ' 26' ' ' LEU . 30.2 p -161.09 147.51 14.75 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.734 0.778 . . . . 0.0 110.601 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.418 ' NH2' ' NH1' ' A' ' 148' ' ' ARG . 74.0 ttt-85 -140.3 141.98 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 42.1 ttm -98.35 161.52 13.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.111 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.429 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 52.5 mt . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.252 0.548 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.83 111.66 23.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 109.855 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -169.51 130.77 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.403 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 43.7 ttm -114.56 133.84 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -106.18 117.6 34.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 103' ' ' MET . 23.5 mt -101.44 148.05 25.64 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.083 0.944 . . . . 0.0 112.121 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.66 127.54 29.41 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 70.3 tt0 -64.13 -23.94 67.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 112.095 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.527 ' O ' ' HB3' ' A' ' 124' ' ' SER . 6.1 m-70 -114.08 159.4 20.06 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.48 -1.387 . . . . 0.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.6 m -59.0 158.88 7.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.379 -0.825 . . . . 0.0 109.431 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 97' ' ' SER . 14.3 t0 85.49 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.832 0.825 . . . . 0.0 108.787 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.443 ' H ' ' HB3' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -176.93 41.18 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.69 -160.32 13.0 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-O 122.281 0.934 . . . . 0.0 111.296 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 67.21 -166.71 40.89 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 17.5 mmt180 -74.47 133.85 42.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.002 -1.293 . . . . 0.0 109.648 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.7 119.14 36.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.171 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 138.39 50.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.5 126.58 45.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.025 -1.047 . . . . 0.0 109.763 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.1 tt -118.83 115.79 25.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.1 ttt -126.4 20.96 7.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.289 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.544 ' H ' HD23 ' A' ' 106' ' ' LEU . 12.1 t70 -144.42 -168.56 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -0.901 . . . . 0.0 110.045 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 47.8 t0 -83.82 132.18 34.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -114.89 81.5 7.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.239 -0.913 . . . . 0.0 109.978 -178.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.29 -29.06 5.19 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.178 1.918 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -134.14 79.4 1.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.517 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 9.8 mt -63.17 -18.62 63.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.942 . . . . 0.0 109.787 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 20.7 mmt -59.76 -40.72 89.12 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.705 0.764 . . . . 0.0 109.33 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -85.28 -23.38 28.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.988 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -75.58 -63.2 1.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.785 -1.197 . . . . 0.0 110.761 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 117' ' ' PHE . 1.4 m-85 -116.49 1.23 12.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.771 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 117' ' ' PHE . 14.7 t-20 49.41 35.96 8.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.9 ttt -146.5 133.28 20.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 120' ' ' SER . 1.3 t -131.56 10.53 4.78 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.3 m-20 -130.1 89.69 2.84 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 119.933 -1.729 . . . . 0.0 113.238 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -107.08 141.25 38.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.048 -1.032 . . . . 0.0 108.535 178.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.493 ' CD2' ' OH ' ' A' ' 155' ' ' TYR . 0.6 OUTLIER -96.36 3.19 53.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 111.133 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.9 t -148.98 154.3 39.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.205 -1.559 . . . . 0.0 110.177 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 38.1 t -163.89 161.98 23.29 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.971 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.495 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 0.8 OUTLIER -146.36 142.56 28.35 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 53.5 t -111.55 122.58 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -0.977 . . . . 0.0 109.623 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 36.1 ttm -71.94 -24.2 61.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.64 . . . . 0.0 109.638 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 163.29 171.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.859 0.838 . . . . 0.0 110.866 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 85.95 -135.71 13.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.553 ' CG ' ' HH ' ' A' ' 146' ' ' TYR . 92.5 m-70 -158.52 134.17 8.86 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.69 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -126.78 136.26 52.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 0.0 111.954 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.9 mt -103.48 132.2 49.94 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 19.2 t -110.02 143.75 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.906 -1.121 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.531 ' CZ ' ' OE1' ' A' ' 144' ' ' GLN . 36.6 m-85 -120.9 124.1 44.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.623 -0.673 . . . . 0.0 110.902 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.69 -26.93 64.36 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 167' ' ' SER . 16.8 mt-30 -122.18 154.21 61.71 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 26.7 Cg_endo -62.25 -171.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.202 2.601 . . . . 0.0 113.823 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 46.66 29.32 0.93 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.387 0.613 . . . . 0.0 110.026 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.487 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 48.3 m-85 59.34 50.84 7.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.639 -0.663 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.3 p -135.89 162.77 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.63 174.76 32.39 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -54.71 111.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -1.035 . . . . 0.0 109.129 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.4 mt-30 -85.97 143.84 27.94 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -123.58 137.99 54.64 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.553 ' HH ' ' CG ' ' A' ' 131' ' ' HIS . 21.3 t80 -97.35 107.53 20.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.486 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.8 mp -102.62 117.14 34.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 108.584 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.511 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 24.7 ptt180 -103.7 178.37 1.19 Allowed Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 Cg_exo -49.37 162.19 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.799 1.666 . . . . 0.0 111.805 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.34 -170.58 13.41 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.86 133.19 56.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -1.001 . . . . 0.0 110.506 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.511 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 20.9 m-85 -110.03 144.45 38.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.704 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 8.6 ptm180 -141.58 -2.42 1.22 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.877 -1.14 . . . . 0.0 112.251 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.533 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 14.2 m -165.49 166.21 18.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.039 -1.663 . . . . 0.0 110.174 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.6 OUTLIER -54.35 -20.24 6.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 108.935 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -83.15 1.44 40.47 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.879 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.704 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.9 m-20 -90.3 -62.9 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 109.138 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -75.88 13.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.54 37.95 93.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.85 -154.43 21.31 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.2 t -153.58 -41.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.4 p -103.61 -153.64 0.48 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 29.5 m -148.87 11.85 0.85 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -66.84 79.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 0.0 112.232 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.7 mtt -107.41 119.78 40.36 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.644 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.79 -26.82 4.01 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.481 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -128.92 150.29 50.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.612 -1.522 . . . . 0.0 111.135 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.16 138.96 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.945 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -122.91 136.42 54.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 171' ' ' ILE . 30.6 ptt85 -93.79 86.29 5.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.893 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 170' ' ' ARG . 97.0 mt . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.453 -0.779 . . . . 0.0 109.875 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -162.1 141.24 9.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -1.134 . . . . 0.0 109.512 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.581 ' CD1' ' CG ' ' A' ' 43' ' ' PHE . 46.7 mt -129.13 133.95 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.651 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.594 HD12 HH21 ' A' ' 37' ' ' ARG . 47.2 mt -119.6 117.8 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -93.59 136.65 33.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 109.463 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE2' HG22 ' A' ' 5' ' ' ILE . 52.5 m-85 -122.28 131.79 54.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -70.19 -22.45 62.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.61 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.532 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 53.9 t0 -80.64 160.49 25.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.876 -1.14 . . . . 0.0 110.326 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.7 mmt85 -60.6 -44.5 96.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.365 -0.835 . . . . 0.0 109.803 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -80.08 -102.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -145.35 43.06 1.29 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.159 -0.963 . . . . 0.0 109.103 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.532 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.12 -169.24 12.13 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.06 -156.11 32.24 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -65.58 114.47 4.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.376 . . . . 0.0 109.092 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -98.07 147.52 24.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.375 -0.828 . . . . 0.0 109.826 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.639 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 27.8 t60 -140.46 124.55 17.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.117 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -94.78 118.33 31.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 109.145 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.5 m -118.98 136.39 54.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.336 -0.852 . . . . 0.0 109.251 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -140.23 9.15 2.28 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.8 t -142.21 155.98 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.321 -0.862 . . . . 0.0 110.417 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.8 p30 -55.2 143.98 25.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 110.472 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 t -140.58 118.87 12.08 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.59 53.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.799 -1.188 . . . . 0.0 109.282 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 39.6 p-10 -134.13 94.27 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.28 -18.17 27.53 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.474 ' ND1' ' C ' ' A' ' 27' ' ' HIS . 10.5 t-80 -56.48 -35.58 68.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -54.92 -59.27 4.97 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 61.3 m-85 -59.38 -51.69 68.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 0.0 110.772 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -151.5 150.61 30.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.033 -1.042 . . . . 0.0 110.548 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' CD2' ' A' ' 27' ' ' HIS . 24.3 t30 -98.06 -5.12 34.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 110.334 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -159.04 157.32 30.94 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.563 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 45.4 t -160.28 128.6 4.73 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -107.23 -10.64 15.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.053 . . . . 0.0 109.748 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -137.01 138.17 40.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 110.794 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.3 mt -130.59 143.11 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.594 HH21 HD12 ' A' ' 5' ' ' ILE . 57.9 ttp85 -133.26 116.5 16.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.087 . . . . 0.0 110.719 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.8 t -104.26 119.88 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -85.87 -29.17 23.9 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 108.907 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -174.86 153.7 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.671 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.72 -144.42 15.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-O 122.445 1.025 . . . . 0.0 111.638 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.1 m -146.2 149.73 34.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.581 ' CG ' ' CD1' ' A' ' 4' ' ' ILE . 7.4 t80 -147.28 137.69 23.36 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.883 -1.136 . . . . 0.0 110.002 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.0 tpt -108.85 127.09 53.73 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 56' ' ' TYR . 16.6 m -116.34 145.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 76' ' ' VAL . 55.4 m-85 -120.82 141.48 50.51 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.69 0.757 . . . . 0.0 111.052 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -74.37 -9.88 59.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.991 -0.443 . . . . 0.0 109.997 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.863 ' O ' ' HB3' ' A' ' 78' ' ' SER . 96.1 mtt180 -131.81 160.75 34.69 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p -68.96 162.02 27.64 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.767 0.794 . . . . 0.0 111.497 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.26 33.46 7.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.793 -0.567 . . . . 0.0 111.416 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.48 ' H ' ' CB ' ' A' ' 78' ' ' SER . 1.8 m-85 59.55 58.69 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.026 -1.046 . . . . 0.0 110.199 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 55.9 mtt -146.28 174.57 11.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.843 -1.16 . . . . 0.0 110.669 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.21 -169.05 51.15 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.97 -1.081 . . . . 0.0 110.42 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -61.68 129.41 40.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.443 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -122.6 154.16 38.33 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.889 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' O ' HG22 ' A' ' 45' ' ' VAL . 94.6 m-85 -133.27 138.37 46.42 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.819 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -92.67 118.1 30.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 108.695 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.0 mt -116.6 115.91 26.6 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.403 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.7 ptt85 -99.39 162.28 13.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.268 -0.895 . . . . 0.0 110.839 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 59' ' ' ARG . 77.7 ttt180 -25.77 114.07 0.05 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.442 0.639 . . . . 0.0 111.099 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.84 172.94 37.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -113.17 127.36 56.16 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.944 . . . . 0.0 108.725 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -107.72 99.85 31.81 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' ARG . 56.9 Cg_endo -73.42 -14.86 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.336 2.024 . . . . 0.0 113.026 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -168.24 140.06 2.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.856 -1.152 . . . . 0.0 108.557 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 25.9 p90 -150.96 36.62 0.62 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.685 -1.26 . . . . 0.0 110.297 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.5 mmt -102.97 -46.94 4.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.069 -1.019 . . . . 0.0 109.689 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.82 -16.0 18.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -86.39 -17.14 35.18 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.8 mtt -116.85 -28.96 6.17 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.03 51.14 4.09 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.068 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 89.3 mtp -119.77 141.66 49.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.307 . . . . 0.0 109.507 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 85.5 m-20 -97.79 51.95 1.07 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.1 -171.86 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.563 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 27.5 p -97.8 -168.18 1.63 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.133 0.968 . . . . 0.0 109.925 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 46' ' ' TYR . 42.4 t -75.74 141.43 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -106.36 -17.17 14.36 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.572 -1.33 . . . . 0.0 107.813 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.863 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.94 164.34 30.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.696 178.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 24.6 p -164.92 152.74 11.57 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.507 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -137.7 141.26 41.07 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.1 ttp -93.17 151.45 19.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 108.976 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.496 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 16.4 mm . . . . . 0 C--N 1.304 -1.378 0 O-C-N 121.08 -1.012 . . . . 0.0 108.891 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.8 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.249 0.547 . . . . 0.0 109.81 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.88 120.12 41.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.777 . . . . 0.0 109.371 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -171.42 130.12 0.71 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.553 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 45.0 ttm -115.13 130.78 57.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.924 -1.11 . . . . 0.0 109.329 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -101.51 117.74 35.54 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' MET . 12.3 mt -103.18 150.09 24.02 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.328 1.061 . . . . 0.0 112.369 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 99' ' ' MET . 37.0 m-85 -137.4 125.83 23.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -63.48 -24.22 67.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 112.07 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.84 ' O ' ' OG ' ' A' ' 124' ' ' SER . 7.5 m-70 -110.94 165.22 12.04 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.371 -1.456 . . . . 0.0 110.651 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.4 m -60.03 158.86 10.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.117 -0.989 . . . . 0.0 110.044 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.534 ' O ' ' SD ' ' A' ' 99' ' ' MET . 1.0 OUTLIER 78.42 -96.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.588 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 21.7 mmt -161.76 35.86 0.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.43 -158.31 28.9 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.293 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.73 -172.43 8.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -72.36 136.0 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.985 -1.303 . . . . 0.0 109.47 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.465 ' O ' ' CG ' ' A' ' 103' ' ' MET . 5.2 ptt? -96.79 121.31 38.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 110.307 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.634 ' SD ' ' CD2' ' A' ' 117' ' ' PHE . 13.9 mtm -118.46 139.83 50.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.948 . . . . 0.0 109.206 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 mp0 -100.37 138.19 37.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.612 HD13 ' SG ' ' A' ' 110' ' ' CYS . 16.8 tp -128.31 118.01 22.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.6 ttm -123.54 -18.53 6.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.446 -0.784 . . . . 0.0 109.234 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.49 ' O ' HD11 ' A' ' 106' ' ' LEU . 52.4 p30 -106.8 -170.21 1.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.831 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -76.62 130.56 38.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.819 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.612 ' SG ' HD13 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -111.3 78.86 1.95 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.092 -1.005 . . . . 0.0 109.358 -179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.71 -27.09 7.65 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.1 1.867 . . . . 0.0 112.407 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.464 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 7.8 t30 -136.05 83.21 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.41 -25.85 67.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.99 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 tpt -55.09 -40.38 70.36 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.858 0.837 . . . . 0.0 109.113 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.464 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 93.1 m-20 -81.01 -23.19 38.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.4 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -74.47 -61.92 1.7 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.622 -1.299 . . . . 0.0 110.629 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.634 ' CD2' ' SD ' ' A' ' 104' ' ' MET . 0.9 OUTLIER -118.92 5.39 11.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.425 -0.797 . . . . 0.0 110.547 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 55.53 41.12 31.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.574 -1.329 . . . . 0.0 107.464 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.4 tpt -143.05 122.41 13.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.2 t -111.82 6.68 19.8 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 110.191 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.8 m-20 -143.39 101.79 3.85 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.413 -1.43 . . . . 0.0 113.699 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.2 m-85 -109.49 140.57 43.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.49 -0.756 . . . . 0.0 109.152 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.442 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 8.1 m-70 -96.81 3.15 52.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 111.103 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.84 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -148.98 154.18 38.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.172 -1.58 . . . . 0.0 110.375 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.553 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 15.4 t -162.19 162.11 28.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.065 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.56 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -149.13 143.47 26.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.139 -0.975 . . . . 0.0 109.693 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.56 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.6 t -113.59 121.7 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.932 . . . . 0.0 109.381 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.408 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 25.1 ttt -72.47 -34.97 68.1 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.0 OUTLIER 176.71 174.38 0.39 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.942 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.15 -164.87 54.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.646 ' CE1' ' HH ' ' A' ' 146' ' ' TYR . 91.8 m-70 -124.66 132.38 53.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -1.067 . . . . 0.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -122.14 129.55 52.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.682 . . . . 0.0 111.412 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -101.58 131.86 47.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 22.0 t -107.83 139.97 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.98 -1.075 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.408 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 53.9 m-85 -116.38 125.09 51.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.554 -0.716 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -60.02 -26.74 66.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.1 mp0 -122.71 154.07 63.42 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.523 ' O ' ' OG1' ' A' ' 141' ' ' THR . 24.1 Cg_endo -61.48 -176.66 0.19 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.203 2.602 . . . . 0.0 113.358 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 51.71 33.37 10.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.516 -0.74 . . . . 0.0 110.58 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.408 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 39.8 m-85 55.08 47.65 21.46 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.592 -0.693 . . . . 0.0 110.048 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 13.7 p -134.44 164.22 27.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.05 173.89 28.96 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -54.02 115.14 1.88 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.122 -1.222 . . . . 0.0 109.001 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 32.4 mt-30 -84.75 142.11 30.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.83 128.87 48.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.646 ' HH ' ' CE1' ' A' ' 131' ' ' HIS . 20.6 t80 -90.93 99.47 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.271 -0.893 . . . . 0.0 109.831 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.0 mp -96.09 124.31 40.05 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.769 0.795 . . . . 0.0 109.078 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.437 ' HB2' ' HD2' ' A' ' 149' ' ' PRO . 20.0 ptt-85 -112.16 178.27 1.01 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 148' ' ' ARG . 85.2 Cg_exo -43.42 165.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.828 1.685 . . . . 0.0 111.809 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.01 177.53 21.01 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -109.55 135.41 50.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.525 -0.985 . . . . 0.0 110.399 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 19.7 m-85 -109.93 143.44 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.59 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 42.9 ptt85 -134.9 -4.4 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.883 -1.136 . . . . 0.0 112.598 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.7 m -171.57 162.71 6.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.952 -1.718 . . . . 0.0 110.128 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -51.66 -9.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 154' ' ' SER . 0.6 OUTLIER -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.048 -1.032 . . . . 0.0 108.892 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.2 m-20 -92.46 -61.1 1.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.144 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.546 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.4 p90 -75.76 15.55 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.3 37.69 93.07 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.72 -177.06 23.93 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 162' ' ' THR . 2.8 m -139.03 10.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 161' ' ' VAL . 52.1 p -158.26 -158.21 0.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.8 m -143.61 11.74 1.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -62.74 72.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.937 -1.102 . . . . 0.0 112.118 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 163' ' ' SER . 60.2 mtt -105.91 115.95 31.1 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.916 -1.115 . . . . 0.0 110.565 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.87 -22.12 6.11 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -132.92 149.83 52.21 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.368 -1.666 . . . . 0.0 111.107 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.8 mt -148.21 141.89 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.744 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -124.84 140.53 52.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 110.062 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 170' ' ' ARG . 13.4 ptt180 -100.0 102.53 13.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 131' ' ' HIS . 3.5 mt . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.761 -0.587 . . . . 0.0 111.602 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.83 139.8 51.14 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.419 -1.047 . . . . 0.0 110.637 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.678 HD11 HD11 ' A' ' 36' ' ' ILE . 19.1 tt -133.48 128.99 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 110.066 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.5 mt -116.26 132.17 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.657 -0.652 . . . . 0.0 109.825 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.592 ' CE2' HD12 ' A' ' 36' ' ' ILE . 86.6 m-85 -97.56 146.07 25.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -133.63 135.51 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -72.87 -45.03 60.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 110.45 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 12.8 t70 -78.72 151.38 32.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -67.21 -34.89 78.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 110.073 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -85.65 40.67 0.86 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.042 -1.036 . . . . 0.0 109.848 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 52.89 54.38 10.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 109.696 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -139.34 -153.84 6.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.88 -148.04 46.02 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -76.46 119.0 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.976 . . . . 0.0 109.476 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -100.82 157.94 16.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -149.48 123.93 9.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.187 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -97.72 124.72 42.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 m -123.7 136.76 54.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -135.46 11.78 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 p -146.21 163.12 36.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.623 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -59.52 144.36 47.54 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 110.646 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -139.03 118.35 12.77 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.42 -12.19 46.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.66 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 40.3 p-10 -132.28 98.04 4.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 79' ' ' CYS . 21.4 mt -96.3 -19.29 19.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.604 ' NE2' ' ND2' ' A' ' 31' ' ' ASN . 14.4 t-80 -58.05 -40.82 81.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.309 -0.869 . . . . 0.0 108.994 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.0 m -52.03 -44.94 64.44 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -70.44 -46.07 64.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.137 -0.977 . . . . 0.0 110.756 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 27.6 p90 -154.46 151.89 29.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.976 -1.077 . . . . 0.0 109.846 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.604 ' ND2' ' NE2' ' A' ' 27' ' ' HIS . 3.1 m120 -95.97 -5.67 40.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 0.0 110.078 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -161.36 159.68 28.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 108.649 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 20.5 t -160.13 120.08 2.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.502 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -95.96 -14.86 22.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.602 -0.686 . . . . 0.0 110.345 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 m -135.54 147.07 48.65 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.645 -1.284 . . . . 0.0 110.859 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.678 HD11 HD11 ' A' ' 4' ' ' ILE . 20.4 tt -148.09 148.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -136.22 122.87 21.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.824 -1.173 . . . . 0.0 112.076 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.05 120.8 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -91.37 -28.87 17.43 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 110.6 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -159.71 152.55 21.62 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.966 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.19 -159.48 52.65 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -132.85 178.69 6.68 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.305 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.34 140.79 19.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.68 -1.263 . . . . 0.0 109.203 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.5 tpt -101.02 117.57 35.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -110.2 143.35 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.874 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.675 ' O ' HG13 ' A' ' 76' ' ' VAL . 26.4 m-85 -122.17 142.0 50.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.698 0.761 . . . . 0.0 111.011 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 29.8 t0 -75.56 -6.65 51.36 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.865 ' O ' ' HB3' ' A' ' 78' ' ' SER . 36.5 ttt180 -131.23 157.87 42.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 0.0 108.709 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 p -69.04 160.7 30.49 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.708 0.765 . . . . 0.0 111.295 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.75 32.89 6.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.7 -0.625 . . . . 0.0 111.326 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.477 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 2.5 m-85 60.63 59.99 2.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.2 -0.937 . . . . 0.0 109.371 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 58.2 mtt -147.76 171.17 16.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 -170.76 42.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -54.19 122.25 9.89 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.074 -1.25 . . . . 0.0 107.633 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -103.83 135.83 44.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 108.804 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -129.36 137.56 51.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.356 -0.84 . . . . 0.0 109.427 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -100.65 119.61 38.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.0 mt -117.15 121.99 42.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.031 -1.043 . . . . 0.0 112.164 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -84.54 166.56 17.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.388 -0.82 . . . . 0.0 109.888 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -52.4 123.16 10.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.973 . . . . 0.0 110.198 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.32 171.7 39.55 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 9.9 pt-20 -102.27 126.73 49.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -1.137 . . . . 0.0 108.712 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -113.02 99.65 49.23 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 51.7 Cg_endo -73.09 -11.99 25.53 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.357 2.038 . . . . 0.0 112.429 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 43.8 m-20 -165.14 136.87 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 27.7 p90 -149.64 21.66 0.91 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.669 -1.27 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 44.0 mtp -97.29 -41.33 8.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.923 -1.111 . . . . 0.0 109.752 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -93.6 -25.56 17.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -81.76 -20.62 38.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.278 -0.889 . . . . 0.0 109.549 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 mtp -101.29 -25.65 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 109.966 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.11 57.19 2.87 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.4 mtp -130.04 140.15 50.9 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -1.15 . . . . 0.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.8 p-10 -93.07 53.64 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.235 -0.915 . . . . 0.0 109.306 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.1 p30 152.98 -171.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.557 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -97.72 -167.02 1.46 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 46' ' ' TYR . 59.5 t -77.73 140.96 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -105.81 -17.0 14.51 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.577 -1.327 . . . . 0.0 107.827 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.865 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.34 157.96 44.98 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.079 -1.013 . . . . 0.0 109.87 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 26' ' ' LEU . 15.7 p -153.03 143.35 22.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.622 0.725 . . . . 0.0 110.432 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 ttt-85 -137.71 140.22 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.7 ttp -90.72 151.23 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.727 HD12 ' N ' ' A' ' 82' ' ' ILE . 2.1 mp . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.028 . . . . 0.0 109.197 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 17.4 m . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 121.4 0.619 . . . . 0.0 110.148 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -120.38 128.66 53.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.598 0.713 . . . . 0.0 109.958 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -168.93 125.37 0.94 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.0 ttm -116.72 135.84 53.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 0.0 109.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -106.62 118.03 35.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 103' ' ' MET . 19.4 mt -101.29 148.5 25.06 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.257 1.027 . . . . 0.0 112.514 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD2' ' SD ' ' A' ' 99' ' ' MET . 38.2 m-85 -132.27 121.88 24.29 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 88.3 tt0 -61.88 -27.86 69.1 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 111.055 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.557 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.06 164.26 12.44 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.523 -1.361 . . . . 0.0 111.062 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.577 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 75.0 p -61.88 157.83 17.45 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.514 -0.741 . . . . 0.0 109.731 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 97' ' ' SER . 29.8 t0 83.47 -95.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.078 -1.014 . . . . 0.0 108.763 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' CD2' ' A' ' 94' ' ' TYR . 21.1 mmt -163.54 30.88 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -98.05 -155.56 29.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.471 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 60.29 -179.24 2.62 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -67.42 132.0 46.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.279 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 11.8 ptt? -93.67 118.24 31.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.3 mtm -119.51 140.73 50.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.053 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -100.71 137.8 38.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.177 -0.952 . . . . 0.0 109.508 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.8 OUTLIER -120.65 117.53 27.77 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.604 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 14.9 ttt -129.96 27.45 5.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 109' ' ' ASP . 17.0 t70 -151.31 -172.26 4.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.518 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 90.1 m-20 -82.95 131.18 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -111.8 84.19 5.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.031 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.4 Cg_endo -77.37 -28.59 5.49 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.243 1.962 . . . . 0.0 111.937 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 112' ' ' ASN . 22.3 p30 -138.17 82.82 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -63.15 -22.95 67.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.351 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 8.1 tpt -58.6 -40.67 83.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.592 0.711 . . . . 0.0 109.414 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -81.57 -22.24 37.91 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 110.335 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -77.57 -64.41 1.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.709 -1.244 . . . . 0.0 111.376 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -108.36 3.03 22.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 110.61 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 114' ' ' MET . 2.4 m-20 54.4 34.6 21.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.886 -1.134 . . . . 0.0 108.932 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 8.6 ptm -148.06 133.65 18.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 54.6 p -116.92 7.55 13.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 110.519 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 163' ' ' SER . 73.6 m-20 -131.3 93.16 3.31 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.361 -1.462 . . . . 0.0 113.379 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -105.19 133.87 49.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.04 4.07 54.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.992 -1.067 . . . . 0.0 111.688 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.2 t -156.23 161.5 40.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 119.758 -1.839 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.48 170.54 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.86 145.81 25.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 76.2 t -113.8 123.37 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.2 tpp -78.13 -34.15 50.09 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 11.7 t70 -177.46 175.77 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.155 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 78.37 -142.2 25.74 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.523 ' CD2' ' OH ' ' A' ' 146' ' ' TYR . 39.8 m80 -151.51 135.26 16.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.662 -0.905 . . . . 0.0 109.094 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -126.02 132.21 52.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 0.0 112.269 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -104.08 133.09 49.61 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 53.4 t -111.9 144.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.752 -1.218 . . . . 0.0 109.64 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.535 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 47.8 m-85 -120.73 123.37 42.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 111.128 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 164' ' ' ARG . 80.2 tt0 -57.03 -28.03 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -118.02 155.69 50.98 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.501 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 25.1 Cg_endo -62.0 -177.12 0.24 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.313 2.675 . . . . 0.0 113.661 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.589 ' N ' ' OG ' ' A' ' 167' ' ' SER . 66.6 m-20 48.67 35.49 6.33 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.622 0.725 . . . . 0.0 110.545 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.726 ' H ' ' CB ' ' A' ' 167' ' ' SER . 8.1 m-85 55.5 52.09 11.75 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.751 -0.593 . . . . 0.0 109.984 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 142' ' ' GLY . 90.5 m -136.94 162.54 32.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.119 -0.988 . . . . 0.0 109.77 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.45 -179.99 32.18 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -54.2 109.89 0.54 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -1.045 . . . . 0.0 108.737 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 3.5 mt-30 -84.58 141.75 30.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.8 132.28 53.75 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.523 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 65.6 t80 -94.78 105.47 17.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.369 -0.832 . . . . 0.0 109.763 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.9 mp -100.47 121.5 41.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.567 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 2.2 ptt180 -109.48 164.14 15.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.5 Cg_exo -32.12 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.76 2.307 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.81 -166.59 13.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.95 135.05 55.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -1.002 . . . . 0.0 110.332 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.567 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 91.6 m-85 -109.77 144.3 38.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.62 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 93.4 mtt180 -129.84 -12.09 4.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.004 . . . . 0.0 112.572 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.54 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.3 p -170.29 170.24 7.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.966 -1.709 . . . . 0.0 110.538 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.547 ' HA ' ' CE2' ' A' ' 158' ' ' TRP . 0.1 OUTLIER -53.4 -19.12 3.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.645 -0.659 . . . . 0.0 109.606 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -84.72 2.23 42.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.069 -1.019 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -57.78 2.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.098 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.547 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 8.4 p90 -79.32 17.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.89 42.37 94.97 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -109.73 -169.51 20.13 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 162' ' ' THR . 4.2 m -151.66 14.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 161' ' ' VAL . 34.8 p -160.6 -163.7 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 16.8 p -137.77 5.29 2.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 109.732 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 136' ' ' GLU . 88.5 mtt180 -65.89 73.8 0.07 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 0.0 112.266 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.2 mtt -102.45 117.94 35.79 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.193 -0.942 . . . . 0.0 109.502 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.93 -26.62 4.33 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.726 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.0 151.6 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.618 -1.519 . . . . 0.0 111.601 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.07 141.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.99 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -126.72 140.95 52.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.221 -0.924 . . . . 0.0 110.632 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.604 ' NH1' ' O ' ' A' ' 107' ' ' MET . 30.3 mtp180 -94.62 102.72 14.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.284 -0.885 . . . . 0.0 108.939 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.499 2.021 0 O-C-N 121.521 -0.737 . . . . 0.0 112.136 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -151.87 145.06 24.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.468 -1.019 . . . . 0.0 110.555 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' CD2' ' A' ' 43' ' ' PHE . 15.2 tt -133.44 135.17 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.881 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.3 mt -119.36 128.73 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -93.84 154.51 17.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -141.12 133.93 28.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 108.927 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -72.2 -33.36 67.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 111.296 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -87.8 151.06 23.16 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.721 -1.237 . . . . 0.0 110.601 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 65' ' ' ASP . 84.3 mtt-85 -67.34 -39.87 85.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.513 -0.742 . . . . 0.0 109.876 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -80.86 38.07 0.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 109.847 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 54.01 64.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 109.471 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.91 -157.68 8.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.16 -151.12 51.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -71.85 121.12 18.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -1.147 . . . . 0.0 108.961 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -102.83 157.86 16.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.247 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.629 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 17.3 t-80 -149.08 124.61 10.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.542 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -98.44 118.15 34.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.042 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' ND1' ' A' ' 17' ' ' HIS . 2.7 m -119.57 139.64 51.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 0.0 109.332 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -144.16 8.33 1.41 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.5 t -140.66 154.01 46.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.469 -0.769 . . . . 0.0 110.735 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 54.0 p30 -47.94 154.43 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.765 . . . . 0.0 110.295 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 15.3 t -154.99 111.79 3.28 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.97 -1.56 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.461 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 42.1 p-10 -142.96 99.42 3.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 76' ' ' VAL . 27.7 mt -97.8 -22.35 16.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.031 -1.043 . . . . 0.0 109.079 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 21.1 t-80 -55.98 -37.15 68.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -49.05 -52.88 22.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 50.8 m-85 -63.31 -45.64 90.39 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 0.0 111.319 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 20.3 p90 -155.19 151.0 27.64 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.018 -1.051 . . . . 0.0 110.091 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -92.53 -3.59 54.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.119 -0.988 . . . . 0.0 110.117 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -164.72 162.45 21.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.542 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 42.2 t -161.64 131.28 4.69 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 84.4 m-70 -110.49 -7.98 14.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.079 -1.013 . . . . 0.0 109.276 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m -135.2 142.8 46.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.931 -1.106 . . . . 0.0 110.459 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -136.28 145.82 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -135.87 116.46 13.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.889 -1.132 . . . . 0.0 111.204 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 21.7 t -103.82 118.69 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.425 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.0 t -169.89 146.33 3.13 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.493 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.581 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 96.14 -130.74 10.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 62.7 m -160.88 155.91 24.23 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.509 ' CD2' HD13 ' A' ' 4' ' ' ILE . 5.3 t80 -140.48 131.87 26.81 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.082 -1.011 . . . . 0.0 109.012 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -98.19 112.86 24.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.51 141.84 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.885 0.85 . . . . 0.0 110.411 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.612 ' O ' HG13 ' A' ' 76' ' ' VAL . 28.0 m-85 -118.13 137.38 52.99 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.887 0.851 . . . . 0.0 111.046 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 42.7 t0 -71.43 -11.68 61.01 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.734 ' O ' ' HB2' ' A' ' 78' ' ' SER . 26.2 ttt-85 -127.88 157.66 39.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.122 -0.986 . . . . 0.0 108.436 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.501 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 18.9 p -68.79 158.08 35.11 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.632 -0.667 . . . . 0.0 111.475 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.584 ' N ' ' OG ' ' A' ' 78' ' ' SER . 18.3 m-20 67.41 36.69 3.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 111.635 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.455 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.8 m-85 58.25 59.56 2.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.7 mtt -145.38 167.06 23.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.69 -165.63 33.69 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -60.22 124.01 18.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.09 136.71 42.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.96 138.48 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 109.85 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 38.6 p90 -101.83 122.68 44.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.304 -0.872 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.2 mt -113.06 117.5 32.18 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.933 -1.105 . . . . 0.0 111.555 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.0 ptt180 -92.71 157.03 16.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 111.209 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.482 ' C ' ' O ' ' A' ' 59' ' ' ARG . 68.9 ttt180 -31.99 109.48 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.43 0.633 . . . . 0.0 110.691 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 178.07 168.58 37.76 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -103.92 123.26 46.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.04 98.1 12.88 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.55 -20.06 65.45 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.254 1.969 . . . . 0.0 112.015 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 10' ' ' ARG . 15.2 t0 -167.07 147.01 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 28.5 p90 -148.22 25.0 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.256 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 7.3 mmt -95.61 -42.35 8.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.373 -0.83 . . . . 0.0 109.427 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -98.09 -17.1 19.28 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.53 -10.52 45.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.715 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.8 mmt -114.32 -33.8 5.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.26 53.15 3.74 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtp -121.72 143.83 49.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -1.008 . . . . 0.0 109.35 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 29.8 t30 -94.27 57.57 2.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.962 . . . . 0.0 109.174 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.35 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.542 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.4 p -100.42 -167.59 1.46 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.935 0.874 . . . . 0.0 109.544 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 46' ' ' TYR . 54.3 t -74.72 139.81 18.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.442 ' HB3' HG22 ' A' ' 49' ' ' THR . 93.4 mtt180 -107.54 -13.84 14.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.616 -1.303 . . . . 0.0 108.335 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.734 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -149.11 165.84 30.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.963 -1.086 . . . . 0.0 109.533 177.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.2 p -163.04 154.44 17.43 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.967 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.507 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 59.0 ttt180 -136.13 141.18 44.12 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 ptm -88.33 142.35 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.078 -1.014 . . . . 0.0 109.085 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.547 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 90.4 mt . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 108.699 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.498 0.665 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -114.3 121.14 42.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.57 -0.707 . . . . 0.0 109.891 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -170.32 128.27 0.84 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.446 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 40.9 ttm -112.2 130.69 55.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.97 -1.081 . . . . 0.0 109.289 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -104.69 116.15 31.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 103' ' ' MET . 13.1 mt -100.46 149.0 24.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.112 0.958 . . . . 0.0 112.556 -177.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' O ' ' A' ' 99' ' ' MET . 31.2 m-85 -135.04 125.0 25.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 86.1 tt0 -63.28 -22.76 67.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.853 -1.154 . . . . 0.0 111.767 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.844 ' O ' ' OG ' ' A' ' 124' ' ' SER . 3.0 m-70 -113.61 162.42 16.23 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.132 -1.605 . . . . 0.0 111.504 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 25.2 p -59.19 158.54 8.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.302 -0.874 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 97' ' ' SER . 5.8 m-20 81.64 -96.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.544 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 17.1 mmt -163.68 30.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.18 -159.93 32.41 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.76 -162.89 47.69 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.451 ' O ' ' HE3' ' A' ' 104' ' ' MET . 57.7 mtp180 -85.81 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -1.172 . . . . 0.0 109.218 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.7 ptt? -95.81 113.65 25.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 110.262 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.451 ' HE3' ' O ' ' A' ' 102' ' ' ARG . 1.3 mpt? -110.66 140.46 45.0 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.59 136.6 43.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.422 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -130.8 120.76 24.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ttt -117.83 -15.84 10.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 52.6 p30 -107.63 -157.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 17.8 p-10 -93.85 138.1 32.37 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -118.99 86.3 31.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.204 -0.935 . . . . 0.0 110.354 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.81 -28.13 6.58 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.178 1.919 . . . . 0.0 112.143 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 5.9 t30 -129.74 83.9 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.34 -27.63 65.52 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.7 mtp -55.41 -39.15 69.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.203 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.487 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 94.9 m-20 -84.84 -20.94 30.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.294 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -77.32 -62.3 1.7 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.654 -1.278 . . . . 0.0 110.334 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -109.02 1.71 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 110.455 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.2 m120 57.66 36.62 26.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.068 . . . . 0.0 109.83 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.453 ' CG ' ' CE2' ' A' ' 122' ' ' PHE . 8.7 ptm -152.44 136.36 16.34 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.4 p -114.41 8.0 16.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.06 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 163' ' ' SER . 46.5 p-10 -134.42 98.56 4.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.348 -1.47 . . . . 0.0 113.898 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.62 134.61 51.75 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -96.83 4.4 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.015 -1.053 . . . . 0.0 111.478 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.844 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -151.02 156.66 41.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.93 -1.731 . . . . 0.0 110.43 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' CYS . . . . . 0.446 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 16.0 t -165.42 164.66 19.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.268 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.83 144.92 26.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.021 -1.049 . . . . 0.0 109.346 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 74.5 t -115.4 126.68 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.8 ttt -76.54 -21.83 55.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.601 -0.687 . . . . 0.0 109.793 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 162.16 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.722 0.773 . . . . 0.0 110.947 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.63 -140.57 21.95 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.591 ' CE1' ' HH ' ' A' ' 146' ' ' TYR . 60.2 m-70 -148.45 130.11 15.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.948 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -123.38 132.34 53.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.392 -0.818 . . . . 0.0 111.648 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.9 mt -103.69 130.16 51.13 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 41.6 t -109.94 142.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.957 -1.089 . . . . 0.0 109.574 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 58.6 m-85 -117.84 124.36 48.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.609 -0.682 . . . . 0.0 111.936 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.4 tt0 -59.26 -27.06 65.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.0 mp0 -122.64 153.99 63.16 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.228 -0.92 . . . . 0.0 108.621 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.417 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 22.6 Cg_endo -61.29 -175.23 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 123.417 2.744 . . . . 0.0 113.602 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 49.29 33.96 5.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.591 0.71 . . . . 0.0 110.055 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.435 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 31.4 m-85 54.22 52.18 13.1 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.484 0.659 . . . . 0.0 109.939 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 142' ' ' GLY . 85.4 m -137.02 162.18 34.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.576 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 141' ' ' THR . . . 99.12 177.38 31.81 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -53.95 109.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.666 -0.903 . . . . 0.0 108.604 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.9 mt-30 -84.49 145.81 27.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 109.409 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -129.39 127.79 41.72 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.195 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.591 ' HH ' ' CE1' ' A' ' 131' ' ' HIS . 1.8 t80 -89.81 106.03 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.8 mp -102.24 123.83 46.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.445 -0.784 . . . . 0.0 109.134 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.569 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -111.48 169.13 6.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' A' ' 148' ' ' ARG . 15.0 Cg_exo -32.76 162.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.846 2.364 . . . . 0.0 112.182 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.39 -169.69 13.36 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.28 133.38 55.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.554 -0.968 . . . . 0.0 110.52 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.569 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 98.3 m-85 -106.87 142.75 36.0 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' SER . 44.1 ptt85 -131.89 -6.61 3.55 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.848 -1.157 . . . . 0.0 113.222 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 153' ' ' ARG . 3.8 m -172.22 170.13 5.23 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.537 -1.977 . . . . 0.0 111.018 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.61 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -56.65 -24.12 46.2 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -78.99 -1.75 36.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.224 -0.922 . . . . 0.0 109.301 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 159' ' ' GLY . 3.5 t0 -89.1 -61.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.593 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 7.0 p90 -74.35 16.17 0.28 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.76 34.23 89.36 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.01 -165.95 32.81 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 161' ' ' VAL . 47.9 t -146.16 -8.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.811 -0.817 . . . . 0.0 109.098 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -139.69 -156.36 0.67 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.5 p -139.79 5.32 2.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.353 -0.842 . . . . 0.0 109.797 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 136' ' ' GLU . 48.0 mtp180 -62.34 74.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.072 -1.017 . . . . 0.0 112.126 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 163' ' ' SER . 65.0 mtt -105.11 116.5 32.06 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.051 -1.031 . . . . 0.0 110.051 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.12 -22.96 4.72 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.225 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.36 150.9 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 119.572 1.686 . . . . 0.0 111.407 -178.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.81 141.36 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.265 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -128.68 144.07 51.08 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.178 -0.951 . . . . 0.0 110.368 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 171' ' ' ILE . 16.2 ptt180 -102.46 91.12 4.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 131' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.981 0 O-C-N 121.495 -0.753 . . . . 0.0 111.027 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtp . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.46 152.09 22.76 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -141.11 144.95 35.18 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.514 -0.992 . . . . 0.0 110.543 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.605 HD13 ' CD2' ' A' ' 43' ' ' PHE . 15.9 tt -135.46 135.03 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.381 -0.824 . . . . 0.0 110.147 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.0 mt -120.22 128.97 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.694 -0.629 . . . . 0.0 109.414 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -96.8 140.6 31.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.368 -0.833 . . . . 0.0 109.24 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -125.82 136.07 52.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.711 -1.243 . . . . 0.0 109.343 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -72.41 -38.49 68.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 110.208 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.3 t70 -83.27 157.68 22.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.068 -1.02 . . . . 0.0 110.122 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' NH1' ' OD1' ' A' ' 11' ' ' ASN . 38.1 ptt85 -71.68 -39.91 69.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.013 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.476 ' OD1' ' NH1' ' A' ' 10' ' ' ARG . 88.6 m-20 -78.26 38.13 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.132 -0.98 . . . . 0.0 109.619 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 53.94 47.14 24.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 109.464 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.57 -158.19 8.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.72 -149.43 49.5 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -73.78 118.73 17.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -1.165 . . . . 0.0 109.221 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -100.73 155.58 17.82 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -146.0 124.08 12.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.91 . . . . 0.0 109.08 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -97.89 121.83 40.28 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.14 -0.975 . . . . 0.0 109.808 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.3 m -122.33 137.79 54.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.541 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.515 ' O ' ' SD ' ' A' ' 81' ' ' MET . 21.3 ptt? -140.76 10.02 2.21 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.393 -0.817 . . . . 0.0 108.941 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.1 t -144.81 158.81 43.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.993 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 22' ' ' ASP . 49.4 p30 -46.51 161.82 0.05 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.504 -0.748 . . . . 0.0 109.807 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 3.6 t -161.66 110.0 1.48 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' A' ' 50' ' ' ASN . . . -94.6 40.56 1.09 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 14.1 p30 -177.39 91.13 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.993 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD21 ' SG ' ' A' ' 79' ' ' CYS . 96.4 mt -98.04 -22.45 16.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.25 -0.906 . . . . 0.0 108.87 178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.55 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 22.3 t-80 -57.93 -42.67 85.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.939 . . . . 0.0 108.758 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.3 t -59.67 -16.65 28.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.741 -0.599 . . . . 0.0 109.841 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -99.98 -47.64 4.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -155.51 145.95 21.95 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.656 -0.652 . . . . 0.0 109.261 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 71.3 m-20 -97.34 -7.49 31.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 110.404 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.2 mtp180 -149.35 149.4 30.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.139 -0.976 . . . . 0.0 108.632 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 38.9 t -154.55 114.52 3.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -96.12 -16.55 21.47 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.716 -0.615 . . . . 0.0 110.01 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.2 t -133.77 142.58 47.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.899 -1.126 . . . . 0.0 110.801 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.97 145.95 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -134.7 121.13 20.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.016 -1.053 . . . . 0.0 111.278 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.8 t -108.97 117.83 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.67 -32.33 23.67 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.225 -0.922 . . . . 0.0 109.433 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.5 t -168.4 151.79 5.64 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 118.658 -1.217 . . . . 0.0 111.224 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.12 -165.19 43.06 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 108.559 -1.816 . . . . 0.0 108.559 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 64.2 m -123.74 153.38 40.98 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.397 -1.061 . . . . 0.0 109.546 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.605 ' CD2' HD13 ' A' ' 4' ' ' ILE . 4.2 t80 -133.64 133.39 41.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 9.0 tpt -103.06 122.52 44.82 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.686 ' HB ' HG11 ' A' ' 76' ' ' VAL . 21.0 m -115.05 146.58 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.03 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.497 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.0 m-85 -121.82 143.77 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.681 0.753 . . . . 0.0 110.481 -178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -78.76 -7.81 58.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.799 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.5 ttm180 -131.21 157.98 41.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.6 p -69.84 155.7 40.15 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.962 0.887 . . . . 0.0 111.231 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.419 HD22 ' HB1' ' A' ' 24' ' ' ALA . 1.1 m120 71.93 33.5 1.66 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.377 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.497 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.0 m-85 61.62 55.22 2.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.914 -1.116 . . . . 0.0 110.049 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 50.2 mtt -143.73 174.19 11.01 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.094 -1.004 . . . . 0.0 110.302 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.65 -170.03 47.71 Favored Glycine 0 N--CA 1.501 2.981 0 O-C-N 120.834 -1.166 . . . . 0.0 110.246 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -55.15 119.85 6.11 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.4 -1.059 . . . . 0.0 108.418 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -101.34 132.25 46.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.331 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -124.48 136.39 53.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.107 -0.995 . . . . 0.0 109.607 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -100.59 116.45 32.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.317 -0.864 . . . . 0.0 109.463 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.51 139.13 42.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 0.0 108.556 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.3 ptt180 -113.25 161.38 17.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.222 -0.924 . . . . 0.0 109.054 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.516 ' C ' ' O ' ' A' ' 59' ' ' ARG . 39.9 ttp180 -35.17 115.52 0.3 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.509 -0.745 . . . . 0.0 109.941 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.09 169.69 31.89 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.45 127.77 53.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.481 -1.011 . . . . 0.0 108.847 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -107.04 100.28 31.36 Favored Pre-proline 0 N--CA 1.491 1.604 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 39.6 Cg_endo -70.01 -20.11 34.1 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.38 2.053 . . . . 0.0 112.716 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 42.2 m-20 -163.65 138.66 6.21 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.512 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.5 p90 -148.63 26.23 0.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.548 -1.345 . . . . 0.0 110.716 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.4 mtt -99.99 -43.62 6.31 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.933 -1.104 . . . . 0.0 109.176 178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -94.61 -22.67 18.02 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 42.9 m -82.1 -19.41 40.18 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.669 -0.644 . . . . 0.0 109.835 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 mmt -105.58 -23.35 12.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.98 -1.075 . . . . 0.0 109.012 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.88 51.98 4.29 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.0 mtp -123.13 -171.48 2.31 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.044 -1.268 . . . . 0.0 109.639 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 63.4 t30 -145.79 55.99 1.2 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.168 -0.958 . . . . 0.0 109.371 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.565 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.0 m-20 150.23 -169.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -96.69 -167.11 1.5 Allowed 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.341 -0.849 . . . . 0.0 109.766 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.686 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.5 m -88.85 148.69 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -106.74 -11.08 15.89 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.058 -1.027 . . . . 0.0 108.376 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.799 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.44 172.54 13.77 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.049 -1.032 . . . . 0.0 110.313 179.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' SG ' HD21 ' A' ' 26' ' ' LEU . 22.1 p -172.09 156.75 4.1 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.869 0.842 . . . . 0.0 110.84 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -134.6 139.58 45.45 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.515 ' SD ' ' O ' ' A' ' 20' ' ' MET . 59.5 ttp -91.43 143.12 26.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.067 -1.02 . . . . 0.0 109.72 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 78.2 mt -110.32 104.12 55.2 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.43 -0.794 . . . . 0.0 108.943 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -81.05 175.64 9.67 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.386 2.057 . . . . 0.0 112.42 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 32.1 mt -74.76 48.6 0.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.673 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -104.27 88.9 3.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.399 -0.813 . . . . 0.0 109.017 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -134.89 93.1 2.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.858 . . . . 0.0 109.765 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.64 -81.06 0.38 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 63.9 m -122.4 151.24 41.44 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.412 -1.052 . . . . 0.0 110.603 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -110.76 116.82 31.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.0 109.6 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -169.4 125.25 0.87 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.062 -1.024 . . . . 0.0 108.775 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.406 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 42.8 ttm -107.09 121.02 43.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -0.914 . . . . 0.0 109.171 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -95.15 115.63 27.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.0 mt -103.7 147.49 27.18 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 122.142 0.972 . . . . 0.0 112.55 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.559 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 30.6 m-85 -135.37 127.28 29.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.491 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 50.2 tt0 -61.52 -27.97 68.98 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.475 -0.766 . . . . 0.0 111.818 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.881 ' O ' ' OG ' ' A' ' 124' ' ' SER . 5.9 m-70 -109.72 165.67 11.51 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.671 -1.268 . . . . 0.0 111.202 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.561 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.7 m -60.52 157.06 14.93 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' A' ' 97' ' ' SER . 8.7 t70 81.82 -96.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.8 mmt -163.29 33.09 0.09 Allowed 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.71 -160.13 31.91 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.313 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 65.0 -149.33 51.73 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.423 ' H ' ' HB2' ' A' ' 95' ' ' GLU . 76.5 mtm-85 -96.14 139.55 32.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.249 -1.148 . . . . 0.0 109.379 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.3 ptt? -96.09 119.48 34.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 0.0 110.195 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.624 ' N ' ' SD ' ' A' ' 104' ' ' MET . 0.3 OUTLIER -115.62 135.8 53.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.009 -1.057 . . . . 0.0 108.817 179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -98.14 132.19 43.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.9 OUTLIER -129.02 117.18 20.48 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 74.7 mtp -123.25 13.62 9.62 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.236 -0.915 . . . . 0.0 109.66 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.548 ' H ' HD23 ' A' ' 106' ' ' LEU . 42.3 p30 -140.09 -162.64 1.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.176 -0.952 . . . . 0.0 110.176 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.407 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 2.0 p30 -87.04 133.22 33.61 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.57 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -117.73 90.81 37.06 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.381 -0.824 . . . . 0.0 109.434 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -77.94 -28.09 5.3 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.206 1.938 . . . . 0.0 112.286 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -135.28 84.99 2.13 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.4 mt -68.79 -27.91 66.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.552 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.5 tpt -57.01 -39.73 75.31 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.59 0.709 . . . . 0.0 109.205 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -84.13 -22.05 31.2 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.012 -1.055 . . . . 0.0 110.216 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -79.32 -63.07 1.5 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.58 -1.325 . . . . 0.0 111.633 -177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -104.6 1.05 29.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.04 . . . . 0.0 110.319 -178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 114' ' ' MET . 17.8 t30 58.87 32.5 22.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.909 -1.119 . . . . 0.0 109.425 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 4.7 ptm -150.32 133.06 15.91 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.445 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 53.7 p -116.57 5.93 13.38 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.621 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 120' ' ' SER . 53.9 m-20 -130.01 90.99 3.05 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.723 -1.236 . . . . 0.0 112.471 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.654 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -100.95 130.94 47.02 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.059 -1.026 . . . . 0.0 108.554 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -93.89 2.92 56.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.968 -1.082 . . . . 0.0 110.92 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.881 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.9 p -147.83 154.07 39.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.146 -1.596 . . . . 0.0 109.935 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.554 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 23.0 t -165.36 163.71 19.84 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.885 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.554 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 7.0 t60 -152.45 148.15 27.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.196 -0.94 . . . . 0.0 109.584 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.522 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 65.4 t -115.95 125.35 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 121.937 0.875 . . . . 0.0 109.252 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.427 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 10.0 tpt -72.79 -32.66 65.73 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 172.95 167.15 0.13 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.827 -179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.93 -155.19 28.68 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.541 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 89.6 m-70 -135.49 130.12 34.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.552 -0.97 . . . . 0.0 110.184 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -121.42 131.13 53.99 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.549 -0.719 . . . . 0.0 111.58 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.484 HD22 ' NE2' ' A' ' 144' ' ' GLN . 5.2 mt -100.86 130.26 46.84 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 34.9 t -109.08 143.45 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.835 -1.166 . . . . 0.0 109.546 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.446 ' OH ' ' NH2' ' A' ' 169' ' ' ARG . 90.4 m-85 -121.04 125.63 47.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.729 -0.607 . . . . 0.0 110.906 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -60.26 -26.09 66.2 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 167' ' ' SER . 26.0 mt-30 -121.68 154.0 59.98 Favored Pre-proline 0 N--CA 1.498 1.928 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 20.3 Cg_endo -60.64 -171.25 0.07 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 123.197 2.598 . . . . 0.0 113.676 -178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 32.8 m120 46.43 30.32 1.05 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.511 0.672 . . . . 0.0 110.149 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.532 ' H ' ' CB ' ' A' ' 167' ' ' SER . 18.5 m-85 57.69 52.43 8.24 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.419 -0.801 . . . . 0.0 109.924 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 16.5 p -138.4 166.09 25.13 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.222 -0.924 . . . . 0.0 109.904 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.15 -179.82 33.87 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -55.33 113.25 1.33 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -1.026 . . . . 0.0 109.121 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.484 ' NE2' HD22 ' A' ' 133' ' ' LEU . 19.2 tt0 -87.58 141.41 28.63 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.149 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -123.85 133.91 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.541 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 81.1 t80 -95.16 102.28 14.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.517 -0.739 . . . . 0.0 109.763 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.1 mp -97.69 120.94 38.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.454 ' CB ' ' CD ' ' A' ' 149' ' ' PRO . 0.9 OUTLIER -104.96 -178.49 0.62 Allowed Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.454 ' CD ' ' CB ' ' A' ' 148' ' ' ARG . 51.9 Cg_exo -52.39 154.21 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.217 1.944 . . . . 0.0 111.847 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.19 -166.33 14.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -122.23 136.71 54.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.334 -1.098 . . . . 0.0 110.44 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -111.54 143.45 42.38 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.679 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 59.1 mtm180 -130.09 -5.84 4.42 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.141 -0.974 . . . . 0.0 112.537 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.572 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 10.0 t -172.01 -178.45 2.14 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.111 -1.618 . . . . 0.0 110.726 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.514 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.5 OUTLIER -60.44 -26.88 67.07 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.508 HD22 ' N ' ' A' ' 156' ' ' ASN . 2.3 m120 -80.19 2.53 23.91 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.096 -1.002 . . . . 0.0 109.911 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.679 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -93.01 -61.13 1.64 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.167 -0.958 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -78.15 18.0 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.5 38.44 95.76 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -108.65 -160.85 20.07 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 50.7 t -148.75 -41.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.8 p -102.71 -158.34 0.66 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.4 p -144.36 11.68 1.51 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.458 -0.776 . . . . 0.0 109.842 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -63.89 74.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.096 -1.003 . . . . 0.0 112.499 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.7 mtt -101.47 119.88 39.45 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.248 -0.908 . . . . 0.0 109.772 178.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.1 -25.98 3.67 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.532 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.94 152.09 51.43 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 119.274 1.537 . . . . 0.0 111.202 -179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 14.2 mt -146.92 142.69 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.639 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.446 ' NH2' ' OH ' ' A' ' 135' ' ' TYR . 45.3 ttp180 -123.7 136.57 54.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 0.0 109.761 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.53 ' NE ' ' OG1' ' A' ' 172' ' ' THR . 45.4 ttp180 -96.05 98.08 10.09 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.548 -0.72 . . . . 0.0 109.4 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 74.5 mt -47.48 103.07 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.53 ' OG1' ' NE ' ' A' ' 170' ' ' ARG . 12.3 m -149.8 60.68 1.0 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -177.78 108.36 0.06 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.486 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.272 0.558 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -64.08 151.46 49.76 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -149.67 147.31 27.93 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.412 -1.052 . . . . 0.0 111.166 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.669 HD13 ' CD2' ' A' ' 43' ' ' PHE . 13.0 tt -133.9 136.79 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.498 -0.751 . . . . 0.0 110.09 179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.5 mt -122.89 130.69 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.606 -0.684 . . . . 0.0 109.524 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -99.21 135.09 41.13 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.455 -0.778 . . . . 0.0 109.038 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -120.17 135.2 55.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -73.8 -32.62 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.177 -0.952 . . . . 0.0 110.956 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -81.88 161.58 23.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.842 -1.161 . . . . 0.0 110.179 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 -76.8 -44.17 33.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.389 -0.819 . . . . 0.0 109.981 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -85.68 47.65 1.47 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 109.672 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 51.25 86.31 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.539 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 177.53 -175.74 47.72 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.8 -146.06 23.02 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -75.82 116.42 16.51 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.972 -1.31 . . . . 0.0 108.699 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -98.19 157.96 15.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.397 -0.814 . . . . 0.0 109.706 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -148.14 122.5 9.67 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.21 -0.931 . . . . 0.0 108.873 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -97.64 120.72 38.53 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.019 -1.051 . . . . 0.0 109.475 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 65.1 m -124.43 137.55 54.44 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.372 -0.83 . . . . 0.0 109.582 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 20.6 ptt? -140.88 11.05 2.22 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 p -141.48 155.16 45.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.413 -0.804 . . . . 0.0 110.147 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.458 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 2.9 p30 -53.26 141.03 24.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.452 -0.78 . . . . 0.0 110.2 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.6 t -138.93 120.45 15.05 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.97 -4.68 58.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.016 -1.053 . . . . 0.0 109.576 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -140.23 93.98 2.69 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 26' ' ' LEU . 34.2 mt -91.13 -16.29 28.02 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.178 -0.951 . . . . 0.0 108.494 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -58.95 -39.94 83.16 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.806 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.5 m -59.97 -18.69 47.51 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.481 -0.762 . . . . 0.0 110.514 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -94.78 -43.26 8.31 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -158.86 153.87 25.14 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.325 0.583 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.698 HD22 ' H ' ' A' ' 31' ' ' ASN . 0.7 OUTLIER -100.41 -7.81 23.94 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.259 -0.901 . . . . 0.0 110.19 -179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -154.04 153.39 31.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.006 -1.059 . . . . 0.0 108.475 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.589 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 46.2 t -155.98 122.78 5.26 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.593 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 36.9 m-70 -104.63 -12.45 16.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.509 -0.744 . . . . 0.0 109.94 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 t -136.06 142.27 44.35 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.141 -0.974 . . . . 0.0 110.422 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -133.8 145.96 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -137.02 116.5 12.8 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.896 -1.127 . . . . 0.0 111.276 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.58 119.52 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -85.37 -32.72 22.26 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.274 -0.891 . . . . 0.0 108.945 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.0 t -171.24 153.46 3.66 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.621 -1.232 . . . . 0.0 111.244 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.57 -169.05 38.73 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 53.9 m -118.93 156.69 29.09 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.287 -1.125 . . . . 0.0 109.151 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CD2' HD13 ' A' ' 4' ' ' ILE . 10.7 t80 -145.53 134.77 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.044 -1.035 . . . . 0.0 108.994 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.61 ' SD ' ' CD2' ' A' ' 146' ' ' TYR . 10.7 ttm -107.24 126.24 52.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 178.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.2 m -113.77 143.56 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.122 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.7 ' O ' HG13 ' A' ' 76' ' ' VAL . 43.5 m-85 -116.8 139.94 50.02 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.63 0.728 . . . . 0.0 110.863 -178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 26.3 t0 -76.37 -10.0 59.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.503 -0.748 . . . . 0.0 110.013 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.697 ' O ' ' HB3' ' A' ' 78' ' ' SER . 71.5 mtt-85 -131.61 155.44 47.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 0.0 108.525 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.2 p -65.98 158.07 29.19 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.682 0.754 . . . . 0.0 110.953 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 70.73 35.47 1.8 Allowed 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.094 0.473 . . . . 0.0 111.76 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.496 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 3.4 m-85 58.58 54.97 5.07 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.913 -1.117 . . . . 0.0 109.952 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.403 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 83.2 mmm -144.32 178.43 7.92 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.219 -0.925 . . . . 0.0 109.843 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.33 -173.44 53.04 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -54.91 124.58 17.1 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.157 -1.202 . . . . 0.0 108.427 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -102.74 133.48 47.71 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -126.47 133.58 51.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.19 -0.944 . . . . 0.0 109.36 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -96.9 120.97 38.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.179 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.5 mt -119.32 117.33 28.26 Favored 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.147 -0.971 . . . . 0.0 111.248 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' HE ' ' CD1' ' A' ' 174' ' ' LEU . 62.0 ttt-85 -95.33 161.85 13.92 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.244 -0.91 . . . . 0.0 111.302 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.496 ' C ' ' O ' ' A' ' 59' ' ' ARG . 47.1 ttp180 -29.33 115.14 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.433 0.635 . . . . 0.0 110.638 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.92 169.49 32.38 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 9.3 pt-20 -108.5 128.44 54.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.483 -1.01 . . . . 0.0 108.997 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -106.7 98.25 20.09 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 35.3 Cg_endo -67.5 -18.92 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.314 2.01 . . . . 0.0 112.362 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 32.5 m-20 -164.84 139.47 5.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -146.44 3.13 0.87 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.48 -1.387 . . . . 0.0 111.194 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.593 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 30.6 mtp -77.64 -39.93 43.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.61 -1.306 . . . . 0.0 109.548 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -96.13 -21.59 17.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.168 -0.958 . . . . 0.0 109.42 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.2 m -83.4 -16.34 46.3 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.474 -0.767 . . . . 0.0 109.703 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 5.7 mmt -109.5 -25.34 10.53 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.417 -0.956 . . . . 0.0 108.417 178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.91 44.81 8.03 Favored Glycine 0 N--CA 1.495 2.632 0 C-N-CA 120.262 -0.97 . . . . 0.0 110.977 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 80.0 mtp -114.71 159.3 20.7 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.037 -1.272 . . . . 0.0 109.585 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.554 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 28.8 p30 -110.4 55.8 0.64 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.101 -0.999 . . . . 0.0 109.302 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.7 p30 152.67 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.589 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.8 p -96.97 -175.09 3.16 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 122.066 0.936 . . . . 0.0 110.255 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 46' ' ' TYR . 59.7 t -68.09 141.83 17.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.27 -17.91 14.16 Favored 'General case' 0 C--N 1.308 -1.21 0 O-C-N 120.707 -1.245 . . . . 0.0 107.821 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.697 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -145.49 168.85 19.59 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.199 -0.938 . . . . 0.0 109.43 178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.422 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 22.9 p -161.68 146.22 13.02 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.492 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' NH1' ' NE ' ' A' ' 148' ' ' ARG . 63.9 ttt180 -132.43 140.3 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 34.5 tpp -92.36 143.1 26.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.05 -1.031 . . . . 0.0 108.602 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.56 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 17.2 mt -85.22 130.72 50.76 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.11 -175.88 2.39 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.406 2.071 . . . . 0.0 112.323 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.501 ' O ' ' C ' ' A' ' 85' ' ' HIS . 30.5 mt -100.68 68.88 1.35 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.451 -0.78 . . . . 0.0 109.174 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.501 ' C ' ' O ' ' A' ' 84' ' ' LEU . 25.7 p80 -33.67 147.75 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.724 -0.61 . . . . 0.0 109.736 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.445 ' N ' ' CD2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -145.77 50.21 1.2 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.419 -0.801 . . . . 0.0 109.594 -178.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.03 -101.29 0.48 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 74.6 p -156.47 173.95 16.16 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.85 -0.794 . . . . 0.0 109.483 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.491 ' CE2' ' OG1' ' A' ' 172' ' ' THR . 14.0 m-85 -111.96 119.61 39.09 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.524 -0.735 . . . . 0.0 109.491 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -167.9 129.24 1.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.3 ttm -117.02 127.66 54.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.325 -0.859 . . . . 0.0 109.269 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -101.06 119.22 38.43 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 125' ' ' CYS . 15.9 mt -101.3 149.06 24.41 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.119 0.961 . . . . 0.0 112.067 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' A' ' 99' ' ' MET . 38.3 m-85 -132.95 122.94 25.02 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 52.6 tt0 -62.12 -26.04 68.08 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.195 -0.941 . . . . 0.0 111.828 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.93 165.4 11.6 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.839 -1.163 . . . . 0.0 110.908 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.54 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 6.1 p -63.53 158.18 21.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.8 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 97' ' ' SER . 32.2 t0 81.67 -95.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.543 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 19.9 mmt -161.64 33.56 0.13 Allowed 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.18 -153.1 26.05 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.51 -0.853 . . . . 0.0 111.019 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.494 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 62.87 -165.57 25.11 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 108.467 -1.853 . . . . 0.0 108.467 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.455 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 79.1 mtm180 -81.01 143.74 32.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.932 -1.334 . . . . 0.0 108.842 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.4 mtt -98.21 115.45 28.36 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.922 -1.111 . . . . 0.0 109.447 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.539 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.3 mpp? -114.42 135.38 54.16 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.109 -0.994 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -99.56 132.1 45.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.276 -0.89 . . . . 0.0 109.665 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.708 HD11 ' HB2' ' A' ' 110' ' ' CYS . 1.0 OUTLIER -122.79 115.78 22.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.2 ttt -126.16 13.09 7.75 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.397 -0.815 . . . . 0.0 109.399 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.542 ' H ' HD23 ' A' ' 106' ' ' LEU . 77.3 m-20 -136.71 -167.68 2.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.626 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -81.99 130.9 35.21 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.708 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -118.69 78.64 15.61 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.997 -1.064 . . . . 0.0 109.52 -179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -78.07 -25.8 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.087 1.858 . . . . 0.0 112.233 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.456 ' CG ' ' O ' ' A' ' 112' ' ' ASN . 51.2 p-10 -131.27 75.61 1.66 Allowed 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.2 mt -62.07 -18.54 61.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.93 -1.106 . . . . 0.0 110.41 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 6.5 tpt -60.88 -42.21 97.49 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.312 -0.867 . . . . 0.0 109.37 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -82.91 -21.51 34.17 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 110.382 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -77.21 -62.15 1.75 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.691 -1.256 . . . . 0.0 111.125 -178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -113.05 2.68 15.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.279 -0.888 . . . . 0.0 110.489 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' MET . 41.3 m-20 50.85 35.36 12.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.871 -1.143 . . . . 0.0 108.769 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 7.5 ptm -148.3 135.64 20.44 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.407 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 78.6 p -125.91 7.09 7.34 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.478 -0.764 . . . . 0.0 111.015 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 163' ' ' SER . 66.6 m-20 -128.42 85.68 2.37 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.552 -1.342 . . . . 0.0 112.786 -178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -98.74 134.69 41.29 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.95 -1.094 . . . . 0.0 108.7 177.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -94.45 2.18 55.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.147 -0.97 . . . . 0.0 111.264 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.533 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.5 t -149.92 156.3 41.51 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.156 -1.59 . . . . 0.0 109.846 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.539 ' HB3' HD23 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -162.69 162.16 26.76 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.832 . . . . 0.0 110.006 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 14.7 t60 -147.95 143.36 27.27 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.143 -0.973 . . . . 0.0 109.89 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 75.9 t -114.26 121.02 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.286 -0.884 . . . . 0.0 109.359 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 23.1 ttt -70.32 -39.44 74.78 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.565 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 0.5 OUTLIER -179.08 173.66 1.14 Allowed 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.253 -179.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 86.33 -144.13 19.77 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.56 ' CD2' ' CG2' ' A' ' 82' ' ' ILE . 66.3 m-70 -147.76 128.44 14.22 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.571 -0.958 . . . . 0.0 109.319 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -124.04 135.42 53.57 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.118 -0.989 . . . . 0.0 112.478 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.8 mt -108.22 134.17 51.45 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 25.4 t -110.06 142.56 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.05 -1.031 . . . . 0.0 109.233 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.49 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 50.9 m-85 -119.13 124.32 46.57 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.618 -0.676 . . . . 0.0 110.762 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.516 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 78.0 tt0 -60.69 -26.62 67.25 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' A' ' 167' ' ' SER . 12.2 mm100 -119.34 150.98 50.55 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.483 ' O ' ' OG1' ' A' ' 141' ' ' THR . 18.1 Cg_endo -59.75 -177.84 0.15 Allowed 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 122.921 2.414 . . . . 0.0 113.398 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.581 ' O ' ' CG ' ' A' ' 140' ' ' TYR . 26.9 m120 52.61 38.61 26.37 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.384 -0.822 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.581 ' CG ' ' O ' ' A' ' 139' ' ' ASN . 5.7 p90 45.75 57.09 5.31 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.65 -0.656 . . . . 0.0 110.51 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 3.8 p -141.42 172.63 12.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.289 -0.882 . . . . 0.0 110.327 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.46 -173.76 40.85 Favored Glycine 0 N--CA 1.497 2.763 0 O-C-N 120.645 -1.284 . . . . 0.0 110.798 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.516 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 70.3 mtm180 -58.19 106.66 0.4 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.605 -0.938 . . . . 0.0 109.432 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 11.9 mt-30 -85.36 143.22 28.77 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.62 0.724 . . . . 0.0 110.184 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -126.85 134.17 50.57 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.61 ' CD2' ' SD ' ' A' ' 44' ' ' MET . 2.4 t80 -95.3 104.84 16.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.927 -1.108 . . . . 0.0 109.984 -179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.0 mp -96.91 121.98 39.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.91 . . . . 0.0 108.887 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' NE ' ' NH1' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -107.26 175.83 1.87 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -44.71 159.06 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.11 1.874 . . . . 0.0 111.773 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.02 -168.87 12.78 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -120.2 136.34 54.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.472 -1.017 . . . . 0.0 110.487 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.524 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 17.6 m-85 -110.73 145.55 37.86 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.601 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 35.2 ptt85 -134.5 -3.86 2.64 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.069 -1.02 . . . . 0.0 112.168 -177.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.579 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 53.8 p -170.17 173.23 5.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.09 -1.631 . . . . 0.0 110.661 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.638 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.77 -21.54 56.02 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.418 ' N ' HD22 ' A' ' 156' ' ' ASN . 3.1 m120 -80.99 -2.52 48.26 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.937 -1.102 . . . . 0.0 109.556 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.6 m-20 -88.55 -61.08 1.79 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.163 -0.961 . . . . 0.0 109.274 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.535 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.2 p90 -76.59 16.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.19 38.26 94.99 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.54 -177.85 23.18 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.55 5.31 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 63.3 p -154.95 -157.32 0.74 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 55.7 m -141.84 12.35 2.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.437 -0.79 . . . . 0.0 110.269 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -64.02 69.38 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.083 -1.01 . . . . 0.0 112.826 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.2 mtt -100.36 118.83 37.42 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.054 -1.028 . . . . 0.0 110.523 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.74 -25.85 4.7 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.442 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -132.47 153.55 50.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.765 -1.433 . . . . 0.0 110.596 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 17.7 mt -150.44 141.32 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.561 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 44.7 ttt85 -122.76 133.89 54.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.426 -0.796 . . . . 0.0 110.152 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.7 ' O ' ' N ' ' A' ' 172' ' ' THR . 23.0 ptt85 -98.78 102.74 14.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.748 HG22 ' O ' ' A' ' 171' ' ' ILE . 82.4 mt -50.17 66.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.811 -0.556 . . . . 0.0 111.715 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 170' ' ' ARG . 4.5 m -139.73 50.69 1.75 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.516 -1.365 . . . . 0.0 110.538 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 172' ' ' THR . 16.1 m-20 -157.57 92.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.268 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.653 ' CD1' ' HE ' ' A' ' 59' ' ' ARG . 3.7 mm? . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 118.021 -0.99 . . . . 0.0 108.763 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' O ' ' A' ' 2' ' ' GLY . 63.0 mtt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 59.9 146.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -148.43 149.24 31.37 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.324 -1.103 . . . . 0.0 110.892 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 36' ' ' ILE . 17.3 tt -134.67 133.5 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.58 -0.7 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 59.6 mt -118.48 130.76 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.678 -0.639 . . . . 0.0 109.462 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -94.61 157.27 16.05 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -144.69 136.35 25.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.876 -1.14 . . . . 0.0 108.454 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 -80.77 -25.12 38.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.016 -1.052 . . . . 0.0 111.267 -178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.617 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 50.9 t0 -80.54 159.06 25.6 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.812 -1.18 . . . . 0.0 110.821 -178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' O ' ' OG ' ' A' ' 35' ' ' SER . 73.7 ttt180 -61.44 -39.84 92.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.657 -0.652 . . . . 0.0 110.064 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 83.2 m-20 -87.48 -90.28 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.071 -1.018 . . . . 0.0 109.323 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.512 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 57.2 m-85 -158.17 63.14 0.45 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.335 -0.853 . . . . 0.0 108.959 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.617 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -152.42 -162.38 10.85 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.18 -149.5 39.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.509 -1.837 . . . . 0.0 108.509 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -74.37 117.04 15.73 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.868 -1.372 . . . . 0.0 108.827 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -104.74 158.81 16.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.466 -0.771 . . . . 0.0 110.101 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -149.72 124.07 9.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.069 -1.019 . . . . 0.0 109.828 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -96.45 118.12 32.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.111 -0.993 . . . . 0.0 109.2 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -114.86 139.03 50.1 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.116 -0.99 . . . . 0.0 109.269 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.3 ptp -138.44 10.78 2.74 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.5 p -143.44 161.79 37.5 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.666 -0.646 . . . . 0.0 109.605 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 49.8 p30 -60.02 146.02 44.23 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.142 -0.974 . . . . 0.0 110.562 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.3 t -141.15 111.93 7.09 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 50' ' ' ASN . . . -83.93 -5.38 59.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.361 -0.837 . . . . 0.0 109.583 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 38.8 p-10 -138.23 93.94 2.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.107 -0.996 . . . . 0.0 109.057 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD11 ' SG ' ' A' ' 79' ' ' CYS . 30.9 mt -94.32 -20.66 19.57 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -58.44 -40.9 83.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 108.88 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.6 p -57.31 -24.24 53.78 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.61 -0.682 . . . . 0.0 110.051 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -89.46 -40.37 12.74 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.137 -0.977 . . . . 0.0 108.705 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -159.08 147.35 17.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.601 -0.687 . . . . 0.0 109.701 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -94.06 -9.68 35.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.113 -0.992 . . . . 0.0 110.254 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -152.5 152.23 31.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.048 -1.033 . . . . 0.0 108.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.514 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 7.7 t -154.45 114.6 3.86 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -95.17 -7.93 37.78 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.42 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.513 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 14.9 m -137.78 144.13 41.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.815 -1.178 . . . . 0.0 110.511 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.597 HD11 HD11 ' A' ' 4' ' ' ILE . 9.1 tt -156.85 154.22 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -155.54 144.82 20.91 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.675 -1.265 . . . . 0.0 111.815 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.55 123.61 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -84.56 -30.51 25.0 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 108.669 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.7 t -166.37 150.29 7.5 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.076 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.88 -142.16 18.24 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.5 m -150.09 163.02 39.25 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -145.63 134.47 22.42 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.871 -1.143 . . . . 0.0 109.816 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.28 110.66 22.9 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.658 ' HB ' HG11 ' A' ' 76' ' ' VAL . 18.9 m -99.8 147.18 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.602 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.506 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 42.2 m-85 -121.73 140.6 52.12 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.684 0.754 . . . . 0.0 111.147 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -75.47 -8.02 55.63 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.764 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.823 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.2 ttt180 -131.38 162.58 29.82 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.0 p -74.15 163.3 28.03 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.976 0.893 . . . . 0.0 111.548 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.549 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.8 OUTLIER 64.42 31.93 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.217 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.616 ' CE2' ' NH2' ' A' ' 80' ' ' ARG . 5.0 m-85 63.08 58.37 1.47 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.348 -0.845 . . . . 0.0 109.905 178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 86.2 mtp -144.29 171.62 14.06 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 85.42 -169.39 43.32 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -58.03 121.29 10.26 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 4.5 mp0 -104.51 136.15 44.61 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.45 -0.781 . . . . 0.0 109.207 -179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -125.77 133.34 52.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 110.21 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -96.97 122.37 39.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.388 -0.82 . . . . 0.0 109.281 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 31.7 mt -117.04 127.99 54.71 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.283 -0.885 . . . . 0.0 109.746 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' O ' ' C ' ' A' ' 60' ' ' ARG . 35.3 ptt180 -97.52 166.35 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.084 -1.01 . . . . 0.0 110.078 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 59' ' ' ARG . 44.4 ttp180 -38.52 112.17 0.21 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.576 -0.702 . . . . 0.0 109.84 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.26 171.85 40.42 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' OE1' ' N ' ' A' ' 62' ' ' GLU . 47.1 mp0 -111.14 130.33 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.375 -1.074 . . . . 0.0 108.667 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -113.33 99.67 49.81 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ARG . 58.1 Cg_endo -75.8 -9.35 19.64 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.343 2.028 . . . . 0.0 112.725 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 44.2 m-20 -164.28 128.93 2.71 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 22.3 p90 -148.4 34.33 0.79 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.62 -1.3 . . . . 0.0 110.408 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 54.5 tpp -102.83 -47.25 4.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.024 -1.047 . . . . 0.0 109.708 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.3 ttm180 -98.54 -19.52 17.57 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 57.1 m -78.9 -23.93 44.47 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 9.3 mmt -101.35 -30.99 11.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 88.21 49.72 3.65 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 64.8 mtp -123.1 143.16 50.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.523 -0.986 . . . . 0.0 109.695 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.56 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.6 p30 -96.13 54.27 1.43 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.157 -0.964 . . . . 0.0 109.298 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.3 m-20 150.55 -168.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.514 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.8 p -97.48 -160.49 0.81 Allowed 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.489 -0.757 . . . . 0.0 109.714 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.658 HG11 ' HB ' ' A' ' 45' ' ' VAL . 6.1 m -92.13 150.25 3.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -110.78 -7.6 14.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.894 -1.129 . . . . 0.0 108.022 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.823 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -146.8 165.14 30.59 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.913 -1.117 . . . . 0.0 109.452 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.486 ' SG ' HD11 ' A' ' 26' ' ' LEU . 23.3 p -164.64 149.84 9.89 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.873 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.616 ' NH2' ' CE2' ' A' ' 51' ' ' PHE . 61.6 ttm-85 -138.2 142.84 39.99 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.6 ptm -95.53 151.38 19.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.461 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.2 mm -105.74 101.2 31.46 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.332 -0.855 . . . . 0.0 109.59 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.54 152.88 8.41 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.347 2.032 . . . . 0.0 112.072 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 31.7 mt -83.85 47.88 1.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.486 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -100.53 77.31 1.9 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 0.0 109.141 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.538 ' ND1' ' OXT' ' A' ' 174' ' ' LEU . 38.6 m170 -97.1 82.37 3.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.92 . . . . 0.0 109.566 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.46 -88.57 0.35 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 95.0 p -117.48 146.67 43.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.433 -1.04 . . . . 0.0 110.236 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -111.05 119.53 39.32 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.459 -0.775 . . . . 0.0 109.527 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -171.59 125.59 0.6 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 47.2 ttm -105.38 127.72 53.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.007 -1.058 . . . . 0.0 109.298 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -104.7 115.56 30.52 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.534 HD23 ' SG ' ' A' ' 125' ' ' CYS . 10.1 mt -104.49 148.15 26.78 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.233 1.016 . . . . 0.0 113.06 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.555 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 25.3 m-85 -133.53 125.66 29.37 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' CB ' ' H ' ' A' ' 102' ' ' ARG . 70.8 tt0 -62.59 -26.34 68.55 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.388 -0.82 . . . . 0.0 111.955 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.762 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.3 m-70 -109.63 164.18 12.78 Favored 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.658 -1.276 . . . . 0.0 110.828 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -61.89 160.63 11.79 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.406 -0.809 . . . . 0.0 109.219 -179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.518 ' O ' ' SD ' ' A' ' 99' ' ' MET . 5.7 m-20 80.05 -96.12 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.6 mmt -162.78 31.72 0.1 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.34 -156.84 30.54 Favored Glycine 0 N--CA 1.491 2.357 0 CA-C-O 122.173 0.874 . . . . 0.0 111.178 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.418 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 64.38 -155.35 46.95 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' H ' ' CB ' ' A' ' 95' ' ' GLU . 57.9 ttt85 -90.9 140.84 29.44 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.162 -1.199 . . . . 0.0 109.204 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 44.0 ttp -97.36 114.89 26.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.826 -1.171 . . . . 0.0 109.834 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.7 mtm -113.81 138.79 49.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.138 -0.976 . . . . 0.0 108.656 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.72 138.31 39.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.466 -0.771 . . . . 0.0 109.169 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.3 tt -137.28 122.61 19.41 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.398 -0.814 . . . . 0.0 108.902 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.519 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 5.8 ttt -123.12 2.73 9.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 110.406 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.495 ' H ' HD23 ' A' ' 106' ' ' LEU . 81.1 m-20 -122.29 -162.7 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.245 -0.909 . . . . 0.0 110.078 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 42.9 p-10 -91.29 139.51 30.66 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.509 ' CB ' HD21 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -120.83 98.22 47.89 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.225 -0.922 . . . . 0.0 110.146 -178.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -82.99 -23.26 3.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.147 1.898 . . . . 0.0 112.311 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -142.25 84.81 1.89 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.946 -1.096 . . . . 0.0 108.337 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 110' ' ' CYS . 96.0 mt -70.89 -26.99 63.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.083 -1.011 . . . . 0.0 110.074 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.521 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.6 tpt -58.59 -40.48 83.32 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.171 -0.956 . . . . 0.0 108.715 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -84.1 -23.0 30.93 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.315 -0.866 . . . . 0.0 110.619 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -79.12 -62.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.538 -1.351 . . . . 0.0 110.824 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -100.3 2.01 42.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.374 -0.829 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.521 ' HA ' ' O ' ' A' ' 114' ' ' MET . 28.3 t-20 59.06 30.56 20.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 110.014 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.555 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 9.0 ptm -153.82 138.92 17.35 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 62.5 m -123.75 5.82 8.8 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.754 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 163' ' ' SER . 37.0 m-20 -128.32 92.43 3.44 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 118.637 -1.225 . . . . 0.0 113.242 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.663 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -104.68 132.97 50.29 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.485 ' CD2' ' OH ' ' A' ' 155' ' ' TYR . 1.1 m-70 -92.01 2.65 56.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.061 . . . . 0.0 111.538 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.762 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.4 p -147.34 153.06 39.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 119.932 -1.73 . . . . 0.0 110.241 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 124' ' ' SER . 35.7 m -157.36 159.04 37.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.482 -0.761 . . . . 0.0 109.481 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.546 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -148.21 141.88 25.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.094 -1.004 . . . . 0.0 108.72 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.546 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 53.3 t -113.25 125.03 70.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.996 -1.065 . . . . 0.0 109.308 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.466 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.0 ttt -73.8 -28.58 61.72 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.671 0.748 . . . . 0.0 109.118 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m-20 166.85 166.05 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.828 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 91.61 -142.67 16.18 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -149.74 129.35 13.14 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.593 -0.945 . . . . 0.0 109.674 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 59.4 m95 -124.1 135.76 53.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.502 -0.749 . . . . 0.0 111.767 -178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 168' ' ' ILE . 6.1 mt -105.02 133.09 50.38 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 43.4 t -111.1 143.0 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.084 -1.01 . . . . 0.0 109.916 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.444 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 41.3 m-85 -120.42 124.19 44.86 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.522 -0.736 . . . . 0.0 111.107 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.529 ' OE1' ' NH1' ' A' ' 143' ' ' ARG . 54.0 tt0 -58.47 -27.32 64.3 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -119.97 155.2 55.54 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 26.0 Cg_endo -62.69 -171.69 0.11 Allowed 'Trans proline' 0 N--CA 1.502 2.0 0 C-N-CA 123.31 2.674 . . . . 0.0 113.686 -178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 47.52 30.5 1.68 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.507 0.67 . . . . 0.0 109.748 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.536 ' H ' ' CB ' ' A' ' 167' ' ' SER . 16.3 m-85 56.86 52.62 9.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.488 -0.757 . . . . 0.0 109.54 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 142' ' ' GLY . 85.6 m -136.89 164.42 28.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.414 -0.804 . . . . 0.0 109.323 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.09 178.51 33.15 Favored Glycine 0 N--CA 1.504 3.177 0 O-C-N 120.886 -1.134 . . . . 0.0 110.657 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.529 ' NH1' ' OE1' ' A' ' 136' ' ' GLU . 69.3 mtt85 -53.98 111.42 0.75 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.942 . . . . 0.0 108.722 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.626 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.0 OUTLIER -86.78 143.53 27.47 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.116 -179.258 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -126.12 129.58 49.36 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.549 0.69 . . . . 0.0 109.254 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -90.75 104.0 16.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.426 -0.796 . . . . 0.0 109.55 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.3 mp -97.98 119.62 36.93 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.854 0.835 . . . . 0.0 109.331 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -105.83 177.69 1.3 Allowed Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.2 Cg_exo -47.01 161.67 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.86 1.707 . . . . 0.0 111.661 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.81 -179.47 18.39 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.32 136.79 49.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.484 -1.009 . . . . 0.0 110.409 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 16.8 m-85 -112.08 142.82 44.05 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.683 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 7.5 ptp180 -134.86 -4.99 2.45 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.032 -1.042 . . . . 0.0 112.476 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.543 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 57.7 m -165.57 165.66 18.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.903 -1.748 . . . . 0.0 110.528 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -52.07 -21.08 2.87 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -82.5 2.5 32.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.912 . . . . 0.0 109.652 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.683 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 2.4 m-20 -92.88 -61.68 1.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.157 -0.965 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.403 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.5 p90 -77.04 16.09 0.6 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.87 37.69 92.42 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -106.19 -161.93 22.69 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.5 t -146.97 -42.19 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.3 p -103.82 -155.46 0.53 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.0 t -146.13 11.9 1.21 Allowed 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.388 -0.82 . . . . 0.0 109.433 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 45.7 mtp85 -65.09 76.88 0.05 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.087 -1.008 . . . . 0.0 112.535 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -102.64 121.56 42.65 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.129 -0.982 . . . . 0.0 110.155 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.9 -26.88 3.41 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.536 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 1.3 t -135.4 153.49 51.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.602 -1.528 . . . . 0.0 111.249 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.478 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 19.7 mt -149.17 143.05 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 70.5 ttt-85 -123.06 139.99 53.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 109.966 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 107' ' ' MET . 53.1 ttp180 -98.82 92.52 5.59 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.444 -0.785 . . . . 0.0 109.293 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.514 ' C ' ' O ' ' A' ' 170' ' ' ARG . 88.8 mt -39.24 100.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.495 ' N ' ' O ' ' A' ' 170' ' ' ARG . 28.0 m -108.09 65.68 0.64 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 174' ' ' LEU . 42.9 t0 -115.7 72.86 0.82 Allowed 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.468 0.651 . . . . 0.0 109.567 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.538 ' OXT' ' ND1' ' A' ' 86' ' ' HIS . 14.8 mt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.235 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 ptt? . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.54 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . -153.7 148.61 19.49 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 89.6 mttt -161.59 145.41 12.72 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.51 -0.994 . . . . 0.0 110.604 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 36' ' ' ILE . 21.0 tt -134.76 133.67 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 109.691 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.83 128.65 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 CA-C-O 121.409 0.623 . . . . 0.0 109.706 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.419 ' CE2' HD12 ' A' ' 36' ' ' ILE . 90.1 m-85 -89.26 165.96 14.09 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -152.92 132.61 13.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.602 -1.311 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -73.59 -43.13 60.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.405 -0.809 . . . . 0.0 111.313 -179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.601 ' HB2' ' H ' ' A' ' 13' ' ' GLY . 88.9 m-20 -69.63 155.77 39.98 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.616 -1.302 . . . . 0.0 110.782 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.484 ' O ' ' O ' ' A' ' 64' ' ' PRO . 72.0 mtp180 -62.09 -44.85 95.76 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.566 -0.709 . . . . 0.0 109.726 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 12' ' ' PHE . 7.8 p30 -74.97 -95.44 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -0.985 . . . . 0.0 109.191 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' H ' ' CG ' ' A' ' 11' ' ' ASN . 51.0 m-85 -156.02 56.4 0.59 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.16 -0.962 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -141.81 -150.93 5.44 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 64.71 -153.37 49.76 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -74.83 120.06 19.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -1.125 . . . . 0.0 109.231 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -106.34 156.7 18.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.765 . . . . 0.0 109.871 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.626 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 1.1 t60 -146.01 128.39 15.89 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.634 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -99.28 121.66 41.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 108.696 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.5 m -122.62 136.55 54.91 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.21 -0.932 . . . . 0.0 109.534 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -141.58 15.27 2.17 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.0 t -145.81 158.19 43.87 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.781 0.8 . . . . 0.0 110.503 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -50.07 143.66 7.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.534 -0.729 . . . . 0.0 110.399 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.4 t -148.68 114.76 5.79 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.75 8.9 41.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.07 -1.019 . . . . 0.0 108.68 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -138.85 98.17 3.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.852 -0.53 . . . . 0.0 109.779 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 78' ' ' SER . 89.2 mt -106.54 -25.31 11.88 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.498 ' CD2' HD22 ' A' ' 31' ' ' ASN . 19.4 t-80 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.417 -0.802 . . . . 0.0 109.002 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.2 m -50.54 -58.71 5.17 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 91.4 m-85 -56.14 -49.25 74.46 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.887 -0.508 . . . . 0.0 111.209 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -155.11 149.21 25.84 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.964 -1.085 . . . . 0.0 110.19 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.498 HD22 ' CD2' ' A' ' 27' ' ' HIS . 7.4 t-20 -95.26 -4.74 45.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.384 -0.822 . . . . 0.0 110.344 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -159.91 158.14 30.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.136 -0.978 . . . . 0.0 108.485 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.542 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 14.4 t -159.11 112.89 2.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.905 -1.122 . . . . 0.0 108.419 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.571 ' ND1' ' SD ' ' A' ' 67' ' ' MET . 60.5 m-70 -92.68 1.0 57.51 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.942 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.498 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 7.3 t -146.13 141.65 27.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.405 -1.434 . . . . 0.0 110.687 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.52 HD11 HD11 ' A' ' 4' ' ' ILE . 19.0 tt -151.11 146.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.441 -0.787 . . . . 0.0 108.921 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -143.07 133.88 25.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.93 -1.106 . . . . 0.0 111.8 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.407 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 22.7 t -105.04 118.89 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -79.83 -33.49 40.21 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.891 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 85.8 p -167.79 156.51 9.41 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.662 -1.215 . . . . 0.0 111.385 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.688 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 86.93 -123.19 6.43 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.688 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 99.1 m -168.64 167.75 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.52 141.05 21.64 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.846 -1.159 . . . . 0.0 109.077 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.2 tpt -99.94 115.06 28.78 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 56' ' ' TYR . 4.5 m -108.71 142.06 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.327 -0.858 . . . . 0.0 109.976 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.485 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 33.2 m-85 -120.02 137.26 54.2 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.809 0.814 . . . . 0.0 111.298 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.493 ' O ' ' NE ' ' A' ' 77' ' ' ARG . 22.6 t0 -71.75 -5.86 37.11 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.616 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.056 ' O ' ' OG ' ' A' ' 78' ' ' SER . 36.2 ttm-85 -131.25 166.82 20.33 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.443 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 1.8 p -79.92 165.25 22.83 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.751 0.786 . . . . 0.0 110.208 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' C ' ' CG ' ' A' ' 51' ' ' PHE . 43.0 t30 63.63 33.06 13.52 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.713 -0.617 . . . . 0.0 110.812 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.536 ' H ' ' CB ' ' A' ' 78' ' ' SER . 0.6 OUTLIER 60.83 61.22 1.7 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.948 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.41 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 64.1 mtp -148.39 166.48 27.97 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.248 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.19 -166.64 30.99 Favored Glycine 0 N--CA 1.497 2.716 0 O-C-N 121.029 -1.045 . . . . 0.0 110.582 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -57.76 112.88 1.61 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 121.246 -1.149 . . . . 0.0 108.073 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -93.37 134.9 35.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.724 -0.61 . . . . 0.0 109.398 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB2' HG23 ' A' ' 45' ' ' VAL . 55.1 m-85 -130.78 137.14 49.32 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.179 -0.951 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.664 ' CE2' ' NH2' ' A' ' 169' ' ' ARG . 30.5 p90 -98.93 116.51 31.33 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.381 -0.824 . . . . 0.0 109.779 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -107.38 112.71 25.65 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.668 -1.27 . . . . 0.0 111.473 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 60' ' ' ARG . 14.2 ptm180 -85.96 160.34 19.39 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.437 -0.789 . . . . 0.0 110.927 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' A' ' 59' ' ' ARG . 60.1 ttt-85 -35.8 114.91 0.29 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.646 -0.659 . . . . 0.0 110.012 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 173.73 166.14 31.52 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.594 -1.289 . . . . 0.0 109.947 179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -103.75 128.16 51.16 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.473 -1.016 . . . . 0.0 108.746 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -117.91 90.05 35.66 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.36 -0.837 . . . . 0.0 109.414 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 10' ' ' ARG . 31.3 Cg_exo -55.86 -11.11 4.79 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.639 2.226 . . . . 0.0 111.973 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -170.25 146.15 2.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.0 108.78 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 30.9 p90 -150.41 31.61 0.66 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.672 -1.268 . . . . 0.0 109.587 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.571 ' SD ' ' ND1' ' A' ' 34' ' ' HIS . 26.1 mtp -102.04 -45.66 5.1 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 109.213 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -96.36 -20.8 18.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -0.953 . . . . 0.0 109.168 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 p -84.17 -12.08 55.5 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 6.9 mtt -110.31 -28.17 8.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 0.0 108.816 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.82 56.02 2.85 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -130.43 166.92 19.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.935 -1.332 . . . . 0.0 109.287 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 8.7 m120 -117.09 53.25 0.91 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.409 -0.807 . . . . 0.0 109.287 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 2.8 m-20 155.33 -168.4 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.542 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 22.4 p -98.83 -166.47 1.36 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.954 0.883 . . . . 0.0 110.29 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 46' ' ' TYR . 19.3 t -77.18 140.97 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.493 ' NE ' ' O ' ' A' ' 47' ' ' ASP . 11.8 mtm180 -102.59 -19.78 14.71 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.762 -1.211 . . . . 0.0 108.008 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 1.056 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 1.0 OUTLIER -150.11 160.19 43.84 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.629 178.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 25.4 p -157.05 159.15 37.65 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.351 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 -146.12 142.5 28.57 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.8 160.76 19.39 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.155 -0.966 . . . . 0.0 108.924 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.493 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 66.2 mt -118.22 95.92 49.07 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.672 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -47.71 148.8 5.59 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.418 2.079 . . . . 0.0 112.476 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -89.75 43.26 1.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.294 -0.879 . . . . 0.0 109.558 -179.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -110.39 105.83 14.96 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.571 ' CG ' ' O ' ' A' ' 86' ' ' HIS . 55.8 p-80 -135.94 109.5 7.97 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.24 -0.913 . . . . 0.0 110.16 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.62 -64.69 3.77 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 107.698 -2.161 . . . . 0.0 107.698 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.468 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 89.5 p -144.43 164.08 31.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.493 -1.004 . . . . 0.0 109.793 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -108.01 113.43 26.59 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.139 -0.976 . . . . 0.0 109.483 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -167.5 132.29 1.91 Allowed 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.254 -0.904 . . . . 0.0 108.892 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.492 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 1.6 ttp -116.44 132.6 56.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -106.43 119.22 38.69 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 103' ' ' MET . 18.2 mt -103.73 151.64 22.77 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 122.074 0.94 . . . . 0.0 112.301 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -136.4 129.78 31.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 25.9 tt0 -63.47 -21.8 66.52 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.472 -0.768 . . . . 0.0 112.217 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 124' ' ' SER . 14.8 m-70 -119.86 163.3 17.72 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.032 -1.667 . . . . 0.0 111.106 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 50.1 m -55.99 157.83 4.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.118 -0.989 . . . . 0.0 109.5 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 97' ' ' SER . 1.0 OUTLIER 83.42 -92.64 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.028 -1.045 . . . . 0.0 109.822 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 2.7 mtt -179.46 45.47 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.75 163.01 22.88 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 109.18 -130.5 10.04 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.525 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 60.5 mtt85 -104.02 119.7 39.49 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.34 -1.094 . . . . 0.0 108.175 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.521 ' O ' ' CG ' ' A' ' 103' ' ' MET . 12.1 ptt? -90.84 119.05 30.73 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.544 -0.722 . . . . 0.0 110.457 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 104' ' ' MET . 3.4 mpp? -114.79 135.85 53.73 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -101.82 133.72 46.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.84 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.8 OUTLIER -123.66 117.67 25.52 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.451 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 9.6 ttt -125.07 15.45 8.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.428 -0.795 . . . . 0.0 109.496 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.467 ' H ' HD23 ' A' ' 106' ' ' LEU . 67.4 m-20 -144.48 -165.01 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.171 -0.956 . . . . 0.0 109.895 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 20.9 p-10 -82.96 128.35 34.38 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.689 ' HB2' HD11 ' A' ' 106' ' ' LEU . 1.2 m -123.33 77.0 53.37 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.166 -0.959 . . . . 0.0 110.694 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -78.4 -31.96 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.54 2.16 . . . . 0.0 112.045 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -117.45 75.86 1.01 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 113' ' ' LEU . 41.1 mt -68.48 -20.73 64.62 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.816 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.453 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.4 tpt -59.43 -40.39 86.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -86.4 -21.79 26.95 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 110.886 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -75.85 -58.81 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.617 -1.302 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -116.76 0.62 12.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.415 -0.803 . . . . 0.0 110.48 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 114' ' ' MET . 51.0 m-20 52.79 34.7 16.89 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.418 ' HG2' ' CE2' ' A' ' 122' ' ' PHE . 2.4 ttt -147.35 134.52 20.49 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 12.8 p -134.0 11.0 3.93 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.602 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 163' ' ' SER . 38.5 m-20 -129.28 94.96 3.91 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.665 -1.272 . . . . 0.0 112.808 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.665 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -111.56 136.45 50.74 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -96.3 3.96 52.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.257 -0.902 . . . . 0.0 110.475 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 98' ' ' ASP . 3.6 m -146.8 152.59 39.02 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.341 -1.474 . . . . 0.0 110.01 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.492 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 53.3 t -161.97 159.7 26.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.869 . . . . 0.0 110.088 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.401 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 21.6 t60 -145.91 143.48 29.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.143 -0.973 . . . . 0.0 109.653 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 96.5 t -113.78 123.41 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.065 -1.022 . . . . 0.0 109.344 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.43 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 23.2 ttt -76.91 -22.82 52.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.668 -0.645 . . . . 0.0 109.941 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.468 ' CB ' ' H ' ' A' ' 88' ' ' SER . 0.5 OUTLIER 170.91 -171.5 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.742 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.535 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 63.09 -135.01 43.11 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.535 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.1 m-70 -159.96 138.24 10.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.905 . . . . 0.0 109.066 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 56.4 m95 -128.51 137.77 51.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 111.635 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.7 mt -104.63 130.34 52.65 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 39.1 t -109.38 141.39 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.918 -1.114 . . . . 0.0 109.408 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.43 125.68 48.56 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.583 -0.698 . . . . 0.0 110.868 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -61.57 -21.45 64.32 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 141' ' ' THR . 82.0 mt-30 -130.32 138.66 33.54 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.18 -0.95 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.443 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 88.0 Cg_exo -43.06 -177.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.708 2.939 . . . . 0.0 114.385 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.4 t30 49.16 32.44 4.17 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.847 -0.533 . . . . 0.0 111.071 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.482 ' H ' ' CB ' ' A' ' 167' ' ' SER . 43.1 m-85 56.93 49.74 13.47 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.682 -0.637 . . . . 0.0 110.469 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 142' ' ' GLY . 87.4 m -137.05 163.29 31.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.255 -0.903 . . . . 0.0 109.454 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.487 ' N ' HG22 ' A' ' 141' ' ' THR . . . 97.6 175.02 33.97 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -49.96 109.78 0.32 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.232 -1.158 . . . . 0.0 108.95 -179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 145' ' ' PHE . 22.8 tm0? -85.48 142.83 28.92 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.093 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.488 ' O ' ' NE2' ' A' ' 144' ' ' GLN . 54.3 m-85 -128.01 132.47 49.13 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.632 0.73 . . . . 0.0 109.384 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.443 ' OH ' ' ND1' ' A' ' 131' ' ' HIS . 84.8 t80 -94.15 104.11 16.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.402 -0.811 . . . . 0.0 109.627 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.9 mp -99.26 121.41 41.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.198 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 -105.07 177.61 1.35 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.482 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 77.5 Cg_exo -46.64 166.28 0.08 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.834 1.689 . . . . 0.0 111.574 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 112.06 -167.64 12.47 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -120.84 132.36 54.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.662 -0.904 . . . . 0.0 110.933 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 17.2 m-85 -110.68 144.75 39.14 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.642 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 10.6 ptm180 -135.6 0.19 2.7 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.89 -1.131 . . . . 0.0 112.132 -177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.565 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.3 p -169.31 167.84 9.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 119.904 -1.747 . . . . 0.0 109.904 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -59.6 -15.24 17.36 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -85.24 -1.25 56.73 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.642 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 3.7 m-20 -89.79 -62.04 1.56 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.566 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 9.9 p90 -73.32 13.28 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 67.94 35.5 84.58 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.15 -165.66 32.56 Favored Glycine 0 N--CA 1.485 1.961 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 t -151.07 3.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.8 p -150.78 -157.33 0.8 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 25.1 p -141.41 1.21 1.56 Allowed 'General case' 0 C--N 1.296 -1.752 0 O-C-N 121.419 -0.8 . . . . 0.0 109.883 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -64.47 77.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.965 -1.084 . . . . 0.0 111.789 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 57.8 mtt -107.3 115.6 30.46 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.129 -0.982 . . . . 0.0 109.125 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.15 -24.96 4.3 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.482 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.2 OUTLIER -125.08 144.71 50.27 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.158 1.479 . . . . 0.0 111.079 -178.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 11.9 mt -147.48 139.51 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.199 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.664 ' NH2' ' CE2' ' A' ' 57' ' ' PHE . 40.4 ttp180 -127.61 138.59 52.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.343 -0.848 . . . . 0.0 110.437 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.704 ' O ' ' N ' ' A' ' 172' ' ' THR . 8.4 ptm180 -97.11 92.5 6.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.394 -0.816 . . . . 0.0 109.598 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.787 HG22 ' O ' ' A' ' 171' ' ' ILE . 46.5 mt -31.89 75.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.704 ' N ' ' O ' ' A' ' 170' ' ' ARG . 19.4 m -113.44 69.61 0.7 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.864 -1.147 . . . . 0.0 109.786 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 174.06 107.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.251 -0.905 . . . . 0.0 109.65 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.3 mt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.652 179.844 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.269 0.557 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.4 166.9 1.21 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -155.74 143.47 19.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.406 -1.055 . . . . 0.0 110.724 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.557 HD13 ' CD2' ' A' ' 43' ' ' PHE . 20.5 tt -135.61 135.34 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.203 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.4 mt -121.18 122.97 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.691 -0.631 . . . . 0.0 109.338 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -88.84 151.56 22.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.0 108.652 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -138.07 137.85 38.18 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.861 -1.149 . . . . 0.0 109.387 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -73.5 -43.95 58.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.367 -0.833 . . . . 0.0 110.647 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.552 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 60.7 m-20 -81.69 156.77 24.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.838 -1.164 . . . . 0.0 110.535 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -70.71 -37.13 73.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.46 -0.775 . . . . 0.0 109.565 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -80.63 35.26 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.222 -0.924 . . . . 0.0 109.558 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 54.55 55.7 7.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.377 -0.827 . . . . 0.0 109.614 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' H ' ' HB2' ' A' ' 9' ' ' ASP . . . -139.09 -151.84 5.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.552 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 59.85 -147.26 43.97 Favored Glycine 0 N--CA 1.49 2.24 0 O-C-N 121.178 -1.189 . . . . 0.0 110.155 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -77.81 129.77 35.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.396 -1.061 . . . . 0.0 109.084 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -112.47 156.22 22.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.455 -0.778 . . . . 0.0 109.845 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 63.6 m80 -145.21 123.26 12.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 108.821 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -97.71 118.77 35.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.172 -0.955 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 m -112.77 136.67 52.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.4 mtp -130.1 6.56 4.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.2 p -149.74 170.98 17.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.429 -0.794 . . . . 0.0 110.156 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.511 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 55.8 p30 -63.77 151.12 43.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.222 -0.924 . . . . 0.0 110.793 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.3 t -143.47 120.64 11.49 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.87 -6.82 57.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.944 -1.097 . . . . 0.0 109.879 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -140.09 94.28 2.74 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 108.817 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.3 mt -91.06 -19.59 22.99 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.109 -0.994 . . . . 0.0 108.42 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 42.5 t-80 -56.27 -36.53 68.69 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.69 -0.804 . . . . 0.0 108.92 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.1 t -53.57 -56.4 17.4 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -60.53 -49.67 76.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 0.0 111.065 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 32.4 p90 -152.93 151.86 30.82 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.111 -0.993 . . . . 0.0 110.503 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.0 p30 -100.14 -7.26 25.04 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.334 -0.854 . . . . 0.0 110.102 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -152.73 151.46 30.54 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.478 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 43.3 t -157.44 120.41 3.97 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.518 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 18.0 m-70 -102.7 -4.03 25.66 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.462 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 t -137.84 139.33 39.88 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.795 -1.19 . . . . 0.0 111.063 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.7 mt -132.97 142.94 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -134.47 106.13 6.89 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.872 -1.143 . . . . 0.0 111.323 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.75 117.09 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -83.37 -31.97 26.45 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.364 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 t -172.23 154.8 3.42 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.168 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.92 -131.66 10.75 Favored Glycine 0 N--CA 1.486 2.007 0 CA-C-O 122.565 1.091 . . . . 0.0 111.47 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.7 m -154.1 152.66 30.69 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.557 ' CD2' HD13 ' A' ' 4' ' ' ILE . 11.1 t80 -146.77 139.2 24.92 Favored 'General case' 0 C--N 1.296 -1.725 0 C-N-CA 119.001 -1.08 . . . . 0.0 109.556 -179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.9 tpt -109.99 123.53 49.81 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.663 ' HB ' HG11 ' A' ' 76' ' ' VAL . 16.6 m -114.19 145.82 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.916 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.484 ' CD2' ' C ' ' A' ' 51' ' ' PHE . 31.8 m-85 -121.12 141.76 50.5 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.798 0.808 . . . . 0.0 111.224 -177.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 24.5 t0 -76.77 -10.54 59.45 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.913 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.144 ' O ' ' OG ' ' A' ' 78' ' ' SER . 18.3 ttm180 -127.56 167.39 16.41 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 78' ' ' SER . 44.2 p -78.47 159.19 28.38 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.404 -0.81 . . . . 0.0 110.911 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.1 m120 68.61 33.4 3.91 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.649 -0.657 . . . . 0.0 110.958 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.484 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.2 m-85 60.38 57.23 2.92 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.189 -0.944 . . . . 0.0 109.972 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.0 mmt -143.64 173.3 11.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.137 -0.977 . . . . 0.0 110.385 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.98 -162.69 39.18 Favored Glycine 0 N--CA 1.503 3.123 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 71' ' ' GLY . 59.0 mtp180 -60.48 119.75 8.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 108.051 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -102.11 133.82 46.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.407 -0.808 . . . . 0.0 109.06 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.585 ' CD1' ' SD ' ' A' ' 70' ' ' MET . 66.2 m-85 -123.16 133.67 54.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.059 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -98.18 117.49 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.439 -0.788 . . . . 0.0 109.221 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 25.3 mt -118.66 117.55 29.25 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.021 -1.05 . . . . 0.0 110.729 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.502 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.6 ptm180 -92.95 164.62 13.23 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.244 -0.91 . . . . 0.0 110.772 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.502 ' C ' ' O ' ' A' ' 59' ' ' ARG . 34.0 ttp180 -32.12 116.07 0.19 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.638 -0.664 . . . . 0.0 110.727 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.89 167.75 31.67 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 79.0 mt-10 -106.99 130.11 54.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.395 -1.062 . . . . 0.0 108.925 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -114.31 91.42 23.77 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.573 -0.705 . . . . 0.0 109.551 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 25.7 Cg_exo -59.09 -14.43 23.47 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.641 2.227 . . . . 0.0 112.429 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -169.3 146.34 3.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.897 -1.127 . . . . 0.0 108.088 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 16.6 p90 -148.94 -9.76 0.34 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.505 -1.372 . . . . 0.0 111.725 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.518 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 15.4 mtt -63.62 -39.93 95.62 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.326 -1.484 . . . . 0.0 110.099 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -92.14 -24.7 19.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.889 -1.132 . . . . 0.0 109.834 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -86.37 -8.88 57.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 0.0 109.527 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.585 ' SD ' ' CD1' ' A' ' 56' ' ' TYR . 19.7 mmt -111.29 -26.11 9.32 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.219 -0.925 . . . . 0.0 109.535 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' NH1' ' A' ' 54' ' ' ARG . . . 80.97 49.24 5.71 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 73.9 mtp -127.4 154.0 45.55 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.177 -1.19 . . . . 0.0 109.987 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.569 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 18.7 t-20 -107.01 60.32 0.62 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.092 -1.005 . . . . 0.0 109.014 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.569 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 7.6 p30 149.55 -169.17 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 -179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.478 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.2 p -98.89 -165.43 1.24 Allowed 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.359 -0.838 . . . . 0.0 109.803 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.663 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.5 m -85.51 147.73 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -108.55 -10.9 15.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.716 -1.24 . . . . 0.0 108.154 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 1.144 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 2.5 p -148.34 164.48 33.93 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.92 -1.112 . . . . 0.0 109.696 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 27.9 p -161.85 151.23 16.11 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.88 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -136.72 140.35 42.58 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.331 0.586 . . . . 0.0 109.492 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.4 ' HG2' ' N ' ' A' ' 82' ' ' ILE . 51.5 ttm -96.33 157.39 15.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.202 -0.936 . . . . 0.0 108.606 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.561 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 77.5 mt -105.42 102.82 39.56 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.0 109.933 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.42 175.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.322 2.015 . . . . 0.0 112.075 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.2 mt -82.47 51.11 1.77 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.237 -0.914 . . . . 0.0 109.727 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -101.19 87.54 3.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.232 -0.918 . . . . 0.0 109.719 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.655 ' HA ' ' H ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER -142.16 59.44 1.47 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.843 . . . . 0.0 109.105 179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -57.65 -62.13 6.68 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.68 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 96.6 p -138.12 162.51 34.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.534 -0.98 . . . . 0.0 110.136 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -112.01 116.57 30.78 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.428 -0.795 . . . . 0.0 109.818 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -171.39 129.35 0.7 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 38.3 ttm -117.94 126.32 52.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.054 -1.029 . . . . 0.0 109.609 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 34.2 mtp180 -102.19 120.96 41.32 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.527 HD23 ' SG ' ' A' ' 125' ' ' CYS . 13.7 mt -104.17 152.61 21.93 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.31 1.052 . . . . 0.0 112.696 -176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.603 ' CD1' ' O ' ' A' ' 99' ' ' MET . 24.6 m-85 -136.88 122.58 19.83 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -59.43 -22.88 62.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.439 -0.788 . . . . 0.0 111.814 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 124' ' ' SER . 4.9 m-70 -114.4 163.73 14.93 Favored 'General case' 0 N--CA 1.507 2.412 0 O-C-N 120.617 -1.302 . . . . 0.0 111.206 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.9 p -58.78 159.34 6.93 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 97' ' ' SER . 3.8 m-20 77.67 -92.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -178.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.603 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -169.48 39.05 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.66 -160.62 24.89 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.333 -0.937 . . . . 0.0 110.767 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 68.05 -147.88 48.34 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -94.87 133.79 38.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.111 -1.229 . . . . 0.0 109.369 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.2 ptt? -93.9 116.58 29.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.89 -1.132 . . . . 0.0 110.469 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 15.4 mtm -118.02 137.5 52.85 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.256 -0.902 . . . . 0.0 108.633 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -99.36 138.95 35.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 0.0 109.459 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 110' ' ' CYS . 1.0 OUTLIER -128.01 118.94 24.45 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.406 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 ttt -129.28 14.93 6.16 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.426 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.534 ' H ' HD23 ' A' ' 106' ' ' LEU . 5.2 p-10 -139.78 -170.35 2.91 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.192 -0.943 . . . . 0.0 109.968 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -79.42 127.21 31.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 108.916 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.656 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -115.24 85.45 12.77 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.462 -0.774 . . . . 0.0 109.676 -179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.89 -23.64 6.59 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.328 2.019 . . . . 0.0 112.047 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -133.92 87.13 2.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 10.9 mt -75.07 -34.63 61.81 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.211 -0.931 . . . . 0.0 110.343 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.474 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.74 -40.96 76.69 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.388 -0.82 . . . . 0.0 109.305 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -80.66 -23.44 39.67 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.188 -0.945 . . . . 0.0 110.571 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -81.12 -55.23 4.89 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.515 -1.366 . . . . 0.0 111.397 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -106.32 -1.38 23.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.041 -1.037 . . . . 0.0 110.351 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.3 m120 63.29 32.89 14.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.812 -1.18 . . . . 0.0 109.12 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.554 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.5 ptm -154.91 137.66 15.29 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.9 t -121.07 9.7 10.59 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.752 -0.592 . . . . 0.0 109.616 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 163' ' ' SER . 16.3 m-20 -135.78 95.54 3.25 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 120.657 -1.277 . . . . 0.0 113.52 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -105.18 137.4 43.01 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.334 -0.854 . . . . 0.0 108.771 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.523 ' CD2' ' OH ' ' A' ' 155' ' ' TYR . 0.9 OUTLIER -98.38 1.45 46.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.243 -0.911 . . . . 0.0 111.345 -179.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.534 ' O ' ' SG ' ' A' ' 125' ' ' CYS . 5.5 t -146.3 150.12 35.13 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.079 -1.638 . . . . 0.0 109.932 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.534 ' SG ' ' O ' ' A' ' 124' ' ' SER . 11.2 m -157.0 156.7 33.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.299 -0.876 . . . . 0.0 109.792 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.451 ' C ' ' CD2' ' A' ' 126' ' ' HIS . 6.0 t60 -142.3 138.77 31.54 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.004 -1.06 . . . . 0.0 109.067 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.64 126.79 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.05 -1.032 . . . . 0.0 109.56 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.486 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 84.0 mmm -76.58 -26.5 55.11 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.68 ' CB ' ' H ' ' A' ' 88' ' ' SER . 1.4 m-20 165.59 -168.66 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.158 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.655 ' H ' ' HA ' ' A' ' 86' ' ' HIS . . . 69.97 -173.8 37.91 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.561 ' NE2' ' CG2' ' A' ' 82' ' ' ILE . 29.9 m170 -116.4 122.31 44.45 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.505 -0.997 . . . . 0.0 109.241 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.57 121.01 43.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 111.551 -178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.639 HD23 HD11 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -96.8 123.7 40.57 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.0 t -109.87 143.82 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.983 -1.073 . . . . 0.0 110.813 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.567 ' CE1' HD12 ' A' ' 133' ' ' LEU . 85.1 m-85 -121.65 123.62 42.36 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.744 -0.597 . . . . 0.0 110.838 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.501 ' O ' ' O ' ' A' ' 164' ' ' ARG . 30.7 tt0 -58.64 -26.93 64.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.417 ' O ' ' HB3' ' A' ' 167' ' ' SER . 13.9 mt-30 -119.86 155.55 54.98 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.463 ' O ' ' OG1' ' A' ' 141' ' ' THR . 28.5 Cg_endo -63.11 -174.09 0.18 Allowed 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 123.028 2.486 . . . . 0.0 113.356 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 35.0 m120 50.83 31.83 6.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.427 -0.796 . . . . 0.0 110.43 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.506 ' H ' ' CB ' ' A' ' 167' ' ' SER . 40.4 m-85 56.07 51.65 11.61 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.571 -0.706 . . . . 0.0 110.237 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 12.2 p -140.79 166.13 25.6 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.45 -0.781 . . . . 0.0 109.779 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.33 173.41 29.86 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 66.5 mtp85 -50.65 113.74 0.97 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.395 -1.062 . . . . 0.0 108.655 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 13.5 mt-30 -84.0 136.13 34.17 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.453 -0.779 . . . . 0.0 110.062 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -119.87 125.01 47.47 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.47 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 72.9 t80 -88.07 107.41 18.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.293 -0.879 . . . . 0.0 109.514 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.532 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.1 mp -105.72 124.69 49.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.298 -0.876 . . . . 0.0 109.206 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 149' ' ' PRO . 0.5 OUTLIER -115.32 169.64 6.54 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.423 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 148' ' ' ARG . 3.6 Cg_exo -35.27 160.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.59 2.194 . . . . 0.0 112.127 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.99 -168.31 12.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -118.95 129.87 55.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.567 -0.96 . . . . 0.0 110.842 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 125' ' ' CYS . 63.1 m-85 -109.14 140.87 42.14 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.748 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 57.6 mtt85 -131.36 -8.32 3.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 112.694 -176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.566 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 58.5 m -169.48 177.46 4.62 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.026 -1.671 . . . . 0.0 111.152 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.609 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.2 OUTLIER -60.02 -14.17 15.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.718 . . . . 0.0 109.428 179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -91.64 0.97 57.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.264 -0.897 . . . . 0.0 109.12 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.748 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.8 m-20 -90.05 -62.4 1.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 108.711 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -75.88 16.2 0.44 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.14 33.93 88.34 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.36 -161.07 31.41 Favored Glycine 0 N--CA 1.482 1.702 0 N-CA-C 109.719 -1.353 . . . . 0.0 109.719 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 1.3 p -151.94 -39.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 42.4 p -103.77 -160.96 0.8 Allowed 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.1 t -145.18 7.57 1.18 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 136' ' ' GLU . 51.1 ttt-85 -64.39 79.74 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.003 -1.06 . . . . 0.0 111.926 -178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 60.9 mtt -103.16 116.2 32.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.249 -0.907 . . . . 0.0 109.282 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -110.72 -24.41 5.56 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.506 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.6 OUTLIER -134.19 148.83 50.96 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 119.448 1.624 . . . . 0.0 111.252 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.7 mt -147.27 142.92 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.07 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -129.61 141.8 50.87 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.381 -0.825 . . . . 0.0 111.035 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 172' ' ' THR . 18.8 ptt180 -95.44 88.3 5.05 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.72 0.771 . . . . 0.0 108.992 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 171' ' ' ILE . 57.5 mt -54.72 81.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.434 -0.791 . . . . 0.0 111.607 -178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 170' ' ' ARG . 11.8 m -94.29 64.61 3.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.834 -1.166 . . . . 0.0 109.37 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -94.64 -120.86 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 122.307 1.051 . . . . 0.0 109.797 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.7 mt . . . . . 0 C--N 1.283 -2.326 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.794 -179.676 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.1 mmm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . -55.49 159.52 6.8 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 87.1 mttt -161.16 146.77 14.22 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.713 -0.875 . . . . 0.0 110.533 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 36' ' ' ILE . 20.8 tt -134.63 135.87 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.808 . . . . 0.0 109.899 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 49.6 mt -122.19 127.18 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.699 -0.625 . . . . 0.0 109.788 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.617 ' CE2' HD12 ' A' ' 36' ' ' ILE . 84.4 m-85 -88.95 160.05 17.33 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -148.2 136.05 20.92 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 120.82 -1.175 . . . . 0.0 108.731 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -76.69 -39.14 53.02 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.159 -0.963 . . . . 0.0 111.114 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -81.73 163.01 22.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.779 -1.201 . . . . 0.0 110.57 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -75.92 -46.65 28.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.541 ' C ' HD22 ' A' ' 11' ' ' ASN . 0.4 OUTLIER -80.61 44.13 0.7 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.056 -1.028 . . . . 0.0 109.761 -179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 53.44 70.82 0.55 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.865 . . . . 0.0 109.524 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.51 -156.4 7.6 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.05 -147.43 44.31 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -75.01 125.82 29.72 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.176 -1.191 . . . . 0.0 109.247 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -110.9 153.92 24.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.516 -0.74 . . . . 0.0 109.933 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -144.89 125.25 13.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.131 -0.981 . . . . 0.0 109.509 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -97.4 121.65 39.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.951 . . . . 0.0 108.926 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 13.0 m -120.43 141.22 50.35 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.293 -0.879 . . . . 0.0 109.599 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -140.92 12.24 2.24 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 52.0 m -146.01 160.77 41.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.436 -0.79 . . . . 0.0 109.663 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.4 p-10 -58.12 148.34 26.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.322 -0.861 . . . . 0.0 110.517 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.42 116.53 10.5 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.33 -4.47 58.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 108.729 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 31.4 p-10 -136.08 99.84 4.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.624 -0.673 . . . . 0.0 109.656 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.2 mt -103.78 -24.62 13.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.247 -0.908 . . . . 0.0 109.286 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.624 ' CE1' HD21 ' A' ' 31' ' ' ASN . 34.5 t-80 -57.74 -40.39 79.55 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.182 -0.949 . . . . 0.0 108.75 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.2 m -50.28 -50.33 50.69 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -65.45 -52.12 55.36 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -0.994 . . . . 0.0 110.916 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -152.2 150.29 29.68 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.003 -1.06 . . . . 0.0 110.376 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.624 HD21 ' CE1' ' A' ' 27' ' ' HIS . 3.1 m120 -95.81 -5.63 41.35 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.186 -0.946 . . . . 0.0 110.426 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -156.81 155.56 31.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.095 -1.003 . . . . 0.0 108.772 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.547 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 33.0 t -158.04 117.02 3.16 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -97.53 -2.87 40.91 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.724 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.501 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 9.7 t -142.71 149.27 38.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.759 -1.213 . . . . 0.0 111.161 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.693 HD11 HD11 ' A' ' 4' ' ' ILE . 18.5 tt -157.35 148.0 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.08 126.31 18.52 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.937 -1.102 . . . . 0.0 111.832 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.4 t -102.43 120.0 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -83.85 -29.04 27.58 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.192 -0.943 . . . . 0.0 109.084 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 17.2 t -169.78 152.75 4.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.702 -1.199 . . . . 0.0 111.863 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.93 -122.61 6.62 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.583 ' SG ' ' N ' ' A' ' 43' ' ' PHE . 29.8 t -171.47 169.57 6.12 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.583 ' N ' ' SG ' ' A' ' 42' ' ' CYS . 0.4 OUTLIER -154.6 142.24 19.85 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.831 -1.168 . . . . 0.0 108.904 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 76.8 mmm -102.03 118.11 36.23 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.7 ' HB ' HG11 ' A' ' 76' ' ' VAL . 18.2 m -109.2 144.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.914 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.489 ' CZ ' ' CD ' ' A' ' 55' ' ' GLN . 58.8 m-85 -120.43 141.8 49.81 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.754 0.787 . . . . 0.0 111.563 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 29.9 t0 -76.09 -9.76 58.87 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.128 0.49 . . . . 0.0 110.157 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.767 ' O ' ' HB3' ' A' ' 78' ' ' SER . 42.6 ttt180 -127.89 159.74 33.99 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.484 ' N ' ' HB3' ' A' ' 77' ' ' ARG . 12.6 p -71.81 157.83 37.18 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.496 0.665 . . . . 0.0 110.729 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 50' ' ' ASN . 0.6 OUTLIER 71.09 33.54 2.03 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.637 -0.664 . . . . 0.0 111.326 178.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.528 ' CB ' ' NH2' ' A' ' 80' ' ' ARG . 1.9 m-85 59.59 56.33 3.69 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 109.757 178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.1 mtt -143.49 172.05 13.32 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.971 -1.08 . . . . 0.0 110.73 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.48 -165.27 42.46 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -57.48 123.89 17.09 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.114 -1.227 . . . . 0.0 108.304 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.489 ' CD ' ' CZ ' ' A' ' 46' ' ' TYR . 6.7 tt0 -108.33 137.51 46.18 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -129.31 134.84 48.12 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.014 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.609 ' C ' HD12 ' A' ' 58' ' ' LEU . 20.1 p90 -96.04 120.98 37.29 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.0 109.089 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.609 HD12 ' C ' ' A' ' 57' ' ' PHE . 10.0 mp -111.42 113.52 26.01 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.059 -1.026 . . . . 0.0 111.532 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.4 ptt180 -86.13 161.08 19.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.239 -0.913 . . . . 0.0 111.034 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 59' ' ' ARG . 40.5 ttp85 -37.8 118.62 0.68 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.582 0.706 . . . . 0.0 110.365 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.98 178.09 41.29 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -115.79 129.34 56.41 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -117.09 100.21 53.16 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -76.16 -6.01 16.83 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.169 1.913 . . . . 0.0 112.619 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 34.4 p-10 -168.71 136.54 2.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.328 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.496 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 36.6 p90 -148.93 24.0 0.95 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.596 -1.315 . . . . 0.0 111.298 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.1 mmt -89.13 -39.71 13.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.673 -1.267 . . . . 0.0 108.902 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -99.28 -17.09 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.346 -0.846 . . . . 0.0 109.458 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.2 p -87.61 -12.62 45.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.075 -1.016 . . . . 0.0 109.26 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 28.2 mtt -115.74 -27.62 7.0 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 108.895 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.92 48.37 5.81 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.328 -0.858 . . . . 0.0 111.14 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 38.0 ttm -120.92 138.54 54.05 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.932 -1.334 . . . . 0.0 109.819 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 34.0 t30 -90.7 56.65 3.34 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.048 -1.033 . . . . 0.0 109.277 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.563 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 1.1 p30 151.79 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.547 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.2 p -98.61 -166.96 1.43 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.927 0.87 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.7 HG11 ' HB ' ' A' ' 45' ' ' VAL . 6.4 m -81.34 147.3 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.484 ' HB3' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -105.77 -11.51 16.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.767 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -151.47 170.61 19.17 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.787 179.044 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.406 ' N ' ' OG ' ' A' ' 78' ' ' SER . 26.6 p -162.3 146.13 11.91 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.998 0.904 . . . . 0.0 110.4 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.628 ' NH1' ' NH2' ' A' ' 148' ' ' ARG . 41.2 ttm180 -132.83 139.76 47.63 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.3 ttp -94.53 152.42 18.56 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.423 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.469 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 24.3 mt -92.02 120.11 67.98 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.204 -0.935 . . . . 0.0 108.634 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.15 155.36 0.65 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.026 1.817 . . . . 0.0 112.116 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -86.7 50.17 1.95 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 109.319 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.501 ' NE2' ' OD2' ' A' ' 129' ' ' ASP . 85.9 t60 -108.12 123.71 49.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.442 -0.786 . . . . 0.0 109.358 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -137.81 86.05 2.15 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 0.0 109.999 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -101.67 -75.76 1.14 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.452 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 80.8 p -144.98 169.37 18.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -1.054 . . . . 0.0 110.391 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -121.06 125.84 48.33 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.186 -0.947 . . . . 0.0 110.4 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.529 ' CE ' ' SD ' ' A' ' 128' ' ' MET . 33.1 ttpt -168.38 129.07 1.28 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.577 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 39.8 ttm -120.17 135.22 55.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.175 -0.953 . . . . 0.0 109.088 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -105.74 120.24 41.19 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 125' ' ' CYS . 14.8 mt -103.05 149.49 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.156 0.979 . . . . 0.0 112.128 -177.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.459 ' CD1' ' O ' ' A' ' 99' ' ' MET . 42.0 m-85 -133.8 124.71 27.03 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.475 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 87.7 tt0 -63.7 -26.15 68.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.43 -0.794 . . . . 0.0 111.468 -177.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.553 ' O ' ' HB3' ' A' ' 124' ' ' SER . 45.6 m170 -110.38 164.39 12.73 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.602 -1.311 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 51.8 p -61.19 157.84 15.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.471 -0.768 . . . . 0.0 110.046 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.531 ' CB ' ' O ' ' A' ' 97' ' ' SER . 0.8 OUTLIER 81.4 -95.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.514 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 18.2 mmt -162.57 35.5 0.11 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.33 -153.79 24.03 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.081 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 58.56 177.95 0.87 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.423 ' O ' ' CE ' ' A' ' 104' ' ' MET . 28.2 mmt180 -64.25 136.21 56.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.24 . . . . 0.0 109.273 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.2 ptt? -98.11 122.47 41.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.993 -1.067 . . . . 0.0 110.383 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.423 ' CE ' ' O ' ' A' ' 102' ' ' ARG . 3.8 mtm -118.87 138.93 52.4 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.45 138.5 40.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.895 . . . . 0.0 109.616 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 ' CZ3' ' A' ' 132' ' ' TRP . 5.6 tp -127.84 118.61 24.0 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.168 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 21.9 ttt -113.81 -11.09 12.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.457 -0.777 . . . . 0.0 109.728 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.32 -159.65 0.78 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -0.934 . . . . 0.0 109.86 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.83 137.49 32.28 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.506 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -116.06 87.28 18.69 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.338 -0.851 . . . . 0.0 109.578 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.5 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.7 Cg_endo -78.09 -27.06 5.93 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.089 1.859 . . . . 0.0 112.249 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -134.16 84.1 2.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.506 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.5 mt -67.94 -26.27 65.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.918 . . . . 0.0 110.004 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.558 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 12.4 tpt -57.67 -40.02 78.43 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.272 -0.893 . . . . 0.0 109.074 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -82.85 -23.43 33.72 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.747 -1.22 . . . . 0.0 110.282 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -77.36 -62.36 1.68 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.644 -1.285 . . . . 0.0 110.9 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.492 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.0 m-85 -105.73 4.48 30.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 110.239 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.7 t-20 52.57 32.72 12.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.65 -1.281 . . . . 0.0 107.612 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.453 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 5.4 ttp -147.23 132.01 17.96 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.444 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 27.8 t -115.26 4.68 14.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.529 -0.732 . . . . 0.0 110.223 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 120' ' ' SER . 14.7 m-20 -132.63 101.08 5.16 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 118.416 -1.314 . . . . 0.0 114.052 -178.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -111.76 135.48 52.32 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -96.1 2.06 52.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.154 -0.966 . . . . 0.0 111.388 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.553 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.0 t -149.86 156.34 41.61 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 119.928 -1.733 . . . . 0.0 110.694 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.577 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 11.1 t -164.29 163.05 22.71 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.243 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.577 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 13.6 t60 -150.07 146.61 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.169 -0.957 . . . . 0.0 109.816 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.454 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.1 t -115.95 125.02 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.366 -0.834 . . . . 0.0 108.96 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.529 ' SD ' ' CE ' ' A' ' 90' ' ' LYS . 17.9 ttt -81.26 -32.55 33.25 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.561 ' OD1' ' N ' ' A' ' 130' ' ' GLY . 13.6 t70 -174.4 175.0 2.68 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.537 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.561 ' N ' ' OD1' ' A' ' 129' ' ' ASP . . . 77.11 -140.66 25.03 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.469 ' CE1' ' CG2' ' A' ' 82' ' ' ILE . 95.4 m-70 -151.8 135.37 16.18 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.548 -0.971 . . . . 0.0 109.284 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . 0.485 ' CZ3' HD23 ' A' ' 106' ' ' LEU . 87.0 m95 -127.39 133.16 50.03 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.119 -0.988 . . . . 0.0 112.212 -178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 mt -106.02 134.45 49.12 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 55.0 t -111.12 144.19 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.985 -1.072 . . . . 0.0 109.481 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -122.13 124.02 42.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.619 -0.675 . . . . 0.0 111.124 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.508 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.5 tt0 -57.49 -27.41 62.5 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -118.52 155.8 51.81 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.45 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 23.4 Cg_endo -61.47 -179.64 0.38 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 123.271 2.647 . . . . 0.0 113.781 -178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.601 ' N ' ' OG ' ' A' ' 167' ' ' SER . 13.6 m120 49.82 35.14 8.66 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.696 0.76 . . . . 0.0 110.886 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.714 ' H ' ' CB ' ' A' ' 167' ' ' SER . 7.7 m-85 57.33 51.42 10.03 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.758 -0.589 . . . . 0.0 110.378 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 142' ' ' GLY . 64.9 m -136.56 164.25 28.64 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.164 -0.96 . . . . 0.0 109.725 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.492 ' N ' HG22 ' A' ' 141' ' ' THR . . . 95.57 179.42 36.46 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -54.03 108.73 0.39 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -1.108 . . . . 0.0 108.808 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 20.8 pt20 -87.52 143.74 27.06 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.783 0.802 . . . . 0.0 110.46 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -125.2 144.32 50.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -104.57 103.57 13.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.302 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.7 mp -101.2 122.72 44.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.073 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.628 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 5.2 ptp180 -110.83 173.12 3.05 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.403 ' O ' ' O ' ' A' ' 148' ' ' ARG . 68.3 Cg_exo -37.29 157.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.982 1.788 . . . . 0.0 112.113 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 126' ' ' HIS . . . 117.07 -166.16 12.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -123.86 136.91 54.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.335 -1.097 . . . . 0.0 110.631 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 21.2 m-85 -114.31 144.61 42.96 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.55 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 14.0 ptm180 -133.17 -1.66 3.23 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.966 -1.084 . . . . 0.0 112.736 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.557 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 3.7 t -171.07 172.3 5.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.175 -1.578 . . . . 0.0 110.39 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -62.84 -8.19 6.5 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.398 -0.814 . . . . 0.0 109.149 179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -92.74 -1.14 57.07 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.172 -0.955 . . . . 0.0 108.819 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.557 ' OD2' ' N ' ' A' ' 154' ' ' SER . 10.5 m-20 -91.51 -60.08 1.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.222 -0.924 . . . . 0.0 109.612 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.7 p90 -76.45 16.45 0.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.54 40.24 96.0 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -104.56 -165.61 24.46 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 t -146.52 -39.93 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.545 -1.279 . . . . 0.0 107.545 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.1 p -106.5 -161.41 0.79 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 11.3 p -137.56 5.62 2.69 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.474 -0.767 . . . . 0.0 109.72 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.508 ' O ' ' O ' ' A' ' 136' ' ' GLU . 70.5 ttt180 -66.79 75.8 0.11 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.889 -1.132 . . . . 0.0 112.142 -177.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 56.7 mtt -100.5 116.93 33.6 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.949 -1.095 . . . . 0.0 109.62 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.19 -25.77 4.9 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.714 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.5 OUTLIER -134.2 151.51 51.36 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.361 -1.67 . . . . 0.0 111.562 -179.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.7 mt -146.69 140.95 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.692 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -126.9 144.17 51.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.154 -0.966 . . . . 0.0 110.066 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.584 ' O ' ' C ' ' A' ' 171' ' ' ILE . 17.1 ptt180 -99.89 91.37 4.79 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.584 ' C ' ' O ' ' A' ' 170' ' ' ARG . 0.1 OUTLIER -32.78 104.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 179.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.43 ' N ' ' O ' ' A' ' 170' ' ' ARG . 49.6 m -114.74 67.03 0.68 Allowed 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -147.91 91.18 1.91 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.2 tp . . . . . 0 C--N 1.3 -1.586 0 CA-C-O 117.89 -1.053 . . . . 0.0 109.264 179.568 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -48.04 164.95 0.22 Allowed Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -148.26 136.17 20.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.56 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.3 mm -122.46 119.65 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.576 -0.702 . . . . 0.0 109.509 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 52.1 mt -113.41 117.17 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.269 -0.894 . . . . 0.0 109.205 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.76 132.42 36.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.559 -0.713 . . . . 0.0 109.38 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -117.11 130.19 56.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.739 -1.226 . . . . 0.0 109.889 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.11 -38.24 90.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.66 -0.65 . . . . 0.0 109.952 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -80.96 158.43 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.113 -0.992 . . . . 0.0 109.703 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -78.86 -37.75 39.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.955 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -84.44 43.4 0.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.122 -0.986 . . . . 0.0 109.813 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 52.68 75.01 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -169.53 -171.03 34.74 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.25 -148.41 31.19 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -78.39 115.79 18.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -1.12 . . . . 0.0 108.928 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -96.74 156.42 16.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.486 -0.759 . . . . 0.0 109.986 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.621 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.9 t60 -145.14 126.65 15.04 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 109.154 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -96.62 118.92 34.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.129 -0.982 . . . . 0.0 108.952 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.5 m -117.26 133.0 56.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.185 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -138.05 6.18 2.61 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.703 -0.623 . . . . 0.0 109.386 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -138.56 150.66 46.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.206 -0.934 . . . . 0.0 110.693 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 36.2 p-10 -47.27 144.92 2.55 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.46 -0.775 . . . . 0.0 110.034 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 25' ' ' ASP . 42.4 t -144.07 110.85 5.66 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.49 -17.32 49.04 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.037 -1.039 . . . . 0.0 108.6 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.457 ' O ' ' SG ' ' A' ' 23' ' ' CYS . 47.3 t0 -126.73 100.72 6.31 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.488 HD11 ' SG ' ' A' ' 79' ' ' CYS . 14.5 mt -97.94 -14.48 20.61 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' SER . 18.7 t-80 -59.62 -41.32 90.15 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' HIS . 21.0 m -50.9 -57.28 8.91 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.621 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 52.6 m-85 -58.97 -53.52 57.45 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.634 -0.666 . . . . 0.0 111.009 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -152.08 150.25 29.72 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.958 -1.089 . . . . 0.0 110.436 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.3 p-10 -98.82 -2.18 38.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.365 -0.834 . . . . 0.0 110.817 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -161.72 158.36 25.74 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.053 -1.029 . . . . 0.0 108.52 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.573 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 27.9 t -161.35 128.16 3.97 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -103.55 -20.64 13.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 109.723 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.9 t -134.04 146.4 50.32 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.996 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.54 143.33 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -129.42 113.45 14.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.829 -1.169 . . . . 0.0 111.34 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.8 t -99.32 114.21 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -79.53 -34.35 41.18 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.105 -0.997 . . . . 0.0 108.976 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 t -171.52 159.39 5.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.902 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.04 179.37 52.84 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 1.5 p -109.16 158.18 18.05 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.723 -0.869 . . . . 0.0 109.822 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -147.63 137.34 22.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.812 -1.18 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.6 tpt -107.05 127.83 53.82 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.645 ' HB ' HG11 ' A' ' 76' ' ' VAL . 16.7 m -118.53 144.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.945 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.443 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 33.5 m-85 -120.39 143.22 48.55 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.712 0.768 . . . . 0.0 111.334 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 28.4 t0 -77.99 -12.18 59.96 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.741 ' O ' ' HB3' ' A' ' 78' ' ' SER . 23.1 ttm180 -126.54 156.41 40.86 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.8 p -71.4 151.37 44.12 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.542 -0.724 . . . . 0.0 111.078 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 t30 76.1 36.23 0.43 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.814 -0.554 . . . . 0.0 111.22 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.518 ' CD2' ' NH2' ' A' ' 80' ' ' ARG . 7.1 m-85 59.51 56.3 3.75 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 110.325 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 38.0 mtt -144.98 173.75 11.61 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.071 -1.018 . . . . 0.0 110.722 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.27 -165.88 45.43 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -59.32 124.52 20.29 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -106.85 133.82 50.93 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -123.84 137.95 54.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 0.0 109.491 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -101.25 116.64 33.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.371 -0.831 . . . . 0.0 109.798 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 18.0 mt -117.49 117.33 29.16 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.004 -1.06 . . . . 0.0 111.576 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.521 ' O ' ' C ' ' A' ' 60' ' ' ARG . 37.4 ptt180 -99.67 163.98 12.25 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.435 -0.791 . . . . 0.0 111.332 -179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 59' ' ' ARG . 67.5 ttt180 -27.49 111.43 0.05 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.465 0.65 . . . . 0.0 110.741 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.69 170.5 36.51 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -107.74 124.86 50.66 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -105.87 100.46 27.87 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -72.12 -18.81 26.94 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.401 2.067 . . . . 0.0 113.221 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -167.31 140.6 3.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.771 -1.206 . . . . 0.0 108.403 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 26.1 p90 -148.59 29.24 0.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.746 -1.221 . . . . 0.0 110.432 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 9.4 mmt -98.19 -42.99 7.18 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.948 -1.095 . . . . 0.0 109.092 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -100.63 -15.9 17.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 28.2 m -86.65 -16.53 36.32 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.196 -0.94 . . . . 0.0 109.317 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 43.1 mtt -114.57 -28.23 7.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.0 108.621 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.86 52.64 4.03 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 88.9 mtp -120.91 140.54 51.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.449 -1.03 . . . . 0.0 109.493 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.566 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 50.5 t30 -94.29 54.13 1.82 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.914 -1.116 . . . . 0.0 109.334 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.566 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.55 -172.33 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.573 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.5 p -95.22 -167.25 1.59 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.033 -1.042 . . . . 0.0 109.207 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.4 m -80.78 145.6 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -104.42 -14.67 15.64 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.741 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -139.97 165.48 27.22 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.155 179.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.512 ' SG ' ' O ' ' A' ' 78' ' ' SER . 12.4 m -161.0 145.9 13.98 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.623 0.725 . . . . 0.0 110.114 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.689 ' NH1' ' HE ' ' A' ' 148' ' ' ARG . 43.0 ttm180 -134.45 137.24 43.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.661 -0.65 . . . . 0.0 109.33 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 52.3 ttp -92.34 152.96 19.5 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.214 -0.929 . . . . 0.0 109.024 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.1 mt -106.31 126.14 31.21 Favored Pre-proline 0 N--CA 1.493 1.725 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -75.43 154.63 40.63 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.182 1.921 . . . . 0.0 112.12 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.1 mt -77.09 48.33 0.6 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.863 . . . . 0.0 109.136 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -88.1 122.82 32.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.4 -0.812 . . . . 0.0 109.446 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.426 ' CD2' ' C ' ' A' ' 86' ' ' HIS . 16.5 t-160 -134.68 82.2 1.95 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.211 -0.931 . . . . 0.0 110.268 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -94.78 -94.31 1.66 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.5 m -115.8 141.59 47.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.581 -0.952 . . . . 0.0 109.829 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -107.85 110.38 22.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -166.0 130.32 2.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 44.4 ttm -110.9 130.1 55.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.062 -1.024 . . . . 0.0 109.217 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.519 HH21 ' CD2' ' A' ' 126' ' ' HIS . 78.2 mtm180 -104.23 113.85 27.69 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' MET . 15.8 mt -99.37 146.65 26.06 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.036 0.922 . . . . 0.0 111.98 -177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' CB ' ' OG ' ' A' ' 124' ' ' SER . 36.5 m-85 -131.52 125.8 33.31 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.466 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 62.2 tt0 -63.58 -27.09 69.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.261 -0.899 . . . . 0.0 112.198 -176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.826 ' O ' ' OG ' ' A' ' 124' ' ' SER . 2.7 m-70 -109.24 161.06 15.6 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.488 -1.382 . . . . 0.0 111.674 -178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 76.8 p -59.48 160.49 6.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.37 -0.831 . . . . 0.0 109.814 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 28.1 t0 81.23 -91.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.442 ' H ' ' HB3' ' A' ' 98' ' ' ASP . 0.4 OUTLIER -171.01 40.76 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -112.29 -152.44 11.69 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 64.04 -174.76 11.77 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -73.22 139.45 46.25 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.047 -1.266 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 8.3 ptp -97.35 117.47 31.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.09 -1.006 . . . . 0.0 110.36 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.486 ' N ' ' SD ' ' A' ' 104' ' ' MET . 2.8 mpp? -111.81 138.63 48.14 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -106.57 136.9 45.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.386 -0.822 . . . . 0.0 109.997 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 tp -130.37 121.91 26.85 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.424 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 11.2 ttt -121.21 6.28 10.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.494 -0.754 . . . . 0.0 109.368 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 107' ' ' MET . 78.4 m-20 -134.99 -163.33 1.36 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.337 -0.852 . . . . 0.0 109.832 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 168' ' ' ILE . 64.0 t0 -86.25 133.33 33.84 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -115.19 90.21 23.3 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.322 -0.862 . . . . 0.0 109.797 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -78.66 -26.76 5.48 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.066 1.844 . . . . 0.0 111.733 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -135.01 86.7 2.27 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.425 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 11.8 mt -67.91 -27.55 66.73 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.305 -0.872 . . . . 0.0 109.232 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 3.2 mmt -55.48 -38.18 68.8 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.775 0.798 . . . . 0.0 109.041 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -86.69 -22.33 26.13 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.167 -0.958 . . . . 0.0 110.927 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.421 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 62.3 ttm-85 -80.51 -60.22 2.4 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.469 -1.394 . . . . 0.0 111.426 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -108.53 -0.2 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 110.085 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 114' ' ' MET . 10.1 t-20 55.83 34.39 23.38 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 0.0 108.384 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.8 ptm -152.22 136.8 16.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 55.2 m -123.75 9.46 8.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.627 -0.671 . . . . 0.0 109.977 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 163' ' ' SER . 23.2 m-20 -131.11 97.73 4.37 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 118.469 -1.292 . . . . 0.0 113.26 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.669 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -112.23 137.11 50.8 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.543 ' ND1' ' N ' ' A' ' 123' ' ' HIS . 1.3 m80 -96.17 6.69 48.25 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.142 -0.974 . . . . 0.0 111.147 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.826 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 3.7 p -154.55 158.59 40.03 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 119.915 -1.741 . . . . 0.0 110.348 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.1 t -168.62 168.04 11.09 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.27 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.564 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 17.5 t60 -152.67 148.38 27.23 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.323 -0.861 . . . . 0.0 109.337 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.451 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 52.9 t -114.93 124.25 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.184 -0.947 . . . . 0.0 109.73 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.463 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 77.9 mmm -74.82 -25.27 58.9 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.508 0.67 . . . . 0.0 109.394 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.463 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.8 OUTLIER 167.67 179.83 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.088 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.494 ' O ' ' CD2' ' A' ' 131' ' ' HIS . . . 74.94 -137.66 22.53 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.494 ' CD2' ' O ' ' A' ' 130' ' ' GLY . 41.2 m80 -153.98 130.51 10.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.623 -0.927 . . . . 0.0 109.185 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -119.5 130.36 55.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.233 -0.917 . . . . 0.0 111.962 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.468 HD23 HD11 ' A' ' 171' ' ' ILE . 0.2 OUTLIER -103.87 128.21 51.36 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 48.7 t -111.01 144.57 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 120.718 -1.239 . . . . 0.0 111.224 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -121.74 126.12 48.17 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.833 -0.542 . . . . 0.0 111.249 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -61.1 -27.54 68.44 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.853 ' O ' ' OG ' ' A' ' 167' ' ' SER . 7.1 mt-30 -120.25 152.87 55.35 Favored Pre-proline 0 N--CA 1.498 1.941 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 19.0 Cg_endo -59.96 -175.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 123.283 2.655 . . . . 0.0 113.523 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 m120 49.99 31.82 5.13 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.538 0.685 . . . . 0.0 109.93 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.469 ' H ' ' CB ' ' A' ' 167' ' ' SER . 13.9 m-85 56.08 52.68 10.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.103 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 142' ' ' GLY . 86.9 m -139.57 164.59 29.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.334 -0.854 . . . . 0.0 109.539 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.71 177.68 32.36 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -54.08 109.56 0.49 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -1.15 . . . . 0.0 108.752 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.1 OUTLIER -86.99 147.02 25.91 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.049 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -126.81 140.46 52.35 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.421 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 78.3 t80 -101.19 104.73 15.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.438 -0.789 . . . . 0.0 109.708 -179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.8 mp -99.76 120.5 39.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.431 -0.793 . . . . 0.0 109.31 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.689 ' HE ' ' NH1' ' A' ' 80' ' ' ARG . 4.1 ptt85 -109.48 163.6 16.68 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.519 ' O ' ' O ' ' A' ' 148' ' ' ARG . 80.9 Cg_exo -31.78 158.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.801 2.334 . . . . 0.0 112.534 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.4 ' O ' ' ND1' ' A' ' 126' ' ' HIS . . . 114.72 -166.45 12.16 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -120.62 132.54 55.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.396 -1.061 . . . . 0.0 110.485 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.504 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 84.9 m-85 -105.76 143.1 34.38 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.661 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 63.2 mtm-85 -125.91 -10.86 6.61 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.151 -0.968 . . . . 0.0 112.95 -177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.563 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.7 t -173.65 -179.17 1.76 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 119.891 -1.756 . . . . 0.0 111.172 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -62.21 -15.26 45.5 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -88.1 0.05 56.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 108.565 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.661 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -58.53 2.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.412 -0.805 . . . . 0.0 109.716 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.571 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.6 p90 -77.51 13.3 1.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.662 -1.215 . . . . 0.0 107.723 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 69.12 39.37 83.65 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -110.09 -161.68 18.64 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 35.6 t -143.06 -39.02 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 31.3 p -109.03 -152.28 0.49 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.8 p -146.35 9.29 1.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.522 -0.736 . . . . 0.0 109.852 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -65.98 81.99 0.08 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.002 -1.061 . . . . 0.0 111.989 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 59.8 mtt -105.73 118.18 35.92 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.936 -1.102 . . . . 0.0 109.708 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -108.33 -24.45 6.2 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.853 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -136.7 152.01 49.9 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.52 -1.576 . . . . 0.0 111.276 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 109' ' ' ASP . 16.3 mt -147.62 142.59 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.94 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -128.95 144.6 51.23 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.46 -0.775 . . . . 0.0 110.662 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.695 ' O ' ' N ' ' A' ' 172' ' ' THR . 19.3 ptt180 -94.6 76.16 3.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.457 -0.777 . . . . 0.0 109.751 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.503 ' C ' ' O ' ' A' ' 170' ' ' ARG . 36.5 mt -19.5 72.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 170' ' ' ARG . 3.8 t -111.56 71.59 0.75 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.963 -1.086 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 33.0 p-10 -177.19 102.35 0.05 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.179 -0.951 . . . . 0.0 110.185 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.379 179.916 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.553 0.692 . . . . 0.0 109.181 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 3' ' ' LYS . . . -178.18 158.85 23.96 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 15.8 ptpt 176.82 157.37 0.3 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.253 -1.145 . . . . 0.0 110.466 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 43' ' ' PHE . 18.0 tt -136.59 135.06 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.529 0.681 . . . . 0.0 110.249 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.7 mt -117.48 124.36 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.644 -0.66 . . . . 0.0 109.412 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -87.23 161.27 18.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.332 -0.855 . . . . 0.0 108.721 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.401 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 29.1 m-85 -147.26 136.46 22.49 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.775 -1.203 . . . . 0.0 108.847 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -76.53 -39.66 52.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 110.76 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -81.25 138.73 35.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.874 -1.141 . . . . 0.0 110.22 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -59.66 -39.75 85.48 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.483 -0.76 . . . . 0.0 110.007 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -84.53 41.06 0.82 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 109.564 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 54.29 85.65 0.06 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.525 -0.734 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.51 -159.1 21.46 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -146.49 49.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.65 124.54 27.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.156 -1.202 . . . . 0.0 109.318 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -109.38 157.08 19.26 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.408 -0.807 . . . . 0.0 109.804 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.622 ' CE1' ' CE1' ' A' ' 29' ' ' TYR . 5.3 t60 -147.58 125.58 12.06 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.0 109.777 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -95.12 119.64 33.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.425 ' SG ' ' CD2' ' A' ' 17' ' ' HIS . 6.6 m -119.34 140.95 49.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.319 -0.863 . . . . 0.0 109.157 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 16.4 ttt -147.99 11.6 0.95 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.8 t -143.45 155.36 44.35 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.363 -0.835 . . . . 0.0 110.321 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -50.44 144.03 8.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.587 -0.696 . . . . 0.0 110.229 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.7 t -144.55 116.87 8.48 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 4.67 51.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.085 -1.009 . . . . 0.0 108.876 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 29.2 p30 -146.28 92.23 2.15 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.569 -0.707 . . . . 0.0 109.582 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 26' ' ' LEU . 74.3 mt -91.18 -19.99 22.46 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.529 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 11.7 t-80 -56.95 -33.2 66.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 108.825 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.3 t -57.84 -42.93 85.41 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 17' ' ' HIS . 80.3 m-85 -74.96 -44.17 49.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.864 -1.147 . . . . 0.0 110.308 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -159.35 152.13 21.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.066 -1.021 . . . . 0.0 109.813 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.529 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 70.8 m-20 -98.11 -6.11 32.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.347 -0.846 . . . . 0.0 110.071 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -155.12 153.83 31.44 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.55 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 39.4 t -157.55 127.86 6.33 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -107.24 -4.48 18.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.709 -0.619 . . . . 0.0 109.627 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.42 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 2.0 p -138.66 139.61 38.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.013 -1.054 . . . . 0.0 110.899 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.9 mt -135.75 145.67 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -138.09 114.51 10.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.798 -1.189 . . . . 0.0 111.497 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.8 t -99.13 119.46 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 177.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -84.72 -31.06 24.25 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.034 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -172.27 156.62 3.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 118.562 -1.255 . . . . 0.0 111.586 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.75 -159.67 46.22 Favored Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.514 -2.234 . . . . 0.0 107.514 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 85.0 m -125.3 164.03 21.25 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -1.206 . . . . 0.0 109.251 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD2' HD13 ' A' ' 4' ' ' ILE . 11.4 t80 -144.59 133.33 22.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.998 -1.064 . . . . 0.0 108.761 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.2 tpt -103.16 118.69 37.37 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.2 m -109.73 142.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.971 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.615 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.0 m-85 -117.94 136.64 53.35 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.681 0.753 . . . . 0.0 110.753 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -73.25 -9.32 58.58 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.898 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.127 ' O ' ' OG ' ' A' ' 78' ' ' SER . 53.6 ttt180 -130.17 156.36 44.71 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 77' ' ' ARG . 25.4 p -68.23 162.99 23.78 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.678 0.751 . . . . 0.0 110.964 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 t30 66.91 33.13 6.09 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.918 -0.488 . . . . 0.0 111.204 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.492 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.9 m-85 58.63 58.58 3.25 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.215 -0.928 . . . . 0.0 109.765 178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.417 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 55.7 mtt -146.78 175.85 10.32 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.197 -0.94 . . . . 0.0 110.288 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 55' ' ' GLN . . . 83.03 -166.33 44.43 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' NH2' ' OH ' ' A' ' 56' ' ' TYR . 77.5 mtp180 -58.26 123.63 16.71 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.221 -1.164 . . . . 0.0 108.024 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.469 ' NE2' ' O ' ' A' ' 53' ' ' GLY . 5.8 mp0 -105.41 136.12 45.53 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.417 ' OH ' ' NH2' ' A' ' 54' ' ' ARG . 83.0 m-85 -128.96 129.72 45.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.534 -0.729 . . . . 0.0 109.749 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.644 ' C ' HD12 ' A' ' 58' ' ' LEU . 23.1 p90 -92.77 121.73 34.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.131 -0.98 . . . . 0.0 109.039 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.644 HD12 ' C ' ' A' ' 57' ' ' PHE . 9.3 mp -113.91 116.85 29.93 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.967 -1.083 . . . . 0.0 111.769 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.49 ' O ' ' C ' ' A' ' 60' ' ' ARG . 36.9 ttp85 -90.83 158.48 16.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.957 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' C ' ' O ' ' A' ' 59' ' ' ARG . 37.3 ttp180 -30.58 116.09 0.14 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.31 0.576 . . . . 0.0 110.744 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.38 168.77 32.66 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -107.32 129.87 54.85 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.462 -1.022 . . . . 0.0 108.786 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -110.19 100.36 43.7 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.44 -14.16 33.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -170.67 141.47 1.86 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.8 p90 -146.71 40.27 1.08 Allowed 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.653 -1.279 . . . . 0.0 109.805 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 12.9 mmt -103.21 -48.47 4.01 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.222 -0.924 . . . . 0.0 109.32 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -100.69 -13.01 18.69 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.3 m -89.98 -15.8 31.18 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.458 -0.776 . . . . 0.0 109.763 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 20.4 mtt -117.22 -29.36 5.92 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.41 52.38 3.59 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.445 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 67.8 mtp -122.88 141.07 52.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.982 -1.305 . . . . 0.0 110.221 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.567 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.2 m120 -95.85 55.86 1.66 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.129 -0.982 . . . . 0.0 109.253 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.567 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.0 p30 150.56 -169.92 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.55 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.7 p -99.44 -168.61 1.64 Allowed 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.132 0.967 . . . . 0.0 109.712 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 46' ' ' TYR . 27.2 t -77.0 141.46 15.59 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB3' HG22 ' A' ' 49' ' ' THR . 66.2 mtt180 -106.28 -17.17 14.38 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 1.127 ' OG ' ' O ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -145.24 166.68 24.78 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.295 -0.878 . . . . 0.0 109.48 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 20.9 p -162.44 149.7 13.68 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.921 0.867 . . . . 0.0 110.744 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -129.73 138.9 51.36 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 ttp -94.6 148.96 21.73 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.033 -1.042 . . . . 0.0 109.086 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.42 ' CG2' ' CE1' ' A' ' 131' ' ' HIS . 71.3 mt -104.38 133.78 20.03 Favored Pre-proline 0 N--CA 1.492 1.65 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.09 147.53 67.39 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.892 1.728 . . . . 0.0 112.059 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 84' ' ' LEU . 3.5 mm? -83.49 46.25 1.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.287 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -112.46 130.87 55.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.552 -0.717 . . . . 0.0 109.448 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -136.16 93.6 2.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.806 . . . . 0.0 109.371 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -85.83 -86.3 1.01 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.447 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.2 m -124.51 151.78 44.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.534 -0.98 . . . . 0.0 110.451 -179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -114.86 119.78 37.73 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.374 -0.829 . . . . 0.0 110.052 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -170.14 128.59 0.88 Allowed 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.4 ttm -113.08 126.5 55.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.054 -1.029 . . . . 0.0 109.288 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -100.73 117.74 35.43 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.482 HD23 ' CB ' ' A' ' 125' ' ' CYS . 19.7 mt -101.38 150.29 23.17 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.389 1.09 . . . . 0.0 112.568 -177.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -131.2 122.23 26.2 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 76.4 tt0 -62.49 -27.94 69.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 111.374 -178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.543 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.9 m-70 -109.88 164.19 12.82 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.767 -1.208 . . . . 0.0 111.542 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 44.2 m -61.77 159.5 13.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.675 -0.641 . . . . 0.0 109.54 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.548 ' O ' ' CG ' ' A' ' 99' ' ' MET . 5.4 m-20 80.28 -98.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -178.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' ASP . 23.2 mtt -163.82 45.49 0.11 Allowed 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.04 -151.25 10.01 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.454 ' HA3' ' HB3' ' A' ' 95' ' ' GLU . . . 61.67 -171.73 8.75 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.425 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 89.0 mtt-85 -73.09 131.82 42.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.933 -1.334 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.411 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 25.1 mtm -91.62 120.92 32.82 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.0 109.694 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 12.1 mtm -119.41 140.06 51.02 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.145 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -105.85 136.93 44.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.387 -0.821 . . . . 0.0 109.926 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tp -130.38 120.86 24.94 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 10.0 ttt -120.69 15.67 11.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.525 -0.734 . . . . 0.0 109.374 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -144.1 -163.21 1.62 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.301 -0.875 . . . . 0.0 110.027 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.418 ' CG ' ' OH ' ' A' ' 140' ' ' TYR . 47.5 t0 -85.1 133.02 34.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.427 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -119.64 84.57 30.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.401 -0.812 . . . . 0.0 109.959 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.89 -29.87 6.48 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.282 1.988 . . . . 0.0 112.131 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.516 ' OD1' ' O ' ' A' ' 112' ' ' ASN . 35.1 p30 -127.5 81.39 2.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.427 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.8 mt -66.72 -24.06 66.19 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 2.6 ttm -60.77 -38.57 85.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.548 0.69 . . . . 0.0 109.57 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -84.13 -20.81 31.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.657 -1.277 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.409 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 63.0 ttm-85 -82.22 -58.86 2.76 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 120.622 -1.299 . . . . 0.0 111.212 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -107.69 0.82 22.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.134 -0.979 . . . . 0.0 109.807 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 114' ' ' MET . 15.8 t30 60.12 34.17 21.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.009 -1.057 . . . . 0.0 109.361 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.562 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 4.1 ptm -152.33 137.91 17.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 t -118.43 8.55 12.15 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.869 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.46 ' OD1' ' C ' ' A' ' 121' ' ' ASP . 6.5 t0 -134.99 93.77 3.05 Favored 'General case' 0 N--CA 1.501 2.088 0 C-N-CA 118.293 -1.363 . . . . 0.0 113.376 -178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -103.13 136.76 42.32 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.418 -0.801 . . . . 0.0 109.106 177.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -97.09 3.21 51.86 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 111.725 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.6 t -160.25 163.18 33.67 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 119.656 -1.902 . . . . 0.0 110.763 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.482 ' CB ' HD23 ' A' ' 93' ' ' LEU . 2.2 p -174.55 178.18 2.0 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.527 -0.733 . . . . 0.0 110.18 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 8.4 t60 -154.12 147.68 25.15 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.204 -0.935 . . . . 0.0 109.347 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.484 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 54.6 t -112.83 121.88 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.111 -0.993 . . . . 0.0 109.497 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.446 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 12.0 tpt -69.32 -33.98 73.97 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.447 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.1 m-20 173.32 166.38 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.433 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 131' ' ' HIS . . . 88.96 -146.32 19.09 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.532 ' CD2' ' OH ' ' A' ' 146' ' ' TYR . 26.9 m80 -141.48 129.05 21.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.66 -0.906 . . . . 0.0 110.061 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -122.08 131.05 53.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.538 -0.726 . . . . 0.0 111.931 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.2 mt -101.82 130.84 48.35 Favored 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 44.5 t -110.47 142.38 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.913 -1.117 . . . . 0.0 109.81 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.73 125.23 49.18 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.696 -0.627 . . . . 0.0 111.312 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.1 -24.63 63.11 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 167' ' ' SER . 4.3 mt-30 -126.86 154.47 76.12 Favored Pre-proline 0 N--CA 1.5 2.066 0 O-C-N 121.29 -0.881 . . . . 0.0 109.001 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.14 -173.36 0.05 OUTLIER 'Trans proline' 0 N--CA 1.505 2.157 0 C-N-CA 123.161 2.574 . . . . 0.0 113.87 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 139' ' ' ASN . 18.6 t-20 45.89 29.73 0.77 Allowed 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 121.468 0.651 . . . . 0.0 110.702 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.467 ' H ' ' CB ' ' A' ' 167' ' ' SER . 34.2 m-85 59.21 48.81 9.89 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.51 -0.744 . . . . 0.0 110.093 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 142' ' ' GLY . 61.7 m -131.64 162.24 30.84 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 108.917 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.404 ' N ' HG22 ' A' ' 141' ' ' THR . . . 96.61 174.52 35.35 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.974 -1.108 . . . . 0.0 110.558 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -54.15 110.58 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.88 -0.776 . . . . 0.0 109.387 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 144' ' ' GLN . 0.3 OUTLIER -86.56 145.74 26.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.582 -179.274 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -127.67 132.07 49.73 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.494 0.664 . . . . 0.0 109.283 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.532 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 70.6 t80 -92.44 107.34 19.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.437 -0.789 . . . . 0.0 109.052 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.0 mp -102.05 122.06 43.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.646 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.0 OUTLIER -104.1 178.16 1.24 Allowed Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -48.26 161.15 0.43 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.964 1.776 . . . . 0.0 111.672 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.16 -167.55 12.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -117.38 133.43 55.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.528 -0.984 . . . . 0.0 110.455 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.646 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 96.4 m-85 -106.17 136.51 45.74 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.612 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 85.4 mtm-85 -123.86 -14.33 7.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.201 -0.937 . . . . 0.0 112.52 -177.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.578 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 38.9 t -171.32 -177.98 2.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.027 -1.671 . . . . 0.0 110.99 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.577 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -63.98 -12.84 41.6 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.778 -0.576 . . . . 0.0 109.555 179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -90.03 -1.2 57.92 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.971 -1.081 . . . . 0.0 108.55 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.612 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.1 m-20 -91.05 -60.53 1.88 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.406 -0.809 . . . . 0.0 109.266 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.526 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 5.2 p90 -76.51 16.84 0.44 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.502 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.03 38.71 95.75 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -103.78 -161.45 24.87 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.1 t -148.53 -40.91 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.3 p -103.41 -161.66 0.85 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.7 p -143.83 7.6 1.45 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.476 -0.765 . . . . 0.0 110.433 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -69.07 82.92 0.33 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.847 -1.158 . . . . 0.0 111.97 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 48.4 mtt -105.35 121.29 43.58 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.714 -1.241 . . . . 0.0 110.126 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.4 -25.82 3.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.467 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -130.04 152.03 49.94 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.653 -1.498 . . . . 0.0 111.388 -179.125 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 15.5 mt -148.92 139.54 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.749 -0.595 . . . . 0.0 109.835 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -121.2 133.06 55.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.173 -0.954 . . . . 0.0 110.049 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 172' ' ' THR . 43.6 ttp180 -92.59 90.69 7.23 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.53 -0.731 . . . . 0.0 109.327 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 170' ' ' ARG . 95.6 mt -42.05 99.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 170' ' ' ARG . 12.0 m -146.69 64.81 1.18 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 172' ' ' THR . 1.5 m-20 176.13 106.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.598 0.714 . . . . 0.0 109.196 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 59.8 tp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.955 -1.022 . . . . 0.0 109.39 179.886 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.3 mmm . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 3' ' ' LYS . . . 73.22 155.44 3.22 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.569 ' CG ' ' O ' ' A' ' 2' ' ' GLY . 62.0 mttm -163.95 146.03 9.17 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.525 -0.985 . . . . 0.0 109.553 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.479 HD11 ' HB2' ' A' ' 43' ' ' PHE . 9.5 mm -124.31 120.08 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.526 -0.734 . . . . 0.0 109.086 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.5 mt -116.05 122.27 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.018 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -94.68 131.84 40.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.453 -0.779 . . . . 0.0 109.174 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -119.37 135.17 54.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.329 -0.857 . . . . 0.0 109.445 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.568 ' N ' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -77.07 -22.97 52.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.535 -0.728 . . . . 0.0 111.218 -179.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.649 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 9.2 t70 -83.21 150.48 26.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.702 -1.249 . . . . 0.0 110.295 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 45.9 mtt-85 -60.02 -44.49 94.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 110.0 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 31.7 m120 -74.52 -94.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.985 . . . . 0.0 109.29 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.425 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 35.0 m-85 -157.26 58.95 0.51 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.185 -0.947 . . . . 0.0 108.882 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.649 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -151.64 -150.74 5.42 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.46 -153.78 52.72 Favored Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -70.6 119.57 14.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -1.131 . . . . 0.0 109.058 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -105.34 156.64 17.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.41 -0.806 . . . . 0.0 110.311 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.537 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 25.0 t60 -147.87 124.94 11.38 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.541 -0.724 . . . . 0.0 109.216 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -98.36 118.33 34.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.098 -1.001 . . . . 0.0 109.54 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.3 m -114.45 136.5 52.93 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.304 -0.873 . . . . 0.0 109.053 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.7 ptm -134.71 9.73 3.64 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.0 p -147.1 163.06 37.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.451 -0.781 . . . . 0.0 110.555 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 41.9 p-10 -56.89 149.18 19.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.399 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.8 t -142.58 115.24 8.6 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.12 -7.5 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.628 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 36.3 p30 -137.84 97.1 3.35 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.58 -19.69 18.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 108.44 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.542 ' CE1' ' OD1' ' A' ' 31' ' ' ASN . 19.2 t-80 -58.5 -39.52 80.28 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.288 -0.882 . . . . 0.0 109.266 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 m -51.03 -57.12 9.44 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.537 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 89.3 m-85 -58.58 -47.71 83.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.758 -0.589 . . . . 0.0 111.257 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -156.85 150.57 24.6 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.886 -1.134 . . . . 0.0 110.335 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.542 ' OD1' ' CE1' ' A' ' 27' ' ' HIS . 68.8 m-20 -97.21 -5.97 35.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.958 -1.089 . . . . 0.0 110.421 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -158.89 156.24 29.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 21.2 t -158.79 126.52 5.04 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -103.28 -0.78 29.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 10' ' ' ARG . 3.7 m -146.04 144.23 29.93 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.513 -1.367 . . . . 0.0 111.152 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.3 mt -138.44 143.09 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.88 107.31 8.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 0.0 111.051 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.9 114.88 29.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -77.71 -32.81 53.17 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.762 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -178.5 161.04 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.633 -1.227 . . . . 0.0 111.457 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.59 -153.12 21.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.2 m -133.97 153.59 51.68 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.479 ' HB2' HD11 ' A' ' 4' ' ' ILE . 12.5 t80 -148.03 141.13 24.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.571 -1.33 . . . . 0.0 109.415 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -108.74 122.16 46.56 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' TYR . 17.9 m -112.53 144.55 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.404 -0.81 . . . . 0.0 110.093 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.565 ' O ' HG13 ' A' ' 76' ' ' VAL . 36.1 m-85 -120.52 138.44 53.84 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 122.016 0.912 . . . . 0.0 111.375 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.62 -8.21 55.04 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.68 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.818 ' O ' ' HB3' ' A' ' 78' ' ' SER . 38.3 ttt180 -130.9 156.5 44.96 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.139 -0.976 . . . . 0.0 108.847 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -66.06 156.86 32.6 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.671 0.748 . . . . 0.0 111.402 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.95 33.74 3.4 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.618 -0.676 . . . . 0.0 111.586 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.495 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.5 m-85 59.84 58.65 2.72 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.573 177.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.409 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.7 mtt -145.96 171.16 15.25 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.988 -1.07 . . . . 0.0 110.142 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.58 -165.43 36.93 Favored Glycine 0 N--CA 1.498 2.776 0 O-C-N 120.657 -1.277 . . . . 0.0 110.566 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -59.47 121.22 10.97 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -102.67 134.64 45.7 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.443 ' O ' HG22 ' A' ' 45' ' ' VAL . 80.9 m-85 -126.54 131.48 51.56 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.432 -0.793 . . . . 0.0 109.686 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -94.76 117.77 30.67 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.506 -0.746 . . . . 0.0 109.736 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.0 mt -120.56 122.82 41.42 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.143 -0.973 . . . . 0.0 111.112 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.526 ' NH1' ' OG1' ' A' ' 172' ' ' THR . 33.4 ptt180 -103.68 168.1 9.36 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.574 0.702 . . . . 0.0 111.058 -178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.494 ' C ' ' O ' ' A' ' 59' ' ' ARG . 51.6 ttp180 -28.62 110.95 0.05 Allowed 'General case' 0 N--CA 1.502 2.173 0 CA-C-O 121.308 0.575 . . . . 0.0 110.911 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.45 165.39 31.47 Favored Glycine 0 N--CA 1.485 1.937 0 C-N-CA 119.533 -1.318 . . . . 0.0 109.957 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -104.41 126.56 51.61 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.408 -1.054 . . . . 0.0 108.422 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.36 96.98 24.18 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 10' ' ' ARG . 44.8 Cg_endo -70.05 -14.22 34.89 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.196 1.931 . . . . 0.0 112.204 -178.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -170.72 143.46 2.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.027 -1.046 . . . . 0.0 108.331 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 35.4 p90 -149.28 41.72 0.9 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.627 -1.296 . . . . 0.0 109.667 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 10.5 mmt -107.13 -46.43 3.9 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.335 -0.853 . . . . 0.0 109.407 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.4 mtm180 -100.23 -15.09 18.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 54.8 m -89.46 -14.46 35.3 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 8.6 mmt -115.37 -30.24 6.31 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.55 50.13 5.15 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.8 mtp -121.88 144.04 49.08 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.816 -1.402 . . . . 0.0 109.401 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 81.9 m-20 -96.16 53.65 1.37 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.222 -0.923 . . . . 0.0 109.014 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.4 p30 152.86 -171.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.513 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.4 p -98.76 -168.1 1.59 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.781 0.8 . . . . 0.0 109.938 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 46' ' ' TYR . 22.5 t -74.6 140.64 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 45.2 mmm-85 -106.52 -16.71 14.46 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.755 -1.215 . . . . 0.0 107.898 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.818 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -147.68 164.3 33.98 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 109.485 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.416 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 26.3 p -161.03 150.64 17.06 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.242 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -136.43 136.86 39.87 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.9 ptm -90.62 158.18 17.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.5 mt -109.44 135.15 20.33 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.615 -0.678 . . . . 0.0 110.233 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.09 154.16 66.72 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.286 1.99 . . . . 0.0 112.286 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.3 mt -73.42 51.44 0.34 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -86.2 113.92 22.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.497 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -139.97 60.15 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 0.0 109.475 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.72 -81.01 1.01 Allowed Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m -134.97 158.04 45.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.507 -0.996 . . . . 0.0 109.969 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -110.11 114.41 27.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.394 -0.816 . . . . 0.0 109.83 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -161.2 123.41 3.05 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.635 ' SD ' HG22 ' A' ' 127' ' ' VAL . 7.5 tpp -107.99 125.35 51.43 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.022 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -99.53 111.72 24.03 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 103' ' ' MET . 20.7 mt -99.79 148.91 23.9 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.881 0.848 . . . . 0.0 112.474 -177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 99' ' ' MET . 26.1 m-85 -136.72 127.09 26.58 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -65.06 -23.55 67.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.402 -0.811 . . . . 0.0 112.386 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.5 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.9 m-70 -113.67 162.28 16.44 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.56 -1.338 . . . . 0.0 111.178 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 77.5 p -58.13 160.3 5.08 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.527 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.514 ' CB ' ' O ' ' A' ' 97' ' ' SER . 4.4 m-20 79.51 -90.8 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.547 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 1.8 mtm -175.37 38.66 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.51 -163.11 23.47 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.416 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 72.23 -146.61 39.64 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -99.39 139.34 35.18 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -1.198 . . . . 0.0 109.197 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 3.6 ptt? -96.96 116.81 29.85 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.131 -0.981 . . . . 0.0 110.374 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.42 ' CE ' ' SD ' ' A' ' 119' ' ' MET . 0.9 OUTLIER -104.98 137.18 43.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.126 179.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -99.1 122.32 42.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 0.0 108.666 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.661 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.9 tt -133.8 118.83 18.47 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 19.5 ptm -129.72 21.4 5.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.005 . . . . 0.0 109.257 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.661 ' H ' HD23 ' A' ' 106' ' ' LEU . 22.9 p-10 -133.97 -166.86 1.86 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 37.4 p-10 -86.45 132.81 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 0.0 109.256 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.508 ' SG ' HD21 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -117.82 89.02 32.44 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.176 -0.952 . . . . 0.0 109.66 -179.287 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -81.03 -20.95 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.084 1.856 . . . . 0.0 111.739 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -139.97 85.14 2.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 14.4 mt -71.27 -26.78 63.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.924 . . . . 0.0 110.057 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -56.16 -39.83 72.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.422 -0.799 . . . . 0.0 109.102 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -85.05 -21.76 29.26 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 110.292 -179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 57.9 ttt85 -80.32 -59.32 2.75 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.77 -1.207 . . . . 0.0 111.085 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -109.06 0.02 19.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.596 -0.69 . . . . 0.0 110.309 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 114' ' ' MET . 12.5 m120 56.49 32.52 20.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.476 1.131 . . . . 0.0 108.587 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.42 ' SD ' ' CE ' ' A' ' 104' ' ' MET . 9.7 ptm -153.29 137.73 16.73 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.416 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 47.2 m -124.86 11.25 8.36 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.466 -178.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 120' ' ' SER . 52.2 m-20 -130.03 94.88 3.8 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 120.631 -1.293 . . . . 0.0 113.191 -178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.68 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.88 136.29 49.41 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -99.23 3.03 46.19 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.145 -0.972 . . . . 0.0 111.281 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.9 t -148.94 154.76 39.87 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.063 -1.648 . . . . 0.0 110.719 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 40.8 t -165.31 163.14 20.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.304 -0.872 . . . . 0.0 110.312 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.514 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 5.0 t60 -147.66 145.08 28.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.416 -0.803 . . . . 0.0 108.893 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.635 HG22 ' SD ' ' A' ' 91' ' ' MET . 67.8 t -113.14 123.2 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.894 -1.129 . . . . 0.0 109.808 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.448 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 21.1 ttm -77.24 -23.34 51.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.749 -0.594 . . . . 0.0 109.854 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.448 ' CG ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 170.73 178.47 0.06 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.595 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 73.53 -134.22 18.91 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 130' ' ' GLY . 94.7 m-70 -162.07 139.77 8.67 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.693 -0.886 . . . . 0.0 108.857 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -131.05 142.45 50.3 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.115 -0.991 . . . . 0.0 112.256 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.9 mt -110.59 134.04 52.77 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 46.3 t -112.29 142.54 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.907 -1.12 . . . . 0.0 110.086 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -120.25 125.06 47.19 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.397 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.53 -26.78 65.62 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 167' ' ' SER . 7.5 mp0 -120.51 153.86 56.53 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.372 -0.83 . . . . 0.0 108.807 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 24.8 Cg_endo -60.92 -177.94 0.21 Allowed 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.309 2.673 . . . . 0.0 113.873 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 51.05 33.3 8.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.302 0.572 . . . . 0.0 110.417 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.442 ' H ' ' CB ' ' A' ' 167' ' ' SER . 23.4 m-85 56.46 51.23 11.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.649 -0.657 . . . . 0.0 110.009 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 142' ' ' GLY . 50.0 m -136.69 162.7 32.43 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.768 -0.582 . . . . 0.0 109.676 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.48 174.07 32.5 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 31.8 mmm-85 -51.56 109.54 0.36 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.469 -1.018 . . . . 0.0 108.99 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.555 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 21.1 pt20 -87.58 147.28 25.38 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.789 0.804 . . . . 0.0 110.089 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -129.74 143.2 50.7 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.558 ' OH ' ' CG ' ' A' ' 131' ' ' HIS . 91.8 t80 -103.73 106.85 17.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.103 -0.998 . . . . 0.0 109.556 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.7 mp -100.04 121.13 40.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.383 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.564 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -107.49 168.99 7.19 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.4 Cg_exo -36.69 164.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.159 1.906 . . . . 0.0 112.0 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 113.49 -164.23 12.07 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -122.84 131.46 53.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.761 -0.847 . . . . 0.0 110.812 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.564 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 23.4 m-85 -109.24 145.83 35.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.635 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 19.0 ptt-85 -137.55 -3.62 1.88 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.789 -1.195 . . . . 0.0 112.41 -177.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.559 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 9.2 m -169.49 167.42 9.85 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.025 -1.672 . . . . 0.0 109.901 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.592 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.1 OUTLIER -57.34 -9.91 1.18 Allowed 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -88.62 -3.64 58.75 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.297 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.635 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 5.2 m-20 -89.64 -60.93 1.81 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.505 -0.747 . . . . 0.0 109.17 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.568 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 10.0 p90 -73.54 12.36 0.64 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 68.19 34.8 81.72 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.72 -160.38 30.88 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 19.0 t -149.16 -39.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 49.1 p -106.72 -156.58 0.58 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 18.7 p -139.09 3.24 2.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -63.98 77.11 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.218 -0.926 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.9 mtt -105.15 116.26 31.66 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.026 -1.046 . . . . 0.0 109.873 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.24 -24.59 5.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.482 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.69 149.33 52.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.59 -1.535 . . . . 0.0 111.286 -178.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.456 ' HB ' ' SG ' ' A' ' 110' ' ' CYS . 18.8 mt -148.88 139.97 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.32 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -127.81 140.29 52.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.412 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.422 ' HG2' ' H ' ' A' ' 170' ' ' ARG . 27.5 ptt85 -94.79 70.46 3.45 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 108.977 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 172' ' ' THR . 5.3 mm 51.78 -141.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.389 -0.925 . . . . 0.0 109.304 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.631 ' H ' HG22 ' A' ' 171' ' ' ILE . 7.5 m -138.73 42.22 2.14 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.353 0.597 . . . . 0.0 109.49 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 172' ' ' THR . 57.0 t0 36.63 41.54 0.17 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.502 0.667 . . . . 0.0 109.805 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.299 -1.61 0 CA-C-O 117.873 -1.06 . . . . 0.0 108.981 179.524 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.341 0.591 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.95 147.96 0.03 OUTLIER Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -147.47 139.74 24.48 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.523 -0.986 . . . . 0.0 110.202 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.554 HG23 ' O ' ' A' ' 4' ' ' ILE . 7.0 tp -125.72 122.35 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.452 -0.78 . . . . 0.0 109.24 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD12 HH21 ' A' ' 37' ' ' ARG . 70.4 mt -121.1 126.24 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 109.272 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -92.94 162.14 14.19 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.198 -0.939 . . . . 0.0 108.917 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 18.5 m-85 -145.98 135.39 23.02 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.678 -1.264 . . . . 0.0 108.744 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.71 -46.21 54.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.36 -0.838 . . . . 0.0 110.933 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.502 ' OD2' ' N ' ' A' ' 14' ' ' GLY . 61.1 m-20 -76.53 148.92 36.8 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.835 -1.166 . . . . 0.0 110.345 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.8 ptt85 -64.7 -41.26 96.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.488 -0.758 . . . . 0.0 110.101 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -87.18 45.08 1.23 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.11 -0.994 . . . . 0.0 109.726 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 52.95 90.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.45 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.93 -171.06 42.4 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.502 ' N ' ' OD2' ' A' ' 9' ' ' ASP . . . 72.15 -141.63 31.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -83.46 123.61 29.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.967 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -107.77 159.94 16.11 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 109.765 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -142.63 123.47 14.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.956 . . . . 0.0 108.921 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -101.85 121.39 42.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.044 -1.035 . . . . 0.0 109.371 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 140.39 50.04 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.774 0.797 . . . . 0.0 109.379 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 48.4 mtt -131.21 6.97 4.57 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.1 m -149.47 168.93 22.09 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.347 -0.846 . . . . 0.0 110.006 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -53.9 151.83 6.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.365 -0.834 . . . . 0.0 110.336 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 16.6 t -148.66 113.18 5.32 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.85 -7.71 39.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.12 -0.988 . . . . 0.0 109.41 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.35 99.19 5.94 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 26' ' ' LEU . 34.6 mt -110.0 -20.61 12.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.96 . . . . 0.0 108.905 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 28' ' ' SER . 33.9 t-80 -61.6 -47.15 86.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.124 -0.985 . . . . 0.0 109.061 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' HIS . 99.2 p -49.51 -55.46 13.23 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -56.14 -42.57 77.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.624 -0.673 . . . . 0.0 111.056 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 30.1 p90 -159.58 153.63 23.38 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.99 -1.069 . . . . 0.0 109.901 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.658 ' ND2' ' H ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -104.98 -8.49 18.54 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.218 -0.926 . . . . 0.0 110.718 -178.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.7 mtp180 -149.37 149.01 30.18 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.992 -1.068 . . . . 0.0 108.734 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.541 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 37.0 t -155.3 125.02 6.47 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -108.51 -9.32 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.829 . . . . 0.0 110.035 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.448 ' OG ' ' CB ' ' A' ' 7' ' ' TYR . 2.6 p -132.27 137.89 47.67 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.226 -0.921 . . . . 0.0 110.589 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.0 mt -134.87 141.92 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.54 ' NE ' ' OE2' ' A' ' 39' ' ' GLU . 29.5 ttp180 -136.27 115.99 13.01 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.859 -1.151 . . . . 0.0 111.754 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.39 117.24 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' OE2' ' NE ' ' A' ' 37' ' ' ARG . 68.6 mm-40 -79.18 -35.39 41.95 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.355 -0.938 . . . . 0.0 108.944 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 28.7 t -174.31 161.94 3.53 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.903 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.72 177.83 51.14 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 58.9 m -98.47 148.79 23.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.582 -0.952 . . . . 0.0 109.925 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.531 ' CZ ' HG21 ' A' ' 4' ' ' ILE . 5.8 t80 -144.3 137.3 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.903 -1.123 . . . . 0.0 109.781 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.546 ' SD ' ' CD1' ' A' ' 146' ' ' TYR . 50.1 mtp -113.23 128.67 56.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' HB ' HG11 ' A' ' 76' ' ' VAL . 21.6 m -114.22 144.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.117 -0.989 . . . . 0.0 109.896 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.679 ' O ' HG13 ' A' ' 76' ' ' VAL . 31.7 m-85 -121.5 139.93 52.85 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.734 0.778 . . . . 0.0 111.694 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -75.39 -6.59 50.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.558 -0.714 . . . . 0.0 109.473 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.893 ' O ' ' HB3' ' A' ' 78' ' ' SER . 19.6 ttm180 -131.86 158.3 41.69 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.5 p -70.5 158.5 35.96 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.688 0.756 . . . . 0.0 111.131 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 68.44 33.85 3.92 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.307 0.575 . . . . 0.0 111.639 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.485 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 3.3 m-85 60.95 61.25 1.66 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.122 -0.986 . . . . 0.0 109.718 178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 82.2 mtp -149.84 172.15 15.61 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.191 -0.943 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.26 -170.25 44.67 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.4 mtp85 -54.44 117.35 3.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -1.178 . . . . 0.0 107.926 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -101.01 134.61 43.74 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -128.14 128.91 45.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.256 -0.903 . . . . 0.0 109.278 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -85.99 118.91 25.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.954 -1.091 . . . . 0.0 108.657 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.702 HD11 ' CZ ' ' A' ' 63' ' ' TYR . 6.3 tp -125.51 118.45 25.81 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.221 -0.924 . . . . 0.0 111.008 -178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 60' ' ' ARG . 8.4 ptm180 -108.9 179.84 4.06 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.132 -0.98 . . . . 0.0 111.884 -178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' A' ' 59' ' ' ARG . 43.5 ttp180 -31.19 108.12 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.496 0.665 . . . . 0.0 111.004 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 178.34 158.35 20.86 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.114 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -105.43 127.16 52.84 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.702 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 71.0 m-85 -116.38 99.84 53.03 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 108.811 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -76.93 -6.96 17.17 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.442 2.095 . . . . 0.0 112.531 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -168.5 135.25 1.95 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.937 -1.102 . . . . 0.0 108.362 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 23.0 p90 -150.07 32.59 0.67 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.563 -1.336 . . . . 0.0 110.744 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 6.3 mmt -97.39 -46.67 5.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.827 -1.17 . . . . 0.0 109.199 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 52.3 mtp85 -99.34 -16.79 18.32 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.3 m -88.91 -20.46 24.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.521 -0.737 . . . . 0.0 109.883 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 72' ' ' MET . 42.4 ttm -107.32 -25.77 11.31 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.997 -1.064 . . . . 0.0 108.388 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.1 52.72 4.18 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 120.17 -1.014 . . . . 0.0 110.771 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.553 ' SD ' ' SD ' ' A' ' 70' ' ' MET . 90.9 mtp -128.6 139.92 52.03 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.349 -1.089 . . . . 0.0 109.832 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.577 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 13.4 m120 -98.43 57.46 1.2 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.222 -0.924 . . . . 0.0 109.491 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 5.6 p30 150.91 -173.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.541 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 29.5 p -95.96 -174.61 3.16 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.293 1.044 . . . . 0.0 110.481 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 46' ' ' TYR . 40.6 t -78.38 143.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -108.07 -16.77 14.2 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.897 -1.127 . . . . 0.0 108.256 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.893 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.05 159.27 42.54 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.061 -1.024 . . . . 0.0 109.925 178.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' A' ' 26' ' ' LEU . 11.0 m -154.74 143.55 20.83 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.37 0.605 . . . . 0.0 110.231 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' NH2' ' CD2' ' A' ' 146' ' ' TYR . 52.7 ttp180 -134.15 138.39 45.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.2 ttm -99.61 159.88 14.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.076 -1.015 . . . . 0.0 109.869 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 88.0 mt -123.7 83.48 54.02 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.433 -0.792 . . . . 0.0 109.151 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -50.71 176.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.702 0 C-N-CA 122.965 2.443 . . . . 0.0 112.798 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.46 57.11 4.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.341 -0.849 . . . . 0.0 109.735 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -67.04 169.43 8.38 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.148 -0.97 . . . . 0.0 109.85 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -46.0 136.25 6.74 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.274 -0.891 . . . . 0.0 109.955 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.595 ' O ' ' O ' ' A' ' 88' ' ' SER . . . -65.86 -66.04 2.6 Favored Glycine 0 N--CA 1.492 2.409 0 O-C-N 121.447 -0.783 . . . . 0.0 113.25 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.595 ' O ' ' O ' ' A' ' 87' ' ' GLY . 25.2 m 10.12 115.37 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.417 -1.049 . . . . 0.0 113.291 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.575 ' CD1' ' O ' ' A' ' 87' ' ' GLY . 38.7 m-85 -126.41 133.58 51.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.684 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -174.17 123.21 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.1 ttm -117.68 135.62 53.89 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.167 -0.958 . . . . 0.0 109.989 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -108.94 121.72 45.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 103' ' ' MET . 14.3 mt -106.02 150.48 25.69 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.502 1.144 . . . . 0.0 112.948 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CG ' ' HA ' ' A' ' 99' ' ' MET . 29.9 m-85 -134.58 121.59 21.15 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.083 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 55.5 tt0 -59.03 -26.54 64.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 111.526 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.554 ' O ' ' HB3' ' A' ' 124' ' ' SER . 39.6 m170 -110.61 162.0 15.17 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 120.503 -1.373 . . . . 0.0 111.12 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 13.2 p -59.15 154.35 16.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.754 -0.591 . . . . 0.0 109.464 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 97' ' ' SER . 7.4 t70 84.24 -90.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -173.94 47.1 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.625 -1.621 . . . . 0.0 106.625 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.63 -159.44 12.61 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-O 122.242 0.912 . . . . 0.0 111.157 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.462 ' CA ' ' ND1' ' A' ' 96' ' ' HIS . . . 61.49 -159.5 30.01 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.086 -1.605 . . . . 0.0 109.086 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.492 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 98.1 mtt180 -79.21 127.42 32.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.99 -1.3 . . . . 0.0 110.048 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.498 ' C ' ' SD ' ' A' ' 103' ' ' MET . 10.1 tmm? -91.14 122.34 33.7 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.206 -0.934 . . . . 0.0 109.619 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.2 mtm -123.14 137.91 54.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.232 -0.917 . . . . 0.0 108.649 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -104.25 142.63 34.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 110.408 -178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.7 tp -132.51 121.28 23.08 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.545 ' O ' ' NH2' ' A' ' 170' ' ' ARG . 9.2 ttt -123.83 21.15 9.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 107' ' ' MET . 54.1 m-20 -145.85 -160.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.419 -0.801 . . . . 0.0 109.407 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 109' ' ' ASP . 39.4 p-10 -90.03 133.77 34.63 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.514 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.98 80.57 14.95 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.227 -0.921 . . . . 0.0 109.649 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -72.71 -33.01 8.74 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.228 1.952 . . . . 0.0 111.884 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.461 HD22 ' H ' ' A' ' 115' ' ' ASP . 10.6 t30 -126.38 78.97 1.82 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.514 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -62.67 -15.31 51.77 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.055 -1.028 . . . . 0.0 109.178 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.429 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 5.6 mmt -63.3 -40.98 98.86 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.471 0.653 . . . . 0.0 109.856 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.461 ' H ' HD22 ' A' ' 112' ' ' ASN . 82.0 m-20 -85.21 -23.01 28.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.921 -1.112 . . . . 0.0 110.98 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . 0.479 ' NE ' ' SG ' ' A' ' 110' ' ' CYS . 49.5 ttm-85 -79.4 -61.04 2.13 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.602 -1.311 . . . . 0.0 111.123 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 118' ' ' ASN . 8.8 m-85 -109.61 0.75 19.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.095 -1.003 . . . . 0.0 109.925 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 117' ' ' PHE . 52.1 m-20 48.33 32.79 3.38 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.424 ' HG3' ' CE2' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -143.4 126.04 15.96 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.7 p -120.53 7.6 10.62 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.573 -0.704 . . . . 0.0 111.174 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.5 m-20 -135.34 88.96 2.46 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.634 -1.292 . . . . 0.0 112.606 -178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.649 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -101.42 139.45 37.08 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.185 -0.947 . . . . 0.0 108.852 177.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.11 3.82 54.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.012 -1.055 . . . . 0.0 111.244 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 5.3 t -152.23 157.54 41.58 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.148 -1.595 . . . . 0.0 110.327 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 1.5 p -169.47 167.96 9.63 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.755 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.449 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 12.7 t60 -149.09 145.91 27.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.383 -0.823 . . . . 0.0 109.597 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.449 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.3 t -114.36 125.3 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 108.771 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.406 ' SD ' ' CD2' ' A' ' 126' ' ' HIS . 86.2 mmm -81.66 -32.0 32.04 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.1 p30 178.29 168.37 0.8 Allowed 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.537 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.71 -152.42 22.45 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.532 ' ND1' ' OH ' ' A' ' 146' ' ' TYR . 68.6 m-70 -137.27 123.57 20.61 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.675 -0.897 . . . . 0.0 109.347 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -112.14 122.97 49.24 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.795 -1.191 . . . . 0.0 112.676 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.657 HD12 ' CE2' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -98.93 123.4 43.19 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 42.9 t -109.15 144.82 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 O-C-N 120.816 -1.178 . . . . 0.0 110.618 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.657 ' CE2' HD12 ' A' ' 133' ' ' LEU . 62.6 m-85 -124.12 125.8 45.11 Favored 'General case' 0 N--CA 1.501 2.081 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.039 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 143' ' ' ARG . 68.2 tt0 -64.44 -21.41 66.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.731 -0.606 . . . . 0.0 109.678 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.663 ' O ' ' OG ' ' A' ' 167' ' ' SER . 93.7 mm-40 -127.6 134.0 25.71 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.315 -0.866 . . . . 0.0 109.646 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.495 ' O ' ' O ' ' A' ' 137' ' ' GLN . 96.0 Cg_exo -38.86 -177.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 123.808 3.005 . . . . 0.0 114.859 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 50.21 31.04 4.74 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.81 -0.556 . . . . 0.0 110.899 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.469 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 57.59 54.33 6.51 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.428 -0.795 . . . . 0.0 110.435 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.612 HG22 ' N ' ' A' ' 142' ' ' GLY . 94.3 m -144.24 168.97 18.79 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.927 -1.108 . . . . 0.0 110.056 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.612 ' N ' HG22 ' A' ' 141' ' ' THR . . . 93.93 -177.01 36.66 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 136' ' ' GLU . 63.4 mtm180 -56.35 106.74 0.31 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -1.08 . . . . 0.0 108.81 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -88.24 147.4 24.85 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.787 0.803 . . . . 0.0 110.184 -179.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -128.02 141.02 51.63 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.63 0.728 . . . . 0.0 109.345 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.546 ' CD1' ' SD ' ' A' ' 44' ' ' MET . 88.1 t80 -99.02 101.66 13.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.364 -0.835 . . . . 0.0 109.593 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.3 mp -97.65 120.73 38.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.91 . . . . 0.0 109.246 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' NH2' ' NH1' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -112.0 166.63 10.53 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 148' ' ' ARG . 88.1 Cg_exo -32.3 156.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.645 2.23 . . . . 0.0 112.302 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.5 -169.82 14.2 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -121.23 136.2 55.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.433 -1.039 . . . . 0.0 110.325 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.437 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 20.6 m-85 -113.07 145.89 40.11 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.639 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 25.0 ptt180 -136.75 0.64 2.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.206 -0.933 . . . . 0.0 111.975 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.553 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.0 m -174.2 171.33 3.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.153 -1.592 . . . . 0.0 110.121 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.561 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -58.8 -17.0 19.65 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.38 -0.825 . . . . 0.0 109.17 -179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -85.08 1.76 46.37 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.0 -1.063 . . . . 0.0 109.326 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.639 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 9.1 m-20 -93.29 -60.35 1.81 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 0.0 109.56 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.451 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 12.8 p90 -78.12 16.72 0.7 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.76 39.39 93.58 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -107.32 -161.6 21.56 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.37 -42.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 30.3 p -109.05 -150.83 0.46 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 26.2 t -147.04 17.62 1.23 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.485 -0.759 . . . . 0.0 109.561 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -67.22 74.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.147 -0.971 . . . . 0.0 111.289 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 46.8 mtt -103.88 118.02 35.69 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.035 -1.041 . . . . 0.0 108.958 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -114.38 -25.97 3.87 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.663 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.1 OUTLIER -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.023 1.412 . . . . 0.0 110.71 -179.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 9.3 mt -145.67 140.61 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.749 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -131.37 145.2 51.73 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.409 -0.807 . . . . 0.0 110.8 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 107' ' ' MET . 0.3 OUTLIER -96.4 74.7 2.87 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 171' ' ' ILE . 2.9 pt -48.94 91.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.459 -0.776 . . . . 0.0 110.005 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.493 ' N ' ' O ' ' A' ' 170' ' ' ARG . 1.6 t -105.95 59.2 0.66 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.302 -0.874 . . . . 0.0 110.068 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 172' ' ' THR . 93.3 m-20 49.88 94.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.025 -1.047 . . . . 0.0 109.071 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 174' ' ' LEU . 6.5 mp . . . . . 0 C--N 1.3 -1.574 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.313 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mmt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.69 103.15 0.08 OUTLIER Glycine 0 N--CA 1.496 2.663 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.361 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -146.42 161.51 40.24 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.049 -1.265 . . . . 0.0 110.73 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.624 HD13 ' CD2' ' A' ' 43' ' ' PHE . 12.2 tt -136.26 136.69 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.494 -0.754 . . . . 0.0 109.974 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.456 HD12 HH21 ' A' ' 37' ' ' ARG . 72.2 mt -121.54 125.99 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.647 -0.658 . . . . 0.0 109.373 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -90.68 154.12 19.79 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -138.85 139.42 38.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.923 -1.111 . . . . 0.0 109.515 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -76.82 -33.36 57.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.468 -0.77 . . . . 0.0 111.072 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.516 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 54.5 t0 -77.69 153.91 32.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.916 -1.115 . . . . 0.0 110.328 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.541 ' O ' ' O ' ' A' ' 64' ' ' PRO . 96.1 mtt180 -61.84 -50.43 72.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.511 -0.743 . . . . 0.0 109.973 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.48 ' O ' ' CG ' ' A' ' 12' ' ' PHE . 88.7 m-20 -71.43 -94.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.996 -1.065 . . . . 0.0 109.273 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.48 ' CG ' ' O ' ' A' ' 11' ' ' ASN . 52.0 m-85 -157.3 69.76 0.58 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.169 -0.957 . . . . 0.0 109.043 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.516 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -163.8 -174.32 33.5 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.85 -152.75 23.24 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.506 ' N ' ' CD ' ' A' ' 15' ' ' ARG . 11.2 mpt_? -75.65 125.82 29.79 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.829 -1.394 . . . . 0.0 108.833 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -109.34 157.11 19.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.462 -0.774 . . . . 0.0 110.167 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -145.99 123.78 11.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.238 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -95.55 117.74 30.99 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.293 -0.879 . . . . 0.0 109.555 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 62.8 m -122.0 140.77 52.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.17 -0.956 . . . . 0.0 109.605 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.5 ptm -147.89 14.3 1.04 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.6 p -145.25 159.8 42.46 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.512 -0.742 . . . . 0.0 110.093 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -51.43 145.82 8.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.51 -0.744 . . . . 0.0 110.041 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.512 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 5.1 t -148.27 115.42 6.15 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 179.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -92.21 12.31 22.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.118 -0.989 . . . . 0.0 108.798 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.512 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 40.3 p-10 -148.57 90.45 1.79 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.638 -0.664 . . . . 0.0 109.615 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.525 HD11 ' SG ' ' A' ' 79' ' ' CYS . 32.0 mt -107.14 -28.79 9.75 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.29 -0.881 . . . . 0.0 109.507 179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.524 ' CG ' ' N ' ' A' ' 28' ' ' SER . 47.3 p-80 -63.48 -39.81 95.44 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -0.943 . . . . 0.0 109.029 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.524 ' N ' ' CG ' ' A' ' 27' ' ' HIS . 18.5 m -55.47 -25.38 36.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.75 -0.594 . . . . 0.0 109.468 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -83.31 -37.11 23.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 17.7 p90 -152.32 151.24 30.64 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -95.15 -9.89 32.16 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 mtt85 -155.7 155.46 33.18 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.03 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.595 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 48.3 t -154.51 123.47 6.3 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -107.51 -4.26 18.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.355 -0.841 . . . . 0.0 110.437 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 t -136.43 140.66 43.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.876 -1.14 . . . . 0.0 110.983 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 91.8 mt -137.22 145.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.521 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 32.0 ttp180 -137.81 116.46 12.17 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.708 -1.245 . . . . 0.0 110.864 -178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.4 t -103.19 119.54 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 177.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.521 ' OE2' ' NH2' ' A' ' 37' ' ' ARG . 92.3 mt-10 -84.72 -29.19 25.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.246 -0.909 . . . . 0.0 109.0 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -174.93 159.41 2.68 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.552 -1.259 . . . . 0.0 111.787 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 79.94 -162.67 46.86 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 15.4 t -123.53 153.18 40.95 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.47 -1.018 . . . . 0.0 109.172 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.624 ' CD2' HD13 ' A' ' 4' ' ' ILE . 10.1 t80 -140.34 135.28 32.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.153 -0.967 . . . . 0.0 109.137 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.1 ttt -106.37 119.94 40.57 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.38 143.92 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 C-N-CA 119.809 -0.757 . . . . 0.0 110.209 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 76' ' ' VAL . 35.7 m-85 -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.599 0.714 . . . . 0.0 110.888 -178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 41.7 t0 -74.36 -9.13 58.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.947 -0.47 . . . . 0.0 109.951 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.843 ' O ' ' HB3' ' A' ' 78' ' ' SER . 27.8 ttt85 -131.52 158.19 41.56 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 22.9 p -68.45 163.65 22.84 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.78 0.8 . . . . 0.0 111.4 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 65.71 32.13 9.22 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.106 0.479 . . . . 0.0 111.499 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CB ' HH21 ' A' ' 80' ' ' ARG . 2.6 m-85 61.0 58.15 2.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.053 -1.029 . . . . 0.0 109.354 178.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.406 ' N ' ' CD2' ' A' ' 46' ' ' TYR . 56.1 mtt -146.04 176.06 9.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.234 -0.917 . . . . 0.0 109.58 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.82 -172.68 48.36 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -55.94 124.15 16.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -102.47 134.19 46.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.055 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -127.0 129.27 47.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.365 -0.834 . . . . 0.0 109.496 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.642 ' C ' HD12 ' A' ' 58' ' ' LEU . 11.1 p90 -91.19 121.38 32.91 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.336 -0.852 . . . . 0.0 108.886 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 57' ' ' PHE . 10.3 mp -108.77 139.74 43.16 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 60' ' ' ARG . 33.0 ptt180 -118.8 158.66 25.18 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.128 -0.982 . . . . 0.0 108.951 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 59' ' ' ARG . 50.8 ttt-85 -29.92 115.37 0.11 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.285 0.564 . . . . 0.0 110.389 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 171.29 164.32 26.77 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -104.62 127.43 52.37 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -110.4 97.68 32.71 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.252 -0.905 . . . . 0.0 108.666 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' O ' ' O ' ' A' ' 10' ' ' ARG . 48.9 Cg_endo -71.47 -11.55 28.45 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.071 1.847 . . . . 0.0 112.348 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 37.5 p-10 -167.27 135.76 2.61 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 15.5 p90 -147.95 20.28 1.13 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.702 -1.249 . . . . 0.0 110.688 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 42.7 tpp -90.99 -44.92 9.02 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.683 -1.261 . . . . 0.0 109.504 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.424 ' H ' ' HG2' ' A' ' 68' ' ' ARG . 12.5 ptp180 -98.45 -20.69 16.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -0.906 . . . . 0.0 109.08 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.3 m -76.8 -30.56 56.48 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.481 -0.762 . . . . 0.0 109.046 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 15.9 mtt -95.08 -39.27 10.23 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.12 44.88 2.71 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 mmm -111.17 150.73 29.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.73 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 26.9 m120 -100.45 49.92 0.9 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.083 -1.011 . . . . 0.0 109.244 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.85 -168.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.595 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 24.6 p -97.85 -170.22 1.95 Allowed 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 121.997 0.903 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 46' ' ' TYR . 46.4 t -78.7 144.38 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -111.17 -15.25 13.72 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 120.597 -1.314 . . . . 0.0 107.719 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.843 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -143.84 166.26 25.42 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 178.362 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' SG ' HD11 ' A' ' 26' ' ' LEU . 30.1 p -160.16 145.25 14.93 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.403 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.504 HH21 ' CB ' ' A' ' 51' ' ' PHE . 35.6 ttm180 -130.68 136.64 48.99 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.3 ttp -95.98 149.6 21.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.866 -1.146 . . . . 0.0 108.956 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 85.3 mt -97.45 115.96 65.81 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.253 -0.904 . . . . 0.0 109.203 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.528 ' O ' ' CE1' ' A' ' 131' ' ' HIS . 72.9 Cg_exo -45.82 148.5 2.58 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.083 1.855 . . . . 0.0 112.0 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.62 ' N ' HD12 ' A' ' 84' ' ' LEU . 9.8 mp -89.5 50.9 1.99 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 109.451 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -104.89 125.22 50.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.54 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -135.95 73.92 1.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.462 -0.773 . . . . 0.0 109.49 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -87.67 -87.37 1.13 Allowed Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.435 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 54.7 m -115.68 144.4 43.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.631 -0.923 . . . . 0.0 109.77 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.62 ' CG ' ' NE ' ' A' ' 170' ' ' ARG . 10.5 m-85 -112.6 118.47 35.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.394 -0.816 . . . . 0.0 109.496 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -171.18 126.98 0.68 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 49.2 ttm -110.43 125.2 53.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.051 -1.031 . . . . 0.0 109.277 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -99.62 118.08 35.39 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.363 -0.976 . . . . 0.0 108.363 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 103' ' ' MET . 16.5 mt -104.52 147.31 27.74 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.191 0.996 . . . . 0.0 112.238 -177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.479 ' CD2' ' C ' ' A' ' 99' ' ' MET . 28.2 m-85 -133.64 125.25 28.31 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' CD ' ' SD ' ' A' ' 119' ' ' MET . 86.8 tt0 -62.36 -27.51 69.12 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.192 -0.942 . . . . 0.0 111.879 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' A' ' 124' ' ' SER . 3.2 m-70 -108.95 164.9 12.0 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.539 -1.35 . . . . 0.0 111.145 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 58.2 m -61.55 156.19 20.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.455 -0.778 . . . . 0.0 109.566 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 97' ' ' SER . 2.3 m-20 81.6 -91.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.484 ' H ' ' HB2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -169.91 41.55 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -106.68 -157.24 21.29 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.507 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.509 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 60.73 -155.64 33.31 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 79.2 mtp180 -87.49 138.6 31.33 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 109.836 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 5.6 ptt? -98.56 123.43 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.354 -0.841 . . . . 0.0 110.072 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.68 136.87 54.23 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -101.9 137.03 40.73 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.421 -0.799 . . . . 0.0 110.122 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -131.36 119.07 21.17 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.57 -15.88 12.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.357 -0.839 . . . . 0.0 109.544 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.7 p30 -111.86 -159.06 0.67 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.339 -0.85 . . . . 0.0 110.352 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.4 139.36 30.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -117.29 88.33 27.45 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.459 -0.776 . . . . 0.0 109.297 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -77.23 -25.76 8.22 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.162 1.908 . . . . 0.0 112.647 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -136.57 80.71 1.84 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 12.7 mt -64.54 -28.46 69.66 Favored 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.201 -0.937 . . . . 0.0 110.012 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.1 tpt -56.78 -39.38 73.97 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -82.35 -23.03 35.27 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.025 -1.047 . . . . 0.0 110.184 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -79.48 -69.11 0.6 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.475 -1.391 . . . . 0.0 110.515 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 113' ' ' LEU . 3.8 m-85 -96.07 3.43 53.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.993 -1.067 . . . . 0.0 110.721 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 114' ' ' MET . 31.4 m-20 52.32 31.85 10.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.563 -1.336 . . . . 0.0 107.514 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.439 ' SD ' ' CD ' ' A' ' 95' ' ' GLU . 4.7 ttp -146.47 132.41 19.15 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 60.2 p -116.13 2.95 13.46 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.507 -0.746 . . . . 0.0 109.801 -178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.489 ' HA ' ' O ' ' A' ' 163' ' ' SER . 50.7 m-20 -131.09 113.13 13.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.564 -1.335 . . . . 0.0 111.594 -179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.2 OUTLIER -123.33 131.77 53.77 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 177.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.478 ' ND1' ' N ' ' A' ' 123' ' ' HIS . 2.8 m80 -93.21 1.87 56.9 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.342 -0.848 . . . . 0.0 111.097 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 6.2 t -147.51 153.81 39.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 119.674 -1.892 . . . . 0.0 110.844 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.451 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 50.3 t -162.44 161.42 27.19 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.411 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.451 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 1.9 t-80 -147.63 141.9 26.22 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.173 -0.955 . . . . 0.0 109.522 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 60.2 t -112.16 122.17 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.189 -0.944 . . . . 0.0 109.817 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.434 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 10.4 tpt -71.87 -32.38 67.41 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 88' ' ' SER . 0.9 OUTLIER 170.95 163.2 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.062 -179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 88.92 -160.63 29.99 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 83' ' ' PRO . 26.0 m80 -127.97 129.4 46.71 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.514 -0.992 . . . . 0.0 110.199 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 84.3 m95 -118.69 126.06 51.07 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.851 0.834 . . . . 0.0 111.91 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.24 125.68 41.95 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 50.5 t -111.23 145.12 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.964 -1.085 . . . . 0.0 110.695 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 141' ' ' THR . 94.8 m-85 -124.73 123.1 39.26 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.694 -0.629 . . . . 0.0 111.113 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 164' ' ' ARG . 71.8 tt0 -57.74 -29.36 64.72 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.838 ' O ' ' OG ' ' A' ' 167' ' ' SER . 5.8 mt-30 -117.27 153.07 49.87 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.422 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 19.2 Cg_endo -60.21 -170.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.504 2.12 0 C-N-CA 123.496 2.797 . . . . 0.0 113.774 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 46.61 29.4 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.318 0.58 . . . . 0.0 110.107 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.603 ' H ' ' CB ' ' A' ' 167' ' ' SER . 17.5 m-85 58.28 53.99 6.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 110.061 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 135' ' ' TYR . 14.2 p -140.39 168.25 20.24 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.516 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 95.95 178.21 36.28 Favored Glycine 0 N--CA 1.503 3.15 0 O-C-N 120.737 -1.227 . . . . 0.0 110.6 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 -53.39 108.0 0.29 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -86.85 141.93 28.43 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.969 -178.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -126.0 132.46 52.01 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.406 ' CD1' ' C ' ' A' ' 146' ' ' TYR . 0.9 OUTLIER -92.66 105.3 17.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.015 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.5 mp -98.35 120.17 38.31 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.954 0.883 . . . . 0.0 109.121 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -105.02 178.73 1.07 Allowed Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.428 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 66.3 Cg_exo -49.42 161.58 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.679 1.586 . . . . 0.0 111.64 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.51 -173.88 14.97 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.484 -1.846 . . . . 0.0 108.484 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -114.75 135.46 54.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.744 -0.857 . . . . 0.0 110.658 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 18.1 m-85 -112.75 143.83 43.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.614 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 41.1 ptt85 -135.12 -1.39 2.65 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.015 -1.053 . . . . 0.0 112.159 -177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.551 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 1.6 t -171.77 168.19 6.2 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 119.896 -1.752 . . . . 0.0 109.924 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -57.6 -14.6 5.58 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -85.82 0.01 54.13 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.244 -0.91 . . . . 0.0 109.231 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.614 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.4 m-20 -92.52 -59.66 2.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.437 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.542 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 11.7 p90 -76.78 18.14 0.36 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.23 37.82 95.06 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -102.49 -166.04 26.43 Favored Glycine 0 N--CA 1.482 1.718 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 68.0 t -144.66 -40.57 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 41.6 p -107.03 -159.87 0.71 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 30.5 t -138.42 11.09 2.76 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 121.461 -0.774 . . . . 0.0 109.497 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.497 ' O ' ' O ' ' A' ' 136' ' ' GLU . 85.6 mtt-85 -69.49 75.6 0.4 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.016 -1.053 . . . . 0.0 112.988 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 42.4 mtt -100.05 122.8 43.48 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.139 -0.976 . . . . 0.0 110.247 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.93 -28.5 2.44 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.838 ' OG ' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -132.85 148.5 52.3 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.421 -1.635 . . . . 0.0 111.2 -179.109 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.5 mt -144.84 140.7 23.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.328 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -125.86 143.83 50.91 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.304 -0.873 . . . . 0.0 110.349 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.764 ' O ' ' N ' ' A' ' 172' ' ' THR . 29.5 ttt180 -97.72 85.48 3.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 108.885 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 171' ' ' ILE . 13.9 mt -38.04 71.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.747 -0.596 . . . . 0.0 112.372 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.764 ' N ' ' O ' ' A' ' 170' ' ' ARG . 64.1 m -159.55 75.85 0.65 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.861 -1.149 . . . . 0.0 110.07 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 172' ' ' THR . 14.4 m-20 -157.23 73.03 0.72 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.113 -0.992 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 174' ' ' LEU . 9.4 mp . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 118.18 -0.914 . . . . 0.0 108.868 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.3 mtp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . 85.17 162.68 36.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -151.9 135.61 16.27 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.442 -1.034 . . . . 0.0 109.715 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.433 HD11 ' CG2' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -122.01 117.16 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mm -115.0 124.4 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.278 -0.888 . . . . 0.0 109.416 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -91.84 159.25 15.88 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.419 ' CB ' ' OG ' ' A' ' 35' ' ' SER . 14.3 m-85 -146.25 135.1 22.42 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.564 -1.335 . . . . 0.0 109.038 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -74.54 -42.52 58.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.123 -0.985 . . . . 0.0 111.069 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.458 ' O ' ' OG ' ' A' ' 35' ' ' SER . 12.6 t70 -81.21 151.19 28.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.889 -1.132 . . . . 0.0 110.542 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -64.49 -40.59 95.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 110.068 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -80.94 39.49 0.5 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.191 -0.943 . . . . 0.0 109.699 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 53.16 59.76 4.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.363 -0.836 . . . . 0.0 109.563 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -144.7 -154.44 6.14 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.41 -145.63 49.59 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -77.7 123.41 26.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.355 -1.085 . . . . 0.0 108.967 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -109.56 156.08 20.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.478 -0.764 . . . . 0.0 109.953 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 34.4 t60 -142.64 124.85 15.44 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.806 . . . . 0.0 109.27 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -99.91 119.83 38.83 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.293 -0.879 . . . . 0.0 109.575 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.37 139.72 50.93 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 0.0 109.5 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' A' ' 20' ' ' MET . 0.8 OUTLIER -131.7 7.17 4.42 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -148.95 169.71 19.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.381 -0.824 . . . . 0.0 109.672 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 40.9 p-10 -61.4 147.32 45.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 110.285 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.1 t -140.06 115.33 9.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.33 -8.31 56.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 0.0 108.859 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 12.2 p-10 -130.98 98.51 4.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 0.0 109.301 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 26' ' ' LEU . 57.8 mt -104.64 -20.2 13.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 108.655 179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.468 ' ND1' ' C ' ' A' ' 27' ' ' HIS . 7.9 t-80 -59.58 -44.7 93.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 27' ' ' HIS . 25.6 t -49.99 -46.28 52.44 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.585 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 53.6 m-85 -70.08 -51.91 28.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -149.11 149.24 30.74 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.999 -1.063 . . . . 0.0 109.839 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -100.91 -5.42 26.05 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.359 -0.838 . . . . 0.0 110.838 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -154.88 153.19 30.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.01 -1.056 . . . . 0.0 108.248 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.53 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 52.7 t -158.96 113.68 2.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.973 -1.079 . . . . 0.0 108.791 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.6 ' CE1' ' SD ' ' A' ' 67' ' ' MET . 35.9 m-70 -95.81 -4.84 43.09 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.713 -0.617 . . . . 0.0 110.994 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 9' ' ' ASP . 2.7 p -139.19 145.93 39.92 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.688 -1.257 . . . . 0.0 111.236 -179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.433 ' CG2' HD11 ' A' ' 4' ' ' ILE . 26.0 mt -140.98 142.5 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -132.71 112.11 11.72 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.942 -1.099 . . . . 0.0 111.081 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.522 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 1.4 t -98.5 115.0 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -83.01 -33.75 26.46 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.442 -0.903 . . . . 0.0 108.685 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 8.3 t -171.74 151.34 2.84 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.138 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.727 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 103.18 -137.92 13.69 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.727 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 60.7 m -170.92 164.41 7.69 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 2.8 p90 -174.84 168.96 3.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.1 -1.0 . . . . 0.0 109.616 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.0 ttm -119.72 141.29 49.55 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.706 ' HB ' HG11 ' A' ' 76' ' ' VAL . 34.8 m -115.74 146.6 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.5 -0.75 . . . . 0.0 109.1 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.431 ' CG ' ' HA ' ' A' ' 51' ' ' PHE . 95.6 m-85 -120.41 142.34 49.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.39 -0.819 . . . . 0.0 111.587 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -9.33 58.55 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.026 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.82 ' O ' ' HB3' ' A' ' 78' ' ' SER . 89.8 mtt-85 -134.52 165.39 25.3 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.525 ' OG1' ' ND2' ' A' ' 50' ' ' ASN . 39.6 p -75.64 160.61 29.9 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.729 0.776 . . . . 0.0 111.476 -178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.525 ' ND2' ' OG1' ' A' ' 49' ' ' THR . 5.2 m-80 68.18 33.03 4.55 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.321 0.581 . . . . 0.0 111.168 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.431 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 4.9 m-85 61.0 60.31 1.85 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.781 178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.423 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 59.1 mtt -146.34 170.95 15.75 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.235 -0.916 . . . . 0.0 110.033 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.15 -173.46 50.25 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -55.16 126.21 23.83 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.097 -1.237 . . . . 0.0 108.128 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -110.37 140.9 44.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 0.0 108.868 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -132.26 137.12 47.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 109.816 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 22.7 p90 -98.85 123.77 43.32 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.404 -0.81 . . . . 0.0 109.241 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.0 mt -122.83 129.49 51.74 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.956 -1.09 . . . . 0.0 111.029 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 60' ' ' ARG . 29.8 ptt180 -104.59 167.45 9.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.39 -0.819 . . . . 0.0 110.922 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 59' ' ' ARG . 72.9 ttt180 -35.6 119.53 0.54 Allowed 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.701 0.763 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 168.81 164.96 25.4 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -102.84 124.42 48.33 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.464 -1.021 . . . . 0.0 108.48 179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -108.27 97.67 23.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.77 -16.63 41.98 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.2 1.933 . . . . 0.0 112.212 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' OD1' ' N ' ' A' ' 65' ' ' ASP . 40.7 p-10 -169.36 145.03 3.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.871 -1.143 . . . . 0.0 107.943 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.503 ' CZ ' ' O ' ' A' ' 33' ' ' CYS . 20.2 p90 -148.0 -16.21 0.35 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.865 -1.147 . . . . 0.0 111.407 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.6 ' SD ' ' CE1' ' A' ' 34' ' ' HIS . 43.8 mtp -57.94 -38.89 76.77 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.439 -1.413 . . . . 0.0 109.994 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -90.6 -25.66 20.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.282 -0.886 . . . . 0.0 109.977 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -88.53 -8.98 53.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.358 -0.838 . . . . 0.0 109.838 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 13.3 mmt -107.98 -27.49 10.13 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 47.1 6.51 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.401 -1.079 . . . . 0.0 110.401 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.4 mtp -124.73 147.26 48.73 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.045 -1.268 . . . . 0.0 109.668 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 73.7 m-80 -98.06 60.18 1.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.573 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 15.4 m-20 148.9 -168.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.53 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 30.9 p -100.45 -163.53 1.03 Allowed 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 109.697 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.706 HG11 ' HB ' ' A' ' 45' ' ' VAL . 3.9 m -92.37 147.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' HE ' ' HB2' ' A' ' 27' ' ' HIS . 65.6 mtp180 -106.69 -11.14 15.9 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.168 -0.957 . . . . 0.0 108.521 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.82 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.75 164.98 28.73 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 119.099 -1.04 . . . . 0.0 110.269 179.052 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.443 ' SG ' HD11 ' A' ' 26' ' ' LEU . 30.2 p -161.09 147.51 14.75 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.734 0.778 . . . . 0.0 110.601 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.418 ' NH2' ' NH1' ' A' ' 148' ' ' ARG . 74.0 ttt-85 -140.3 141.98 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.676 -0.64 . . . . 0.0 109.356 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 42.1 ttm -98.35 161.52 13.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.315 -0.866 . . . . 0.0 109.111 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.429 ' CG2' ' NE2' ' A' ' 131' ' ' HIS . 52.5 mt -99.87 135.19 20.53 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -68.6 150.72 75.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.21 1.94 . . . . 0.0 111.974 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.8 mt -82.0 51.91 1.86 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -0.924 . . . . 0.0 109.641 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -105.45 117.5 34.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.302 -0.874 . . . . 0.0 109.535 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -133.48 78.23 1.76 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.314 -0.866 . . . . 0.0 109.48 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -83.75 -78.19 1.1 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.545 ' H ' ' CB ' ' A' ' 129' ' ' ASP . 66.5 m -135.45 156.43 48.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.684 -0.892 . . . . 0.0 110.054 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -109.83 111.66 23.23 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.468 -0.77 . . . . 0.0 109.855 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -169.51 130.77 1.1 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.403 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 43.7 ttm -114.56 133.84 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.129 -0.982 . . . . 0.0 109.341 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -106.18 117.6 34.46 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.525 ' O ' ' HA ' ' A' ' 103' ' ' MET . 23.5 mt -101.44 148.05 25.64 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 122.083 0.944 . . . . 0.0 112.121 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -135.66 127.54 29.41 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 70.3 tt0 -64.13 -23.94 67.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 0.0 112.095 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.527 ' O ' ' HB3' ' A' ' 124' ' ' SER . 6.1 m-70 -114.08 159.4 20.06 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.48 -1.387 . . . . 0.0 111.353 -178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.581 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.6 m -59.0 158.88 7.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.379 -0.825 . . . . 0.0 109.431 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.581 ' CB ' ' O ' ' A' ' 97' ' ' SER . 14.3 t0 85.49 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.832 0.825 . . . . 0.0 108.787 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.443 ' H ' ' HB3' ' A' ' 98' ' ' ASP . 0.5 OUTLIER -176.93 41.18 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.69 -160.32 13.0 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-O 122.281 0.934 . . . . 0.0 111.296 -178.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' CA ' ' CD2' ' A' ' 96' ' ' HIS . . . 67.21 -166.71 40.89 Favored Glycine 0 N--CA 1.482 1.751 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' A' ' 95' ' ' GLU . 17.5 mmt180 -74.47 133.85 42.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.002 -1.293 . . . . 0.0 109.648 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -98.7 119.14 36.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.171 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.81 138.39 50.34 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 108.722 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -99.5 126.58 45.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.025 -1.047 . . . . 0.0 109.763 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 108' ' ' ASP . 1.1 tt -118.83 115.79 25.16 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.1 ttt -126.4 20.96 7.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.289 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.544 ' H ' HD23 ' A' ' 106' ' ' LEU . 12.1 t70 -144.42 -168.56 2.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.258 -0.901 . . . . 0.0 110.045 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.501 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 47.8 t0 -83.82 132.18 34.84 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.517 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -114.89 81.5 7.52 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.239 -0.913 . . . . 0.0 109.978 -178.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.29 -29.06 5.19 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.178 1.918 . . . . 0.0 111.764 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -134.14 79.4 1.81 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.517 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 9.8 mt -63.17 -18.62 63.67 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.192 -0.942 . . . . 0.0 109.787 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 20.7 mmt -59.76 -40.72 89.12 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.705 0.764 . . . . 0.0 109.33 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -85.28 -23.38 28.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 110.988 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -75.58 -63.2 1.34 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.785 -1.197 . . . . 0.0 110.761 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 117' ' ' PHE . 1.4 m-85 -116.49 1.23 12.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.771 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 117' ' ' PHE . 14.7 t-20 49.41 35.96 8.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.9 ttt -146.5 133.28 20.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 120' ' ' SER . 1.3 t -131.56 10.53 4.78 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.202 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 163' ' ' SER . 9.3 m-20 -130.1 89.69 2.84 Favored 'General case' 0 N--CA 1.51 2.544 0 O-C-N 119.933 -1.729 . . . . 0.0 113.238 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.683 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -107.08 141.25 38.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.048 -1.032 . . . . 0.0 108.535 178.082 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.493 ' CD2' ' OH ' ' A' ' 155' ' ' TYR . 0.6 OUTLIER -96.36 3.19 53.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 111.133 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.527 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 4.9 t -148.98 154.3 39.18 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.205 -1.559 . . . . 0.0 110.177 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' ' 126' ' ' HIS . 38.1 t -163.89 161.98 23.29 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.971 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.495 ' N ' ' SG ' ' A' ' 125' ' ' CYS . 0.8 OUTLIER -146.36 142.56 28.35 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 -179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 53.5 t -111.55 122.58 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.136 -0.977 . . . . 0.0 109.623 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 36.1 ttm -71.94 -24.2 61.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.64 . . . . 0.0 109.638 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.545 ' CB ' ' H ' ' A' ' 88' ' ' SER . 1.3 m-20 163.29 171.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.859 0.838 . . . . 0.0 110.866 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' HIS . . . 85.95 -135.71 13.6 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.553 ' CG ' ' HH ' ' A' ' 146' ' ' TYR . 92.5 m-70 -158.52 134.17 8.86 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.516 -0.991 . . . . 0.0 109.69 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 53.7 m95 -126.78 136.26 52.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 0.0 111.954 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.9 mt -103.48 132.2 49.94 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.582 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 19.2 t -110.02 143.75 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.906 -1.121 . . . . 0.0 109.339 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.531 ' CZ ' ' OE1' ' A' ' 144' ' ' GLN . 36.6 m-85 -120.9 124.1 44.13 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.623 -0.673 . . . . 0.0 110.902 -179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -58.69 -26.93 64.36 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.429 ' O ' ' HB3' ' A' ' 167' ' ' SER . 16.8 mt-30 -122.18 154.21 61.71 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.427 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 26.7 Cg_endo -62.25 -171.34 0.1 OUTLIER 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 123.202 2.601 . . . . 0.0 113.823 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 46.66 29.32 0.93 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.387 0.613 . . . . 0.0 110.026 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.487 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 48.3 m-85 59.34 50.84 7.27 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.639 -0.663 . . . . 0.0 110.28 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.3 p -135.89 162.77 31.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.363 -0.836 . . . . 0.0 109.411 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 98.63 174.76 32.39 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 50.0 mtp180 -54.71 111.7 0.87 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -1.035 . . . . 0.0 109.129 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.4 mt-30 -85.97 143.84 27.94 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -123.58 137.99 54.64 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.553 ' HH ' ' CG ' ' A' ' 131' ' ' HIS . 21.3 t80 -97.35 107.53 20.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 0.0 109.486 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.8 mp -102.62 117.14 34.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 108.584 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.511 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 24.7 ptt180 -103.7 178.37 1.19 Allowed Pre-proline 0 N--CA 1.488 1.44 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.47 ' HA ' ' HB ' ' A' ' 127' ' ' VAL . 71.9 Cg_exo -49.37 162.19 0.58 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.799 1.666 . . . . 0.0 111.805 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.34 -170.58 13.41 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.86 133.19 56.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -1.001 . . . . 0.0 110.506 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.511 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 20.9 m-85 -110.03 144.45 38.57 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.704 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 8.6 ptm180 -141.58 -2.42 1.22 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.877 -1.14 . . . . 0.0 112.251 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.533 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 14.2 m -165.49 166.21 18.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.039 -1.663 . . . . 0.0 110.174 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.6 OUTLIER -54.35 -20.24 6.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.295 -0.878 . . . . 0.0 108.935 179.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -83.15 1.44 40.47 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.879 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.704 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.9 m-20 -90.3 -62.9 1.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.138 -0.976 . . . . 0.0 109.138 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 11.1 p90 -75.88 13.85 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.54 37.95 93.0 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.85 -154.43 21.31 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 99.2 t -153.58 -41.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.4 p -103.61 -153.64 0.48 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 29.5 m -148.87 11.85 0.85 Allowed 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.471 -0.768 . . . . 0.0 109.978 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -66.84 79.49 0.12 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.928 -1.107 . . . . 0.0 112.232 -178.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.7 mtt -107.41 119.78 40.36 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.166 -0.959 . . . . 0.0 109.644 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.79 -26.82 4.01 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.481 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.3 OUTLIER -128.92 150.29 50.43 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.612 -1.522 . . . . 0.0 111.135 -179.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.1 mt -148.16 138.96 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.945 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -122.91 136.42 54.86 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.219 -0.926 . . . . 0.0 110.136 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 172' ' ' THR . 30.6 ptt85 -93.79 86.29 5.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 109.893 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.492 ' C ' ' O ' ' A' ' 170' ' ' ARG . 97.0 mt -34.76 92.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.453 -0.779 . . . . 0.0 109.875 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.557 ' N ' ' O ' ' A' ' 170' ' ' ARG . 25.6 m -136.22 76.92 1.63 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 172' ' ' THR . 0.2 OUTLIER 169.5 109.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.434 -0.791 . . . . 0.0 109.43 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.482 179.742 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.359 0.6 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.17 162.08 32.03 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -162.1 141.24 9.52 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -1.134 . . . . 0.0 109.512 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.581 ' CD1' ' CG ' ' A' ' 43' ' ' PHE . 46.7 mt -129.13 133.95 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.651 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.594 HD12 HH21 ' A' ' 37' ' ' ARG . 47.2 mt -119.6 117.8 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -93.59 136.65 33.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 109.463 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE2' HG22 ' A' ' 5' ' ' ILE . 52.5 m-85 -122.28 131.79 54.09 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.592 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -70.19 -22.45 62.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.215 -0.928 . . . . 0.0 110.61 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.532 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 53.9 t0 -80.64 160.49 25.03 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.876 -1.14 . . . . 0.0 110.326 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 13.7 mmt85 -60.6 -44.5 96.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.365 -0.835 . . . . 0.0 109.803 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -80.08 -102.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.368 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -145.35 43.06 1.29 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.159 -0.963 . . . . 0.0 109.103 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.532 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -133.12 -169.24 12.13 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.06 -156.11 32.24 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.1 ttm-85 -65.58 114.47 4.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.376 . . . . 0.0 109.092 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -98.07 147.52 24.46 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.375 -0.828 . . . . 0.0 109.826 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.639 ' CE1' ' CD1' ' A' ' 29' ' ' TYR . 27.8 t60 -140.46 124.55 17.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.117 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -94.78 118.33 31.57 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.254 -0.904 . . . . 0.0 109.145 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.5 m -118.98 136.39 54.12 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.336 -0.852 . . . . 0.0 109.251 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -140.23 9.15 2.28 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.8 t -142.21 155.98 45.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.321 -0.862 . . . . 0.0 110.417 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 52.8 p30 -55.2 143.98 25.86 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.559 -0.713 . . . . 0.0 110.472 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.5 t -140.58 118.87 12.08 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.59 53.0 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.799 -1.188 . . . . 0.0 109.282 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 39.6 p-10 -134.13 94.27 3.22 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.2 mt -89.28 -18.17 27.53 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.474 ' ND1' ' C ' ' A' ' 27' ' ' HIS . 10.5 t-80 -56.48 -35.58 68.12 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -54.92 -59.27 4.97 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CD1' ' CE1' ' A' ' 17' ' ' HIS . 61.3 m-85 -59.38 -51.69 68.84 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.673 -0.642 . . . . 0.0 110.772 -179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -151.5 150.61 30.58 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.033 -1.042 . . . . 0.0 110.548 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.457 ' OD1' ' CD2' ' A' ' 27' ' ' HIS . 24.3 t30 -98.06 -5.12 34.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 110.334 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -159.04 157.32 30.94 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.563 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 45.4 t -160.28 128.6 4.73 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -107.23 -10.64 15.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.053 . . . . 0.0 109.748 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 t -137.01 138.17 40.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.899 -1.126 . . . . 0.0 110.794 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.3 mt -130.59 143.11 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.594 HH21 HD12 ' A' ' 5' ' ' ILE . 57.9 ttp85 -133.26 116.5 16.25 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.96 -1.087 . . . . 0.0 110.719 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.8 t -104.26 119.88 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -85.87 -29.17 23.9 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.31 -0.868 . . . . 0.0 108.907 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 m -174.86 153.7 1.76 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 118.56 -1.256 . . . . 0.0 111.671 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 103.72 -144.42 15.92 Favored Glycine 0 N--CA 1.49 2.251 0 CA-C-O 122.445 1.025 . . . . 0.0 111.638 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 99.1 m -146.2 149.73 34.5 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.581 ' CG ' ' CD1' ' A' ' 4' ' ' ILE . 7.4 t80 -147.28 137.69 23.36 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.883 -1.136 . . . . 0.0 110.002 -178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.0 tpt -108.85 127.09 53.73 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 56' ' ' TYR . 16.6 m -116.34 145.28 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.114 -0.991 . . . . 0.0 110.364 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 76' ' ' VAL . 55.4 m-85 -120.82 141.48 50.51 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.69 0.757 . . . . 0.0 111.052 -178.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -74.37 -9.88 59.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.991 -0.443 . . . . 0.0 109.997 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.863 ' O ' ' HB3' ' A' ' 78' ' ' SER . 96.1 mtt180 -131.81 160.75 34.69 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.3 p -68.96 162.02 27.64 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 121.767 0.794 . . . . 0.0 111.497 -179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.26 33.46 7.19 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.793 -0.567 . . . . 0.0 111.416 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.48 ' H ' ' CB ' ' A' ' 78' ' ' SER . 1.8 m-85 59.55 58.69 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.026 -1.046 . . . . 0.0 110.199 177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 55.9 mtt -146.28 174.57 11.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.843 -1.16 . . . . 0.0 110.669 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.21 -169.05 51.15 Favored Glycine 0 N--CA 1.501 2.985 0 O-C-N 120.97 -1.081 . . . . 0.0 110.42 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -61.68 129.41 40.91 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.443 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -122.6 154.16 38.33 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.889 -179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' O ' HG22 ' A' ' 45' ' ' VAL . 94.6 m-85 -133.27 138.37 46.42 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.819 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -92.67 118.1 30.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 0.0 108.695 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.0 mt -116.6 115.91 26.6 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.218 -0.926 . . . . 0.0 111.403 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.7 ptt85 -99.39 162.28 13.13 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.268 -0.895 . . . . 0.0 110.839 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' C ' ' O ' ' A' ' 59' ' ' ARG . 77.7 ttt180 -25.77 114.07 0.05 Allowed 'General case' 0 N--CA 1.506 2.341 0 CA-C-O 121.442 0.639 . . . . 0.0 111.099 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.84 172.94 37.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -113.17 127.36 56.16 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.596 -0.944 . . . . 0.0 108.725 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -107.72 99.85 31.81 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 10' ' ' ARG . 56.9 Cg_endo -73.42 -14.86 25.16 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.336 2.024 . . . . 0.0 113.026 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -168.24 140.06 2.86 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.856 -1.152 . . . . 0.0 108.557 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.556 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 25.9 p90 -150.96 36.62 0.62 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.685 -1.26 . . . . 0.0 110.297 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 15.5 mmt -102.97 -46.94 4.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.069 -1.019 . . . . 0.0 109.689 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.82 -16.0 18.22 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -86.39 -17.14 35.18 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 18.8 mtt -116.85 -28.96 6.17 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.03 51.14 4.09 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.068 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 89.3 mtp -119.77 141.66 49.26 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.978 -1.307 . . . . 0.0 109.507 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 85.5 m-20 -97.79 51.95 1.07 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.105 -0.997 . . . . 0.0 109.165 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 3.2 m-20 153.1 -171.86 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.563 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 27.5 p -97.8 -168.18 1.63 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 122.133 0.968 . . . . 0.0 109.925 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 46' ' ' TYR . 42.4 t -75.74 141.43 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -106.36 -17.17 14.36 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 120.572 -1.33 . . . . 0.0 107.813 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.863 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -141.94 164.34 30.45 Favored 'General case' 0 N--CA 1.503 2.188 0 C-N-CA 119.654 -0.818 . . . . 0.0 109.696 178.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . 24.6 p -164.92 152.74 11.57 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.507 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 69.9 ttt-85 -137.7 141.26 41.07 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 58.1 ttp -93.17 151.45 19.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.068 -1.02 . . . . 0.0 108.976 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.496 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 16.4 mm -88.88 129.23 49.23 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.08 -1.012 . . . . 0.0 108.891 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.71 148.13 41.12 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.189 1.926 . . . . 0.0 111.976 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.0 mt -80.19 47.37 0.9 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.306 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -110.99 73.42 0.82 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.506 -0.746 . . . . 0.0 109.496 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -91.5 89.95 7.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.585 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -90.43 -90.86 1.29 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 49.8 m -121.02 148.06 44.65 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.465 -1.02 . . . . 0.0 109.81 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -110.88 120.12 41.33 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.777 . . . . 0.0 109.371 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -171.42 130.12 0.71 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.553 ' SD ' ' SG ' ' A' ' 125' ' ' CYS . 45.0 ttm -115.13 130.78 57.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.924 -1.11 . . . . 0.0 109.329 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -101.51 117.74 35.54 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' MET . 12.3 mt -103.18 150.09 24.02 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.328 1.061 . . . . 0.0 112.369 -177.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 99' ' ' MET . 37.0 m-85 -137.4 125.83 23.44 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -63.48 -24.22 67.73 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.0 112.07 -177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.84 ' O ' ' OG ' ' A' ' 124' ' ' SER . 7.5 m-70 -110.94 165.22 12.04 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.371 -1.456 . . . . 0.0 110.651 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 37.4 m -60.03 158.86 10.27 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.117 -0.989 . . . . 0.0 110.044 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.534 ' O ' ' SD ' ' A' ' 99' ' ' MET . 1.0 OUTLIER 78.42 -96.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.407 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.588 ' O ' ' CD2' ' A' ' 94' ' ' TYR . 21.7 mmt -161.76 35.86 0.13 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.43 -158.31 28.9 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.293 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 61.73 -172.43 8.27 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.641 -1.784 . . . . 0.0 108.641 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -72.36 136.0 46.03 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.985 -1.303 . . . . 0.0 109.47 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.465 ' O ' ' CG ' ' A' ' 103' ' ' MET . 5.2 ptt? -96.79 121.31 38.51 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.214 -0.929 . . . . 0.0 110.307 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.634 ' SD ' ' CD2' ' A' ' 117' ' ' PHE . 13.9 mtm -118.46 139.83 50.81 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.182 -0.948 . . . . 0.0 109.206 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 mp0 -100.37 138.19 37.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.438 -0.789 . . . . 0.0 109.49 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.612 HD13 ' SG ' ' A' ' 110' ' ' CYS . 16.8 tp -128.31 118.01 22.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 47.6 ttm -123.54 -18.53 6.13 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.446 -0.784 . . . . 0.0 109.234 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.49 ' O ' HD11 ' A' ' 106' ' ' LEU . 52.4 p30 -106.8 -170.21 1.68 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.301 -0.874 . . . . 0.0 109.831 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -76.62 130.56 38.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 0.0 108.819 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.612 ' SG ' HD13 ' A' ' 106' ' ' LEU . 0.5 OUTLIER -111.3 78.86 1.95 Allowed Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.092 -1.005 . . . . 0.0 109.358 -179.351 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.71 -27.09 7.65 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.1 1.867 . . . . 0.0 112.407 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.464 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 7.8 t30 -136.05 83.21 1.99 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.0 mt -65.41 -25.85 67.72 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.979 . . . . 0.0 109.99 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 7.6 tpt -55.09 -40.38 70.36 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.858 0.837 . . . . 0.0 109.113 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.464 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 93.1 m-20 -81.01 -23.19 38.82 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 110.4 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -74.47 -61.92 1.7 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.622 -1.299 . . . . 0.0 110.629 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.634 ' CD2' ' SD ' ' A' ' 104' ' ' MET . 0.9 OUTLIER -118.92 5.39 11.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.425 -0.797 . . . . 0.0 110.547 -178.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 55.53 41.12 31.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.574 -1.329 . . . . 0.0 107.464 -178.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.4 tpt -143.05 122.41 13.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.2 t -111.82 6.68 19.8 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.269 -0.895 . . . . 0.0 110.191 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 163' ' ' SER . 1.8 m-20 -143.39 101.79 3.85 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 120.413 -1.43 . . . . 0.0 113.699 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.644 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 1.2 m-85 -109.49 140.57 43.08 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.49 -0.756 . . . . 0.0 109.152 178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.442 ' N ' ' CD2' ' A' ' 123' ' ' HIS . 8.1 m-70 -96.81 3.15 52.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.008 -1.057 . . . . 0.0 111.103 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.84 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -148.98 154.18 38.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.172 -1.58 . . . . 0.0 110.375 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.553 ' SG ' ' SD ' ' A' ' 91' ' ' MET . 15.4 t -162.19 162.11 28.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.263 -0.898 . . . . 0.0 110.065 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.56 ' CD2' ' N ' ' A' ' 127' ' ' VAL . 0.4 OUTLIER -149.13 143.47 26.0 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.139 -0.975 . . . . 0.0 109.693 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.56 ' N ' ' CD2' ' A' ' 126' ' ' HIS . 71.6 t -113.59 121.7 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.932 . . . . 0.0 109.381 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.408 ' O ' ' CG ' ' A' ' 129' ' ' ASP . 25.1 ttt -72.47 -34.97 68.1 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 88' ' ' SER . 1.0 OUTLIER 176.71 174.38 0.39 Allowed 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.942 -179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.15 -164.87 54.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.646 ' CE1' ' HH ' ' A' ' 146' ' ' TYR . 91.8 m-70 -124.66 132.38 53.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.386 -1.067 . . . . 0.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -122.14 129.55 52.42 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.682 . . . . 0.0 111.412 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -101.58 131.86 47.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 22.0 t -107.83 139.97 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.98 -1.075 . . . . 0.0 109.878 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.408 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 53.9 m-85 -116.38 125.09 51.57 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.554 -0.716 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -60.02 -26.74 66.34 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.1 mp0 -122.71 154.07 63.42 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.523 ' O ' ' OG1' ' A' ' 141' ' ' THR . 24.1 Cg_endo -61.48 -176.66 0.19 Allowed 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.203 2.602 . . . . 0.0 113.358 -178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 51.71 33.37 10.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.516 -0.74 . . . . 0.0 110.58 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.408 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 39.8 m-85 55.08 47.65 21.46 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.592 -0.693 . . . . 0.0 110.048 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.523 ' OG1' ' O ' ' A' ' 138' ' ' PRO . 13.7 p -134.44 164.22 27.92 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.51 -0.744 . . . . 0.0 109.228 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 101.05 173.89 28.96 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -54.02 115.14 1.88 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.122 -1.222 . . . . 0.0 109.001 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 32.4 mt-30 -84.75 142.11 30.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -125.83 128.87 48.32 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.646 ' HH ' ' CE1' ' A' ' 131' ' ' HIS . 20.6 t80 -90.93 99.47 12.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.271 -0.893 . . . . 0.0 109.831 -178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 147' ' ' LEU . 7.0 mp -96.09 124.31 40.05 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.769 0.795 . . . . 0.0 109.078 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.437 ' HB2' ' HD2' ' A' ' 149' ' ' PRO . 20.0 ptt-85 -112.16 178.27 1.01 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 148' ' ' ARG . 85.2 Cg_exo -43.42 165.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.828 1.685 . . . . 0.0 111.809 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 110.01 177.53 21.01 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -109.55 135.41 50.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.525 -0.985 . . . . 0.0 110.399 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 152' ' ' TYR . 19.7 m-85 -109.93 143.44 39.88 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.59 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 42.9 ptt85 -134.9 -4.4 2.48 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.883 -1.136 . . . . 0.0 112.598 -177.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.535 ' N ' ' OD2' ' A' ' 157' ' ' ASP . 4.7 m -171.57 162.71 6.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 119.952 -1.718 . . . . 0.0 110.128 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -51.66 -9.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.313 -0.867 . . . . 0.0 109.59 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' A' ' 154' ' ' SER . 0.6 OUTLIER -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.048 -1.032 . . . . 0.0 108.892 179.823 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.59 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 8.2 m-20 -92.46 -61.1 1.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 109.144 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.546 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 14.4 p90 -75.76 15.55 0.5 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.527 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 66.3 37.69 93.07 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -105.72 -177.06 23.93 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 162' ' ' THR . 2.8 m -139.03 10.15 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' O ' ' A' ' 161' ' ' VAL . 52.1 p -158.26 -158.21 0.7 Allowed 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 3.8 m -143.61 11.74 1.67 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.213 -0.929 . . . . 0.0 110.178 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -62.74 72.99 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.937 -1.102 . . . . 0.0 112.118 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 163' ' ' SER . 60.2 mtt -105.91 115.95 31.1 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.916 -1.115 . . . . 0.0 110.565 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.87 -22.12 6.11 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.5 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.2 OUTLIER -132.92 149.83 52.21 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.368 -1.666 . . . . 0.0 111.107 -179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 12.8 mt -148.21 141.89 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.744 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.9 ttp85 -124.84 140.53 52.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.357 -0.839 . . . . 0.0 110.062 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 172' ' ' THR . 13.4 ptt180 -100.0 102.53 13.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 131' ' ' HIS . 3.5 mt -51.26 68.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.761 -0.587 . . . . 0.0 111.602 -178.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.671 ' N ' ' O ' ' A' ' 170' ' ' ARG . 14.4 m -131.13 78.74 1.85 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 0.0 110.466 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 0.9 OUTLIER 168.75 111.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.284 -0.885 . . . . 0.0 108.806 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.271 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -52.72 154.66 5.75 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -129.83 139.8 51.14 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.419 -1.047 . . . . 0.0 110.637 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.678 HD11 HD11 ' A' ' 36' ' ' ILE . 19.1 tt -133.48 128.99 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 110.066 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.5 mt -116.26 132.17 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.657 -0.652 . . . . 0.0 109.825 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.592 ' CE2' HD12 ' A' ' 36' ' ' ILE . 86.6 m-85 -97.56 146.07 25.63 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -133.63 135.51 44.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.0 109.295 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -72.87 -45.03 60.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 110.45 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.462 ' HB3' ' H ' ' A' ' 13' ' ' GLY . 12.8 t70 -78.72 151.38 32.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -67.21 -34.89 78.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.373 -0.83 . . . . 0.0 110.073 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -85.65 40.67 0.86 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.042 -1.036 . . . . 0.0 109.848 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 52.89 54.38 10.57 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.903 . . . . 0.0 109.696 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.462 ' H ' ' HB3' ' A' ' 9' ' ' ASP . . . -139.34 -153.84 6.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 60.88 -148.04 46.02 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -76.46 119.0 19.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.54 -0.976 . . . . 0.0 109.476 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -100.82 157.94 16.34 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.517 -0.739 . . . . 0.0 109.605 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -149.48 123.93 9.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.187 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -97.72 124.72 42.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.093 -1.004 . . . . 0.0 109.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 m -123.7 136.76 54.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.162 -0.961 . . . . 0.0 109.596 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -135.46 11.78 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.0 p -146.21 163.12 36.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.515 -0.741 . . . . 0.0 109.623 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -59.52 144.36 47.54 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.639 0.733 . . . . 0.0 110.646 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.4 t -139.03 118.35 12.77 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.42 -12.19 46.9 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.033 -1.042 . . . . 0.0 109.66 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 40.3 p-10 -132.28 98.04 4.29 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 79' ' ' CYS . 21.4 mt -96.3 -19.29 19.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.604 ' NE2' ' ND2' ' A' ' 31' ' ' ASN . 14.4 t-80 -58.05 -40.82 81.91 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.309 -0.869 . . . . 0.0 108.994 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.0 m -52.03 -44.94 64.44 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -70.44 -46.07 64.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.137 -0.977 . . . . 0.0 110.756 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 27.6 p90 -154.46 151.89 29.49 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.976 -1.077 . . . . 0.0 109.846 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.604 ' ND2' ' NE2' ' A' ' 27' ' ' HIS . 3.1 m120 -95.97 -5.67 40.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.245 -0.91 . . . . 0.0 110.078 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -161.36 159.68 28.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.954 . . . . 0.0 108.649 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.557 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 20.5 t -160.13 120.08 2.89 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.502 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 0.3 OUTLIER -95.96 -14.86 22.73 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.602 -0.686 . . . . 0.0 110.345 -179.154 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.511 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.9 m -135.54 147.07 48.65 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.645 -1.284 . . . . 0.0 110.859 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.678 HD11 HD11 ' A' ' 4' ' ' ILE . 20.4 tt -148.09 148.51 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -136.22 122.87 21.0 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.824 -1.173 . . . . 0.0 112.076 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -108.05 120.8 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -91.37 -28.87 17.43 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 110.6 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -159.71 152.55 21.62 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.966 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.19 -159.48 52.65 Favored Glycine 0 N--CA 1.478 1.495 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 -178.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -132.85 178.69 6.68 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.661 -0.905 . . . . 0.0 109.305 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.34 140.79 19.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.68 -1.263 . . . . 0.0 109.203 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 12.5 tpt -101.02 117.57 35.29 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -110.2 143.35 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.874 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.675 ' O ' HG13 ' A' ' 76' ' ' VAL . 26.4 m-85 -122.17 142.0 50.87 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.698 0.761 . . . . 0.0 111.011 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 29.8 t0 -75.56 -6.65 51.36 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.865 ' O ' ' HB3' ' A' ' 78' ' ' SER . 36.5 ttt180 -131.23 157.87 42.08 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.312 -0.867 . . . . 0.0 108.709 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 39.6 p -69.04 160.7 30.49 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.708 0.765 . . . . 0.0 111.295 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.75 32.89 6.56 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.7 -0.625 . . . . 0.0 111.326 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.477 ' HA ' ' CG ' ' A' ' 46' ' ' TYR . 2.5 m-85 60.63 59.99 2.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.2 -0.937 . . . . 0.0 109.371 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.444 ' O ' ' HB3' ' A' ' 46' ' ' TYR . 58.2 mtt -147.76 171.17 16.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.1 -1.0 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 86.47 -170.76 42.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -54.19 122.25 9.89 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.074 -1.25 . . . . 0.0 107.633 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -103.83 135.83 44.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 108.804 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -129.36 137.56 51.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.356 -0.84 . . . . 0.0 109.427 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -100.65 119.61 38.83 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.162 -0.961 . . . . 0.0 109.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.0 mt -117.15 121.99 42.81 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.031 -1.043 . . . . 0.0 112.164 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -84.54 166.56 17.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.388 -0.82 . . . . 0.0 109.888 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' CZ ' ' OXT' ' A' ' 174' ' ' LEU . 31.7 ptt180 -52.4 123.16 10.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.144 -0.973 . . . . 0.0 110.198 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.32 171.7 39.55 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 62' ' ' GLU . 9.9 pt-20 -102.27 126.73 49.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -1.137 . . . . 0.0 108.712 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -113.02 99.65 49.23 Favored Pre-proline 0 N--CA 1.49 1.525 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 51.7 Cg_endo -73.09 -11.99 25.53 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.357 2.038 . . . . 0.0 112.429 -178.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 64' ' ' PRO . 43.8 m-20 -165.14 136.87 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.471 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 27.7 p90 -149.64 21.66 0.91 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.669 -1.27 . . . . 0.0 110.919 -179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 44.0 mtp -97.29 -41.33 8.31 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.923 -1.111 . . . . 0.0 109.752 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -93.6 -25.56 17.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.119 -0.988 . . . . 0.0 109.29 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -81.76 -20.62 38.9 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.278 -0.889 . . . . 0.0 109.549 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 7.6 mtp -101.29 -25.65 13.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.875 -1.141 . . . . 0.0 109.966 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.11 57.19 2.87 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.4 mtp -130.04 140.15 50.9 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.245 -1.15 . . . . 0.0 109.683 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.536 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 2.8 p-10 -93.07 53.64 2.01 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.235 -0.915 . . . . 0.0 109.306 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.1 p30 152.98 -171.16 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.557 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 26.6 p -97.72 -167.02 1.46 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 46' ' ' TYR . 59.5 t -77.73 140.96 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -105.81 -17.0 14.51 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.577 -1.327 . . . . 0.0 107.827 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.865 ' HB3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -139.34 157.96 44.98 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.079 -1.013 . . . . 0.0 109.87 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB3' HD11 ' A' ' 26' ' ' LEU . 15.7 p -153.03 143.35 22.48 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.622 0.725 . . . . 0.0 110.432 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.418 HH22 ' CG ' ' A' ' 83' ' ' PRO . 78.0 ttt-85 -137.71 140.22 40.6 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.7 ttp -90.72 151.23 21.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.727 HD12 ' N ' ' A' ' 82' ' ' ILE . 2.1 mp -74.02 123.22 89.08 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.054 -1.028 . . . . 0.0 109.197 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' CG ' HH22 ' A' ' 80' ' ' ARG . 73.2 Cg_exo -45.71 177.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.337 2.025 . . . . 0.0 112.549 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.3 mt -102.65 64.8 0.89 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.409 -0.807 . . . . 0.0 109.617 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -46.25 147.73 1.04 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.168 -0.958 . . . . 0.0 109.739 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.414 ' N ' ' CD2' ' A' ' 86' ' ' HIS . 0.4 OUTLIER -151.27 33.13 0.58 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.024 -1.047 . . . . 0.0 109.591 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -129.06 -90.61 0.62 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.42 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 17.4 m -164.93 -171.32 2.21 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.61 -0.935 . . . . 0.0 110.148 -179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -120.38 128.66 53.43 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.598 0.713 . . . . 0.0 109.958 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -168.93 125.37 0.94 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 37.0 ttm -116.72 135.84 53.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 0.0 109.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -106.62 118.03 35.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 103' ' ' MET . 19.4 mt -101.29 148.5 25.06 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.257 1.027 . . . . 0.0 112.514 -177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.522 ' CD2' ' SD ' ' A' ' 99' ' ' MET . 38.2 m-85 -132.27 121.88 24.29 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 178.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' HB3' ' HA3' ' A' ' 101' ' ' GLY . 88.3 tt0 -61.88 -27.86 69.1 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.171 -0.956 . . . . 0.0 111.055 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.557 ' O ' ' HB3' ' A' ' 124' ' ' SER . 2.5 m-70 -108.06 164.26 12.44 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.523 -1.361 . . . . 0.0 111.062 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.577 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 75.0 p -61.88 157.83 17.45 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.514 -0.741 . . . . 0.0 109.731 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.577 ' CB ' ' O ' ' A' ' 97' ' ' SER . 29.8 t0 83.47 -95.55 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.078 -1.014 . . . . 0.0 108.763 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.522 ' SD ' ' CD2' ' A' ' 94' ' ' TYR . 21.1 mmt -163.54 30.88 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -98.05 -155.56 29.68 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.471 ' CA ' ' CG ' ' A' ' 96' ' ' HIS . . . 60.29 -179.24 2.62 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -67.42 132.0 46.8 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -1.078 . . . . 0.0 109.279 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 11.8 ptt? -93.67 118.24 31.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 110.174 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 119' ' ' MET . 10.3 mtm -119.51 140.73 50.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.966 . . . . 0.0 109.053 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -100.71 137.8 38.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.177 -0.952 . . . . 0.0 109.508 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 110' ' ' CYS . 0.8 OUTLIER -120.65 117.53 27.77 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.604 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 14.9 ttt -129.96 27.45 5.16 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.495 ' CG ' ' H ' ' A' ' 109' ' ' ASP . 17.0 t70 -151.31 -172.26 4.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.405 -0.81 . . . . 0.0 109.518 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.495 ' H ' ' CG ' ' A' ' 108' ' ' ASP . 90.1 m-20 -82.95 131.18 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.435 ' SG ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -111.8 84.19 5.21 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.14 -0.975 . . . . 0.0 110.031 -178.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 167' ' ' SER . 58.4 Cg_endo -77.37 -28.59 5.49 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.243 1.962 . . . . 0.0 111.937 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 112' ' ' ASN . 22.3 p30 -138.17 82.82 1.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' CD2' ' SG ' ' A' ' 110' ' ' CYS . 8.3 mt -63.15 -22.95 67.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.328 -0.858 . . . . 0.0 109.351 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.445 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 8.1 tpt -58.6 -40.67 83.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.592 0.711 . . . . 0.0 109.414 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -81.57 -22.24 37.91 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.063 -1.023 . . . . 0.0 110.335 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -77.57 -64.41 1.15 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.709 -1.244 . . . . 0.0 111.376 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -108.36 3.03 22.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.497 -0.752 . . . . 0.0 110.61 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 114' ' ' MET . 2.4 m-20 54.4 34.6 21.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.886 -1.134 . . . . 0.0 108.932 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.581 ' SD ' ' SD ' ' A' ' 104' ' ' MET . 8.6 ptm -148.06 133.65 18.78 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 54.6 p -116.92 7.55 13.26 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 110.519 -178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 163' ' ' SER . 73.6 m-20 -131.3 93.16 3.31 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.361 -1.462 . . . . 0.0 113.379 -178.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.656 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -105.19 133.87 49.23 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.04 4.07 54.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.992 -1.067 . . . . 0.0 111.688 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.557 ' HB3' ' O ' ' A' ' 96' ' ' HIS . 3.2 t -156.23 161.5 40.26 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 119.758 -1.839 . . . . 0.0 110.502 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.48 170.54 6.89 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.968 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.86 145.81 25.91 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 76.2 t -113.8 123.37 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.2 tpp -78.13 -34.15 50.09 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' A' ' 130' ' ' GLY . 11.7 t70 -177.46 175.77 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.155 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.521 ' N ' ' CG ' ' A' ' 129' ' ' ASP . . . 78.37 -142.2 25.74 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.523 ' CD2' ' OH ' ' A' ' 146' ' ' TYR . 39.8 m80 -151.51 135.26 16.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.662 -0.905 . . . . 0.0 109.094 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 37.9 m95 -126.02 132.21 52.03 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.052 -1.03 . . . . 0.0 112.269 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.4 mt -104.08 133.09 49.61 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 53.4 t -111.9 144.39 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.752 -1.218 . . . . 0.0 109.64 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.535 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 47.8 m-85 -120.73 123.37 42.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.551 -0.718 . . . . 0.0 111.128 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 164' ' ' ARG . 80.2 tt0 -57.03 -28.03 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -118.02 155.69 50.98 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.501 ' HA ' ' OG ' ' A' ' 167' ' ' SER . 25.1 Cg_endo -62.0 -177.12 0.24 Allowed 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 123.313 2.675 . . . . 0.0 113.661 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.589 ' N ' ' OG ' ' A' ' 167' ' ' SER . 66.6 m-20 48.67 35.49 6.33 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.622 0.725 . . . . 0.0 110.545 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.726 ' H ' ' CB ' ' A' ' 167' ' ' SER . 8.1 m-85 55.5 52.09 11.75 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.751 -0.593 . . . . 0.0 109.984 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 142' ' ' GLY . 90.5 m -136.94 162.54 32.99 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.119 -0.988 . . . . 0.0 109.77 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 141' ' ' THR . . . 98.45 -179.99 32.18 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 88.8 mtt-85 -54.2 109.89 0.54 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -1.045 . . . . 0.0 108.737 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 3.5 mt-30 -84.58 141.75 30.46 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 109.889 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -123.8 132.28 53.75 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.523 ' OH ' ' CD2' ' A' ' 131' ' ' HIS . 65.6 t80 -94.78 105.47 17.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.369 -0.832 . . . . 0.0 109.763 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.9 mp -100.47 121.5 41.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.362 -0.836 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.567 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 2.2 ptt180 -109.48 164.14 15.44 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.463 ' O ' ' O ' ' A' ' 148' ' ' ARG . 99.5 Cg_exo -32.12 154.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.76 2.307 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.81 -166.59 13.91 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -120.95 135.05 55.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -1.002 . . . . 0.0 110.332 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.567 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 91.6 m-85 -109.77 144.3 38.39 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.62 ' H ' ' CG ' ' A' ' 157' ' ' ASP . 93.4 mtt180 -129.84 -12.09 4.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.093 -1.004 . . . . 0.0 112.572 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.54 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 46.3 p -170.29 170.24 7.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 119.966 -1.709 . . . . 0.0 110.538 -179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.547 ' HA ' ' CE2' ' A' ' 158' ' ' TRP . 0.1 OUTLIER -53.4 -19.12 3.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.645 -0.659 . . . . 0.0 109.606 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 36.1 m120 -84.72 2.23 42.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.069 -1.019 . . . . 0.0 108.961 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.62 ' CG ' ' H ' ' A' ' 153' ' ' ARG . 1.2 m-20 -94.88 -57.78 2.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -0.885 . . . . 0.0 110.098 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.547 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 8.4 p90 -79.32 17.91 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 178.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 65.89 42.37 94.97 Favored Glycine 0 N--CA 1.485 1.934 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -109.73 -169.51 20.13 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.518 ' O ' HG23 ' A' ' 162' ' ' THR . 4.2 m -151.66 14.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 161' ' ' VAL . 34.8 p -160.6 -163.7 1.12 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 16.8 p -137.77 5.29 2.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.373 -0.829 . . . . 0.0 109.732 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 136' ' ' GLU . 88.5 mtt180 -65.89 73.8 0.07 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 0.0 112.266 -177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 55.2 mtt -102.45 117.94 35.79 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.193 -0.942 . . . . 0.0 109.502 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -111.93 -26.62 4.33 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.726 ' CB ' ' H ' ' A' ' 140' ' ' TYR . 0.9 OUTLIER -134.0 151.6 51.51 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.618 -1.519 . . . . 0.0 111.601 -179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 13.6 mt -147.07 141.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.99 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -126.72 140.95 52.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.221 -0.924 . . . . 0.0 110.632 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.755 ' O ' ' N ' ' A' ' 172' ' ' THR . 30.3 mtp180 -94.62 102.72 14.65 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.284 -0.885 . . . . 0.0 108.939 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -45.57 69.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.521 -0.737 . . . . 0.0 112.136 -178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.755 ' N ' ' O ' ' A' ' 170' ' ' ARG . 20.6 p -116.78 64.64 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.161 -0.962 . . . . 0.0 110.357 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -175.5 104.92 0.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.224 -0.923 . . . . 0.0 109.304 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.482 ' OXT' ' CZ ' ' A' ' 60' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.047 -0.977 . . . . 0.0 109.902 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 mtm . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.289 0.566 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.425 ' CA ' ' O ' ' A' ' 40' ' ' SER . . . -63.04 162.31 31.86 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -151.87 145.06 24.63 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.468 -1.019 . . . . 0.0 110.555 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.509 HD13 ' CD2' ' A' ' 43' ' ' PHE . 15.2 tt -133.44 135.17 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.881 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.3 mt -119.36 128.73 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -93.84 154.51 17.69 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -141.12 133.93 28.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.691 -1.256 . . . . 0.0 108.927 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -72.2 -33.36 67.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 111.296 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -87.8 151.06 23.16 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.721 -1.237 . . . . 0.0 110.601 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.525 HH12 ' CG ' ' A' ' 65' ' ' ASP . 84.3 mtt-85 -67.34 -39.87 85.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.513 -0.742 . . . . 0.0 109.876 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -80.86 38.07 0.44 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.217 -0.927 . . . . 0.0 109.847 -179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 54.01 64.2 1.91 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.291 -0.88 . . . . 0.0 109.471 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -153.91 -157.68 8.24 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.16 -151.12 51.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -71.85 121.12 18.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -1.147 . . . . 0.0 108.961 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -102.83 157.86 16.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 0.0 110.247 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.629 ' NE2' ' CD1' ' A' ' 29' ' ' TYR . 17.3 t-80 -149.08 124.61 10.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.542 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -98.44 118.15 34.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.137 -0.977 . . . . 0.0 109.042 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.595 ' SG ' ' ND1' ' A' ' 17' ' ' HIS . 2.7 m -119.57 139.64 51.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.165 -0.959 . . . . 0.0 109.332 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.0 ptt? -144.16 8.33 1.41 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.5 t -140.66 154.01 46.22 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.469 -0.769 . . . . 0.0 110.735 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 54.0 p30 -47.94 154.43 0.53 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.477 -0.765 . . . . 0.0 110.295 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 15.3 t -154.99 111.79 3.28 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.97 -1.56 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.461 ' OD1' ' SG ' ' A' ' 23' ' ' CYS . 42.1 p-10 -142.96 99.42 3.46 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.683 -0.636 . . . . 0.0 110.228 -179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 76' ' ' VAL . 27.7 mt -97.8 -22.35 16.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.031 -1.043 . . . . 0.0 109.079 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' PHE . 21.1 t-80 -55.98 -37.15 68.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.27 -0.894 . . . . 0.0 108.668 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.9 t -49.05 -52.88 22.89 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CD1' ' NE2' ' A' ' 17' ' ' HIS . 50.8 m-85 -63.31 -45.64 90.39 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 0.0 111.319 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 27' ' ' HIS . 20.3 p90 -155.19 151.0 27.64 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.018 -1.051 . . . . 0.0 110.091 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -92.53 -3.59 54.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.119 -0.988 . . . . 0.0 110.117 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -164.72 162.45 21.25 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.542 ' N ' ' HB3' ' A' ' 75' ' ' CYS . 42.2 t -161.64 131.28 4.69 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 65' ' ' ASP . 84.4 m-70 -110.49 -7.98 14.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.079 -1.013 . . . . 0.0 109.276 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.407 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.0 m -135.2 142.8 46.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.931 -1.106 . . . . 0.0 110.459 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -136.28 145.82 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 66.1 ttt180 -135.87 116.46 13.85 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.889 -1.132 . . . . 0.0 111.204 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.4 ' HB ' ' H ' ' A' ' 61' ' ' GLY . 21.7 t -103.82 118.69 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -89.65 -28.56 19.4 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.425 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.0 t -169.89 146.33 3.13 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.446 -1.302 . . . . 0.0 111.493 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.581 ' O ' ' SG ' ' A' ' 42' ' ' CYS . . . 96.14 -130.74 10.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 41' ' ' GLY . 62.7 m -160.88 155.91 24.23 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 178.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.509 ' CD2' HD13 ' A' ' 4' ' ' ILE . 5.3 t80 -140.48 131.87 26.81 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.082 -1.011 . . . . 0.0 109.012 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 10.4 tpt -98.19 112.86 24.69 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -107.51 141.84 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 121.885 0.85 . . . . 0.0 110.411 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.612 ' O ' HG13 ' A' ' 76' ' ' VAL . 28.0 m-85 -118.13 137.38 52.99 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.887 0.851 . . . . 0.0 111.046 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 47' ' ' ASP . 42.7 t0 -71.43 -11.68 61.01 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.491 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.734 ' O ' ' HB2' ' A' ' 78' ' ' SER . 26.2 ttt-85 -127.88 157.66 39.89 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.122 -0.986 . . . . 0.0 108.436 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.501 ' HA ' ' OG ' ' A' ' 78' ' ' SER . 18.9 p -68.79 158.08 35.11 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.632 -0.667 . . . . 0.0 111.475 -178.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.584 ' N ' ' OG ' ' A' ' 78' ' ' SER . 18.3 m-20 67.41 36.69 3.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.523 -0.736 . . . . 0.0 111.635 178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.455 ' C ' ' CD2' ' A' ' 46' ' ' TYR . 1.8 m-85 58.25 59.56 2.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.452 -0.78 . . . . 0.0 109.405 177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 56.7 mtt -145.38 167.06 23.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.753 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.69 -165.63 33.69 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -60.22 124.01 18.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -103.09 136.71 42.39 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -131.96 138.48 48.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.323 -0.861 . . . . 0.0 109.85 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.52 ' CG ' ' O ' ' A' ' 57' ' ' PHE . 38.6 p90 -101.83 122.68 44.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.304 -0.872 . . . . 0.0 109.556 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.2 mt -113.06 117.5 32.18 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.933 -1.105 . . . . 0.0 111.555 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' O ' ' C ' ' A' ' 60' ' ' ARG . 34.0 ptt180 -92.71 157.03 16.66 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.271 -0.893 . . . . 0.0 111.209 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' C ' ' O ' ' A' ' 59' ' ' ARG . 68.9 ttt180 -31.99 109.48 0.06 Allowed 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.43 0.633 . . . . 0.0 110.691 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 38' ' ' VAL . . . 178.07 168.58 37.76 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -103.92 123.26 46.83 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.04 98.1 12.88 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.55 -20.06 65.45 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.254 1.969 . . . . 0.0 112.015 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.525 ' CG ' HH12 ' A' ' 10' ' ' ARG . 15.2 t0 -167.07 147.01 5.45 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' O ' ' CD2' ' A' ' 66' ' ' TYR . 28.5 p90 -148.22 25.0 1.01 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.256 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 7.3 mmt -95.61 -42.35 8.46 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.373 -0.83 . . . . 0.0 109.427 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -98.09 -17.1 19.28 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.53 -10.52 45.89 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.143 -1.023 . . . . 0.0 108.715 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.8 mmt -114.32 -33.8 5.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.26 53.15 3.74 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtp -121.72 143.83 49.14 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.486 -1.008 . . . . 0.0 109.35 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.556 ' O ' ' CB ' ' A' ' 74' ' ' ASP . 29.8 t30 -94.27 57.57 2.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.16 -0.962 . . . . 0.0 109.174 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.556 ' CB ' ' O ' ' A' ' 73' ' ' ASN . 4.9 p30 150.35 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.542 ' HB3' ' N ' ' A' ' 33' ' ' CYS . 28.4 p -100.42 -167.59 1.46 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.935 0.874 . . . . 0.0 109.544 179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 46' ' ' TYR . 54.3 t -74.72 139.81 18.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.442 ' HB3' HG22 ' A' ' 49' ' ' THR . 93.4 mtt180 -107.54 -13.84 14.97 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.616 -1.303 . . . . 0.0 108.335 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.734 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -149.11 165.84 30.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.963 -1.086 . . . . 0.0 109.533 177.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 30.2 p -163.04 154.44 17.43 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.967 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.507 ' CZ ' ' NH1' ' A' ' 148' ' ' ARG . 59.0 ttt180 -136.13 141.18 44.12 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 ptm -88.33 142.35 27.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.078 -1.014 . . . . 0.0 109.085 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.547 ' CG2' ' CD2' ' A' ' 131' ' ' HIS . 90.4 mt -93.92 113.73 61.29 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.224 -0.922 . . . . 0.0 108.699 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.77 150.56 2.49 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.121 1.88 . . . . 0.0 112.383 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.4 mt -92.49 47.35 1.3 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.876 . . . . 0.0 109.523 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -112.64 132.25 55.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.482 -0.761 . . . . 0.0 109.104 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -135.83 73.34 1.46 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.317 -0.864 . . . . 0.0 109.711 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -76.18 -85.96 0.37 Allowed Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.3 m -125.49 149.83 47.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.347 -1.09 . . . . 0.0 110.708 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -114.3 121.14 42.74 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.57 -0.707 . . . . 0.0 109.891 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -170.32 128.27 0.84 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.446 ' CG ' ' SG ' ' A' ' 125' ' ' CYS . 40.9 ttm -112.2 130.69 55.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.97 -1.081 . . . . 0.0 109.289 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -104.69 116.15 31.55 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 103' ' ' MET . 13.1 mt -100.46 149.0 24.13 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.112 0.958 . . . . 0.0 112.556 -177.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.544 ' CD1' ' O ' ' A' ' 99' ' ' MET . 31.2 m-85 -135.04 125.0 25.65 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB3' ' H ' ' A' ' 102' ' ' ARG . 86.1 tt0 -63.28 -22.76 67.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.853 -1.154 . . . . 0.0 111.767 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.844 ' O ' ' OG ' ' A' ' 124' ' ' SER . 3.0 m-70 -113.61 162.42 16.23 Favored 'General case' 0 N--CA 1.508 2.471 0 O-C-N 120.132 -1.605 . . . . 0.0 111.504 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.547 ' O ' ' CB ' ' A' ' 98' ' ' ASP . 25.2 p -59.19 158.54 8.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.302 -0.874 . . . . 0.0 109.676 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 97' ' ' SER . 5.8 m-20 81.64 -96.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.544 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 17.1 mmt -163.68 30.95 0.08 Allowed 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -96.18 -159.93 32.41 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 67.76 -162.89 47.69 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 108.92 -1.672 . . . . 0.0 108.92 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.451 ' O ' ' HE3' ' A' ' 104' ' ' MET . 57.7 mtp180 -85.81 139.09 31.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -1.172 . . . . 0.0 109.218 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 4.7 ptt? -95.81 113.65 25.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.007 -1.058 . . . . 0.0 110.262 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.451 ' HE3' ' O ' ' A' ' 102' ' ' ARG . 1.3 mpt? -110.66 140.46 45.0 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.59 136.6 43.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -0.886 . . . . 0.0 109.422 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.3 tp -130.8 120.76 24.21 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 13.9 ttt -117.83 -15.84 10.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.227 -0.921 . . . . 0.0 109.592 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 108' ' ' ASP . 52.6 p30 -107.63 -157.71 0.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.519 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 109' ' ' ASP . 17.8 p-10 -93.85 138.1 32.37 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -118.99 86.3 31.17 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.204 -0.935 . . . . 0.0 110.354 -179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -76.81 -28.13 6.58 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.178 1.919 . . . . 0.0 112.143 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 115' ' ' ASP . 5.9 t30 -129.74 83.9 2.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.2 mt -69.34 -27.63 65.52 Favored 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.411 -0.806 . . . . 0.0 109.518 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.616 ' O ' ' HA ' ' A' ' 118' ' ' ASN . 10.7 mtp -55.41 -39.15 69.86 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.664 0.745 . . . . 0.0 109.203 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.487 ' CG ' ' ND2' ' A' ' 112' ' ' ASN . 94.9 m-20 -84.84 -20.94 30.09 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.242 -0.912 . . . . 0.0 110.294 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -77.32 -62.3 1.7 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.654 -1.278 . . . . 0.0 110.334 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -109.02 1.71 20.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.665 -0.647 . . . . 0.0 110.455 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 114' ' ' MET . 3.2 m120 57.66 36.62 26.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.99 -1.068 . . . . 0.0 109.83 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.453 ' CG ' ' CE2' ' A' ' 122' ' ' PHE . 8.7 ptm -152.44 136.36 16.34 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 81.4 p -114.41 8.0 16.46 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.514 -0.741 . . . . 0.0 110.06 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 163' ' ' SER . 46.5 p-10 -134.42 98.56 4.12 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.348 -1.47 . . . . 0.0 113.898 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.688 ' CD1' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -109.62 134.61 51.75 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -96.83 4.4 51.71 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.015 -1.053 . . . . 0.0 111.478 -178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.844 ' OG ' ' O ' ' A' ' 96' ' ' HIS . 2.8 p -151.02 156.66 41.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 119.93 -1.731 . . . . 0.0 110.43 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' CYS . . . . . 0.446 ' SG ' ' CG ' ' A' ' 91' ' ' MET . 16.0 t -165.42 164.66 19.57 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.268 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -149.83 144.92 26.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.021 -1.049 . . . . 0.0 109.346 -179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 74.5 t -115.4 126.68 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.506 ' O ' ' CB ' ' A' ' 129' ' ' ASP . 24.8 ttt -76.54 -21.83 55.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.601 -0.687 . . . . 0.0 109.793 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.3 m-20 162.16 176.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.722 0.773 . . . . 0.0 110.947 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.63 -140.57 21.95 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.591 ' CE1' ' HH ' ' A' ' 146' ' ' TYR . 60.2 m-70 -148.45 130.11 15.02 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.588 -0.948 . . . . 0.0 109.136 179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -123.38 132.34 53.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.392 -0.818 . . . . 0.0 111.648 -178.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.9 mt -103.69 130.16 51.13 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 144' ' ' GLN . 41.6 t -109.94 142.16 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.957 -1.089 . . . . 0.0 109.574 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 140' ' ' TYR . 58.6 m-85 -117.84 124.36 48.15 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.609 -0.682 . . . . 0.0 111.936 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 164' ' ' ARG . 79.4 tt0 -59.26 -27.06 65.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 167' ' ' SER . 8.0 mp0 -122.64 153.99 63.16 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.228 -0.92 . . . . 0.0 108.621 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.417 ' HA ' ' CB ' ' A' ' 167' ' ' SER . 22.6 Cg_endo -61.29 -175.23 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.106 0 C-N-CA 123.417 2.744 . . . . 0.0 113.602 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 49.29 33.96 5.79 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.591 0.71 . . . . 0.0 110.055 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.435 ' C ' ' CD2' ' A' ' 135' ' ' TYR . 31.4 m-85 54.22 52.18 13.1 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.484 0.659 . . . . 0.0 109.939 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 142' ' ' GLY . 85.4 m -137.02 162.18 34.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.866 . . . . 0.0 109.576 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 141' ' ' THR . . . 99.12 177.38 31.81 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -53.95 109.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.666 -0.903 . . . . 0.0 108.604 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 134' ' ' VAL . 22.9 mt-30 -84.49 145.81 27.92 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 109.409 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -129.39 127.79 41.72 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.538 -0.726 . . . . 0.0 109.195 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.591 ' HH ' ' CE1' ' A' ' 131' ' ' HIS . 1.8 t80 -89.81 106.03 18.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 109.478 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 147' ' ' LEU . 6.8 mp -102.24 123.83 46.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.445 -0.784 . . . . 0.0 109.134 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.569 ' N ' ' OH ' ' A' ' 152' ' ' TYR . 0.1 OUTLIER -111.48 169.13 6.64 Favored Pre-proline 0 N--CA 1.493 1.718 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.558 ' O ' ' O ' ' A' ' 148' ' ' ARG . 15.0 Cg_exo -32.76 162.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.846 2.364 . . . . 0.0 112.182 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.39 -169.69 13.36 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -119.28 133.38 55.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.554 -0.968 . . . . 0.0 110.52 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.569 ' OH ' ' N ' ' A' ' 148' ' ' ARG . 98.3 m-85 -106.87 142.75 36.0 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' SER . 44.1 ptt85 -131.89 -6.61 3.55 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.848 -1.157 . . . . 0.0 113.222 -177.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 153' ' ' ARG . 3.8 m -172.22 170.13 5.23 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 119.537 -1.977 . . . . 0.0 111.018 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.61 ' O ' ' N ' ' A' ' 160' ' ' GLY . 0.0 OUTLIER -56.65 -24.12 46.2 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -78.99 -1.75 36.91 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.224 -0.922 . . . . 0.0 109.301 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 159' ' ' GLY . 3.5 t0 -89.1 -61.84 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -0.886 . . . . 0.0 109.01 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.593 ' CE2' ' HA ' ' A' ' 155' ' ' TYR . 7.0 p90 -74.35 16.17 0.28 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 157' ' ' ASP . . . 64.76 34.23 89.36 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.986 -1.645 . . . . 0.0 108.986 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 155' ' ' TYR . . . -97.01 -165.95 32.81 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 161' ' ' VAL . 47.9 t -146.16 -8.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.811 -0.817 . . . . 0.0 109.098 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -139.69 -156.36 0.67 Allowed 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 121' ' ' ASP . 4.5 p -139.79 5.32 2.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.353 -0.842 . . . . 0.0 109.797 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.467 ' O ' ' O ' ' A' ' 136' ' ' GLU . 48.0 mtp180 -62.34 74.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.072 -1.017 . . . . 0.0 112.126 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 163' ' ' SER . 65.0 mtt -105.11 116.5 32.06 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.051 -1.031 . . . . 0.0 110.051 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -115.12 -22.96 4.72 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 120.348 -0.929 . . . . 0.0 111.225 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 137' ' ' GLN . 0.3 OUTLIER -130.36 150.9 51.38 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 119.572 1.686 . . . . 0.0 111.407 -178.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 16.9 mt -149.81 141.36 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.265 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 51.8 ttt180 -128.68 144.07 51.08 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.178 -0.951 . . . . 0.0 110.368 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.582 ' O ' ' N ' ' A' ' 172' ' ' THR . 16.2 ptt180 -102.46 91.12 4.11 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.449 HD12 ' HB3' ' A' ' 131' ' ' HIS . 0.8 OUTLIER -40.39 86.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.495 -0.753 . . . . 0.0 111.027 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 170' ' ' ARG . 3.6 t -127.06 76.68 1.67 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.977 -1.077 . . . . 0.0 108.895 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 173' ' ' ASP . 0.8 OUTLIER 169.46 111.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.34 -0.85 . . . . 0.0 109.09 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 27.2 tp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.401 -179.996 . . . . . . . . 0 0 . 1 stop_ save_